"SID","PMID","DOI","EID","Date","Title"
"0033608388","10071037","","2-s2.0-0033608388","1999-02-27","Ex vivo depletion of T cells from bone marrow grafts with CAMPATH-1 in acute leukemia: Graft-versus-host disease and graft-versus-leukemia effect"
"0030877079","9250818","","2-s2.0-0030877079","1997-09-09","Autologous transplantation with CD52 monoclonal antibody-purged marrow for acute lymphoblastic leukemia: Long-term follow-up"
"0030906149","9148769","","2-s2.0-0030906149","1997-03-15","Antibody selection against CD52 produces a paroxysmal nocturnal haemoglobinuria phenotype in human lymphocytes by a novel mechanism"
"0030177999","9345418","","2-s2.0-0030177999","1996-12-01","CAMPATH-IH in multiple sclerosis"
"0028787543","8534657","10.1136/bjo.79.11.1054","2-s2.0-0028787543","1995-01-01","Monoclonal antibody therapy of chronic intraocular inflammation using Campath-IH"
"0028137788","8019459","","2-s2.0-0028137788","1994-02-23","Total lymphoid irradiation, anti-lymphocyte globulin and Campath 1-G for immunosuppression prior to bone marrow transplantation for aplastic anomia after repeated graft rejection"
"0026348881","1799264","","2-s2.0-0026348881","1991-12-01","Monoclonal antibodies in immunosuppression"
"0023760716","3061978","10.3109/03630268808991651","2-s2.0-0023760716","1988-01-01","Bone mrrow transplantation in βtwiassemia major the israeli experience"
"0008389289","3106970","10.1073/pnas.84.10.3439","2-s2.0-0008389289","1987-08-07","Chimeric mouse-human IgG1 antibody that can mediate lysis of cancer cells"
"0023094919","3548798","10.1111/j.1365-2141.1987.00137.x-i1","2-s2.0-0023094919","1987-01-01","Cytogenetic follow‐up studies of recipients of T‐cell depleted allogeneic bone marrow"
"0035691895","11911422","10.1080/10428190127515","2-s2.0-0035691895","2001-12-01","Immunophenotype changes and loss of CD52 expression in two patients with relapsed T-cell prolymphocytic leukaemia"
"0034825963","11461662","10.1089/027245701750293466","2-s2.0-0034825963","2001-10-01","The development of monoclonal antibody therapy in leukemias"
"0034655759","10798751","","2-s2.0-0034655759","2000-04-15","Immune reconstitution after allogeneic bone marrow transplantation depleted of T cells"
"0029042586","7622867","","2-s2.0-0029042586","1995-07-17","An improved assay for antibody dependent cellular cytotoxicity based on time resolved fluorometry"
"0028910758","7762819","10.1021/ac00101a008","2-s2.0-0028910758","1995-03-22","Mass spectrometry of the humanized monoclonal antibody CAMPATH 1H"
"0027215061","8324942","","2-s2.0-0027215061","1993-04-27","CAMPATH-1H in inflammatory arthritis"
"0024314759","2661437","10.1007/BF01644010","2-s2.0-0024314759","1989-05-01","Infectious complications after allogeneic bone marrow transplantation with and without T-cell depletion of donor marrow"
"0023621441","3500259","","2-s2.0-0023621441","1987-12-01","Comparison of the effector functions of human immunoglobulins using a matched set of chimeric antibodies"
"0022357518","3980990","","2-s2.0-0022357518","1985-12-01","Therapeutic potential of rat monoclonal antibodies: Isotype specificity of antibody-dependent cell-mediated cytotoxicity with human lymphocytes"
"0020837148","6390085","","2-s2.0-0020837148","1983-10-01","Removal of T cells from bone marrow for transplantation. Comparison of rat monoclonal anti-lymphocyte antibodies of different isotypes."
"0034754677","12171723","10.1080/146532401753173990","2-s2.0-0034754677","2001-11-20","Infectious complications following T-cell depleted hematopoietic stem-cell transplantation"
"0035075989","11342359","","2-s2.0-0035075989","2001-04-24","A phase II multicenter study of CAMPATH-1H antibody in previously treated patients with nonbulky non-Hodgkin's lymphoma"
"0035226390","11722986","","2-s2.0-0035226390","2001-01-01","Immunotherapy of Non-Hodgkin's lymphomas."
"0030897222","9193354","","2-s2.0-0030897222","1997-04-01","Phase II multicenter study of human CD52 antibody in previously treated chronic lymphocytic leukemia"
"0029893681","8690449","","2-s2.0-0029893681","1996-07-04","Recognition of CD52 allelic gene products by CAMPATH-1H antibodies"
"0028126777","7584499","","2-s2.0-0028126777","1994-11-14","Engineering multiple-domain forms of the therapeutic antibody CAMPATH-IH: Effects on complement lysis"
"0023901347","3257510","10.1016/0022-1759(88)90280-3","2-s2.0-0023901347","1988-01-21","An ELISA method for detecting antibodies to the T cell antigen receptor"
"0023027621","3528046","","2-s2.0-0023027621","1986-12-01","New approaches for the prevention of rejection and graft-vs.-host disease in clinical bone marrow transplantation"
"0019989719","6286831","","2-s2.0-0019989719","1982-01-01","Transformation of mammalian cells to antibiotic resistance with a bacterial gene under control of the SV40 early region promoter"
"0017681196","271968","","2-s2.0-0017681196","1977-12-01","DNA sequencing with chain-terminating inhibitors."
"0032867415","10477459","","2-s2.0-0032867415","1999-09-01","Mobilization and selection of peripheral blood hematopoietic progenitors in children with systemic sclerosis"
"0033559501","10092828","","2-s2.0-0033559501","1999-03-15","Elimination of the immunogenicity of therapeutic antibodies"
"0025794279","1903536","","2-s2.0-0025794279","1991-05-15","Reshaping a therapeutic CD4 antibody"
"0025819151","2070132","","2-s2.0-0025819151","1991-01-01","The effect of in vitro T lymphocyte depletion on generation of IL2-activated cytotoxic cells"
"0025982092","1675214","10.1002/jca.2920060111","2-s2.0-0025982092","1991-01-01","Collection and cryopreservation of human stem and progenitor cells for bone marrow transplantation"
"0025319831","2138367","","2-s2.0-0025319831","1990-01-01","Evidence that reduction of immunogenicity of T-depleted bone marrow depends on additional depletion of accessory cells implications for prevention of graft rejection"
"0023795555","3263310","","2-s2.0-0023795555","1988-01-01","Influence of Campath-1 on T- and NK cells"
"0022495404","3529531","","2-s2.0-0022495404","1986-01-01","Pilot study of campath–1, a rat monolonal antibody that fixes human complement, as an immunosuppressant in organ transplantation"
"0022344325","3909385","","2-s2.0-0022344325","1985-12-01","Quantitation of human bone marrow T cells after in vitro depletion by the monoclonal antibody Campath-1"
"0034759325","12171730","10.1080/146532401753174061","2-s2.0-0034759325","2001-11-20","Manufacture and quality control of CAMPATH-1 antibodies for clinical trials"
"0032918226","10335520","","2-s2.0-0032918226","1999-04-01","Recent developments in drug therapy for multiple sclerosis"
"0030707662","9337053","","2-s2.0-0030707662","1997-10-01","Enhancement of megakaryocytopoiesis by Campath-1G-treated natural killer cells"
"0030855804","9228156","","2-s2.0-0030855804","1997-09-03","Persistence of CD4+ T cells in the arthritic joint after CAMPATH-1H treatment [3]"
"0030965992","9188478","10.1074/jbc.272.25.15804","2-s2.0-0030965992","1997-06-20","Toward antibody-directed enzyme prodrug therapy with the T268G mutant of human carboxypeptidase A1 and novel in vivo stable prodrugs of methotrexate"
"0030453977","8981930","","2-s2.0-0030453977","1996-12-15","Mechanism of first-dose cytokine-release syndrome by CAMPATH 1-H: Involvement of CD16 (FcγRIII) and CD11a/CD18 (LFA-1) on NK cells"
"0027194472","7688956","","2-s2.0-0027194472","1993-09-01","Structure of the CAMPATH-1 antigen, a glycosylphosphatidylinositol-anchored glycoprotein which is an exceptionally good target for complement lysis"
"0023197452","2953090","","2-s2.0-0023197452","1987-01-01","Evidence for the involvement of host-derived OKT8-positive T cells in the rejection of t-depleted, HLA-identical bone marrow grafts"
"0023029942","3543275","","2-s2.0-0023029942","1986-12-01","The cellular composition of human lymph nodes after allogeneic bone marrow transplantation: An immunohistological study"
"0022300310","3916080","","2-s2.0-0022300310","1985-12-01","Surface immunoglobulin of B-lymphocytic tumours as a therapeutic target."
"0035412369","11418459","10.1182/blood.V98.1.29","2-s2.0-0035412369","2001-07-01","Quantitation of minimal disease levels in chronic lymphocytic leukemia using a sensitive flow cytometric assay improves the prediction of outcome and can be used to optimize therapy"
"0033522647","10366506","10.1006/jmbi.1999.2750","2-s2.0-0033522647","1999-06-04","1.9 Å structure of the therapeutic antibody CAMPATH-1H Fab in complex with a synthetic peptide antigen"
"0031757274","9779699","","2-s2.0-0031757274","1998-10-01","CAMPATH-1H monoclonal antibody in therapy for previously treated low- grade non-Hodgkin's lymphomas: A phase II multicenter study"
"0031945659","9578307","","2-s2.0-0031945659","1998-04-01","The effect of T cell depletion with Campath-1M on immune reconstitution after chemotherapy and allogeneic bone marrow transplant as treatment for leukaemia"
"0029898331","8738190","10.1016/0731-7085(95)01646-5","2-s2.0-0029898331","1996-03-01","High-performance liquid chromatographic mapping of the oligosaccharides released from the humanised immunoglobulin, CAMPATH ™ 1 H"
"0028972037","7579421","","2-s2.0-0028972037","1995-10-15","Analysis of β-globin mutations shows stable mixed chimerism in patients with thalassemia after bone marrow transplantation"
"0027749164","8124250","","2-s2.0-0027749164","1993-12-01","In vitro and in vivo depletion of T cells"
"0024491459","2472335","","2-s2.0-0024491459","1989-01-01","Cercopithecus aethiops monkey as a reliable model for in vitro study of T cell depletion of bone marrow with Campath-1 plus complement."
"0022876723","3540463","10.1016/0145-2126(86)90015-9","2-s2.0-0022876723","1986-01-01","Standard conditioning regimen and t-depleted donor bone marrow for transplantation in chronic myeloid leukemia"
"0019119230","7441755","","2-s2.0-0019119230","1980-12-01","Crystallographic refinement and atomic models of the intact immunoglobulin molecule Kol and its antigen-binding fragment at 3.0 θ and 1.9 θ resolution"
"0033793501","11147488","","2-s2.0-0033793501","2000-10-30","Monoclonal antibody-based therapy of lymphoid neoplasms: What's on the horizon?"
"0034153968","10773997","","2-s2.0-0034153968","2000-01-01","Prope tolerance with induction using Campath 1H and low-dose cyclosporin monotherapy in 31 cadaveric renal allograft recipients."
"0033209751","10528911","","2-s2.0-0033209751","1999-10-29","New biologic therapies"
"0027240401","7687895","","2-s2.0-0027240401","1993-08-06","Effect of CAMPATH-1H antibody on human hematopoietic progenitors in vitro"
"0024576799","2784335","","2-s2.0-0024576799","1989-01-01","Optimal conditions for in vitro T cell depletion of human bone marrow by Campath-1a plus complement as demonstrated by limiting dilution analysis"
"0023691376","2973413","10.1002/eji.1830181006","2-s2.0-0023691376","1988-01-01","IMPORTANCE OF ANTIGEN SPECIFICITY FOR COMPLEMENT‐MEDIATED LYSIS BY MONOCLONAL ANTIBODIES"
"0022614916","3513818","10.1111/j.1365-2141.1986.tb02953.x","2-s2.0-0022614916","1986-01-01","Successful haploidentical mismatched bone marrow transplantation in severe combined immunodeficiency: T cell removal using CAMPATH‐I monoclonal antibody and E‐rosetting"
"0021826932","2580239","10.1038/314268a0","2-s2.0-0021826932","1985-12-01","A hapten-specific chimaeric IgE antibody with human physiological effector function"
"0020051098","6276389","","2-s2.0-0020051098","1982-01-01","Evolution of human immunoglobulin κ J region genes"
"0034754598","12171720","10.1080/146532401753174089","2-s2.0-0034754598","2001-11-20","Friends, faithfulness and fortunes"
"0032413976","9747629","","2-s2.0-0032413976","1998-12-01","Advances in immunotherapy of hematologic malignancies"
"0031020558","9054677","10.1046/j.1365-2141.1997.d01-2050.x","2-s2.0-0031020558","1997-03-04","Successful engraftment of haploidentical stem cell transplant for familial haemophagocytic lymphohistiocytosis using both bone marrow and peripheral blood stem cells"
"9544240330","8784367","","2-s2.0-9544240330","1996-09-01","Bone marrow transplantation from genetically HLA-nonidentical donors in children with fatal inherited disorders excluding severe combined immunodeficiencies: Use of two monoclonal antibodies to prevent graft rejection"
"0029788549","8864469","","2-s2.0-0029788549","1996-08-01","In vivo CAMPATH-1 followed by T cell depleted bone marrow transplantation: A potential new mode of therapy for hepatitis associated severe aplastic anemia (SAA)"
"0029670929","8671618","10.1093/intimm/8.3.325","2-s2.0-0029670929","1996-03-12","Emergence of CD52-, glycosylphosphatidylinositol-anchor-deficient lymphocytes in rheumatoid arthritis patients following Campath-1H treatment"
"0030029341","8546734","10.1002/art.1780390132","2-s2.0-0030029341","1996-01-31","Synovial tissue responses following treatment of rheumatoid arthritis with the humanized monoclonal antibody CAMPATH-1H"
"0029157186","7662637","10.1136/bjo.79.7.687","2-s2.0-0029157186","1995-01-01","Ischaemic retinopathy occurring in patients receiving bone marrow allografts and campath- 1 G: A clinicopathological study"
"0027991085","7922004","","2-s2.0-0027991085","1994-09-30","CAMPATH-1 monoclonal antibodies in bone marrow transplantation"
"0025166875","2346286","","2-s2.0-0025166875","1990-01-01","Tumour necrosis factor in organ transplantation"
"37649012732","17984184","10.1200/JCO.2007.13.7810","2-s2.0-37649012732","2007-12-10","Have we forgotten the purpose of phase III studies?"
"0035138229","11527007","","2-s2.0-0035138229","2001-02-06","Alemtuzumab Millennium/ILEX"
"0033256366","10848438","","2-s2.0-0033256366","1999-12-01","Recent developments in humanized MAbs for immunotherapy: a personal tribute to Dr. Martin Lockwood."
"0032169555","9737590","","2-s2.0-0032169555","1998-09-01","Mechanisms of protection induced by attenuated Simian immunodeficiency virus II. Lymphocyte depletion does not abrogate protection"
"9844258325","9367397","","2-s2.0-9844258325","1997-11-12","Humanized anti-CD4 monoclonal antibody therapy of autoimmune and inflammatory disease"
"0028887830","7531440","10.1002/art.1780380215","2-s2.0-0028887830","1995-01-01","Synovial tissue response to treatment with campath‐1h"
"0027861106","8405223","","2-s2.0-0027861106","1993-12-01","Effect of bone marrow T lymphocytes treated with CAMPATH 1G on megakaryocyte colony formation"
"0026590722","1600413","","2-s2.0-0026590722","1992-05-25","In vivo use of Campath-1G to prevent graft-versus-host disease and graft rejection after bone marrow transplantation"
"0023872635","3043753","","2-s2.0-0023872635","1988-01-01","Pulmonary function after bone marrow transplantation for chronic myeloid leukaemia"
"0022744885","3096824","","2-s2.0-0022744885","1986-07-01","T-cell depletion with the monoclonal antibody Campath 1 to prevent graft-versus-host disease in ten high-risk adult patients."
"17944366282","12171727","10.1080/146532401753174034","2-s2.0-17944366282","2001-01-01","Allogeneic stem-cell transplantation for lymphoproliferative disorders using BEAM-CAMPATH (± fludarabine) conditioning combined with post-transplant donor-lymphocyte infusion"
"0034032889","10889906","10.1136/mp.53.2.77","2-s2.0-0034032889","2000-04-13","Characterisation of a mouse monoclonal anti-idiotype reactive with a V region sequence commonly used by human immunoglobulins"
"0032159604","9809379","","2-s2.0-0032159604","1998-09-01","Non-specific immunosuppression in multiple sclerosis"
"0031297197","9464849","","2-s2.0-0031297197","1997-12-01","Human epididymal secreted protein CD52 on ejaculated spermatozoa: Correlations with semen characteristics and the effect of its antibody"
"0029589904","8618827","10.1073/pnas.92.26.11980","2-s2.0-0029589904","1995-12-19","Improved biodistribution, tumor targeting, and reduced immunogenicity in mice with a γ4 variant of Campath-1H"
"0028791694","7491698","","2-s2.0-0028791694","1995-11-15","Elevated inflammatory cytokine levels in bone marrow graft rejection"
"0026684012","1504665","","2-s2.0-0026684012","1992-07-27","Clinical application of intrauterine bone marrow transplantation for treatment of genetic diseases - Feasibility studies"
"0025068211","2308978","","2-s2.0-0025068211","1990-01-01","Purging in auto- and allografts: monoclonal antibodies which use human complement and other natural effector mechanisms."
"0022411083","3909387","","2-s2.0-0022411083","1985-12-01","Transplantation of allogeneic bone marrow treated in vitro with monoclonal antibody Campath-1"
"0021781392","3901693","","2-s2.0-0021781392","1985-01-01","Elimination of graft versus host disease in matched allogeneic leukemic transplant recipients using CAMPATH-1."
"17944375123","12171726","10.1080/146532401753174025","2-s2.0-17944375123","2001-11-20","In vivo CAMPATH-1H prevents GvHD following nonmyeloablative stem-cell transplantation"
"0034501632","11085457","10.1097/00001622-200011000-00010","2-s2.0-0034501632","2000-12-01","Campath-1H monoclonal antibody therapy"
"0031790767","9824507","10.1046/j.1365-2567.1998.00615.x","2-s2.0-0031790767","1998-11-17","Cross-linking of the CAMPATH-1 antigen (CD52) mediates growth inhibition in human B- and T-lymphoma cell lines, and subsequent emergence of CD52- deficient cells"
"0030667450","9337063","","2-s2.0-0030667450","1997-10-01","A laboratory comparison of T cell depletion by CD34+ cell immunoaffinity selection and in vitro Campath-1M treatment: Clinical implications for bone marrow transplantation and donor leukocyte therapy"
"0030994222","9163593","","2-s2.0-0030994222","1997-06-09","Sustained remission of severe resistant autoimmune neutropenia with Campath-1H"
"0028807213","8543073","10.1038/eye.1995.140","2-s2.0-0028807213","1995-01-01","Prevention of immune-mediated corneal graft destruction with the anti-lymphocyte monoclonal antibody, CAMPATH-1H"
"0027419001","8448560","","2-s2.0-0027419001","1993-03-30","Bone marrow transplantation from unrelated donors: The Italian experience"
"0024362237","2660360","","2-s2.0-0024362237","1989-01-01","T cell depletion of human bone marrow"
"0022339938","4093982","10.1016/0022-2836(85)90137-8","2-s2.0-0022339938","1985-12-05","Domain association in immunoglobulin molecules. The packing of variable domains"
"0017855552","618887","","2-s2.0-0017855552","1978-01-01","Preliminary refinement and structural analysis of the Fab fragment from human immunoglobulin New at 2.0 Å resolution"
"0035344594","11377483","","2-s2.0-0035344594","2001-12-01","Monoclonal anti-CD52 antibodies: A potential mode of therapy for parvovirus B19 hepatitis"
"0034864666","11585011","10.1517/14656566.2.6.953","2-s2.0-0034864666","2001-08-27","Antibody therapy of lymphoma"
"0035819523","11158184","","2-s2.0-0035819523","2001-02-07","FDA panel recommends two new cancer drugs for approval"
"0035555519","12171714","10.1080/146532401317070899","2-s2.0-0035555519","2001-01-01","Pharmacokinetics of CAMPATH-1H in BMT patients"
"0005741287","12171729","10.1080/146532401753174052","2-s2.0-0005741287","2001-01-01","CAMPATH-1M T-cell depleted BMT for SCID: Long-term follow-up of 19 children treated 1987-98 in a single center"
"0029934535","8782148","","2-s2.0-0029934535","1996-06-01","Monoclonal antibody therapy of diffuse cutaneous scleroderma with CAMPATH-1H"
"0029875268","8620297","","2-s2.0-0029875268","1996-03-01","Campath-1H in rheumatoid arthritis - An intravenous dose-ranging study"
"0027516475","8096935","","2-s2.0-0027516475","1993-01-01","Adverse reactions to Campath-1H monoclonal antibody [36]"
"0034941907","11583062","10.1517/14656566.2.7.1109","2-s2.0-0034941907","2001-07-24","New developments in the prophylaxis and treatment of graft versus host disease"
"0034307366","11001893","","2-s2.0-0034307366","2000-10-01","In vivo CAMPATH-1H prevents graft-versus-host disease following nonmyeloablative stem cell transplantation"
"0033571271","10573085","","2-s2.0-0033571271","1999-11-15","Anti-globulin responses to rat and humanized CAMPATH-1 monoclonal antibody used to treat transplant rejection"
"0032882173","10482259","10.1002/1531-8249(199909)46:3&lt;296::AID-ANA4&gt;3.0.CO;2-#","2-s2.0-0032882173","1999-09-13","Monoclonal antibody treatment exposes three mechanisms underlying the clinical course of multiple sclerosis"
"17644442155","9707017","","2-s2.0-17644442155","1998-08-25","Double T cell depletion of bone marrow using sequential positive and negative cell immunoaffinity or CD34+ cell selection followed by Campath-1M; effect on CD34+ cells and progenitor cell recoveries"
"1842369667","9291477","10.1002/(SICI)1098-2795(199710)48:2&lt;267::AID-MRD15&gt;3.0.CO;2-V","2-s2.0-1842369667","1997-10-01","Interaction of the human epididymal protein CD52 (HE5) with epididymal spermatozoa from men and cynomolgus monkeys"
"0029823434","9137963","","2-s2.0-0029823434","1996-12-01","Clinical experience with 2'-deoxycoformycin"
"0027170545","8241978","","2-s2.0-0027170545","1993-09-22","Graft rejection by a population of primed CDw52- host T cells after in vivo/ex vivo T-depleted bone marrow transplantation"
"0023095069","3545877","","2-s2.0-0023095069","1987-05-12","Quantity and nature of residual bone marrow T cells after treatment of the marrow with Campath-1"
"0034958954","11449628","10.1007/s001080170124","2-s2.0-0034958954","2001-07-09","Clinical application of monoclonal antibodies in malignant lymphoma"
"0035397382","11449871","","2-s2.0-0035397382","2001-07-01","Monoclonal antibody licensed for third-line treatment of B-cell chronic lymphocytic leukemia"
"0033780906","11035276","10.1016/S0955-3886(00)00079-5","2-s2.0-0033780906","2000-10-01","T cell depletion of allogeneic stem cell grafts with anti-CD 52 monoclonal antibodies: The Ulm experience from 1983-1999"
"0029563888","8720080","10.1093/glycob/5.8.813","2-s2.0-0029563888","1995-01-01","Glycosylation and biological activity of CAMPATH-1H expressed in different cell lines and grown under different culture conditions"
"0027138872","8260716","","2-s2.0-0027138872","1993-12-31","A deficiency in CDw52 (Campath-1 antigen) of paroxysmal nocturnal hemoglobinuria lymphocytes [4]"
"0027283918","8366859","10.1016/0161-5890(93)90155-5","2-s2.0-0027283918","1993-01-01","Efficient complement-mediated lysis of cells containing the CAMPATH-1 (CDw52) antigen"
"0026783632","1356177","10.1016/0140-6736(92)92294-P","2-s2.0-0026783632","1992-09-26","Humanised monoclonal antibody therapy for rheumatoid arthritis"
"0025348259","2165283","10.1111/j.1399-0039.1990.tb01767.x","2-s2.0-0025348259","1990-01-01","The CAMPATH‐1 antigen (CDw52)"
"0020656308","6344750","","2-s2.0-0020656308","1983-01-01","Biological and clinical implications of lymphocyte hybridomas: tumor therapy with monoclonal antibodies."
"0034156645","11122838","","2-s2.0-0034156645","2000-03-01","Biotherapy for lymphoma."
"0032214614","9838682","","2-s2.0-0032214614","1998-12-01","""Almost tolerance"" in the clinic"
"0031926821","9668276","10.1111/j.1749-6632.1998.tb10964.x","2-s2.0-0031926821","1998-08-17","Homology of an antiacetylcholine receptor monoclonal antibody with a monoclonal antibody to Campath-1 antigen suggests usage of the same V(H) genes"
"0031900323","9630324","","2-s2.0-0031900323","1998-04-01","Haploidentical related transplants and unrelated donor transplants with T cell addback"
"0030804775","9235735","","2-s2.0-0030804775","1997-08-26","Campath-1H - A monoclonal antibody for patients with non-Hodgkin's lymphoma and chronic lymphatic leukemia"
"9444257631","8790160","","2-s2.0-9444257631","1996-09-10","Unrelated donor bone marrow trans-plantation for children with relapsed acute lymphoblastic leukaemia in second complete remission"
"0029680801","8756101","10.1002/(SICI)1096-8652(199607)52:3&lt;236::AID-AJH23&gt;3.0.CO;2-C","2-s2.0-0029680801","1996-08-16","In vivo CAMPATH-1 monoclonal antibodies: A novel mode of therapy for acute graft-versus-host disease [4]"
"0028862268","7488279","10.1002/art.1780381110","2-s2.0-0028862268","1995-01-01","Campath‐1h, a humanized monoclonal antibody, in refractory rheumatoid arthritis"
"0026518375","1339322","10.1111/j.1365-2249.1992.tb06421.x","2-s2.0-0026518375","1992-01-01","Humanized monoclonal antibody CAMPATH‐1H: myeloma cell expression of genomic constructs, nucleotide sequence of cDNA constructs and comparison of effector mechanisms of myeloma and Chinese hamster ovary cell‐derived material"
"0034235910","10891435","","2-s2.0-0034235910","2000-07-01","Estimating leukemia-free survival after allografting for chronic myeloid leukemia: A new method that takes into account patients who relapse and are restored to complete remission"
"0034061309","10611109","10.1136/bjo.84.1.107","2-s2.0-0034061309","2000-01-01","Campath-1H therapy in refractory ocular inflammatory disease"
"0030960290","9195505","","2-s2.0-0030960290","1997-06-01","Subcutaneous administration of CAMPATH®-1H: Clinical and biological outcomes"
"0031027623","9054672","10.1046/j.1365-2141.1997.d01-2061.x","2-s2.0-0031027623","1997-03-04","Subcutaneous CAMPATH-1H in fludarabine-resistant/relapsed chronic lymphocytic and B-prolymphocytic leukaemia"
"9044245304","8562410","","2-s2.0-9044245304","1996-01-12","Role of allogeneic bone marrow transplantation from an HLA-identical sibling or a matched unrelated donor in the treatment of children with juvenile chronic myeloid leukaemia"
"0028877185","8991975","","2-s2.0-0028877185","1995-10-16","Induction of TNF-α and proinflammatory secretory phospholipase A2 by intravenous administration of CAMPATH-1H in patients with rheumatoid arthritis"
"0029056848","7655382","","2-s2.0-0029056848","1995-06-27","In vivo/ex vivo T cell depletion reduces the morbidity of allogeneic bone marrow transplantation in patients with acute leukaemias in first remission without increasing the risk of treatment failure: Comparison with cyclosporin/methotrexate"
"0026773515","1390211","10.1111/j.1365-2141.1992.tb08244.x","2-s2.0-0026773515","1992-01-01","HLA‐identical sibling donor bone marrow transplantation for chronic myeloid leukaemia in first chronic phase: influence of GVHD prophylaxis on outcome"
"0023615397","3655386","10.1016/0022-1759(87)90242-0","2-s2.0-0023615397","1987-10-23","Isolation of low-frequency class-switch variants from rat hybrid myelomás"
"0023023078","3492041","","2-s2.0-0023023078","1986-12-01","Effects on marrow cellularity and graft versus host disease of transplant T cell depletion"
"0034909888","11477365","","2-s2.0-0034909888","2001-08-20","Will mixed chimerism cure autoimmune diseases after a nonmyeloablative stem cell transplant?"
"0034027095","10792280","10.1046/j.1365-2141.2000.01879.x","2-s2.0-0034027095","2000-05-30","Preliminary experience of allogeneic stem cell transplantation for lymphoproliferative disorders using BEAM-CAMPATH conditioning: An effective regimen with low procedure-related toxicity"
"0034022540","10752996","","2-s2.0-0034022540","2000-04-03","Seropositive polyarthritis and skin manifestations in T-prolymphocytic leukemia/Sezary cell leukemia variant"
"0033214208","10498594","","2-s2.0-0033214208","1999-10-01","Children with acute lymphoblastic leukemia who receive T-cell-depleted HLA mismatched marrow allografts from unrelated donors have an increased incidence of primary graft failure but a similar overall transplant outcome"
"0024498443","2562939","10.1016/0090-1229(89)90119-0","2-s2.0-0024498443","1989-01-01","Recent advances in bone marrow transplantation"
"0023838101","3122385","","2-s2.0-0023838101","1988-01-01","Delayed allograft rejection in primates treated with anti-IL-2 receptor monoclonal antibody campath-6"
"0023465401","3501389","","2-s2.0-0023465401","1987-12-01","Comparison of efficiency of complements from various species for T-cell depletion from Cercopithecus aethiops bone marrow with Campath-1 MoAb in vitro."
"0023184888","3584980","","2-s2.0-0023184888","1987-08-19","Characterization of a mouse/human chimeric monoclonal antibody (17-1A) to a colon cancer tumor-associated antigen"
"0023023075","2878268","10.1016/S0140-6736(86)92052-0","2-s2.0-0023023075","1986-12-13","LEUKAEMIC RELAPSE AFTER CAMPATH 1 TREATED BONE MARROW TRANSPLANTATION FOR LEUKAEMIA"
"0021227678","6147548","10.1016/S0140-6736(84)92564-9","2-s2.0-0021227678","1984-09-01","ELIMINATION OF GRAFT-VERSUS-HOST DISEASE BY IN-VITRO DEPLETION OF ALLOREACTIVE LYMPHOCYTES WITH A MONOCLONAL RAT ANTI-HUMAN LYMPHOCYTE ANTIBODY (CAMPATH-1)"
"0029135091","7557898","10.1002/hon.2900130406","2-s2.0-0029135091","1995-01-01","Transplantation of t‐lymphocyte depleted marrow with an addback of T cells"
"0023836757","3278419","","2-s2.0-0023836757","1988-01-01","The repopulation capacity of bone marrow grafts following pretreatment with monoclonal antibodies against t lymphocytes in rhesus monkeys"
"0035919585","11510560","10.1016/S0021-9673(01)00956-6","2-s2.0-0035919585","2001-07-20","Separation of proteins using hydrophobic interaction membrane chromatography"
"0032053671","9777606","10.1016/S0731-7085(97)00168-4","2-s2.0-0032053671","1998-04-01","A kinetic enzyme immunoassay for the quantitation of antibodies to a humanized monoclonal antibody in human serum"
"0028346432","7914262","10.1016/S0140-6736(94)91339-0","2-s2.0-0028346432","1994-07-30","Preliminary evidence from magnetic resonance imaging for reduction in disease activity after lymphocyte depletion in multiple sclerosis"
"0028122240","7858503","10.3109/10428199409051678","2-s2.0-0028122240","1994-01-01","Autoimmune thrombocytopenic purpura complicating lymphoproliferative disorders"
"0027538001","8448531","","2-s2.0-0027538001","1993-03-30","Matched unrelated donor bone marrow transplantation for chronic myeloid leukaemia in chronic phase: Comparison of ex vivo and in vivo T-cell depletion"
"0026353531","1787497","","2-s2.0-0026353531","1991-12-01","Humanized monoclonal antibody treatment in rheumatoid arthritis"
"0023197907","3614380","","2-s2.0-0023197907","1988-12-01","Generation of an antibody with enhanced affinity and specificity for its antigen by protein engineering"
"0023613298","3331647","","2-s2.0-0023613298","1987-12-01","An immunotoxin made up with campath 1 and saporin 6: Preliminary 'in vitro' experience"
"0022533201","3016742","10.1073/pnas.83.16.6075","2-s2.0-0022533201","1986-12-19","Immunoglobulin heavy chain locus the rat: Striking homology to mouse antibody genes"
"0020835433","6438435","","2-s2.0-0020835433","1983-10-01","Effects of monoclonal anti-lymphocyte antibodies in vivo in monkeys and humans."
"0034765992","12171722","10.1080/146532401753173981","2-s2.0-0034765992","2001-11-20","CAMPATH-1 antibodies in stem-cell transplantation"
"0035372509","12113127","","2-s2.0-0035372509","2001-06-01","Berlex Laboratories to market new treatment for B-CLL."
"0033546980","10489036","","2-s2.0-0033546980","1999-09-11","Quantitative MRI in patients with secondary progressive MS treated with monoclonal antibody Campath 1H"
"0032905912","10211898","10.1002/1529-0131(199904)42:4&lt;807::AID-ANR26&gt;3.0.CO;2-T","2-s2.0-0032905912","1999-04-01","Marked and sustained improvement two years after autologous stem cell transplantation in a girl with systemic sclerosis"
"0030812012","9215839","","2-s2.0-0030812012","1997-07-01","Treatment of T-cell prolymphocytic leukemia with human CD52 antibody"
"0031022899","9020367","","2-s2.0-0031022899","1997-02-04","Clonal CD8+ and CD52- T cells are induced in responding B cell lymphoma patients treated with Campath-1H (anti-CD52)"
"0026741584","1352921","","2-s2.0-0026741584","1992-01-01","The distribution of the CDw52 molecule on blood cells and characterization of its involvement in T cell activation"
"0025318333","2180151","","2-s2.0-0025318333","1990-01-01","Comparative analysis of in vivo T cell depletion with radiotherapy, combination chemotherapy, and the monoclonal antibody campath-1G, using limiting dilution methodology"
"0020051235","7032624","","2-s2.0-0020051235","1982-01-01","Utilization of monoclonal antibodies in the treatment of leukemia and lymphoma"
"0344695779","7017722","","2-s2.0-0344695779","1981-01-01","Selection for animal cells that express the Escherichia coli gene coding for xanthine-guanine phosphoribosyltransferase"
"0035559387","12113137","","2-s2.0-0035559387","2001-12-01","Update on prophylaxis and therapy of infection in patients with chronic lymphocytic leukemia"
"0034930416","11879313","10.1046/j.1523-5394.2001.94010.x","2-s2.0-0034930416","2001-07-21","Alemtuzumab: A new option for refractory chronic lymphocytic leukemia?"
"0035344039","11296131","","2-s2.0-0035344039","2001-05-01","Novel treatment strategies in chronic lymphocytic leukemia."
"0033610681","10589966","","2-s2.0-0033610681","1999-11-27","Campath IH allows low-dose cyclosporine monotherapy in 31 cadaveric renal allograft recipients"
"0032925436","10050661","10.1093/molehr/5.1.46","2-s2.0-0032925436","1999-01-01","A sialoglycoprotein, gp20, of the human capacitated sperm surface is a homologue of the leukocyte CD52 antigen: Analysis of the effect of anti-CD52 monoclonal antibody (CAMPATH-1) on capacitated spermatozoa"
"0030786588","9204983","","2-s2.0-0030786588","1997-08-29","Sezary cell leukaemia: A distinct T cell disorder or a variant form of T prolymphocytic leukaemia?"
"0028937083","7773229","","2-s2.0-0028937083","1995-04-10","Availability of Campath-1 antibodies for bone marrow transplantation [3]"
"0022623585","3081877","10.1093/nar/14.4.1779","2-s2.0-0022623585","1986-02-25","Sequence of a human immunoglobulin gamma 3 heavy chain constant region gene: Comparison with the other human Cγ genes"
"0022432255","2989795","10.1093/nar/13.12.4431","2-s2.0-0022432255","1985-06-25","Improved oligonudeotide site-directed rautagenesis using M13 vectors"
"0020591822","6349718","","2-s2.0-0020591822","1983-11-26","Removal of T cells from bone marrow for transplantation: A monoclonal antilymphocyte antibody that fixes human complement"
"0033794975","11022631","","2-s2.0-0033794975","2000-10-13","The Cape Town experience with haematopoietic stem cell transplantation: The paediatric programme"
"18844467941","10845940","","2-s2.0-18844467941","2000-06-15","T-cell depletion of bone marrow transplants for leukemia from donors other than HLA-identical siblings: Advantage of T-cell antibodies with narrow specificities"
"0032490341","9734890","","2-s2.0-0032490341","1998-06-06","Prope tolerance, perioperative campath 1H, and low-dose cyclosporin monotherapy in renal allograft recipients"
"0029852737","8973608","","2-s2.0-0029852737","1996-12-04","A therapeutic human IgG4 monoclonal antibody that depletes target cells in humans"
"0029928384","8704678","","2-s2.0-0029928384","1996-03-01","Recent results using CAMPATH-1 antibodies to control GVHD and graft rejection"
"0029564864","8750280","","2-s2.0-0029564864","1995-12-01","Severe migratory polyarthritis following in vivo CAMPATH-1G"
"0029143898","7575711","10.1002/art.1780380903","2-s2.0-0029143898","1995-01-01","Treatment of active refractory rheumatoid arthritis with humanized monoclonal antibody campath‐1h administered by daily subcutaneous injection"
"0025350361","2337682","10.1007/BF01728789","2-s2.0-0025350361","1990-04-01","In vitro hemopoiesis in human micro long-term bone marrow cultures recharged with either allogeneic, T-cell-depleted allogeneic, or syngeneic bone marrow cells"
"0021776233","3901694","","2-s2.0-0021776233","1985-01-01","Rat monoclonal antibodies for bone marrow transplantation--the CAMPATH series."
"0001444987","6438633","","2-s2.0-0001444987","1984-12-01","Enhancer-dependent expression of human κ immunoglobulin genes introduced into mouse pre-B lymphocytes by electroporation"
"0034760878","12171725","10.1080/146532401753174133","2-s2.0-0034760878","2001-11-20","CAMPATH-1H in the treatment of autoimmune cytopenias"
"0034265810","11037855","","2-s2.0-0034265810","2000-09-01","Fludarabine-based protocol for haploidentical peripheral blood stem cell transplantation in Hurler syndrome"
"0033996579","10723585","","2-s2.0-0033996579","2000-03-07","The effect of the serotherapy regimen used and the marrow cell dose received on rejection, graft-versus-host disease and outcome following unrelated donor bone marrow transplantation for leukaemia"
"0031900971","9630323","","2-s2.0-0031900971","1998-04-01","Unrelated donor marrow transplantation for inborn errors"
"0027853686","8405234","","2-s2.0-0027853686","1993-12-01","Effects of CAMPATH-1 antibodies on the functional activity of monocytes and polymorphonuclear neutrophils"
"0026013747","1367214","10.1038/nbt0191-64","2-s2.0-0026013747","1991-01-22","High level expression of the humanized monoclonal antibody Campath-1H in Chinese hamster ovary cells"
"0026064076","2043872","","2-s2.0-0026064076","1991-01-01","High dose melphalan and total body irradiation with autologous marrow rescue in childhood acute lymphoblastic leukaemia after relapse"
"0022558297","3713831","10.1038/321522a0","2-s2.0-0022558297","1986-12-01","Replacing the complementarity-determining regions in a human antibody with those from a mouse"
"0022965430","3332120","","2-s2.0-0022965430","1986-12-01","Bone marrow transplantation for patients with chronic myeloid leukaemia: T-cell depletion with Campath-1 reduces the incidence of graft-versus-host disease but may increase the risk of leukaemic relapse"
"0033035045","10417047","10.1089/106161299320262","2-s2.0-0033035045","1999-07-14","Enhancement of hematopoietic reconstitution with recombinant cytokines: Effect of rhIL-6 in combination with rhGM-CSF and rhIL-3 on unmodified or T cell-depleted bone marrow"
"0032254624","9866817","","2-s2.0-0032254624","1998-12-01","Leukocyte depletion for leukaemia and multiple sclerosis."
"0031553988","9126378","10.1006/abio.1997.2036","2-s2.0-0031553988","1997-04-05","Characterization of monoclonal antibody glycosylation: Comparison of expression systems and identification of terminal α-linked galactose"
"0029824828","8899185","","2-s2.0-0029824828","1996-10-01","Campath-1G impairs human natural killer (NK) cell-mediated cytotoxicity"
"0029937765","8611450","10.1046/j.1365-2141.1996.450989.x","2-s2.0-0029937765","1996-05-02","Humanized CD52 monoclonal antibody Campath-1H as first-line treatment in chronic lymphocytic leukaemia"
"0025995822","1908152","","2-s2.0-0025995822","1991-10-11","Reversal of allograft rejection using the monoclonal antibody, Campath-1G"
"0025563369","1713884","","2-s2.0-0025563369","1990-12-01","T-cell depletion and haematological side effects of two cytotoxic monoclonal antibodies"
"0025299676","2323363","","2-s2.0-0025299676","1990-06-07","Purification of peripheral blood hematopoietic cells using Campath-1M monoclonal antibody"
"0025260601","2238056","","2-s2.0-0025260601","1990-01-01","8-methoxypsoralen and ultraviolet a therapy for cutaneous manifestations of graft-versus-host disease"
"0035967493","11375079","10.1098/rstb.2001.0848","2-s2.0-0035967493","2001-05-29","The future of organ transplantation: From the laboratory to the clinic"
"0032693874","10561025","","2-s2.0-0032693874","1999-11-18","Chronic lymphocytic leukemia"
"0030964964","9207420","","2-s2.0-0030964964","1997-07-03","In vivo 'purging' of residual disease in CLL with Campath-1H"
"0029948935","8733704","","2-s2.0-0029948935","1996-05-01","Campath-1G in vivo confers a low incidence of graft-versus-host disease associated with a high incidence of mixed chimaerism after bone marrow transplantation for severe aplastic anaemia using HLA-identical sibling donors"
"0028791093","8654681","","2-s2.0-0028791093","1995-12-21","Clinical trials with CAMPATH-I and other monoclonal antibodies"
"0028964750","7890742","10.1074/jbc.270.11.6088","2-s2.0-0028964750","1995-01-01","Primary structure of CD52"
"0024446254","2790337","","2-s2.0-0024446254","1989-01-01","Recurrent graft failure following syngeneic bone marrow transplantation for aplastic anaemia"
"0023885441","3260131","10.1007/BF00199934","2-s2.0-0023885441","1988-06-01","An immunotoxin containing a rat IgM monoclonal antibody (Campath 1) and saporin 6: effect on T lymphocytes and hemopoietic cells"
"0022795586","3096200","10.1007/BF02798902","2-s2.0-0022795586","1986-10-01","Depletion of human lymphocytes from peripheral blood and bone marrow by affinity ligands conjugated to agarose-polyacrolein microsphere beads"
"37649004407","17984186","10.1200/JCO.2007.12.9098","2-s2.0-37649004407","2007-12-10","Alemtuzumab compared with chlorambucil as first-line therapy for chronic lymphocytic leukemia"
"0035727902","11847424","","2-s2.0-0035727902","2001-12-01","Engineered antibodies take center stage"
"0034932492","11420384","","2-s2.0-0034932492","2001-07-24","Changes of the major sperm maturation-associated epididymal protein HE5 (CD52) on human ejaculated spermatozoa during incubation in capacitation conditions"
"0035053076","11298593","10.1046/j.1365-2141.2001.02677.x","2-s2.0-0035053076","2001-04-30","Biological and molecular characterization of PNH-like lymphocytes emerging after Campath-1H therapy"
"0035075569","11257744","","2-s2.0-0035075569","2001-04-10","Cd52 antigen - A review"
"0034033048","10744652","","2-s2.0-0034033048","2000-04-22","The CD45 tyrosine phosphatase regulates Campath-1H (CD52)-induced TCR-dependent signal transduction in human T cells"
"0032812440","10524207","10.1016/S0167-4781(99)00103-7","2-s2.0-0032812440","1999-09-02","Structure and chromosomal location of mouse and human CD52 genes"
"0025285979","2184907","","2-s2.0-0025285979","1990-01-01","The use of recombinant cytokines for enhancing immunohematopoietic reconstitution following bone marrow transplantation. II. The influence of lymphokines on CFU-GM colonies from human untreated, ASTA-Z or Campath-1M treated bone marrow"
"0023940821","3291930","","2-s2.0-0023940821","1988-01-01","Bone marrow transplantation for chronic myeloid leukaemia in first chronic phase: Importance of a graft-versus-leukaemia effect"
"0023848820","2452479","","2-s2.0-0023848820","1988-01-01","Supraintensive therapy followed by autologous bone marrow transplant for hematologic neoplasias and solid tumors"
"0033949148","10918407","","2-s2.0-0033949148","2000-07-26","CD52 antibodies for prevention of graft-versus-host disease and graft rejection following transplantation of allogeneic peripheral blood stem cells"
"0032839386","10444204","10.1046/j.1365-2141.1999.01576.x","2-s2.0-0032839386","1999-08-02","Autoimmune thrombocytopenia after treatment with Campath 1H in a patient with chronic lymphocytic leukaemia [8]"
"0033139847","10907481","","2-s2.0-0033139847","1999-06-01","Chronic lymphocytic leukaemia. Current strategy and new perspectives of treatment."
"0031874443","9712499","","2-s2.0-0031874443","1998-08-13","A retrospective Dutch study comparing T cell-depleted allogeneic blood stem cell transplantation vs T cell-depleted allogeneic bone marrow transplantation"
"0028352208","8027367","","2-s2.0-0028352208","1994-06-07","Immunohistochemical analysis of CDw52 antigen expression in non-Hodgkin's lymphomas"
"0025063076","2338131","","2-s2.0-0025063076","1990-07-02","Bone marrow transplantation for chronic myeloid leukemia: The use of histocompatible unrelated volunteer donors"
"0024818727","2692692","10.1111/j.1365-2141.1989.tb00282.x","2-s2.0-0024818727","1989-01-01","Enhancement of monoclonal antibody dependent cell mediated cytotoxicity by IL2 and GM‐CSF"
"0023522487","3500064","10.1002/eji.1830171104","2-s2.0-0023522487","1987-01-01","Idiotype switching of CD4‐specific monoclonal antibodies can prolong the therapeutic effectiveness in spite of host anti‐mouse IgG antibodies"
"0020382551","6817141","10.1038/300709a0","2-s2.0-0020382551","1982-12-01","Arrangement of human immunoglobulin heavy chain constant region genes implies evolutionary duplication of a segment containing γ, ε and α genes"
"0034810956","11778765","10.1385/MO:18:2:99","2-s2.0-0034810956","2001-10-16","Campath-1H (Anti-CD52) monoclonal antibody therapy in Lymphoproliferative disorders"
"0035091343","11160771","10.1146/annurev.med.52.1.125","2-s2.0-0035091343","2001-03-19","Antibody-targeted immunotherapy for treatment of malignancy"
"0033624358","10960874","","2-s2.0-0033624358","2000-09-20","Waldenstrom's macroglobulinaemia: Laboratory diagnosis and treatment"
"0032589668","10561018","","2-s2.0-0032589668","1999-11-18","The role of CAMPATH-I antibodies in the treatment of lymphoid malignancies"
"0031299076","9502298","","2-s2.0-0031299076","1997-12-01","Collaborative multicenter investigation of marrow transplantation for sickle cell disease: Current results and future directions"
"0029780251","8844262","","2-s2.0-0029780251","1996-09-05","Specific cleavage of immunoglobulin G by copper ions"
"9444232751","8864449","","2-s2.0-9444232751","1996-08-01","Risk factors for developing EBV-related B cell lymphoproliferative disorders (BLPD) after non-HLA-identical BMT in children"
"0028978684","7632956","","2-s2.0-0028978684","1995-08-15","Emergence of CD52-, phosphatidylinositolglycan-anchor-deficient T lymphocytes after in vivo application of Campath-1H for refractory B-cell non-Hodgkin lymphoma"
"0026681758","1635559","10.1016/0161-5890(92)90119-I","2-s2.0-0026681758","1992-01-01","Synthesis and secretion of a functional antibody in a vaccinia virus expression system"
"0023278330","3681981","10.1016/0022-2836(87)90412-8","2-s2.0-0023278330","1987-08-20","Canonical structures for the hypervariable regions of immunoglobulins"
"0035029829","11360116","10.1038/sj.bmt.1702994","2-s2.0-0035029829","2001-05-17","Four year follow-up of a case of fucosidosis treated with unrelated donor bone marrow transplantation"
"0034189685","11249458","","2-s2.0-0034189685","2000-01-01","Almost-tolerance halves cyclosporine dose."
"0032736327","10520035","10.1046/j.1365-2141.1999.01676.x","2-s2.0-0032736327","1999-11-06","The PNH phenotype cells that emerge in most patients after CAMPATH-1H therapy are present prior to treatment"
"0030300084","9049965","","2-s2.0-0030300084","1996-12-01","Immunosuppressive toxicity of CAMPATH®1H monoclonal antibody in the treatment of patients with recurrent low grade lymphoma"
"15844389121","8733715","","2-s2.0-15844389121","1996-05-01","T cell-depleted allogeneic bone marrow transplantation from a partially HLA-mismatched unrelated donor for progressive chronic lymphocytic leukemia and fludarabine-induced bone marrow failure"
"0028870425","7718516","10.1093/intimm/7.1.69","2-s2.0-0028870425","1995-01-01","Cross-linking of the CAMPATH-1 antigen (CD52) triggers activation of normal human T lymphocytes"
"0025973002","1985691","","2-s2.0-0025973002","1991-01-15","Reduction of graft failure by a monoclonal antibody (anti-LFA-1 CD11a) after HLA nonidentical bone marrow transplantation in children with immunodeficiencies, osteopetrosis, and Fanconi's anemia: A European group for immunodeficiency/European group for bone marrow transplantation report"
"0024005507","3048490","","2-s2.0-0024005507","1988-05-01","Specificity of monoclonal antibody Campath-1."
"0019131970","6775818","10.1016/0092-8674(80)90168-3","2-s2.0-0019131970","1980-12-01","Cloned human and mouse kappa immunoglobulin constant and J region genes conserve homology in functional segments"
"0034655355","10798754","","2-s2.0-0034655355","2000-04-15","Bone marrow transplantation depleted of t cells followed by repletion with incremental doses of donor lymphocytes for relapsing patients with chronic myeloid leukemia: A therapeutic strategy"
"0033034356","10350345","","2-s2.0-0033034356","1999-06-08","High dose methyl prednisolone in refractory chronic lymphocytic leukaemia"
"0033583814","10329437","10.1006/bbrc.1999.0554","2-s2.0-0033583814","1999-05-19","Biochemical and MALDI analysis of the human sperm antigen gp20, homologue of leukocyte CD52"
"0032553334","9811544","10.1006/jmbi.1998.2157","2-s2.0-0032553334","1998-11-20","Crystal structures of a rat anti-CD52 (CAMPATH-1) therapeutic antibody Fab fragment and its humanized counterpart"
"0029583823","9373346","","2-s2.0-0029583823","1995-12-01","Synthetic peptide mimotope of the CAMPATH-1 (CD52) antigen, a small glycosylphosphatidylinositol-anchored glycoprotein"
"0029144465","7572995","10.1002/ajh.2830500213","2-s2.0-0029144465","1995-01-01","Clearance of PCR‐detectable lymphoma cells from the peripheral blood, but not bone marrow after therapy with campath‐1H"
"0024437686","2480280","","2-s2.0-0024437686","1989-01-01","Bone marrow transplantation for the treatment of leukaemia-results of the Munich Cooperative Group"
"0024004140","3048491","","2-s2.0-0024004140","1988-05-01","Immunological reconstitution after bone marrow transplantation with Campath-1 treated bone marrow."
"0023067203","3304736","","2-s2.0-0023067203","1987-03-04","Immunological reconstitution after bone marrow transplant with Campath-1 treated bone marrow"
"0023642819","2879121","","2-s2.0-0023642819","1987-01-03","Leukaemic relapse after Campath 1-treated bone-marrow transplantation for leukaemia."
"0033945717","10894353","10.1089/15258160050079425","2-s2.0-0033945717","2000-07-17","Drug therapy for acute graft-versus-host disease prophylaxis"
"0034090521","12042050","","2-s2.0-0034090521","2000-06-19","Impact on T-cell depletion and CD34+ cell recovery using humanised CD52 monoclonal antibody (CAMPATH-1H) in BM and PSBC collections; Comparison with CAMPATH-1M and CAMPATH-1G"
"0033214901","10498590","","2-s2.0-0033214901","1999-10-01","Risk of lymphoproliferative disorders after bone marrow transplantation: A multi-institutional study"
"0029129542","7575719","10.1002/art.1780380912","2-s2.0-0029129542","1995-01-01","Emergence of oligoclonal t cell populations following therapeutic t cell depletion in rheumatoid arthritis"
"0028838033","7530212","","2-s2.0-0028838033","1995-01-01","G-CSF-mobilized peripheral blood progenitor cells for allogeneic transplantation: Comparison of T cell depletion strategies using different CD34+ selection systems or CAMPATH-1"
"0027462047","7685389","10.1016/0165-0378(93)90007-5","2-s2.0-0027462047","1993-01-01","The glycosylphosphatidylinositol-anchored lymphocyte antigen CDw52 is associated with the epididymal maturation of human spermatozoa"
"0025963364","1998598","10.1111/j.1365-2141.1991.tb07949.x","2-s2.0-0025963364","1991-01-01","Origin and function of adherent lymphokine activated killer cells in patients with chronic myeloid leukaemia who relapse following bone marrow transplantation"
"0025505183","2104246","","2-s2.0-0025505183","1990-10-01","The significance of tumour necrosis factor serum levels in organ transplantation."
"0024294794","3067007","","2-s2.0-0024294794","1988-10-22","Prevention of graft versus host disease by in vitro depletion of T lymphocytes with monoclonal antibodies (Campath-1) in patients undergoing bone marrow transplantation"
"0023239023","3623632","10.1016/0165-2478(87)90038-1","2-s2.0-0023239023","1987-01-01","The inheritance of a Macaca fascicularis red cell antigen detected by CAMPATH-1 antibody"
"0034623830","11149212","10.1055/s-2000-9116","2-s2.0-0034623830","2000-12-08","Therapeutic monoclonal antibodies"
"0033782087","11013436","10.1002/1098-2795(200011)57:3&lt;280::AID-MRD10&gt;3.0.CO;2-5","2-s2.0-0033782087","2000-10-23","Maturational changes of the CD52-like epididymal glycoprotein on cynomolgus monkey sperm and their apparent reversal in capacitation conditions"
"0033870698","10950363","","2-s2.0-0033870698","2000-08-29","What choices are available for treatment of the patient with chronic lymphocytic leukemia who is fludarabine-refractory?"
"0032522959","9531622","","2-s2.0-0032522959","1998-04-15","Risks of developing Epstein-Barr virus-related lymphoproliferative disorders after T-cell-depleted marrow transplants"
"0032005642","9593475","10.1016/S0145-2126(97)00158-6","2-s2.0-0032005642","1998-02-01","Levels of expression of CD52 in normal and leukemic B and T cells: Correlation with in vivo therapeutic responses to Campath-1H"
"0027537357","8094189","10.1016/0140-6736(93)93024-U","2-s2.0-0027537357","1993-02-13","Differential response in a patient treated with Campath-1H monoclonal antibody for refractory non-Hodgkin lymphoma"
"0027456571","8477804","10.1002/eji.1830230518","2-s2.0-0027456571","1993-01-01","Structural motifs involved in human IgG antibody effector functions"
"0024512227","2786388","","2-s2.0-0024512227","1989-01-01","Beneficial effect of monoclonal antibody to interleukin 2 receptor on activated T cells in rheumatoid arthritis"
"0024376261","2671531","","2-s2.0-0024376261","1989-01-01","Prevention of acute graft-versus-host disease with three different prophylactic regimens"
"0023029402","2878219","10.1016/S0140-6736(86)91482-0","2-s2.0-0023029402","1986-12-06","LEUKAEMIC RELAPSE FOLLOWING CAMPATH 1 TREATED BONE MARROW TRANSPLANTATION FOR LEUKAEMIA"
"0035233974","11219009","","2-s2.0-0035233974","2001-02-21","Specific protein degradation by copper(II) ions."
"0034327171","11045999","","2-s2.0-0034327171","2000-11-01","Cutting edge: Anti-CD154 therapeutic antibodies induce infectious transplantation tolerance"
"0033775935","11040273","","2-s2.0-0033775935","2000-01-01","Monoclonal antibody therapy in lymphoid malignancies"
"0029981025","8652811","","2-s2.0-0029981025","1996-06-15","National Cancer Institute-sponsored Working Group guidelines for chronic lymphocytic leukemia: Revised guidelines for diagnosis and treatment"
"0028946632","7599563","","2-s2.0-0028946632","1995-04-24","In vivo/ex vivo T cell depletion for GVHD prophylaxis influences onset and course of active cytomegalovirus infection and disease after BMT"
"0024566393","2713487","","2-s2.0-0024566393","1989-01-01","Effects of CAMPATH-1 antibodies in vivo in patients with lymphoid malignancies: Influence of antibody isotype"
"0023573125","3332190","","2-s2.0-0023573125","1987-12-01","Monoclonal rat anti-human lymphocyte antibody Campath-1 binds to T and B lymphocytes but effectively lyses only T cells"
"0022629899","2867383","10.1016/S0140-6736(86)92303-2","2-s2.0-0022629899","1986-01-18","LEUKAEMIC RELAPSE ASSOCIATED WITH PHENOTYPIC CHANGE AFTER CAMPATH-1 PURGED AUTOLOGOUS BONE MARROW TRANSPLANTATION"
"0033552391","10568572","10.1016/S0140-6736(99)02429-0","2-s2.0-0033552391","1999-11-13","Pulsed monoclonal antibody treatment and autoimmune thyroid disease in multiple sclerosis"
"0030016433","8690051","","2-s2.0-0030016433","1996-08-16","Anti-CD45 and anti-CD52 (Campath) monoclonal antibodies effectively eliminate systemically disseminated human non-Hodgkin's lymphoma B cells in Scid mice"
"0028987120","7734348","10.1111/j.1365-2141.1995.tb08356.x","2-s2.0-0028987120","1995-01-01","T‐cell‐depleted allogeneic bone marrow transplantation for acute leukaemia using Campath‐1 antibodies and post‐transplant administration of donor's peripheral blood lymphocytes for prevention of relapse"
"0028557044","7711666","","2-s2.0-0028557044","1994-12-01","Salivary immunoglobulins in recipients of bone marrow grafts. I. A longitudinal follow-up"
"0026649387","1391938","","2-s2.0-0026649387","1992-01-01","Enhanced marrow recovery by short preincubation of marrow allografts with human recombinant interleukin-3 and granulocyte-macrophage colony-stimulating factor"
"0026557569","1581219","10.1111/j.1365-2141.1992.tb08149.x","2-s2.0-0026557569","1992-01-01","Transfer of specific immunity from donor to recipient of an allogeneic bone marrow graft: effect of conditioning on the specific immune response of the graft recipient"
"0025216323","2328322","","2-s2.0-0025216323","1990-04-15","Therapy for chronic myelogenous leukemia with unrelated donor bone marrow transplantation: Results in 102 cases"
"0024315714","2667209","","2-s2.0-0024315714","1989-01-01","Campath-1m— prophylactic use after kidney transplantation: A randomized controlled clinical trial"
"0022527509","3531347","10.1016/0022-1759(86)90172-9","2-s2.0-0022527509","1986-09-27","Direct antibody rosette-forming reactions using monoclonal markers of lymphocyte subpopulations. Methodology and applications illustrated by investigations with rat pan-T antibodies of the CAMPATH series"
"0021813140","3890929","10.1111/j.1365-2141.1985.tb07383.x","2-s2.0-0021813140","1985-01-01","Reactivity of rat monoclonal antibody CAMPATH‐1 with human leukaemia cells and its possible application for autologous bone marrow transplantation"
"0032995790","10417050","10.1089/106161299320299","2-s2.0-0032995790","1999-07-14","Comparison of T-cell-depleted BMT and PBPCT with respect to chimerism, graft rejection, and leukemic relapse"
"0031913342","9509982","","2-s2.0-0031913342","1998-03-03","T cell depletion of allogeneic peripheral blood stem cells [1]"
"0029922179","8611731","","2-s2.0-0029922179","1996-05-01","Analysis of T-cell repopulation after allogeneic bone marrow transplantation: Significant differences between recipients of T-cell depleted and unmanipulated grafts"
"0029962890","8722340","","2-s2.0-0029962890","1996-03-01","Transplantation of peripheral blood progenitor cells from unrelated donors"
"0029429152","9358610","","2-s2.0-0029429152","1995-12-01","Ex-vivo whole blood cultures for predicting cytokine-release syndrome: Dependence on target antigen and antibody isotype"
"0029558207","8643100","10.1016/0161-5890(95)00118-2","2-s2.0-0029558207","1995-01-01","The effect of the removal of sialic acid, galactose and total carbohydrate on the functional activity of Campath-1H"
"0027965889","7997943","10.1007/BF00196711","2-s2.0-0027965889","1994-07-01","Mechanisms of endothelial cell injury in vasculitis"
"0028208561","8054913","","2-s2.0-0028208561","1994-05-24","Control of graft-versus-host disease and graft rejection by T cell depletion of donor and recipient with Campath-1 antibodies. Results of matched sibling transplants for malignant diseases"
"0025878925","1711975","10.1002/eji.1830210714","2-s2.0-0025878925","1991-01-01","Characterization of the CAMPATH‐1 (CDw52) antigen: biochemical analysis and cDNA cloning reveal an unusually small peptide backbone"
"0021016329","6198242","10.1016/0378-1119(83)90230-5","2-s2.0-0021016329","1983-01-01","A simple and very efficient method for generating cDNA libraries"
"0034765991","12171721","10.1080/146532401753174098","2-s2.0-0034765991","2001-11-20","The CD52 antigen and development of the CAMPATH antibodies"
"20244383278","10390197","10.1016/S0301-472X(99)00052-1","2-s2.0-20244383278","1999-07-01","Engraftment of marrow allografts treated with Campath-1 monoclonal antibodies"
"0032402158","9834254","","2-s2.0-0032402158","1998-12-01","Reconstitution of the T-cell compartment after bone marrow transplantation: Restoration of the repertoire by thymic emigrants"
"0031936430","9482528","","2-s2.0-0031936430","1998-03-10","Old and new therapies in chronic lymphocytic leukemia: Now is the time for a reassessment of therapeutic goals"
"0029035247","7762066","","2-s2.0-0029035247","1995-05-15","Cytotoxic T lymphocyte precursor frequency analyses in bone marrow transplantation with volunteer unrelated donors: Value in donor selection"
"0028290250","7920312","","2-s2.0-0028290250","1994-07-12","T cell depletion by exposure to Campath-1G in vitro prevents graft-versus-host disease"
"0027200638","8217808","10.1111/j.1365-2141.1993.tb03117.x","2-s2.0-0027200638","1993-01-01","CAMPATH‐1 monoclonal antibody therapy in severe refractory autoimmune thrombocytopenic purpura"
"0026676711","1438436","","2-s2.0-0026676711","1992-01-01","Campath-1M antibodies for T cell depletion of haploidentical marrow transplanted to children with malignant osteopetrosis."
"0025904672","1878698","","2-s2.0-0025904672","1991-01-01","An assessment of chimeric transcript detection in CML patients after bone marrow transplantation"
"0023626937","3609184","","2-s2.0-0023626937","1987-12-01","Enrichment of progenitor cells from human marrow"
"0035178658","11760553","","2-s2.0-0035178658","2001-12-10","New directions in chronic lymphocytic leukemia"
"17844403981","11438820","10.1038/sj.bmt.1703024","2-s2.0-17844403981","2001-07-10","Comparison of allogeneic T cell-depleted peripheral blood stem cell and bone marrow transplantation: Effect of stem cell source on short- and long-term outcome"
"0035109602","11277178","10.1038/sj.bmt.1702778","2-s2.0-0035109602","2001-03-10","Screening for cytomegalovirus (CMV) infection in allogeneic bone marrow transplantation using a quantitative whole blood polymerase chain reaction (PCR) method: Analysis of potential risk factors for CMV infection"
"0033694554","11268323","","2-s2.0-0033694554","2000-12-04","Haploidentical peripheral blood and marrow stem cell transplantation in nine cases of primary immunodeficiency"
"0034062199","10713664","","2-s2.0-0034062199","2000-03-30","Campath-1H in B-chronic lymphocytic leukemia: Report on a patient treated thrice in a 3 year period"
"0031414124","9471061","10.1007/s00282-997-0045-0","2-s2.0-0031414124","1997-11-01","New therapeutic issues in CLL"
"0023924847","3282358","","2-s2.0-0023924847","1988-01-01","T cell depletion with campath-1 in allogeneic bone marrow transplantation"
"0023057104","3538379","","2-s2.0-0023057104","1986-01-01","Transplantation with allogeneic bone marrow after in vitro T-cell depletion with monoclonal Campath 1"
"0020317803","6811139","10.1016/0092-8674(82)90183-0","2-s2.0-0020317803","1982-01-01","Structure of human immunoglobulin gamma genes: implications for evolution of a gene family"
"0016236512","4851220","10.1111/j.1432-1033.1974.tb03576.x","2-s2.0-0016236512","1974-01-01","Crystal and Molecular Structure of a Dimer Composed of the Variable Portions of the Bence‐Jones Protein REI"
"0035237083","11722982","","2-s2.0-0035237083","2001-01-01","Chronic lymphocytic leukemia: case-based session."
"0032608473","10565991","","2-s2.0-0032608473","1999-01-01","Campath-1G. Campath IgG, Campath-1-IgG antibody."
"0032535279","9845524","","2-s2.0-0032535279","1998-12-15","Improving the outcome of bone marrow transplantation by using CD52 monoclonal antibodies to prevent graft-versus-host disease and graft rejection"
"0031058173","9051241","","2-s2.0-0031058173","1997-02-02","In vitro T cell depletion using Campath 1M for mismatched BMT for severe combined immunodeficiency (SCID)"
"0029677898","9238651","","2-s2.0-0029677898","1996-12-01","CD52 is the 'major maturation-associated' sperm membrane antigen"
"0026487081","1384718","10.1016/0167-4781(92)90152-P","2-s2.0-0026487081","1992-11-15","Identification of an abundant monkey epididymal transcript encoding a homologue of human CAMPATH-1 antigen precursor"
"0026444716","1543952","","2-s2.0-0026444716","1992-01-01","Transmission of toxoplasmosis by bone marrow transplant associated with Campath-1G."
"0024204319","2904526","10.1016/S0140-6736(88)90588-0","2-s2.0-0024204319","1988-12-17","REMISSION INDUCTION IN NON-HODGKIN LYMPHOMA WITH RESHAPED HUMAN MONOCLONAL ANTIBODY CAMPATH-1H"
"0023009274","3539172","10.1111/j.1365-2141.1986.tb02203.x","2-s2.0-0023009274","1986-01-01","Ex vivo T‐cell depletion with the monoclonal antibody Campath‐1 plus human complement effectively prevents acute graft‐versus‐host disease in allogeneic bone marrow transplantation"
"0020666053","6401310","","2-s2.0-0020666053","1983-03-24","Anti-oxazolone hybridomas and the structure of the oxazolone idiotype"
"0033933282","10877047","","2-s2.0-0033933282","2000-07-12","Clinical overview of pentostatin (Nipent) use in lymphoid malignancies"
"0029869119","8624684","10.1093/brain/119.1.225","2-s2.0-0029869119","1996-03-19","Transient increase in symptoms associated with cytokine release in patients with multiple sclerosis"
"0024581574","2910352","","2-s2.0-0024581574","1989-01-01","Proliferation and maturation of human erythroid progenitors in liquid culture"
"0023463779","3500899","","2-s2.0-0023463779","1987-12-01","T-cell depletion of Cercopithecus aethiops monkey bone marrow with Campath-1 monoclonal antibody and complement."
"0023544732","3121901","","2-s2.0-0023544732","1987-12-01","T-cell killing of target cells induced by hybrid antibodies: Comparison of two bispecific monoclonal antibodies"
"0035296404","2002153009","","2-s2.0-0035296404","2001-01-01","Campath-1H."
"0035522776","2002152951","","2-s2.0-0035522776","2001-01-01","Alemtuzumab."
"0033655656","","","2-s2.0-0033655656","2000-12-01","T Cell-Depleted Unrelated Donor Bone Marrow Transplantation for Acute Myeloid Leukemia"
"0034211303","2002160928","","2-s2.0-0034211303","2000-01-01","Behçet's syndrome. Wise after the event."
"0032997230","","","2-s2.0-0032997230","1999-02-19","CAMPATH-1H Cambridge University"
"0031905196","","","2-s2.0-0031905196","1998-03-31","T-cell prolymphocytic leukemia"
"0029175679","","10.1007/BF00749653","2-s2.0-0029175679","1995-10-01","Development of a serum-free culture medium for the large scale production of recombinant protein from a Chinese hamster ovary cell line"
"0030042960","","10.1007/BF00767768","2-s2.0-0030042960","1995-01-01","The use of serum-free medium for the production of functionally active humanised monoclonal antibody from NS0 mouse myeloma cells engineered using glutamine synthetase as a selectable marker"
"0025041808","","10.3109/10428199009042487","2-s2.0-0025041808","1990-01-01","Reactivity of human monoclonal antibody campath-1 with human leukemia lymphoma cell lines of varying maturation"
"0019739585","","10.1016/0076-6879(81)73054-4","2-s2.0-0019739585","1981-12-01","[1] Preparation of monoclonal antibodies: Strategies and procedures"
"0034517516","","10.1159/000055001","2-s2.0-0034517516","2000-12-01","The monoclonal antibodies Campath-1H and Rituximab in the therapy of chronic lymphocytic leukemia"
"0026028117","","10.3109/10428199109107913","2-s2.0-0026028117","1991-01-01","T-cell receptor and immunoglobulin gene rearrangements in acute myeloid and undifferentiated leukemias of adults: Correlation with weak surface expression of CD45 and CDw52 antigens"
"0025652892","","10.3109/10428199009053522","2-s2.0-0025652892","1990-01-01","Remission induction in patients with lymphoid malignancies using unconjugated CAMPATH-1 monoclonal antibodies"
"0025978976","1987490","","2-s2.0-0025978976","1991-12-01","Man-made antibodies"
"0023230248","3496952","10.1016/0165-4608(87)90364-5","2-s2.0-0023230248","1987-01-01","Complex translocation t(8;12;14) in a cell line derived from a child with nonendemic Burkitt-type acute lymphoblastic leukemia"
"0029187782","","10.1007/BF00749657","2-s2.0-0029187782","1995-10-01","The culture of rat myeloma and rat hybridoma cells in a protein-free medium"
"0001127374","6933469","","2-s2.0-0001127374","1980-12-01","Isolation of Chinese hamster cell mutants deficient in dihydrofolate reductase activity"
"0029173973","","10.1007/BF00749658","2-s2.0-0029173973","1995-10-01","Adaptation of cholesterol-requiring NS0 mouse myeloma cells to high density growth in a fully defined protein-free and cholesterol-free culture medium"
"0025516520","2104281","","2-s2.0-0025516520","1990-11-01","The antiglobulin response to therapeutic antibodies"
"0028365150","","","2-s2.0-0028365150","1994-06-06","(4) Monoclonal antibodies as therapeutic agents"
"0027034181","1369497","10.1007/BF02521750","2-s2.0-0027034181","1992-02-01","Process development for the production of recombinant antibodies using the glutamine synthetase (GS) system"
"0023911111","3127726","","2-s2.0-0023911111","1988-12-01","Reshaping human antibodies for therapy"
"0020038931","6799391","","2-s2.0-0020038931","1982-01-01","Chemical typing of human kappa light chain subgroups expressed by human hybrid myelomas"
"84936513287","","","2-s2.0-84936513287","0000-07-17",""
"14744277083","","","2-s2.0-14744277083","1991-12-01","High level expression of the humanized monoclonal antibody Campath-1H in Chinese hamster ovary cells"
"14744283551","","","2-s2.0-14744283551","1992-12-01","High-level expression of a recombinant antibody from myeloma cells using a glutamine synthetase gene as an amplifiable selectable marker"
"0023224766","3585251","","2-s2.0-0023224766","1987-01-01","Cholesterol requirement of P3-X63-Ag8 and X63-Ag8.653 mouse myeloma cells for growth in vitro"
"84936513288","","","2-s2.0-84936513288","0000-07-17",""
"0029617624","","","2-s2.0-0029617624","1995-12-01","The epididymal influence on sperm maturation"
"0029561832","","","2-s2.0-0029561832","1995-12-01","Molecular biology of sperm maturation in the human epididymis"
"0027386707","8418821","10.1002/mrd.1080340103","2-s2.0-0027386707","1993-01-01","A major mRNA of the human epididymal principal cells, HE5, encodes the leucocyte differentiation CDw52 antigen peptide backbone"
"0021320928","6693399","","2-s2.0-0021320928","1984-01-01","Characterization of a maturation-associated glycoprotein on the plasma membrane of rat caudal epididymal sperm"
"0029925313","8665901","","2-s2.0-0029925313","1996-12-01","The human cysteine-rich secretory protein (CRISP) family Primary structure and tissue distribution of CRISP-1, CRISP-2 and CRISP-3"
"0029983024","8838800","10.1006/geno.1996.0131","2-s2.0-0029983024","1996-03-15","Characterization of a human glycoprotein with a potential role in sperm-egg fusion: cDNA cloning, immunohistochemical localization, and chromosomal assignment of the gene (AEGL1)"
"0029941015","8722621","","2-s2.0-0029941015","1996-05-01","Cases of human infertility are associated with the absence of P34H, an epididymal sperm antigen"
"0028211641","7515288","","2-s2.0-0028211641","1994-01-01","A major messenger ribonucleic acid of the rodent epididymis encodes a small glycosylphosphatidylinositol-anchored lymphocyte surface antigen"
"0030202287","9239671","","2-s2.0-0030202287","1996-12-01","The role of phosphocreatine kinase in the motility of human spermatozoa supported by different metabolic substrates"
"0029084165","7484449","","2-s2.0-0029084165","1995-01-01","Role of the epididymis in mediating changes in the male gamete during maturation"
"0028799369","7482810","","2-s2.0-0028799369","1995-11-16","The potential role of therapeutic antibodies in the regulation of rejection"
"0029001840","7541557","","2-s2.0-0029001840","1995-12-01","In vivo transfer of GPI-linked complement restriction factors from erythrocytes to the endothelium"
"84892193128","","10.1007/978-3-540-78355-8_3","2-s2.0-84892193128","2010-12-01","Physiology of sperm maturation and fertilization"
"0026521538","1562325","10.1002/mrd.1080310107","2-s2.0-0026521538","1992-01-01","Redistribution of a rat sperm epididymal glycoprotein after in vitro and in vivo capacitation"
"0029986469","8722620","10.1095/biolreprod54.5.1009","2-s2.0-0029986469","1996-05-01","Surface localization of P34H, an epididymal protein, during maturation, capacitation, and acrosome reaction of human spermatozoa"
"0025826573","1686187","","2-s2.0-0025826573","1991-08-12","A major human epididymis-specific cDNA encodes a protein with sequence homology to extracellular proteinase inhibitors"
"0027529607","8418812","10.1002/mrd.1080340104","2-s2.0-0027529607","1993-01-01","Region‐specific variation of gene expression in the human epididymis as revealed by in situ hybridization with tissue‐specific cDNAs"
"0027290672","8373950","","2-s2.0-0027290672","1993-01-01","Changes in movement characteristics of human spermatozoa along the length of the epididymis"
"0027478377","7683035","","2-s2.0-0027478377","1993-05-01","Physiologic relevance of the membrane attack complex inhibitory protein CD59 in human seminal plasma: CD59 is present on extracellular organelles (Prostasomes), binds cell membranes, and inhibits complement-mediated lysis"
"0028009798","8129926","10.1002/mrd.1080370115","2-s2.0-0028009798","1994-01-01","Characterization of a cell surface glycoprotein associated with maturation of rat spermatozoa"
"0030089901","9238677","","2-s2.0-0030089901","1996-12-01","Cell-to-cell transfer of glycosylphosphatidylinositol-anchored membrane proteins during sperm maturation"
"0029865964","8601633","","2-s2.0-0029865964","1996-04-01","GPI-anchored complement regulatory proteins in seminal plasma: An analysis of their physical condition and the mechanisms of their binding to exogenous cells"
"0003567225","","","2-s2.0-0003567225","1992-07-13",""
"0028086145","7519171","","2-s2.0-0028086145","1994-01-01","High-density lipoproteins can act as carriers of glycophosphoinositol lipid-anchored CD59 in human plasma"
"0029951829","8816328","10.1016/0165-0378(96)00959-X","2-s2.0-0029951829","1996-05-01","The monoclonal antibody GZS-1 detects a maturation-associated antigen of human spermatozoa that is also present on the surface of human mononuclear blood cells"
"0028868144","7536047","10.1095/biolreprod52.2.267","2-s2.0-0028868144","1995-02-10","FLB1, a human protein of epididymal origin that is involved in the sperm- oocyte recognition process"
"0026001212","1658652","","2-s2.0-0026001212","1991-01-01","Early treatment with ganciclovir to prevent cytomegalovirus disease after allogeneic bone marrow transplantation"
"0027526116","8429851","","2-s2.0-0027526116","1993-03-04","Analysis of 462 transplantations from unrelated donors facilitated by the national marrow donor program"
"0020063202","6122004","10.1016/S0140-6736(82)92619-8","2-s2.0-0020063202","1982-03-27","USE OF ANTI-T-CELL MONOCLONAL ANTIBODY OKT3 TO PREVENT ACUTE GRAFT-VERSUS-HOST DISEASE IN ALLOGENEIC BONE-MARROW TRANSPLANTATION FOR ACUTE LEUKAEMIA"
"0028206129","8193379","","2-s2.0-0028206129","1994-06-01","Minimal residual disease is more common in patients who have mixed T-cell chimerism after bone marrow transplantation for chronic myelogenous leukemia"
"4243829263","","","2-s2.0-4243829263","1996-09-27","Effect of ATG in conditioning for unrelated BMT on GVHD prophylaxis. A preliminary report of prospective cooperative study in Japan"
"0008947293","9521984","10.1056/NEJM199804023381405","2-s2.0-0008947293","1998-04-02","Bone marrow transplants from unrelated donors for patients with chronic myeloid leukemia"
"0021064615","6366143","","2-s2.0-0021064615","1983-12-01","Marrow transplantation for malignant diseases"
"0020682081","6337286","10.1001/jama.1983.03330330044034","2-s2.0-0020682081","1983-03-04","Bone Marrow Transplantation for Acute Myelogenous Leukemia: Factors Associated With Early Mortality"
"24844468378","","","2-s2.0-24844468378","1998-09-29","ATG as part of the conditioning in matched unrelated (MUD) BMT"
"0008709892","","","2-s2.0-0008709892","1998-07-13","ATG reduces the risk of severe aGVHD in MUD or haploidentical BMT"
"0018973048","6996481","10.1016/0002-9343(80)90380-0","2-s2.0-0018973048","1980-10-10","Chronic Graft-Versus-Host syndrome in man. A long-term clinicopathologic study of 20 Seattle patients"
"0029162614","7632974","","2-s2.0-0029162614","1995-01-01","Unrelated donor bone marrow transplantation: Influence of HLA A and B incompatibility on outcome"
"0029164624","7632970","","2-s2.0-0029164624","1995-01-01","The significance of HLA-DRB1 matching on clinical outcome after HLA-A, B, DR identical unrelated donor marrow transplantation"
"0019390679","6115110","10.1016/S0140-6736(81)90647-4","2-s2.0-0019390679","1981-08-15","TRANSPLANTATION FOR ACUTE LEUKAEMIA WITH HLA-A AND B NONIDENTICAL PARENTAL MARROW CELLS FRACTIONATED WITH SOYBEAN AGGLUTININ AND SHEEP RED BLOOD CELLS"
"0001359582","","","2-s2.0-0001359582","1998-03-07","ATG serotherapy during pre-transplant conditioning in unrelated donor BMT: Dose-dependent modulation of GVHD"
"0022461904","3521712","10.1111/j.1365-2141.1986.tb05544.x","2-s2.0-0022461904","1986-01-01","Graft rejection following HLA matched T‐lymphocyte depleted bone marrow transplantation"
"24844462272","","","2-s2.0-24844462272","1998-09-29","Pre-transplant ATG vs Campath IG for GVHD prophylaxis in pediatric recipients of unrelated BMT. An AIEOP-GITMO retrospective analysis of 112 patients"
"0029073339","7655390","","2-s2.0-0029073339","1995-01-01","Similar incidence of graft-versus-host disease using HLA-A, -B and -DR identical unrelated bone marrow donors as with HLA-identical siblings"
"0022622360","3511810","","2-s2.0-0022622360","1986-06-25","Marrow transplantation for the treatment of chronic myelogenous leukemia"
"0024339447","2659114","","2-s2.0-0024339447","1989-01-01","The use of unrelated bone marrow donors in the treatment of patients with chronic myelogenous leukemia: Experience of four marrow transplant centers"
"0023368537","3299923","","2-s2.0-0023368537","1987-01-01","Graft-versus-host disease prevention in allogeneic bone marrow transplantation from histocompatible siblings: A pilot study using immunotoxins form cell depletion of donor bone marrow"
"0027514621","8422471","","2-s2.0-0027514621","1993-01-15","Unrelated donor marrow transplantation therapy for chronic myelogenous leukemia: Initial experience of the National Marrow Donor Program"
"0023189896","3296349","","2-s2.0-0023189896","1987-01-01","Graft rejection in recipients of T-cell-depleted hla-nonidentical marrow transplants for leukemia: Identification of host-derived antidonor allocytotoxic T lymphocytes"
"0021345180","6142207","10.1016/S0140-6736(84)92848-4","2-s2.0-0021345180","1984-03-03","DEPLETION OF T LYMPHOCYTES IN DONOR MARROW PREVENTS SIGNIFICANT GRAFT-VERSUS-HOST DISEASE IN MATCHED ALLOGENEIC LEUKAEMIC MARROW TRANSPLANT RECIPIENTS"
"0016187133","4153799","","2-s2.0-0016187133","1974-01-01","Clinical manifestations of graft-versus-host disease in human recipients of marrow from hl-a-matched sibling donors&lt;sup&gt;1&lt;/sup&gt;"
"0027213870","8394169","10.3109/10428199309148532","2-s2.0-0027213870","1993-01-01","Fludarabine and arabinosylcytosine therapy of refractory and relapsed acute myelogenous leukemia"
"18244425426","3332174","","2-s2.0-18244425426","1987-10-01","The treatment of acute non-lymphoblastic leukemia by allogeneic marrow transplantation."
"0032558686","9780337","10.1056/NEJM199810223391701","2-s2.0-0032558686","1998-10-22","Effect of matching of class I HLA alleles on clinical outcome after transplantation of hematopoietic stem cells from an unrelated donor"
"0028331004","8167329","","2-s2.0-0028331004","1994-05-01","Treatment and prevention of cytomegalovirus pneumonia after bone marrow transplantation: Where do we stand?"
"0022643765","3510388","","2-s2.0-0022643765","1986-04-24","Bone marrow transplantation for patients with chronic myeloid leukemia"
"0343931659","","","2-s2.0-0343931659","2000-07-13","Allogeneic stem cell transplantation for lymphoproliferative disorders using BEAM-Campath conditioning"
"0031054161","9028553","","2-s2.0-0031054161","1997-02-01","Increased incidence of cytomegalovirus (CMV) infection and CMV-associated disease after allogeneic bone marrow transplantation from unrelated donors"
"0027376925","8391772","","2-s2.0-0027376925","1993-08-01","Allogeneic bone marrow transplantation for chronic myeloid leukemia using sibling and volunteer unrelated donors: A comparison of complications in the first 2 years"
"24844440871","","","2-s2.0-24844440871","1996-09-29","ATG as part of the pre-transplant conditioning regimen reduces transplant-related mortality in CML patients undergoing allogeneic transplantation"
"0033608119","10075606","10.1097/00007890-199901270-00028","2-s2.0-0033608119","1999-01-27","Peripheral blood stem cells from unrelated donors for allogeneic transplantation"
"0342625670","","","2-s2.0-0342625670","1993-11-16","Ganciclovir prophylaxis to prevent cytomegalovirus disease after allogeneic marrow transplant"
"0030916159","9166868","","2-s2.0-0030916159","1997-06-07","Transplantation of marrow cells from unrelated donors for treatment of high-risk acute leukemia: The effect of leukemic burden, donor HLA-matching, and marrow cell dose"
"0028820426","7482734","","2-s2.0-0028820426","1995-10-27","Impact of racial genetic polymorphism on the probability of finding an hla-matched donor"
"0027946435","7949160","","2-s2.0-0027946435","1994-01-01","A special report: Bone marrow transplants using volunteer donors - Recommendations and requirements for a standardized practice throughout the world - 1994 Update"
"0028145782","10155543","10.1016/0955-3886(94)90134-1","2-s2.0-0028145782","1994-01-01","Effect of HLA incompatibility in marrow transplantation from unrelated and HLA-mismatched related donors"
"0027361368","8275037","","2-s2.0-0027361368","1993-01-01","Prospective evaluation of unrelated donor bone marrow transplantation"
"0025112785","2201915","","2-s2.0-0025112785","1990-09-13","Prognostic subgroups in B-cell chronic lymphocytic leukemia defined by specific chromosomal abnormalities"
"0028224082","7909866","10.1016/S0140-6736(94)92398-1","2-s2.0-0028224082","1994-05-14","Randomised trial of monoclonal antibody for adjuvant therapy of resected Dukes' C colorectal carcinoma"
"0027225899","7688995","","2-s2.0-0027225899","1993-08-15","Autologous and allogeneic bone marrow transplantation for poor prognosis patients with B-cell chronic lymphocytic leukemia"
"0026712850","1498329","","2-s2.0-0026712850","1992-08-15","Monoclonal antibody-based therapies of leukemia and lymphoma"
"0028073281","7533576","10.3109/10428199409052690","2-s2.0-0028073281","1994-01-01","The expanding role of fludarabine in hematologic malignancies"
"0026637511","1282428","10.3109/10428199209053623","2-s2.0-0026637511","1992-01-01","Evaluation of residual disease in b-cell chronic lymphocytic leukemia patients in clinical and bone-marrow remission using CD5-CD19 markers and PCR study of gene rearrangements"
"0028945716","7884417","","2-s2.0-0028945716","1995-03-01","2-Chlorodeoxyadenosine activity in patients with untreated chronic lymphocytic leukemia"
"0344631763","10556210","","2-s2.0-0344631763","1999-11-01","Induction of donor-type chimerism and transplantation tolerance across major histocompatibility barriers in sublethally irradiated mice by Sca- 1+Lin- Bone marrow progenitor cells: Synergism with non-alloreactive (host x donor) F1 T cells"
"0004419585","","","2-s2.0-0004419585","1998-07-13","Long term outcome of autoimmune disease following allogeneic bone marrow transplantation"
"0030031644","8550837","","2-s2.0-0030031644","1996-01-01","Allogeneic hematolymphoid microchimerism and prevention of autoimmune disease in the rat: A relationship between allo- and autoimmunity"
"0032836986","10516675","","2-s2.0-0032836986","1999-10-18","Autologous haematopoietic stem cell transplants for autoimmune disease - Feasibility and transplant-related mortality"
"0026505616","1543947","","2-s2.0-0026505616","1992-01-01","Resolution of immune-mediated diseases following allogeneic bone marrow transplantation for leukaemia"
"0031909332","9506573","10.1002/1529-0131(199803)41:3&lt;453::AID-ART11&gt;3.0.CO;2-#","2-s2.0-0031909332","1998-03-01","Long-term outcome of autoimmune disease following allogeneic bone marrow transplantation"
"0029671326","8598488","","2-s2.0-0029671326","1996-01-01","Mixed allogeneic chimerism induced by a sublethal approach prevents autoimmune diabetes and reverses insulitis in nonobese diabetic (NOD) mice"
"0032616805","10465099","","2-s2.0-0032616805","1999-12-01","Mixed chimerism: Preclinical studies and clinical applications"
"0023069478","3109455","","2-s2.0-0023069478","1987-01-01","The lymphocyte function-associated LFA-1, CD2, and LFA-3 molecules: cell adhesion receptors of the immune system."
"0023026618","2877234","10.1016/S0140-6736(86)90477-0","2-s2.0-0023026618","1986-11-08","BONE-MARROW TRANSPLANTATION FOR IMMUNODEFICIENCIES AND OSTEOPETROSIS: EUROPEAN SURVEY, 1968-1985"
"0026657206","1353913","","2-s2.0-0026657206","1992-01-01","Prolongation of allograft and xenograft survival in mice by anti-CD2 monoclonal antibodies"
"0025998827","1682413","","2-s2.0-0025998827","1991-11-01","Anti-CD2 antibodies induce T cell unresponsiveness in vivo"
"0024265020","3061078","","2-s2.0-0024265020","1988-01-01","Regulation of cytotoxic T lymphocyte-mediated graft rejection following bone marrow transplantation"
"0025346482","2142343","","2-s2.0-0025346482","1990-01-01","Specific elimination of alloreactive T cells by an anti-interleukin-2 receptor B chain-specific immunotoxin"
"0028069390","7903681","10.1084/jem.179.1.341","2-s2.0-0028069390","1994-01-01","Anti-CD2 receptor and anti-CD2 ligand (CD48) antibodies synergize to prolong allograft survival"
"0024399796","2665844","","2-s2.0-0024399796","1989-01-01","Successful HLA nonidentical bone marrow transplantation in three patients with the leukocyte adhesion deficiency"
"0025980207","1670971","","2-s2.0-0025980207","1991-01-01","Anti-CD2 monoclonal antibodies alter cellmediated immunity in vivo"
"0029126818","7632973","","2-s2.0-0029126818","1995-08-15","Results of allogeneic bone marrow transplantation in patients with leukocyte adhesion deficiency"
"0024815240","2698644","","2-s2.0-0024815240","1989-12-01","The use of HLA-non identical T-cell-depleted marrow transplants for correction of severe combined immunodeficiency disease"
"0027437515","8219187","","2-s2.0-0027437515","1993-11-15","Splenectomy and/or bone marrow transplantation in the management of the Wiskott-Aldrich syndrome: Long-term follow-up of 62 cases"
"0025718843","1960605","10.1016/S0022-3476(05)83041-0","2-s2.0-0025718843","1991-01-01","Marrow transplantation from human leukocyte antigen-identical or haploidentical donors for correction of Wiskott-Aldrich syndrome"
"0026667450","1383383","","2-s2.0-0026667450","1992-11-01","CD48 is a counter-receptor for mouse CD2 and is involved in T cell activation"
"0027092058","1467526","","2-s2.0-0027092058","1992-12-15","Myeloid and lymphoid chimerism after T-cell-depleted bone marrow transplantation: Evaluation of conditioning regimens using the polymerase chain reaction to amplify human minisatellite regions of genomic DNA"
"0027446688","8229525","10.1016/S0022-3476(05)80388-9","2-s2.0-0027446688","1993-01-01","Major histocompatibility complex class II deficiency: Clinical manifestations, immunologic features, and outcome"
"0027525387","8410508","10.1016/S0022-3476(05)80951-5","2-s2.0-0027525387","1993-01-01","Severe combined immunodeficiency: A retrospective single-center study of clinical presentation and outcome in 117 patients"
"0026072162","1680913","","2-s2.0-0026072162","1991-10-01","Induction of negative signal through CD2 during antigen-specific T cell activation"
"0025856309","1716919","","2-s2.0-0025856309","1991-01-01","Role of lymphocyte adhesion receptors in transient interactions and cell locomotion"
"0027163180","7686212","","2-s2.0-0027163180","1993-01-01","Specific interaction of lymphocyte function-associated antigen 3 with CD2 can inhibit T cell responses"
"0026704425","1377404","","2-s2.0-0026704425","1992-06-26","Overlapping but nonidentical binding sites on CD2 for CD58 and a second ligand CD59"
"0028006550","8274744","","2-s2.0-0028006550","1994-01-01","Attenuation of graft-versus-host disease and graft rejection by ex vivo immunotoxin elimination of alloreactive T cells in an H-2 haplotype disparate mouse combination"
"0022993593","2877223","10.1016/S0140-6736(86)90465-4","2-s2.0-0022993593","1986-11-08","PREVENTION OF GRAFT FAILURE BY AN ANTI-HLFA-1 MONOCLONAL ANTIBODY IN HLA-MISMATCHED BONE-MARROW TRANSPLANTATION"
"9544243065","","","2-s2.0-9544243065","1994-12-16",""
"0024472149","2576417","","2-s2.0-0024472149","1989-01-01","The structural biology of CD2"
"0024472152","2483402","","2-s2.0-0024472152","1989-01-01","T-lymphocyte activation: The biology and function of CD2 and CD4"
"0024426267","2673457","","2-s2.0-0024426267","1989-01-01","In vivo infusion of anti LFA-1 antibody in HLA non-identical bone marrow transplantation in children: Serum concentrations and biological effects"
"0020381828","6815269","","2-s2.0-0020381828","1982-12-01","Is the E receptor on human T lymphocytes a 'negative signal receptor'?"
"0027496475","8400285","","2-s2.0-0027496475","1993-01-01","Treatment of familial hemophagocytic lymphohistiocytosis with antithymocyte globulins, steroids, and cyclosporin A"
"0022634829","3510681","","2-s2.0-0022634829","1986-06-03","HLA-haploidentical bone marrow transplantation for severe combined immunodeficiency using E rosette fractionation and cyclosporine"
"0020691120","6217853","","2-s2.0-0020691120","1983-04-07","Transplantation for severe combined immunodeficiency with HLA-A,B,D,DR incompatible parental marrow cells fractionated by soybean agglutinin and sheep red blood cells"
"4243760216","","","2-s2.0-4243760216","2000-01-18","Approach to post-testicular contraception"
"0033031511","10221711","","2-s2.0-0033031511","1999-03-25","Experience with external quality control in spermatology"
"0030949124","9177342","10.1038/42408","2-s2.0-0030949124","1997-06-05","Functional rafts in cell membranes"
"2442754050","10465523","10.1093/humupd/5.4.314","2-s2.0-2442754050","1999-07-01","Carbohydrate-based interactions on the route of a spermatozoon to fertilization"
"0023105575","3295232","10.1016/0165-0378(87)90051-9","2-s2.0-0023105575","1987-01-01","Establishment and characterization of a human hybridoma secreting monoclonal antibody with high titers of sperm immobilizing and agglutinating activities against human seminal plasma"
"0027751395","8150894","","2-s2.0-0027751395","1993-12-01","Preliminaries to fertilization: The role of cholesterol during capacitation of human spermatozoa"
"0028850479","8567809","","2-s2.0-0028850479","1995-10-01","Changes in the sialylglycoconjugate distribution on the human sperm surface during in-vitro capacitation: Partial purification of a 20 kda sialylglycoprotein of capacitated spermatozoa"
"0026343224","1770139","","2-s2.0-0026343224","1991-11-01","Opinion site of antisperm antibody action"
"0032904597","10336018","10.1093/humupd/5.2.141","2-s2.0-0032904597","1999-03-01","Recent biochemical approaches to post-testicular, epididymal contraception"
"0033982487","10618662","10.1002/(SICI)1098-2795(200002)55:2&lt;220::AID-MRD12&gt;3.0.CO;2-I","2-s2.0-0033982487","2000-01-24","cAMP-dependent protein kinase control of plasma membrane lipid architecture in boar sperm"
"0035208037","11114591","","2-s2.0-0035208037","2001-01-01","New insights into the origin, structure and role of CD52: A major component of the mammalian sperm glycocalyx"
"0031736457","9796613","","2-s2.0-0031736457","1998-09-01","A flow cytometric technique using peanut agglutinin for evaluating acrosomal loss from human spermatozoa"
"0029657896","8916050","10.1002/(SICI)1098-2795(199611)45:3&lt;378::AID-MRD16&gt;3.0.CO;2-V","2-s2.0-0029657896","1996-11-01","Bicarbonate/CO2, an effector of capacitation, induces a rapid and reversible change in the lipid architecture of boar sperm plasma membranes"
"0031907450","9542968","10.1093/molehr/4.2.119","2-s2.0-0031907450","1998-02-01","Specific localization in the equatorial region of gp20, a 20 kDa sialylglycoprotein of the capacitated human spermatozoon acquired during epididymal transit which is necessary to penetrate zona-free hamster eggs"
"0003101245","","","2-s2.0-0003101245","1999-07-13","Regulation of sperm transport in the mammalian oviduct"
"0002833204","","","2-s2.0-0002833204","1997-11-07","Physiology of sperm maturation and fertilization"
"0031776647","9674986","10.1095/biolreprod59.1.7","2-s2.0-0031776647","1998-07-01","Role of cholesterol in sperm capacitation"
"0002302562","","","2-s2.0-0002302562","1994-03-28","Mammalian fertilization"
"0031779607","9665631","10.1093/molehr/4.5.447","2-s2.0-0031779607","1998-05-01","Epididymal secretion of CD52 as measured in human seminal plasma by a fluorescence immunoassay"
"0000888921","","","2-s2.0-0000888921","1990-07-13","Coating antigens of human seminal plasma involved in fertilization"
"0026568653","1617009","","2-s2.0-0026568653","1992-01-01","Comparative studies of the antigens recognized by sperm-immobilizing monoclonal antibodies"
"0030729271","9369181","10.1095/biolreprod57.5.1136","2-s2.0-0030729271","1997-11-01","Biochemical characterization of sperm agglutination antigen-1, a human sperm surface antigen implicated in gamete interactions"
"0003567251","","","2-s2.0-0003567251","1999-03-28",""
"0033783552","","","2-s2.0-0033783552","2000-01-01","Sperm maturation in the human epididymis"
"0032815454","10428755","","2-s2.0-0032815454","1999-08-23","N-linked glycan of a sperm CD52 glycoform associated with human infertility"
"0002647611","","","2-s2.0-0002647611","1971-07-13","The culture of mouse embryos in vitro"
"0038475121","10514467","10.1074/jbc.274.42.29862","2-s2.0-0038475121","1999-10-15","Male-specific modification of human CD52"
"0026708871","1624001","","2-s2.0-0026708871","1992-01-01","Internal quality control of semen analysis"
"0031956353","9603240","10.1095/biolreprod58.5.1102","2-s2.0-0031956353","1998-05-01","The modulation of sperm function by the oviductal epithelium"
"0031282203","9356178","","2-s2.0-0031282203","1997-11-01","Analysis of the process of localization of fertilin to the sperm posterior head plasma membrane domain during sperm maturation in the epididymis"
"0028872592","7875608","10.1016/0378-1119(94)00739-F","2-s2.0-0028872592","1995-02-14","The monkey ESP14.6 mRNA, a novel transcript expressed at high levels in the epididymis"
"0029890555","8737043","","2-s2.0-0029890555","1996-06-06","Maturation of sperm motility in the epididymis of the common marmoset (Callithrix jacchus) and the cynomolgus monkey (Macaca fascicularis)"
"0029867339","8924506","10.1095/biolreprod54.4.857","2-s2.0-0029867339","1996-04-01","Molecular cloning and characterization of EPI-1, the major protein in chimpanzee (Pan troglodytes) cauda epididymal fluid"
"0032226989","10645268","","2-s2.0-0032226989","1998-01-01","Plasma membrane structure and remodelling during sperm maturation in the epididymis."
"0032921248","9890751","10.1002/(SICI)1098-2795(199902)52:2&lt;196::AID-MRD11&gt;3.0.CO;2-A","2-s2.0-0032921248","1999-01-11","Biochemical maturation of Spam1 (PH-20) during epididymal transit of mouse sperm involves modifications of N-linked oligosaccharides"
"0025151870","2229175","","2-s2.0-0025151870","1990-11-21","Evidence that proteolysis of the surface is an initial step in the mechanism of formation of sperm cell surface domains"
"0025240758","1693137","10.1111/j.1365-2605.1990.tb00972.x","2-s2.0-0025240758","1990-01-01","Cloning and analysis of mRNAs expressed specifically in the human epididymis"
"0029797551","8889706","","2-s2.0-0029797551","1996-10-21","Maturation of monkey spermatozoa in the epididymis with respect to their ability to undergo the acrosome reaction"
"0031282021","9356177","","2-s2.0-0031282021","1997-11-01","Evidence for distinct serine protease activities with a potential role in processing the sperm protein fertilin"
"2442745953","10465522","10.1093/humupd/5.4.302","2-s2.0-2442745953","1999-07-01","The glycocalyx of the sperm surface"
"0031861167","9685187","10.1530/ror.0.0030086","2-s2.0-0031861167","1998-07-16","Molecular characterization of epididymal proteins"
"0029866407","8924505","10.1095/biolreprod54.4.847","2-s2.0-0029866407","1996-04-01","Molecular cloning and characterization of HE1, a major secretory protein of the human epididymis"
"0018913067","6773889","10.1111/j.1365-2605.1980.tb00099.x","2-s2.0-0018913067","1980-01-01","Seasonality in Endocrine and Exocrine Testicular Function of the Adult Rhesus Monkey (Macaca mulatta) Maintained in a Controlled Laboratory Environment"
"0000738053","","","2-s2.0-0000738053","1998-07-13","Epididymis"
"0025695634","2148564","","2-s2.0-0025695634","1990-12-01","Cholesterol controls the clustering of the glycophospholipid-anchored membrane receptor for 5-methyltetrahydrofolate"
"0030814765","9235917","10.1074/jbc.272.31.19242","2-s2.0-0030814765","1997-08-01","Signal transduction via glycosyl phosphatidylinositol-anchored proteins in T cells is inhibited by lowering cellular cholesterol"
"0028900312","7875380","10.1006/dbio.1995.1050","2-s2.0-0028900312","1995-02-01","Rat Sperm Plasma Membrane Mannosidase: Localization and Evidence for Proteolytic Processing during Epididymal Maturation"
"0030872253","9282981","10.1095/biolreprod57.3.487","2-s2.0-0030872253","1997-09-01","Mammalian fertilization: A carbohydrate-mediated event"
"0032227044","10645269","","2-s2.0-0032227044","1998-01-01","Role of luminal fluid glycosyltransferases and glycosidases in the modification of rat sperm plasma membrane glycoproteins during epididymal maturation."
"0026082050","1865391","10.1016/0165-0378(91)90040-W","2-s2.0-0026082050","1991-01-01","Evaluation of human sperm-zona pellucida tight binding by presence of monoclonal antibodies to sperm antigens"
"0031968903","9603241","10.1095/biolreprod58.5.1105","2-s2.0-0031968903","1998-05-01","The oviductal sperm reservoir in mammals: Mechanisms of formation"
"0025788975","1714914","","2-s2.0-0025788975","1991-09-27","Endoproteolytic cleavage in the extracellular domain of the integral plasma membrane protein CE9 precedes its redistribution from the posterior to the anterior tail of the rat spermatozoon during epididymal maturation"
"0030770471","9322098","10.1093/humupd/3.3.205","2-s2.0-0030770471","1997-05-01","Maturation of human spermatozoa (from selected epididymides of prostatic carcinoma patients) with respect to their morphology and ability to undergo the acrosome reaction"
"0031800745","9665629","10.1093/molehr/4.5.429","2-s2.0-0031800745","1998-05-01","Macaque MDC family of proteins: Sequence analysis, tissue distribution and processing in the male reproductive tract"
"0029861018","8923217","","2-s2.0-0029861018","1996-10-01","Testicular biosynthesis and epididymal endoproteolytic processing of rat sperm surface antigen 2B1"
"0028871935","7492795","","2-s2.0-0028871935","1995-01-01","CD8-depleted donor lymphocyte infusion as treatment for relapsed chronic myelogenous leukemia after allogeneic bone marrow transplantation"
"0027409544","8426208","","2-s2.0-0027409544","1993-12-01","Second allogeneic marrow transplantation for patients with recurrent leukemia after initial transplant with total-body irradiation-containing regimens"
"0026602322","1536963","","2-s2.0-0026602322","1992-01-01","Donor leukocyte infusions for chronic myeloid leukemia in relapse after allogeneic bone marrow transplantation [3]"
"2942712161","9053463","","2-s2.0-2942712161","1997-02-01","Donor leukocyte infusions in 140 patients with relapsed malignancy after allogeneic bone marrow transplantation"
"0006778743","","","2-s2.0-0006778743","1997-07-13","Leukemia-free survival after allogeneic transplantation for chronic myeloid leukemia: Effect of reclassifying responders to donor lymphocyte infusions as 'currently free of leukemia'"
"0021344640","6142357","10.1016/S0140-6736(84)92179-2","2-s2.0-0021344640","1984-03-24","ALLOGENEIC BONE-MARROW TRANSPLANTATION FOR CHRONIC MYELOGENOUS LEUKAEMIA"
"23444449333","8259165","10.1056/NEJM199401133300204","2-s2.0-23444449333","1994-01-13","Induction of graft-versus-host disease as immunotherapy for relapsed chronic myeloid leukemia"
"0027437385","8400284","","2-s2.0-0027437385","1993-01-01","Salvage immunotherapy using donor leukocyte infusions as treatment for relapsed chronic myelogenous leukemia after allogeneic bone marrow transplantation: Efficacy and toxicity of a defined T-cell dose"
"0028863238","7579468","","2-s2.0-0028863238","1995-11-01","Bone Marrow Transplantation for Chronic Myeloid Leukemia with Volunteer Unrelated Donors Using Ex Vivo or in Vivo T-Cell Depletion: Major Prognostic Impact of HLA Class I Identity between Donor and Recipient"
"0343351784","","","2-s2.0-0343351784","2004-07-13","Estimation of current leukemia free survival following donor lymphocyte infusion therapy for patients with leukemia who relapse after allografting: Application of a multistate model"
"0033015210","10080600","","2-s2.0-0033015210","1999-02-01","Comparative outcomes of T-cell-depleted and non-T-cell-depleted allogeneic bone marrow transplantation for chronic myelogenous leukemia: Impact of donor lymphocyte infusion"
"33845382806","","10.1080/01621459.1958.10501452","2-s2.0-33845382806","1958-01-01","Nonparametric Estimation from Incomplete Observations"
"0027275074","8400243","","2-s2.0-0027275074","1993-09-15","Competitive polymerase chain reaction to estimate the number of BCR-ABL transcripts in chronic myeloid leukemia patients after bone marrow transplantation"
"0029092530","7632930","","2-s2.0-0029092530","1995-08-15","Adoptive Immunotherapy Evaluating Escalating Doses of Donor Leukocytes for Relapse of Chronic Myeloid Leukemia after Bone Marrow Transplantation: Separation of Graft-Versus-Leukemia Responses from Graft-Versus-Host Disease"
"0031470510","9432048","","2-s2.0-0031470510","1997-12-01","The rate and kinetics of molecular response to donor leucocyte transfusions in chronic myeloid leukaemia patients treated for relapse after allogeneic bone marrow transplantation"
"0025678601","2265242","","2-s2.0-0025678601","1990-12-15","Donor leukocyte transfusions for treatment of recurrent chronic myelogenous leukemia in marrow transplant patients"
"0033566306","10397710","","2-s2.0-0033566306","1999-07-15","T-cell depletion plus salvage immunotherapy with donor leukocyte infusions as a strategy to treat chronic-phase chronic myelogenous leukemia patients undergoing HLA-identical sibling marrow transplantation"
"0024694111","2673466","","2-s2.0-0024694111","1989-07-01","Proposals for standardized reporting of results of bone marrow transplantation for leukaemia."
"0028237517","8193375","","2-s2.0-0028237517","1994-06-01","Relapse of chronic myeloid leukemia after allogeneic bone marrow transplant: The case for giving donor leukocyte transfusions before the onset of hematologic relapse"
"0032006125","9446633","","2-s2.0-0032006125","1998-02-01","Nonmyeloablative stem cell transplantation and cell therapy as an alternative to conventional bone marrow transplantation with lethal cytoreduction for the treatment of malignant and nonmalignant hematologic diseases"
"0032605618","10465105","","2-s2.0-0032605618","1999-12-01","Long-term follow-up of patients who achieved complete remission after donor leukocyte infusions"
"0023690307","3285744","","2-s2.0-0023690307","1988-01-01","Bone marrow transplantation for chronic myelogenous leukemia in chronic phase. Increased risk for relapse associated with T-cell depletion"
"0026049124","1912589","","2-s2.0-0026049124","1991-10-15","T-cell depletion of HLA-identical transplants in leukemia"
"0027367294","7693042","","2-s2.0-0027367294","1993-11-15","Outcome for patients who relapse after allogeneic bone marrow transplantation for chronic mveloid leukemia"
"0029100438","7655033","","2-s2.0-0029100438","1995-01-01","Graft-versus-leukemia effect of donor lymphocyte transfusions in marrow grafted patients"
"0027514995","8400248","","2-s2.0-0027514995","1993-01-01","Treatment of chronic myeloid leukemia by marrow transplantation"
"0033962014","10607686","","2-s2.0-0033962014","2000-01-01","Comparison of single-dose and escalating-dose regimens of donor lymphocyte infusion for relapse after allografting for chronic myeloid leukemia"
"0029915037","8775529","","2-s2.0-0029915037","1996-03-21","Five year leukaemia-free survival of 72% and 77% for early stage acute and chronic myeloid leukaemia treated by HLA-identical sibling bone marrow transplantation"
"0030757710","9326220","","2-s2.0-0030757710","1997-10-01","Use of α-2a-interferon to treat cytogenetic relapse of chronic myeloid leukemia after marrow transplantation"
"0021690190","6501888","10.1016/0022-1759(84)90291-6","2-s2.0-0021690190","1984-11-30","Measurement of primary in vivo IgM- and IgG-antibody response to KLH in humans: Implications of pre-immune IgM binding in antigen-specific ELISA"
"0022978832","3531239","","2-s2.0-0022978832","1986-12-01","Designed transfer of specific immune response with bone marrow transplantation"
"0025122037","2136894","","2-s2.0-0025122037","1990-01-01","Requirements for the adoptive transfer of antibody responses to a priming antigen in man"
"0025135114","2207316","","2-s2.0-0025135114","1990-01-01","Reconstitution of antibody response after allogeneic bone marrow transplantation: Effect of lymphocyte depletion by counterflow centrifugal elutriation on the expression of hemagglutinins"
"0019485955","6454452","","2-s2.0-0019485955","1981-10-26","Recovery of antibody production in human allogeneic marrow graft recipients: Influence of time posttransplantation, the presence or absence of chronic graft-versus-host disease, and antithymocyte globulin treatment"
"85004740158","","","2-s2.0-85004740158","1986-12-18","Reconstitution of the B‐cell system following allogeneic BMT: an accelerated recapitulation of ontogenic development"
"0022656382","2868294","10.1016/S0140-6736(86)92315-9","2-s2.0-0022656382","1986-02-15","TRANSFER OF A FUNCTIONING HUMORAL IMMUNE SYSTEM IN TRANSPLANTATION OF T-LYMPHOCYTE-DEPLETED BONE MARROW"
"0023154659","2882184","10.1016/S0140-6736(87)92800-5","2-s2.0-0023154659","1987-04-04","IMMUNE DONORS CAN PROTECT MARROW-TRANSPLANT RECIPIENTS FROM SEVERE CYTOMEGALOVIRUS INFECTIONS"
"0021307005","6230723","","2-s2.0-0021307005","1984-01-01","Immunologic reconstitution after human marrow grafting"
"85004914039","","","2-s2.0-85004914039","1987-12-18","Ex vivo lymphocyte depletion of donor marrow with Campath‐1 destroys donor memory B‐cells. (Abstract)"
"0023761867","3263573","","2-s2.0-0023761867","1988-12-01","B-cell memory is short-lived in the absence of antigen"
"0022621521","3005424","","2-s2.0-0022621521","1986-01-01","Risk factors for cytomegalovirus infection after human marrow transplantation"
"0016860720","235092","","2-s2.0-0016860720","1975-04-24","Bone-marrow transplantation (second of two parts)."
"0023094767","3542077","","2-s2.0-0023094767","1987-01-01","The kinetics of immune reconstitution after human marrow transplantation"
"0025347511","2186835","","2-s2.0-0025347511","1990-01-01","Review: Reconstruction of the haemopoietic and immune systems after marrow transplantation"
"85004776344","","","2-s2.0-85004776344","1986-12-18","In vitro detection of antibody secreting cells after in vivo immunization with tetanus toxoid and helix pomatia hemocyanin"
"0017287455","947647","","2-s2.0-0017287455","1976-12-01","Primary immune response to Helix pomatia haemocyanin in malignant melanoma. Relationship between 19S and 7S antibody response and in vitro lymphocyte transformation"
"0022574136","3511982","","2-s2.0-0022574136","1986-01-01","The detection of specific antibody formation to recall antigens after human bone marrow transplantation"
"0023105211","3549902","","2-s2.0-0023105211","1987-06-05","B cell development and regulation after T cell-depleted marrow transplantation"
"0025602219","2124933","","2-s2.0-0025602219","1990-12-01","Immunity against Pseudomonas aeruginosa adoptively transferred to bone marrow transplant recipients"
"0023281442","3274586","","2-s2.0-0023281442","1987-02-01","Transfer of B memory cells to a T-dependent antigen in murine bone marrow transplantation."
"0024204129","3059190","","2-s2.0-0024204129","1988-12-01","Transfer of allergen-specific IgE-mediated hypersensitivity with allogeneic bone marrow transplantation"
"0021249959","6204376","10.1111/j.1365-3083.1984.tb00968.x","2-s2.0-0021249959","1984-01-01","Detection of Single Antibody‐Secreting Cells Generated After in Vitro Antigen‐Induced Stimulation of Human Peripheral Blood Lymphocytes"
"85004914027","","","2-s2.0-85004914027","1987-12-18","Immune reconstitution following bone marrow transplantation in man"
"0023719303","3056548","","2-s2.0-0023719303","1988-01-01","Transfer of specific immunity in marrow recipients given HLA-mismatched, T cell-depleted, or HLA-identical marrow grafts"
"85004806625","","","2-s2.0-85004806625","1984-12-18","The immune response to primary immunogens in man"
"84912650604","","","2-s2.0-84912650604","1983-12-07",""
"0025318298","2111124","","2-s2.0-0025318298","1990-01-01","Genes associated with rheumatoid arthritis and mild inflammatory arthritis. II. Association of HLA with complement C3 and immunoglobulin Gm allotypes"
"0025360302","2366834","","2-s2.0-0025360302","1990-07-26","Monoclonal-antibody therapy in systemic vasculitis"
"0025602264","1980112","10.1002/eji.1830201232","2-s2.0-0025602264","1990-01-01","The induction of skin graft tolerance in major histocompatibility complex‐mismatched or primed recipients: primed T cells can be tolerized in the periphery with anti‐CD4 and anti‐CD8 antibodies"
"0025068741","2319138","10.1016/0022-1759(90)90335-S","2-s2.0-0025068741","1990-02-20","A simple method for measuring patient anti-globulin responses against isotypic or idiotypic determinants"
"0024353080","2469440","","2-s2.0-0024353080","1989-01-01","Manipulation of T-cell responses with monoclonal antibodies"
"0023432812","2444978","","2-s2.0-0023432812","1987-10-01","Interferon beta 2/B-cell stimulatory factor type 2 shares identity with monocyte-derived hepatocyte-stimulating factor and regulates the major acute phase protein response in liver cells."
"0023841168","3276066","","2-s2.0-0023841168","1988-01-01","Increased infections associated with the use of OKT3 for treatment of steroid-resistant rejection in renal transplantation"
"0025743242","1678821","10.1016/0140-6736(91)91133-F","2-s2.0-0025743242","1991-08-31","Treatment of inflammatory bowel disease with anti-CD4 monoclonal antibody"
"0025862110","1677143","10.1016/0140-6736(91)90464-Z","2-s2.0-0025862110","1991-08-03","Chimaeric CD4 monoclonal antibody in treatment of generalised pustular psoriasis"
"0026539424","1535492","10.1136/ard.51.5.577","2-s2.0-0026539424","1992-01-01","Immunotherapy of rheumatoid arthritis"
"0025516477","2104282","","2-s2.0-0025516477","1990-11-01","Humanisation of monoclonal antibodies for therapy"
"0022548675","3486938","","2-s2.0-0022548675","1986-01-01","Tolerance to rat monoclonal antibodies. Implications for serotherapy"
"12744255642","","","2-s2.0-12744255642","1986-12-08","Induction of tolerance by administration of monoclonal antibody to L3T4"
"0024308844","2584938","10.1084/jem.170.6.2153","2-s2.0-0024308844","1989-12-22","The immunogenicity of chimeric antibodies"
"0025348745","2194461","10.1002/art.1780330602","2-s2.0-0025348745","1990-01-01","How important are t cells in chronic rheumatoid synovitis?"
"84920218812","","","2-s2.0-84920218812","1992-01-09","OKT3 in allogeneic transplantation: clinical efficacy, mode of action, and side effects"
"0026500625","1370512","","2-s2.0-0026500625","1992-02-01","CD58 and CD59 molecules exhibit potentializing effects in T cell adhesion and activation"
"0027498149","8425894","10.1083/jcb.120.3.657","2-s2.0-0027498149","1993-02-09","Biosynthesis of glycosylphosphatidylinositol (GPI)-anchored membrane proteins in intact cells: Specific amino acid requirements adjacent to the site of cleavage and GPI attachment"
"0026457327","1385527","","2-s2.0-0026457327","1992-12-01","Signal transduction through decay-accelerating factor - Interaction of glycosyl-phophatidylinositol anchor and protein tyrosine kinases p56lckandp59fyn"
"0024456866","2475570","","2-s2.0-0024456866","1989-01-01","CD59, an LY-6-like protein expressed in human lymphoid cells, regulates the action of the complement membrane attack complex on homologous cells"
"0021713655","6238120","","2-s2.0-0021713655","1984-12-01","Inhibition of complement activation on the surface of cells after incorporation of decay-accelerating factor (DAF) into their membranes"
"0026348933","1836788","","2-s2.0-0026348933","1991-12-01","Fusion of sequence elements from non-anchored proteins to generate a fully functional signal for glycophosphatidylinositol membrane anchor attachment"
"0016640079","163658","","2-s2.0-0016640079","1975-12-01","Human chronic myelogenous leukemia cell line with positive Philadelphia chromosome"
"0020361983","6759145","10.1002/eji.1830121116","2-s2.0-0020361983","1982-01-01","Human in vivo antigenic modulation induced by the anti‐T cell OKT3 monoclonal antibody"
"0020564003","6345676","10.1016/0022-1759(83)90160-6","2-s2.0-0020564003","1983-07-15","The characterisation of monoclonal antibodies against haemopoietic cells: Comparison of an immunoperoxidase method with fluorescence activated cell sorting"
"0003173875","","10.1016/0167-5699(83)90013-0","2-s2.0-0003173875","1983-01-01","Advantages of rat monoclonal antibodies"
"0020415501","6821397","","2-s2.0-0020415501","1982-12-01","Monoclonal antibodies against rat immunoglobulin kappa chains"
"85004709310","","","2-s2.0-85004709310","1972-12-18","Rosette‐forming human lymphoid cell lines. I. Establishment and evidence for origin of thymus‐derived lymphocytes"
"0017155490","178611","10.1002/ijc.2910170504","2-s2.0-0017155490","1976-01-01","Establishment and characterization of a human histiocytic lymphoma cell line (U‐937)"
"0020510240","6409188","","2-s2.0-0020510240","1983-10-06","Use of an antibody-ricin A-chain conjugate to delete neoplastic B cells from human bone marrow"
"85004894368","","","2-s2.0-85004894368","1984-12-18","Elimination of graft versus host disease by in vitro depletion of alloreactive lymphocytes with a monoclonal rat anti‐human antibody (CAMPATH‐1)"
"0018424389","310519","10.1038/277131a0","2-s2.0-0018424389","1979-12-01","Rat x rat hybrid myelomas and a monoclonal anti-Fd portion of mouse IgG [11]"
"85004849518","","","2-s2.0-85004849518","1984-12-18","Removal of neuroblastoma cells from bone marrow with monoclonal antibodies conjugated to magnetic microspheres"
"0015309208","4333769","10.1093/jnci/48.3.623","2-s2.0-0015309208","1972-01-01","Human lymphoblastoid cell lines. III. Cocu itivation technique for establishment of new lines"
"0018932978","","","2-s2.0-0018932978","1980-01-01","Childhood acute lymphoblastic leukemia: Autologous transplantation with bone marrow treated with antileukemic antibodies."
"0014304475","4174339","","2-s2.0-0014304475","1968-07-01","Surface IgM-kappa Specificity on a Burkitt Lymphoma Cell In Vivo and in Derived Culture Lines"
"0019171140","7216541","10.1002/ijc.2910260605","2-s2.0-0019171140","1980-01-01","Two neoplastic cell lines with unique features derived from Hodgkin's disease"
"0019987517","6956782","10.1016/0145-2126(82)90091-1","2-s2.0-0019987517","1982-01-01","Analysis of human leukemia/lymphoma cell lines with monoclonal antibodies BA-1, BA-2 and BA-3"
"0014802868","5310665","","2-s2.0-0014802868","1970-06-01","Conjugation of fluorescein isothiocyanate to antibodies. I. Experiments on the conditions of conjugation."
"0018408021","83966","10.1002/ijc.2910230206","2-s2.0-0018408021","1979-01-01","Characterization of a leukemic cell line of the pre‐B phenotype"
"0018949394","6931854","","2-s2.0-0018949394","1980-01-01","Modulation of human acute lymphoblastic leukemia antigen induced by monoclonal antibody in vitro"
"0017702412","68013","10.1002/ijc.2910190505","2-s2.0-0017702412","1977-01-01","Characterization of EBV‐genome negative “null” and “T” cell lines derived from children with acute lymphoblastic leukemia and leukemic transformed non‐Hodgkin lymphoma"
"0019271427","","10.1007/BF01561573","2-s2.0-0019271427","1980-02-01","Monoclonal antibodies identifying a novel T-Cell antigen and Ia antigens of human lymphocytes"
"0001206491","14278051","10.1002/1097-0142(196504)18:4&lt;522::AID-CNCR2820180418&gt;3.0.CO;2-J","2-s2.0-0001206491","1965-01-01","Continuous culture of human lymphoblasts from peripheral blood of a child with acute leukemia"
"0017412602","301573","","2-s2.0-0017412602","1977-01-01","A non T, non B human leukemia cell line (NALM 1): establishment of the cell line and presence of leukemia associated antigens"
"85004881641","","","2-s2.0-85004881641","1983-12-26","Autologous bone marrow transplantation in cALLa positive acute lymphoblastic leukemia after in vitro treatment with J5 monoclonal antibody and complement"
"0019454149","6970174","","2-s2.0-0019454149","1981-01-01","Antigenic modulation of lymphocytic surface immunoglobulin yielding resistance to complement-mediated lysis. I. Characterization with syngeneic and xenogeneic complements"
"0013410384","","10.1016/0145-2126(77)90063-7","2-s2.0-0013410384","1977-01-01","The establishment and cytological, cytochemical and immunological characterisation of human haemic cell lines: Evidence for heterogeneity"
"4243615925","","","2-s2.0-4243615925","1999-09-27","""CAMPATH-1H treatment of T-PLL"""
"0032925443","9894466","","2-s2.0-0032925443","1999-01-01","World Health Organization classification of neoplastic diseases of the hematopoietic and lymphoid tissues: A progress report"
"0022625608","3488584","10.1111/j.1600-0609.1986.tb02278.x","2-s2.0-0022625608","1986-01-01","Morphological and immunological change in the predominant type of leukaemic cells in a patient with T‐cell chronic lymphocytic leukaemia"
"0026350676","1742486","","2-s2.0-0026350676","1991-12-15","Clinical and laboratory features of 78 cases of T-prolymphocytic leukemia"
"0026451377","1545518","","2-s2.0-0026451377","1992-01-01","Adult T-cell leukemia with cervical bone tumor showing immunophenotypic change"
"0028151443","7989933","","2-s2.0-0028151443","1994-12-01","The role of pentostatin in the treatment of T-cell malignancies: Analysis of response rate in 145 patients according to disease subtype"
"33749816517","","","2-s2.0-33749816517","1199-10-20","New approaches to the therapy of autoimmune diseases: Rheumatoid arthritis as a paradigm"
"0024311364","","10.1111/j.1365-2133.1989.tb05981.x","2-s2.0-0024311364","1989-01-01","(5) Induction of remission in systemic vasculitis with monoclonal antibody Campath‐1H"
"0006257872","","","2-s2.0-0006257872","1997-12-01","Transplantation of allogeneic cd34 blood cells additionally t-cell depleted with campath-1h"
"0029984124","8796978","","2-s2.0-0029984124","1996-07-05","Biologic agents in the treatment of inflammatory rheumatic diseases"
"0025905102","1916931","10.1016/0165-2478(91)90205-O","2-s2.0-0025905102","1991-01-01","Immunosuppressive therapy in bone marrow transplantation"
"33749694818","","","2-s2.0-33749694818","1998-10-20","Leukosite and ilex oncology investigate campath-1h in a pivotal clinical trial"
"0026520442","1557261","","2-s2.0-0026520442","1992-04-10","Graft versus host disease in extremely low birth weight neonate [7]"
"33749769669","","","2-s2.0-33749769669","1991-10-20","Monoclonal antibody CAMPATH 1G used to eliminate graft vs. host disease (GvHO) stimulates"
"0026650477","1509294","","2-s2.0-0026650477","1992-07-20","Graft-versus-leukemia without graft-versus-host disease: An elusive goal of bone marrow transplantation"
"0029983008","8704706","","2-s2.0-0029983008","1996-03-01","Reconstitution with Philadelphia chromosome-negative recipient haematopoiesis early after allogeneic BMT for CML"
"0027474142","8437243","","2-s2.0-0027474142","1993-04-09","The immunobiology and clinical use of current immunosuppressive therapy for renal transplantation"
"4244181383","","","2-s2.0-4244181383","1998-09-27","LeukoSite's lead product useful in MS"
"4244140216","","","2-s2.0-4244140216","1996-09-27","Prevention of graft-versus-host disease by transplantation of allogeneic CD34+ blood cells additionally T-cell depleted with CAMPATH-1H"
"33749797308","","","2-s2.0-33749797308","1995-10-20","Clinical Trials with CAM PATH-1 and other antibodies"
"0026769937","","","2-s2.0-0026769937","1992-08-17","New horizons in cancer therapy"
"33749758637","","","2-s2.0-33749758637","1997-10-20","BMT for children with beta-thalassemia major in the UK"
"4243752691","","","2-s2.0-4243752691","1996-11-12","Sustained lymphocyte suppression after single dose CAMPATH-1H (C-1H) infusion: A long term follow-up"
"0343488531","9040585","10.1016/S0140-6736(05)61187-7","2-s2.0-0343488531","1997-02-15","Peripheral blood stem-cell transplantation for refractory autoimmune thrombocytopenic purpura"
"0029820588","8871712","","2-s2.0-0029820588","1996-08-01","Assessment of brain changes with registered MR before and after bone marrow transplantation for chronic myeloid leukemia"
"0030763580","9308643","","2-s2.0-0030763580","1997-09-01","Chronic anemia due to parvovirus B19 infection in a bone marrow transplant patient after platelet transfusion"
"0006162347","","","2-s2.0-0006162347","1992-12-09","Treatment of rheumatoid arthritis (RA) with single-dose infusion of CAMPATH-1H"
"0029861524","8914801","","2-s2.0-0029861524","1996-11-13","Immunotherapy for non-Hodgkin's lymphoma"
"0030444375","8971386","","2-s2.0-0030444375","1996-12-01","Molecular analysis of transient cytogenetic relapse after allogeneic bone marrow transplantation for chronic myeloid leukaemia"
"33749749579","","","2-s2.0-33749749579","1997-10-20","ILEX Oncology announces second quarter 1997 results ILEX Oncology"
"0006210475","","","2-s2.0-0006210475","1995-07-13","Subcutaneous titration of Campath-1H: Clinical and biological outcomes"
"33749735609","","","2-s2.0-33749735609","1998-10-20","LeukoSite Reports Year-End 1997 Financial Results, Strategic Alliances and Financing Accelerate Drug"
"0029995946","","","2-s2.0-0029995946","1996-08-10","The current status and future prospects for biological targeted therapies for rheumatoid arthritis"
"33749756616","","","2-s2.0-33749756616","1997-10-20","Lilly links with ILEX on anticancers"
"0025853699","1916909","10.1016/0165-2478(91)90211-R","2-s2.0-0025853699","1991-01-01","Monoclonal antibody therapy for the induction of transplantation tolerance"
"0030626129","","","2-s2.0-0030626129","1997-10-01","Treatment of B-cell chronic lymphocytic leukaemia: Current status and future perspectives"
"33749686631","","","2-s2.0-33749686631","1995-10-20","Genetically engineered proteins for immunoregulation"
"33749811613","","","2-s2.0-33749811613","1997-10-20","ILEX Oncology Announces Third Quarter 1997 Results ILEX Oncology"
"33749810557","","","2-s2.0-33749810557","1997-10-20","Leukosite LDP-03 US phase III study in fludarabineresistent leukemia"
"0024469120","2790335","","2-s2.0-0024469120","1989-01-01","Recovery of circulating haemopoietic progenitor cells in the early phase of haemopoietic reconstitution after autologous and allogeneic bone marrow transplantation"
"0029783053","","","2-s2.0-0029783053","1996-09-05","MRI in the assessment of putative treatments for multiple sclerosis"
"33749706113","","","2-s2.0-33749706113","1998-10-20","Morphosys postpones listing, cites global market turmoil"
"0000338685","","","2-s2.0-0000338685","1997-09-27","Campath-1H therapy for patients with refractory chronic lymphocytic leukemia"
"0031929960","","10.1517/13543784.7.3.373","2-s2.0-0031929960","1998-03-21","Immunoscreening protocols for the identification of clinically useful antibodies and antigens"
"0029665232","8652391","","2-s2.0-0029665232","1996-12-01","Matched and mismatched unrelated donor bone marrow transplantation for juvenile chronic myeloid leukaemia"
"33749726237","","","2-s2.0-33749726237","1995-10-20","British Technology Group (company brochure 1995)"
"33749797302","","","2-s2.0-33749797302","1997-10-20","Hambrecht and Quist Healthcare Conference"
"33749764829","","","2-s2.0-33749764829","1994-10-20","BTG seeks new development capital licensing opportunities"
"0001276736","","","2-s2.0-0001276736","1995-10-22","Objective clinical responses in patients with recurrent low grade lymphoma treated with CAMPATH-1H monoclonal antibody"
"0030751968","","","2-s2.0-0030751968","1997-07-30","Antibodies in the therapy of autoimmune thrombocytopenia: Practical recommendations"
"0030944188","9114824","","2-s2.0-0030944188","1997-01-01","Current and investigational therapies used to alter the course of disease in multiple sclerosis"
"0030771945","9314336","10.1016/S0091-6749(97)70237-9","2-s2.0-0030771945","1997-10-03","Human eosinophils"
"33749692613","","","2-s2.0-33749692613","1998-10-20","ILEX Oncology announces fourth quarter and year-end results, record revenue achieved for 1997 ILEX Oncology"
"33749737318","","","2-s2.0-33749737318","1994-10-20","Wellcome discontinues studies of CAMPATH-1 H"
"0023720441","","","2-s2.0-0023720441","1988-01-01","Compath-1 for prevention of graft-versus-host disease and graft rejection. Summary of results from a multi-centre study"
"0006170359","","","2-s2.0-0006170359","1996-10-20","Comparative analysis of CD34+ selected and Campath treated bone marrow (BM): Evaluation of T-cell content and progenitor proliferative potential"
"33749710901","","","2-s2.0-33749710901","1997-10-20","ILEX Oncology and LeukoSite form joint venture to develop anti-leukemia compound"
"33749774057","","","2-s2.0-33749774057","1998-10-20","ILEX/LeukoSite start pivotal trial with CAMPATH in CLL"
"0029825373","","","2-s2.0-0029825373","1996-10-25","Drugs in development for the treatment of multiple sclerosis: Antigen non-specific therapies"
"0006156558","","","2-s2.0-0006156558","1992-07-13","T-cell depletion by exposure to campath 1G in vitro virtually abolishes acute graft-versus-host disease"
"0030098264","8650433","","2-s2.0-0030098264","1996-03-01","Immunosuppressive therapy for vasculitides"
"33749749402","","","2-s2.0-33749749402","1998-10-20","LeukoSite reports second quarter results"
"0006162353","","","2-s2.0-0006162353","1997-12-01","Ex vivo t-cell depletion with campath 1g completely abrogates graft-versus-host disease (GVHD) in peripheral blood stem cell (PBSC) allografts"
"0027418258","8448530","","2-s2.0-0027418258","1993-03-30","Prevention and treatment of acute GvHD - New modalities"
"33749738110","","","2-s2.0-33749738110","2006-10-20","ILEX Oncology announces first quarter 1998 results ILEX Oncology"
"0025945424","1756322","","2-s2.0-0025945424","1991-11-18","Graft-versus-leukaemia following allogeneic bone marrow transplantation: Emergence of cytotoxic T lymphocytes reacting to host leukaemia cells"
"0024511355","","","2-s2.0-0024511355","1989-01-01","PUVA treatment of the cutaneous graft-versus-host reactions after allogeneic bone marrow grafting"
"33749746677","","","2-s2.0-33749746677","1998-10-20","Open house presentation - ILEX Oncology Inc"
"33749705198","","","2-s2.0-33749705198","2006-10-20",""
"33749692240","","","2-s2.0-33749692240","1997-10-20","LeukoSite/Genzyme inflammation deal"
"0031011793","9178842","","2-s2.0-0031011793","1997-12-01","Monoclonal antibodies in the treatment of non-Hodgkin's lymphoma: Recent results and future prospects"
"33749813055","","","2-s2.0-33749813055","1997-10-20","Factors influencing the outcome of bone marrow transplants using unrelated donors"
"0006239154","","","2-s2.0-0006239154","1989-07-13","Purification and preliminary characterization of the CAMPATH-1 antigen"
"0006167881","","","2-s2.0-0006167881","1997-12-01","T-cell depletion of bone marrow grafts with campath 1 ex vivo prevents oraft-versus-host disease without abrogating the antileukaemic effect of transplantation"
"0026523294","1613738","","2-s2.0-0026523294","1992-03-02","Biological agents in rheumatoid arthritis"
"0029666221","","","2-s2.0-0029666221","1996-05-20","Repopulation of blood lymphocytes sub-populations in rheumatoid arthritis patients treated with the depleting humanized monoclonal antibody, CAMPATH-1H"
"0030457118","","","2-s2.0-0030457118","1996-12-01","Antibodies as cytotoxic therapy for hematological malignant disease"
"33749767608","","","2-s2.0-33749767608","2006-10-20",""
"33749773580","","","2-s2.0-33749773580","1996-10-20",""
"33749743418","","","2-s2.0-33749743418","1988-10-20",""
"0006170358","","","2-s2.0-0006170358","1997-07-13","BTG licenses Campath-1H to LeukoSite"
"0030477330","9059264","","2-s2.0-0030477330","1996-12-01","Short term immunosuppressive therapy and long term immunoregulation: Promises and problems"
"4243752688","","","2-s2.0-4243752688","1997-09-27","Differential expression of CAMPATH-1H (CD52) antigen in normal and leukemic B and T cells: A rational for the antibody responses ""in vivo"""
"33749728662","","","2-s2.0-33749728662","2006-10-20","ILEX Oncology Announces Second Quarter 1998 Results Total Revenues Increase 42 Percent"
"33749779475","","","2-s2.0-33749779475","1992-10-20",""
"33749708918","","","2-s2.0-33749708918","1990-10-20","Immune-reconstitution after BMT with or without CAMPATH-1-M treatment of HLA identical sibling or unrelated donor marrow"
"33749745352","","","2-s2.0-33749745352","1990-10-20",""
"0029834325","8891753","","2-s2.0-0029834325","1996-10-10","Therapeutic approaches to allergic and inflammatory diseases: Fourth annual midwest meeting of the Inflammation Research Association"
"33749705456","","","2-s2.0-33749705456","1998-10-20","LeukoSite generates S12M for antibody drugs"
"0025055647","2406886","10.3109/00365529008999203","2-s2.0-0025055647","1990-01-01","Liver transplantation today"
"33749703346","","","2-s2.0-33749703346","1998-10-20","ILEX Oncology completes enrollment in CAMPATH-1H pivotal investigational clinical trial"
"33749732416","","","2-s2.0-33749732416","1998-10-20","ILEX Oncology announces third quarter results. Company remains on schedule with development of lead compound, CAMPATH"
"0006200555","","","2-s2.0-0006200555","1990-07-13","In-vivo T cell depletion with Campath-1G monoclonal antibody as compared to radiotherapy and combination chemotherapy using limiting dilution analysis"
"33749807310","","","2-s2.0-33749807310","1998-10-20","LeukoSite reports first quarter results and progress on three clinical programs"
"0026528159","1539279","","2-s2.0-0026528159","1992-03-20","Cold ex vivo administration of monoclonal antibodies for conditioning small bowel allografts"
"33749747360","","","2-s2.0-33749747360","1997-10-20","ILEX and LeukoSite to develop CAMPATH"
"33749742045","","","2-s2.0-33749742045","1998-10-20","American College of Rheumatology - 62nd National Meeting, San Diego, ÇA, USA"
"0031866747","","10.1517/13543776.8.7.831","2-s2.0-0031866747","1998-07-14","Recent advances in preclinical drug development in multiple sclerosis"
"10544240368","8932805","","2-s2.0-10544240368","1996-11-01","Unrelated-donor bone marrow transplantation for Philadelphia chromosome-positive chronic myelogenous leukemia in children: Experience of eight European countries"
"33749723840","","","2-s2.0-33749723840","1993-10-20","Adverse reactions to CAMPATH-1H monoclonal antibody [letter, comment]"
"0029794420","8781456","","2-s2.0-0029794420","1996-09-26","Donor lymphocyte infusion for a patient with relapsing myelodysplastic syndrome after allogeneic bone marrow transplantation [7]"
"0026718112","1410859","","2-s2.0-0026718112","1992-01-01","Antilymphocyte antibodies in the treatment of allograft rejection: targets, mechanisms of action, monitoring, and efficacy"
"33749811291","","","2-s2.0-33749811291","1990-10-20","Remission induction in patients with lymphoid malignancies using ünconjugated CAMPATH-1 monoclonal antibodies"
"33749797984","","","2-s2.0-33749797984","1995-10-20","The use of serum-free medium for the production of functionally active humanised monoclonal antibody from NSO mouse myeloma cells engineered using glutamine synthetase as a selectable marker"
"33749815812","","","2-s2.0-33749815812","1995-10-20","Cross-linking of the CAMPATH-1 antigen (CD52) triggers activation of normal human T lymphocytes"
"0027008595","1286872","","2-s2.0-0027008595","1992-12-01","Engineering antibodies for therapy"
"0030749329","9246157","","2-s2.0-0030749329","1997-08-20","The biological therapy of acute and chronic leukemia"
"33749791308","","","2-s2.0-33749791308","2006-10-20",""
"0029068059","7538814","","2-s2.0-0029068059","1995-01-01","Retrovirally marked CD34-enriched peripheral blood and bone marrow cells contribute to long-term engraftment after autologous transplantation"
"0007055495","","","2-s2.0-0007055495","1993-07-13","Addition of Thiotepa improves results in T-cell depleted bone marrow transplant for advanced leukemia"
"4243304652","","","2-s2.0-4243304652","1996-09-27","Hematopoietic and stromal reconstitution after haploidentical allogenic bone marrow transplantation"
"0024952091","2627619","","2-s2.0-0024952091","1989-12-01","Bone marrow transplantation monitoring by DNA analysis"
"0024835023","2573397","","2-s2.0-0024835023","1989-12-01","Allogeneic transplantation of blood-derived, T cell-depleted hemopoietic stem cells after myeloablative treatment in a patient with acute lymphoblastic leukemia"
"0024441169","2572271","10.1111/j.1365-2141.1989.tb00223.x","2-s2.0-0024441169","1989-01-01","Autografting for patients with chronic myeloid leukaemia in chronic phase: peripheral blood stem cells may have a finite capacity for maintaining haemopoiesis"
"0023897720","3282353","","2-s2.0-0023897720","1988-01-01","Probability of finding HLA-matched unrelated marrow donors"
"0021968318","","","2-s2.0-0021968318","1985-01-01","Transplantation of marrow-depleted T cells by soybean lectin agglutination and E-rosette depletion: Major histocompatibility complex-related graft resistance in leukemic transplant recipients"
"0028922505","7537109","","2-s2.0-0028922505","1995-05-01","Peripheral blood progenitor cells mobilized by recombinant human granulocyte colony-stimulating factor plus recombinant rat stem cell factor contain long-term engrafting cells capable of cellular proliferation for more than two years as shown by serial transplantation in mice"
"0027364345","7905331","","2-s2.0-0027364345","1993-01-01","Immune reconstitution following peripheral blood stem cell transplantation, autologous bone marrow transplantation and allogeneic bone marrow transplantation"
"0007054257","","","2-s2.0-0007054257","1994-07-13","Unrelated (URD) bone marrow transplantation for primary immunodeficiencies: An international review"
"0007055945","","","2-s2.0-0007055945","1988-07-13","The host barrier in animal models of T-cell depleted allogenic bone marrow transplantation"
"0029086756","7546208","10.1016/0167-5699(95)80021-2","2-s2.0-0029086756","1995-01-01","Bone marrow transplantation across HLA barriers by increasing the number of transplanted cells"
"0031036639","9057667","","2-s2.0-0031036639","1997-03-11","Long-term maintenance of hematopoiesis in irradiated mice by retrovirally transduced peripheral blood stem cells"
"0003215365","","","2-s2.0-0003215365","1996-07-13","Purified CD34+ blood stem cells from HLA-haploidentical parental donors for transplantation in SCID"
"10144249600","8704219","","2-s2.0-10144249600","1996-08-01","Reconstruction of the immune system after unrelated or partially matched T-cell-depleted bone marrow transplantation in children: Immunophenotypic analysis and factors affecting the speed of recovery"
"0029095946","7545459","","2-s2.0-0029095946","1995-01-01","Combined transplantation of allogeneic bone marrow and CD34+ blood cells"
"0025104618","2120811","","2-s2.0-0025104618","1990-01-01","Enhancement of T cell-depleted bone marrow allografts in mice by thiotepa"
"0028078755","8111055","","2-s2.0-0028078755","1994-01-01","Bone marrow transplantation (BMT) in Europe for primary immunodeficiencies other than severe combined immunodeficiency: A report from the European group for BMT and the European group for immunodeficiency"
"0030951437","9116266","","2-s2.0-0030951437","1997-04-01","The biology and clinical uses of blood stem cells"
"0007007521","","","2-s2.0-0007007521","1988-07-13","Marrow transplants From HLA haploidentical donors: Failure to engraft and late graft failure"
"0007005607","","","2-s2.0-0007005607","1994-07-13","Report of a WHO Scientific Group: Primary immunodeficiency disease"
"0027010641","1345680","","2-s2.0-0027010641","1992-12-01","Design of large-scale separation systems for positive and negative immunomagnetic selection of cells using superparamagnetic microspheres."
"0021826986","3890287","","2-s2.0-0021826986","1985-01-01","Pretransplant conditioning with busulfan (myleran) and cyclophosphamide for nonmalignant diseases: Assessment of engraftment following histocompatible allogeneic bone marrow transplantation"
"0002333879","","","2-s2.0-0002333879","1996-07-13","Transplantation"
"0028125191","7524753","","2-s2.0-0028125191","1994-12-01","Successful engraftment of T-cell-depleted haploidentical ""Three-Loci"" incompatible transplants in leukemia patients by addition of recombinant human granulocyte colony-stimulating factor-mobilized peripheral blood progenitor cells to bone marrow inoculum"
"0028968604","7888684","","2-s2.0-0028968604","1995-01-01","Allogeneic blood stem cell transplantation for refractory leukemia and lymphoma: Potential advantage of blood over marrow allografts"
"0023102095","3098843","","2-s2.0-0023102095","1987-03-24","Abrogation of bone marrow allograft resistance in mice by increased total body irradiation correlates with eradication of host clonable T cells and alloreactive cytotoxic precursors"
"0025230226","1967604","","2-s2.0-0025230226","1990-01-01","Autologous transplantation with peripheral blood stem cells: A review of clinical results"
"0027970797","7524760","","2-s2.0-0027970797","1994-11-01","A comparative study of the phenotype and proliferative capacity of peripheral blood (PB) CD34+ cells mobilized by four different protocols and those of steady-Phase PB and bone marrow CD34+ cells"
"0007099549","","","2-s2.0-0007099549","1990-07-13","European experience of bone marrow transplantation for severe combined immunodeficiency"
"0019138013","6774747","","2-s2.0-0019138013","1980-12-01","Primary structure of human γ3 immunoglobulin deletion mutant: γ3 Heavy-chain disease protein Wis"
"0021686793","6099311","10.1016/0378-1119(84)90049-0","2-s2.0-0021686793","1984-01-01","A new selective phage cloning vector, λ2001, with sites for XbaI, BamHI, HindIII, EcoRI, SstI and XhoI"
"0021487761","6092053","","2-s2.0-0021487761","1984-09-01","Structural analysis of the murine IgG3 constant region gene."
"0014671153","5782707","","2-s2.0-0014671153","1969-01-11","Structural studies of immunoglobulin G."
"0022393228","3862103","","2-s2.0-0022393228","1985-12-01","Intron sequences reveal evolutionary relationships among major histocompatibility complex class I genes"
"0018597853","113060","","2-s2.0-0018597853","1979-12-01","The amino acid sequences of the three heavy chain constant region domains of a human IgG2 myeloma protein"
"0021112458","6310503","10.1093/nar/11.16.5521","2-s2.0-0021112458","1983-08-25","An improved strategy for rapid direct sequencing of both strands of long DNA molecules cloned in a plasmid"
"0018887047","6774012","","2-s2.0-0018887047","1980-01-01","The primary structure of a human IgG2 heavy chain: Genetic, evolutionary, and functional implications"
"0021061389","6417658","","2-s2.0-0021061389","1983-12-01","Transcriptional activation of an unrearranged and untranslocated c-myc oncogene by translocation of a C(λ) locus in Burkitt lymphoma cells"
"84968929998","","","2-s2.0-84968929998","0000-05-25",""
"0014759363","4192699","","2-s2.0-0014759363","1970-03-01","Human immunoglobulin subclasses. Partial amino acid sequence of the constant region of a gamma 4 chain."
"0020700687","6402305","10.1016/0092-8674(83)90508-1","2-s2.0-0020700687","1983-01-01","Evolution of immunoglobulin V genes: Evidence indicating that recently duplicated human Vκ sequences have diverged by gene conversion"
"0017365792","402363","","2-s2.0-0017365792","1977-01-01","Primary structure of the ''hinge'' region of human IgG3. Probable quadruplication of a 15 amino acid residue basic unit"
"0020265211","6808505","10.1073/pnas.79.10.3260","2-s2.0-0020265211","1982-12-01","γ Heavy chain disease in man: cDNA sequence supports partial gene deletion model"
"0020050314","7063411","10.1093/nar/10.2.459","2-s2.0-0020050314","1982-01-22","A catalogue of splice junction sequences"
"0020339799","6234164","","2-s2.0-0020339799","1982-12-01","The sequence of a human immunoglobulin epsilon heavy chain constant region gene, and evidence for three non-allelic genes."
"0014513216","5257969","","2-s2.0-0014513216","1969-05-01","The covalent structure of an entire gammaG immunoglobulin molecule."
"0020609206","6297797","10.1016/0092-8674(83)90471-3","2-s2.0-0020609206","1983-01-01","Gene conversion and polymorphism: Generation of mouse immunoglobulin γ2a chain alleles by differential gene conversion by γ2b chain gene"
"0018137436","690433","","2-s2.0-0018137436","1978-12-01","The primary structure of a human immunoglobulin G2 (IgG2) pFc' fragment"
"0019841554","6795593","10.1093/nar/9.18.4509","2-s2.0-0019841554","1981-09-25","Human immunoglobulin heavy chain genes: Evolutionary comparisons of Cμ, Cδ and Cγ genes and associated switch sequences"
"18344409944","6438434","","2-s2.0-18344409944","1983-09-01","Instability of the human immunoglobulin heavy chain constant region locus indicated by different inherited chromosomal deletions."
"0018679651","115593","10.1016/0092-8674(79)90072-2","2-s2.0-0018679651","1979-01-01","Cloning and complete nucleotide sequence of mouse immunoglobulin γ1 chain gene"
"0020320162","6956859","10.1073/pnas.79.14.4298","2-s2.0-0020320162","1982-12-01","'Nonrandom' DNA sequence analysis in bacteriophage M13 by the dideoxy chain-termination method"
"0020510266","6413581","","2-s2.0-0020510266","1983-01-01","Structural studies of a human γ3 myeloma protein (Jir) bearing the allotypic marker Gm(st)"
"0019830478","7018693","","2-s2.0-0019830478","1981-12-01","Gene conversion: Some implications for immunoglobulin genes"
"0019748856","6299662","","2-s2.0-0019748856","1981-12-01","Nucleotide sequence of a human immunoglobulin Cγ4 gene"
"0019401001","6805411","10.1111/j.1469-1809.1981.tb00346.x","2-s2.0-0019401001","1981-01-01","Immunoglobulin heavy chain genes in humans are located on chromosome 14"
"0015383914","5082088","","2-s2.0-0015383914","1972-08-01","The primary structure of a monoclonal IgG1 immunoglobulin (myeloma protein Nie). II. Amino acid sequence of the constant part of the H-chain, localization of genetic factors"
"0015289418","4333982","","2-s2.0-0015289418","1972-02-01","Epstein-Barr virus: transformation, cytopathic changes, and viral antigens in squirrel monkey and marmoset leukocytes."
"0017375464","881736","10.1016/0022-2836(77)90052-3","2-s2.0-0017375464","1977-06-15","Labeling deoxyribonucleic acid to high specific activity in vitro by nick translation with DNA polymerase I"
"84968929992","","","2-s2.0-84968929992","1970-05-25",""
"0019410679","6790622","","2-s2.0-0019410679","1981-01-01","Structural studies of a human γ3 myeloma protein (Goe) that binds Staph protein A"
"0020454947","6817143","10.1038/300760a0","2-s2.0-0020454947","1982-12-01","Inherited deletion of immunoglobulin heavy chain constant region genes in normal human individuals"
"0017089669","822353","10.1038/263211a0","2-s2.0-0017089669","1976-12-01","3′ Non-coding region sequences in eukaryotic messenger RNA"
"0017367397","322279","","2-s2.0-0017367397","1977-12-01","Screening λgt recombinant clones by hybridization to single plaques in situ"
"84968868176","","","2-s2.0-84968868176","1981-05-25",""
"0019590475","6170065","","2-s2.0-0019590475","1981-07-01","Multiple differences between the nucleic acid sequences of the IgG2aa and IgG2ab alleles of the mouse."
"0020317363","6288268","10.1016/0092-8674(82)90185-4","2-s2.0-0020317363","1982-01-01","Duplication and deletion in the human immunoglobulin ε{lunate} genes"
"0019462488","6262729","10.1093/nar/9.6.1365","2-s2.0-0019462488","1981-03-25","The complete nucleotide sequence of mouse immunoglobulin γ2a gene and evolution of heavy chain genes: Further evidence for intervening sequence-mediated domain transfer"
"0017140548","823945","10.1016/0006-291X(76)90741-5","2-s2.0-0017140548","1976-08-23","The amino acid sequence of ""heavy chain disease"" protein ZUC. Structure of the Fc fragment of immunoglobulin G3"
"0018891226","6766534","10.1038/283786a0","2-s2.0-0018891226","1980-12-01","Complete nucleotide sequence of immunoglobulin γ2b chain gene cloned from newborn mouse DNA [25]"
"0020340895","6329676","","2-s2.0-0020340895","1982-12-01","Comparison of the hinge-coding segments in human immunoglobulin gamma heavy chain genes and the linkage of the gamma 2 and gamma 4 subclass genes."
"0019982096","6804948","","2-s2.0-0019982096","1982-01-01","Linkage and sequence homology of two human immunoglobulin γ heavy chain constant region genes"
"0021247949","6421489","10.1016/0092-8674(84)90348-9","2-s2.0-0021247949","1984-01-01","Mechanisms of divergence and convergence of the human immunoglobulin α1 and α2 constant region gene sequences"
"0020479274","6287432","10.1093/nar/10.13.4071","2-s2.0-0020479274","1982-07-10","The nucleotide sequence of a human immnnoglobulin Cγl gene"
"0001605366","","","2-s2.0-0001605366","2013-06-26","The clinical significance of positive blood cultures in the 1900s: A prospective comprehensive evaluation of the microbiology, epidemiology, and outcome of bacteremia and fungemia in adults"
"0033916181","10918433","","2-s2.0-0033916181","2000-08-12","Febrile neutropenia in allogeneic and autologous peripheral blood stem cell transplantation and conventional chemotherapy for malignancies"
"17544395211","10654023","","2-s2.0-17544395211","2000-02-23","Fulminant hepatitis B following bone marrow transplantation in an HBsAg-negative, HBsAb-positive recipient; Reactivation of dormant virus during the immunosuppressive period"
"0024514532","2539877","","2-s2.0-0024514532","1989-01-01","Treatment of cytomegalovirus pneumonia after bone marrow transplantation with cytomegalovirus immunoglobulin combined with ganciclovir"
"0027254322","8504275","","2-s2.0-0027254322","1993-06-16","Pentamidine aerosol for prophylaxis of Pneumocystis carinii pneumonia after BMT"
"0016803914","234595","","2-s2.0-0016803914","1975-12-01","Bone marrow transplantation"
"0033562823","10233878","","2-s2.0-0033562823","1999-05-15","Influence of intestinal bacterial decontamination using metronidazole and ciprofloxacin or ciprofloxacin alone on the development of acute graft- versus-host disease after marrow transplantation in patients with hematologic malignancies: Final results and long-term follow-up of an open-label prospective randomized trial"
"0034331491","11054442","","2-s2.0-0034331491","2000-11-01","Meropenem versus ceftazidime in the treatment of cancer patients with febrile neutropenia: A randomized, double-blind trial"
"0018764526","109934","","2-s2.0-0018764526","1979-12-01","A modified right atrial catheter for access to the venous system in marrow transplant recipients"
"0032745317","10577325","","2-s2.0-0032745317","1999-11-02","Clinical utility of blood cultures drawn from indwelling central venous catheters in hospitalized patients with cancer"
"0026593563","1571709","","2-s2.0-0026593563","1992-01-01","Central venous catheter-related complications after bone marrow transplantation in children with hematological malignancies"
"84879091871","","","2-s2.0-84879091871","1988-06-26","Empiric antimicrobials therapy or febrile granulocytopenic cancer patients: Lessons from four EORTC trials"
"0028065443","8049448","","2-s2.0-0028065443","1994-08-15","Increased risk of infection in marrow transplant patients receiving methylprednisolone for graft-versus-host disease prevention"
"0027991886","7994240","","2-s2.0-0027991886","1994-01-01","Life-threatening infections occurring more than 3 months after BMT"
"0014842614","5509845","","2-s2.0-0014842614","1970-12-01","Iodination of a single tyrosine in crystals of α-chymotrypsin"
"0015813208","4517781","10.1038/newbio245165a0","2-s2.0-0015813208","1973-10-10","Structure at 4.5 Å resolution of a phosphorylcholine-binding fab"
"0015579353","4510294","","2-s2.0-0015579353","1973-02-01","The reverse turn as a polypeptide conformation in globular proteins."
"0014650140","4195396","","2-s2.0-0014650140","1969-12-01","Properties of halves of immunoglobulin light chains."
"0014962882","5469166","","2-s2.0-0014962882","1970-10-25","Bence-Jones proteins and light chains of immunoglobulins. V. X-ray crystallographic investigation of the amino-terminal half of a kappa Bence-Jones protein."
"85005727229","","","2-s2.0-85005727229","1953-12-20",""
"0000651098","","10.1107/S0567739471000986","2-s2.0-0000651098","1971-01-01","A real‐space refinement procedure for proteins"
"0015901579","4737866","10.1016/0022-2836(73)90448-8","2-s2.0-0015901579","1973-07-05","Structure of the complex formed by bovine trypsin and bovine pancreatic trypsin inhibitor. Crystal structure determination and stereochemistry of the contact region"
"0003711494","","","2-s2.0-0003711494","1972-07-13",""
"85005561671","","","2-s2.0-85005561671","1969-12-20",""
"0015100790","5288755","","2-s2.0-0015100790","1971-08-01","Independent folding of the variable and constant halves of a lambda immunoglobulin light chain."
"0015765830","4215722","10.1515/bchm2.1973.354.2.1651","2-s2.0-0015765830","1973-01-01","The primary structure of a crystalline, monoclonal immunoglobulin-l-chain of the x type, subgroup i (bence-jones protein rei.): A contribution to the elucidation of the three-dimensional structure of the immunoglobulins"
"0014347799","5685102","10.1002/bip.1968.360061006","2-s2.0-0014347799","1968-01-01","Stereochemical criteria for polypeptides and proteins. V. Conformation of a system of three linked peptide units"
"0014449278","4184996","","2-s2.0-0014449278","1969-01-01","The antibody problem."
"0014690568","4183096","","2-s2.0-0014690568","1969-06-25","Bence-Jones proteins and light chains of immunoglobulins. I. Formation and characterization of amino-terminal (variant) and carboxyl-terminal (constant) halves."
"85005760007","","","2-s2.0-85005760007","1972-12-20",""
"0015107119","5209322","10.1515/bchm2.1971.352.2.1134","2-s2.0-0015107119","1971-01-01","Die isolierung und kristallisation des variablen fragments eines bence-jones-proteins"
"84980085491","","10.1107/S0567739469000246","2-s2.0-84980085491","1969-01-01","Experimental absorption correction: results"
"85005741885","","","2-s2.0-85005741885","1973-12-20","Three-Dimensional Structure of the Fab' Fragment of a Human Immunoglobulin at 2.8-A Resolution"
"0015239107","5543687","","2-s2.0-0015239107","1971-02-25","Topography of Bence-Jones protein. Determination of the reactivities of tyrosines and histidines to iodination."
"0015840644","4773847","","2-s2.0-0015840644","1973-12-01","Structure of a λ-type Bence-Jones protein at 3.5-Å resolution"
"0000894359","","","2-s2.0-0000894359","1961-12-07","The crystal structure of myoglobin: Phase determination to a resolution of 2 Å by the method of isomorphous replacement"
"85005727260","","","2-s2.0-85005727260","1966-12-20",""
"0014828908","5508247","","2-s2.0-0014828908","1970-08-01","An analysis of the sequences of the variable regions of Bence Jones proteins and myeloma light chains and their implications for antibody complementarity."
"0015922143","4569769","","2-s2.0-0015922143","1973-12-01","An active antibody fragment (Fv) composed of the variable portions of heavy and light chains"
"0015518708","5070867","10.1016/0022-2836(72)90233-1","2-s2.0-0015518708","1972-08-21","Crystallographic evidence for structurally similar domains in the human κ-type Bence-Jones protein Rei"
"0242620854","","10.1016/0014-5793(70)80412-4","2-s2.0-0242620854","1970-09-18","On the isolation, characterisation, and crystallisation of a human Bence-Jones protein of kappa type"
"85005724747","","","2-s2.0-85005724747","1953-12-20",""
"0020045295","6977374","10.1111/j.1365-2141.1982.tb01928.x","2-s2.0-0020045295","1982-01-01","ELIMINATION OF T‐LYMPHOCYTES FROM HUMAN BONE MARROW WITH MONOCLONAL T‐ANTIBODIES AND CYTOLYTIC COMPLEMENT"
"0014311463","4876498","","2-s2.0-0014311463","1968-01-01","The selective elimination of immunologically competent cells from bone marrow and lymphatic cell mixtures II. Mouse spleen cell fractionation on a discontinuous albumin gradient"
"0017642631","18618","10.1001/jama.1977.03280070031019","2-s2.0-0017642631","1977-08-15","Severe Combined Immunodeficiency Disease: Characterization of the Disease and Results of Transplantation"
"84990437218","","","2-s2.0-84990437218","1985-10-16",""
"0021417392","6377501","","2-s2.0-0021417392","1984-04-01","Conditioning regimens for marrow grafting"
"0020047768","7039661","10.1111/j.1365-2141.1982.tb01962.x","2-s2.0-0020047768","1982-01-01","A technique for rapid isolation of bone marrow mononuclear cells using Ficoll‐Metrizoate and the IBM 2991 blood cell processor"
"0019405265","7022956","","2-s2.0-0019405265","1981-01-01","Successful bone marrow transplantation across major histocompatibility barriers in rhesus monkeys"
"0019919319","6983936","","2-s2.0-0019919319","1982-12-29","Effect of red cell transfusions, thymic hormone and deoxycytidine in severe combined immunodeficiency due to adenosine deaminase deficiency"
"0020838428","6416728","","2-s2.0-0020838428","1983-10-01","Application of bone marrow transplantation in genetic diseases"
"0021319506","6143084","10.1016/S0140-6736(84)91277-7","2-s2.0-0021319506","1984-04-07","IMMUNORECONSTITUTION IN SEVERE COMBINED IMMUNODEFICIENCY AFTER TRANSPLANTATION OF HLA-HAPLOIDENTICAL, T-CELL-DEPLETED BONE MARROW"
"0021016326","6360233","","2-s2.0-0021016326","1983-12-01","Problems of mismatched bone marrow transplantation for severe combined immunodeficiency after soybean lectin fractionation"
"84990466606","","","2-s2.0-84990466606","1984-10-16","Mismatched bone marrow transplantation for severe combined immunodeficiency"
"0018851278","6985646","","2-s2.0-0018851278","1980-04-04","Humoral and cell-mediated immune responses in fully allogeneic bone marrow chimera in mice"
"84990466601","","","2-s2.0-84990466601","1983-10-16","Transplantation of hemopoeitic cells for lethal congenital immunodeficiencies"
"0015515283","4117384","10.1016/S0140-6736(72)92345-8","2-s2.0-0015515283","1972-11-18","ADENOSINE-DEAMINASE DEFICIENCY IN TWO PATIENTS WITH SEVERELY IMPAIRED CELLULAR IMMUNITY"
"0021023751","6360231","","2-s2.0-0021023751","1983-12-01","European experience with fetal tissue transplantation in severe combined immunodeficiency (SCID)"
"0018350673","38963","10.1007/BF00538940","2-s2.0-0018350673","1979-09-01","Bone marrow transplantation for severe combined immunodeficiency disease - Reported from 1968 to 1977"
"0020954952","6349887","","2-s2.0-0020954952","1983-09-01","Primary immunodeficiency diseases. Report prepared for the WHO by a scientific group on immunodeficiency"
"0017034022","11584","","2-s2.0-0017034022","1976-12-01","Bone marrow transplantation in rats across strong histocompatibility barriers by selective elimination of lymphoid cells in donor marrow"
"0025893168","1715244","10.1016/0092-8674(91)90124-H","2-s2.0-0025893168","1991-08-23","Calcineurin is a common target of cyclophilin-cyclosporin A and FKBP-FK506 complexes"
"12644262358","9238056","10.1073/pnas.94.16.8789","2-s2.0-12644262358","1997-08-05","CTLA4-Ig and anti-CD40 ligand prevent renal allograft rejection in primates"
"0003212283","","","2-s2.0-0003212283","2000-12-01","Basiliximab (bamab) - a selective interleukin-2 receptor (il-2r) antagonist - as therapy for refractory acute graft versus host disease (agvhd) following bone marrow transplantation (bmt)"
"0003323686","","","2-s2.0-0003323686","2000-12-30","Infliximab for the treatment of graft-versus-host disease in allogeneic transplant recipients: An update"
"0034045586","10878285","10.1016/S0162-3109(00)00188-0","2-s2.0-0034045586","2000-05-01","Mycophenolate mofetil and its mechanisms of action"
"0034728055","10665560","","2-s2.0-0034728055","2000-01-29","Sirolimus-tacrolimus combination immunosuppression"
"0029829009","8962411","","2-s2.0-0029829009","1996-12-21","The European experience with mycophenolate mofetil"
"0033575397","10438301","","2-s2.0-0033575397","1999-07-16","Tolerating differences"
"0030590745","8918281","10.1016/S0140-6736(96)10310-X","2-s2.0-0030590745","1996-11-16","Mycophenolate mofetil"
"0029065035","7781137","10.1007/BF00685845","2-s2.0-0029065035","1995-05-01","Phase I study of NKT-01"
"0032105481","9721431","10.1016/S0009-9120(98)00045-9","2-s2.0-0032105481","1998-07-01","Rapamune® (RAPA, rapamycin, sirolimus): Mechanism of action immunosuppressive effect results from blockade of signal transduction and inhibition of cell cycle progression"
"0029418483","9552353","","2-s2.0-0029418483","1995-12-01","Mechanism of action of rapamycin: new insights into the regulation of G1-phase progression in eukaryotic cells."
"0033916538","10877057","","2-s2.0-0033916538","2000-07-12","An old drug for a new disease: Pentostatin (Nipent) in acute graft- versus-host disease"
"0033519661","10352162","10.1056/NEJM199906033402202","2-s2.0-0033519661","1999-06-03","Transplantation of anergic histoincompatible bone marrow allografts"
"0344141613","10071016","","2-s2.0-0344141613","1999-02-27","Mycophenolate mofetil and cyclosporine as graft-versus-host disease prophylaxis after allogeneic blood stem cell transplantation"
"0000642263","","","2-s2.0-0000642263","1995-08-22","A phase II/III randomized, double-blind, placebo-controlled multicenter trial of humanized anti-Tac for prevention of acute graft-versus-host disease (GVHD) in recipients of marrow transplants from unrelated donors"
"0034043418","10844529","10.1046/j.1365-2249.2000.01235.x","2-s2.0-0034043418","2000-06-27","Absence of platelet CD40L identifies patients with X-linked hyper IgM syndrome"
"0344613988","10545997","10.1038/15256","2-s2.0-0344613988","1999-11-01","Blocking both signal 1 and signal 2 of T-cell activation prevents apoptosis of alloreactive t cells and induction of peripheral allograft tolerance"
"0001542719","","","2-s2.0-0001542719","1999-07-13","Outpatient allografting with minimally myelosuppressive, immunosuppressive conditioning of low-dose TBI and postgrafting cyclosporine (CSP) and mycophenolate mofetil (MMF)"
"0003236832","","","2-s2.0-0003236832","2000-07-13","Pentostatin: A novel treatment for steroid refractory acute GVHD"
"0032146529","9691083","","2-s2.0-0032146529","1998-08-01","CD4+ T cells tolerized ex vivo to host alloantigen by anti-CD40 ligand (CD40L:CD154) antibody lose their graft-versus-host disease lethality capacity but retain nominal antigen responses"
"15844395463","8605372","","2-s2.0-15844395463","1996-04-15","FK506 (Tacrolimus) monotherapy for prevention of graft-versus-host disease after histocompatible sibling allogeneic bone marrow transplantation"
"10544242968","8932845","","2-s2.0-10544242968","1996-11-01","Minimizing graft rejection in allogeneic T cell-depleted bone marrow transplantation"
"0029851095","8962412","","2-s2.0-0029851095","1996-12-21","Rescue therapy with mycophenolate mofetil"
"0003270216","","","2-s2.0-0003270216","1998-09-27","Potent effects of ATG used as part of the conditioning in matched unrelated donor transplantation"
"0032774414","10430977","","2-s2.0-0032774414","1999-08-11","Mycophenolate mofetil in cadaveric renal transplantation"
"0033048519","10188761","10.2165/00003495-199957020-00006","2-s2.0-0033048519","1999-03-17","Basiliximab"
"0030671039","9355822","10.1097/00007890-199710270-00002","2-s2.0-0030671039","1997-10-27","Administration of mycophenolate mofetil in a murine model of acute graft-versus-host disease after bone marrow transplantation"
"0002994923","","","2-s2.0-0002994923","2000-07-13","Rapamycin induces long term bone marrow chimerism in the absence of long term immunosuppression in mismatched stem cell transplantation: Application to sickle cell mice"
"0033561405","10221486","10.1097/00007890-199904150-00013","2-s2.0-0033561405","1999-04-15","A randomized, double-blinded comparison of thymoglobulin versus Atgam for induction immunosuppressive therapy in adult renal transplant recipients"
"0025890101","2070147","","2-s2.0-0025890101","1991-01-01","Prophylaxis of graft-versus-host disease by administration of the murine anti-IL-2 receptor antibody 2A3"
"0027451441","8228826","","2-s2.0-0027451441","1993-11-01","Long-term acceptance of major histocompatibility complex mismatched cardiac allografts induced by CTLA4Ig plus donor-specific transfusion"
"0034102824","10828867","","2-s2.0-0034102824","2000-05-30","Mycophenolate mofetil (MMF) as therapy for refractory chronic GVHD (cGVHD) in children receiving bone marrow transplantation"
"0032878696","10512062","10.1592/phco.19.15.1127.30582","2-s2.0-0032878696","1999-10-07","A review of interleukin-2 receptor antagonists in solid organ transplantation"
"0032996618","10371494","10.1038/9458","2-s2.0-0032996618","1999-06-01","Graft tolerance: A duel of two signals"
"0001745049","","","2-s2.0-0001745049","1997-08-19","Phase III study comparing tacrolimus (FK506) with cyclosporine (CSP) for prophylaxis of acute graft-versus-host disease (GVHD) after marrow transplantation from unrelated donors"
"0032188990","9746768","","2-s2.0-0032188990","1998-10-01","Phase III study comparing methotrexate and tacrolimus (prograf, FK506) with methotrexate and cyclosporine for graft-versus-host disease prophylaxis after HLA-identical sibling bone marrow transplantation"
"0033642532","10905770","","2-s2.0-0033642532","2000-12-01","Hydroxychloroquine for the Treatment of Chronic Graft-Versus-Host Disease"
"0030463216","8970605","10.1097/00007890-199612150-00003","2-s2.0-0030463216","1996-12-01","Tolerance in a rat cardiac allograft model after short-term treatment with LF 08-0299: Absence of clonal deletion and evidence of CD4+ suppressor cells"
"0032884873","10516680","","2-s2.0-0032884873","1999-10-18","Tacrolimus and minidose methotrexate for prevention of acute graft-versus-host disease after HLA-mismatched marrow or blood stem cell transplantation"
"0028903939","7536798","","2-s2.0-0028903939","1995-01-01","CD28-B7 blockade after alloantigenic challenge in vivo inhibits Th1 cytokines but spares Th2"
"0032989225","10408631","10.1016/S0192-0561(99)00017-X","2-s2.0-0032989225","1999-05-01","Analysis of in vivo immunosuppressive and in vitro interaction with constitutive heat shock protein 70 activity of LF08-0299 (Tresperimus) and analogues"
"0033083303","9973447","","2-s2.0-0033083303","1999-02-01","Blocking OX-40/OX-40 ligand interaction in vitro and in vivo leads to decreased T cell function and amelioration of experimental allergic encephalomyelitis"
"0032996025","10371508","10.1038/9536","2-s2.0-0032996025","1999-06-01","Treatment with humanized monoclonal antibody against CD154 prevents acute renal allograft rejection in nonhuman primates"
"0032055163","9516160","","2-s2.0-0032055163","1998-04-01","Synergism between mycophenolate mofetil and cyclosporine in preventing graft-versus-host disease among lethally irradiated dogs given DLA- nonidentical unrelated marrow grafts"
"10544224147","8943876","","2-s2.0-10544224147","1996-12-01","Tacrolimus and minidose methotrexate for prevention of acute graft- versus-host disease after matched unrelated donor marrow transplantation"
"0033964862","10607689","","2-s2.0-0033964862","2000-01-01","Daclizumab, a humanized anti-interleukin-2 receptor alpha chain antibody, for treatment of acute graft-versus-host disease"
"0033519712","10352169","10.1056/NEJM199906033402209","2-s2.0-0033519712","1999-06-03","The new immunology - The end of immunosuppressive drug therapy?"
"0034571546","11071258","","2-s2.0-0034571546","2000-12-01","Graft-Versus-Host Disease Prevention by Rapamycin: Cellular Mechanisms"
"0028831347","7879054","","2-s2.0-0028831347","1995-01-01","LF 08-0299 induces tolerance after short-term treatment in a fully major histocompatibility mismatched rat cardiac allograft model"
"0032573044","9808489","10.1097/00007890-199810270-00013","2-s2.0-0032573044","1998-10-27","Immunosuppressive effects and safety of a sirolimus/cyclosporine combination regimen for renal transplantation"
"0032219621","9694951","","2-s2.0-0032219621","1998-12-01","Pharmacokinetics/dynamics of Ciao, a monoclonal antibody to CD154 (CD40 ligand) suppression of an immune response in monkeys"
"0032832979","10482936","","2-s2.0-0032832979","1999-09-17","Salvage therapy for refractory chronic graft-versus-host disease with mycophenolate mofetil and tacrolimus"
"0034331937","11258483","","2-s2.0-0034331937","2000-12-01","Two distinct action mechanisms of immunophilin-ligand complexes for the blockade of T-cell activation"
"10344238083","8896434","","2-s2.0-10344238083","1996-11-01","FK506 in combination with methotrexate for the prevention of graft- versus-host disease after marrow transplantation from matched unrelated donors"
"0033571215","10573065","","2-s2.0-0033571215","1999-11-15","Population pharmacokinetics and exposure-response relationships for basiliximab in kidney transplantation"
"0033931997","10894358","10.1089/15258160050079470","2-s2.0-0033931997","2000-07-17","Treatment of steroid-resistant acute graft-versus-host disease with rabbit antithymocyte globulin"
"0028900536","7584950","10.1038/nm0195-32","2-s2.0-0028900536","1995-01-01","Immunophilins and nervous system"
"0345161813","10221490","10.1097/00007890-199904150-00017","2-s2.0-0345161813","1999-04-15","Sirolimus (rapamycin)-based therapy in human renal transplantation: Similar efficacy and different toxicity compared with cyclosporine"
"0028824356","8587293","","2-s2.0-0028824356","1995-12-27","Mycophenolate mofetil in renal transplantation: Results from the U.S. randomized trials"
"0028869086","8588237","","2-s2.0-0028869086","1995-01-01","Rapamune (Sirolimus, Rapamycin): An Overview and Mechanism of Action"
"4244142203","","","2-s2.0-4244142203","2004-09-27","Recombinant human soluble tumor necrosis factor receptor fusion protein (Enbrel) as a treatment for chronic graft-versus-host disease following allogeneic bone marrow transplantation"
"0029052071","7723546","10.1016/S0140-6736(95)90978-8","2-s2.0-0029052071","1995-05-06","Impairment of leukaemia-free survival by addition of interleukin-2-receptor antibody to standard graft-versus-host prophylaxis"
"0027512830","8485477","","2-s2.0-0027512830","1993-01-01","Use of an anti-interleukin-2 receptor monoclonal antibody for GVHD prophylaxis in unrelated donor BMT"
"0004553889","","","2-s2.0-0004553889","1999-07-13","Evaluation of non-myeloablative conditioning combining BEAM with in-vivo pre-transplant Campath-1G for allogeneic transplantation in patients with lymphoma"
"0019518954","7024811","","2-s2.0-0019518954","1981-12-29","Clinical and immunologic effects of fractionated total lymphoid irradiation in refractory rheumatoid arthritis"
"84988129238","","","2-s2.0-84988129238","1994-09-26","Multicenter trial of an anti‐CD5 immunoconjugate in rheumatoid arthritis"
"0027093377","1486748","10.1007/BF02283116","2-s2.0-0027093377","1992-12-01","Treatment of rheumatoid arthritis with anti CD4 monoclonal antibody. Open study of 25 patients with the B-F5 clone"
"0025980476","1994909","10.1002/art.1780340202","2-s2.0-0025980476","1991-01-01","Treatment of rheumatoid arthritis with an anti‐CD4 monoclonal antibody"
"0018602875","117708","10.1016/0002-9343(79)90636-3","2-s2.0-0018602875","1979-01-01","Immunopathogenesis of rheumatoid arthritis"
"0026656620","1354392","","2-s2.0-0026656620","1992-01-01","Treatment of rheumatoid arthritis with single dose or weekly pulses of chimaeric anti-CD4 monoclonal antibody"
"0023945481","3358796","10.1002/art.1780310302","2-s2.0-0023945481","1988-01-01","The american rheumatism association 1987 revised criteria for the classification of rheumatoid arthritis"
"84988057590","","","2-s2.0-84988057590","1992-09-26","Humanised monoclonal antibody therapy for rheumatoid arthritis"
"0025266158","2109613","10.1002/art.1780330403","2-s2.0-0025266158","1990-01-01","Analysis of improvement in individual rheumatoid arthritis patients treated with disease‐modifying antirheumatic drugs, based on the findings in patients treated with placebo"
"0026752620","1622409","10.1002/art.1780350702","2-s2.0-0026752620","1992-01-01","The importance of the t cell in initiating and maintaining the chronic synovitis of rheumatoid arthritis"
"0019455461","6456414","","2-s2.0-0019455461","1981-12-29","Treatment of intractable rheumatoid arthritis with total lymphoid irradiation"
"0023852831","2894520","10.1016/S0140-6736(88)91382-7","2-s2.0-0023852831","1988-03-12","RESPONSE TO MONOCLONAL CD7 ANTIBODY IN RHEUMATOID ARTHRITIS"
"0025304539","2271017","","2-s2.0-0025304539","1990-01-01","Rheumatoid arthritis. Pathophysiology and implications for therapy"
"0017509126","302707","10.1002/art.1780200614","2-s2.0-0017509126","1977-01-01","Lymphocyte Involvement in Rheumatoid Arthritis"
"0016815881","168488","","2-s2.0-0016815881","1975-12-01","Predominantly T cell infiltrate in rheumatoid synovial membranes"
"84988113717","","","2-s2.0-84988113717","1992-09-26","Clinical status of rheumatoid arthritis patients 18 months after treatment with chimeric anti‐CD4 antibody"
"0027503243","8095785","10.1002/art.1780360304","2-s2.0-0027503243","1993-01-01","Use of a chimeric monoclonal anti‐CD4 antibody in patients with refractory rheumatoid arthritis"
"0027299097","7683881","10.1002/art.1780360508","2-s2.0-0027299097","1993-01-01","Effects of administration of an anti‐cd5 plus immunoconjugate in rheumatoid arthritis. results of two phase ii studies"
"0024208892","3190040","","2-s2.0-0024208892","1988-12-01","Cyclosporin A in severe, treatment-refractory rheumatoid arthritis: A randomized study"
"0027156307","8099991","10.1016/0140-6736(93)90759-A","2-s2.0-0027156307","1993-06-26","Long-term remission of intractable systemic vasculitis with monoclonal antibody therapy"
"84988098927","","","2-s2.0-84988098927","1994-09-26","Treatment of rheumatoid arthritis with humanized monoclonal antibody, CAMPATH‐1H"
"0025974324","1846103","10.1210/endo-128-1-341","2-s2.0-0025974324","1991-01-01","Biological activity and metabolic clearance of a recombinant human thyrotropin produced in chinese hamster ovary cells"
"0003877374","","","2-s2.0-0003877374","1994-07-13",""
"0025261190","2108149","","2-s2.0-0025261190","1990-04-25","The polypeptide of immunoglobulin G influences its galactosylation in vivo"
"0023893055","3052290","","2-s2.0-0023893055","1988-01-01","Glycobiology"
"0025648540","2074834","","2-s2.0-0025648540","1990-12-01","Characterization of recombinant proteins"
"0027508081","7506033","10.1016/0167-5699(93)90261-I","2-s2.0-0027508081","1993-01-01","Interaction of the natural anti-Gal antibody with α-galactosyl epitopes: a major obstacle for xenotransplantation in humans"
"0019309619","7391051","","2-s2.0-0019309619","1980-12-01","Carbohydrate-mediated clearance of immune complexes from the circulation. A role for galactose residues in the hepatic uptake of IgG.antigen complexes"
"0011162513","","","2-s2.0-0011162513","1988-07-13",""
"0026426005","1789448","","2-s2.0-0026426005","1991-12-15","Integration of mass spectrometry in analytical biotechnology"
"0026095033","1749386","10.1016/0161-5890(91)90039-M","2-s2.0-0026095033","1991-01-01","Diversification of the IgG molecule by oligosaccharides"
"0021041854","6579549","","2-s2.0-0021041854","1983-12-01","Biological significance of carbohydrate chains on monoclonal antibodies"
"0000196248","","","2-s2.0-0000196248","1992-07-13",""
"0011194834","","","2-s2.0-0011194834","1994-07-13",""
"0025981417","1823155","10.1093/glycob/1.2.115","2-s2.0-0025981417","1991-03-01","Glycosylation of recombinant protein therapeutics: Control and functional implications"
"0000153994","","","2-s2.0-0000153994","1994-07-13","Profiling glycosphingolipid structural detail: Periodate oxidation, electrospray, collision-induced dissociation and tandem mass spectrometry"
"0026329947","1367802","10.1038/nbt1091-921","2-s2.0-0026329947","1991-01-01","Characterizing recombinant proteins"
"0027485672","8274187","10.1016/0167-5699(93)90259-N","2-s2.0-0027485672","1993-01-01","Does endogenous glycosylation prevent the use of mouse monoclonal antibodies as cancer therapeutics?"
"0011167058","","","2-s2.0-0011167058","1989-07-13",""
"0026787654","1390770","","2-s2.0-0026787654","1992-12-01","Role of glycosylation on the secretion and biological activity of erythropoietin"
"0022414766","3927174","10.1038/316452a0","2-s2.0-0022414766","1985-12-01","Association of rheumatoid arthritis and primary osteoarthritis with changes in the glycosylation pattern of total serum IgG"
"34447326804","","10.1016/0008-6215(84)85242-8","2-s2.0-34447326804","1984-08-15","A simple and rapid method for the permethylation of carbohydrates"
"0021753546","6713442","10.1016/0008-6215(84)85106-X","2-s2.0-0021753546","1984-04-02","An improved procedure for the methylation analysis of oligosaccharides and polysaccharides"
"0024297335","2460463","","2-s2.0-0024297335","1988-11-25","Man, apes, and Old World monkeys differ from other mammals in the expression of alpha-galactosyl epitopes on nucleated cells."
"0024414839","2514791","","2-s2.0-0024414839","1989-12-01","Cell-type-specific and site-specific N-glycosylation of type I and type II human tissue plasminogen activator"
"0027513767","8429003","","2-s2.0-0027513767","1993-02-15","Site-specific glycosylation of recombinant rat and human soluble CD4 variants expressed in Chinese hamster ovary cells"
"0027462384","7680267","","2-s2.0-0027462384","1993-02-16","Selective identification and differentiation of N- and O-linked oligosaccharides in glycoproteins by liquid chromatography-mass spectrometry"
"0025319235","2354167","10.1021/bi00468a024","2-s2.0-0025319235","1990-05-23","Distribution of Galα1→3Galβ1→4GlcNAc residues on secreted mammalian glycoproteins (thyroglobulin, fibrinogen, and immunoglobulin G) as measured by a sensitive solid-phase radioimmunoassay"
"0026730966","1422284","10.1016/0268-960X(92)90027-N","2-s2.0-0026730966","1992-01-01","Monoclonal antibody (MoAb) therapy in non-Hodgkin's lymphomas"
"0026539909","1446723","10.1111/j.1600-0609.1992.tb00913.x","2-s2.0-0026539909","1992-01-01","Mechanisms of thrombocytopenia in patients with lymphoproliferative diseases"
"0021895409","3920431","10.1007/BF01733073","2-s2.0-0021895409","1985-01-01","Platelet survival determined with51Cr Versus111In"
"0021869541","4006405","10.1111/j.1365-2257.1985.tb00002.x","2-s2.0-0021869541","1985-01-01","The relative incidence of idiopathic and secondary autoimmune thrombocytopenia: a clinical and serological evaluation in 508 patients"
"0015368158","5064806","10.1002/1097-0142(197207)30:1&lt;220::AID-CNCR2820300132&gt;3.0.CO;2-Z","2-s2.0-0015368158","1972-01-01","Hodgkin's disease presenting as “idiopathic” thrombocytopenic purpura"
"0027267640","8369659","10.1016/S0268-960X(05)80020-7","2-s2.0-0027267640","1993-01-01","Platelet volume: Laboratory measurement and clinical application"
"0025095665","1688494","","2-s2.0-0025095665","1990-01-01","Flow cytometric analysis of thiazole orange uptake by platelets: A diagnostic aid in the evaluation of thrombocytopenic disorders"
"0018597016","575704","10.1002/ajh.2830070410","2-s2.0-0018597016","1979-01-01","Idiopathic thrombocytopenic purpura occurring in Hodgkin disease after splenectomy: Report of two cases and review of the literature"
"0003165976","13889001","","2-s2.0-0003165976","1962-01-01","Autoimmune thrombocytopenic purpura (""ITP"" type) with chronic lymphocytic leukemia."
"0018759772","426906","","2-s2.0-0018759772","1979-12-01","Immune thrombocytopenia in lymphoproliferative diseases"
"0019832145","7025627","10.1016/0002-9343(81)90243-6","2-s2.0-0019832145","1981-01-01","Peripheral destruction of platelets in chronic lymphocytic leukemia: Recognition, prognosis and therapeutic implicatio"
"0015620324","4574456","10.1002/1097-0142(197305)31:5&lt;1092::AID-CNCR2820310509&gt;3.0.CO;2-B","2-s2.0-0015620324","1973-01-01","Autoimmune disorders and malignant lymphoma"
"0024418966","2478227","","2-s2.0-0024418966","1989-01-01","Therapy of chronic idiopathic thrombocytopenic purpura in adults"
"0017073525","944086","10.1002/1097-0142(197604)37:4&lt;1999::AID-CNCR2820370451&gt;3.0.CO;2-U","2-s2.0-0017073525","1976-01-01","Idiopathic thrombocytopenic purpura in lymphoma"
"0017279834","942845","10.1001/archinte.1976.03630010046008","2-s2.0-0017279834","1976-01-01","Idiopathic Thrombocytopenic Purpura Complicating Chronic Lymphocytic Leukemia: Management With Sequential Splenectomy and Chemotherapy"
"0019944197","7112030","10.1111/j.1600-0609.1982.tb00533.x","2-s2.0-0019944197","1982-01-01","Primary and Secondary Autoimmune Thrombocytopenia: A Serological and Clinical Analysis"
"0032832588","10523804","","2-s2.0-0032832588","1999-09-01","Chimeric monoclonal anti-CD20 antibody (rituximab) - An effective treatment for a patient with relapsing hairy cell leukaemia"
"0003609573","","","2-s2.0-0003609573","2000-07-13","Comparison of the efficacy and safety of Gemtuzumab Ozogamicin (CMA-676) in patients &lt;60 and &gt;60 years"
"0029033582","7590766","","2-s2.0-0029033582","1995-01-01","Radioimmunotherapy of ovarian cancer"
"0033016566","10071268","","2-s2.0-0033016566","1999-03-01","Rituximab therapy in hematologic malignancy patients with circulating blood tumor cells: Association with increased infusion-related side effects and rapid blood tumor clearance"
"0033214207","10498591","","2-s2.0-0033214207","1999-10-01","Cytokine-release syndrome in patients with B-cell chronic lymphocytic leukemia and high lymphocyte counts after treatment with an anti-CD20 monoclonal antibody (rituximab, IDEC-C2B8)"
"0003525960","","","2-s2.0-0003525960","1994-07-13","Achievements, failings and promises of radioimmunotherapy"
"0029915902","8648397","","2-s2.0-0029915902","1996-04-01","Radioimmunotherapy: Recent results and future directions"
"0028231359","8142644","","2-s2.0-0028231359","1994-04-01","A phase 1B trial of humanized monoclonal antibody M195 (anti-CD33) in myeloid leukemia: Specific targeting without immunogenicity"
"0003279034","","","2-s2.0-0003279034","1997-05-03","Molecular remission induction without relapse after anti-CD33 monoclonal antibody HuM195 in acute promyelocytic leukemia (APL)"
"0000281479","","","2-s2.0-0000281479","1997-06-08","Targeted alpha-particle therapy for myeloid leukemias: A phase I trial of bismuth-213-HuM195 (anti-CD33)"
"0032800546","10475235","10.1089/027245799315862","2-s2.0-0032800546","1999-06-01","Use of monoclonal antibodies for the diagnosis and treatment of bladder cancer"
"0024401832","2725060","","2-s2.0-0024401832","1989-01-01","Monoclonal antibody M195: A diagnostic marker for acute myelogenous leukemia"
"0027194197","8324745","","2-s2.0-0027194197","1993-01-01","Preparation and Characterization of Monoclonal Antibody Conjugates of the Calicheamicins: A Novel and Potent Family of Antitumor Antibiotics"
"0032869052","10530710","","2-s2.0-0032869052","1999-10-28","Antibody-targeted therapy for myeloid leukemia"
"0024509637","2716349","","2-s2.0-0024509637","1989-01-01","Restricted expression of an early myeloid and monocytic cell surface antigen defined by monoclonal antibody M195"
"0034043849","10901614","10.1007/s002779900141","2-s2.0-0034043849","2000-05-01","Successful treatment and re-treatment of resistant B-cell chronic lymphocytic leukemia with the monoclonal anti-CD20 antibody rituximab"
"0023228244","3470307","","2-s2.0-0023228244","1987-06-26","Treatment of acute myeloid leukemia cells in vitro with a monoclonal antibody recognizing a myeloid differentiation antigen allows normal progenitor cells to be expressed"
"0000281480","","","2-s2.0-0000281480","1997-08-26","Selective ablation of acute myeloid leukemia using an anti-CD33 calicheamicin immunoconjugate"
"0031749971","9626458","","2-s2.0-0031749971","1998-06-01","Supersaturating infusional humanized anti-CD33 monoclonal antibody HuM195 in myelogenous leukemia"
"0003247440","","","2-s2.0-0003247440","1998-04-07","Interim analysis of the efficacy and safety of CMA-676 in patients with AML in first relapse"
"0003679722","","","2-s2.0-0003679722","2000-07-13","Short-term outcomes after treatment for relapsed AML: A comparison of recent CMA-676 clinical trial data and historical control data"
"0026617131","","10.1016/0009-2509(92)80208-T","2-s2.0-0026617131","1992-01-01","Fast protein chromatography on analytical and preparative scale using modified microporous membranes"
"0032006744","","10.1002/(SICI)1097-4660(199802)71:2&lt;95::AID-JCTB823&gt;3.0.CO;2-J","2-s2.0-0032006744","1998-02-01","Purification of proteins by membrane chromatography"
"0023649847","3654846","10.1016/S0021-9673(01)96522-7","2-s2.0-0023649847","1987-01-01","Rapid analysis of proteins and peptides by reversed-phase chromatography"
"0029394929","","10.1002/bit.260480414","2-s2.0-0029394929","1995-01-01","Protein A immunoaffinity hollow fiber membranes for immunoglobulin G purification: Experimental characterization"
"0035865814","","10.1016/S0376-7388(00)00574-3","2-s2.0-0035865814","2001-02-15","A new matrix for membrane affinity chromatography and its application to the purification of concanavalin A"
"0026577074","","10.1016/0021-9673(92)85004-D","2-s2.0-0026577074","1992-04-10","Membrane chromatographic systems for high-throughput protein separations"
"0035847162","11217020","10.1016/S0021-9673(00)01041-4","2-s2.0-0035847162","2001-01-12","Membrane ion-exchange chromatography for process-scale antibody purification"
"0032508589","9792514","10.1016/S0378-4347(98)00047-4","2-s2.0-0032508589","1998-09-11","Cellulose as a (bio)affinity carrier: Properties, design and applications"
"0001825885","","","2-s2.0-0001825885","1990-08-31","Hydrophobic interaction chromatography of biopolymers"
"0028822083","","10.1016/0021-9673(95)00641-9","2-s2.0-0028822083","1995-12-01","Preparation of a hydrophobic porous membrane containing phenyl groups and its protein adsorption performance"
"0030900519","9098993","10.1016/S0021-9673(96)00894-1","2-s2.0-0030900519","1997-03-07","Mass transfer limitations in protein separations using ion-exchange membranes"
"0029672753","","","2-s2.0-0029672753","1996-04-01","Purification of Bovine Immunoglobulin G via Protein G Affinity Membranes"
"0028519528","","10.1016/0376-7388(94)00171-5","2-s2.0-0028519528","1994-10-24","Chitosan modified sulfonated poly (ethersulfone) as a support for affinity separations"
"0025804251","","10.1016/S0021-9673(01)83990-X","2-s2.0-0025804251","1991-05-17","Non-porous hydrophilic resin-based packings for the separation of biopolymers"
"0032582106","","10.1016/S0376-7388(98)00183-5","2-s2.0-0032582106","1998-09-30","Cross-linked macroporous chitosan anion-exchange membranes for protein separations"
"0028057693","8136904","10.1016/0021-9673(94)85186-7","2-s2.0-0028057693","1994-02-11","Purification of human tumour necrosis factor by membrane chromatography"
"0017184389","942051","10.1016/0003-2697(76)90527-3","2-s2.0-0017184389","1976-05-07","A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding"
"0026502058","1601978","10.1016/0021-9673(92)87006-T","2-s2.0-0026502058","1992-01-24","High-performance membrane chromatography of serum and plasma membrane proteins"
"0034669857","","10.1016/S0376-7388(00)00514-7","2-s2.0-0034669857","2000-11-15","Affinity membranes: A 10-year review"
"0032489399","9542126","10.1016/S0021-9673(97)00873-X","2-s2.0-0032489399","1998-03-06","Effect of porous structure of macroporous polymer supports on resolution in high-performance membrane chromatography of proteins"
"0027331423","8275177","10.1016/0021-9673(93)83062-W","2-s2.0-0027331423","1993-11-12","Characterization and application of strong ion-exchange membrane adsorbers as stationary phases in high-performance liquid chromatography of proteins"
"0025826727","","10.1016/S0021-9673(01)87170-3","2-s2.0-0025826727","1991-08-30","High-performance membrane chromatography of proteins, a novel method of protein separation"
"0033084125","","","2-s2.0-0033084125","1999-12-01","Application of membranes and compact, porous units for the separation of biopolymers"
"0028816757","","10.1016/0021-9673(94)00911-R","2-s2.0-0028816757","1995-01-13","High-throughput processing of proteins using a porous and tentacle anion-exchange membrane"
"0027199724","","10.1016/0021-9673(93)83340-X","2-s2.0-0027199724","1993-09-03","High-performance membrane chromatography: Highly efficient separation method for proteins in ion-exchange, hydrophobic interaction and reversed-phase modes"
"0021296674","6372650","","2-s2.0-0021296674","1984-01-01","Graft-versus-host disease: pathophysiological and clinical aspects."
"84930781402","","","2-s2.0-84930781402","1984-06-18","Circulating suppressor cells in patients post bone marrow transplantation [Abstract]"
"0016315350","4155153","","2-s2.0-0016315350","1974-12-01","Histopathology of graft vs. host reaction (GvHR) in human recipients of marrow from HL A matched sibling donors"
"0021970692","3897863","","2-s2.0-0021970692","1985-11-28","Marrow transplantation from related donors other than HLA-identical siblings"
"0019460001","7296955","10.1111/j.1365-2230.1981.tb02303.x","2-s2.0-0019460001","1981-01-01","Sensitivity of mononuclear cells to PUVA: effect on subsequent stimulation with mitogens and on exclusion of trypan blue dye"
"0001704181","","10.1016/0167-5699(84)90126-9","2-s2.0-0001704181","1984-01-01","Graft-versus-host reactions: clues to the etiopathology of a spectrum of immunological diseases"
"0020533736","6187815","","2-s2.0-0020533736","1983-07-07","Mechanism of UV-B-induced impairment of the antigen-presenting capacity of murine epidermal cells"
"84930782199","","","2-s2.0-84930782199","1983-06-18","The mechanism of immune Suppression by UVR"
"0019416318","6168700","","2-s2.0-0019416318","1981-01-01","Antigen presentation by murine epidermal Langerhans cells and its alteration by ultraviolet B light"
"0021142336","6748744","","2-s2.0-0021142336","1984-01-01","Treatment of parapsoriasis and mycosis fungoides: The role of psoralen and long-wave ultraviolet light a (PUVA)"
"0020839523","6315285","","2-s2.0-0020839523","1983-10-01","The pathophysiology and treatment of graft-versus-host disease"
"0019351639","7004534","","2-s2.0-0019351639","1981-04-13","Chronic graft-versus-host disease in 52 patients: Adverse natural course and successful treatment with combination immunosuppression"
"0021321596","6607557","","2-s2.0-0021321596","1984-01-01","Suppression of epidermal graft-versus-host disease with ultraviolet radiation"
"0021947015","3980801","","2-s2.0-0021947015","1985-03-06","Methoxsalen and ultraviolet A radiation in treatment of chronic cutaneous graft-versus-host reaction"
"16244411735","","","2-s2.0-16244411735","1983-04-20","Graft-versus-host-disease"
"0021256861","6709010","","2-s2.0-0021256861","1984-06-22","Cutaneous squamous-cell carcinoma in patients treated with PUVA"
"84930780634","","","2-s2.0-84930780634","1980-06-18","Seattle Marrow Transplantat Team. Graft-versus-host disease in allogeneic marrow transplantation"
"0022822583","3502781","","2-s2.0-0022822583","1986-12-01","PUVA therapy for drug-resistant graft-versus-host disease."
"0019462576","6453905","10.1111/1523-1747.ep12525745","2-s2.0-0019462576","1981-06-29","Ultraviolet light depletes surface markers of Langerhans cells"
"0021263848","6381872","10.1007/BF01716464","2-s2.0-0021263848","1984-07-01","Immunohistological skin alterations in allogeneic bone marrow transplantation"
"0019867398","6461932","10.1007/BF01892183","2-s2.0-0019867398","1981-09-01","Suppression of contact hypersensitivity by ultraviolet radiation: An experimental model"
"84930782507","","","2-s2.0-84930782507","1987-06-18","Risiken der Photo-and Photochemother apie"
"0343684304","","","2-s2.0-0343684304","1983-11-24","Local effects of ultraviolet radiation on immune function in mice"
"0017701265","872221","10.1016/0008-8749(77)90018-1","2-s2.0-0017701265","1977-06-01","Evidence for the generation of suppressor cells by ultraviolet radiation"
"0019452046","6972226","10.1111/j.1365-2133.1981.tb15310.x","2-s2.0-0019452046","1981-01-01","In vivo effects of PUVA on lymphocyte function"
"0020363632","6218658","","2-s2.0-0020363632","1982-01-01","Chronic graff-versus-host disease in the rat radiation chimera: Ii. Immunological evaluation in long-term chimeras"
"84930783360","","","2-s2.0-84930783360","1977-06-18","Fischer MS"
"0024401258","2788053","10.1016/0090-1229(89)90162-1","2-s2.0-0024401258","1989-01-01","In Vivo use of monoclonal antibodies against murine T cell antigens"
"0023647924","3646094","10.1016/0092-8674(87)90283-2","2-s2.0-0023647924","1987-05-08","The genome organization of STLV-3 is similar to that of the AIDS virus except for a truncated transmembrane protein"
"0023224795","3497350","","2-s2.0-0023224795","1987-12-01","Sequence of simian immunodeficiency virus and its relationship to the human immunodeficiency viruses"
"0028337166","8207839","","2-s2.0-0028337166","1994-07-01","Temporal association of cellular immune responses with the initial control of viremia in primary human immunodeficiency virus type 1 syndrome"
"0028296114","8198871","","2-s2.0-0028296114","1994-01-01","Passive immunization of cynomolgus macaques with immune sera or a pool of neutralizing monoclonal antibodies failed to protect against challenge with SIVmac251"
"15844389650","8649512","10.1038/381667a0","2-s2.0-15844389650","1996-06-28","HIV-1 entry into CD4+ cells is mediated by the chemokine receptor CC-CKR-5"
"0026505071","1736942","","2-s2.0-0026505071","1992-01-01","Population sequence analysis of a simian immunodeficiency virus (32H reisolate of SIV(mac251): A virus stock used for international vaccine studies"
"0031550781","9123856","10.1006/viro.1996.8419","2-s2.0-0031550781","1997-03-03","Macaques infected with live attenuated SIVmac are protected against superinfection via the rectal mucosa"
"0024843742","2556312","","2-s2.0-0024843742","1989-12-01","Animal models of AIDS"
"0028972541","8573398","","2-s2.0-0028972541","1995-01-01","Highly attenuated SIV(mac142) is immunogenic but does not protect against SIV(mac251) challenge"
"0022967777","2431484","","2-s2.0-0022967777","1986-12-01","CD8+ lymphocytes can control HIV infection in vitro by suppressing virus replication"
"0027043276","1470917","","2-s2.0-0027043276","1992-12-01","Protective effects of a live attenuated SIV vaccine with a deletion in the nef gene"
"0027301677","8392626","","2-s2.0-0027301677","1993-08-01","In vivo role of lymphocyte subpopulations in the control of virus excretion and mucosal antibody responses of cattle infected with rotavirus"
"0028866238","7584989","10.1038/nm1195-1167","2-s2.0-0028866238","1995-01-01","Early suppression of SIV replication by CD8+ nef-specific cytotoxic T cells in vaccinated macaques"
"0027473614","8427714","","2-s2.0-0027473614","1993-01-01","Studies on the specificity of the vaccine effect elicited by inactivated simian immunodeficiency virus"
"0030175604","8811357","10.1016/0165-2478(96)02567-9","2-s2.0-0030175604","1996-06-01","Attenuated SIV imparts immunity to challenge with pathogenic spleen-derived SIV but cannot prevent repair of the nef deletion"
"0027935344","8053500","","2-s2.0-0027935344","1994-08-01","Early events in tissues during infection with pathogenic (SIVmac239) and nonpathogenic (SIVmac1A11) molecular clones of simian immunodeficiency virus"
"0028210969","8139022","","2-s2.0-0028210969","1994-04-01","Immunopathogenic events in acute infection of rhesus monkeys with simian immunodeficiency virus of macaques"
"9044225149","8648735","","2-s2.0-9044225149","1996-06-03","Simian immunodeficiency virus DNA vaccine trial in macaques"
"0029151884","7666529","","2-s2.0-0029151884","1995-01-01","Vaccine-induced virus-neutralizing antibodies and cytotoxic T cells do not protect macaques from experimental infection with simian immunodeficiency virus SIVmac32H (J5)"
"0028360649","7917517","","2-s2.0-0028360649","1994-01-01","Analysis of cytotoxic T lymphocyte responses to SIV proteins in SIV- infected macaques using antigen-specific stimulation with recombinant vaccinia and fowl poxviruses"
"0021079076","6639872","","2-s2.0-0021079076","1983-12-01","Effects of cyclosporin A on mouse lymphoid tissues"
"0028851139","7738143","10.1016/0166-0934(94)00109-T","2-s2.0-0028851139","1995-01-01","The development of PCR based assays for the detection and differentiation of simian immunodeficiency virus in vivo"
"0030755079","9266988","","2-s2.0-0030755079","1997-08-01","Mechanisms of protection induced by attenuated simian immunodeficiency virus. I. Protection cannot be transferred with immune serum"
"0030658804","9339847","","2-s2.0-0030658804","1997-12-08","Longitudinal study of HIV-specific cytotoxic lymphocytes in HIV type 1- infected patients: Relative balance between host immune response and the spread of HIV type 1 infection"
"0028051847","7865336","","2-s2.0-0028051847","1994-12-13","Evaluation of cytotoxic T cell responses to candidate HIV-1 vaccines in HIV-1-uninfected individuals"
"0025108695","2206278","10.1016/0167-5699(90)90127-U","2-s2.0-0025108695","1990-01-01","Animal models for AIDS"
"0002854902","","","2-s2.0-0002854902","1994-07-13","Protection against simian immunodeficiency virus infection of macaques by cellular or viral antigens"
"0025372584","1970593","","2-s2.0-0025372584","1990-05-15","Simian immunodeficiency virus is restricted to a subset of blood CD4+ lymphocytes that includes memory cells"
"0028041344","8057491","","2-s2.0-0028041344","1994-09-01","Virus-specific CD8+ cytotoxic T-lymphocyte activity associated with control of viremia in primary human immunodeficiency virus type 1 infection"
"34548197226","","","2-s2.0-34548197226","1997-09-04","Virological and immunological parameters in cynomolgus macaques infected with pathogenic or attenuated SIV: Correlations with the outcome of a challenge with SHIV or SIVSMM(PBJ14)?"
"0030858557","9223268","10.1073/pnas.94.15.7811","2-s2.0-0030858557","1997-07-22","Immunity to retroviral infection: The friend virus model"
"0028135456","7933084","","2-s2.0-0028135456","1994-11-01","A partially attenuated simian immunodeficiency virus induces host immunity that correlates with resistance to pathogenic virus challenge"
"0029811908","8760810","","2-s2.0-0029811908","1996-08-01","Interleukin-2 regulates CC chemokine receptor expression and chemotactic responsiveness in T lymphocytes"
"0027538456","8455722","","2-s2.0-0027538456","1993-12-01","HIV infection is active and progressive in lymphoid tissue during the clinically latent stage of disease"
"0030744349","9206992","10.1084/jem.186.1.7","2-s2.0-0030744349","1997-07-07","Evasion of cytotoxic T lymphocyte (CTL) responses by nef-dependent induction of Fas ligand (CD95L) expression on simian immunodeficiency virus- infected cells"
"0025743306","2032289","10.1016/0092-8674(91)90097-I","2-s2.0-0025743306","1991-05-17","Importance of the nef gene for maintenance of high virus loads and for development of AIDS"
"0025010824","2171343","","2-s2.0-0025010824","1990-01-01","T-lymphocyte effects on murine cytomegalovirus pulmonary infection"
"0029069803","7662192","","2-s2.0-0029069803","1995-01-01","HIV-2-specific cytotoxic T-lymphocyte activity is inversely related to proviral load"
"0029099149","7561117","","2-s2.0-0029099149","1995-01-01","Cytokine patterns during progression to AIDS in children with perinatal HIV infection"
"0030954607","9191329","","2-s2.0-0030954607","1997-07-03","Cytokine profiling of simian immunodeficiency virus infection of Cynomologus macaques. Pathogenic SIVmac251 pJ5C versus non-pathogenic attenuated SIVmac251 pC8C reveals divergence"
"0026685823","1333378","10.1016/0090-1229(92)90151-D","2-s2.0-0026685823","1992-01-01","HIV-1 expression in chimpanzees can be activated by CD8+ cell depletion or CMV infection"
"0030154959","8892036","","2-s2.0-0030154959","1996-06-01","Do cytotoxic T lymphocytes clear some HIV/SIV infections?"
"0029417004","8525373","","2-s2.0-0029417004","1995-12-15","Identification of RANTES, MIP-1α, and MIP-1β as the major HIV-suppressive factors produced by CD8+ T cells"
"0030665257","9367954","10.1126/science.278.5342.1447","2-s2.0-0030665257","1997-11-21","Vigorous HIV-1-specific CD4+ T cell responses associated with control of viremia"
"0030175872","8811353","10.1016/0165-2478(96)02563-1","2-s2.0-0030175872","1996-06-01","Passive immune globulin therapy in the SIV/macaque model: Early interventisn can alter disease profile"
"0028035324","7848685","","2-s2.0-0028035324","1994-01-01","Fine analysis of humoral antibody response to envelope glycoprotein of SIV in infected and vaccinated macaques"
"0031985775","9420212","","2-s2.0-0031985775","1998-01-01","Administration of an anti-CD8 monoclonal antibody interferes with the clearance of chimeric simian/human immunodeficiency virus during primary infections of rhesus macaques"
"0027516822","8096068","","2-s2.0-0027516822","1993-12-01","Massive covert infection of helper T lymphocytes and macrophages by HIV during the incubation period of AIDS"
"12644274812","8597950","10.1038/nm0496-412","2-s2.0-12644274812","1996-07-01","Relative resistance to HIV-1 infection of CD4 lymphocytes from persons who remain uninfected despite multiple high-risk sexual exposures"
"0029652922","7752758","10.1016/S0140-6736(95)92540-6","2-s2.0-0029652922","1995-05-27","Protection by attenuated simian immunodeficiency virus in macaques against challenge with virus-infected cells"
"0028985668","7742041","","2-s2.0-0028985668","1995-02-28","Distribution of SIV in lymph nodes of serially sacrificed rhesus monkeys"
"0027939480","7532426","","2-s2.0-0027939480","1994-01-01","HIV-1-specific cytotoxic T lymphocyte response in healthy, long-term nonprogressing seropositive persons"
"0029022873","7546912","","2-s2.0-0029022873","1995-01-01","Passive immunization of rhesus macaques against SIV infection and disease"
"0028944667","7892606","","2-s2.0-0028944667","1995-12-01","Pathogenicity of live, attenuated SIV after mucosal infection of neonatal macaques"
"0023228920","3649576","10.1038/328543a0","2-s2.0-0023228920","1987-09-07","Sequence of simian immunodeficiency virus from macaque and its relationship to other human and simian retroviruses"
"0026486222","1460429","","2-s2.0-0026486222","1992-12-01","Vaccination of rhesus monkeys with synthetic peptide in a fusogenic proteoliposome elicits simian immunodeficiency virus-specific CD8+ cytotoxic T lymphocytes"
"0027404894","8437240","","2-s2.0-0027404894","1993-03-01","Simian immunodeficiency virus-specific CD8+ lymphocyte response in acutely infected rhesus monkeys"
"34548198553","","","2-s2.0-34548198553","1997-09-04","CTL-response in cynomolgus macaques infected with pathogenic or attenuated SIV: Correlations with the outcome of a challange with SHIV?"
"0030769854","9289848","10.1126/science.277.5329.1035","2-s2.0-0030769854","1997-09-15","Novel campaign to test live HIV vaccine"
"0030806029","9311855","","2-s2.0-0030806029","1997-09-26","Induction of vigorous cytotoxic T-lymphocyte responses by live attenuated simian immunodeficiency virus"
"0021994898","3159089","10.1126/science.3159089","2-s2.0-0021994898","1985-12-04","Isolation of T-cell tropic HTLV-III-like retrovirus from macaques"
"0030039735","8819192","","2-s2.0-0030039735","1996-07-01","Influence of selective T-lymphocyte depletion on the lung pathology of gnotobiotic calves and the distribution of different T-lymphocyte subsets following challenge with bovine respiratory syncytial virus"
"0028929463","7639966","","2-s2.0-0028929463","1995-01-01","Different patterns of HIV-1-specific cytotoxic T-lymphocyte activity after primary infection"
"0028374067","7966237","10.1111/j.1600-0684.1994.tb00105.x","2-s2.0-0028374067","1994-01-01","Immunization with whole inactivated vaccine protects from infection by SIV grown in human but not macaque cells"
"0030042402","8924248","","2-s2.0-0030042402","1996-01-22","Evidence for type 2 cytokine production and lymphocyte activation in the early phases of HIV-1 infection"
"0028216765","8203463","","2-s2.0-0028216765","1994-06-01","Early stages of simian immunodeficiency virus infection in lymph nodes: Evidence for high viral load and successive populations of target cells"
"0023335820","3037674","","2-s2.0-0023335820","1987-05-01","Animal models for acquired immunodeficiency syndrome."
"0025648199","1979369","10.1016/0140-6736(90)93310-L","2-s2.0-0025648199","1990-12-22","Preliminary report: protection of cynomolgus macaques against simian immunodeficiency virus by fixed infected-cell vaccine"
"0025058788","1689787","10.1016/0140-6736(90)90748-T","2-s2.0-0025058788","1990-03-03","The immunological principles of vaccination"
"0026800713","1501302","","2-s2.0-0026800713","1992-09-01","Interference established in mice by infection with friend murine leukemia virus"
"0028326110","8126450","","2-s2.0-0028326110","1994-01-01","Molecular and biological characterization of simian immunodeficiency virus macaque strain 32H proviral clones containing nef size variants"
"0027328704","8394442","","2-s2.0-0027328704","1993-09-01","Protection against retroviral diseases after vaccination is conferred by interference to superinfection with attenuated murine leukemia viruses"
"0004584383","","","2-s2.0-0004584383","2001-07-13","Campath recommended for approval for CLL patients who have failed to respond to prior therapy"
"0000431595","","","2-s2.0-0000431595","1996-07-13","A randomized comparison of fludarabine and chlorambucil for patients with previously untreated chronic lymphocytic leukemia"
"0002043061","","","2-s2.0-0002043061","1990-07-13","The CAMPATH antigen"
"0000470701","","","2-s2.0-0000470701","1999-07-13","Campath-1H therapy in 29 patients with refractory CLL: 'True' complete remission is an attainable goal"
"0001673478","","","2-s2.0-0001673478","2000-07-13","Phase II clinical trial of Campath-1H in refractory hematological malignancies expressing the surface antigen CD52"
"0003296838","","","2-s2.0-0003296838","1995-07-13","Immunosuppression and opportunistic infections (OI) in patients with chronic lymphocytic leukemia (CLL) following Campath 1-H therapy"
"0032968981","10373075","","2-s2.0-0032968981","1999-06-09","Selective removal of alloreactive cells from haematopoietic stem cell grafts: Graft engineering for GVHD prophylaxis"
"0029760436","8817388","","2-s2.0-0029760436","1996-06-01","The ISHAGE guidelines for CD34+ cell determination by flow cytometry"
"0032732330","10501426","10.1093/rheumatology/38.8.751","2-s2.0-0032732330","1999-08-01","The depletion of T cells from haematopoietic stem cell transplants"
"0004476629","","","2-s2.0-0004476629","1995-07-13","Expression of cell surface markers during differentiation of CD34+, CD38 -/lo fetal and adult bone marrow cells"
"0022453667","3529524","","2-s2.0-0022453667","1986-01-01","Monoclonal antibodies for the prevention of graft-versus-host disease and marrow graft rejection: The depletion of t cell subsets in vitro and in vivo"
"0005425371","","","2-s2.0-0005425371","1998-07-13","CAMPATH-1 Antigen (CD52)"
"0025228924","2109379","","2-s2.0-0025228924","1990-01-01","In vivo cell activation following OKT3 administration: Systemic cytokine release and modulation by corticosteroids"
"0031719315","9758337","","2-s2.0-0031719315","1998-10-12","Allogeneic transplantation of selected CD34+ cells from peripheral blood: Experience of 62 cases using immunoadsorption or immunomagnetic technique"
"0343952135","","","2-s2.0-0343952135","2000-07-13","Allogeneic peripheral blood stem cell transplantation"
"0348091437","","","2-s2.0-0348091437","1988-07-13","Remission induction in non-Hodgkin s lymphoma with a reshaped human monoclonal antibody Campath 1 H"
"0025324988","2142440","","2-s2.0-0025324988","1990-07-15","Selective depletion of CD8+ T lymphocytes for prevention of graft-versus-host disease after allogeneic bone marrow transplantation"
"0027365965","8413388","10.1056/NEJM199310213291703","2-s2.0-0027365965","1993-01-01","Cyclosporine, methotrexate, and prednisone compared with cyclosporine and prednisone for prophylaxis of acute graft-versus-host disease"
"0026779259","1391947","","2-s2.0-0026779259","1992-10-01","Acute graft-versus-host disease: Analysis of risk factors after allogeneic marrow transplantation and prophylaxis with cyclosporine and methotrexate"
"0029150223","7545476","","2-s2.0-0029150223","1995-10-01","Allogeneic Blood Stem Cell Transplantation: Peripheralization and Yield of Donor-Derived Primitive Hematopoietic Progenitor Cells (CD34+ Thy-1dim) and Lymphoid Subsets, and Possible Predictors of Engraftment and Graft-Versus-Host Disease"
"0032918482","","","2-s2.0-0032918482","1999-01-01","Improved outcome with T-cell-depleted bone marrow transplantation for acute leukemia"
"0013804295","5323965","","2-s2.0-0013804295","1965-01-01","Adoptive Immunotherapy of Acute Leukemia: Experimental and Clinical Results"
"0028964505","7598453","10.1146/annurev.med.46.1.169","2-s2.0-0028964505","1995-01-01","Marrow transplantation from unrelated volunteer donors"
"0024429365","2529927","","2-s2.0-0024429365","1989-01-01","Graft failure after T-cell-depleted human leukocyte antigen identical marrow transplants for leukemia: II. In vitro analayses of host effector mechanisms"
"0027048743","1467511","","2-s2.0-0027048743","1992-12-15","Cytokine dysregulation and acute graft-versus-host disease"
"0028843985","8541530","","2-s2.0-0028843985","1995-01-01","Pretreatment of donor mice with granulocyte colony-stimulating factor polarizes donor T lymphocytes toward type-2 cytokine production and reduces severity of experimental graft-versus-host disease"
"0018257740","363972","","2-s2.0-0018257740","1978-12-01","Lethal graft versus host disease after bone marrow transplantation across minor histocompatibility barriers in mice. Prevention by removing mature T cells from marrow"
"0024510510","2653461","","2-s2.0-0024510510","1989-01-01","Methotrexate and cyclosporine versus cyclosporine alone for prophylaxis of graft-versus-host disease in patients given HLA-identical marrow grafts for leukemia: Long-term follow-up of a controlled trial"
"0032620815","10534058","","2-s2.0-0032620815","1999-12-01","Cyclosporine, methotrexate, and prednisone compared with cyclosporine and prednisone for prevention of acute graft-vs.-host disease: Effect on chronic graft-vs.-host disease and long-term survival"
"0022620989","3521427","","2-s2.0-0022620989","1986-09-04","Treatment of donor bone marrow with monoclonal anti-T-cell antibody and complement for the prevention of graft-versus-host disease. A prospective, randomized, double-blind trial"
"0031028329","9057645","","2-s2.0-0031028329","1997-03-11","Suppression of alloantigen-induced T-cell proliferation by CD14+ cells derived from granulocyte colony-stimulating factor-mobilized peripheral blood mononuclear cells"
"0028913975","7534141","","2-s2.0-0028913975","1995-01-01","Primary transplantation of allogeneic peripheral blood progenitor cells mobilized by filgrastim (granulocyte colony-stimulating factor)"
"0024566585","2653460","","2-s2.0-0024566585","1989-01-01","Influence of acute and chronic graft-versus-host disease on relapse and survival after bone marrow transplantation from HLA-identical siblings as treatment of acute and chronic leukemia"
"0023940608","3287016","","2-s2.0-0023940608","1988-01-01","Prevention of graft-versus-host disease by ex vivo T cell depletion: Reduction in graft failure with augmented total body irradiation"
"0000640293","","","2-s2.0-0000640293","1999-02-13","Results of a phase I-II study of radioimmunotherapy for the intensification of conditioning prior to stem cell transplantation for patients with high-risk haematological malignancies"
"17744412916","9486492","","2-s2.0-17744412916","1998-01-01","Lymphocyte reconstitution after allogeneic blood stem cell transplantation for hematologic malignancies"
"0021330880","6142206","10.1016/S0140-6736(84)92847-2","2-s2.0-0021330880","1984-03-03","EX-VIVO TREATMENT OF DONOR BONE MARROW WITH ANTI-T-CELL IMMUNOTOXINS FOR PREVENTION OF GRAFT-VERSUS-HOST DISEASE"
"0033566795","10438711","","2-s2.0-0033566795","1999-08-15","Phase I study of 131I-anti-CD45 antibody plus cyclophosphamide and total body irradiation for advanced acute leukemia and myelodysplastic syndrome"
"0024315206","2543925","","2-s2.0-0024315206","1989-01-01","Severe herpesvirus infections in an adolescent without natural killer cells"
"0023764402","3053241","10.1111/j.1600-0609.1988.tb01188.x","2-s2.0-0023764402","1988-01-01","T‐cell depletion versus methotrexate as GvHD‐prophylaxis in allogeneic bone marrow transplantation for leukaemia"
"0015956298","","10.1002/eji.1830040107","2-s2.0-0015956298","1974-01-01","Anti‐lymphocytic antibodies and marrow transplantation. III. Effect of heterologous anti‐brain antibodies on acute secondary disease in mice"
"0029839210","8839875","","2-s2.0-0029839210","1996-10-01","Improved immune reconstitution after allotransplantation of peripheral blood stem cells instead of bone marrow"
"0032834494","10541824","10.1007/s002590050582","2-s2.0-0032834494","1999-10-16","Preparation and evaluation of the rhenium-188-labelled anti-NCA antigen monoclonal antibody BW 250/183 for radioimmunotherapy of leukaemia"
"0031454791","9389688","","2-s2.0-0031454791","1997-12-15","Transplantation of filgrastim-mobilized peripheral blood stem cells from HLA-identical sibling or alternative family donors in patients with hematologic malignancies: A prospective comparison on clinical outcome, immune reconstitution, and hematopoietic chimerism"
"0025828983","1850779","","2-s2.0-0025828983","1991-05-01","Natural killer (NK) cell response to virus infections in mice with severe combined immunodeficiency. The stimulation of NK cells and the NK cell-Dependent control of virus infections occur independently of T and B cell function"
"0346200160","","","2-s2.0-0346200160","1994-07-13","Improved disease-free survival in recipients of T cell-depleted (SBA-E)-bone marrow allografts for acute non-lymphocytic leukemia in first remission"
"0025852066","2070130","","2-s2.0-0025852066","1991-01-01","Are new conditioning regimens for transplants in acute myelogenous leukemia better?"
"10544235444","8943847","","2-s2.0-10544235444","1996-12-01","Transplantation of allogeneic CD34+ peripheral blood stem cells in patients with advanced hematologic malignancy"
"0024853217","2573398","","2-s2.0-0024853217","1989-12-01","CD8+/DR+/CD25- T-lymphocytes associated with marrow graft failure"
"0025357105","1693327","","2-s2.0-0025357105","1990-06-01","Cellular and molecular basis of the protective immune response to cytomegalovirus infection"
"0023294094","3547943","","2-s2.0-0023294094","1987-02-01","Graft failure and leukemia relapse following T lymphocyte-depleted bone marrow transplants: effect of intensification of immunosuppressive conditioning."
"0030476554","8971376","","2-s2.0-0030476554","1996-12-01","Allogeneic transplantation of positively selected peripheral blood CD34+ progenitor cells from matched related donors"
"0032555912","9743523","10.1084/jem.188.6.1047","2-s2.0-0032555912","1998-09-21","Hierarchical and redundant lymphocyte subset control precludes cytomegalovirus replication during latent infection"
"0000083039","","","2-s2.0-0000083039","1992-06-26","The use of radiolabelled anti-CD33 antibody to augment marrow irradiation prior to marrow transplantation for acute myelogenous leukemia"
"0028054895","8291119","","2-s2.0-0028054895","1994-01-01","Selective depletion of CD8&lt;sup&gt;+&lt;/sup&gt; cells for prevention of graft-versus-host disease after bone marrow transplantation: A randomized controlled trial"
"0000576610","","","2-s2.0-0000576610","1994-07-13","Graft-versus-host disease"
"0025244983","1705459","","2-s2.0-0025244983","1990-01-01","Graft failure after T cell-depleted bone marrow transplantation: clinical and immunological characteristics and response to immunosuppressive therapy"
"0026347036","1750063","","2-s2.0-0026347036","1991-01-01","Hepatic dysfunction following T-cell-depleted allogeneic bone marrow transplantation"
"0027488659","7691265","","2-s2.0-0027488659","1993-10-15","T-cell regeneration after bone marrow transplantation: Differential CD45 isoform expression on thymic-derived versus thymic-independent progeny"
"0029163414","8535315","","2-s2.0-0029163414","1995-10-03","T cell reconstitution after bone marrow transplantation into adult patients does not resemble T cell development in early life"
"0021984561","3896348","","2-s2.0-0021984561","1985-11-28","Effects of in vitro depletion of T cells in HLA-identical allogeneic marrow grafts"
"0032862789","10516672","","2-s2.0-0032862789","1999-10-18","HLA-identical sibling peripheral blood progenitor cell transplants (PBPCT)"
"0025890204","2015394","","2-s2.0-0025890204","1991-04-15","Allogeneic marrow transplantation in patients with chronic myeloid leukemia in the chronic phase: A randomized trial of two irradiation regimens"
"0033041419","10100577","","2-s2.0-0033041419","1999-01-01","Immune reconstitution following allogeneic peripheral blood stem cell transplants"
"0025243778","2224134","","2-s2.0-0025243778","1990-11-01","Allogeneic marrow transplantation in patients with acute myeloid leukemia in first remission: A randomized trial of two irradiation regimens"
"0002706768","","","2-s2.0-0002706768","1995-06-26","Transplantation of allogeneic blood stem cells mobilized by recombinant human recombinant granulocyte colony-stimulating factor"
"0028353829","8142663","","2-s2.0-0028353829","1994-04-01","Recovery of HLA-restricted cytomegalovirus (CMV)-specific T-cell responses after allogeneic bone marrow transplant: Correlation with CMV disease and effect of ganciclovir prophylaxis"
"0025011798","2249952","10.1016/0198-8859(90)90071-V","2-s2.0-0025011798","1990-01-01","Effect of HLA incompatibility on graft-versus-host disease, relapse, and survival after marrow transplantation for patients with leukemia or lymphoma"
"0000791705","","","2-s2.0-0000791705","1957-12-04","Treatment of murine leukaemia with X-rays and homologous bone marrow"
"0029952312","8703830","","2-s2.0-0029952312","1996-01-01","Duration of filgrastim mobilization and apheresis yield of CD34+ progenitor cells and lymphoid subsets in normal donors for allogeneic transplantation"
"0025096695","1967432","10.1016/0140-6736(90)90003-N","2-s2.0-0025096695","1990-01-20","Rejection of bone-marrow graft by recipient-derived cytotoxic T lymphocytes against minor histocompatibility antigens"
"0003197107","","","2-s2.0-0003197107","1999-02-13","G-CSF blocks IL-12 production by antigen presenting cells: Implications for improved immune reconstitution after haploidentical hematopoietic transplantation"
"0025100777","2297567","","2-s2.0-0025100777","1990-02-01","Graft-versus-leukemia reactions after bone marrow transplantation"
"0005457265","8982051","","2-s2.0-0005457265","1996-12-01","Transplantation of peripheral blood progenitor cells from HLA-identical sibling donors"
"0025246375","2178709","","2-s2.0-0025246375","1990-01-01","Chronic graft-versus-host disease"
"0000231754","","","2-s2.0-0000231754","1999-07-13","Results of allogeneic stem cell transplantation for malignant disorders"
"0030873666","9376591","","2-s2.0-0030873666","1997-10-15","Natural killer (NK) cells are functionally abnormal and NK cell progenitors are diminished in granulocyte colony-stimulating factor-mobilized peripheral blood progenitor cell collections"
"0030896218","9108425","","2-s2.0-0030896218","1997-04-15","CD6-depleted allogeneic bone marrow transplantation for acute leukemia in first complete remission"
"0031885659","9543057","","2-s2.0-0031885659","1998-03-02","T cell-depleted bone marrow transplantation and delayed T cell add-back to control acute GVHD and conserve a graft-versus-leukemia effect"
"0033555440","9885208","","2-s2.0-0033555440","1999-01-15","Comparison of immune reconstitution after unrelated and related T-cell- depleted bone marrow transplantation: Effect of patient age and donor leukocyte infusions"
"0025924216","2043874","","2-s2.0-0025924216","1991-01-01","Total lymhoid irradiation to prevent graft rejection in recipients of HLA non-identical T cell-depleted allogeneic marrow"
"0031019163","9039782","10.1016/S0952-7915(97)80155-0","2-s2.0-0031019163","1997-02-01","Activation and function of natural killer cell responses during viral infections"
"0023046991","3528866","10.1038/323164a0","2-s2.0-0023046991","1986-12-01","Monoclonal antibodies to promote marrow engraftment and tissue graft tolerance"
"0027249574","8338933","","2-s2.0-0027249574","1993-08-01","Characterization of cells emerging at the time of graft failure after bone marrow transplantation from an unrelated marrow donor"
"0032558759","9780338","10.1056/NEJM199810223391702","2-s2.0-0032558759","1998-10-22","Treatment of high-risk acute leukemia with T-cell-depleted stem cells from related donors with one fully mismatched hla haplotype"
"0003296126","","","2-s2.0-0003296126","1993-12-31","Results of allogeneic bone marrow transplant following 131 I-M 195/Busulfan/ Cyclophosphamide Bu/Cy in patients with advanced/ refractory myeloid malignancies"
"0025634104","2247120","","2-s2.0-0025634104","1990-12-27","Bone marrow-allograft rejection by T lymphocytes recognizing a single amino acid difference in HLA-B44"
"0029068764","7581111","","2-s2.0-0029068764","1995-01-01","Multiple minor histocompatibility antigen-specific cytotoxic T lymphocyte clones can be generated during graft rejection after HLA-identical bone marrow transplantation"
"0022624255","3513012","","2-s2.0-0022624255","1986-06-11","Methotrexate and cyclosporine compared with cyclosporine alone for prophylaxis of acute graft versus host disease after marrow transplantation for leukemia"
"0024427624","2804361","","2-s2.0-0024427624","1989-01-01","Graft failure after T-cell-depleted human leukocyte antigen identical marrow transplants for leukemia: I. Analysis of risk factors and results of secondary transplants"
"0029945209","8639865","","2-s2.0-0029945209","1996-06-01","Transplantation of allogeneic CD34+ blood cells"
"0028936249","7849300","","2-s2.0-0028936249","1995-01-01","Development of a marrow transplant regimen for acute leukemia using targeted hematopoietic irradiation delivered by 131I-labeled anti-CD45 antibody, combined with cyclophosphamide and total body irradiation"
"0030801512","9255622","10.1111/j.1600-065X.1997.tb00974.x","2-s2.0-0030801512","1997-08-02","Pathways of T-cell regeneration in mice and humans: Implications for bone marrow transplantation and immmunotherapy"
"31544434508","16219797","10.1182/blood-2005-06-2395","2-s2.0-31544434508","2006-02-01","Fludarabine plus cyclophosphamide versus fludarabine alone in first-line therapy of younger patients with chronic lymphocytic leukemia"
"19944429446","15138165","10.1182/blood-2004-03-0796","2-s2.0-19944429446","2005-01-01","Addition of rituximab to fludarabine may prolong progression-free survival and overall survival in patients with previously untreated chronic lymphocytic leukemia: An updated retrospective comparative analysis of CALGB 9712 and CALGB 9011"
"0037092951","11986207","10.1182/blood.V99.10.3554","2-s2.0-0037092951","2002-05-15","Therapeutic role of alemtuzumab (Campath-1H) in patients who have failed fludarabine: Results of a large international study"
"33644847307","16344317","10.1200/JCO.2005.03.1021","2-s2.0-33644847307","2006-01-20","Select high-risk genetic features predict earlier progression following chemoimmunotherapy with fludarabine and rituximab in chronic lymphocytic leukemia: Justification for risk-adapted therapy"
"33947541773","17283364","10.1200/JCO.2006.08.0762","2-s2.0-33947541773","2007-03-01","Phase III trial of fludarabine plus cyclophosphamide compared with fludarabine for patients with previously untreated chronic lymphocytic leukemia: US intergroup trial E2997"
"33947544426","17283363","10.1200/JCO.2006.08.3089","2-s2.0-33947544426","2007-03-01","Comprehensive assessment of genetic and molecular features predicting outcome in patients with chronic lymphocytic leukemia: Results from the US intergroup phase III trial E2997"
"23044510136","15767648","10.1200/JCO.2005.12.051","2-s2.0-23044510136","2005-12-01","Early results of a chemoimmunotherapy regimen of fludarabine, cyclophosphamide, and rituximab as initial therapy for chronic lymphocytic leukemia"
"0034649696","11114313","10.1056/NEJM200012143432402","2-s2.0-0034649696","2000-12-14","Fludarabine compared with chlorambucil as primary therapy for chronic lymphocytic leukemia"
"33845786517","17145843","10.1158/1078-0432.CCR-06-1275","2-s2.0-33845786517","2006-12-01","Heterogeneous CD52 expression among hematologic neoplasms: Implications for the use of alemtuzumab (CAMPATH-1H)"
"0036839469","12384407","10.1182/blood-2002-03-0972","2-s2.0-0036839469","2002-11-01","Phase 2 study of a combined immunochemotherapy using rituximab and fludarabine in patients with chronic lymphocytic leukemia"
"34047217206","17296974","10.1200/JCO.2006.07.1191","2-s2.0-34047217206","2007-03-20","Randomized phase III trial of fludarabine plus cyclophosphamide with or without oblimersen sodium (Bcl-2 antisense) in patients with relapsed or refractory chronic lymphocytic leukemia"
"34249655671","17530018","10.1038/sj.onc.1210380","2-s2.0-34249655671","2007-05-28","Alemtuzumab (Campath-1H) in the treatment of chronic lymphocytic leukemia"
"34447530283","17658394","10.1016/S0140-6736(07)61125-8","2-s2.0-34447530283","2007-07-21","Assessment of fludarabine plus cyclophosphamide for patients with chronic lymphocytic leukaemia (the LRF CLL4 Trial): a randomised controlled trial"
"3042871056","2911570","","2-s2.0-3042871056","1989-01-01","Rapid typing of tandemly repeated hypervariable loci by the polymerase chain reaction: Application to the apolipoprotein B 3' hypervariable region"
"0025854340","1673490","10.1016/0140-6736(91)91704-X","2-s2.0-0025854340","1991-05-04","PCR-fingerprinting for selection of HLA matched unrelated marrow donors"
"0026630961","1519966","","2-s2.0-0026630961","1992-01-01","Myelodysplastic syndromes"
"0022446552","3486010","","2-s2.0-0022446552","1986-01-01","Juvenile chronic myelogenous leukemia: Characterization of the disease using cell cultures"
"0029073949","7606014","","2-s2.0-0029073949","1995-07-15","Role of busulfan and total body irradiation on growth of prepubertal children receiving bone marrow transplantation and results of treatment with recombinant human growth hormone"
"0027498443","8426579","10.1002/mpo.2950210115","2-s2.0-0027498443","1993-01-01","Congenital juvenile chronic myelogenous leukemia: Therapeutic trial with interferon alpha‐2"
"0024240878","3049951","","2-s2.0-0024240878","1988-12-01","Regimen-related toxicity in patients undergoing bone marrow transplantation"
"0028221279","8182940","","2-s2.0-0028221279","1994-05-01","Busulfan, cyclophosphamide and melphalan as conditioning regimen for bone marrow transplantation in children with myelodysplastic syndromes"
"0027724465","8136746","","2-s2.0-0027724465","1993-12-01","Graft-versus-host disease in children: The AIEOP-BMT group experience with cyclosporin A"
"0026560027","1571710","","2-s2.0-0026560027","1992-01-01","Allogeneic marrow transplantation using T cell depletion for patients with juvenile chronic myelogenous leukemia without HLA-identical siblings"
"0023574955","3311203","","2-s2.0-0023574955","1987-12-01","Bone marrow transplantation for leukemia following a new busulfan and cyclophosphamide regimen"
"0023726520","2968914","","2-s2.0-0023726520","1988-01-01","Cell culture studies and oncogene expression in juvenile chronic myelogenous leukemia"
"0024426981","2679915","","2-s2.0-0024426981","1989-01-01","Granulocyte-macrophage colony-stimulating factor is an endogenous regulator of cell proliferation in juvenile chronic myelogenous leukemia"
"0023678331","3052147","","2-s2.0-0023678331","1988-01-01","Juvenile chronic myelogenous leukemia"
"0021233189","6589029","10.1002/1097-0142(1984)54:4&lt;675::AID-CNCR2820540415&gt;3.0.CO;2-Q","2-s2.0-0021233189","1984-01-01","Subacute and chronic myelomonocytic leukemia in children (juvenile CML). Clinical and hematologic observations, and identification of prognostic factors"
"0001416208","","","2-s2.0-0001416208","1994-01-05","The role of graft-versus-leukemia in bone marrow transplantation for juvenile chronic myeloid leukemia"
"0025778002","2009366","","2-s2.0-0025778002","1991-01-01","Increased risk of leukemia relapse with high-dose cyclosporine A after allogeneic marrow transplantation for acute leukemia"
"0027143184","8260710","","2-s2.0-0027143184","1993-01-01","Results of intensive therapy in childhood acute myeloid leukemia, incorporating high-dose melphalan and autologous bone marrow transplantation in first complete remission"
"0028319307","7920314","","2-s2.0-0028319307","1994-01-01","Treatment of juvenile chronic myelomonocytic leukemia by allogeneic bone marrow transplantation"
"0023544709","3478101","","2-s2.0-0023544709","1987-12-01","Residual juvenile chronic myelogenous leukemia cells detected in peripheral blood during clinical remission"
"0026035273","1671853","10.1007/BF00210825","2-s2.0-0026035273","1991-02-01","Detection of complex alleles by direct analysis of DNA heteroduplexes"
"0026691249","1357775","10.1111/j.1399-0039.1992.tb01940.x","2-s2.0-0026691249","1992-01-01","HLA‐DR typing by PCR amplification with sequence‐specific primers (PCR‐SSP) in 2 hours: An alternative to serological DR typing in clinical practice including donor‐recipient matching in cadaveric transplantation"
"0023924301","3281722","","2-s2.0-0023924301","1988-01-01","Allogeneic marrow transplantation for children with juvenile chronic myelogenous leukemia"
"0027401455","8467291","","2-s2.0-0027401455","1993-01-01","Successful allogeneic bone marrow transplantation in juvenile CML: Conditioning or graft-versus-leukaemia effect?"
"0023485829","2445935","","2-s2.0-0023485829","1987-12-01","The value of intensive combination chemotherapy for juvenile chronic myelogenous leukemia"
"0029794831","8781449","","2-s2.0-0029794831","1996-09-01","Enhancement of thymopoiesis after bone marrow transplant by in vivo interleukin-7"
"0027935476","8064232","10.1084/jem.180.3.1159","2-s2.0-0027935476","1994-09-01","Antigen-independent activation of naive and memory resting T cells by a cytokine combination"
"0023231481","3038215","","2-s2.0-0023231481","1987-01-01","Effects of herpes virus carrier status on peripheral T lymphocyte subsets"
"0024332461","2500349","10.1002/eji.1830190518","2-s2.0-0024332461","1989-01-01","Peripheral T lymphocytes: expansion potential and homeostatic regulation of pool sizes and CD4/CD8 ratios in vivo"
"0025285129","2197342","10.1093/infdis/162.2.496","2-s2.0-0025285129","1990-01-01","Response to tetanus toxoid immunization after allogeneic bone marrow transplantation"
"17144456465","9116614","","2-s2.0-17144456465","1997-01-02","Rapid immunologic reconstitution following transplantation with mobilized peripheral blood stem cells as compared to bone marrow"
"0031570446","9190943","","2-s2.0-0031570446","1997-06-15","TCR β-Chain Variable Region-Driven Selection and Massive Expansion of HLA-Class I-Restricted Antitumor CTL Lines from HLA-A*0201+ Melanoma Patients"
"0026001221","1768967","","2-s2.0-0026001221","1991-01-01","The reappearance of 10 differentiation antigens on peripheral blood lymphocytes after allogeneic bone marrow transplantation"
"13344261401","8555504","","2-s2.0-13344261401","1996-01-15","Stable clonal expansion of T cells induced by bone marrow transplantation"
"0027943847","7919391","","2-s2.0-0027943847","1994-10-15","In vivo T-cell clonal amplification at time of acute graft-versus-host disease"
"0024788996","2585021","","2-s2.0-0024788996","1989-12-01","High frequency of benign mediastinal uptake of gallium-67 after completion of chemotherapy in children with high-grade non-Hodgkin's lymphoma"
"0027461784","8459219","","2-s2.0-0027461784","1993-01-01","The life span of naive α/β T cells in secondary lymphoid organs"
"0028200617","7920294","","2-s2.0-0028200617","1994-01-01","Marrow transplants from HLA matched unrelated donors: An NMDP update and the Seattle experience"
"0029077277","7645867","10.1111/j.1749-6632.1995.tb44555.x","2-s2.0-0029077277","1995-10-16","Oligoclonal T-cell repertoire and graft-versus-host disease after allogeneic bone marrow transplantation"
"0025995695","1652311","","2-s2.0-0025995695","1991-09-01","Cytotoxic T-lymphocyte response to cytomegalovirus after human allogeneic bone marrow transplantation: Pattern of recovery and correlation with cytomegalovirus infection and disease"
"0030691757","9348298","10.1084/jem.186.9.1407","2-s2.0-0030691757","1997-11-03","Phenotypic and functional separation of memory and effector human CD8+ T cells"
"0030975523","9207421","","2-s2.0-0030975523","1997-07-03","Thymic function in adults: Evidence derived from immune recovery patterns following myeloablative chemotherapy and stem cell infusion"
"0030176389","8824582","10.1016/0198-8859(96)00085-7","2-s2.0-0030176389","1996-06-01","T-cell repertoire complexity after allogeneic bone marrow transplantation"
"0023687670","3262940","","2-s2.0-0023687670","1988-01-01","Abnormal distribution of T cell subsets in the thymus of cyclosporin A (CsA)-treated mice"
"0029142996","8522452","10.1016/0198-8859(95)00056-A","2-s2.0-0029142996","1995-01-01","Molecular analysis of T cell repertoires. Spectratypes generated by multiplex polymerase chain reaction and evaluated by radioactivity or fluorescence"
"0030023568","8598492","","2-s2.0-0030023568","1996-01-01","In vivo response of mature T cells to Mlsa antigens: Long-term progeny of dividing cells include cells with a naive phenotype"
"0024392719","2809194","","2-s2.0-0024392719","1989-01-01","Effect of cyclosporin A on lymphopoiesis. II. Developmental defects of immature and mature thymocytes in fetal thymus organ cultures treated with cyclosporin A"
"0027447547","8431713","","2-s2.0-0027447547","1993-01-01","Immune reconstitution after BMT in children"
"0027979646","7506956","","2-s2.0-0027979646","1994-01-15","Oligoclonal expansion of CD8+CD57+ T cells with restricted T-cell receptor β chain variability after bone marrow transplantation"
"9444262434","8864444","","2-s2.0-9444262434","1996-08-01","Clonal predominance of cytomegalovirus-specific CD8+ cytotoxic T lymphocytes in bone marrow recipients"
"0027471418","7682955","10.1002/eji.1830230512","2-s2.0-0027471418","1993-01-01","Age‐related accumulation of LFA‐1high cells in a CD8+CD45RAhigh T cell population"
"0024811034","2623737","","2-s2.0-0024811034","1989-12-01","Cyclosporine a prevents the generation of single positive mature T cells in newborn mice"
"0030765961","9257813","","2-s2.0-0030765961","1997-09-12","Thymic and extrathymic differentiation and expansion of T lymphocytes following bone marrow transplantation in irradiated recipients"
"0027360966","7691252","","2-s2.0-0027360966","1993-10-01","Prediction of graft-versus-host disease by phenotypic analysis of early immune reconstitution after CD6-depleted allogeneic bone marrow transplantation"
"0020573814","6351369","","2-s2.0-0020573814","1983-01-01","Human T lymphocyte phenotypes after bone marrow transplantation: T cells expressing Ia-like antigen"
"0029835451","8913288","","2-s2.0-0029835451","1996-11-26","Stimulation of immune reconstitution by interleukin-7 after syngeneic bone marrow transplantation in mice"
"0019956303","6211202","","2-s2.0-0019956303","1982-09-10","T-cell subpopulations identified by monoclonal antibodies after human marrow transplantation. I. Helper-inducer and cytotoxic-suppressor subsets"
"0031042008","9034287","10.1002/(SICI)1096-8652(199702)54:2&lt;131::AID-AJH6&gt;3.0.CO;2-Y","2-s2.0-0031042008","1997-02-26","Infectious morbidity in long-term survivors of allogeneic marrow transplantation is associated with low CD4 T cell counts"
"0030913588","9153957","10.1016/S0167-5699(97)81664-7","2-s2.0-0030913588","1997-05-01","T-cell regeneration: All repertoires are not created equal"
"0029665310","","","2-s2.0-0029665310","1996-01-01","Viruses and T cell turnover: Evidence for bystander proliferation"
"0030754129","9226186","","2-s2.0-0030754129","1997-07-15","Essential role of the thymus to reconstitute naive (CD45RA+) T-helper cells after human allogeneic bone marrow transplantation"
"0023518554","3314529","","2-s2.0-0023518554","1987-12-01","Pathology of the thymus after allogeneic bone marrow transplantation in man. A histologic immunohistochemical study of 36 patients"
"0028864497","7490450","","2-s2.0-0028864497","1995-11-16","Intrafamily fragment analysis of the T cell receptor β chain CDR3 region"
"0029395828","9118285","","2-s2.0-0029395828","1995-11-01","The effect of thymic function on immunocompetence following bone marrow transplantation."
"0028220953","8176227","","2-s2.0-0028220953","1994-01-01","Circulating T cell repertoire complexity in normal individuals and bone marrow recipients analyzed by CDR3 size spectratyping: Correlation with immune status"
"0028812436","7800006","10.1056/NEJM199501193320303","2-s2.0-0028812436","1995-01-01","Age, thymopoiesis, and CD4+ T-lymphocyte regeneration after intensive chemotherapy"
"0022608377","3011326","","2-s2.0-0022608377","1986-06-18","T lymphocyte regeneration after transplantation of T cell depleted allogeneic bone marrow"
"0025889765","1824270","","2-s2.0-0025889765","1991-01-01","Effect of graft-versus-host disease on hematopoiesis after bone marrow transplantation in mice"
"0021237464","6372896","","2-s2.0-0021237464","1984-08-09","T lymphocyte repopulation and differentiation after bone marrow transplantation. Early shifts in the ratio between T4+ and T8+ T lymphocytes correlate with the occurrence of acute graft-versus-host disease"
"0028787748","7594519","","2-s2.0-0028787748","1995-01-01","Oligoclonal expansion of CTLs directed against a restricted number of dominant minor histocompatibility antigens in hemopoietic chimeras"
"0018859023","6989042","","2-s2.0-0018859023","1980-01-01","T cell functional defect associated with thymic epithelial cell injury induced by a graft-versus-host reaction"
"0029974048","8896418","","2-s2.0-0029974048","1996-11-01","Heterogeneity of the human CD4+ T-cell population: Two distinct CD4+ T-cell subsets characterized by coexpression of CD45RA and CD45RO isoforms"
"0028009202","8019452","","2-s2.0-0028009202","1994-01-01","Bone marrow transplantation activity in Europe 1992: Report from the European Group for Bone Marrow Transplantation (EBMT)"
"0022531203","3513603","","2-s2.0-0022531203","1986-11-19","Immunohistology of the thymus in bone marrow transplant recipients"
"0028264442","7910987","","2-s2.0-0028264442","1994-01-01","The phenotype and reconstitution of immunoregulatory t cell subsets after t cell-depleted allogeneic and autologous bone marrow transplantation"
"0024396068","2543471","","2-s2.0-0024396068","1989-01-01","CD3+, 4+ and/or 8+ T cells and CD3+, 4-, 8- T cells repopulate at different rates after allogeneic bone marrow transplantation"
"0023893710","2965180","","2-s2.0-0023893710","1988-05-13","Loss of CD45R and gain of UCHL1 reactivity is a feature of primed T cells"
"0030610153","9259585","","2-s2.0-0030610153","1997-08-15","Characterization oft cell repertoire in patients with graft-versus- leukemia after donor lymphocyte infusion"
"0029943897","8648103","","2-s2.0-0029943897","1996-06-15","Thymic-independent T cell regeneration occurs via antigen-driven expansion of peripheral T cells resulting in a repertoire that is limited in diversity and prone to skewing"
"0021839270","2990611","","2-s2.0-0021839270","1985-10-31","Recovery of T cell subsets after autologous bone marrow transplantation is mainly due to proliferation of mature T cells in the graft"
"0030176090","8824581","10.1016/0198-8859(96)00082-1","2-s2.0-0030176090","1996-06-01","T cell receptor clonal diversity following allogeneic marrow grafting"
"0023161541","2884832","","2-s2.0-0023161541","1987-01-01","Human marrow transplantation: an immunological perspective."
"0031157726","9267666","","2-s2.0-0031157726","1997-06-01","Immune reconstitution following T-cell depleted bone marrow transplantation: Effect of age and posttransplant graft rejection prophylaxis"
"84889526771","","","2-s2.0-84889526771","1997-12-18","Persistence of CD4+ T cells in the arthritic joint after CAMPATH-1H treatment"
"0029115051","7639806","10.1002/art.1780380812","2-s2.0-0029115051","1995-01-01","A randomized, double‐blind, placebo‐controlled study of cd4 monoclonal antibody therapy in early rheumatoid arthritis"
"0027523369","8448639","","2-s2.0-0027523369","1993-01-01","Cyclosporin A in rheumatoid arthritis: Overview of efficacy"
"0025265635","1970370","10.1016/0140-6736(90)92630-Z","2-s2.0-0025265635","1990-05-05","Low-dose cyclosporin versus placebo in patients with rheumatoid arthritis"
"0000614854","","","2-s2.0-0000614854","1993-07-13","Etiology and pathogenesis of rheumatoid arthritis"
"84889506336","","","2-s2.0-84889506336","0000-12-18","A kinetic enzyme immunoassay for the quantitation of antibodies to a humanized monoclonal antibody in human serum"
"0030010263","8721426","10.1007/BF01369821","2-s2.0-0030010263","1996-04-01","Analysis of a short tandem repeat locus on chromosome 19 (D19S253)"
"0030891163","9108108","10.1073/pnas.94.8.4080","2-s2.0-0030891163","1997-04-15","Hematopoietic cells differentiate into both microglia and macroglia in the brains of adult mice"
"0032941197","10226749","10.1097/00019052-199904000-00007","2-s2.0-0032941197","1999-05-17","Bone marrow transplantation as effective treatment of central nervous system disease in globoid cell leukodystrophy, metachromatic leukodystrophy, adrenoleukodystrophy, mannosidosis, fucosidosis, aspartylglucosaminuria, Hurler, Maroteaux-Lamy, and Sly syndromes, and Gaucher disease type III"
"0032584132","9520466","10.1073/pnas.95.7.3908","2-s2.0-0032584132","1998-03-31","Engraftment and migration of human bone marrow stromal cells implanted in the brains of albino rats - Similarities to astrocyte grafts"
"0032693385","10546790","10.1097/00062752-199911000-00004","2-s2.0-0032693385","1999-11-08","Bone marrow transplantation for globoid cell leukodystrophy, adrenoleukodystrophy, metachromatic leukodystrophy, and Hurler syndrome"
"0026562410","1609845","","2-s2.0-0026562410","1992-01-01","Amelioration of clinical disease following bone marrow transplantation in fucosidase-deficient dogs"
"0026753902","1521098","","2-s2.0-0026753902","1992-01-01","State of the art review bone marrow transplantation treatment for storage diseases - Keystone January 23, 1992"
"0023948528","3278379","","2-s2.0-0023948528","1988-01-01","Donor-derived cells in the central nervous system of twitcher mice after bone marrow transplantation"
"0005102216","","","2-s2.0-0005102216","1992-07-13","Myelination and dysmyelination"
"0032537062","9545360","10.1056/NEJM199804163381605","2-s2.0-0032537062","1998-04-16","Hematopoietic stem-cell transplantation in globoid-cell leukodystrophy"
"0002406492","","","2-s2.0-0002406492","1996-07-13","Bone marrow transplantation treatment for globoid cell leukodystrophy, metachromatic leukodystrophy, adrenoleukodystrophy, and Hurler syndrome"
"0027275150","8103085","","2-s2.0-0027275150","1993-01-01","Male donor-derived cells in the brains of female sex-mismatched bone marrow transplant recipients: A Y-chromosome specific in situ hybridization study"
"0016213272","4206842","10.1016/S0022-3476(74)80019-3","2-s2.0-0016213272","1974-01-01","Fucosidosis: Clinical, biochemical, immunologic, and genetic studies in two new cases"
"0026026852","2012122","10.1002/ajmg.1320380125","2-s2.0-0026026852","1991-02-11","Fucosidosis revisited: A review of 77 patients"
"0029143678","7582569","10.1016/0963-6897(95)00021-O","2-s2.0-0029143678","1995-01-01","Microglia: The effector cell for reconstitution of the central nervous system following bone marrow transplantation for lysosomal and peroxisomal storage diseases"
"0005079582","","","2-s2.0-0005079582","1998-07-13",""
"0028789792","7570000","","2-s2.0-0028789792","1995-01-01","Gene therapy in peripheral blood lymphocytes and bone marrow for ADA- immunodeficient patients"
"0022526817","3083887","","2-s2.0-0022526817","1986-01-01","Bone marrow transplantation for Hurler syndrome: Assessment of metabolic correction"
"0026511868","1566710","","2-s2.0-0026511868","1992-01-01","Formation, maturation, and disorders of white matter"
"0023732540","3409541","10.1111/j.1399-0004.1988.tb02608.x","2-s2.0-0023732540","1988-01-01","Intrafamilial variability in fucosidosis"
"0028963342","7742750","","2-s2.0-0028963342","1995-01-01","Allogeneic bone marrow transplantation for fucosidosis"
"0028842801","7593188","","2-s2.0-0028842801","1995-11-01","Exogenous glycosyl phosphatidylinositol-anchored CD59 associates with kinases in membrane clusters on U937 cells and becomes Ca2+-signaling competent"
"0026011310","1672451","","2-s2.0-0026011310","1991-12-01","Tyrosine phosphatase CD45 is required for T-cell antigen receptor and CD2-mediated activation of a protein tyrosine kinase and interleukin 2 production"
"0023133248","3104795","","2-s2.0-0023133248","1987-12-01","Thy-1-mediated T-cell activation requires co-expression of CD3/Ti complex"
"0026079656","1710238","","2-s2.0-0026079656","1991-01-01","CD59 functions as a signal-transducing molecule for human T cell activation"
"0021243527","6714028","10.1002/cyto.990050216","2-s2.0-0021243527","1984-01-01","Fluorescence energy transfer measurements on cell surfaces: A critical comparison of steady‐state fluorimetric and flow cytometric methods"
"0027475743","8433999","","2-s2.0-0027475743","1993-02-15","Correlation between Src family member regulation by the protein-tyrosine-phosphatase CD45 and transmembrane signaling through the T-cell receptor"
"0029952074","8879224","10.1084/jem.184.4.1525","2-s2.0-0029952074","1996-10-01","Selective activation of the calcium signaling pathway by altered peptide ligands"
"0029864147","8666928","10.1084/jem.183.4.1707","2-s2.0-0029864147","1996-04-01","CD45-null transgenic mice reveal a positive regulatory role for CD45 in early thymocyte development, in the selection of CD4+CD8+ thymocytes, and in B cell maturation"
"0024342937","2732468","","2-s2.0-0024342937","1989-01-01","Physical association between MHC class I and class II molecules detected on the cell surface by flow cytometric energy transfer"
"0030000401","8611704","","2-s2.0-0030000401","1996-05-01","Signal transduction and glycophosphatidylinositol-linked proteins (LYN, LCK, CD4, CD45, G proteins, and CD55) selectively localize in triton-insoluble plasma membrane domains of human leukemic cell lines and normal granulocytes"
"0026544338","1531041","10.1016/0092-8674(92)90208-T","2-s2.0-0026544338","1992-01-10","The T cell receptor/CD3 complex is composed of at least two autonomous transduction modules"
"0021341026","6142077","","2-s2.0-0021341026","1984-01-01","T cell-activating properties of an anti-Thy-1 monoclonal antibody. Possible analogy to OKT3/LEU-4"
"0024316870","2530588","10.1073/pnas.86.22.8959","2-s2.0-0024316870","1989-12-14","Expression of CD45 alters phosphorylation of the lck-encoded tyrosine protein kinase in murine lymphoma T-cell lines"
"0025297050","2164155","","2-s2.0-0025297050","1990-12-01","Tyrosine phosphatase CD45 is essential for coupling T-cell antigen receptor to the phosphatidyl inositol pathway"
"0030598858","8780693","10.1006/bbrc.1996.1254","2-s2.0-0030598858","1996-08-23","Differential regulation of Src-family protein tyrosine kinases in GPI domains of T lymphocyte plasma membranes"
"0023905133","2895789","","2-s2.0-0023905133","1988-01-01","Thy-1- and Ly-6-mediated lymphokine production and growth inhibition of a T cell hybridoma require co-expression of the T cell antigen receptor complex"
"0020595443","6309146","","2-s2.0-0020595443","1983-07-21","Changes in the levels of inositol phosphates after agonist-dependent hydrolysis of membrane phosphoinositides"
"0031986139","9368189","","2-s2.0-0031986139","1998-12-01","Activation of T Cells via CD55 Recruitment of Early Components of the CD3-TCR Pathway Is Required for IL-2 Secretion"
"0032509947","9501972","","2-s2.0-0032509947","1998-02-12","Membrane biology: Do glycolipid microdomains really exist?"
"0030267031","8816400","","2-s2.0-0030267031","1996-10-01","Supramolecular Complexes of MHC Class I, MHC Class II, CD20, and Tetraspan Molecules (CD53, CD81, and CD82) at the Surface of a B Cell Line JY"
"0027050564","1464315","","2-s2.0-0027050564","1992-12-01","CD45 tyrosine phosphatase-activated p59fyn couples the T cell antigen receptor to pathways of diacylglycerol production, protein kinase C activation and calcium influx"
"0032498231","9489702","10.1016/S0092-8674(00)80901-0","2-s2.0-0032498231","1998-01-09","LAT: The ZAP-70 tyrosine kinase substrate that links T cell receptor to cellular activation"
"0027957731","7908828","10.1093/intimm/6.2.169","2-s2.0-0027957731","1994-02-01","Activation of CD45-deficient T cell clones by lectin mitogens but not anti-Thy-1"
"0029866039","8642247","10.1084/jem.183.3.1053","2-s2.0-0029866039","1996-03-01","Lck regulates the tyrosine phosphorylation of the T cell receptor subunits and ZAP-70 in murine thymocytes"
"0027397544","8381210","","2-s2.0-0027397544","1993-12-01","Inositol trisphosphate and calcium signalling"
"0026709411","1387661","","2-s2.0-0026709411","1992-09-15","Role of Ly-6A/E and T cell receptor-ζ for IL-2 production: Phosphatidylinositol-anchored Ly-6A/E antagonizes T cell receptor-mediated IL-2 production by a ζ-independent pathway"
"0024449097","2530453","","2-s2.0-0024449097","1989-12-01","A glycophospholipid anchor is required for Qa-2-mediated T cell activation"
"0018464261","262414","","2-s2.0-0018464261","1979-05-01","The orientational freedom of molecular probes. The orientation factor in intramolecular energy transfer."
"0026438835","1394448","10.1016/0008-8749(92)90252-K","2-s2.0-0026438835","1992-10-15","Characterization of T cell proliferative responses induced by anti-Qa-2 monoclonal antibodies"
"0027437247","7693479","10.1002/eji.1830231118","2-s2.0-0027437247","1993-01-01","Cross‐linking of CD59 and of other glycosyl phosphatidylinositol‐anchored molecules on neutrophils triggers cell activation via tyrosine kinase"
"0033534533","9989491","10.1016/S0092-8674(00)80953-8","2-s2.0-0033534533","1999-01-08","Adaptors and molecular scaffolds in immune cell signaling"
"0031022715","9034725","","2-s2.0-0031022715","1997-02-20","Accessory molecule and costimulation requirements for CD4 T cell response"
"0030453582","8978819","","2-s2.0-0030453582","1996-12-01","Exclusion of CD45 inhibits activity of p56lck associated with glycolipid-enriched membrane domains"
"0024588735","2665777","10.1016/0167-5699(89)90324-1","2-s2.0-0024588735","1989-01-01","Ly-6: a multigene family in search of a function"
"0024416009","2550143","10.1016/0092-8674(89)90504-7","2-s2.0-0024416009","1989-09-22","Evidence that the leukocyte-common antigen is required for antigen-induced T lymphocyte proliferation"
"0028800590","7879212","","2-s2.0-0028800590","1995-03-09","Successful treatment of renal allograft rejection with a humanized antilymphocyte monoclonal antibody"
"0032101348","9655486","10.1016/S1074-7613(00)80577-4","2-s2.0-0032101348","1998-06-01","Membrane compartmentation is required for efficient T cell activation"
"0001385151","","","2-s2.0-0001385151","1997-07-13","The role of the CD45 phosphotyrosine phosphatase in lymphocyte signalling"
"0027389272","8428589","","2-s2.0-0027389272","1993-01-01","CD45 specifically modulates binding of Lck to a phosphopeptide encompassing the negative regulatory tyrosine of Lck"
"0024456069","2550543","","2-s2.0-0024456069","1989-01-01","Antibodies to 5'-nucleotidase (CD73), a glycosyl-phosphatidylinositol-anchored protein, cause human peripheral blood T cells to proliferate"
"0032212728","9846483","","2-s2.0-0032212728","1998-11-01","LAT is required for TCR-mediated activation of PLCγ1 and the Ras pathway"
"0025130728","1976251","","2-s2.0-0025130728","1990-09-01","Intimate association of Thy-1 and the T-cell antigen receptor with the CD45 tyrosine phosphatase"
"0031805250","9638371","10.1016/S0952-7915(98)80173-8","2-s2.0-0031805250","1998-06-01","Adaptor proteins in lymphocyte antigen-receptor signaling"
"0031570545","9190928","","2-s2.0-0031570545","1997-06-15","Aberrant TCR-Mediated Signaling in CD45-Null Thymocytes Involves Dysfunctional Regulation of Lck, Fyn, TCR-ζ, and ZAP-70"
"0021273333","6428482","10.1016/S0006-3495(84)84240-X","2-s2.0-0021273333","1984-08-02","Flow cytometric measurement of fluorescence resonance energy transfer on cell surfaces. Quantitative evaluation of the transfer efficiency on a cell-by-cell basis"
"0027401729","8454600","","2-s2.0-0027401729","1993-03-25","Regulation of glycoinositol phospholipid anchor assembly in human lymphocytes: Absent mannolipid synthesis in affected T and natural killer cell lines from paroxysmal nocturnal hemoglobinuria patients"
"0026465067","1460030","","2-s2.0-0026465067","1992-01-01","Affected paroxysmal nocturnal hemoglobinuria T lymphocytes harbor a common defect in assembly of N-acetyl-D-glucosamine inositol phospholipid corresponding to that in class A Thy-1- murine lymphoma mutants"
"0025887081","1829456","","2-s2.0-0025887081","1991-12-01","Identification of defects in glycosylphosphatidylinositol anchor biosynthesis in the thy-1 expression mutants"
"0027412627","7680492","","2-s2.0-0027412627","1993-02-26","The cloning of PIG-A, a component in the early step of GPI-anchor biosynthesis"
"0027310539","8500164","10.1016/0092-8674(93)90250-T","2-s2.0-0027310539","1993-05-21","Deficiency of the GPI anchor caused by a somatic mutation of the PIG-A gene in paroxysmal nocturnal hemoglobinuria"
"0027989523","8086096","10.1016/0167-5699(94)90074-4","2-s2.0-0027989523","1994-01-01","Biology of GPI anchors and pathogenesis of paroxysmal nocturnal hemoglobinuria"
"9044219894","","","2-s2.0-9044219894","1992-09-04","Lifespan of immune cells and molecules"
"0023681070","2459203","","2-s2.0-0023681070","1988-01-01","Decay-accelerating factor functions as a signal transducing molecule for human T cells"
"0025823110","1828068","","2-s2.0-0025823110","1991-12-01","Defective glycosyl phosphatidylinositol biosynthesis in extracts of three Thy-1 negative lymphoma cell mutants"
"0028224269","8081362","10.1093/hmg/3.5.751","2-s2.0-0028224269","1994-05-01","Genomic organization of the X-linked gene (PIG-A) that is mutated in paroxysmal nocturnal haemoglobinuria and of a related autosomal pseudogene mapped to 12q21"
"0026327989","1835975","","2-s2.0-0026327989","1991-12-05","Functional analysis of T-cell mutants defective in the biosynthesis of glycosylphosphatidylinositol anchor: Relative importance of glycosylphosphatidylinositol anchor versus n-linked glycosylation in T-cell activation"
"0024044319","3261742","","2-s2.0-0024044319","1988-07-01","Separation of immunoglobulins and lactoferrin from cheese whey by chelating chromatography."
"33749749916","","","2-s2.0-33749749916","1990-10-20",""
"0025689597","2095560","10.1023/A:1015925519154","2-s2.0-0025689597","1990-01-01","Analytical Approaches to the Study of Monoclonal Antibody Stability"
"0015218694","5165635","","2-s2.0-0015218694","1971-10-10","Ternary coordination complex between human serum albumin, copper (II), and L-histidine."
"0014212805","6029938","","2-s2.0-0014212805","1967-02-21","Separation of dansyl-amino acids by polyamide layer chromatography"
"0016717761","1678","10.1038/258598a0","2-s2.0-0016717761","1975-12-01","Metal chelate affinity chromatography, a new approach to protein fractionation"
"0023392093","3674393","10.1016/0003-2697(87)90519-7","2-s2.0-0023392093","1987-08-01","High-performance analytical applications of immobilized metal ion affinity chromatography"
"77956941440","","10.1016/S1874-6047(08)60411-4","2-s2.0-77956941440","1971-12-01","20 Other Bacterial, Mold, and Yeast Proteases"
"33749728340","","","2-s2.0-33749728340","1989-10-20",""
"0022068293","4019034","10.1111/j.1399-3011.1985.tb02208.x","2-s2.0-0022068293","1985-01-01","Preferential cleavage at aspartyl‐prolyl peptide bonds in dilute acid"
"0014949207","5432063","10.1038/227680a0","2-s2.0-0014949207","1970-12-01","Cleavage of structural proteins during the assembly of the head of bacteriophage T4"
"0027520019","8408004","","2-s2.0-0027520019","1993-01-01","Intrinsic stoichiometric equilibrium constants for the binding of zinc(II) and copper(II) to the high affinity site of serum albumin"
"0020485446","7159420","10.1016/0006-291X(82)91581-9","2-s2.0-0020485446","1982-11-16","The effect of cupric ion on the reoxidation pathway of an IgG1 immunoglobulin"
"0024806396","2687836","10.1023/A:1015929109894","2-s2.0-0024806396","1989-01-01","Stability of Protein Pharmaceuticals"
"0000896420","","","2-s2.0-0000896420","1986-07-13","Preparation and purification of active fragments from mouse monoclonal antibodies"
"0029129405","7561127","","2-s2.0-0029129405","1995-12-01","Acid hydrolysis of monoclonal antibodies"
"0542415283","","","2-s2.0-0542415283","1990-07-17","Isolation of Immunoglobulins by Competitive Displacement of Cheese Whey Proteins During Metal Chelate Interaction Chromatography"
"0021423543","6331222","10.1016/0003-2697(84)90836-4","2-s2.0-0021423543","1984-05-01","Peptide mapping by polyacrylamide gel electrophoresis after cleavage at aspartyl-prolyl peptide bonds in sodium dodecyl sulfate-containing buffers"
"0007683899","","","2-s2.0-0007683899","1989-07-13","Isolation of egg yolk immunoglobulin-rich fractions using copper-loaded metal chelate interaction chromatography"
"0021967194","","10.1016/0167-7799(85)90068-X","2-s2.0-0021967194","1985-01-01","Purification of proteins by IMAC"
"0017637023","22018","10.1016/0076-6879(77)47017-4","2-s2.0-0017637023","1977-12-01","[15] Cleavage at aspartyl{single bond}prolyl bonds"
"0027057977","1429705","","2-s2.0-0027057977","1992-11-25","Oxidative fragmentation of collagen and prolyl peptide by Cu(II)/H2O2: Conversion of proline residue to 2-pyrrolidone"
"33749796891","","","2-s2.0-33749796891","1989-10-20",""
"0014429855","5690816","","2-s2.0-0014429855","1968-07-25","Sites of binding of copper (II) ion by peptide (1-24) of bovine serum albumin."
"0023922250","","","2-s2.0-0023922250","1988-01-01","Therapeutic proteins: The need for analysis"
"0023390969","2957983","10.1001/archneur.1987.00520200032014","2-s2.0-0023390969","1987-01-01","Cyclophosphamide ‘Pulses’ in Chronic Progressive Multiple Sclerosis: A Preliminary Clinical Trial"
"0023636606","3426169","10.1002/ana.410220513","2-s2.0-0023636606","1987-01-01","Total lymphoid irradiation in multiple sclerosis: Blood lymphocytes and clinical course"
"0027196941","8388090","","2-s2.0-0027196941","1993-05-01","Intermittent cyclophosphamide pulse therapy in progressive multiple sclerosis: Final report of the Northeast Cooperative Multiple Sclerosis Treatment Group"
"0027787937","8155256","10.1006/jaut.1993.1063","2-s2.0-0027787937","1993-12-01","Treamtment of multiple sclerosis with anti-CD4 monoclonal antibody. A preliminary report on B-F5 in 21 patients"
"0024335124","2659736","","2-s2.0-0024335124","1989-01-01","Randomised double blind controlled trial of cyclosporin in multiple sclerosis"
"0014007245","5906182","","2-s2.0-0014007245","1966-02-06","Multiple sclerosis and the autoimmunization process. Treatment by antimitotics"
"0027418515","8469318","","2-s2.0-0027418515","1993-04-01","Interferon beta-1b is effective in relapsing-remitting multiple sclerosis. I. Clinical results of a multicenter, randomized, double-blind, placebo-controlled trial"
"0025967752","1671468","10.1016/0140-6736(91)93389-Q","2-s2.0-0025967752","1991-02-23","The Canadian cooperative trial of cyclophosphamide and plasma exchange in progressive multiple sclerosis"
"0029934518","8649558","","2-s2.0-0029934518","1996-06-01","Risk of cancer from azathioprine therapy in multiple sclerosis: A case-control study"
"0029854588","8909421","","2-s2.0-0029854588","1996-11-01","Low-dose oral methotrexate in chronic progressive multiple sclerosis: Analyses of serial MRIs"
"0019971311","6124759","10.1016/S0140-6736(82)90547-5","2-s2.0-0019971311","1982-08-14","DOUBLE-BLIND CONTROLLED TRIAL OF IMMUNOSUPPRESSION IN THE TREATMENT OF MULTIPLE SCLEROSIS: FINAL REPORT"
"0018387575","458481","","2-s2.0-0018387575","1979-01-01","Prolonged azathioprine treatment of non-remitting multiple sclerosis"
"0018826728","6157011","10.1007/BF00313182","2-s2.0-0018826728","1980-06-01","Effect of intensive immunosuppression on the course of chronic progressive multiple sclerosis"
"0028264426","7912347","10.1016/S0140-6736(94)91046-4","2-s2.0-0028264426","1994-07-02","Cladribine in treatment of chronic progressive multiple sclerosis"
"0004834372","","","2-s2.0-0004834372","1995-05-21","Double-blind, placebo-controlled, MR monitored exploratory trial of chimeric anti-CD4 antibodies in MS"
"0026317943","1783915","10.1136/jnnp.54.12.1055","2-s2.0-0026317943","1951-01-01","Intense immunosuppression in chronic progressive multiple sclerosis: The Kaiser study"
"0031040238","9048709","","2-s2.0-0031040238","1997-02-01","Therapeutic effect of mitoxantrone combined with methylprednisolone in multiple sclerosis: A randomised multicentre study of active disease using MRI and clinical criteria"
"0022546035","3790190","","2-s2.0-0022546035","1986-01-01","Genetic toxicology profile of the new antineoplastic drug mitoxantrone in the mammalian test systems"
"0025345601","2193613","10.1002/ana.410270603","2-s2.0-0025345601","1990-01-01","Efficacy and toxicity of cyclosporine in chronic progressive multiple sclerosis: A randomized, double‐blinded, placebo‐controlled clinical trial"
"0023905890","3281916","10.1007/BF02334408","2-s2.0-0023905890","1988-02-01","Double blind controlled randomized study on azathioprine efficacy in multiple sclerosis. Preliminary results"
"0003254838","","","2-s2.0-0003254838","1989-12-27","Clinical controlled randomized trial of azathioprine in multiple sclerosis"
"0029983154","8643695","10.1073/pnas.93.4.1716","2-s2.0-0029983154","1996-02-20","The treatment of chronic progressive multiple sclerosis with cladribine"
"0020068590","7047686","10.1016/0022-510X(82)90201-5","2-s2.0-0020068590","1982-01-01","Azathioprine in treatment of multiple sclerosis. Final results of a 4 1 2-Year controlled study of its effectiveness covering 115 patients"
"0027954178","8126497","","2-s2.0-0027954178","1994-01-01","Total lymphoid irradiation in multiple sclerosis"
"7844228620","","","2-s2.0-7844228620","1995-11-19","Aspects physiologiques, cliniques, thérapeutiques et actuels de la sclérose en plaques"
"0020683886","6294517","","2-s2.0-0020683886","1983-03-03","Intensive immunosuppression in progressive multiple sclerosis. A randomized, three-arm study of high-dose intravenous cyclophosphamide, plasma exchange, and ACTH"
"0023836524","3276298","10.1001/archneur.1988.00520250033014","2-s2.0-0023836524","1988-01-01","Controlled Pilot Trial of Monthly Intravenous Cyclophosphamide in Multiple Sclerosis"
"7844249990","","","2-s2.0-7844249990","1973-12-28","Azathioprine and multiple sclerosis"
"0021744523","6385266","","2-s2.0-0021744523","1984-12-01","Clinical safety and tolerance of mitoxantrone"
"0014672407","4180869","","2-s2.0-0014672407","1969-04-12","Cyclophosphamide in multiple sclerosis."
"0026098973","1985289","","2-s2.0-0026098973","1991-01-01","The efficacy of azathioprine in relapsing-remitting multiple sclerosis"
"1542683643","","","2-s2.0-1542683643","1992-07-13","Incidence of malignancy following cyclophosphamide or azathioprine treatment of multiple sclerosis"
"0023394826","2820359","10.1001/archneur.1987.00520200027013","2-s2.0-0023394826","1987-01-01","Cyclophosphamide in Chronic Progressive Multiple Sclerosis: Maintenance vs Nonmaintenance Therapy"
"0017332050","65452","10.1007/BF00316148","2-s2.0-0017332050","1977-09-01","Intensive immunosuppression with cyclophosphamide in multiple sclerosis - Follow up of 110 patients for 2-6 Years"
"0028906384","7818255","10.1002/ana.410370108","2-s2.0-0028906384","1995-01-01","Low‐dose (7.5 mg) oral methotrexate reduces the rate of progression in chronic progressive multiple sclerosis"
"0028796522","7760994","10.1007/BF00588624","2-s2.0-0028796522","1995-02-01","Serial gadolinium-enhanced magnetic resonance imaging in patients with multiple sclerosis treated with mitoxantrone"
"0025172758","2147900","10.1007/BF02190090","2-s2.0-0025172758","1990-09-01","A 10-year matched-pairs study comparing azathioprine and no immunosuppression in multiple sclerosis"
"0027419280","8469348","","2-s2.0-0027419280","1993-04-01","Long-term safety of azathioprine therapy in multiple sclerosis"
"0023707296","3278672","10.1002/ana.410230110","2-s2.0-0023707296","1988-01-01","Cyclosporine versus azathioprine in the long‐term treatment of multiple sclerosis—results of the german multicenter study"
"8044242916","9050955","10.1007/s004150050066","2-s2.0-8044242916","1997-03-12","Randomized placebo-controlled trial of mitoxantrone in relapsing-remitting multiple sclerosis: 24-month clinical and MRI outcome"
"0029075759","7665724","","2-s2.0-0029075759","1995-06-30","Noninvasive assessment of mitoxantrone cardiotoxicity in relapsing remitting multiple sclerosis"
"7844226843","","","2-s2.0-7844226843","1985-11-19","Follow-up evaluation after at least two years' treatment with azathioprine in a double-blind trial"
"0024462396","2668784","","2-s2.0-0024462396","1989-01-01","A placebo-controlled, randomized, double-masked, variable dosage, clinical trial of azathioprine with and without methylprednisolone in multiple sclerosis"
"0025986898","1681364","10.1016/0140-6736(91)91909-E","2-s2.0-0025986898","1991-10-26","Overview of azathioprine treatment in multiple sclerosis"
"0023793331","2899660","","2-s2.0-0023793331","1988-01-01","Double-masked trial of azathioprine in multiple sclerosis"
"0024327899","2653373","","2-s2.0-0024327899","1989-01-01","Clonal expansion versus functional clonal inactivation: A costimulatory signalling pathway determines the outcome of T cell antigen receptor occupancy"
"0022578629","2418145","","2-s2.0-0022578629","1986-01-01","Functional expression of the murine Thy-1.2 gene in transfected human T cells"
"0027731604","8266076","","2-s2.0-0027731604","1993-12-17","Sharing of the interleukin-2 (IL-2) receptor γ chain between receptors for IL-2 and IL-4"
"0023270342","3023490","","2-s2.0-0023270342","1987-01-01","Stimulation of T cells via the TAP molecule, a member in a family of activating proteins encoded in the Ly-6 locus"
"0022535524","2873512","10.1038/322181a0","2-s2.0-0022535524","1986-12-01","Thy-1 functions as a signal transduction molecule in T lymphocytes and transfected B lymphocytes"
"0024061316","3261394","","2-s2.0-0024061316","1988-12-01","Dissociation of phosphoinositide hydrolysis and Ca2+ fluxes from the biological responses of a T-cell hybridoma"
"0022869679","3493149","10.1002/eji.1830161218","2-s2.0-0022869679","1986-01-01","Biochemical characterization of a soluble form of the 53‐kDa monocyte surface antigen"
"0027275642","8349730","","2-s2.0-0027275642","1993-08-01","Signal transducing molecules and glycosyl-phosphatidylinositol-linked proteins form a caveolin-rich insoluble complex in MDCK cells"
"84968405726","","","2-s2.0-84968405726","1986-05-23","Role of Ly-6in lymphocyte activation: II. Induction of T cell activation by monclonal anti-Ly6 antibodies"
"0025963594","1847722","","2-s2.0-0025963594","1991-12-01","Binding of the B cell activation antigen B7 to CD28 costimulates T cell proliferation and interleukin 2 mRNA accumulation"
"0025824523","1678398","","2-s2.0-0025824523","1991-08-15","Evidence of synergy between Thy-1 and CD3/TCR complex in signal delivery to murine thymocytes for cell death"
"0024322167","2500480","","2-s2.0-0024322167","1989-01-01","Anti-Qa-2-induced T cell activation. The parameters of activation, the definition of mitogenic and nonmitogenic antibodies, and the differential effects on CD4+ vs CD8+ T cells"
"0022326904","2415139","","2-s2.0-0022326904","1985-12-01","T-lymphocyte recognition of antigen in association with gene products of the major histocompatibility complex."
"0025741824","1831224","","2-s2.0-0025741824","1991-08-15","CD24, a signal transducer modulating B cell activation responses, is a very short peptide with a glycosyl phosphatidylinositol membrane anchor"
"0006060147","","","2-s2.0-0006060147","1992-09-22","OKT3 in allogeneic transplantation: Clinical efficacy, mode of action, and side effects"
"0027751556","8266077","","2-s2.0-0027751556","1993-12-17","Interleukin-2 receptor γ chain: A functional component of the interleukin-7 receptor"
"0024317080","2572642","","2-s2.0-0024317080","1989-01-01","Internalization of phosphatidylinositol-anchored lymphocyte proteins. I. Documentation and potential significance for T cell stimulation"
"0025307161","1972721","","2-s2.0-0025307161","1990-07-01","Costimulation of proliferative responses of resting CD4+ T cells by the interaction of VLA-4 and VLA-5 with fibronectin or VLA-6 with laminin"
"0023154034","3493556","","2-s2.0-0023154034","1987-01-01","Polyclonal activation of rat T lymphocytes by RT6 alloantisera"
"0025200349","2147207","","2-s2.0-0025200349","1990-12-01","Identification and gene cloning of a new phosphatidylinositol-linked antigen expressed on mature lymphocytes: Down-regulation by lymphocyte activation"
"0026013817","1826601","","2-s2.0-0026013817","1991-12-01","Phosphatidylinositol membrane anchors and T-cell activation"
"0025823714","1715364","","2-s2.0-0025823714","1991-01-01","Association of the CD59 and CD55 cell surface glycoproteins with other membrane molecules"
"0025806949","1713610","","2-s2.0-0025806949","1991-01-01","Human T cell recognition of influenza A nucleoprotein: Specificity and genetic restriction of immunodominant T helper cell epitopes"
"0023677182","2459290","","2-s2.0-0023677182","1988-01-01","Synergistic T cell activation via the physiological ligands for CD2 and the T cell receptor"
"0026352248","1719635","","2-s2.0-0026352248","1991-11-15","GPI-anchored cell-surface molecules complexed to protein tyrosine kinases"
"0025942859","1717633","","2-s2.0-0025942859","1991-10-01","Analysis of T cell stimulation by superantigen plus major histocompatibility complex class II molecules or by CD3 monoclonal antibody: Costimulation by purified adhesion ligands VCAM-1, ICAM-1, but not ELAM-1"
"0025053145","1975259","","2-s2.0-0025053145","1990-01-01","Human T cell activation: Synergy between CD73 (ecto-5'-nucleotidase) and signals delivered through CD3 and CD2 molecules"
"0023695546","2839033","","2-s2.0-0023695546","1988-01-01","In search of a second messenger for insulin"
"0027515313","8104797","10.1002/eji.1830231039","2-s2.0-0027515313","1993-01-01","Mitogenicity of anti‐Thy‐1 monoclonal antibodies attributable to an Fc‐dependent mechanism"
"0023118918","2435787","","2-s2.0-0023118918","1987-01-01","Expression and functional significance of the J11d marker on mouse thymocytes"
"0024149641","3289571","","2-s2.0-0024149641","1988-12-01","The immunoglobulin superfamily - Domains for cell surface recognition"
"0025104379","2118158","","2-s2.0-0025104379","1990-09-15","Expression cloning of a cDNA encoding M1/69-J11d heat-stable antigens"
"0020643144","6604731","","2-s2.0-0020643144","1983-01-01","Cell fractionation with affinity ligands conjugated to agarose-polyacrolein microsphere beads"
"0021921205","","","2-s2.0-0021921205","1985-01-01","Prevention of graft-versus-host disease in allogeneic bone marrow transplantation for leukemia by T cell depletion in vitro prior to transplantation"
"0000539176","","","2-s2.0-0000539176","1968-07-13","Isolation of mononuclear cells and granulocytes from human blood"
"0015036636","4398506","","2-s2.0-0015036636","1971-03-01","Allogeneic bone marrow transplantation after elimination of immunocompetent cells by means of density gradient centrifugation."
"0016242897","4547224","","2-s2.0-0016242897","1974-12-01","Immunologic functions of isolated human lymphocyte subpopulations. I. Quantitative isolation of human T and B cells and response to mitogens"
"84936553508","","","2-s2.0-84936553508","1984-07-17",""
"0014831414","5471041","10.1002/jcp.1040760111","2-s2.0-0014831414","1970-01-01","Human bone marrow colony growth in agar‐gel"
"0020711001","6846811","10.1016/0003-2697(83)90384-6","2-s2.0-0020711001","1983-02-01","Novel effective immunoadsorbents based on agarose-polyaldehyde microsphere beads: Synthesis and affinity chromatography"
"0016318139","4833274","","2-s2.0-0016318139","1974-12-01","Production of colony stimulating activity by human lymphocytes"
"0017128871","9202","10.1016/0008-8749(76)90103-9","2-s2.0-0017128871","1976-01-01","Separation of mouse thymocytes into two subpopulations by the use of peanut agglutinin"
"84933726448","","","2-s2.0-84933726448","1976-07-07",""
"0016363547","4611686","","2-s2.0-0016363547","1974-12-01","Separation methods for lymphocyte populations."
"0008316043","7015346","10.1073/pnas.78.3.1791","2-s2.0-0008316043","1981-11-30","Studies of a human T lymphocyte antigen recognized by a monoclonal antibody"
"0020002414","7166562","","2-s2.0-0020002414","1982-01-01","Polyacrolein microspheres as a new tool in cell biology"
"0018254462","310348","10.1016/0008-8749(78)90224-1","2-s2.0-0018254462","1978-01-01","Preparation, characterization, and functions of rabbit lymph node cell populations. I. Preparation of KLH primed T and B memory cells with anti-Fab′ affinity columns"
"0018775823","87465","","2-s2.0-0018775823","1979-12-01","Properties and applications of monoclonal antibodies directed against determinants of the THY-1 locus"
"33644794887","","","2-s2.0-33644794887","2006-03-16",""
"0029071114","7585089","10.1038/nm0595-428","2-s2.0-0029071114","1995-01-01","The essential roles of parenchymal tissues and passenger leukocytes in the tolerance induced by liver grafting in rats"
"0029033078","7778182","","2-s2.0-0029033078","1995-01-01","Renal transplantation without chronic immunosuppression after T cell-depleted, HLA-mismatched bone marrow transplantation"
"0028799575","7839442","","2-s2.0-0028799575","1995-01-01","Weaning of immunosuppression in long - Term liver transplant recipients"
"0029838383","8782458","10.1038/nm0996-1005","2-s2.0-0029838383","1996-09-01","Soluble HLA class I molecules induce apoptosis in alloreactive cytotoxic T lymphocytes"
"0025271537","2316027","","2-s2.0-0025271537","1990-01-01","Peroperative appearance of serum class I antigen during liver transplantation"
"33644807554","","","2-s2.0-33644807554","1995-03-16",""
"0028243287","8197602","","2-s2.0-0028243287","1994-01-01","Tolerance of porcine renal allografts induced by donor spleen cells and seven days' treatment with cyclosporin"
"33644789785","","","2-s2.0-33644789785","2006-03-16",""
"33644789641","","","2-s2.0-33644789641","1969-03-16",""
"0344747623","","","2-s2.0-0344747623","1997-07-13","Allogeneic sibling PBSC transplantation results in improved engraftment kinetics but is associated with a high incidence of chronic GVHD"
"0025230869","2310832","","2-s2.0-0025230869","1990-03-15","Allogeneic bone marrow transplantation for leukemia with marrow grafts depleted of lymphocytes by counterflow centrifugation"
"0029738289","8877708","","2-s2.0-0029738289","1996-08-01","Allogeneic peripheral blood progenitor cells: Current status and future directions"
"0003035752","","","2-s2.0-0003035752","1997-09-27","Clinical outcome of 112 patients following HLA-identical allogeneic peripheral blood stem cell transplantation"
"0029098565","7632815","10.1007/BF01696229","2-s2.0-0029098565","1995-07-01","An update on peripheral blood progenitor cell transplantation"
"0028903242","7534140","","2-s2.0-0028903242","1995-01-01","Transplantation of allogeneic peripheral blood stem cells mobilized by recombinant human granulocyte colony-stimulating factor"
"12644253851","9123501","10.1016/S0041-1345(96)00443-5","2-s2.0-12644253851","1997-04-05","Strong antileukemic effect of chronic graft-versus-host disease in allogeneic marrow transplant recipients having acute leukemia treated with methotrexate and cyclosporine"
"9544241334","8831993","","2-s2.0-9544241334","1996-07-01","Allogeneic peripheral blood progenitor cell transplantation: Analysis of short-term engraftment and acute GVHD incidence in 33 cases"
"0028318787","8043876","","2-s2.0-0028318787","1994-08-01","Cyclophosphamide combined with antithymocyte globulin in preparation for allogeneic marrow transplants in patients with aplastic anemia"
"0002091226","","","2-s2.0-0002091226","1985-07-13","Graft-versus-host disease"
"15844394102","8733685","","2-s2.0-15844394102","1996-05-01","Allogeneic blood cell transplants for haematological malignancy: Preliminary comparison of outcomes with bone marrow transplantation"
"0028345004","8180405","","2-s2.0-0028345004","1994-05-15","Allogeneic bone marrow transplantation with a fixed low number of T cells in the marrow graft"
"0025020570","2297577","","2-s2.0-0025020570","1990-01-01","A fixed low number of T cells in HLA-identical allogeneic bone marrow transplantation"
"0022855253","3332128","","2-s2.0-0022855253","1986-12-01","Graft-versus-host disease following transplantation of 'one log' versus 'two log' T-lymphocyte-depleted bone marrow from HLA-identical donors."
"0028944982","7537998","","2-s2.0-0028944982","1995-01-01","Collection of progenitor cells for allogeneic transplantation from peripheral blood of normal donors"
"2642683853","","","2-s2.0-2642683853","1997-10-20","Allogeneic PBPC transplantation is associated with increased risk of chronic GVHD"
"15844382914","8722354","","2-s2.0-15844382914","1996-04-01","High incidence of chronic GVHD after primary allogeneic peripheral blood stem cell transplantation in patients with hematologic malignancies"
"0023713979","3048492","","2-s2.0-0023713979","1988-01-01","T cell depletion in bone marrow transplantation"
"0023115090","3101763","","2-s2.0-0023115090","1987-06-16","Initial experience in treating human lymphoma with a chimeric univalent derivative of monoclonal anti-idiotype antibody"
"85001314937","","","2-s2.0-85001314937","1989-12-13","Reactivity of rat monoclonal antibody CAMPATH-1 with human leukaemia cells and its possible application for autologous bone marrow transplantation"
"84956961533","","","2-s2.0-84956961533","1990-02-13","A new human B-cell non-Hodgkin lymphoma cell line exhibiting both t(14;18) and t(4;11) chromosomal translocations"
"0023775236","2846094","","2-s2.0-0023775236","1988-01-01","Therapy of patients with human T-cell lymphotropic virus I-induced adult T-cell leukemia with anti-Tac, a monoclonal antibody to the receptor for interleukin 2"
"0021795011","3888313","","2-s2.0-0021795011","1985-08-28","A clinical trial of anti-idiotype therapy for B cell malignancy"
"0024563994","2465038","","2-s2.0-0024563994","1989-01-01","Recombinant human granulocyte/macrophage colony-stimulating factor enhances monocyte cytotoxicity and secretion of tumor necrosis factor α and interferon in cancer patients"
"84987480164","","10.1002/ijc.2910410819","2-s2.0-84987480164","1988-01-01","Treatment of B cell malignancies with 131I LYM‐1 monoclonal antibodies"
"0023789406","3291988","","2-s2.0-0023789406","1988-01-01","Bone marrow origin of a B-cell lymphoma"
"85001390500","","","2-s2.0-85001390500","1989-12-13","Reshaping human antibodies for therapy"
"85001390503","","","2-s2.0-85001390503","1988-12-13","Remission induction in non-Hodgkin lymphoma with reshaped human monoclonal antibody, CAMPATH-1H"
"0022271257","2414870","","2-s2.0-0022271257","1985-01-01","Therapeutic potential of monoclonal antibodies to the leukocyte-common antigen: Synergy and interference in complement-mediated lysis"
"0024602608","2784122","10.1002/hon.2900070207","2-s2.0-0024602608","1989-01-01","A phase 1a clinical trial of LYM‐1 monoclonal antibody serotherapy in patients with refractory b cell malignancies"
"0020571742","6403649","","2-s2.0-0020571742","1983-01-01","Therapy of murine leukemia with monoclonal antibody against a normal differentiation antigen"
"78651010566","18860765","","2-s2.0-78651010566","1948-12-01","Temporary remissions in acute leukemia in children produced by folic"
"0019856786","7040212","","2-s2.0-0019856786","1981-12-01","A new model for investigations of T-cell functions in mice: Differential immunosuppressive effects of two monoclonal anti-Thy-1.2 antibodies"
"0024356409","2546634","","2-s2.0-0024356409","1989-01-01","T-cell receptor δ/α rearrangements in lymphoid neoplasms"
"0024321013","2666588","","2-s2.0-0024321013","1989-01-01","Treatment of refractory non-Hodgkin's lymphoma with radiolabeled MB-1 (anti-CD37) antibody"
"85001246587","","","2-s2.0-85001246587","1988-12-13","A three-stage immunophenotyping technique for rapid diagnosis of haematological malignancies"
"84956965194","","","2-s2.0-84956965194","1990-02-13",""
"1842360038","3104914","10.1073/pnas.84.8.2396","2-s2.0-1842360038","1987-07-21","Mechanism of the t(14;18) chromosomal translocation: Structural analysis of both derivative 14 and 18 reciprocal partners"
"0022997894","3098093","10.1002/ajh.2830230408","2-s2.0-0022997894","1986-01-01","Pure red cell aplasia: Response to therapy with anti‐thymocyte globulin"
"0033586275","10082680","","2-s2.0-0033586275","1999-03-20","Bone marrow transplantation for autoimmune diseases"
"0024989497","1698487","10.1007/BF02076698","2-s2.0-0024989497","1990-08-01","Pure red cell aplasia: Review of treatment and proposal for a treatment strategy"
"84879111669","","","2-s2.0-84879111669","2000-06-26","Autoimmune cytopenias"
"8944225498","8704187","","2-s2.0-8944225498","1996-07-01","Idiopathic thrombocytopenic purpura: A practice guideline developed by explicit methods for the American Society of Hematology"
"0021980235","3965050","","2-s2.0-0021980235","1985-01-01","Cyclosporine for pure red cell aplasia."
"84879118665","","","2-s2.0-84879118665","1992-06-26","Successful remission-induction of T cell prolymphocytic leukaemia with humanised MoAb CAMPATH-1H"
"0029665464","","","2-s2.0-0029665464","1996-01-01","The use of rh-G-CSF in chronic autoimmune neutropenia, reversal of autoimmune phenomena, a case history"
"0030900678","9108386","","2-s2.0-0030900678","1997-04-15","Intravenous anti-D treatment of immune thrombocytopenic purpura: Experience in 272 patients"
"0004750551","10929019","10.1046/j.1365-2141.2000.02069.x","2-s2.0-0004750551","2000-08-19","Guidelines on the investigation and management of the antiphospholipid syndrome"
"0030840852","9218149","","2-s2.0-0030840852","1997-07-22","Successful treatment of autoimmune neutropenia with recombinant human granulocyte-colony stimulating factor (R-metHuG-CSF)"
"0027945617","7954433","","2-s2.0-0027945617","1994-01-01","Concomitant Increases in Galectin-1 and Its Glycoconjugate Ligands (Carcinoembryonic Antigen, Lamp-1, and Lamp-2) in Cultured Human Colon Carcinoma Cells by Sodium Butyrate"
"0014832992","5448520","","2-s2.0-0014832992","1970-08-01","Paroxysmal nocturnal hemoglobinuria: evidence for monoclonal origin of abnormal red cells."
"0021999569","2858198","","2-s2.0-0021999569","1985-01-01","Cell-surface-antigen mutants of haematopoietic cells. Tools to study differentiation, biosynthesis and function"
"0028353422","8167330","","2-s2.0-0028353422","1994-05-01","Mutations within the Piga gene in patients with paroxysmal nocturnal hemoglobinuria"
"0025667366","1978413","","2-s2.0-0025667366","1990-11-16","Correction of a defect in mammalian GPI anchor biosynthesis by a transfected yeast gene"
"0026705731","1313004","","2-s2.0-0026705731","1992-04-05","Identification of a missing link in glycosylphosphatidylinositol anchor biosynthesis in mammalian cells"
"0028290901","8193350","","2-s2.0-0028290901","1994-06-01","Characterization of genomic PIG-A gene: A gene for glycosylphosphatidylinositol-anchor biosynthesis and paroxysmal nocturnal hemoglobinuria"
"0026024501","1898593","10.1016/0014-4827(91)90155-N","2-s2.0-0026024501","1991-01-01","Reversible effects of sodium butyrate on the differentiation of F9 embryonal carcinoma cells"
"0027412005","8426120","","2-s2.0-0027412005","1993-02-01","Deficient biosynthesis of N-acetylglucosaminyl-phosphatidylinositol, the first intermediate of glycosyl phosphatidylinositol anchor biosynthesis, in cell lines established from patients with paroxysmal nocturnal hemoglobinuria"
"0028057618","8272086","10.1056/NEJM199401273300404","2-s2.0-0028057618","1994-01-27","Abnormalities of PIG-A transcripts in granulocytes from patients with paroxysmal nocturnal hemoglobinuria"
"34447497441","","","2-s2.0-34447497441","2007-07-24",""
"0028897279","7531514","","2-s2.0-0028897279","1995-01-01","Somatic mutations of the PIG-A gene found in Japanese patients with paroxysmal nocturnal hemoglobinuria"
"0022019168","3886232","","2-s2.0-0022019168","1985-02-01","Paroxysmal nocturnal haemoglobinuria."
"0027198876","8389477","","2-s2.0-0027198876","1993-01-01","Specific defect in N-acetylglucosamine incorporation in the biosynthesis of the glycosylphosphatidylinositol anchor in cloned cell lines from patients with paroxysmal nocturnal hemoglobinuria"
"0025236387","2138614","","2-s2.0-0025236387","1990-12-01","Glycolipid precursors for the membrane anchor of Trypanosoma brucei variant surface glycoproteins I. Can structure of the phosphatidylinositol-specific phospholipase c sensitive and resistant glycolipids"
"0025637788","1702310","10.1111/j.1365-2141.1990.tb07913.x","2-s2.0-0025637788","1990-01-01","Enhanced complement‐susceptibility and dysfunction of lymphocytes in paroxysmal nocturnal haemoglobinuria (PNH)"
"0026049442","1679568","10.1007/BF01233060","2-s2.0-0026049442","1991-07-01","Sodium butyrate causes reexpression of three membrane proteins on glycolipid-anchoring mutants"
"0026596863","1547338","","2-s2.0-0026596863","1992-03-15","The problem of clonality in aplastic anemia: Dr Dameshek's riddle, restated"
"0000275754","","","2-s2.0-0000275754","1992-12-09","Biosynthesis of glycosyl-phosphatidylinositol membrane protein anchors"
"0017148259","987581","","2-s2.0-0017148259","1976-12-01","A general method for isolation of high molecular weight DNA from eukaryotes"
"0028057807","8306954","","2-s2.0-0028057807","1994-12-01","Paroxysmal nocturnal haemoglobinuria (PNH) is caused by somatic mutations in the PIG-A gene"
"0028299834","7909012","10.1016/S0140-6736(94)90068-X","2-s2.0-0028299834","1994-04-16","Somatic mutations and cellular selection in paroxysmal nocturnal haemoglobinuria"
"0030816688","9231050","","2-s2.0-0030816688","1997-07-22","A CTLA-4 gene polymorphism is associated with both Graves' disease and autoimmune hypothyroidism"
"0022642908","2938014","10.1038/320449a0","2-s2.0-0022642908","1986-12-01","Induction of tolerance by monoclonal antibody therapy"
"0023851810","3347339","","2-s2.0-0023851810","1988-01-01","Autoimmunity in multiple sclerosis"
"0027195760","8316943","10.1111/j.1399-0039.1993.tb01991.x","2-s2.0-0027195760","1993-01-01","HLA‐DQB1 and ‐DQA1 typing by PCR amplification with sequence‐specific primers (PCR‐SSP) in 2 hours"
"0030876399","9311363","","2-s2.0-0030876399","1997-09-01","Autoimmune hyperthyroidism in patients with multiple sclerosis treated with interferon beta-1b"
"0031431007","9349577","","2-s2.0-0031431007","1997-12-01","Opposite changes in serum soluble CD8 in patients at the active stages of Graves' and Hashimoto's diseases"
"0027509812","8094734","","2-s2.0-0027509812","1993-03-01","Evidence that the T cell repertoire of normal rats contains cells with the potential to cause diabetes. Characterization of the CD4+ T cell subset that inhibits this autoimmune potential"
"0030880011","9270561","","2-s2.0-0030880011","1997-08-01","Treatment of multiple sclerosis with the monoclonal anti-CD4 antibody cM-T412: Results of a randomized, double-blind, placebo-controlled, MR- monitored phase II trial"
"0028339493","7912172","","2-s2.0-0028339493","1994-01-01","Measurement of thyroid stimulating immunoglobulins in a new cell line transfected with a functional human TSH receptor (JPO9 cells), compared with an assay using FRTL-5 cells"
"0022506855","3486383","","2-s2.0-0022506855","1986-01-01","Immunologic responses of progressive multiple sclerosis patients treated with an anti-T-cell monoclonal antibody, anti-T12"
"0022348063","3936865","10.1007/BF00915335","2-s2.0-0022348063","1985-11-01","Lymphocytes from multiple sclerosis patients produce elevated levels of gamma interferon in vitro"
"0016764764","1081932","","2-s2.0-0016764764","1975-12-01","Thyroiditis in T cell depleted rats. Influence of strain, radiation dose, adjuvants and antilymphocyte serum"
"0031661676","9762680","","2-s2.0-0031661676","1998-06-01","Disease activity and the immune set in multiple sclerosis: Blood markers for immunotherapy"
"0032512301","9863795","","2-s2.0-0032512301","1998-12-12","Delayed occurrence of Graves' disease after immune restoration with HAART"
"0023956698","3286231","10.1210/edrv-9-1-106","2-s2.0-0023956698","1988-01-01","Autoantibodies to the thyrotropin receptor"
"0031473847","9504803","10.1002/elps.1150181505","2-s2.0-0031473847","1997-12-01","SWISS-MODEL and the Swiss-PdbViewer: An environment for comparative protein modeling"
"0020467471","7162519","10.1016/0161-5890(82)90273-5","2-s2.0-0020467471","1982-01-01","Classification of mouse VK groups based on the partial amino acid sequence to the first invariant tryptophan: Impact of 14 new sequences from IgG myeloma proteins"
"0027201551","7916694","10.1002/eji.1830230709","2-s2.0-0027201551","1993-01-01","Cloning and sequencing of human immunoglobulin λ. gene segments"
"0028978504","7492751","10.3233/HAB-1995-6203","2-s2.0-0028978504","1995-01-01","Dual recognition of lipid A and DNA by human antibodies encoded by the VH4-21 gene: A possible link between infection and lupus"
"0019844452","6170937","10.1093/nar/9.18.4485","2-s2.0-0019844452","1981-09-25","Complete sequence of an immunoglobulin mRNA using specific priming and the dideoxynucleotide method of RNA sequencing"
"0024329957","2788611","","2-s2.0-0024329957","1989-01-01","Human monoclonal anti-idiotypic antibody to the tumour-associated antibody 791T/36"
"0028147507","7519718","","2-s2.0-0028147507","1994-01-01","Anti-Human IgE Monoclonal Antibodies Recognizing Epitopes Related to the Binding Sites of High and Low Affinity IgE Receptors"
"0030267309","8816406","","2-s2.0-0030267309","1996-10-01","Staphylococcal Protein A Simultaneously Interacts with Framework Region 1, Complementarity-Determining Region 2, and Framework Region 3 on Human VH3-Encoded Igs"
"0021080455","6417237","","2-s2.0-0021080455","1983-12-01","Lack of pokeweed mitogen-induced IgE formation in vitro by human peripheral blood mononuclear cells: Detection of cross-reacting idiotypic determinants on polyclonal Ig by antibodies to a single IgE myeloma protein"
"0031741579","9824417","10.1046/j.1365-2222.1998.00378.x","2-s2.0-0031741579","1998-12-21","Primary sequence and molecular model of the variable region of a mouse monoclonal anti-Der p 1 antibody showing a similar epitope specificity as human IgE"
"0028326520","8149953","10.1002/eji.1830240409","2-s2.0-0028326520","1994-01-01","A directory of human germ‐line Vχ segments reveals a strong bias in their usage"
"0028118817","8294882","","2-s2.0-0028118817","1994-02-01","Expression of functional high affinity immunoglobulin E receptors (FcεRI) on monocytes of atopic individuals"
"0030053370","8674685","","2-s2.0-0030053370","1996-02-22","ProMod and Swiss-model: Internet-based tools for automated comparative protein modelling"
"0019442186","6788376","10.1016/0092-8674(81)90089-1","2-s2.0-0019442186","1981-01-01","Heavy chain variable region contribution to the NPb family of antibodies: somatic mutation evident in a γ2a variable region"
"0019214271","6774258","10.1038/286676a0","2-s2.0-0019214271","1980-12-01","Two types of somatic recombination are necessary for the generation of complete immunoglobulin heavy-chain genes"
"0028129394","8300591","","2-s2.0-0028129394","1994-01-28","Comparison and Evolution of Human Immunoglobulin VH Segments Located in the 3′ 0.8-Megabase Region: Evidence for Unidirectional Transfer of Segmental Gene Sequences"
"0027380757","8228264","","2-s2.0-0027380757","1993-11-15","Molecular selection of human antibodies with an unconventional bacterial B cell antigen"
"0028986982","7779254","10.1016/0167-5699(95)80166-9","2-s2.0-0028986982","1995-01-01","The human immunoglobulin VH repertoire"
"0025198397","2128464","10.1093/intimm/2.1.41","2-s2.0-0025198397","1990-01-01","Structure and evolution of mammalian VHfamilies"
"0023280686","2442247","","2-s2.0-0023280686","1987-01-01","Epitope mapping on two major inhalant allergens, Der p I and Der f I, from mites of the genus dermatophagoides"
"0023123378","3103124","","2-s2.0-0023123378","1987-01-01","V(κ) and J(κ) gene segments of A/J Ars-A antibodies: Somatic recombination generates the essential arginine at the junction of the variable and joining regions"
"0026785856","1404388","10.1016/0022-2836(92)90223-7","2-s2.0-0026785856","1992-10-05","The repertoire of human germline vH sequences reveals about fifty groups of VH segments with different hypervariable loops"
"0021723276","6150440","10.1038/312548a0","2-s2.0-0021723276","1984-12-01","Therapy with monoclonal antibodies by elimination of T-cell subsets in vivo"
"84932402322","","","2-s2.0-84932402322","1986-07-01",""
"0018591369","316981","10.1111/j.1749-6632.1979.tb47136.x","2-s2.0-0018591369","1979-01-01","T‐CELL GROWTH FACTOR‐MEDIATED T‐CELL PROLIFERATION"
"84932417101","","","2-s2.0-84932417101","1985-07-01",""
"0001701591","2939456","","2-s2.0-0001701591","1986-01-01","Therapy with monoclonal antibody to interleukin 2 receptor spares suppressor T cells and prevents or reverses acute allograft rejection in rats"
"0021832394","3925068","10.1084/jem.162.1.358","2-s2.0-0021832394","1985-09-25","Administration of an anti-interleukin 2 receptor monoclonal antibody prolongs cardiac allograft survival in mice"
"0024600728","2649174","","2-s2.0-0024600728","1989-01-01","Immune reconstitution following bone marrow transplantation: Comparison of recipients of T-cell depleted marrow with recipients of conventional marrow grafts"
"0020046467","7036468","","2-s2.0-0020046467","1982-01-01","Immunological recovery in 48 patients following syngeneic marrow transplantation for hematological malignancy"
"0029128441","7664791","10.1002/eji.1830250824","2-s2.0-0029128441","1995-01-01","Self‐reactive T cell clones in a restricted population of interleukin‐2 receptor β+ cells expressing intermediate levels of the T cell receptor in the liver and other immune organs"
"0015321963","4552363","","2-s2.0-0015321963","1972-01-01","The effect of pretreatment of allogeneic bone marrow graft recipients with antilymphocytic serum on the acute graft-versus-host reaction in monkeys"
"0025369212","2372989","","2-s2.0-0025369212","1990-01-01","IgG subclass levels and immune reconstitution after T cell-depleted allogeneic bone marrow transplantation"
"0023240210","2959412","","2-s2.0-0023240210","1987-10-30","Rapid recovery of helper activity following T cell depleted allogeneic marrow transplant"
"0003633894","","","2-s2.0-0003633894","1980-03-28",""
"0024514025","2495037","","2-s2.0-0024514025","1989-01-01","Endogenously generated activated killer cells circulate after autologous and allogeneic marrow transplantation but not after chemotherapy"
"0030981650","9156262","","2-s2.0-0030981650","1997-05-01","The in vitro detection of anti-leukaemia-specific cytotoxicity after autologous bone marrow transplantation for acute leukaemia"
"0020662544","6303653","","2-s2.0-0020662544","1983-01-01","T lymphocyte reconstitution following autologous bone marrow transplantation"
"0022600689","3513817","10.1111/j.1365-2141.1986.tb02952.x","2-s2.0-0022600689","1986-01-01","Natural killer cell activity following T‐cell depleted allogeneic bone marrow transplantation"
"0031432876","","","2-s2.0-0031432876","1997-12-01","Understanding the graft-versus-leukaemia reaction: Progress towards the immunotherapy of leukaemia"
"0031038460","9012764","10.1016/S0025-7125(05)70514-9","2-s2.0-0031038460","1997-01-01","Arthritis syndromes associated with human T cell lymphotropic virus type I infection"
"0029088033","8619093","","2-s2.0-0029088033","1995-01-01","T cells in rheumatoid arthritis: Paradigms and facts"
"0027998848","8068951","","2-s2.0-0027998848","1994-09-01","Clinical spectrum of clonal proliferations of T-large granular lymphocytes: A T-cell clonopathy of undetermined significance?"
"0032104102","9614908","10.1016/S0165-4608(97)00410-X","2-s2.0-0032104102","1998-06-01","Abnormalities of chromosomes 8, 11, 14, and X in T-prolymphocytic leukemia studied by fluorescence in situ hybridization"
"0034090042","10850396","10.1097/00007691-200006000-00010","2-s2.0-0034090042","2000-06-01","Rituximab (IDEC-C2B8): Validation of a sensitive enzyme-linked immunoassay applied to a clinical pharmacokinetic study"
"0032983478","10081632","","2-s2.0-0032983478","1999-01-01","Screening for basiliximab exposure-response relationships in renal allotransplantation"
"0014770620","5443170","","2-s2.0-0014770620","1970-04-01","Metabolic properties of IgG subclasses in man."
"85007192705","","","2-s2.0-85007192705","1999-01-05","Serum levels of CAMPATH-1H in recipients of unrelated bone marrow transplants"
"0035133203","11167809","10.1046/j.1365-2141.2001.02519.x","2-s2.0-0035133203","2001-02-24","Cytomegalovirus seropositivity adversely influences outcome after T-depleted unrelated donor transplant in patients with chronic myeloid leukaemia: The case for tailored graft-versus-host disease prophylaxis"
"84918438264","","","2-s2.0-84918438264","1985-12-23",""
"0019986753","6180009","","2-s2.0-0019986753","1982-12-04","A monoclonal antibody against a surface antigen shared by human large granular lymphocytes and granulocytes"
"0011063954","14772379","","2-s2.0-0011063954","1950-06-01","Factors influencing the agglutinability of red cells: the demonstration of a variation in the susceptibility to agglutination exhibited by the red cells of individual oxen."
"0021715106","6394651","10.1016/0022-1759(84)90111-X","2-s2.0-0021715106","1984-12-31","Discrimination between innate and cytophilic immunoglobulin on human peripheral blood lymphocytes: Analysis by the direct antiglobulin rosette-forming reaction"
"0021925816","3881188","10.1016/0008-8749(85)90181-9","2-s2.0-0021925816","1985-01-01","Fcγ-receptor-bearing, non-B lymphocytes in human peripheral blood: Cytophilic immunoglobulin binds almost exclusively to large granular lymphocytes"
"0019942986","6184415","10.1016/0022-1759(82)90317-9","2-s2.0-0019942986","1982-11-12","Cryopreservation of antibody-coupled red cells for use in immunoassays"
"0021824717","3892175","10.1016/0145-2126(85)90303-0","2-s2.0-0021824717","1985-01-01","Detection of surface membrane antigens by a rosette assay using antibody coupled red cells"
"0017688538","","10.1016/0022-1759(77)90157-0","2-s2.0-0017688538","1977-01-01","Comparison of the direct antiglobulin rosetting reaction with the mixed antiglobulin rosetting reaction for the detection of immunoglobulin on lymphocytes"
"0018821673","6162195","10.1111/j.1365-3083.1980.tb00059.x","2-s2.0-0018821673","1980-01-01","Serological and Physicochemical Reactivity of Bovine Erythrocytes before and after Trypsin Treatment"
"0021029571","6315824","10.1016/0022-1759(83)90378-2","2-s2.0-0021029571","1983-11-11","Glutaraldehyde stabilization of antibody-linked erythrocytes for use in reverse passive and related haemagglutination assays"
"8944242140","","10.1016/0167-5699(84)90238-X","2-s2.0-8944242140","1984-01-01","An Fc receptor-bearing, third population of human mononuclear cells with cytotoxic and regulatory function"
"0021163983","6467685","","2-s2.0-0021163983","1984-01-01","The relationship of HNK-1 (Leu 7) and VEP13 antigens on human cells mediating natural killing"
"0021819626","2992071","10.1111/j.1365-3083.1985.tb01858.x","2-s2.0-0021819626","1985-01-01","Isolation of Highly Purified Lymphocyte Subsets for Functional Studies by Means of an Indirect Rosette Technique"
"0014152005","4169033","","2-s2.0-0014152005","1967-11-01","Chromic chloride: a coupling reagent for passive hemagglutination reactions."
"0021223230","6233371","","2-s2.0-0021223230","1984-08-23","The Fc receptor for IgG on human natural killer cells: Phenotypic, functional, and comparative studies with monoclonal antibodies"
"0021805302","2930991","10.1159/000206305","2-s2.0-0021805302","1985-01-01","Detection of human lymphocyte subpopulations by using monoclonal antibodies and protein A-coated erythrocytes"
"0021505421","6238409","","2-s2.0-0021505421","1984-10-01","Definition of the cell types within the ""null lymphocyte"" population of human peripheral blood: An analysis of phenotypes and functions"
"0017575406","323365","10.1016/0022-1759(77)90065-5","2-s2.0-0017575406","1977-01-01","Use of antibody-coated red cells for the sensitive detection of antigen and in rosette tests for cells bearing surface immunoglobulins"
"0019412995","6786981","","2-s2.0-0019412995","1981-10-09","Properties of monoclonal antibodies to human immunoglobulin kappa and lambda chains"
"0019868986","7334211","10.1016/0022-1759(81)90282-9","2-s2.0-0019868986","1981-12-30","A critical appraisal of the direct antibody-rosette test for the detection of cell surface antigens"
"0020510416","6341468","10.1016/0022-1759(83)90030-3","2-s2.0-0020510416","1983-01-01","Isolation of Ia positive human leukocytes by a direct rosette assay"
"84910519691","","","2-s2.0-84910519691","1983-12-23",""
"0021319189","6363554","10.1016/0022-1759(84)90250-3","2-s2.0-0021319189","1984-01-01","Detection of monoclonal antibodies against cell surface antigens: the use of antiglobulins coupled to red blood cells"
"0017579545","839542","10.1016/S0022-2836(77)80034-X","2-s2.0-0017579545","1977-01-15","Genetic studies of the lac repressor. I. Correlation of mutational sites with specific amino acid residues: Construction of a colinear gene-protein map"
"0013908549","5327905","","2-s2.0-0013908549","1966-05-01","Conjugation in Escherichia coli."
"2642699794","3881765","","2-s2.0-2642699794","1985-01-01","Rapid and efficient site-specific mutagenesis without phenotypic selection"
"84968779139","","","2-s2.0-84968779139","1984-05-25",""
"0021687639","6386179","10.1016/0092-8674(84)90283-6","2-s2.0-0021687639","1984-01-01","Different base/base mismatches are corrected with different efficiencies by the methyl-directed DNA mismatch-repair system of E. coli"
"0021107943","6615786","","2-s2.0-0021107943","1983-12-01","Site-directed mutagenesis as a probe of enzyme structure and catalysis: Tyrosyl-tRNA synthetase cysteine-35 to glycine-35 mutation"
"0021768550","6096830","10.1093/nar/12.24.9441","2-s2.0-0021768550","1984-12-21","The gapped duplex DNA approach to oligonucleotide-directed mutation construction"
"0021251828","6690998","10.1038/307187a0","2-s2.0-0021251828","1984-12-01","A large increase in enzyme-substrate affinity by protein engineering"
"0021504608","6488318","10.1016/0092-8674(84)90278-2","2-s2.0-0021504608","1984-01-01","The use of double mutants to detect structural changes in the active site of the tyrosyl-tRNA synthetase (Bacillus stearothermophilus)"
"0021745024","6096100","","2-s2.0-0021745024","1984-12-01","Oligonucleotide-directed mutagenesis using plasmid DNA templates and two primers"
"0020491290","6757864","10.1093/nar/10.20.6487","2-s2.0-0020491290","1982-10-25","Oligonucleotide-directed mutagenesis using M13-derived vectors: An efficient and general procedure for the production of point mutations in any fragment of DNA"
"0011448278","333444","","2-s2.0-0011448278","1977-12-01","Filamentous coliphage M13 as a cloning vehicle: insertion of a HindII fragment of the lac regulatory region in M13 replicative form in vitro"
"0021073779","6323249","10.1016/0378-1119(83)90040-9","2-s2.0-0021073779","1983-01-01","Construction of improved M13 vectors using oligodeoxynucleotide-directed mutagenesis"
"84915717090","","","2-s2.0-84915717090","1985-11-25",""
"33745416757","","","2-s2.0-33745416757","1973-07-07","Nonchromosomal antibiotic resistance in bacteria: Genetic transformation of E. coli by R-factor DNA"
"0020491275","6294606","10.1093/nar/10.20.6475","2-s2.0-0020491275","1982-10-25","Directed mutagenesis of DNA cloned in filamentous phage: Influence of hemimethylated GATC sites on marker recovery from restriction fragments"
"0019969022","6811955","10.1038/299756a0","2-s2.0-0019969022","1982-12-01","Redesigning enzyme structure by site-directed mutagenesis: Tyrosyl tRNA synthetase and ATP binding"
"0017193425","796661","10.1007/BF00332898","2-s2.0-0017193425","1976-01-01","Overproduction of phage Lambda repressor under control of the lac promotor of Escherichia coli"
"0019769854","7335495","10.1093/nar/9.24.6907","2-s2.0-0019769854","1981-12-21","The structure of two subgenomic RNAs from human infhienza virus A/PR/8/34"
"0021672088","6096101","","2-s2.0-0021672088","1984-12-01","Oligonucleotide-directed mutagenesis: A simple method using two oligonucleotide primers and a single-stranded DNA template"
"0021101167","6308572","10.1093/nar/11.15.5103","2-s2.0-0021101167","1983-08-11","Efficient site-directed mutagenesis by simultaneous use of two primers"
"0018601460","232555","10.1017/S0033583500005461","2-s2.0-0018601460","1979-01-01","Structures and mechanisms of DNA restriction and modification enzymes"
"0016853254","1100850","10.1016/0022-2836(75)90175-8","2-s2.0-0016853254","1975-08-15","Genetic studies with heteroduplex DNA of bacteriophage f1. Asymmetric segregation, base correction and implications for the mechanism of genetic recombination"
"0019376491","6267988","","2-s2.0-0019376491","1981-01-01","Structure and mechanism of multifunctional restriction endonucleases."
"0019154418","","10.1016/0165-2478(80)90002-4","2-s2.0-0019154418","1980-01-01","Differences in the ability of rat IgG subclasses to consume complement in homologous and heterologous serum"
"0021932713","","","2-s2.0-0021932713","1985-01-01","Polymorphism of human Fc receptors for mouse IgG1 and IgG2b"
"0021967361","3918141","","2-s2.0-0021967361","1985-01-01","Importance of immunoglobulin isotype in human antibody-dependent, cell-mediated cytotoxicity directed by murine monoclonal antibodies"
"0023251925","3302044","10.1016/0022-1759(87)90209-2","2-s2.0-0023251925","1987-06-16","Assays using red cell-labelled antibodies"
"0344742797","","","2-s2.0-0344742797","1986-12-26","Isotype switch variants"
"0020608528","6879183","","2-s2.0-0020608528","1983-01-01","Human macrophages armed with murine immunoglobulin G2a antibodies to tumors destroy human cancer cells"
"0020636586","6603980","10.1002/eji.1830130806","2-s2.0-0020636586","1983-01-01","The mechanism of synergistic complement‐mediated lysis of rat red cells by monoclonal IgG antibodies"
"84910538712","","","2-s2.0-84910538712","1985-11-26","Switching the isotype of monoclonal antibodies"
"84910532591","","","2-s2.0-84910532591","1985-11-26","The generation of better monoclonal antibodies through somatic mutation"
"0020415586","6208128","","2-s2.0-0020415586","1982-12-01","Monoclonal antibodies specific for rat IgG1, IgG2a, and IgG2b subclasses, and kappa chain monotypic and allotypic determinants: Reagents for use with rat monoclonal antibodies"
"0019848470","7327198","10.1002/eji.1830111212","2-s2.0-0019848470","1981-01-01","Activation of mouse complement by monoclonal mouse antibodies"
"0018612959","521057","","2-s2.0-0018612959","1979-12-01","Activation of mouse complement by different classes of mouse antibody"
"0019773989","7323946","10.1007/BF01538755","2-s2.0-0019773989","1981-11-01","Expression of spleen cell immunoglobulin phenotype in hybrids with myeloma cell lines"
"84910545142","","","2-s2.0-84910545142","1982-11-26","Antibodies in somatic cell hybrids"
"0020607917","6134771","","2-s2.0-0020607917","1983-01-01","Cell-mediated lysis of tumor targets directed by murine monoclonal antibodies of IgM and all IgG isotypes"
"0021169795","6744288","","2-s2.0-0021169795","1984-09-01","Unusually Efficient Tumor Cell Lysis by Human Effectors of Antibody-dependent Cellular Cytotoxicity Mediated by Monoclonal Antibodies"
"0022510683","","","2-s2.0-0022510683","1986-01-01","The detectection and characterization of antigen-specific monoclonal antibodies using anti-immunoglobulin isotype antibodies couples to red blood cells"
"0021157869","6491299","10.1016/0022-1759(84)90042-5","2-s2.0-0021157869","1984-10-12","Red cell-labelled monoclonal antibodies for assay of human chorionic gonadotropin and luteinising hormone by reverse passive haemagglutination"
"0017584586","303545","10.1016/0092-8674(77)90266-5","2-s2.0-0017584586","1977-01-01","Analysis of cell surfaces by xenogeneic myeloma-hybrid antibodies: Differentiation antigens of rat lymphocytes"
"0004995825","","","2-s2.0-0004995825","1986-07-14","Depletion of T-cells with campath-1 and human complement. Analysis of GvHD and graft failure in a multicentre study"
"0028178454","7909829","","2-s2.0-0028178454","1994-05-15","TCR Vβ3+ and Vβ6+ CTL recognize tumor-associated antigens related to HER2/neu expression in HLA-A2+ ovarian cancers"
"0028826973","8579752","10.1016/0167-5699(95)80082-4","2-s2.0-0028826973","1995-01-01","Analysis of TCR usage in human tumors: a new tool for assessing tumor-specific immune responses"
"0028125308","7930628","","2-s2.0-0028125308","1994-11-01","T cell repertoire in patients with B chronic lymphocytic leukemia: Evidence for multiple in vivo T cell clonal expansions"
"1842363307","","","2-s2.0-1842363307","1995-11-22","Restricted usage of Vα/Jα gene segments with different nucleotide but identical amino acid sequences in HLA-DR3 sarcoidosis patients+"
"0016740933","1139039","","2-s2.0-0016740933","1975-12-01","Clinical staging of chronic lymphocytic leukemia"
"0028944105","7728746","","2-s2.0-0028944105","1995-05-01","Tumor Regression in Monoclonal Antibody-treated Patients Correlates with the Presence of Anti-Idiotype-reactive T Lymphocytes"
"0024347970","2787530","","2-s2.0-0024347970","1989-12-01","Monoclonal antibody-mediated tumor regression by induction of apoptosis"
"0024342726","2668874","10.1093/nar/17.13.4937","2-s2.0-0024342726","1989-07-11","Direct solid phase sequencing of genomic and plasmid DNA using magnetic beads as solid support"
"0025854354","1901744","","2-s2.0-0025854354","1991-01-01","Predominant T cell receptor V gene usage in patients with abnormal clones of B cells"
"0014887939","4921480","","2-s2.0-0014887939","1970-12-01","The concept of immunological surveillance."
"0023680745","3262013","10.1007/BF00200021","2-s2.0-0023680745","1988-09-01","Immunohistochemical monitoring of metastatic colorectal carcinoma in patients treated with monoclonal antibodies (MAb 17-1A)"
"0028299216","8301131","","2-s2.0-0028299216","1994-02-01","Stimulation of tumor-draining lymph node cells with superantigenic staphylococcal toxins leads to the generation of tumor-specific effector T cells"
"0025354958","2137853","","2-s2.0-0025354958","1990-01-01","Presence of clonal T cell populations in chronic B lymphocytic leukemia and smoldering myeloma"
"0015956495","4142565","","2-s2.0-0015956495","1974-01-01","Towards a network theory of the immune system"
"0028041267","8077684","","2-s2.0-0028041267","1994-09-15","Oligoclonality of tumor-infiltrating lymphocytes from human melanomas"
"0027251463","8483950","","2-s2.0-0027251463","1993-05-01","The sizes of the CDR3 hypervariable regions of the murine T-cell receptor β chains vary as a function of the recombined germ-line segments"
"3342970282","","","2-s2.0-3342970282","1971-08-15","Report of the committee on Hodgkin's disease staging"
"0028852682","7836765","","2-s2.0-0028852682","1995-01-01","Accumulation of distinct T cell clonotypes in human solid tumors"
"0028955369","7722460","","2-s2.0-0028955369","1995-01-01","T cell receptor repertoire in polymyositis: Clonal expansion of autoaggressive CD8+ T cells"
"0015443592","4118965","","2-s2.0-0015443592","1972-12-01","A controlled trial antilymphocyte globulin therapy (ALG) in man."
"0015033141","4937969","","2-s2.0-0015033141","1971-03-01","Controlled clinical trial of antilymphocyte globulin in human renal allografts."
"0021909898","3883593","","2-s2.0-0021909898","1985-01-01","Improved patient and graft survival after treatment of acute rejections of cadaveric renal allografts with rabbit antithymocyte globulin"
"84930782668","","","2-s2.0-84930782668","1970-06-18","Antilymphocyte-serum preparations in treatment of renal-allograft rejection"
"0014054539","4163340","","2-s2.0-0014054539","1967-02-01","The use of heterologous antilymphoid agents in canine renal and liver homotransplantation and in human renal homotransplantation."
"84930782664","","","2-s2.0-84930782664","1984-06-18","Elimination of graftversus- host disease by in-vitro depletion of alloreactive lymphocytes with a monoclonal rat anti-human lymphocyte antibody (Campath-1)"
"84930779495","","","2-s2.0-84930779495","1985-06-18","A randomized clinical trial of OKT3 monoclonal antibody for acute rejection of cadaveric renal transplants"
"0018701862","314668","","2-s2.0-0018701862","1979-12-01","Monoclonal antibodies defining distinctive human T cell surface antigens"
"84930781169","","","2-s2.0-84930781169","1987-06-18","Prevention of rejection of kidney transplants by monoclonal antibody directed against interleukin"
"0016756272","1172191","10.1038/256495a0","2-s2.0-0016756272","1975-12-01","Continuous cultures of fused cells secreting antibody of predefined specificity"
"0020536803","6344386","","2-s2.0-0020536803","1983-01-01","Uses of antilymphocyte globulin in renal transplantation"
"0021999927","","","2-s2.0-0021999927","1985-01-01","Efficacy of Minnesota antilymphoblast globulin in renal transplantation: A multicenter, placebo-controlled, prospective, randomized, double-blind study"
"0009065302","","","2-s2.0-0009065302","2016-06-23","Remission induction in non-Hodgkin lymphoma with reshaped monoclonal antibody CAMPATH-1H"
"0021033083","6356523","","2-s2.0-0021033083","1983-01-01","Antithymocyte globulin as the primary treatment for renal allograft rejection"
"0022544549","3520988","","2-s2.0-0022544549","1986-01-01","Prophylactic use of OKT3 monoclonal antibody in cadaver kidney recipients: Utilization of OKT3 as the sole immunosuppressive agent"
"84930549801","","","2-s2.0-84930549801","1983-06-14","Reversal of transplant rejection by monoclonal antiblast antibody"
"0021043898","6197792","","2-s2.0-0021043898","1983-01-01","Treatment of acute renal allograft rejection with monoclonal anti-T12 antibody"
"0022455246","","","2-s2.0-0022455246","1986-01-01","Prolonged administration of a monoclonal anti-T3 cell antibody (ORTHOCLONE OKT3) to kidney allograft recipients"
"84930783385","","","2-s2.0-84930783385","0000-06-18","Effects of Campath- 1 antibodies in vivo in patients with lymphoid malignancies: Influence of antibody isotype"
"0018578368","390784","","2-s2.0-0018578368","1979-01-01","Use of antithymocyte globulin for reversal of acute allograft rejection"
"84930778535","","","2-s2.0-84930778535","1987-06-18","Monoclonal antibodies which recognise activated human lymphocytes: Experimental and clinical studies"
"0023099139","3099442","","2-s2.0-0023099139","1987-01-01","A randomized clinical trial comparing okt3 and steroids for treatment of hepatic allograft rejection"
"0027462585","8465436","","2-s2.0-0027462585","1993-01-01","Consensus statement regarding OKT3-induced cytokine-release syndrome and human antimouse antibodies"
"0028107507","8110730","","2-s2.0-0028107507","1994-01-01","Human immune respone to monoclonal antibodies"
"0028862395","8581409","10.1016/0966-3274(95)80027-1","2-s2.0-0028862395","1995-01-01","The OKT3 antibody response study: a multicentre study of human anti-mouse antibody (HAMA) production following OKT3 use in solid organ tranplantation"
"0028468516","8556470","","2-s2.0-0028468516","1994-07-01","Will immunogenicity limit the use, efficacy, and future development of therapeutic monoclonal antibodies?"
"0344612166","","","2-s2.0-0344612166","1993-07-13","Humanised monoclonal antibody treatment for intractable systemic vasculitis"
"0025176807","2296577","","2-s2.0-0025176807","1990-12-01","Influence of the hinge region on complement activation, C1q binding, and segmental flexibility in chimeric human immunoglobulins"
"0023933120","2965792","","2-s2.0-0023933120","1988-12-01","Localization of the binding site for the human high-affinity fc receptor on igg"
"84989504677","","","2-s2.0-84989504677","1987-10-10",""
"0025145337","2125362","10.1111/j.1365-3083.1990.tb03192.x","2-s2.0-0025145337","1990-01-01","Enhancement of Complement Activation and Cytolysis of Human IgG3 by Deletion of Hinge Exons"
"84989539753","","","2-s2.0-84989539753","1982-10-10",""
"0026016571","1703960","10.1002/eji.1830210103","2-s2.0-0026016571","1991-01-01","Human IgG subclass pattern of inducing complement‐mediated cytolysis depends on antigen concentration and to a lesser extent on epitope patchiness, antibody affinity and complement concentration"
"0025759052","2007852","","2-s2.0-0025759052","1991-04-01","The differential ability of human IgG1 and IgG4 to activate complement is determined by the COOH-terminal sequence of the CH2 domain"
"0023716475","3140243","","2-s2.0-0023716475","1988-01-01","Universal bispecific antibody for targeting tumor cells for destruction by cytotoxic T cells"
"0026567110","1530984","10.1016/0161-5890(92)90156-R","2-s2.0-0026567110","1992-01-01","Multiple binding sites on the CH2 domain of IgG for mouse FcγR11"
"0025943212","1833770","","2-s2.0-0025943212","1991-10-15","Identification of the Fcγ receptor class I binding site in human IgG through the use of recombinant IgG1/IgG2 hybrid and point-mutated antibodies"
"0021810220","4033670","10.1016/0161-5890(85)90147-6","2-s2.0-0021810220","1985-01-01","Preparation and biologic characterization of fragments containing dimeric and monomeric Cγ2 domain of rabbit IgG"
"0026519686","1578132","","2-s2.0-0026519686","1992-05-15","Therapy with monoclonal antibodies: An in vivo model for the assessment of therapeutic potential"
"0016682479","1127227","","2-s2.0-0016682479","1975-12-01","The structure and function of immunoglobulin domains. II. The importance of interchain disulfide bonds and the possible role of molecular flexibility in the interaction between immunoglobulin G and complement"
"0019522383","7236608","","2-s2.0-0019522383","1981-12-01","Crystallographic refinement and atomic models of a human Fc fragment and its complex with fragment B of protein A from Staphylococcus aureus at 2.9- and 2.8-Å resolution"
"0017250165","814165","","2-s2.0-0017250165","1976-12-01","The structure and function of immunoglobulin domains. IV. The distribution of some effector functions among the Cγ2 and Cγ3 homology regions of human immunoglobulin G1"
"0025666553","2148808","10.1016/0161-5890(90)90027-W","2-s2.0-0025666553","1990-01-01","Molecular definition of interaction sites on human IgG for Fc receptors (huFcγR)"
"0023402551","3317749","","2-s2.0-0023402551","1987-09-01","The function of antibody and complement in the lysis of bacteria."
"0025058762","2311645","10.1002/eji.1830200208","2-s2.0-0025058762","1990-01-01","Complement activation by immunoglobulin does not depend solely on C1q binding"
"0025762394","1827828","","2-s2.0-0025762394","1991-06-01","The binding affinity of human IgG for its high affinity Fc receptor is determined by multiple amino acids in the CH2 domain and is modulated by the hinge region"
"84989517649","","","2-s2.0-84989517649","1989-10-10",""
"0023846387","2963069","","2-s2.0-0023846387","1988-01-01","The clearance of tetanus toxoid/anti-tetanus toxoid immune complexes from the circulation of humans. Complement- and erythrocyte complement receptor 1-dependent mechanisms"
"0023897194","3258649","","2-s2.0-0023897194","1988-12-01","The binding site for C1q on IgG"
"0020025142","6979442","","2-s2.0-0020025142","1982-01-01","Complement-mediated inhibition of immune precipitation. I. Role of the classical and alternative pathways"
"0025882501","2019290","10.1002/eji.1830210413","2-s2.0-0025882501","1991-01-01","Targeting behavior of rat monoclonal IgG antibodies in vivo: role of antibody isotype, specificity and the target cell antigen density"
"0025944556","1915551","10.1002/eji.1830211013","2-s2.0-0025944556","1991-01-01","Chimeric mouse human IgG3 antibodies with an IgG4‐like hinge region induce complement‐mediated lysis more efficiently than IgG3 with normal hing"
"0026507779","1533898","10.1016/0161-5890(92)90200-H","2-s2.0-0026507779","1992-01-01","Mapping and comparison of the interaction sites on the Fc region of IgG responsible for triggering antibody dependent cellular cytotoxicity (ADCC) through different types of human Fcγ receptor"
"0021331061","6198355","","2-s2.0-0021331061","1984-01-01","Immunoenzymatic labeling of monoclonal antibodies using immune complexes of alkaline phosphatase and monoclonal anti-alkaline phosphatase (APAAP complexes)"
"0025057661","2297573","","2-s2.0-0025057661","1990-02-01","A new human B-cell non-Hodgkin's lymphoma cell line (Karpas 422) exhibiting both t(14;18) and t(4;11) chromosomal translocations"
"0004181406","","","2-s2.0-0004181406","1987-01-24",""
"0013524261","","","2-s2.0-0013524261","1987-07-13","Non-lineage, LFA-1 family, and leucocyte common antigens: New and previously defined clusters"
"0023944337","3052274","","2-s2.0-0023944337","1988-01-01","Cell-surface anchoring of proteins via glycosyl-phosphatidylinositol structures"
"84995032452","","","2-s2.0-84995032452","1987-11-20",""
"0023109897","3547846","","2-s2.0-0023109897","1987-01-01","Current developments in marrow transplantation"
"84995084329","","","2-s2.0-84995084329","1987-11-20","Depletion of T cells from human bone marrow using a new monoclonal antibody 097 and human complement"
"0018868972","6156981","","2-s2.0-0018868972","1980-10-06","Subclass restriction of murine antibodies. III. Antigens that stimulate IgG 3 in mice stimulate IgG 2c in rats"
"84995100208","","","2-s2.0-84995100208","1990-11-20","Purification and preliminary characterisation of the CAMPATH‐I antigen"
"0018149594","79606","","2-s2.0-0018149594","1978-12-01","Subclass restriction of murine anti-carbohydrate antibodies"
"70449158340","13428781","","2-s2.0-70449158340","1957-05-01","A simple method for the isolation and purification of total lipides from animal tissues."
"84958932541","","","2-s2.0-84958932541","1990-05-26",""
"0021176984","6379121","","2-s2.0-0021176984","1984-01-01","Therapy of chronic lymphocytic leukemia and cutaneous T-cell lymphoma with T101 monoclonal antibody"
"84871466246","","","2-s2.0-84871466246","1993-04-18","Interim clinical results of phase I/early phase 2 CAMPATH-1H studies in NHL/CLL"
"0030069871","8562959","","2-s2.0-0030069871","1996-02-01","Treatment of cutaneous T-cell lymphoma with chimeric anti-CD4 monoclonal antibody"
"0025246367","2188675","","2-s2.0-0025246367","1990-01-01","The T lymphocyte in experimental allergic encephalomyelitis"
"84988087165","","","2-s2.0-84988087165","1994-09-26","Disease specific alterations in the peripheral T cell repertoire of rheumatoid arthritis patients (abstract)"
"0027243784","8496681","","2-s2.0-0027243784","1993-06-01","Clonal Vα12.1+ T cell expansions in the peripheral blood of rheumatoid arthritis patients"
"0028113950","7962553","","2-s2.0-0028113950","1994-11-01","Dominant clonotypes in the repertoire of peripheral CD4+ T cells in rheumatoid arthritis"
"0020559450","6352849","","2-s2.0-0020559450","1983-01-01","Immunoelectron microscopic study of the distribution of T cell subsets in rheumatoid synovium"
"0026673844","1357036","","2-s2.0-0026673844","1992-12-01","Development of murine lupus in CD4-depleted NZB/NZW mice: Sustained inhibition of residual CD4+ T cells is required to suppress autoimmunity"
"0028032155","8293460","10.1016/0092-8674(94)90330-1","2-s2.0-0028032155","1994-01-28","Positive selection of lymphocytes"
"0026764802","1315549","10.1002/art.1780350505","2-s2.0-0026764802","1992-01-01","Lymphocyte subsets associated with T cell receptor β‐chain gene rearrangement in patients with rheumatoid arthritis and neutropenia"
"0021816056","2861567","","2-s2.0-0021816056","1985-10-16","A randomized clinical trial of OKT3 monoclonal antibody for acute rejection of cadaveric renal transplants"
"0026680392","1623929","10.1002/eji.1830220735","2-s2.0-0026680392","1992-01-01","The use of a non‐depleting anti‐CD4 monoclonal antibody to re‐establish tolerance to β cells in NOD mice"
"0026701264","1279168","","2-s2.0-0026701264","1992-01-01","Chimeric CD7 monoclonal antibody therapy in rheumatoid arthritis"
"0022645984","3946976","","2-s2.0-0022645984","1986-05-28","Rheumatoid arthritis associated with expanded populations of granular lymphocytes"
"0024346908","2479030","10.1073/pnas.86.22.8941","2-s2.0-0024346908","1989-12-14","Interaction of Staphylococcus aureus toxin 'superantigens' with human T cells"
"0027248183","8335912","","2-s2.0-0027248183","1993-07-15","Restrictions in the Repertoire of Allospecific T Cells: Contribution of the α-Helical Sequence Polymorphism of HLA-DR Molecules"
"0023869521","3340835","","2-s2.0-0023869521","1988-12-01","Genomic amplification with transcript sequencing"
"0028238428","7911664","10.1002/art.1780370610","2-s2.0-0028238428","1994-01-01","Treatment of refractory rheumatoid arthritis with a chimeric ANTI‐CD4 monoclonal antibody"
"0028151819","8293461","10.1016/0092-8674(94)90331-X","2-s2.0-0028151819","1994-01-28","Negative selection of lymphocytes"
"0021965670","3919141","","2-s2.0-0021965670","1985-01-01","Successful treatment of autoimmunity in NZB/NZW F1 mice with monoclonal antibody to L3T4"
"0027958044","8278351","10.1073/pnas.91.1.123","2-s2.0-0027958044","1994-01-04","Anti-CD3 antibody induces long-term remission of overt autoimmunity in nonobese diabetic mice"
"0022327489","3933533","","2-s2.0-0022327489","1985-12-01","Molecular genetics of the T cell-receptor beta chain."
"0023912807","3368786","","2-s2.0-0023912807","1988-12-01","A molecular basis for MHC class II - Associated autoimmunity"
"0026515954","1730259","10.1002/eji.1830220110","2-s2.0-0026515954","1992-01-01","Treatment of rats with monoclonal anti‐CD4 induces long‐term resistance to streptococcal cell wall‐induced arthritis"
"0027413090","8452767","","2-s2.0-0027413090","1993-01-01","Interplay of T lymphocytes and HLA-DR molecules in rheumatoid arthritis"
"0019851727","7041358","","2-s2.0-0019851727","1981-01-01","Treatment of acute renal allograft rejection with OKT3 monoclonal antibody"
"0009970136","","","2-s2.0-0009970136","1984-09-01",""
"0021910086","","","2-s2.0-0021910086","1985-01-01","Prophylactic treatment of allograft recipients with a monoclonal anti-T3+ cell antibody"
"0021984096","","","2-s2.0-0021984096","1985-01-01","Treatment of rejection: Antithymocyte globulin versus monoclonal antibodies"
"0021993860","","","2-s2.0-0021993860","1985-01-01","Observations on paratopic segmental pancreas grafting with splenic venous drainage"
"0021925539","","","2-s2.0-0021925539","1985-01-01","Reversal of acute allograft rejection with monoclonal antibody"
"0021065613","6196581","10.1016/S0140-6736(83)91212-6","2-s2.0-0021065613","1983-11-19","REVERSAL OF TRANSPLANT REJECTION BY MONOCLONAL ANTIBLAST ANTIBODY"
"0017365573","831755","10.1038/bjc.1977.1","2-s2.0-0017365573","1977-01-01","Design and analysis of randomized clinical trials requiring prolonged observation of each patient. II. Analysis and examples"
"84909756649","","","2-s2.0-84909756649","1985-11-23","Paratopic segmental pancreas grafting-a technique with portal venous drainage"
"0021922145","","","2-s2.0-0021922145","1985-01-01","Use of monoclonal antibodies for kidney transplant patients"
"84910769592","","","2-s2.0-84910769592","1983-11-27","Recipient operation"
"0022000912","","","2-s2.0-0022000912","1985-01-01","Follow-up on initial trials of kidney transplant rejection reversal by a monoclonal antiblast antibody"
"0343628585","","","2-s2.0-0343628585","1993-07-13","Endothelial dysfunction and activation of haemostasis (anticardiolipin antibodies, thrombin-antithrombin complexes (TAT), prothrombin fragments (F1+2), D-dimers) as markers of disease activity in patients with systemic necrotizing vasculitis"
"0027216493","8353286","","2-s2.0-0027216493","1993-08-15","Human endothelial cells express proteinase 3, the target antigen of anticytoplasmic antibodies in Wegener's Granulomatosis"
"0027724283","8159318","10.1093/oxfordjournals.ndt.a092392","2-s2.0-0027724283","1993-01-01","Pooled human immunoglobulin (phig) inhibits the binding of antiendothelial cell antibodies to endothelial cells"
"0015779503","","10.1016/S0065-2776(08)60298-9","2-s2.0-0015779503","1973-12-01","Immune Complex Disease in Experimental Animals and Man"
"0025852135","2070557","10.1111/j.1365-2249.1991.tb05675.x","2-s2.0-0025852135","1991-01-01","Vascular damage in Wegener's granulomatosis and microscopic polyarteritis: presence of anti‐endothelial cell antibodies and their relation to anti‐neutrophil cytoplasm antibodies"
"0022407708","4048389","10.1093/oxfordjournals.qjmed.a067893","2-s2.0-0022407708","1985-01-01","Microscopic polyarteritis: Presentation, pathology and prognosis"
"0025345612","2161532","10.1073/pnas.87.11.4115","2-s2.0-0025345612","1990-07-20","Anti-neutrophil cytoplasmic autoantibodies induce neutrophils to degranulate and produce oxygen radicals in vitro"
"0023217465","2889238","10.1093/oxfordjournals.qjmed.a068094","2-s2.0-0023217465","1987-03-01","Polyarteritis and the Kidney"
"0023693986","3187329","10.1007/BF00270453","2-s2.0-0023693986","1988-08-01","Spontaneous and induced immunoglobulin synthesis and anti-neutrophil cytoplasm antibodies in Wegener's granulomatosis: relation to leukocyte subpopulations in blood and active lesions"
"0024999139","1975893","10.1016/0140-6736(90)92205-V","2-s2.0-0024999139","1990-09-22","Prevention of relapses in Wegener's granulomatosis by treatment based on antineutrophil cytoplasmic antibody titre"
"0025193011","2154347","","2-s2.0-0025193011","1990-01-01","Anti-myleoperoxidase antibodies in systemic vasculitis"
"0025934581","1658170","","2-s2.0-0025934581","1991-01-01","Antibodies against granule proteins activate neutrophils in vitro"
"0026582593","1351434","","2-s2.0-0026582593","1992-06-11","Antineutrophil cytoplasmic antibody (cANCA and pANCA) titers in relation to disease activity in patients with necrotizing vasculitis: A longitudinal study"
"0026591220","1381003","","2-s2.0-0026591220","1992-01-01","HLA class II specificities in vasculitis with antibodies to neutrophil cytoplasmic antigens"
"0025197964","2258192","","2-s2.0-0025197964","1990-10-01","The endothelial cell as a regulator of T-cell function"
"0027223387","8394537","10.1093/oxfordjournals.ndt.a092524","2-s2.0-0027223387","1993-01-01","Renal allograft rejection: examination of adhesion blockade by antilymphocyte antibody drugs"
"84935359995","","","2-s2.0-84935359995","1991-07-12","Animal models of vasculitis"
"0026584904","1311014","","2-s2.0-0026584904","1992-01-01","Reactivity of antineutrophil cytoplasmic autoantibodies with mononuclear phagocytes"
"0000652834","6297657","","2-s2.0-0000652834","1982-12-01","Segmental necrotising glomerulonephritis with antineutrophil antibody: Possible arbovirus aetiology?"
"0019988348","7113976","","2-s2.0-0019988348","1982-01-01","The acute vasculitis of Wegener's granulomatosis in renal biopsies"
"0026677515","1458677","","2-s2.0-0026677515","1992-01-01","Interference of Wegener's granulomatosis autoantibodies with neutrophil Proteinase 3 activity"
"0025234675","2355993","","2-s2.0-0025234675","1990-04-25","The role of the c-ANCA antigen in the pathogenesis of Wegener's granulomatosis. A hypothesis based on both humoral and cellular mechanisms"
"0025582994","","","2-s2.0-0025582994","1990-12-01","Activation of blood coagulation and endothelial dysfunction in patients with Wegener's granulomatosis and related disorders"
"0025999667","1754104","","2-s2.0-0025999667","1991-01-01","Anti-neutrophil cytoplasmic antibodies and disease activity during long-term follow-up of 70 patients with systemic vasculitis"
"0025284852","2377228","","2-s2.0-0025284852","1990-12-01","Wegener's autoantigen decoded"
"0027169129","8101607","10.1016/0140-6736(93)91513-L","2-s2.0-0027169129","1993-08-07","Environmental trigger for anti-neutrophil cytoplasmic antibodies?"
"0025225389","2240162","","2-s2.0-0025225389","1990-11-01","Ultrastructural localization of proteinase 3, the target antigen of anti-cytoplasmic antibodies circulating in Wegener's granulomatosis"
"0021673673","6384024","10.1016/S0046-8177(84)80124-0","2-s2.0-0021673673","1984-01-01","Renal biopsy findings in Wegener's granulomatosis: Segmental necrotizing glomerulonephritis with glomerular thrombosis"
"0025880258","1946253","","2-s2.0-0025880258","1991-01-01","Bronchoalveolar lavage in Wegener's granulomatosis"
"0023279838","2884494","10.1016/S0140-6736(87)90591-5","2-s2.0-0023279838","1987-06-20","PROSPECTIVE STUDY OF RADIOIMMUNOASSAY FOR ANTIBODIES AGAINST NEUTROPHIL CYTOPLASM IN DIAGNOSIS OF SYSTEMIC VASCULITIS"
"0025805247","2012946","10.1093/rheumatology/30.2.144","2-s2.0-0025805247","1991-04-01","Wegener's granulomatosis occurring in siblings"
"0001050168","","","2-s2.0-0001050168","1991-07-12","Immunohistopathology of renal biopsies in Wegener's granulomatosis (WG): Clues to its pathogenesis?"
"0025304016","1690903","","2-s2.0-0025304016","1990-01-01","Cytokines and endothelial cell biology"
"0023735887","3417290","10.1016/S0046-8177(88)80088-1","2-s2.0-0023735887","1988-01-01","The pulmonary biopsy in the early diagnosis of Wegener's (pathergic) granulomatosis: A study based on 35 open lung biopsies"
"0028307148","8306499","","2-s2.0-0028307148","1994-01-01","Activated neutrophils express proteinase 3 on their plasma membrane in vitro and in vivo"
"84935375201","","","2-s2.0-84935375201","0000-07-12",""
"29344460974","","","2-s2.0-29344460974","1993-07-12","Processing and presentation of peptides by vascular endothelial cells to CD4&lt;sup&gt;+&lt;/sup&gt; T cell lines"
"0024426605","2684074","","2-s2.0-0024426605","1989-01-01","Association between active Wegener's granulomatosis and anticytoplasmic antibodies"
"0025354569","1696867","","2-s2.0-0025354569","1990-01-01","Enhanced expression of the tumour necrosis factor/cachectin gene in peripheral blood mononuclear cells from patients with systemic vasculitis"
"0002937877","","","2-s2.0-0002937877","1993-08-09","Polyarteritis, Wegener's granulomatosis and Churg-Strauss syndrome"
"84935375227","","","2-s2.0-84935375227","0000-07-12",""
"0027238106","8093706","","2-s2.0-0027238106","1993-01-01","Antibodies against intercellular adhesion molecule-1 and lymphocyte function-associated antigen-1 prevent glomerular injury in rat experimental crescentic glomerulonephritis"
"0013963677","5923596","","2-s2.0-0013963677","1966-10-01","Limited forms of angiitis and granulomatosis of Wegener's type"
"0026480849","1424279","","2-s2.0-0026480849","1992-01-01","Activation of normal neutrophils by anti-neutrophil cytoplasm antibodies"
"0028158243","8129773","10.1002/art.1780370206","2-s2.0-0028158243","1994-01-01","Nomenclature of Systemic Vasculitides"
"0023878734","2453802","","2-s2.0-0023878734","1988-01-01","Anti-neutrophil cytoplasmic autoantibodies with specificity for myeloperoxidase in patients with systemic vasculitis and idiopathic necrotizing and crescentic glomerulonephritis"
"0027419010","8096069","10.1093/oxfordjournals.ndt.a092401","2-s2.0-0027419010","1993-01-01","Little evidence for anti-endothelial cell antibodies in microscopic polyarteritis and wegener's granulomatosis"
"0025353345","2189509","","2-s2.0-0025353345","1990-01-01","Specificity of anti-neutrophil cytoplasmic autoantibodies for proteinase 3 (I)"
"0025037503","1978703","","2-s2.0-0025037503","1990-01-01","Titration of antibodies against neutrophil cytoplasmic antigens is useful in monitoring disease activity in systemic vasculitides"
"0027599166","7915959","","2-s2.0-0027599166","1993-05-01","Anti-neutrophil cytoplasm antibodies can recognize vascular endothelial cell-bound anti-neutrophil cytoplasm antibody-associated autoantigens."
"4243406091","","","2-s2.0-4243406091","1993-01-01","Activation of neutrophils by anti-neutrophil cytoplasmic antibodies is FcR-dependent"
"0027716883","7512705","10.1093/oxfordjournals.ndt.a092393","2-s2.0-0027716883","1993-01-01","Expression of e-selectin in the human kidney"
"84935385661","","","2-s2.0-84935385661","1992-07-12","Anti-myeloperoxidase antibodies (αMPO) activate neutrophils using a phospholipase D-containing signal transduction pathway"
"0026057726","1990940","","2-s2.0-0026057726","1991-01-01","Immunoglobulin G antineutrophil cytoplasmic antibodies are produced in the respiratory tract of patients with Wegener's granulomatosis"
"0022623890","2867676","","2-s2.0-0022623890","1986-01-01","Idiopathic microscopic polyarteritis nodosa: Ultrastructural observations on the renal vascular and glomerular lesions"
"0017726153","908847","","2-s2.0-0017726153","1977-12-01","Leukocytoclastic vasculitis: Sequential appearance of immunoreactants and cellular changes in serial biopsies"
"0018703911","487670","10.1016/0090-1229(79)90150-8","2-s2.0-0018703911","1979-01-01","Association of Wegener's granulomatosis with HLA-B8"
"0026501713","1313124","","2-s2.0-0026501713","1992-02-01","Anti-myeloperoxidase antibodies stimulate neutrophils to damage human endothelial cells"
"52649164105","","","2-s2.0-52649164105","1991-07-14","ANCA specificity in microscopic poliarteritis, Churg-Strauss syndrome and polyarteritis nodosa"
"0027193883","8499060","10.1006/jaut.1993.1020","2-s2.0-0027193883","1993-06-01","Cellular immune responses and pathogenesis in c-ANCA positive vasculitides"
"0025948537","1682080","","2-s2.0-0025948537","1991-01-01","Renal expression of intercellular adhesion molecule-1 in different forms of glomerulonephritis"
"0024441068","2478451","","2-s2.0-0024441068","1989-01-01","Serum cytokine changes in systemic vasculitis"
"0027532596","8455368","","2-s2.0-0027532596","1993-03-01","In situ production of TNF-α, IL-1β and IL-2R in ANCA-positive glomerulonephritis"
"0002835650","8361125","","2-s2.0-0002835650","1993-01-01","Role of leukocyte-endothelial cell adhesion molecules in renal inflammation: In vitro and in vivo studies"
"0025971931","1993362","10.1111/j.1365-2249.1991.tb05631.x","2-s2.0-0025971931","1991-01-01","Anti‐idiotypes against anti‐neutrophil cytoplasmic antigen autoantibodies in normal human polyspecific IgG for therapeutic use and in the remission sera of patients with systemic vasculitis"
"0025726619","1851056","10.1111/j.1365-2249.1991.tb08154.x","2-s2.0-0025726619","1991-01-01","Detection of anti‐myeloperoxidase and anti‐elastase antibodies in vasculitides and infections"
"0020694581","6130772","10.1002/art.1780260118","2-s2.0-0020694581","1983-01-01","HLA antigen frequencies in systemic vasculitis: increase in HLA‐DR2 in wegener's granulomatosis"
"0025936027","1655318","10.1111/j.1365-2249.1991.tb05779.x","2-s2.0-0025936027","1991-01-01","Anti‐neutrophil cytoplasm antibodies in rheumatoid arthritis"
"84935375226","","","2-s2.0-84935375226","1993-07-12","Classification of vasculitis"
"0025852122","2044229","","2-s2.0-0025852122","1991-01-01","IgG subclass distribution of autoantibodies to neutrophil cytoplasmic antigens in systemic vasculitis"
"0025064337","2153032","","2-s2.0-0025064337","1990-01-01","In situ localization by double-labeling immunoelectron microscopy of anti-neutrophil cytoplasmic autoantibodies in neutrophils and monocytes"
"0027398625","8443965","","2-s2.0-0027398625","1993-01-01","Serum markers of T cell activation in relapses of Wegener's granulomatosis"
"0019154181","7427471","10.1136/bmj.281.6244.836","2-s2.0-0019154181","1980-09-27","Relapses in Wegener's granulomatosis: The role of infection"
"0027982876","7507411","10.1016/0092-8674(94)90337-9","2-s2.0-0027982876","1994-01-28","Traffic signals for lymphocyte recirculation and leukocyte emigration: The multistep paradigm"
"0025753156","1674023","10.1016/0140-6736(91)92797-6","2-s2.0-0025753156","1991-05-11","Treatment of systemic vasculitis with pooled intravenous immunoglobulin"
"0025073210","2302834","","2-s2.0-0025073210","1990-01-01","Anti-endothelial cell antibodies in patients with Wegener's granulomatosis and micropolyarteritis"
"0016604819","123546","","2-s2.0-0016604819","1975-12-01","Demonstration of immune complexes in spontaneous and histamine induced lesions and in normal skin of patients with leukocytoclastic angiitis"
"0017172173","972774","","2-s2.0-0017172173","1976-01-01","An ultrastructural study of the pathogenesis of tissue injury in limited wegener's granulomatosis"
"0024435458","2679910","","2-s2.0-0024435458","1989-01-01","Wegener's granulomatosis autoantigen is a novel neutrophil serine proteinase"
"0026081417","1848489","10.1111/j.1365-2249.1991.tb05647.x","2-s2.0-0026081417","1991-01-01","Predominance of IgGl and IgG4 subclasses of anti‐neutrophil cytoplasmic autoantibodies (ANCA) in patients with Wegener's granulomatosis and clinically related disorders"
"0027423663","7693806","","2-s2.0-0027423663","1993-11-15","Differential induction of VCAM-1 on human iliac venous and arterial endothelial cells and its role in adhesion"
"0025048694","2242605","","2-s2.0-0025048694","1990-01-01","Autoantibodies to endothelial cells and neutrophil cytoplasmic antigens in systemic vasculitis"
"0020581578","6601459","10.1016/0002-9343(83)91030-6","2-s2.0-0020581578","1983-01-01","Pulmonary vasculitis (Wegener's granulomatosis). Immunohistochemical study of T and B cell markers"
"0024414954","2791359","","2-s2.0-0024414954","1989-01-01","Severe pulmonary hemorrhage and systemic vasculitis in association with circulating antineutrophil cytoplasm antibodies of IgM class only"
"0026705320","1323218","","2-s2.0-0026705320","1992-08-01","Autoantibodies developing to myeloperoxidase and proteinase 3 in systemic vasculitis stimulate neutrophil cytotoxicity toward cultured endothelial cells"
"84920235395","","10.1016/S0140-6736(85)91147-X","2-s2.0-84920235395","1985-02-23","AUTOANTIBODIES AGAINST NEUTROPHILS AND MONOCYTES: TOOL FOR DIAGNOSIS AND MARKER OF DISEASE ACTIVITY IN WEGENER'S GRANULOMATOSIS"
"0024389175","2683800","","2-s2.0-0024389175","1989-01-01","Anti-neutrophil cytoplasmic autoantibody-associated glomerulonephritis and vasculitis"
"0026499960","1377920","10.1016/0167-5699(92)90149-2","2-s2.0-0026499960","1992-01-01","Endothelial cell interactions with granulocytes: tethering and signaling molecules"
"0027508370","7906421","10.1093/oxfordjournals.qjmed.a068761","2-s2.0-0027508370","1993-01-01","Relapses in patients with a systemic vasculitis"
"0025359620","1971074","10.1016/0140-6736(90)92755-7","2-s2.0-0025359620","1990-05-19","""False-positive"" anti-neutrophil cytoplasmic antibodies in HIV infection"
"0026438866","1336132","10.1093/oxfordjournals.ndt.a092026","2-s2.0-0026438866","1992-01-01","Endothelium myeloperoxidase-antimyeloperoxidase interaction in vasculitis"
"0027134911","7504599","","2-s2.0-0027134911","1993-01-01","Antibodies to proteinase 3 increase adhesion of neutrophils to human endothelial cells"
"0027405384","8384653","","2-s2.0-0027405384","1993-01-01","Antimyeloperoxidase-associated proliferative glomerulonephritis: An animal model"
"84935375200","","","2-s2.0-84935375200","0000-07-12",""
"0024432516","2681270","","2-s2.0-0024432516","1989-01-01","Wegener's granulomatosis autoantibodies identify a novel diisopropylfluorophosphate-binding protein in the lysosomes of normal human neutrophils"
"0025145696","2200820","10.1016/S0091-6749(05)80067-3","2-s2.0-0025145696","1990-01-01","A distinct subset of antineutrophil cytoplasmic antibodies is associated with inflammatory bowel disease"
"0026632718","1623646","10.1016/0090-1229(92)90232-D","2-s2.0-0026632718","1992-01-01","Antibodies to endothelial cells in primary vasculitides mediate in vitro endothelial cytotoxicity in the presence of normal peripheral blood mononuclear cells"
"0021960964","3871238","","2-s2.0-0021960964","1985-01-01","Wegener's granulomatosis: Observations on treatment with antimicrobial agents"
"0023237155","3033023","","2-s2.0-0023237155","1987-09-08","New mechanism for glomerular injury. Myeloperoxidase-hydrogen peroxide-halide system"
"0024695976","2569736","","2-s2.0-0024695976","1989-07-01","Morphologic differences between polyarteritis and Wegener's granulomatosis using light, electron and immunohistochemical techniques."
"0026338708","1724689","","2-s2.0-0026338708","1991-12-01","Expression of VCAM-1 in the normal and diseased kidney"
"0003274992","","","2-s2.0-0003274992","1992-07-13","Involvement of cytokines in granuloma formation within primary systemic vasculitis"
"0027281257","8388693","10.1006/jaut.1993.1022","2-s2.0-0027281257","1993-01-01","Animal models of systemic vasculitis"
"0000247001","","10.1016/0167-5699(87)90010-7","2-s2.0-0000247001","1987-01-01","Platelet-activating factor and cellular immune responses"
"0028363228","8306501","","2-s2.0-0028363228","1994-01-01","Anti-idiotypic activity against anti-myeloperoxidase antibodies in pooled human immunoglobulin"
"0033529235","10393960","10.1073/pnas.96.14.8132","2-s2.0-0033529235","1999-07-06","Long-term survival and function of intrahepatic islet allografts in rhesus monkeys treated with humanized anti-CD154"
"0000770628","9725217","","2-s2.0-0000770628","1998-09-01","On histocompatibility barriers, Th1 to Th2 immune deviation, and the nature of the allograft responses"
"0030006103","8752898","","2-s2.0-0030006103","1996-07-15","T cell regulation in adult transplantation tolerance"
"0031945499","9597144","10.1146/annurev.immunol.16.1.619","2-s2.0-0031945499","1998-05-05","How do monoclonal antibodies induce tolerance? A role for infectious tolerance?"
"0345476290","10545998","10.1038/15260","2-s2.0-0345476290","1999-11-01","Requirement for T-cell apoptosis in the induction of peripheral transplantation tolerance"
"0028027043","7925565","10.1002/eji.1830241019","2-s2.0-0028027043","1994-01-01","Mechanisms in CD4 antibody‐mediated transplantation tolerance: kinetics of induction, antigen dependency and role of regulatory T cells"
"0032696447","10545989","10.1038/15197","2-s2.0-0032696447","1999-11-01","Transplantation tolerance - Where do we stand?"
"0022539647","3085299","","2-s2.0-0022539647","1986-01-01","Skin allograft rejection by l3/t4 and lyt-2 t cell subests"
"0031755395","9794831","10.1016/S0952-7915(98)80217-3","2-s2.0-0031755395","1998-10-01","Infectious tolerance"
"0032103285","9616216","","2-s2.0-0032103285","1998-06-01","Long-term survival of skin allografts induced by donor splenocytes and anti-CD154 antibody in thymectomized mice requires CD4+ T cells, interferon- γ, and CTLA4"
"0013880752","5327056","","2-s2.0-0013880752","1966-02-01","Studies on heterologous anti-lymphocyte serum in mice. II. Effect on the immune response."
"0026772133","1378631","","2-s2.0-0026772133","1992-07-15","A 39-kDa protein on activated helper T cells binds CD40 and transduces the signal for cognate activation of B cells"
"0027479685","8094901","","2-s2.0-0027479685","1993-02-12","""Infectious"" transplantation tolerance"
"0028882526","7568172","10.1073/pnas.92.21.9560","2-s2.0-0028882526","1995-10-10","Survival of mouse pancreatic islet allografts in recipients treated with allogeneic small lymphocytes and antibody to CD40 ligand"
"0005984244","13099277","10.1038/172603a0","2-s2.0-0005984244","1953-12-01","""Actively acquired tolerance"" of foreign cells"
"15844404353","8632801","10.1038/381434a0","2-s2.0-15844404353","1996-06-10","Long-term acceptance of skin and cardiac allografts after blocking CD40 and CD28 pathways"
"0025674112","1702726","10.1002/eji.1830201231","2-s2.0-0025674112","1990-01-01","Induction of tolerance in peripheral T cells with monoclonal antibodies"
"0032751201","10528180","","2-s2.0-0032751201","1999-11-06","CD40 ligand blockade induces CD4+ T cell tolerance and linked suppression"
"0019194810","6105155","","2-s2.0-0019194810","1980-12-01","On the cloning of eukaryotic total poly(A)-RNA populations in Escherichia coli"
"0020025366","6173760","10.1038/295206a0","2-s2.0-0020025366","1982-12-01","Molecular cloning establishes proenkephalin as precursor of enkephalin-containing peptides"
"0020055185","6287227","","2-s2.0-0020055185","1982-01-01","High-efficiency cloning of full-length cDNA"
"0018317843","233259","10.1038/277054a0","2-s2.0-0018317843","1979-12-01","mRNA species directing synthesis of milk proteins in normal and tumour tissue from human mammary gland [11]"
"0018639079","518835","","2-s2.0-0018639079","1979-12-01","Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease"
"0019352790","6260967","","2-s2.0-0019352790","1981-01-01","Viral DNA synthesized in vitro by avian retrovirus particles permeabilized with melittin. II. Evidence for a strand displacement mechanism in plus-strand synthesis"
"0017171465","62360","","2-s2.0-0017171465","1976-12-01","Stepwise biosynthesis in vitro of globin genes from globin mRNA by DNA polymerase of avian myeloblastosis virus"
"0017260082","60178","10.1016/0092-8674(76)90027-1","2-s2.0-0017260082","1976-01-01","Enzymatic in vitro synthesis of globin genes"
"0017404845","558827","10.1016/0092-8674(77)90090-3","2-s2.0-0017404845","1977-01-01","The primary structure of rabbit β-globin mRNA as determined from cloned DNA"
"0018846636","6246368","10.1016/S0076-6879(80)65059-9","2-s2.0-0018846636","1980-12-01","[57] Sequencing end-labeled DNA with base-specific chemical cleavages"
"0018800089","388356","10.1093/nar/7.6.1513","2-s2.0-0018800089","1979-11-24","A rapid alkaline extraction procedure for screening recombinant plasmid DNA"
"0019467224","6166921","10.1093/nar/9.10.2251","2-s2.0-0019467224","1981-05-25","5′-terminal sequences of eucaryotic mRNA can be cloned with high efficiency"
"0019186230","6154930","","2-s2.0-0019186230","1980-12-01","RNA primer used in synthesis of anticomplementary DNA by reverse transcriptase of avian myeloblastosis virus"
"0017616363","845942","10.1016/S0022-2836(77)80102-2","2-s2.0-0017616363","1977-02-15","Analysis of restriction fragments of T7 DNA and determination of molecular weights by electrophoresis in neutral and alkaline gels"
"0003890119","","","2-s2.0-0003890119","1992-07-13",""
"0020048094","6276759","10.1038/295202a0","2-s2.0-0020048094","1982-12-01","Cloning and sequence analysis of cDNA for bovine adrenal preproenkephalin"
"0019847070","7025909","10.1016/0005-2787(81)90014-9","2-s2.0-0019847070","1981-09-28","Transformation of E. coli using homopolymer-linked plasmid chimeras"
"0022262016","3886132","","2-s2.0-0022262016","1985-01-01","Aberrant Glycosylation in Cancer Cell Membranes as Focused on Glycolipids: Overview and Perspectives"
"0023518736","3330997","10.1016/0890-8508(87)90013-2","2-s2.0-0023518736","1987-01-01","Cell-surface markers on haemopoietic precursors. Reagents for the isolation and analysis of progenitor cell subpopulations"
"0023520978","3622658","","2-s2.0-0023520978","1987-12-01","Isolation of hemopoietic progenitor cells from human umbilical cord blood"
"0005432250","","","2-s2.0-0005432250","1987-10-28","Epitope mapping of the human leucocyte common antigen by competitive binding and synergistic lysis"
"0023212157","3495590","","2-s2.0-0023212157","1987-01-01","Forssman glycolipid, an antigenic marker for a major subpopulation of macrophages from murine spleen and peripheral lymph nodes"
"0023571657","3327753","10.1016/0378-1119(87)90365-9","2-s2.0-0023571657","1987-01-01","High-copy-number and low-copy-number plasmid vectors for lacZα-complementation and chloramphenicol- or kanamycin-resistance selection"
"0023525839","3625258","","2-s2.0-0023525839","1987-12-01","Ganglioside G(D2) specific monoclonal antibody 3F8: A phase I study in patients with neuroblastoma and malignant melanoma"
"0023508137","3696009","10.1111/j.1348-0421.1987.tb03153.x","2-s2.0-0023508137","1987-01-01","Preparation of Monoclonal Antibodies against a Glycolipid Asialo GM1"
"0023941841","3344434","","2-s2.0-0023941841","1988-12-01","Generation of cDNA Probes Directed by Amino Acid Sequence: Cloning of Urate Oxidase"
"0004712263","3464977","","2-s2.0-0004712263","1986-12-01","Regression of cutaneous metastatic melanoma by intralesional injection with human monoclonal antibody to ganglioside GD2"
"84989499399","","","2-s2.0-84989499399","1988-10-10",""
"0018082103","81133","10.1002/eji.1830080802","2-s2.0-0018082103","1978-01-01","Monoclonal xenogeneic antibodies to murine cell surface antigens: identification of novel leukocyte differentiation antigens"
"0023163745","2432147","","2-s2.0-0023163745","1987-01-01","Pancratic islet cell surface glycoproteins containing Galβ1-4GlcNAc-R identified by a cytotoxic monoclonal autoantibody"
"84989502851","","","2-s2.0-84989502851","1989-10-10",""
"0021141051","6611488","10.1016/0161-5890(84)90066-X","2-s2.0-0021141051","1984-01-01","Hematopoietic subpopulations express cross-reactive, lineage-specific molecules detected by monoclonal antibody"
"0023989064","3162770","","2-s2.0-0023989064","1988-04-01","Improved tools for biological sequence comparison."
"0018890975","","10.1016/0005-2760(80)90227-1","2-s2.0-0018890975","1980-01-18","A procedure for the quantitative isolation of brain gangliosides"
"0015240283","4108384","","2-s2.0-0015240283","1971-10-25","Glycoproteins of cell surfaces. A comparative study of three different cell surfaces of the rat."
"0018110116","364941","","2-s2.0-0018110116","1978-12-01","Prediction of the secondary structure of proteins from their amino acid sequence."
"84989508459","","","2-s2.0-84989508459","1989-10-10",""
"0021999503","2579340","10.1038/314053a0","2-s2.0-0021999503","1985-12-01","Demonstration by monoclonal antibodies that carbohydrate structures of glycoproteins and glycolipids are onco-developmental antigens"
"0023165018","3100030","","2-s2.0-0023165018","1987-01-01","Disialoganglioside GD2 on Human Neuroblastoma Cells: Target Antigen for Monoclonal Antibody-mediated Cytolysis and Suppression of Tumor Growth"
"84989560601","","","2-s2.0-84989560601","1988-10-10",""
"84989544136","","","2-s2.0-84989544136","1989-10-10",""
"0025311330","2161448","","2-s2.0-0025311330","1990-01-01","Phase I trial of murine monoclonal antibody L6 in breast, colon, ovarian, and lung cancer"
"84989508445","","","2-s2.0-84989508445","1990-10-10",""
"84989560605","","","2-s2.0-84989560605","1984-10-10",""
"0022366934","2865681","10.1038/318062a0","2-s2.0-0022366934","1985-12-01","Phosphatidylinositol is the membrane-anchoring domain of the Thy-1 glycoprotein"
"0024831717","2533105","","2-s2.0-0024831717","1989-12-01","Chol-1: a cholinergic-specific ganglioside of possible significance in central nervous system neurochemistry and neuropathology."
"0024588431","2469454","10.1038/bjc.1989.111","2-s2.0-0024588431","1989-01-01","Purification and biochemical characterisation of a novel breast carcinoma associated mucin-like glycoprotein defined by antibody 3E1.2"
"0023748670","3044717","10.1007/BF01535798","2-s2.0-0023748670","1988-09-01","Fulminant hepatitis due to reactivation of chronic hepatitis B virus infection after allogeneic bone marrow transplantation"
"0020079497","7065560","","2-s2.0-0020079497","1982-05-28","Reactivation of chronic hepatitis B virus infection by cancer chemotherapy"
"0027283738","8319786","10.1111/j.1600-0609.1993.tb00158.x","2-s2.0-0027283738","1993-01-01","Thrombocytopenia induced by human parvovirus B19 infections"
"0032495670","9734945","","2-s2.0-0032495670","1998-03-08","Parvovirus B19 and acute hepatitis in adults"
"0028823762","7489971","10.1016/0270-9139(95)90188-4","2-s2.0-0028823762","1995-01-01","Parvovirus B19 as a possible causative agent of fulminant liver failure and associated aplastic anemia"
"0025288730","2165747","","2-s2.0-0025288730","1990-01-01","Severe anemia due to b19 parvovirus infection in children with acute leukemia in remission"
"0030892008","9091802","10.1056/NEJM199704103361504","2-s2.0-0030892008","1997-04-10","Hepatitis-associated aplastic anemia"
"0024413978","2548098","","2-s2.0-0024413978","1989-01-01","Pure red-cell aplasia of 10 years' duration due to persistent parvovirus B19 infection and its cure with immunoglobulin therapy"
"0028916425","7612225","","2-s2.0-0028916425","1995-01-01","Hepatitis B virus immunopathogenesis"
"0028851607","7590649","10.1016/0270-9139(95)90138-8","2-s2.0-0028851607","1995-01-01","T-cell-mediated autologous hepatocytotoxicity in patients with chronic hepatitis C virus infection"
"0025301969","2160551","10.1001/jama.1990.03440220089037","2-s2.0-0025301969","1990-06-13","Flaviviruses and Bone Marrow Failure"
"0027981139","7914998","10.1016/S0140-6736(94)92014-1","2-s2.0-0027981139","1994-08-27","Transient disturbance of consciousness and hepatic dysfunction associated with human parvovirus B19 infection"
"3142662303","9517662","10.1016/S0002-9270(98)00012-4","2-s2.0-3142662303","1998-03-01","Hepatitis-associated aplastic anemia and acute parvovirus B19 infection: A report of two cases and a review of the literature"
"0023148891","2882143","10.1016/S0140-6736(87)90370-9","2-s2.0-0023148891","1987-03-28","HUMAN PARVOVIRUS B19 INFECTIONS IN UNITED KINGDOM 1984-86"
"0026586084","1539606","","2-s2.0-0026586084","1992-01-01","Case report: Fulminant hepatitis C viral infection after allogeneic bone marrow transplantation"
"0016671490","1117835","","2-s2.0-0016671490","1975-01-01","Aplastic anemia following viral hepatitis: Report of two fatal cases and literature review"
"0032576405","9848349","","2-s2.0-0032576405","1998-11-28","Acute parvovirus B19 infection associated with fulminant hepatitis of favourable prognosis in young children"
"0026569125","1313118","10.1001/jama.1992.03480150057037","2-s2.0-0026569125","1992-04-15","Aplastic Anemia and Viral Hepatitis: Non-A, Non-B, Non-C?"
"0029890795","8703826","","2-s2.0-0029890795","1996-07-02","Differential expression of CD3 and CD7 in T-cell malignancies: A quantitative study by flow cytometry"
"0024400513","2658909","","2-s2.0-0024400513","1989-01-01","Issues of quality assurance in clinical flow cytometry"
"0028942720","7723388","","2-s2.0-0028942720","1995-01-01","Differential TdT expression in acute leukemia by flow cytometry: A quantitative study"
"0024672318","2714113","10.1002/cyto.990100308","2-s2.0-0024672318","1989-01-01","Model system evaluating fluorescein‐labeled microbeads as internal standards to calibrate fluorescence intensity on flow cytometers"
"0030015673","8813949","","2-s2.0-0030015673","1996-07-25","Differential expression of T cell antigens in normal peripheral blood lymphocytes: A quantitative analysis by flow cytometry"
"0026576637","1557047","10.1016/0161-5890(92)90025-S","2-s2.0-0026576637","1992-01-01","Antibody mediated lysis of hapten-conjugated target cells by macrophages and by complement: The influence of IgG subclass, antibody and hapten density"
"84939310956","","","2-s2.0-84939310956","1983-08-22","Autologous bone marrow transplantation in acute leukaemia: A phase I study of in vitro treatment of marrow with 4-hydro peroxycyclophosphamide to purge tumor cells"
"0022202979","3849317","10.1007/BF00320115","2-s2.0-0022202979","1985-08-01","Platelet-adjusted IFN dosage in the treatment of advanced hairy cell leukemia"
"84939314254","","","2-s2.0-84939314254","1986-08-22","Haemopoietic reconstitution after bone marrow transplantation"
"0018132103","308988","","2-s2.0-0018132103","1978-12-01","Identification of lactoferrin as the granulocyte-derived inhibitor of colony-stimulating activity production"
"0021992902","3971044","","2-s2.0-0021992902","1985-01-01","Effects of in vitro purging with 4-hydroperoxycyclophosphamide on the hematopoietic and microenvironmental elements of human bone marrow"
"0019409079","6972999","","2-s2.0-0019409079","1981-01-01","Identification of leukemia-associated inhibition activity as acidic isoferritins. A regulatory role for acidic isoferritins in the production of granulocytes and macrophages"
"0022407506","3932579","10.1084/jem.162.5.1512","2-s2.0-0022407506","1985-12-01","Natural killer (NK) cell-derived hematopoietic colony-inhibiting activity and NK cytotoxic factor. Relationship with tumor necrosis factor and synergism with immune interferon"
"84939304536","","","2-s2.0-84939304536","1985-08-22","Total lymphoid irradiation as adjuvant immunosuppressor for preventing late graft failure (LGF) associated with T-cell depleted allografts [Abstract no. 209]"
"84939309686","","","2-s2.0-84939309686","1979-08-22","Granulocytic and erythroid progenitor cells in recovering aplastic anaemia"
"0018187636","304600","","2-s2.0-0018187636","1978-12-01","Limitation of excessive myelopoiesis by the intrinsic modulation of macrophage-derived prostaglandin E"
"0021245174","6434793","10.1007/BF01728176","2-s2.0-0021245174","1984-06-01","Bone marrow transplantation for treatment of severe aplastic anaemia, acute leukaemia and chronic granulocytic leukaemia: Results of the ""ulm bone marrow transplantation group"""
"84934706238","","","2-s2.0-84934706238","1980-08-22","Transplantation for acute leukemia with HLA-A and Β nonidentical parental marrow cells fractionated by sheep red blood cells and soybean agglutinin"
"0017760521","336380","10.1002/eji.1830070915","2-s2.0-0017760521","1977-01-01","Evidence for a similar or common mechanism for natural killer cell activity and resistance to hemopoietic grafts"
"84939318346","","","2-s2.0-84939318346","1980-08-22",""
"84939303268","","","2-s2.0-84939303268","1985-08-22","A clinical trial of in vitro depletion of T cells in donor marrow for prevention of acute graft versus host disease"
"84909720441","","","2-s2.0-84909720441","1985-11-23","Increased total body irradiation abrogates resistance to HLA-matched marrow grafts depleted of T-cells by lectin agglutination and E-rosette depletion"
"0021878695","3838767","","2-s2.0-0021878695","1985-01-01","Inhibition of bone marrow colony formation by human natural killer cells and by natural killer cell-derived colony-inhibiting activity"
"0021363317","6609315","10.1038/309166a0","2-s2.0-0021363317","1984-12-01","A novel human lymphokine that inhibits haematopoietic progenitor cell proliferation"
"0018719188","381925","","2-s2.0-0018719188","1979-12-01","Marrow transplantation for acute nonlymphoblastic leukemia in first remission"
"1842402749","3918301","","2-s2.0-1842402749","1985-01-01","Interferon is a mediator of hematopoietic suppression in aplastic anemia in vitro and possibly in vivo"
"0021930041","","","2-s2.0-0021930041","1985-01-01","A clinical trial of in vitro depletion of T cells in donor marrow for prevention of acute graft-versus-host disease"
"0019898639","6215058","10.1111/j.1365-2141.1982.tb03911.x","2-s2.0-0019898639","1982-01-01","Generation of CFU‐C suppressor T cells in vitro: V. A. MULTISTEP PROCESS"
"0020047281","7034811","","2-s2.0-0020047281","1982-04-09","Marrow transplantation with or without donor buffy coat cells for 65 transfused aplastic anemia patients"
"0021330348","6228576","","2-s2.0-0021330348","1984-02-23","Effect of activated lymphocytes on the regulation of hematopoieses: Suppression of in vitro granulopoiesis by OKT8+Ia+T cells induced by alloantigen stimulation"
"0022006029","2981406","","2-s2.0-0022006029","1985-03-20","Circulating activated suppressor T lymphocytes in aplastic anemia"
"0015246254","4107917","10.1016/S0140-6736(71)90287-X","2-s2.0-0015246254","1971-10-30","A RAPID BANDING TECHNIQUE FOR HUMAN CHROMOSOMES"
"0017405634","324473","10.1016/0006-291X(77)91458-9","2-s2.0-0017405634","1977-04-25","Recognition of IgG by Fc receptor and complement: Effects of glycosidase digestion"
"0020679435","6338115","10.1016/0022-1759(83)90414-3","2-s2.0-0020679435","1983-01-28","Routine large-scale production of monoclonal antibodies in a protein-free culture medium"
"0024461826","2507312","","2-s2.0-0024461826","1989-01-01","The immunoglobulin κ locus contains a second, stronger B-cell-specific enhancer which is located downstream of the constant region"
"85004896365","","","2-s2.0-85004896365","1976-12-18","Review of the notation for the allotypic and related markers of human immunoglobulins"
"0025015722","2120679","10.1093/nar/18.19.5609","2-s2.0-0025015722","1990-10-11","The importance of the 3′-enhancer region in immunoglobulin x gene expression"
"85004875498","","","2-s2.0-85004875498","1968-12-18","Isolation of mononuclear cells and granulocytes from human blood"
"0021866261","4033665","10.1016/0161-5890(85)90125-7","2-s2.0-0021866261","1985-01-01","Effector functions of a monoclonal aglycosylated mouse IgG2a: Binding and activation of complement component C1 and interaction with human monocyte Fc receptor"
"0020265993","6811596","","2-s2.0-0020265993","1982-12-01","Rat monoclonal antitubulin antibodies derived by using a new nonsecreting rat cell line"
"0024205715","3075018","","2-s2.0-0024205715","1988-01-01","Human immunological response to mouse monoclonal antibodies in the treatment or diagnosis of malignant diseases"
"0025321833","1366536","10.1038/nbt0590-421","2-s2.0-0025321833","1990-01-01","Environmental effects on protein glycosylation"
"0021999401","3871353","","2-s2.0-0021999401","1985-02-01","Human Anti-Murine Immunoglobulin Responses in Patients Receiving Monoclonal Antibody Therapy"
"0024504681","2498512","","2-s2.0-0024504681","1989-01-01","Effects of galactose depletion from oligosaccharide chains on immunological activities of human IgG"
"0016803494","181343","10.1159/000149930","2-s2.0-0016803494","1975-01-01","An EBV-genome-negative cell line established from an American burkitt lymphoma; receptor characteristics. EBV infectibility and permanent conversion into EBV-positive sublines by in vitro infection"
"0017274375","178101","10.1016/0042-6822(76)90302-0","2-s2.0-0017274375","1976-01-01","Epstein-Barr virus (EBV)-induced change in the saturation sensitivity and serum dependence of established, EBV-negative lymphoma lines in vitro"
"0019832817","","","2-s2.0-0019832817","1981-12-01","Induction of differentiation with phorbol ester in a human T cell line (Be13) expressing both prothymocyte and thymocyte characteristics"
"0343987290","","","2-s2.0-0343987290","1982-12-07","Marker profiles of 55 human leukemia-lymphoma cell lines"
"85001399397","","","2-s2.0-85001399397","1984-12-13","Elimination of GVHD by in-vitro depletion of alloreactive lymphocytes with a monoclonal rat anti-human lymphocyte antibody (Campath-1)"
"0001139633","14304234","","2-s2.0-0001139633","1965-05-01","A STUDY OF MALIGNANT TUMOURS IN NIGERIA BY SHORT-TERM TISSUE CULTURE."
"0015394127","4567231","10.1093/jnci/49.3.891","2-s2.0-0015394127","1972-01-01","Brief communication: Rosette-forming human lymphoid cell lines. i. establishment and evidence for origin of thymus-derived lymphocytes12"
"0014353208","4878906","","2-s2.0-0014353208","1968-11-01","Relation between Epstein-Barr viral and cell membrane immunofluorescence of Burkitt tumor cells. I. Dependence of cell membrane immunofluorescence on presence of EB virus."
"85001424434","","","2-s2.0-85001424434","1975-12-13","Comparison between growth characteristics of an EBV-genome negative lymphoma line and its EBV-converted subline"
"0017329178","188769","10.1002/ijc.2910190105","2-s2.0-0017329178","1977-01-01","Establishment in continuous culture of a new type of lymphocyte from a “burkitt‐like” malignant lymphoma (line d.g.‐75)"
"0021813369","2981779","10.1002/ijc.2910350106","2-s2.0-0021813369","1985-01-01","Establishment of the amsalem T‐cell line from a patient with acute lymphoblastic leukemia. Expression of E‐receptor‐associated antigens in cells incapable of forming E‐rosettes"
"0016835245","179629","","2-s2.0-0016835245","1975-12-01","Establishment and characterization of an Epstein Barr virus (EBV) negative lymphoblastoid B cell line (BJA B) from an exceptional, EBV genome negative African Burkitt's lymphoma"
"0018898653","6154663","10.1002/ijc.2910250506","2-s2.0-0018898653","1980-01-01","Establishment in continuous culture of a T‐lymphoid cell line (HD‐Mar) from a patient with Hodgkin's lymphoma"
"0018079501","365240","10.1016/0304-419X(78)90008-2","2-s2.0-0018079501","1978-10-27","Patterns of gene expression and the cellular origins of human leukaemias"
"0014115428","6042436","10.3181/00379727-125-32327","2-s2.0-0014115428","1967-09-08","Production of Free Light Chains of Immunoglobulin by a Hematopoietic Cell Line Derived from a Patient with Multiple Myeloma"
"0018194762","566614","","2-s2.0-0018194762","1978-01-01","Establishment of a Human Plasma Cell Line in Vitro"
"0018817727","14768698","10.1002/ijc.2910250604","2-s2.0-0018817727","1980-01-01","Establishment and characterization of a new leukaemic T‐cell line (Peer) with an unusual phenotype"
"85001350774","","","2-s2.0-85001350774","1984-12-13","Removal of neuroblastoma cells from bone marrow with monoclonal antibodies conjugated to magnetic microspheres"
"0014863885","4097745","","2-s2.0-0014863885","1970-10-01","Established immunoglobulin producing myeloma (IgE) and lymphoblastoid (IgG) cell lines from an IgE myeloma patient."
"0033512908","10356144","","2-s2.0-0033512908","1999-12-01","Influence of severe combined immunodeficiency phenotype on the outcome of HLA non-identical, T-cell - depleted bone marrow transplantation: A retrospective European survey from the European Group for Bone Marrow Transplantation and the European Society for Immunodeficiency"
"0034663152","10942363","","2-s2.0-0034663152","2000-08-15","Nonmyeloablative stem cell transplantation for congenital immunodeficiencies"
"85007189385","","","2-s2.0-85007189385","1997-01-05","Immune reconstitution following T cell depleted bone marrow transplantation for severe combined immunodeficiency syndromes"
"0033580210","10021479","10.1056/NEJM199902183400711","2-s2.0-0033580210","1999-02-18","Thirty years of bone marrow transplantation for severe combined immunodeficiency"
"0034604048","10793165","10.1056/NEJM200005043421804","2-s2.0-0034604048","2000-05-04","Thymic function after hematopoietic stem-cell transplantation for the treatment of severe combined immunodeficiency"
"0033751632","11091267","10.1046/j.1365-2249.2000.01359.x","2-s2.0-0033751632","2000-11-27","Severe combined immunodeficiencies (SCID)"
"0034060179","10800072","","2-s2.0-0034060179","2000-05-23","Dental manifestations in severe combined immunodeficiency following bone marrow transplantation"
"0025182977","1976883","10.1016/0140-6736(90)92348-L","2-s2.0-0025182977","1990-10-06","European experience of bone-marrow transplantation for severe combined immunodeficiency"
"0034026027","10648370","10.1136/adc.82.2.144","2-s2.0-0034026027","2000-05-30","Unsuspected Pneumocystis carinii pneumonia at presentation of severe primary immunodeficiency"
"0026740611","1611094","","2-s2.0-0026740611","1992-07-01","Unrelated donor bone marrow transplantation for correction of lethal congenital immunodeficiencies"
"0027477193","8471764","","2-s2.0-0027477193","1993-01-01","Immune reconstitution in severe combined immunodeficiency disease after lectin-treated, T-cell-depleted haplocompatible bone marrow transplantation"
"0030937723","9150740","10.1007/s004390050428","2-s2.0-0030937723","1997-05-01","B-cell-negative severe combined immunodeficiency associated with a common γ chain mutation"
"0029029246","7581076","","2-s2.0-0029029246","1995-06-01","1994 Consensus Conference on Acute GVHD Grading."
"0029977220","8733714","","2-s2.0-0029977220","1996-05-01","Disseminated BCG infection in severe combined immunodeficiency presenting with severe anaemia and associated with gross hypersplenism after bone marrow transplantation"
"0024453862","2804359","","2-s2.0-0024453862","1989-01-01","Development of immunologic functions after bone marrow transplantation in 33 patients with severe combined immunodeficiency"
"85007167925","","","2-s2.0-85007167925","1998-01-05","Long-term outcome of bone marrow transplantation for severe combined immunodeficiency"
"0029161926","7608815","10.1016/S0022-3476(95)70260-1","2-s2.0-0029161926","1995-01-01","Treatment of Omenn syndrome by bone marrow transplantation"
"0033693177","11108309","","2-s2.0-0033693177","2000-12-07","Respiratory viral infections in primary immune deficiencies: Significance and relevance to clinical outcome in a single BMT unit"
"0035161258","11133745","10.1182/blood.V97.1.81","2-s2.0-0035161258","2001-01-01","V(D)J recombination defects in lymphocytes due to RAG mutations: Severe immunodeficiency with a spectrum of clinical presentations"
"0028805263","8584325","","2-s2.0-0028805263","1995-01-01","Cytomegalovirus infection in severe combined immunodeficiency: Eradication with foscarnet"
"0034597508","11058677","10.1056/NEJM200011023431806","2-s2.0-0034597508","2000-11-02","Advances in Immunology: Primary immunodeficiency diseases due to defects in lymphocytes"
"0033580206","10021471","10.1056/NEJM199902183400703","2-s2.0-0033580206","1999-02-18","Hematopoietic stem-cell transplantation for the treatment of severe combined immunodeficiency"
"0032162058","9782636","","2-s2.0-0032162058","1998-01-01","Parainfluenza virus and respiratory syncytial virus infection in infants undergoing bone marrow transplantation for severe combined immunodeficiency."
"85007254796","","","2-s2.0-85007254796","0000-01-05","Rapid protein based assays for the diagnosis of T-B+ severe combined immunodeficiency"
"0031953724","9618769","10.1007/BF00792603","2-s2.0-0031953724","1998-05-19","Stem cell transplantation for immunodeficiency"
"0032833976","10515898","","2-s2.0-0032833976","1999-10-15","Long-term chimerism and B-cell function after bone marrow transplantation in patients with severe combined immunodeficiency with B cells: A single-center study of 22 patients"
"0029926194","8722352","","2-s2.0-0029926194","1996-04-01","Bone marrow 'boosts' following T cell-depleted haploidentical bone marrow transplantation"
"0027939098","7949150","","2-s2.0-0027939098","1994-12-01","Relationship between patterns of engraftment in peripheral blood and immune reconstitution after allogeneic bone marrow transplantation for (severe) combined immunodeficiency"
"0034672163","11110711","","2-s2.0-0034672163","2000-12-01","Similar pattern of thymic-dependent T-cell reconstitution in infants with serve combined immunodeficiency after human leukocyte antigen (HLA)-identical and HLA-nonidentical stem cell transplantation"
"0033998583","10741387","10.1002/1521-4141(200003)30:3&lt;732::AID-IMMU732&gt;3.0.CO;2-L","2-s2.0-0033998583","2000-05-03","Intrinsic defects of B cell function in X-linked severe combined immunodeficiency"
"0029970645","8732639","","2-s2.0-0029970645","1996-04-01","Bone marrow transplantation in immunodeficiency diseases"
"18244411938","9573000","","2-s2.0-18244411938","1998-05-15","Long-term immune reconstitution and outcome after HLA-nonidentical T- cell-depleted bone marrow transplantation for severe combined immunodeficiency: A European retrospective study of 116 patients"
"0034062271","10734295","","2-s2.0-0034062271","2000-03-29","Matched unrelated bone marrow transplantation for combined immunodeficiency"
"0023607261","3436096","","2-s2.0-0023607261","1987-12-01","Heterogeneity of biochemical, clinical and immunological parameters in severe combined immunodeficiency due to adenosine deaminase deficiency"
"0015438979","4617353","","2-s2.0-0015438979","1972-12-01","Lymphocyte mediated cytotoxicity in vitro. Induction and inhibition by humoral antibody and nature of effector cells."
"0024268801","3220507","","2-s2.0-0024268801","1988-12-01","K-cell-mediated cytotoxicity induced with rat monoclonal antibodies. I. Antibodies of various isotypes differ in their ability to induce cytotoxicity mediated by rat and human effectors"
"0022577929","2944627","10.1016/0008-8749(86)90255-8","2-s2.0-0022577929","1986-01-01","IL-2- and IFNγ-enhanced natural cytotoxic activity: Analysis of the role of different lymphoid subsets and implications for activation routes"
"0023108383","3100957","","2-s2.0-0023108383","1987-12-01","Recombinant interleukin-2 directly augments the cytotoxicity of human monocytes"
"0023007058","3491142","","2-s2.0-0023007058","1986-12-01","Biosynthetic human GM-CSF modulates the number and affinity of neutrophil f-Met-Leu-Phe receptors"
"85004811193","","","2-s2.0-85004811193","1988-12-18","Effects of monoclonal antibodies of the Campath series in vivo: requirements for effective antibody therapy. (Abstract)"
"0022886227","3542238","10.1016/0008-8749(86)90108-5","2-s2.0-0022886227","1986-01-01","T-cell depletion of allogeneic bone marrow prevents acceleration of graft-versus-host disease induced by exogenous interleukin 2"
"85004759411","","","2-s2.0-85004759411","1988-12-18","Addition of total lymphoid irradiation (TLI) and chemotherapy assures engraftment in T cell depleted (TCD) donor marrow in allogeneic bone marrow transplant (BMT) for leukaemia. (Abstract)"
"85004737771","","","2-s2.0-85004737771","1988-12-18","HLA‐partially matched marrow transplantation with a monoclonal antibody (BMA031) against the T cell receptor. First results of a phase I/II trial"
"0023945496","2829673","","2-s2.0-0023945496","1988-01-01","Treatment of severe Epstein-Barr virus-induced polyclonal B-lymphocyte proliferation by anti-B-cell monoclonal antibodies. Two cases after HLA-mismatched bone marrow transplantation"
"0022340429","3926894","","2-s2.0-0022340429","1985-12-01","Activation of human polymorphonuclear neutrophil functions by interferon-γ and tumor necrosis factors"
"0023511435","3312847","","2-s2.0-0023511435","1987-12-01","Biosynthetic granulocyte-macrophage colony-stimulating factor enhances neutrophil cytotoxicity toward human leukemia cells"
"0017164069","777029","","2-s2.0-0017164069","1976-12-01","Defective neutrophil chemotaxis in bone marrow transplant patients"
"0022457920","3019508","10.1002/1097-0142(19861015)58:8&lt;1663::AID-CNCR2820580815&gt;3.0.CO;2-I","2-s2.0-0022457920","1986-01-01","Influence of chemotherapy on superoxide anion‐generating activity of polymorphonuclear leukocytes in patients with lung cancer"
"0018898412","6765970","","2-s2.0-0018898412","1980-01-01","Analysis of cytotoxic effector cell function in patients with leukemia or aplastic anemia before and after marrow transplantation"
"85004757601","","","2-s2.0-85004757601","1984-12-18","Depletion of T lymphocytes in donor marrow prevents significant graft‐versus‐host disease in matched allogeneic leukaemic marrow transplant recipients"
"85004843106","","","2-s2.0-85004843106","1989-12-18","Donor marrow T cell depletion for prevention of GvHD without loss of the GvL effect. Current results in acute myeloblastic leukaemia and future directions"
"0016527840","125298","","2-s2.0-0016527840","1975-07-01","Antibody-dependent cell-mediated cytotoxicity in humans. I. Characterization of the effector cell."
"0024587817","2644737","10.1111/j.1423-0410.1989.tb03047.x","2-s2.0-0024587817","1989-01-01","Detection of Granulocyte Antibodies Using Flow Cytometric Analysis of Leucocyte Immunofluorescence"
"0019173017","7014234","","2-s2.0-0019173017","1980-12-01","Granulocyte function in human allogeneic marrow graft recipients"
"0023034808","3021817","","2-s2.0-0023034808","1986-12-01","Recombinant human granulocyte-macrophage colony-stimulating factor stimulates in vitro mature human neutrophil and eosinophil function, surface receptor expression, and survival"
"0023157901","3100615","","2-s2.0-0023157901","1987-04-06","Immune interferon enhances functional properties of human granulocytes: Role of Fc receptors and effect of lymphotoxin, tumor necrosis factor, and granulocyte-macrophage colony-stimulating factor"
"0023156947","3545853","10.1002/eji.1830170108","2-s2.0-0023156947","1987-01-01","Human large granular lymphocytes induce immunoglobulin synthesis after bone marrow transplantation"
"0023938478","3283234","","2-s2.0-0023938478","1988-08-03","In vitro analysis of the interactions of recombinant IL-2 with regenerating lymphoid and myeloid cells after allogeneic marrow transplantation"
"0023131409","3024757","","2-s2.0-0023131409","1987-01-01","Human GM-CSF primes neutrophils for enhanced oxidative metabolism in response to the major physiological chemoattractants"
"0021720154","6390681","10.1126/science.6390681","2-s2.0-0021720154","1984-12-01","Purified human granulocyte-macrophage colony-stimulating factor: Direct action on neutrophils"
"0023765625","3260935","","2-s2.0-0023765625","1988-01-01","Human monoclonal IgG isotypes differ in complement activating function at the level of C4 as well as C1q"
"0023865173","3277406","","2-s2.0-0023865173","1988-01-01","Treatment of acute graft-versus-host disease with anti-CD3 monoclonal antibodies"
"0023186963","2955043","","2-s2.0-0023186963","1987-01-01","Polymorphonuclear leukocyte function triggered through the high affinity Fc receptor for monomeric IgG"
"0025352392","2197980","","2-s2.0-0025352392","1990-07-20","Antibody-antigen complexes"
"0027109248","","10.1016/0022-0248(92)90256-I","2-s2.0-0027109248","1992-08-02","Strategies in the crystallization of glycoproteins and protein complexes"
"84944812221","","10.1107/S0108767389009633","2-s2.0-84944812221","1990-01-01","Extension of molecular replacement: a new search strategy based on Patterson correlation refinement"
"0028556362","7993911","","2-s2.0-0028556362","1994-12-01","Comparison of crystal structures of two homologous proteins: Structural origin of altered domain interactions in immunoglobulin light-chain dimers"
"0027405752","","10.1016/0959-440X(93)90210-C","2-s2.0-0027405752","1993-01-01","Antibody-antigen interactions"
"0022429703","3936934","10.1016/0022-2836(85)90120-2","2-s2.0-0022429703","1985-11-20","Formation of an infinite β-sheet arrangement dominates the crystallization behavior of λ-type antibody light chains"
"0026015985","1989247","","2-s2.0-0026015985","1991-01-01","The anti-IL-2 receptor monoclonal antibody YTH-906 in liver transplantation"
"0026802451","1436040","","2-s2.0-0026802451","1992-12-01","Crystal structure of a streptococcal protein G domain bound to an Fab fragment"
"0010348361","","","2-s2.0-0010348361","1993-07-13","The effect of CAMPATH-1H monoclonal-antibody therapy on the T-cell receptor (TCR) repertoire of patients with rheumatoid arthritis"
"0032536197","9466909","10.1006/jmbi.1997.1442","2-s2.0-0032536197","1998-01-16","Conformations of the third hypervariable region in the VH domain of immunoglobulins"
"0023090513","2436051","","2-s2.0-0023090513","1987-12-01","Three-dimensional structure of a complex of antibody with influenza virus neuraminidase"
"0024844388","2687698","","2-s2.0-0024844388","1989-12-01","Conformations of immunoglobulin hypervariable regions"
"0026117004","2025413","10.1107/S0108767390010224","2-s2.0-0026117004","1991-03-01","Improved methods for building protein models in electron density maps and the location of errors in these models."
"0003076963","","","2-s2.0-0003076963","1992-07-13","Recent changes to the MOSFLM package for processing film and image plate data"
"0026597444","18481394","","2-s2.0-0026597444","1992-12-01","Free R value: A novel statistical quantity for assessing the accuracy of crystal structures"
"0000243829","","","2-s2.0-0000243829","1993-03-28","PROCHECK: A program to check the stereochemical quality of protein structures"
"0027955736","7908437","10.1002/prot.340180107","2-s2.0-0027955736","1994-01-01","X‐ray structures of fragments from binding and nonbinding versions of a humanized anti‐CD18 antibody: Structural indications of the key role of VH residues 59 to 65"
"0017411710","875032","10.1016/S0022-2836(77)80200-3","2-s2.0-0017411710","1977-05-25","The protein data bank: A computer-based archival file for macromolecular structures"
"0004032583","","","2-s2.0-0004032583","1991-03-28",""
"0003769049","","","2-s2.0-0003769049","1992-03-28",""
"0025964038","1988675","10.1016/0022-2836(91)90617-F","2-s2.0-0025964038","1991-01-05","Structure, function and properties of antibody binding sites"
"0016804680","1182131","","2-s2.0-0016804680","1975-12-01","The molecular structure of a dimer composed of the variable portions of the bence-jones protein REI refined at 2.0-Å resolution"
"0343055582","2762305","","2-s2.0-0343055582","1989-01-01","Structure of an antibody-antigen complex: Crystal structure of the HyHEL-10 Fab-lysozyme complex"
"0010304849","","","2-s2.0-0010304849","1993-07-13","Single-dose subcutaneous CAMPATH-1H in the treatment of rheumatoid-arthritis"
"0028103275","","10.1107/S0907444994003112","2-s2.0-0028103275","1994-01-01","The CCP4 suite: Programs for protein crystallography"
"0010305690","","","2-s2.0-0010305690","1986-07-13","Phosphocholine binding immunoglobulin Fab McP603: An X-ray diffraction study at 2.7 Å"
"0026587998","1546293","","2-s2.0-0026587998","1992-01-01","Structural evidence for induced fit as a mechanism for antibody-antigen recognition"
"0026240806","","10.1107/S0021889891007240","2-s2.0-0026240806","1991-10-01","Ribbons 2.0"
"0002583957","","","2-s2.0-0002583957","1994-07-13","DM: An automated procedure for phase improvement by density modification"
"0023447105","2446316","","2-s2.0-0023447105","1987-11-01","Three-dimensional structure of an antibody-antigen complex."
"0025063143","2118959","10.1016/S0022-2836(05)80102-0","2-s2.0-0025063143","1990-09-05","Framework residue 71 is a major determinant of the position and conformation of the second hypervariable region in the VH domains of immunoglobulins"
"0001533163","","","2-s2.0-0001533163","1991-03-28","A rapid finite difference algorithm, utilizing successive over-relaxation to solve the Poisson-Boltzmann equation"
"0026559783","1560463","10.1016/0022-2836(92)91010-M","2-s2.0-0026559783","1992-03-20","Antibody framework residues affecting the conformation of the hypervariable loops"
"4243931374","","","2-s2.0-4243931374","1996-09-27","Structure of the variable domain of human immunoglobulin kappa-IV light chain LEN"
"0025850586","1712773","","2-s2.0-0025850586","1991-12-01","Crystallographic refinement of the three-dimensional structure of the FabD1.3-lysozyme complex at 2.5-Å resolution"
"0026451628","1433294","10.1016/0022-2836(92)90532-O","2-s2.0-0026451628","1992-10-20","Binding of the dye congo red to the amyloid protein pig insulin reveals a novel homology amongst amyloid-forming peptide sequences"
"0014432781","5700707","","2-s2.0-0014432781","1968-04-28","Solvent content of protein crystals"
"0030577371","8980108","10.1016/S0014-5793(96)01252-5","2-s2.0-0030577371","1996-12-09","Structural classification of CDR-H3 in antibodies"
"0025119206","2123450","","2-s2.0-0025119206","1990-11-29","Three-dimensional structure determination of an anti-2-phenyloxazolone antibody: The role of somatic mutation and heavy/light chain pairing in the maturation of an immune response"
"84944812409","","10.1107/S0108767386099622","2-s2.0-84944812409","1986-01-01","Improved Fourier coefficients for maps using phases from partial structures with errors"
"0010351105","","","2-s2.0-0010351105","1988-07-13","The refinement and structure of MCG Bence-Jones dimer at 2.3 Ångstroms resolution"
"0027467623","8095303","","2-s2.0-0027467623","1993-12-01","X-ray structures of the antigen-binding domains from three variants of humanized anti-p185HER2 antibody 4D5 and comparison with molecular modeling"
"0028774708","7704531","10.1016/S0969-2126(94)00123-5","2-s2.0-0028774708","1994-01-01","Crystal structure of a diabody, a bivalent antibody fragment"
"84920325457","","10.1107/S0108767393007597","2-s2.0-84920325457","1994-01-01","AMoRe: an automated package for molecular replacement"
"3543012707","9757107","10.1107/S0907444998003254","2-s2.0-3543012707","1998-09-01","Crystallography and NMR system: A new software suite for macromolecular structure determination"
"0027429483","7691244","","2-s2.0-0027429483","1993-10-01","Syngeneic transplantation with peripheral blood mononuclear cells collected after the administration of recombinant human granulocyte colony-stimulating factor"
"0020169871","6289317","","2-s2.0-0020169871","1982-08-01","IgG2a monoclonal antibodies inhibit human tumor growth through interaction with effector cells."
"0027459540","8435662","","2-s2.0-0027459540","1993-01-01","T cell and NK cell mediated graft-versus-leukaemia reactivity following donor buffy coat transfusion to treat relapse after marrow transplantation for chronic myeloid leukaemia"
"1842332587","","","2-s2.0-1842332587","1995-01-11","Use of G-CSF mobilized T-cell depleted peripheral blood and bone marrow stem cells for allogeneic BMT"
"0029868846","8630379","","2-s2.0-0029868846","1996-03-15","Allogeneic cell therapy with donor peripheral blood cells and recombinant human interleukin-2 to treat leukemia relapse after allogeneic bone marrow transplantation"
"0029618806","8542946","","2-s2.0-0029618806","1995-12-01","Allogeneic cell therapy for relapsed leukemia after bone marrow transplantation with donor peripheral blood lymphocytes"
"0023792164","2903193","","2-s2.0-0023792164","1988-01-01","Functional and biochemical analysis of CD16 antigen on natural killer cells and granulocytes"
"0027254022","8099182","10.1016/0140-6736(93)90929-B","2-s2.0-0027254022","1993-06-05","Peripheral blood stem cells as an alternative to marrow for allogeneic transplantation"
"0027465449","8093257","","2-s2.0-0027465449","1993-12-01","IL-2 reduces graft-versus-host disease and preserves a graft-versus-leukemia effect by selectively inhibiting CD4+ T cell activity"
"0027169167","8401179","10.3109/10428199309148199","2-s2.0-0027169167","1993-01-01","Graft-versus-leukemia reactions in clinical bone marrow transplantation"
"0025009978","2252954","","2-s2.0-0025009978","1990-01-01","The graft-versus-leukemia (GVL) phenomenon: Is GVL separable from GVHD?"
"0024391085","2530273","","2-s2.0-0024391085","1989-01-01","Comparative studies of human FcRIII-positive and negative natural killer cells"
"0025180593","2143580","","2-s2.0-0025180593","1990-08-01","Purification and characterization of cytolytic and noncytolytic human natural killer cell subsets"
"0020614952","6833758","","2-s2.0-0020614952","1983-07-07","Human natural killer cells analyzed by B73.1, a monoclonal antibody blocking Fc receptor functions. I. Characterization of the lymphocyte subset reactive with B73.1"
"0025292140","2379219","10.1007/BF01789175","2-s2.0-0025292140","1990-07-01","Characterization of effector cells of graft vs leukemia following allogeneic bone marrow transplantation in mice inoculated with murine B-cell leukemia"
"10244260248","","","2-s2.0-10244260248","1996-01-11","Natural killer (NK) cell recovery following autologous peripheral blood stem cell transplantation is significantly faster than that following autologous or allogeneic bone marrow transplantation: Use of G-CSF contributes to accelerate NK cell recovery"
"0027394458","7680245","","2-s2.0-0027394458","1993-03-15","Allogeneic granulocyte colony-stimulating factor-mobilized peripheral blood progenitor cells for treatment of engraftment failure after bone marrow transplantation [2]"
"0017367776","325576","","2-s2.0-0017367776","1977-01-01","Antibody dependent cell mediated cytolysis (ADCC): analyses and projections"
"0023735385","3262658","","2-s2.0-0023735385","1988-01-01","The effects of IL-4 on human natural killer cell: A potent regulator of IL-2 activation and proliferation"
"10244260247","","","2-s2.0-10244260247","1995-01-11","The development and relationship between natural killer (NK) and T cells post-bone marrow transplantation (BMT)"
"0022530989","3489062","","2-s2.0-0022530989","1986-01-01","Dissection of the lymphokine-activated killer phenomenon. Relative contribution of peripheral blood natural killer cells and T lymphocytes to cytolysis"
"0344962275","","","2-s2.0-0344962275","1981-07-13",""
"0023472472","2449095","10.1016/0003-2697(87)90587-2","2-s2.0-0023472472","1987-11-01","Tricine-sodium dodecyl sulfate-polyacrylamide gel electrophoresis for the separation of proteins in the range from 1 to 100 kDa"
"0000366607","","","2-s2.0-0000366607","1979-07-13","Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: Procedure and some applications"
"0023473794","3442324","10.1016/0003-2697(87)90166-7","2-s2.0-0023473794","1987-01-01","Rapid isoelectric focusing in a vertical polyacrylamide minigel system"
"0025193334","2324006","","2-s2.0-0025193334","1990-01-01","Sialylglycoconjugates release during in vitro capacitation of human spermatozoa"
"0031422845","9471060","10.1007/s00282-997-0041-4","2-s2.0-0031422845","1997-11-01","Complications in the treatment of CLL with purine analogues"
"0026645858","1354425","","2-s2.0-0026645858","1992-09-05","Listeriosis in patients with chronic lymphocytic leukemia who were treated with fludarabine and prednisone"
"0025816949","1904989","","2-s2.0-0025816949","1991-07-11","Cost effectiveness of prophylactic intravenous immune globulin in chronic lymphocytic leukemia"
"0031952390","9482531","","2-s2.0-0031952390","1998-03-10","The infectious complications of chronic lymphocytic leukemia"
"0002072030","","","2-s2.0-0002072030","1998-09-27","Campath-1H therapy of patients with previously untreated chronic lymphocytic leukemia"
"0003276474","","","2-s2.0-0003276474","1998-07-13","Combination of fludarabine, ara-c, novantrone and dexamethasone (FAND) in young patients with previously treated CLL"
"4244202310","","","2-s2.0-4244202310","1999-09-27","Phase II trial of fludarabine and cyclophosphamide (Flu/Cy) in patients with previously untreated chronic lymphocytic leukemia: An Eastern Cooperative Oncology Group study (E1997)"
"0032856636","10439375","","2-s2.0-0032856636","1999-08-24","Opsonising immunoglobulins and mannan-binding lectin in chronic lymphocytic leukemia"
"4244087165","","","2-s2.0-4244087165","1999-09-27","Fludarabine plus cyclosphosphamide (FC) and dose intensified chlorambucil (DIC) for the treatment of chronic lymphocytic leukemia (CLL): Results of two Phase II studies (CLL-2-Protocol) of the German CLL Study Group (GCLLSG)"
"0344867044","10214856","","2-s2.0-0344867044","1999-05-05","2-Chlorodeoxyadenosine (Cladribine) in the treatment of patients with chronic lymphocytic leukemia 55 years old and younger"
"0032886463","10543369","10.1007/s00282-999-0145-0","2-s2.0-0032886463","1999-08-01","Infectious complications in chronic lymphocytic leukaemia"
"0030877290","9250791","","2-s2.0-0030877290","1997-09-02","Antimicrobial prophylaxis to prevent opportunistic infections in patients with chronic lymphocytic leukemia after allogeneic blood or marrow transplantation"
"0027323550","8400226","","2-s2.0-0027323550","1993-09-15","Results of fludarabine and prednisone therapy in 264 patients with chronic lymphocytic leukemia with multivariate analysis-derived prognostic model for response to treatment"
"0027200169","8499626","","2-s2.0-0027200169","1993-06-01","Long-term follow-up of patients with chronic lymphocytic leukemia treated with fludarabine as a single agent"
"4243972437","","","2-s2.0-4243972437","1998-09-27","Fludarabine and cyclophosphamide combination in chronic lymphocytic leukemia"
"0023764718","2901668","","2-s2.0-0023764718","1988-01-01","Intravenous immunoglobulin for the prevention of infection in chronic lymphocytic leukemia. A randomized, controlled clinical trial"
"0028264370","7525186","10.2165/00003495-199400476-00005","2-s2.0-0028264370","1994-01-01","Immunological and Genetic Abnormalities in Chronic Lymphocytic Leukaemia: Impact of the Purine Analogues"
"0019205702","6969092","10.1111/j.1365-2141.1980.tb06021.x","2-s2.0-0019205702","1980-01-01","REDUCED T‐COLONY FORMING CAPACITY BY T‐LYMPHOCYTES FROM B‐CHRONIC LYMPHOCYTIC LEUKAEMIA"
"0030696074","9324281","","2-s2.0-0030696074","1997-11-05","Fludarabine and granulocyte colony-stimulating factor (G-CSF) in patients with chronic lymphocytic leukemia"
"0032529509","9694704","","2-s2.0-0032529509","1998-08-15","Long-term follow-up of patients with chronic lymphocytic leukemia (CLL) receiving fludarabine regimens as initial therapy"
"0018830415","6157721","","2-s2.0-0018830415","1980-11-10","Defective spontaneous and antibody-dependent cytotoxicity mediated by E-rosette-positive and E-rosette-negative cells in untreated patientswith chronic lymphocytic leukemia: Augmentation by in vitro treatment with interferon"
"0027283739","7686506","10.1111/j.1600-0609.1993.tb00165.x","2-s2.0-0027283739","1993-01-01","Severe immunodeficiency in patients treated with fludarabine monophosphate"
"4244081851","","","2-s2.0-4244081851","1998-09-27","Fludarabine and cyclophosphamide: A highly active and well tolerated regimen in patients with previously untreated chronic lymphocytic leukemia"
"0023428147","3317855","","2-s2.0-0023428147","1987-10-01","Mechanisms of infection in chronic lymphocytic leukemia"
"0006015767","","","2-s2.0-0006015767","1997-07-13","Infectious events in indolent lymphoproliferative disorders treated with regimens including fludarabine"
"0032189459","9758577","","2-s2.0-0032189459","1998-10-01","Infections in patients with chronic lymphocytic leukemia treated with fludarabine"
"0001005961","","","2-s2.0-0001005961","1993-05-21","Hypogammaglobulinemia and disordered immunity in CLL"
"0345593600","10350343","","2-s2.0-0345593600","1999-06-08","2-Chlorodeoxyadenosine (Cladribine) in the treatment of elderly patients with B-cell chronic lymphocytic leukemia"
"4243824044","","","2-s2.0-4243824044","1998-08-16","Randomized multicenter study of the effectiveness of 2-chlorodeoxyadenosine with prednisone versus chlorambucil with prednisone in previously untreated Chronic Lymphocytic Leukemia (CLL)"
"0028357998","8120556","","2-s2.0-0028357998","1994-03-01","Phase I study of the combination of fludarabine, mitoxantrone, and dexamethasone in low-grade lymphoma"
"0031036424","9053466","","2-s2.0-0031036424","1997-02-01","Treatment of refractory chronic lymphocytic leukemia with fludarabine phosphate via the group C protocol mechanism of the national cancer institute: Five-year follow-up report"
"0006889225","","","2-s2.0-0006889225","1998-09-27","The impact of therapy with chlorambucil (C), fludarabine (F), of fludarabine+chlorambucil (F+C) on infeclions in patients with chronic lymphocytic leukemia"
"0000974982","","","2-s2.0-0000974982","1996-09-27","Systemic and mucosal immunoglobulin levels and risk of infection in patients with chronic lymphocytic leukemia and multiple myeloma"
"0024551346","2784491","","2-s2.0-0024551346","1989-01-01","Pentostatin in chronic lymphocytic leukemia: A phase II trial of Cancer and Leukemia Group B"
"0023758320","2901280","","2-s2.0-0023758320","1988-01-01","2-Chlorodeoxyadenosine: An effective new agent for the treatment of chronic lymphocytic leukemia"
"0032941221","10458259","","2-s2.0-0032941221","1999-01-01","B-cell chronic lymphocytic leukemia: A bird of a different feather"
"0000274986","","","2-s2.0-0000274986","1998-10-10","Randomized Phase II study in untreated B-cell chronic lymphocytic leukemia (B-CLL) comparing fludarabine (FAMP) vs. high dose continuous chlorambucil (HD-CLB)"
"0029783494","8751471","","2-s2.0-0029783494","1996-09-01","The complement system is defective in chronic lymphatic leukemia patients and in their healthy relatives"
"0030321441","8641639","","2-s2.0-0030321441","1996-12-01","Prophylaxis against infections with low-dose intravenous immunoglobulins (IVIG) in chronic lymphocytic leukemia. Results of a crossover study"
"0003151121","","","2-s2.0-0003151121","1999-09-19","Treatment of chronic lymphocytic leukemia (CLL) with the anti-CD20 antibody rituximab"
"4244134640","","","2-s2.0-4244134640","1993-09-27","Complete and partial response (CR, PR) in treatment of advanced refractory B-cell chronic lymphomytic leukemia (B-CLL) using Campath-1H"
"0028999305","7771465","10.1002/ajh.2830490207","2-s2.0-0028999305","1995-01-01","Opportunistic pulmonary infections with fludarabine in previously treated patients with low‐grade lymphoid malignancies: A role for pneumocystis carinii pneumonia prophylaxis"
"0029691456","8791134","","2-s2.0-0029691456","1996-12-09","Adoptive cell therapy with donor lymphocytes for EBV-associated lymphomas developing after allogeneic marrow transplants."
"0023697166","2845789","","2-s2.0-0023697166","1988-01-01","The pathology of posttransplant lymphoproliferative disorders occurring in the setting of cyclosporine A-prednisone immunosuppression"
"0023748386","2840986","","2-s2.0-0023748386","1988-01-01","Epstein-Barr virus lymphoproliferation after bone marrow transplantation"
"0019979634","6282364","","2-s2.0-0019979634","1982-09-20","A monoclonal immunoblastic sarcoma in donor cells bearing Epstein-Barr virus genomes following allogeneic marrow grafting for acute lymphoblastic leukemia"
"0019814457","6272971","","2-s2.0-0019814457","1981-11-01","Clinical Spectrum of Lymphoproliferative Disorders in Renal Transplant Recipients and Evidence for the Role of Epstein-Barr Virus"
"0025794063","2023604","","2-s2.0-0025794063","1991-05-23","Anti-B-cell monoclonal antibodies in the treatment of severe B-cell lymphoproliferative syndrome following bone marrow and organ transplantation"
"0028507671","7804695","","2-s2.0-0028507671","1994-09-01","Secondary malignancies after marrow transplantation for leukemia or aplastic anemia."
"0026045680","1717080","","2-s2.0-0026045680","1991-10-15","Selective depletion of bone marrow T lymphocytes with anti-CD5 monoclonal antibodies: Effective prophylaxis for graft-versus-host disease in patients with hematologic malignancies"
"0028296089","8167350","","2-s2.0-0028296089","1994-05-01","Direct correlation between the load of Epstein-Barr virus-infected lymphocytes in the peripheral blood of pediatric transplant patients and risk of lymphoproliferative disease"
"0025860868","1685038","10.1007/BF02899562","2-s2.0-0025860868","1991-12-01","Fatal B-cell lymphoproliferative syndrome in allogeneic marrow graft recipients - A clinical, immunobiological and pathological study"
"0028948651","7756374","","2-s2.0-0028948651","1995-01-01","Epstein-Barr virus and bone marrow transplantation"
"0023914384","3258958","","2-s2.0-0023914384","1988-01-01","Treatment of B-cell lymphoproliferative disorders with interferon alfa and intravenous gamma globulin"
"0021965947","","","2-s2.0-0021965947","1985-01-01","Acyclovir therapy of Epstein-Barr virus-induced posttransplant lymphoproliferative diseases"
"0023890609","2833828","","2-s2.0-0023890609","1988-01-01","The frequency of epstein-barr virus infection and associated lymphoproliferative syndrome after transplantation and its manifestations in children"
"0023946601","2833957","","2-s2.0-0023946601","1988-01-01","Epstein-Barr virus associated B cell lymphoproliferative disorders following bone marrow transplantation"
"0029915469","8630428","","2-s2.0-0029915469","1996-03-15","The development of cellular immunity to Epstein-Barr virus after allogeneic bone marrow transplantation"
"0343320882","","","2-s2.0-0343320882","1982-04-14","Abrogation of histo-incompatibility barriers in Rhesus monkeys"
"0021194133","6087703","","2-s2.0-0021194133","1984-11-08","Fatal Epstein-Barr-virus-associated proliferation of donor B cells after treatment of acute graft-versus-host disease with a murine anti-T-cell antibody"
"0033506131","10648942","10.1016/S0022-1759(99)00161-1","2-s2.0-0033506131","1999-12-10","Generating improved single-chain Fv molecules for tumor targeting"
"0033136030","10232603","","2-s2.0-0033136030","1999-05-01","Improving the efficacy of antibody-interleukin 2 fusion proteins by reducing their interaction with Fc receptors"
"0008691609","","","2-s2.0-0008691609","2004-07-13",""
"0008700864","","","2-s2.0-0008700864","2000-07-13","The story of CAMPATH-1"
"0033214576","10490962","","2-s2.0-0033214576","1999-10-01","T cell memory against colon carcinoma is long-lived in the absence of antigen"
"0029914040","8910359","10.1074/jbc.271.44.27677","2-s2.0-0029914040","1996-11-13","Metal binding properties of a monoclonal antibody directed toward metal- chelate complexes"
"0034667881","11035100","","2-s2.0-0034667881","2000-10-15","Induction of vigorous helper and cytotoxic T cell as well as B cell responses by dendritic cells expressing a modified antigen targeting receptor-mediated internalization pathway"
"17944380435","11498595","10.1126/science.1061692","2-s2.0-17944380435","2001-08-10","Crystal structure of a neutralizing human IgG against HIV-1: A template for vaccine design"
"0008692035","","","2-s2.0-0008692035","2004-07-13",""
"0034705696","10869561","10.1016/S0014-5793(00)01701-4","2-s2.0-0034705696","2000-06-23","Development and application of cytotoxic T lymphocyte-associated antigen 4 as a protein scaffold for the generation of novel binding ligands"
"0344223475","10357807","10.1093/emboj/18.11.2941","2-s2.0-0344223475","1999-06-01","Functional glycan-free adhesion domain of human cell surface receptor CD58: Design, production and NMR studies"
"0033839159","10852127","","2-s2.0-0033839159","2000-09-18","Antibodies in human infectious disease"
"4243898627","","","2-s2.0-4243898627","2000-09-27","Purification and characterization of human growth hormone expressed and isolated from corn seed"
"0008700613","","","2-s2.0-0008700613","1998-08-02",""
"0031560775","9171284","10.1006/jmbi.1997.0981","2-s2.0-0031560775","1997-05-09","Selectively-infective phage (SIP): A mechanistic dissection of a novel in vivo selection for protein-ligand interactions"
"0029836763","8755561","10.1073/pnas.93.15.7826","2-s2.0-0029836763","1996-07-23","An antibody-interleukin 2 fusion protein overcomes tumor heterogeneity by induction of a cellular immune response"
"0035221240","11182887","","2-s2.0-0035221240","2001-02-22","Protein microarrays for highly parallel detection and quantitation of specific proteins and antibodies in complex solutions."
"0030993535","9048207","","2-s2.0-0030993535","1997-04-05","Finally! The Brambell receptor (FcRB)"
"0033765304","10950140","","2-s2.0-0033765304","2000-11-25","Recombinant anti-carcinoembryonic antigen antibodies for targeting cancer"
"0033513516","10648943","10.1016/S0022-1759(99)00162-3","2-s2.0-0033513516","1999-12-10","Taking engineered anti-CEA antibodies to the clinic"
"0035895505","11181995","10.1126/science.1058040","2-s2.0-0035895505","2001-02-16","The sequence of the human genome"
"0008715462","","","2-s2.0-0008715462","2004-07-13","Xenotransplantation: Will pigs fly?"
"0031574037","9396828","10.1093/nar/25.24.5132","2-s2.0-0031574037","1997-12-15","Antibody-ribosome-mRNA (ARM) complexes as efficient selection particles for in vitro display and evolution of antibody combining sites"
"0034682480","10890891","10.1073/pnas.140210597","2-s2.0-0034682480","2000-07-18","Site-specific chemical modification with polyethylene glycol of recombinant immunotoxin anti-Tac(Fv)-PE38 (LMB-2) improves antitumor activity and reduces animal toxicity and immunogenicity"
"0033733267","11075357","","2-s2.0-0033733267","2000-11-27","Selecting and evolving functional proteins in vitro by ribosome display"
"0008732769","","","2-s2.0-0008732769","2004-07-13",""
"0008714002","","","2-s2.0-0008714002","2004-07-13",""
"0030974119","9144168","10.1073/pnas.94.10.4937","2-s2.0-0030974119","1997-05-13","In vitro selection and evolution of functional proteins by using ribosome display"
"0032564346","9826665","10.1073/pnas.95.24.14130","2-s2.0-0032564346","1998-11-24","Ribosome display efficiently selects and evolves high-affinity antibodies in vitro from immune libraries"
"0034069669","12861355","","2-s2.0-0034069669","2000-05-01","What to do with targeted IL-2"
"0008723782","","","2-s2.0-0008723782","2004-07-13",""
"0032826457","10473426","","2-s2.0-0032826457","1999-01-01","Staphylococcal surface display of immunoglobulin A (IgA)-and IgE- specific in vitro-selected binding proteins (affibodies) based on Staphylococcus aureus protein A"
"0032977886","10404162","10.1038/10897","2-s2.0-0032977886","1999-07-17","An in vivo library-versus-library selection of optimized protein- protein interactions"
"0032562661","9553057","10.1074/jbc.273.17.10107","2-s2.0-0032562661","1998-04-24","Generation of constitutively active recombinant caspases-3 and -6 by rearrangement of their subunits"
"0029890636","8674062","","2-s2.0-0029890636","1996-07-01","Minibody: A novel engineered anti-carcinoembryonic antigen antibody fragment (single-chain Fv-CH3) which exhibits rapid, high-level targeting of xenografts"
"0034072727","10766189","","2-s2.0-0034072727","2000-04-01","Molecular determinants of apoptosis induced by the cytotoxic ribonuclease onconase: Evidence for cytotoxic mechanisms different from inhibition of protein synthesis"
"0029035201","7732380","","2-s2.0-0029035201","1995-12-01","Generation and assembly of secretory antibodies in plants"
"0033066489","10096285","10.1038/6966","2-s2.0-0033066489","1999-03-19","Smartbombs and cloaking devices"
"0028955535","7724529","","2-s2.0-0028955535","1995-01-01","Phenotypic knockout of the high-affinity human interleukin 2 receptor by intracellular single-chain antibodies against the α subunit of the receptor"
"0242353714","10880576","10.1073/pnas.150228297","2-s2.0-0242353714","2000-07-18","High-resolution microPET imaging of carcinoembryonic antigen-positive xenografts by using a copper-64-labeled engineered antibody fragment"
"0034718615","10984501","","2-s2.0-0034718615","2000-09-26","Directed evolution of antibody fragments with monovalent femtomolar antigen-binding affinity"
"0033536048","10359815","10.1073/pnas.96.12.6925","2-s2.0-0033536048","1999-06-08","Multiple event activation of a generic prodrug trigger by antibody catalysis"
"0029839956","8751726","","2-s2.0-0029839956","1996-09-03","Dominant expression of a 1.3 Mb human Igκ locus replacing mouse light chain production"
"0032906897","10394718","","2-s2.0-0032906897","1999-05-10","Feasibility of antibody production in plants for human therapeutic use"
"0027146691","7505442","","2-s2.0-0027146691","1993-12-15","The CD58 (LFA-3) binding site is a localized and highly charged surface area on the AGFCC′C″ face of the human CD2 adhesion domain"
"0029891262","8643606","","2-s2.0-0029891262","1996-05-28","The protection receptor for IgG catabolism is the β2-microglobulin-containing neonatal intestinal transport receptor"
"0008737030","","","2-s2.0-0008737030","2006-08-02",""
"0033927216","10914732","","2-s2.0-0033927216","2000-07-01","Immunotoxins with increased activity against epidermal growth factor receptor vIII-expressing cells produced by antibody phage display"
"0008700865","","","2-s2.0-0008700865","2004-07-13",""
"0033982964","10627565","10.1128/JVI.74.3.1533-1537.2000","2-s2.0-0033982964","2000-01-24","Cloning the antibody response in humans with chronic inflammatory disease: Immunopanning of subacute sclerosing panencephalitis (SSPE) brain sections with antibody phage libraries prepared from SSPE brain enriches for antibody recognizing measles virus antigens in situ"
"0033960675","10655088","10.1038/72200","2-s2.0-0033960675","2000-02-01","Vaccines and the induction of functional antibodies: Time to look beyond the molecules of natural infection?"
"0034680852","10969070","10.1074/jbc.M002765200","2-s2.0-0034680852","2000-11-17","Generation and characterization of a recombinant human CCR5-specific antibody: A phage display approach for rabbit antibody humanization"
"0033545862","10318939","10.1073/pnas.96.10.5651","2-s2.0-0033545862","1999-05-11","Selection of functional T cell receptor mutants from a yeast surface- display library"
"0008723781","","","2-s2.0-0008723781","2004-07-13",""
"0028986610","7877976","10.1073/pnas.92.5.1327","2-s2.0-0028986610","1995-03-16","Development of anti-p185(HER2) immunoliposomes for cancer therapy"
"0032555214","9671778","10.1073/pnas.95.15.8910","2-s2.0-0032555214","1998-07-21","A phage display approach for rapid antibody humanization: Designed combinatorial V gene libraries"
"0030891425","9070436","","2-s2.0-0030891425","1997-03-01","The counterreceptor binding site of human CD2 exhibits an extended surface patch with multiple conformations fluctuating with millisecond to microsecond motions"
"0027275371","8356098","","2-s2.0-0027275371","1993-01-01","Design, intracellular expression, and activity of a human anti-human immunodeficiency virus type 1 gp120 single-chain antibody"
"0032827243","10504699","10.1038/13679","2-s2.0-0032827243","1999-01-01","Selective targeting and photocoagulation of ocular angiogenesis mediated by a phage-derived human antibody fragment"
"0028938503","7849022","","2-s2.0-0028938503","1995-12-01","Composition and sequence specific resonance assignments of the heterogeneous N-linked glycan in the 13.6 kDa adhesion domain of human CD2 as determined by NMR on the intact glycoprotein"
"0034333243","11042284","10.1016/S0022-1759(00)00275-1","2-s2.0-0034333243","2000-11-01","Isolation and tissue profiles of a large panel of phage antibodies binding to the human adipocyte cell surface"
"0034734973","10967225","10.1016/S0169-409X(00)00068-5","2-s2.0-0034734973","2000-09-30","The use of phage display for the development of tumour targeting agents"
"0033572942","10585255","10.1006/excr.1999.4718","2-s2.0-0033572942","1999-12-15","Natural and engineered cytotoxic ribonucleases: Therapeutic potential"
"0030700632","9359110","10.1038/nbt1197-1271","2-s2.0-0030700632","1997-01-01","Targeting by affinity–matured recombinant antibody fragments of an angiogenesis associated fibronectin isoform"
"0008705172","","","2-s2.0-0008705172","2004-07-13",""
"0008732406","","","2-s2.0-0008732406","2004-07-13",""
"0031026481","8999802","10.1126/science.275.5299.547","2-s2.0-0031026481","1997-01-24","Tumor infarction in mice by antibody-directed targeting of tissue factor to tumor vasculature"
"0033748715","11075355","","2-s2.0-0033748715","2000-11-27","Selectively infective phage technology"
"0034717218","10821955","10.1016/S0022-1759(00)00152-6","2-s2.0-0034717218","2000-05-26","In vivo selection of sFv from phage display libraries"
"0032715903","10586092","","2-s2.0-0032715903","1999-12-28","Antibody repertoires of four- and five-feature translocus mice carrying human immunoglobulin heavy chain and κ and λ light chain yeast artificial chromosomes"
"0003400039","","","2-s2.0-0003400039","2001-06-30",""
"0008687483","","","2-s2.0-0008687483","2004-07-13",""
"0034193558","10917677","10.1016/S0167-7799(99)01408-0","2-s2.0-0034193558","2000-05-01","Evolution of the display technologies"
"17044454065","10815889","","2-s2.0-17044454065","2000-05-01","Radioimmunoguided surgery in colorectal cancer using a genetically engineered anti-CEA single-chain Fv antibody"
"0033983443","10699932","10.1002/(SICI)1097-0215(20000215)85:4&lt;571::AID-IJC20&gt;3.0.CO;2-1","2-s2.0-0033983443","2000-02-12","Catalytic activity of an in vivo tumor targeted anti-CEA scFv::carboxypeptidase G2 fusion protein"
"0034730144","10954734","","2-s2.0-0034730144","2000-08-29","Novel folded protein domains generated by combinatorial shuffling of polypeptide segments"
"0008737024","","","2-s2.0-0008737024","2004-07-13",""
"0032441151","9843987","10.1073/pnas.95.25.14897","2-s2.0-0032441151","1998-12-08","Identification of a proline-binding motif regulating CD2-triggered T lymphocyte activation"
"0033119007","10197611","","2-s2.0-0033119007","1999-04-01","Novel genes in the PAGE and GAGE family of tumor antigens found by homology walking in the dbEST database"
"0033664270","11101809","10.1038/82407","2-s2.0-0033664270","2000-12-23","Picomolar affinity antibodies from a fully synthetic naive library selected and evolved by ribosome display"
"0033485916","10570296","","2-s2.0-0033485916","1999-12-01","Reduction of the nonspecific animal toxicity of anti-Tac(Fv)-PE38 by mutations in the framework regions of the Fv which lower the isoelectric point"
"0024246527","3265633","10.1038/bjc.1988.293","2-s2.0-0024246527","1988-01-01","A cytotoxic agent can be generated selectively at cancer sites"
"0032168040","9724777","10.1073/pnas.95.18.10757","2-s2.0-0032168040","1998-09-01","PAGE-1, an X chromosome-linked GAGE-like gene that is expressed in normal and neoplastic prostate, testis, and uterus"
"0034984611","11413337","10.1128/JVI.75.14.6692-6699.2001","2-s2.0-0034984611","2001-07-07","Identification and characterization of a peptide that specifically binds the human, broadly neutralizing anti-human immunodeficiency virus type 1 antibody b12"
"0034624983","10779548","10.1073/pnas.080078297","2-s2.0-0034624983","2000-05-09","In vitro evolution of a T cell receptor with high affinity for peptide/MHC"
"0008732770","","","2-s2.0-0008732770","2004-07-13",""
"0032432730","","","2-s2.0-0032432730","1998-12-01","Anti-HER2 immunoliposomes for targeted drug delivery"
"0034327783","11038282","10.1006/abio.2000.4788","2-s2.0-0034327783","2000-11-01","Applying phage antibodies to proteomics: Selecting single chain Fv antibodies to antigens blotted on nitrocellulose"
"0008717548","","","2-s2.0-0008717548","2004-07-13",""
"0033833117","10964986","","2-s2.0-0033833117","2000-10-03","ScFv multimers of the anti-neuraminidase antibody NC10: Shortening of the linker in single-chain Fv fragment assembled in V(L) to V(H) orientation drives the formation of dimers, trimers, tetramers and higher molecular mass multimers"
"0034665746","10970733","10.1006/jmbi.2000.4070","2-s2.0-0034665746","2000-09-15","Mass spectral analysis of a protein complex using single-chain antibodies selected on a peptide target: Applications to functional genomics"
"0035136397","11196161","","2-s2.0-0035136397","2001-01-01","A retrogen strategy for presentation of an intracellular tumor antigen as an exogenous antigen by dendritic cells induces potent antitumor t helper and ctl responses"
"0034282466","10987281","","2-s2.0-0034282466","2000-09-01","XAGE-1, a new gene that is frequently expressed in Ewing's sarcoma"
"0008738716","","","2-s2.0-0008738716","2004-07-13",""
"0008737022","","","2-s2.0-0008737022","2000-07-24","Diagnostic and Therapeutic Antibodies (Methods in Molecular Medicine)"
"0035852708","11172030","10.1073/pnas.031567598","2-s2.0-0035852708","2001-02-13","Anti-DNA antibodies are a major component of the intrathecal B cell response in multiple sclerosis"
"0008692041","","","2-s2.0-0008692041","2006-08-02",""
"0008732394","","","2-s2.0-0008732394","2004-07-13",""
"0032539715","9465089","10.1073/pnas.95.4.1752","2-s2.0-0032539715","1998-02-17","Impact of antigenemia on the bioactivity of infused anti-Tac antibody: Implications for dose selection in antibody immunotherapies"
"0008687988","","","2-s2.0-0008687988","2004-07-13",""
"0034671634","11120846","","2-s2.0-0034671634","2000-12-15","Inhibition of TNF-α produced by Kupffer cells protects against the nonspecific liver toxicity of immunotoxin anti-TAC(Fv)-PE38, LMB-2"
"0030817279","9356443","10.1073/pnas.94.23.12297","2-s2.0-0030817279","1997-11-11","RNA-peptide fusions for the in vitro selection of peptides and proteins"
"0008718202","","","2-s2.0-0008718202","2004-07-13",""
"0033617248","10329137","10.1006/jmbi.1999.2678","2-s2.0-0033617248","1999-04-30","Targeted gene delivery to mammalian cells by filamentous bacteriophage"
"0008723785","","","2-s2.0-0008723785","2004-07-13",""
"0033781431","11024361","10.1016/S0958-1669(00)00133-6","2-s2.0-0033781431","2000-01-01","The use of recombinant antibodies in proteomics"
"0033082054","10376954","10.1016/S0165-5728(98)00243-4","2-s2.0-0033082054","1999-02-01","Cloning the antibody response in humans with inflammatory CNS disease: Isolation of measles virus-specific antibodies from phage display libraries of a subacute sclerosing panencephalitis brain"
"0008737028","","","2-s2.0-0008737028","2004-07-13",""
"0033791994","11105590","","2-s2.0-0033791994","2000-01-01","Designer genes: Recombinant antibody fragments for biological imaging"
"0008718206","","","2-s2.0-0008718206","2004-07-13",""
"0008700868","","","2-s2.0-0008700868","2004-07-13",""
"0033776128","11017048","","2-s2.0-0033776128","2000-12-01","Manipulation of human minichromosomes to carry greater than megabase-sized chromosome inserts"
"0008716683","","","2-s2.0-0008716683","2004-07-13",""
"0008701014","","","2-s2.0-0008701014","2004-07-13",""
"0008714004","","","2-s2.0-0008714004","2004-07-13",""
"0008732390","","","2-s2.0-0008732390","2004-07-13",""
"0034690581","10745207","10.1002/(SICI)1097-0290(20000520)68:4&lt;389::AID-BIT4&gt;3.0.CO;2-N","2-s2.0-0034690581","2000-05-20","Glutathione excretion in response to heterologous protein secretion Saccharomyces cerevisiae"
"13144261717","9600934","10.1073/pnas.95.11.6157","2-s2.0-13144261717","1998-05-26","Efficient construction of a large nonimmune phage antibody library: The production of high-affinity human single-chain antibodies to protein antigens"
"0034681178","10639168","10.1073/pnas.97.2.847","2-s2.0-0034681178","2000-01-18","Rapid antibody responses by low-dose, single-step, dendritic cell- targeted immunization"
"0025112794","1696028","","2-s2.0-0025112794","1990-08-28","Searching for peptide ligands with an epitope library"
"0030835822","9255793","10.1038/nbt0897-772","2-s2.0-0030835822","1997-01-01","Binding proteins selected from combinatorial libraries of an α-helical bacterial receptor domain"
"0033779404","11050939","","2-s2.0-0033779404","2000-10-26","In vitro selection and evolution of proteins"
"0034607856","10788485","10.1074/jbc.275.18.13668","2-s2.0-0034607856","2000-05-05","The rabbit antibody repertoire as a novel source for the generation of therapeutic human antibodies"
"0033536626","10512694","10.1006/jmbi.1999.3130","2-s2.0-0033536626","1999-10-08","Yeast polypeptide fusion surface display levels predict thermal stability and soluble secretion efficiency"
"0033233170","10648938","10.1016/S0022-1759(99)00134-9","2-s2.0-0033233170","1999-12-10","Inhibition of expression of the Galα 1-3Gal epitope on porcine cells using an intracellular single-chain antibody directed against α1,3Galactosyltransferase"
"0032109043","9835425","10.1016/S0923-2494(98)80013-8","2-s2.0-0032109043","1998-07-01","Production of antibodies in transgenic plants"
"0033987925","10625396","10.1038/71958","2-s2.0-0033987925","2000-01-21","Exploiting recombination in single bacteria to make large phage antibody libraries"
"0031938775","9419370","10.1073/pnas.95.1.300","2-s2.0-0031938775","1998-01-06","Discovery of three genes specifically expressed in human prostate by expressed sequence tag database analysis"
"0029665818","8666917","10.1084/jem.183.4.1587","2-s2.0-0029665818","1996-04-01","Metabolism of Tac (IL2Rα): Physiology of cell surface shedding and renal catabolism, and suppression of catabolism by antibody binding"
"0031898857","9570278","","2-s2.0-0031898857","1998-04-21","Production of a diverse repertoire of human antibodies in genetically engineered mice"
"0032717780","10556248","","2-s2.0-0032717780","1999-11-24","Affinity maturation of a Taq DNA polymerase specific affibody by helix shuffling"
"0033180521","10415080","10.1006/abio.1999.4176","2-s2.0-0033180521","1999-08-01","Automated kinetic exclusion assays to quantify protein binding interactions in homogeneous solution"
"0033708769","11103810","","2-s2.0-0033708769","2000-11-15","Targeting of bivalent anti-ErbB2 diabody antibody fragments to tumor cells is independent of the intrinsic antibody affinity"
"0008732402","","","2-s2.0-0008732402","2000-07-13","Corn seed production of therapeutic proteins moves forward"
"0031942906","9652755","","2-s2.0-0031942906","1998-05-09","Prolonged in vivo tumour retention of a human diabody targeting the extracellular domain of human HER2/neu"
"9544250404","8782454","10.1038/nm0996-979","2-s2.0-9544250404","1996-09-01","Clinical evidence of efficient tumor targeting based on single-chain Fv antibody selected from a combinatorial library"
"0032555478","9705314","10.1074/jbc.273.34.21769","2-s2.0-0032555478","1998-08-21","Design and use of a phage display library: Antibodies with subnanomolar affinity against a marker of angiogenesis eluted from a two-dimensional gel"
"0034635335","10656818","10.1006/jmbi.1999.3444","2-s2.0-0034635335","2000-02-11","Fully synthetic human combinatorial antibody libraries (HuCAL) based on modular consensus frameworks and CDRs randomized with trinucleotides"
"0032006660","9458094","","2-s2.0-0032006660","1998-02-01","Increased affinity leads to improved selective tumor delivery of single- chain Fv antibodies"
"0033017466","10360364","10.1038/9359","2-s2.0-0033017466","1999-06-09","Structure, specificity and CDR mobility of a class II restricted single- chain T-cell receptor"
"0033181011","10398368","10.1002/(SICI)1097-0134(19990801)36:2&lt;217::AID-PROT7&gt;3.0.CO;2-X","2-s2.0-0033181011","1999-08-01","Design and expression of soluble CTLA-4 variable domain as a scaffold for the display of functional polypeptides"
"0035836675","11296304","10.1073/pnas.071058398","2-s2.0-0035836675","2001-04-10","Human single-chain Fv intrabodies counteract in situ huntingtin aggregation in cellular models of Huntington's disease"
"0033499632","10648939","10.1016/S0022-1759(99)00158-1","2-s2.0-0033499632","1999-12-10","Extended half-life and elevated steady-state level of a single-chain Fv intrabody are critical for specific intracellular retargeting of its antigen, caspase-7"
"0033819367","11036658","","2-s2.0-0033819367","2000-10-19","Methods for generating multivalent and bispecific antibody fragments"
"0034681121","10639146","10.1073/pnas.97.2.722","2-s2.0-0034681121","2000-01-18","Double trans-chromosomic mice: Maintenance of two individual human chromosome fragments containing Ig heavy and κ loci and expression of fully human antibodies"
"2042437650","11237011","10.1038/35057062","2-s2.0-2042437650","2001-02-15","Initial sequencing and analysis of the human genome"
"0034091784","10688878","10.1073/pnas.030540397","2-s2.0-0034091784","2000-03-16","A space-time structure determination of human CD2 reveals the CD58- binding mode"
"0034161846","10677374","10.1042/0264-6021:3460519","2-s2.0-0034161846","2000-03-01","Crystal structure of the anti-(carcinoembryonic antigen) single-chain Fv antibody MFE-23 and a model for antigen binding based on intermolecular contacts"
"0008700611","","","2-s2.0-0008700611","2004-07-13",""
"0033506366","10648937","10.1016/S0022-1759(99)00157-X","2-s2.0-0033506366","1999-12-10","High avidity scFv multimers; diabodies and triabodies"
"0033168617","10381513","","2-s2.0-0033168617","1999-07-01","A high-affinity human antibody that targets tumoral blood vessels"
"0034425742","10973222","10.1038/79494","2-s2.0-0034425742","2000-12-01","Antibody arrays for high-throughput screening of antibody-antigen interactions"
"0008705168","","","2-s2.0-0008705168","2004-07-13",""
"0032493715","9680484","10.1006/jmbi.1998.1907","2-s2.0-0032493715","1998-08-07","The role of structure in antibody cross-reactivity between peptides and folded proteins"
"0008705171","","","2-s2.0-0008705171","2004-07-13",""
"0008718208","","","2-s2.0-0008718208","2004-07-13",""
"0034712874","10772973","10.1006/viro.2000.0239","2-s2.0-0034712874","2000-04-25","Antibody and virus: Binding and neutralization"
"0008737023","","","2-s2.0-0008737023","2004-07-13",""
"0033555628","9927045","","2-s2.0-0033555628","1999-01-16","Increased binding affinity and valence of recombinant antibody fragments lead to improved targeting of tumoral angiogenesis"
"0029920670","8637007","10.1006/jmbi.1996.0284","2-s2.0-0029920670","1996-05-24","Probing the basis of antibody reactivity with a panel of constrained peptide libraries displayed by filamentous phage"
"0033529917","10430935","10.1073/pnas.96.16.9287","2-s2.0-0033529917","1999-08-03","High expression of a specific T-cell receptor γ transcript in epithelial cells of the prostate"
"0034283551","10966812","10.1006/jmbi.2000.4026","2-s2.0-0034283551","2000-09-01","Selection of tumor-specific internalizing human antibodies from phage libraries"
"0033819491","11036659","","2-s2.0-0033819491","2000-10-19","Design and use of phage display libraries for the selection of antibodies and enzymes"
"0034662916","10931945","","2-s2.0-0034662916","2000-08-15","TARP: A nuclear protein expressed in prostate and breast cancer cells derived from an alternate reading frame of the T cell receptor γ chain locus"
"12944288238","10741695","","2-s2.0-12944288238","2000-03-01","Antibody-directed enzyme prodrug therapy: Efficacy and mechanism of action in colorectal carcinoma"
"0033056238","10385321","10.1038/9872","2-s2.0-0033056238","1999-06-01","Improving antibody affinity by mimicking somatic hypermutation in vitro"
"0008716819","","","2-s2.0-0008716819","2004-07-13",""
"0034129672","10886402","10.1046/j.1365-2567.2000.00034.x","2-s2.0-0034129672","2000-06-24","The role of the Brambell receptor (FcRB) in liver: Protection of endocytosed immunoglobulin G (IgG) from catabolism in hepatocytes rather than transport of IgG to bile"
"0034151778","10965493","","2-s2.0-0034151778","2000-03-01","Human breast carcinoma cells express type II IL-4 receptors and are sensitive to antitumor activity of a chimeric IL-4-Pseudomonas exotoxin fusion protein in vitro and in vivo."
"0030575802","8918938","10.1006/jmbi.1996.0598","2-s2.0-0030575802","1996-11-08","Isolation of picomolar affinity anti-c-erbB-2 single-chain Fv by molecular evolution of the complementarity determining regions in the center of the antibody binding site"
"0034001076","10764422","","2-s2.0-0034001076","2000-04-01","Phase I trial of recombinant immunotoxin anti-Tac(Fv)-PE38 (LMB-2) in patients with hematologic malignancies"
"0034625656","10862985","10.1016/S0168-1656(00)00232-7","2-s2.0-0034625656","2000-06-09","Ligands selected from combinatorial libraries of protein A for use in affinity capture of apolipoprotein A-1(M) and Taq DNA polymerase"
"0034244316","10908365","","2-s2.0-0034244316","2000-08-01","By-passing selection: direct screening for antibody-antigen interactions using protein arrays."
"0028959129","7805042","","2-s2.0-0028959129","1995-02-15","Development of a Humanized Disulfide-stabilized Anti-p185HER2 Fv-β-Lactamase Fusion Protein for Activation of a Cephalosporin Doxorubicin Prodrug"
"0041855383","","","2-s2.0-0041855383","1995-07-13","Unrelated Donor Bone Marrow Transplantation in children"
"0042356339","","","2-s2.0-0042356339","1993-07-13","Marrow Transplantation for storage diseases: The plan and need for a control study"
"0028135342","7996361","10.1016/S0022-3476(05)82004-9","2-s2.0-0028135342","1994-01-01","Bone marrow transplantation for autosomal recessive osteopetrosis A report from the Working Party on Inborn Errors of the European Bone Marrow Transplantation Group"
"0030905099","","","2-s2.0-0030905099","1997-01-01","Unrelated donor marrow transplantation for genetic diseases"
"7344266888","9695972","10.1046/j.1365-2141.1998.00790.x","2-s2.0-7344266888","1998-08-05","Unrelated donor marrow transplantation for chronic myelogenous leukaemia"
"2642683404","","","2-s2.0-2642683404","1996-07-13",""
"0030034035","8673056","","2-s2.0-0030034035","1996-02-05","Unrelated donor marrow transplantation: Initial experience of the Italian Bone Marrow Transplant Group (GITMO)"
"0014661390","4894426","10.1038/223472a0","2-s2.0-0014661390","1969-12-01","Induction of immunological tolerance by porcine liver allografts"
"17044453983","9000652","10.1097/00007890-199701150-00002","2-s2.0-17044453983","1997-01-15","FN18-CRM9 immunotoxin promotes tolerance in primate renal allografts"
"0029789322","8795595","","2-s2.0-0029789322","1996-09-01","Magnetic resonance imaging changes with recombinant human interferon-β-1a: A short term study in relapsing-remitting multiple sclerosis"
"0032231764","9576653","","2-s2.0-0032231764","1998-04-01","Patterns of lesion development in multiple sclerosis: Longitudinal observations with T1-weighted spin-echo and magnetization transfer MR"
"0025854083","1859184","10.1002/ana.410290515","2-s2.0-0025854083","1991-01-01","Serial gadolinium‐enhanced magnetic resonance imaging scans in patients with early, relapsing‐remitting multiple sclerosis: Implications for clinical trials and natural history"
"0020686503","6847134","10.1002/ana.410130302","2-s2.0-0020686503","1983-01-01","New diagnostic criteria for multiple sclerosis: Guidelines for research protocols"
"0032494792","9820296","10.1016/S0140-6736(98)10039-9","2-s2.0-0032494792","1998-11-07","Placebo-controlled multicentre randomised trial of interferon β-1b in treatment of secondary progressive multiple sclerosis"
"0027503708","8239560","10.1002/ana.410340507","2-s2.0-0027503708","1993-01-01","Correlation between magnetic resonance imaging findings and lesion development in chronic, active multiple sclerosis"
"0029814538","8843362","10.1016/0730-725X(96)00018-5","2-s2.0-0029814538","1996-08-29","Quantification of MRI lesion load in multiple sclerosis: A comparison of three computer-assisted techniques"
"0028815032","7854522","","2-s2.0-0028815032","1995-01-01","Correlations between changes in disability and T&lt;inf&gt;2&lt;/inf&gt;-weighted brain mri activity in multiple sclerosis: A follow-up study"
"0344599717","","","2-s2.0-0344599717","1999-07-13","Pulsed monoclonal antibody treatment modulates T cell responses in multiple sclerosis but induces autoimmune thyroid disease"
"0029894034","8836938","10.1007/BF00886870","2-s2.0-0029894034","1996-08-01","A spinal cord MRI study of benign and secondary progressive multiple sclerosis"
"0031400608","9090605","10.1002/jmri.1880070232","2-s2.0-0031400608","1997-12-01","A reproducible repositioning method for serial magnetic resonance imaging studies of the brain in treatment trials for multiple sclerosis"
"0021035886","6685237","","2-s2.0-0021035886","1983-01-01","Rating neurologic impairment in multiple sclerosis: An expanded disability status scale (EDSS)"
"8944248824","8673483","10.1093/brain/119.3.701","2-s2.0-8944248824","1996-06-01","Spinal cord atrophy and disability in multiple sclerosis. A new reproducible and sensitive MRI method with potential to monitor disease progression"
"9044245703","8572668","10.1002/ana.410390104","2-s2.0-9044245703","1996-02-14","Guidelines for the use of magnetic resonance techniques in monitoring the treatment of multiple sclerosis"
"0028988737","7755356","10.1002/ana.410370511","2-s2.0-0028988737","1995-01-01","The effect of interferon‐β on blood—brain barrier disruptions demonstrated by constrast‐enhanced magnetic resonance imaging in relapsing—remitting multiple sclerosis"
"0030453516","9010005","10.1093/brain/119.6.2009","2-s2.0-0030453516","1996-12-01","Progressive cerebral atrophy in multiple sclerosis. A serial MRI study"
"0031973909","9549485","10.1093/brain/121.1.3","2-s2.0-0031973909","1998-01-01","The role of magnetic resonance techniques in understanding and managing multiple sclerosis"
"0030989875","9183256","10.1093/brain/120.5.865","2-s2.0-0030989875","1997-05-01","Biotechnological agents for the immunotherapy of multiple sclerosis. Principles, problems and perspectives"
"0031844371","9595975","","2-s2.0-0031844371","1998-05-01","Histopathologic correlate of hypointense lesions on T1-weighted spin- echo MRI in multiple sclerosis"
"0031745694","9647295","","2-s2.0-0031745694","1998-05-01","Measures of brain and spinal cord atrophy in multiple sclerosis"
"0025332089","2320230","","2-s2.0-0025332089","1990-01-01","Serial study of gadolinium-DTPA MRI enhancement in multiple sclerosis"
"0029420091","9345394","","2-s2.0-0029420091","1995-12-01","Early treatment of multiple sclerosis with Rebif (recombinant human interferon beta): design of the study."
"0032581188","9702685","10.1016/S0022-510X(98)00110-5","2-s2.0-0032581188","1998-06-30","Quantitative volumetric analysis of brain magnetic resonance imaging from patients with multiple sclerosis"
"0029730733","8960729","","2-s2.0-0029730733","1996-12-01","Accumulation of hypointense lesions ('black holes') on T1 spin-echo MRI correlates with disease progression in multiple sclerosis"
"0344599716","","","2-s2.0-0344599716","1991-07-13","EDSS reliability"
"0030935805","9069488","","2-s2.0-0030935805","1997-01-01","Gadolinium enhanced MRI predicts clinical and MRI disease activity in relapsing-remitting multiple sclerosis"
"0030072651","9345438","","2-s2.0-0030072651","1996-12-01","Clinical and magnetic resonance imaging predictors of disability in primary and secondary progressive multiple sclerosis"
"0345601517","9820297","10.1016/S0140-6736(98)03334-0","2-s2.0-0345601517","1998-11-07","Randomised double-blind placebo-controlled study of interferon β-1a in relapsing/remitting multiple sclerosis"
"0003226770","","","2-s2.0-0003226770","1998-09-27","Monitoring of residual disease after Campath-1H therapy of refractory chronic lymphocytic leukaemia"
"0006987777","","","2-s2.0-0006987777","2000-09-27","Rituximab induced complement cascade activation is related to adverse events and bone marrow involvement"
"17144455839","9336364","","2-s2.0-17144455839","1997-10-01","Idec-c2b8: Results of a phase I multiple-dose trial in patients with relapsed non-Hodgkin's lymphoma"
"0026793994","1406793","","2-s2.0-0026793994","1992-10-22","Induction of immune responses in patients with B-cell lymphoma against the surface-immunoglobulin idiotype expressed by their tumors"
"0031759837","9779698","","2-s2.0-0031759837","1998-10-01","Maximum-tolerated dose, toxicity, and efficacy of 131I-Lym-1 antibody for fractionated radioimmunotherapy of non-Hodgkin's lymphoma"
"0003101584","","","2-s2.0-0003101584","1998-07-13","I-131 anti-B1 antibody for previously untreated follicular lymphoma (FL): Clinical and molecular remissions"
"0003258926","","","2-s2.0-0003258926","2000-07-13","Final results of a randomized controlled study of the Zevalin radioimmunotherapy regimen versus a standard course of rituximab immunotherapy for B-cell NHL"
"0031759838","9779701","","2-s2.0-0031759838","1998-10-01","Follow-up of relapsed B-cell lymphoma patients treated with iodine-131- labeled anti-CD20 antibody and autologous stem-cell rescue"
"0033855660","10963642","","2-s2.0-0033855660","2000-09-18","Rituximab anti-CD20 monoclonal antibody therapy in non-Hodgkin's lymphoma: Safety and efficacy of re-treatment"
"0003224870","","","2-s2.0-0003224870","2000-07-13","Immunotherapy of NHL with epratuzumab (anti-CD22 monoclonal antibody): Excellent tolerability with objective responses"
"0034066127","10792269","10.1046/j.1365-2141.2000.01926.x","2-s2.0-0034066127","2000-01-01","The emerging role of radioimmunotherapy in haematological malignancies"
"0027479127","8450856","","2-s2.0-0027479127","1993-04-08","Treatment of non-Hodgkin's lymphoma"
"0000524707","","","2-s2.0-0000524707","1996-09-27","The anti-tumor effect of monoclonal anti-CD20 antibody therapy includes direct anti-proliferative activity and induction of apoptosis in CD20 positive non-Hodgkin's lymphoma cell lines"
"0020031557","6173751","","2-s2.0-0020031557","1982-01-01","Treatment of B-cell lymphoma with monoclonal anti-idiotype antibody"
"0024341614","2667754","","2-s2.0-0024341614","1989-09-01","Endocytosis and Degradation of Monoclonal Antibodies Targeting Human B-Cell Malignancies"
"0032791210","10442187","10.1023/A:1008389119525","2-s2.0-0032791210","1999-08-02","Extended rituximab (anti-CD20 monoclonal antibody) therapy for relapsed or refractory low-grade or follicular non-Hodgkin's lymphoma"
"0345337254","9704735","","2-s2.0-0345337254","1998-08-01","Rituximab chimeric anti-CD20 monoclonal antibody therapy for relapsed indolent lymphoma: Half of patients respond to a four-dose treatment program"
"0028108050","7524522","10.1016/0167-5699(94)90276-3","2-s2.0-0028108050","1994-01-01","CD20: a regulator of cell-cycle progression of B lymphocytes"
"0026586054","1370636","","2-s2.0-0026586054","1992-01-01","Serotherapy of B-cell neoplasms with anti-B4-blocked ricin: A phase I trial of daily bolus infusion"
"8944248819","8683227","","2-s2.0-8944248819","1996-07-25","Iodine-131-anti-B1 radioimmunotherapy for B-cell lymphoma"
"0004009703","","","2-s2.0-0004009703","1989-07-13","Dose fractionated radioimmunotherapy of lymphoma with I-131 Lym-1"
"4243219650","","","2-s2.0-4243219650","2004-09-27","Intracellular pathways of CD20-induced apoptosis"
"0032740188","10561026","","2-s2.0-0032740188","1999-11-18","Stem cell function and engraftment is not affected by 'in vivo purging' with rituximab for autologous stem cell treatment for patients with low-grade non-Hodgkin's lymphoma"
"0027376013","8211209","","2-s2.0-0027376013","1993-01-01","Natural history of and therapy for the indolent non-Hodgkin's lymphomas"
"0021199345","6482933","","2-s2.0-0021199345","1984-12-06","Treatment of advanced non-Hodgkin's lymphoma with recombinant leukocyte A interferon"
"0032529703","9694706","","2-s2.0-0032529703","1998-08-15","Anti-idiotype antibodies can induce long-term complete remissions in non-Hodgkin's lymphoma without eradicating the malignant clone"
"9244224115","8616860","","2-s2.0-9244224115","1996-05-01","Comparative metabolism and retention of iodine-125, yttrium-90, and indium-111 radioimmunoconjugates by cancer cells"
"0032697615","10541378","","2-s2.0-0032697615","1999-10-01","Pharmacokinetics, dosimetry, and initial therapeutic results with 131I- and 111In-/90Y-labeled humanized LL2 anti-CD22 monoclonal antibody in patients with relapsed, refractory non-Hodgkin's lymphoma"
"0003308546","","","2-s2.0-0003308546","1999-07-13","Pilot study of Rituxan in combination with fludarabine chemotherapy in patients with low-grade or follicular non-Hodgkin's lymphoma"
"0030800131","10851464","","2-s2.0-0030800131","1997-09-01","Chimeric anti-CD20 (idec-C2B8) monoclonal antibody sensitizes a B cell lymphoma cell line to cell killing by cytotoxic drugs"
"0003101578","","","2-s2.0-0003101578","1998-09-27","Iodine-131 anti-B1 antibody for non-Hodgkin's lymphoma (NHL): Overall clinical trial experience"
"0032761164","10577851","","2-s2.0-0032761164","1999-12-01","Phase I/II trial of IDEC-Y2B8 radioimmunotherapy for treatment of relapsed or refractory CD20+ B-cell non-Hodgkin's lymphoma"
"0027208577","7687326","10.1056/NEJM199308123290703","2-s2.0-0027208577","1993-01-01","Radioimmunotherapy of B-cell lymphoma with [131I]anti-B1 (anti-CD20) antibody"
"0000968039","","","2-s2.0-0000968039","1998-07-13","Multicenter phase III study of iodine-131 tositumomab (anti-B1 antibody) for chemotherapy-refractory low-grade or transformed low-grade non-Hodgkin's lymphoma (NHL)"
"0004010391","","","2-s2.0-0004010391","2000-07-13","Mabthera (rituximab) plus CHOP is superior to CHOP alone in elderly patients with diffuse large B-cell lymphoma: Interim results of a randomised GELA trial"
"0033794001","11147485","","2-s2.0-0033794001","2000-10-30","Monoclonal antibodies in lymphoid neoplasia: Principles for optimal combined therapy"
"0344766075","10458242","","2-s2.0-0344766075","1999-01-01","Treatment of patients with low-grade B-cell lymphoma with the combination of chimeric anti-CD20 monoclonal antibody and CHOP chemotherapy"
"0034662510","10942366","","2-s2.0-0034662510","2000-08-15","Radioimmunotherapy with iodine 131I tositumomab for relapsed or refractory B-cell non-Hodgkin lymphoma: Updated results and long-term follow-up of the University of Michigan experience"
"0003351083","","","2-s2.0-0003351083","2000-07-13","Phase I trial of humanized 1D10 (Hu1D10) monoclonal antibody targeting class II molecules in patients with relapsed lymphoma"
"0001198608","","","2-s2.0-0001198608","2000-09-27","Iodine-131 tositumomab for non-Hodgkin's lymphoma (NHL) patients who progressed after treatment with rituximab: Results of a multicenter phase II study"
"1842368507","9310469","","2-s2.0-1842368507","1997-09-15","IDEC-C2B8 (rituximab) anti-CD20 monoclonal antibody therapy in patients with relapsed low-grade non-Hodgkin's lymphoma"
"0027484445","7692295","10.1056/NEJM199310213291702","2-s2.0-0027484445","1993-01-01","Radiolabeled-antibody therapy of B-cell lymphoma with autologous bone marrow support"
"0026064277","1991174","","2-s2.0-0026064277","1991-02-01","Evidence of a graft-versus-lymphoma effect associated with allogeneic bone marrow transplantation"
"0027057483","1403052","","2-s2.0-0027057483","1992-12-01","Autologous versus allogeneic bone marrow transplantation for non-Hodgkin's lymphoma: A case-controlled analysis of the European Bone Marrow Transplant Group registry data"
"0032951328","10458261","","2-s2.0-0032951328","1999-01-01","International consensus conference on high-dose therapy with hematopoietic stem cell transplantation in aggressive non-Hodgkin's lymphomas: Report of the jury"
"0031879197","9704734","","2-s2.0-0031879197","1998-08-01","Transplant-lite: Induction of graft-versus-malignancy using fludarabine- based nonablative chemotherapy and allogeneic blood progenitor-cell transplantation as treatment for lymphoid malignancies"
"9044237273","8636773","","2-s2.0-9044237273","1996-02-01","Bone marrow transplants from HLA-identical siblings in advanced Hodgkin's disease"
"0028790440","7477169","10.1056/NEJM199512073332305","2-s2.0-0028790440","1995-01-01","Autologous bone marrow transplantation as compared with salvage chemotherapy in relapses of chemotherapy-sensitive non-Hodgkin's lymphoma"
"85007170585","","","2-s2.0-85007170585","2000-01-05","Allogeneic stem cell transplantation with fludarabine based less intensive conditioning as adoptive immunotherapy in advanced Hodgkin's disease"
"0027404777","8096958","10.1016/0140-6736(93)92411-L","2-s2.0-0027404777","1993-04-24","Dose intensification with autologous bone-marrow transplantation in relapsed and resistant Hodgkin's disease: results of a BNLI randomised trial"
"0032170122","9716615","","2-s2.0-0032170122","1998-09-01","Allogeneic bone marrow transplantation for low-grade lymphoma"
"0032755477","10583237","10.1046/j.1365-2141.1999.01709.x","2-s2.0-0032755477","1999-11-22","Comparative serial quantitative measurements of chimaerism following unmanipulated allogeneic transplantation of peripheral blood stem cells and bone marrow"
"0025911979","1679155","10.1016/0140-6736(91)90609-S","2-s2.0-0025911979","1991-09-07","GM-CSF instead of autologous bone-marrow transplantation after the BEAM regimen"
"0032778810","10631455","10.1023/A:1008380527502","2-s2.0-0032778810","1999-12-23","Allogeneic hematopoietic transplantation for mantle-cell lymphoma: Molecular remissions and evidence of graft-versus-malignancy"
"0030831750","9354692","","2-s2.0-0030831750","1997-11-15","Allogeneic versus autologous bone marrow transplantation for refractory and recurrent low-grade non-Hodgkin's lymphoma"
"0027483826","8246023","","2-s2.0-0027483826","1993-12-01","Allogeneic, syngeneic, and autologous marrow transplantation for Hodgkin's disease: The 21-year seattle experience"
"0027534424","8443375","","2-s2.0-0027534424","1993-01-01","The place of high-dose BEAM therapy and autologous bone marrow transplantation in poor-risk Hodgkin's disease. A single-center eight-year study of 155 patients"
"85007261355","","","2-s2.0-85007261355","1997-01-05","Engraftment of allogeneic haematopoietic progenitor cells with purine analog containing chemotherapy: Harnessing graft-versus-leukaemia without myeloablative therapy"
"0031963055","9486487","","2-s2.0-0031963055","1998-01-01","Allogeneic and autologous transplantation for haematological diseases, solid tumours and immune disorders: Current practice in Europe in 1998"
"0028959923","7773226","","2-s2.0-0028959923","1995-01-01","High-dose melphalan allows durable engraftment of allogeneic bone marrow"
"0030942265","9028312","","2-s2.0-0030942265","1997-02-01","Comparison between conventional salvage therapy and high-dose therapy with autografting for recurrent or refractory Hodgkin's disease"
"85007263350","","","2-s2.0-85007263350","1999-01-05","Report of an international workshop to standardise response criteria for non-Hodgkin's lymphomas. [NCI Sponsored International Working Group]"
"0006724304","","","2-s2.0-0006724304","1999-09-27","Reduced toxicity and transplant related mortality (TRM) following nonmyeloablative allogeneic peripheral blood stem cell transplantation for malignant diseases"
"0033044208","10416001","","2-s2.0-0033044208","1999-07-12","Carmustine, etoposide, cytarabine and melphalan as a preparative regimen for allogeneic transplantation for high-risk malignant lymphoma"
"0034067082","10828860","","2-s2.0-0034067082","2000-05-30","Allogeneic peripheral blood stem cell transplantation using a fludarabine-based low intensity conditioning regimen for malignant lymphoma"
"0028074547","8049425","","2-s2.0-0028074547","1994-08-15","Prospective comparative trial of autologous versus allogeneic bone marrow transplantation in patients with non-Hodgkin's lymphoma"
"85007263360","","","2-s2.0-85007263360","1990-01-05","The CAMPATH-1 antigen (CD52)"
"0028939820","7884421","","2-s2.0-0028939820","1995-03-01","High-dose cyclophosphamide, carmustine, and etoposide followed by allogeneic bone marrow transplantation in patients with lymphoid malignancies who had received prior dose-limiting radiation therapy"
"0033996949","10723575","","2-s2.0-0033996949","2000-03-07","Mini-allografts: Ongoing trials in humans"
"85007204548","","","2-s2.0-85007204548","1999-01-05","Transplant lite using fludarabine-cyclophosphamide (FC) for low-grade lymphoma (LGL)"
"0030008082","8648386","","2-s2.0-0030008082","1996-04-01","Allogeneic bone marrow transplant is not better than autologous transplant for patients with relapsed Hodgkin's disease"
"0034554782","11099321","","2-s2.0-0034554782","2000-12-01","Autografting followed by nonmyeloablative immunosuppressive chemotherapy and allogeneic peripheral-blood hermatopoietic stem-cell transplantation as treatment of resistant Hodgkin's disease and non-Hodgkin's lymphoma"
"10144243981","8839876","","2-s2.0-10144243981","1996-10-01","High-dose therapy and autologous bone marrow transplantation in patients with follicular lymphoma during first remission"
"18744384700","","","2-s2.0-18744384700","1993-03-01","Effect of culture conditions on IgM antibody structure, pharmacokinetics and activity"
"11944272604","","","2-s2.0-11944272604","1990-05-01","Environmental effects on protein glycosylation"
"0025909201","1717254","","2-s2.0-0025909201","1991-12-01","Antibody variable region glycosylation: Position effects on antigen binding and carbohydrate structure"
"0024438061","2507634","","2-s2.0-0024438061","1989-01-01","Studies of aglycosylated chimeric mouse-human IgG. Role of carbohydrate in the structure and effector functions mediated by the human IgG constant region"
"0024555155","2687607","","2-s2.0-0024555155","1989-01-01","Detection of residual T-cells in T-cell depleted bone marrow: A comparison of immunofluorescence and limiting dilution culture techniques"
"0027722191","8167724","","2-s2.0-0027722191","1993-12-01","Chimerism and immune reconstitution following allogeneic bone marrow transplantation for severe combined immunodeficiency disease"
"1842289612","","","2-s2.0-1842289612","1996-07-13",""
"25344435076","","","2-s2.0-25344435076","1996-10-07","Campath 1G for the depletion of T cells after positive selection of CD34+ cells in haploidentical BMT in primary immunodeficiencies"
"0014433553","4177932","","2-s2.0-0014433553","1968-12-28","Immunological reconstitution of sex-linked lymphopenic immunological deficiency."
"0028928027","","","2-s2.0-0028928027","1995-01-01","Severe combined immunodeficiency clinicopathological features and treatment"
"0021081708","6422974","10.1111/j.1365-2141.1983.tb02840.x","2-s2.0-0021081708","1983-01-01","Allogeneic bone marrow transplantation: the monitoring of granulocyte macrophage colonies following the collection of bone marrow mononuclear cells and after the subsequent in‐vitro cytolysis of OKT3 positive lymphocytes"
"1842327219","","","2-s2.0-1842327219","1991-07-13","European experience of bone marrow transplantation for severe combined immunodeficiency"
"1842375487","","","2-s2.0-1842375487","1996-07-13","Allogeneic peripheral blood progenitor cell (PBPC) transplantation: Collection of filgrastim-mobilized PBPCs from normal donors weighing 40 kg or less"
"0027731695","8167725","","2-s2.0-0027731695","1993-12-01","Bone marrow transplantation in severe combined immunodeficiency: Potential and current limitations"
"0001089075","","","2-s2.0-0001089075","1991-07-13","Quantitative assays for human hematopoietic progenitor cells"
"0020199626","6764536","","2-s2.0-0020199626","1982-12-01","Reconstruction after transplantation with T-lymphocyte-depleted HLA haplotype-mismatched bone marrow for severe combined immunodeficiency"
"0028064668","7522181","","2-s2.0-0028064668","1994-01-01","Sensitive detection and enumeration of CD34+ cells in peripheral and cord blood by flow cytometry"
"0027420443","7905667","","2-s2.0-0027420443","1993-01-01","Haploidentical bone marrow stem cell transplantation in human severe combined immunodeficiency"
"0026072606","1884401","10.1016/0008-8749(91)90059-K","2-s2.0-0026072606","1991-10-01","Optimising a limiting dilution culture system for quantitating frequencies of alloreactive cytotoxic T lymphocyte precursors"
"0028353582","8140631","","2-s2.0-0028353582","1994-01-01","Cytotoxic T lymphocyte precursor frequency does not correlate with either the incidence or severity of graft-versus-host disease after matched unrelated donor bone marrow transplantation"
"0027493594","8212168","","2-s2.0-0027493594","1993-01-01","The frequency of pretransplant donor cytotoxic T cell precursors with anti-host specificity predicts survival of patients transplanted with bone marrow from donors other than HLA-identical siblings"
"0023868362","2894727","","2-s2.0-0023868362","1988-01-01","A dna-rflp typing system that positively identifies serologically well-defined and ill-defined HLA-DR and DQ alleles, including DRw10"
"0000533595","","","2-s2.0-0000533595","1989-07-13","A standardized method for detection of HLA-A and HLA-B alleles by one-dimensional isoelectric focusing (IEF) gel electrophoresis"
"0023927902","3048479","","2-s2.0-0023927902","1988-01-01","Frequency analysis of cytotoxic T lymphocyte precursors - Possible relevance to HLA-matched unrelated donor bone marrow transplantation"
"84930543434","","","2-s2.0-84930543434","1985-06-14","Rat monoclonal antibod ies for bone marrow transplantation (BMT)"
"0023572360","3304467","","2-s2.0-0023572360","1987-12-01","Unrelated donor bone marrow transplantation therapy for chronic myelogenous leukemia"
"84930552624","","","2-s2.0-84930552624","1991-06-14","Incidence of'HLA-DPBl mismatches in HLA-A, B and DR serologically matched bone marrow transplant pairs"
"0025978290","1994541","","2-s2.0-0025978290","1991-01-01","Marrow transplantation from HLA-matched unrelated donors for treatment of hematologic malignancies"
"8544235790","","","2-s2.0-8544235790","1993-12-12","Analysis of correlation between alloimmune cytotoxic responses generated from unrelated donors and severity of acute graft-versus-host disease"
"0024431496","2508280","","2-s2.0-0024431496","1989-01-01","Prediction of graft versus host disease by frequency analysis of cytotoxic T cells after unrelated donor bone marrow transplantation"
"0022905810","3535929","","2-s2.0-0022905810","1986-12-01","Histocompatible unrelated volunteer donors compared with HLA nonidentical family donors in marrow transplantation for aplastic anemia and leukemia"
"84930549813","","","2-s2.0-84930549813","0000-06-14","HLA-C frequency data by serology and PCR-SSP in 393 random individuals"
"0023022289","3490518","10.1016/0022-1759(86)90183-3","2-s2.0-0023022289","1986-11-06","An improved colorimetric assay for interleukin 2"
"0021988924","3156935","10.1016/0022-1759(85)90036-5","2-s2.0-0021988924","1985-03-18","A rapid colorimetric assay for the determination of IL-2-producing helper T cell frequencies"
"0022998464","2944556","","2-s2.0-0022998464","1986-12-01","Recipient immune-competent T lymphocytes can survive intensive conditioning for bone marrow transplantation"
"0019468220","7009746","","2-s2.0-0019468220","1981-01-01","Limiting dilution assays for the determination of immunocompetent cell frequencies. I. Data analysis"
"0343524707","","","2-s2.0-0343524707","1989-07-13","T-cell depleted marrow transplants for the treatment of leukemia"
"84930779978","","","2-s2.0-84930779978","1986-06-18","Graft rejection following Tlymphocyte depleted bone marrow transplantation with two different TBI regimens"
"0020835432","6209527","","2-s2.0-0020835432","1983-10-01","Immunosuppression with monoclonal antibodies. A model to determine the rules for effective serotherapy."
"0023098978","3542078","","2-s2.0-0023098978","1987-04-17","Successful graft-versus-host disease prevention without graft failure in 32 HLA-identical allogeneic bone marrow transplantations with marrow depleted of T cells by monoclonal antibodies and complement"
"2242420757","3520563","","2-s2.0-2242420757","1986-09-24","Demonstration of clonable alloreactive host T cells in a primate model for bone marrow transplantation"
"0021061819","6606682","10.1016/0022-1759(83)90303-4","2-s2.0-0021061819","1983-12-16","Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxicity assays"
"0022635957","3485685","","2-s2.0-0022635957","1986-01-01","Estimation by limiting dilution analysis of human IL 2-secreting T cells: Detection of IL 2 produced by single lymphokine-secreting T cells"
"0021078390","6363024","10.1007/BF00154722","2-s2.0-0021078390","1983-12-01","Organ-culture preservation of human corneas"
"0026325760","1889217","","2-s2.0-0026325760","1991-12-01","Tectonic keratoplasty for peripheral ulcerative keratitis"
"0027467436","8438499","","2-s2.0-0027467436","1993-01-01","Effect of monoclonal antibody on corneal graft survival across major and minor histocompatibility mismatches"
"0026721468","1741146","","2-s2.0-0026721468","1992-01-01","Paracentral rheumatoid corneal ulceration: Clinical features and cyclosporine therapy"
"0020054727","6280121","","2-s2.0-0020054727","1982-01-01","Decision-making in the therapy of external eye disease. Noninfected corneal ulcers"
"0026801355","1417537","10.1001/archopht.1992.01080220054021","2-s2.0-0026801355","1992-01-01","The Collaborative Corneal Transplantation Studies (CCTS): Effectiveness of Histocompatibility Matching in High-Risk Corneal Transplantation"
"0026613778","1464419","","2-s2.0-0026613778","1992-10-01","Reprogramming the immune system for peripheral tolerance with CD4 and CD8 monoclonal antibodies"
"0025720565","1680112","","2-s2.0-0025720565","1991-01-01","Promotion of murine orthotopic corneal allograft survival by systemic administration of anti-CD4 monoclonal antibody"
"0025718901","1680111","","2-s2.0-0025718901","1991-01-01","Autoimmune ocular disease in MRL/Mp-lpr/lpr mice is suppressed by anti-CD4 antibody"
"0018248243","289223","","2-s2.0-0018248243","1978-12-01","Systemic immunosuppression in marginal keratolysis"
"0026752375","1631942","","2-s2.0-0026752375","1992-01-01","Patterns of corneal graft rejection in the rabbit and reversal of rejection with monoclonal antibodies"
"0028069619","8302545","","2-s2.0-0028069619","1994-02-08","Systemic cyclosporine in high-risk keratoplasty: Short-versus long-term therapy"
"0014497673","4887869","","2-s2.0-0014497673","1969-04-01","Transplantation and rejection of individual cell layers of the cornea."
"0026579612","1584581","","2-s2.0-0026579612","1992-01-01","Penetrating keratoplasty in patients with rheumatoid arthritis"
"0014190807","4166406","","2-s2.0-0014190807","1967-09-02","Prevention of corneal-graft failure with the immunosuppressive drug azathioprine."
"84966173102","","","2-s2.0-84966173102","0000-05-18","Prolongation of rat corneal graft survival by treatment with anti-cd4 monoclonal antibody"
"0023281496","3274568","","2-s2.0-0023281496","1987-02-01","Use of locally injected anti-T monoclonal antibodies in the treatment of acute corneal graft rejection."
"0025293271","1973156","","2-s2.0-0025293271","1990-01-01","Inhibition of autoimmune uveitis by anti-CD4 antibody"
"0024571784","2523173","","2-s2.0-0024571784","1989-01-01","Usefulness of CD3 or CD6 anti-T monoclonal antibodies in the treatment of acute corneal graft rejection"
"0021153655","6233985","10.1002/art.1780270602","2-s2.0-0021153655","1984-01-01","Rheumatoid arthritis and sterile corneal ulceration"
"0017263097","1357","","2-s2.0-0017263097","1976-12-01","Induction of corneal graft rejection by passive cell transfer"
"0026689035","1565452","","2-s2.0-0026689035","1992-01-01","Factors predictive of corneal graft survival: Report from the Australian Corneal Graft Registry"
"0018839290","6992019","","2-s2.0-0018839290","1980-01-01","Immunosuppressive therapy for external ocular inflammatory disease"
"0017764449","921342","","2-s2.0-0017764449","1977-12-01","Ulceration of the cornea in rheumatoid arthritis"
"0025134729","2219310","","2-s2.0-0025134729","1990-01-01","Prolongation of heterotopic human corneal graft survival in mice treated with an anti-CD4 monoclonal antibody"
"0344579797","3443202","10.1038/eye.1987.73","2-s2.0-0344579797","1987-01-01","‘Pulsed’ immunosuppressive therapy in the treatment of immunologically induced corneal and scleral disease"
"0027208911","8339567","","2-s2.0-0027208911","1993-01-01","Graft failure in keratoepithelioplasty"
"0018346505","220878","","2-s2.0-0018346505","1979-01-01","Peripheral rheumatoid ulceration and evidence for conjunctival collagenase production"
"0024546379","2912362","","2-s2.0-0024546379","1989-01-01","Chronic lymphocytic leukemia: Recommendations for diagnosis, staging, and response criteria"
"0023153705","3492263","10.1002/1097-0142(19870215)59:4&lt;767::AID-CNCR2820590417&gt;3.0.CO;2-6","2-s2.0-0023153705","1987-01-01","B‐chronic lymphocytic leukemia. Prognostic implication of bone marrow histology in 120 patients experience from a single hematology unit"
"0026038974","1912574","","2-s2.0-0026038974","1991-01-01","B-cell chronic lymphocytic leukemia: Present status and future directions"
"0019518522","7259986","10.1111/j.1365-2141.1981.tb02727.x","2-s2.0-0019518522","1981-01-01","Chronic Lymphocytic Leukaemia: Proposals for a Revised Prognostic Staging System: Report from the International Workshop on CLLby the Writing Committee:"
"0001171057","","","2-s2.0-0001171057","1994-07-13","Treatment of B-chronic lymphocytic leukemia with the monoclonal antibody Campath-1H"
"0032962895","10319389","","2-s2.0-0032962895","1999-05-18","Bone marrow transplantation for low-grade lymphoma and chronic lymphocytic leukemia"
"0028959982","7612488","","2-s2.0-0028959982","1995-04-10","Chronic lymphocytic leukemia: Present status"
"0030000389","8726414","","2-s2.0-0030000389","1996-05-20","Fludarabine monophosphate in refractory B-chronic lymphocytic leukemia: Maintenance may be significant to sustain response"
"0026315454","","10.3109/10428199109103390","2-s2.0-0026315454","1991-01-01","Prolonged intermittent chlorambucil administration in b-chronic lymphocytic leukemia: Experience from a single hematology unit"
"0032946191","10319379","","2-s2.0-0032946191","1999-05-18","B-chronic lymphocytic leukemia, small lymphocytic lymphoma, and lymphoplasmacytic lymphoma, including Waldenstrom's macroglobulinemia: A clinical, morphologic, and biologic spectrum of similar disorders"
"0024319910","2473795","","2-s2.0-0024319910","1989-01-01","Fludarabine: A new agent with major activity against chronic lymphocytic leukemia"
"0027457275","8471770","","2-s2.0-0027457275","1993-04-15","High frequency of monoallelic retinoblastoma gene deletion in B-cell chronic lymphoid leukemia shown by interphase cytogenetics"
"0342755133","","","2-s2.0-0342755133","1992-12-30","Treatment of refractory chronic lymphocytic leukemia (CLL) with fludarabine monophosphate (FAMP) under the group C protocol"
"0026776598","1377051","","2-s2.0-0026776598","1992-07-01","Response assessment in chronic lymphocytic leukemia after fludarabine plus prednisone: Clinical, pathologic, immunophenotypic, and molecular analysis"
"0024318576","2738163","","2-s2.0-0024318576","1989-01-01","Proposals for the classification of chronic (mature) B and T lymphoid leukaemias"
"0028064764","8068936","","2-s2.0-0028064764","1994-09-01","A revised European-American classification of lymphoid neoplasms: A proposal from the International Lymphoma Study Group"
"0003777114","","","2-s2.0-0003777114","1989-05-18",""
"0023907985","3277904","10.1002/hon.2900060103","2-s2.0-0023907985","1988-01-01","Treatment of early chronic lymphocytic leukemia: Intermittent chlorambucil versus observation"
"0027288539","7683927","","2-s2.0-0027288539","1993-01-01","Fluorescent in situ hybridization and cytogenetic studies of trisomy 12 in chronic lymphocytic leukemia"
"0000585311","","","2-s2.0-0000585311","1995-01-25","The serum β2-microglobulin (β2m) level is more powerful than stage in predicting response and survival in chronic lymphocytic leukemia (CLL)"
"0025132331","2223648","10.1111/j.1365-2141.1990.tb07835.x","2-s2.0-0025132331","1990-01-01","Natural history of stage A chronic lymphocytic leukaemia untreated patients"
"0026015638","1702145","","2-s2.0-0026015638","1991-12-01","Fludarabine: A new agent with marked cytoreductive activity in untreated chronic lymphocytic leukemia"
"0027396831","8490658","10.1038/ng0193-67","2-s2.0-0027396831","1993-01-01","Evidence for a new tumour suppressor locus (DBM) in human B–cell neoplasia telomeric to the retinoblastoma gene"
"0021270274","6466871","","2-s2.0-0021270274","1984-01-01","Bone marrow histologic pattern - The best single prognostic parameter in chronic lymphocytic leukemia: A multivariate survival analysis of 329 cases"
"0025901050","1713049","10.1038/bjc.1991.253","2-s2.0-0025901050","1991-01-01","Fludarabine phosphate for the treatment of low grade lymphoid malignancy"
"0012960364","","","2-s2.0-0012960364","1993-07-13","Diagnosis and treatment of CLL variants"
"0017751562","890666","10.1002/1097-0142(197708)40:2&lt;855::AID-CNCR2820400239&gt;3.0.CO;2-1","2-s2.0-0017751562","1977-01-01","A clinical staging system for chronic lymphocytic leukemia. Prognostic significance"
"0023717101","3189311","10.1002/ajh.2830290307","2-s2.0-0023717101","1988-01-01","Guidelines for clinical protocols for chronic lymphocytic leukemia: Recommendations of the national cancer institute‐sponsored working group"
"0027465143","8097528","","2-s2.0-0027465143","1993-12-01","High complete remission rate from 2-chloro-2′-deoxyadenosine in previously treated patients with B-cell chronic lymphocytic leukemia: Response predicted by rapid decrease of blood lymphocyte count"
"0026091985","1868250","","2-s2.0-0026091985","1991-08-15","Progression and survival studies in early chronic lymphocytic leukemia"
"13344287042","8554226","","2-s2.0-13344287042","1996-02-01","HLA-identical sibling bone marrow transplantation in younger patients with chronic lymphocytic leukemia"
"0025231329","2180493","","2-s2.0-0025231329","1990-04-01","A randomized clinical trial of chlorambucil versus COP in stage B chronic lymphocytic leukemia"
"0022534682","3487341","10.1111/j.1365-2141.1986.tb05563.x","2-s2.0-0022534682","1986-01-01","The relationship between chronic lymphocytic leukaemia and prolymphocytic leukaemia: I. CLINICAL AND LABORATORY FEATURES OF 300 PATIENTS AND CHARACTERIZATION OF AN INTERMEDIATE GROUP"
"0029099349","7666104","","2-s2.0-0029099349","1995-09-01","Infectious and immunosuppressive complications of purine analog therapy"
"0027436745","8241511","","2-s2.0-0027436745","1993-01-01","p53 gene mutation in B-cell chronic lymphocytic leukemia is associated with drug resistance and is independent of MDR1/MDR3 gene expression"
"0028987180","7888675","","2-s2.0-0028987180","1995-03-15","p53 Gene deletion predicts for poor survival and non-response to therapy with purine analogs in chronic B-cell leukemias"
"0029079152","7780145","","2-s2.0-0029079152","1995-01-01","Comparative genomic hybridization in chronic B-cell leukemias shows a high incidence of chromosomal gains and losses"
"0027986616","7931486","","2-s2.0-0027986616","1994-10-01","Soluble CD23 reliably reflects disease activity in B-cell chronic lymphocytic leukemia"
"0029135341","7620169","","2-s2.0-0029135341","1995-01-01","True T-cell chronic lymphocytic leukemia: A morphologic and immunophenotypic study of 25 cases"
"0025772439","1715191","10.1007/BF01714952","2-s2.0-0025772439","1991-07-01","Treatment of advanced chronic lymphocytic leukemia by fludarabine - Results of a clinical phase-II study"
"0000087591","","","2-s2.0-0000087591","1987-03-21","A critical analysis of staging in CLL"
"0028289052","8151318","","2-s2.0-0028289052","1994-04-01","Autologous and allogeneic bone marrow transplantation for chronic lymphocytic leukemia: Preliminary results"
"0027239823","8104532","","2-s2.0-0027239823","1993-01-01","bcl-2 Gene hypomethylation and high-level expression in B-cell chronic lymphocytic leukemia"
"0020503919","6225799","","2-s2.0-0020503919","1983-11-26","Subpopulations of human natural killer cells defined by expression of the Leu-7 (HNK-1) and Leu-11 (NK-15) antigens"
"0022357814","2410496","","2-s2.0-0022357814","1985-12-01","T cell activation via CD2 [T, gp50] molecules: Accessory cells are required to trigger T cell activation via CD2-D66 plus CD2-9.6/T111 epitopes"
"0023920595","2451287","","2-s2.0-0023920595","1988-12-01","Reshaping human antibodies: Grafting an antilysozyme activity"
"0019379384","6969782","10.1084/jem.153.1.207","2-s2.0-0019379384","1981-03-30","Identification of a human T lymphocyte surface protein associated with the E-rosette receptor"
"0021880562","3924633","10.1002/eji.1830150702","2-s2.0-0021880562","1985-01-01","Mechanisms by which accessory cells contribute in growth of resting T lymphocytes initiated by OKT3 antibody"
"0024544168","2467820","10.1002/eji.1830190226","2-s2.0-0024544168","1989-01-01","Triggering of the alternative pathway of human T cell activation involves members of the T 200 family of glycoproteins"
"0022539521","3091691","","2-s2.0-0022539521","1986-01-01","Monoclonal antibodies to the CD5 antigen can provide the necessary second signal for activation of isolated resting T cells by solid-phase-bound OKT3"
"0022445895","2426350","","2-s2.0-0022445895","1986-01-01","A common pathway for T lymphocyte activation involving both the CD3-Ti complex and CD2 sheep erythrocyte receptor determinants"
"0022458229","3088111","","2-s2.0-0022458229","1986-01-01","Synergy between the T3/antigen receptor complex and Tp44 in the activation of human T cells"
"44949268271","","10.1016/0167-5699(90)90017-4","2-s2.0-44949268271","1990-01-01","Do CD2 and CD3-TCR T-cell activation pathways function independently?"
"0023849635","3337901","","2-s2.0-0023849635","1988-01-01","Lineage- and stage-specific adhesion of human hematopoietic progenitor cells to extracellular matrices from marrow fibroblasts"
"0023202131","2438349","","2-s2.0-0023202131","1987-01-01","Three different erythrocyte surface molecules are required for spontaneous T cell rosette formation"
"0008423878","","","2-s2.0-0008423878","1989-07-13","Purification and preliminary characterization of the CAMPATH-1 antigen"
"0022500017","2427570","","2-s2.0-0022500017","1986-11-19","T cell activation via CD2 [T, gp50]: The role of accessory cells in activating resting T cells via CD2"
"0024324920","2568380","","2-s2.0-0024324920","1989-01-01","CD44 contributes to T cell activation"
"0018868973","6967511","","2-s2.0-0018868973","1980-10-06","An antigen shared by a human T cell subset and B cell chronic lymphocytic leukemic cells. Distribution of normal and malignant lymphoid cell"
"0023173670","3102676","","2-s2.0-0023173670","1987-01-01","Purified lymphocyte function-associated antigen 3 binds to CD2 and mediates T lymphocyte adhesion"
"0345564048","","","2-s2.0-0345564048","1989-06-14","Cluster report: CDw52"
"0023819248","2454190","10.1002/eji.1830180505","2-s2.0-0023819248","1988-01-01","Triggering CD 28 molecules synergize with CD 2 (T11.1 and T11,2)‐mediated T cell activation"
"0020053611","6175720","10.1084/jem.155.5.1317","2-s2.0-0020053611","1982-07-13","Phenomenon of human T cells rosetting with sheep erythrocytes analyzed with monoclonal antibodies. 'Modulation' of a partially hidden epitope determining the conditions of interaction between T cells and erythrocytes"
"0023848235","2893822","","2-s2.0-0023848235","1988-01-01","Regulation of the CD2 alternate pathway of T cell activation by CD3. Evidence for heterologous desensitization"
"0023633204","2444644","","2-s2.0-0023633204","1987-12-01","The T11 (CD2) molecule is functionally linked to the T3/T1 T cell receptor in the majority of T cells"
"0022001931","3155770","","2-s2.0-0022001931","1985-05-14","The isolation and characterization of the human suppressor inducer T cell subset"
"0020525643","6191218","10.1038/303808a0","2-s2.0-0020525643","1983-12-01","Evidence for the T3-associated 90K heterodimer as the T-cell antigen receptor"
"0023935541","2894395","","2-s2.0-0023935541","1988-01-01","A T cell surface molecule different from CD2 is involved in spontaneous rosette formation with erythrocytes"
"0345331591","","","2-s2.0-0345331591","1989-07-13","The delivery of distinct activation signals to T-cells via CD2"
"0021140557","6231105","10.1016/0092-8674(84)90039-4","2-s2.0-0021140557","1984-01-01","An alternative pathway of T-cell activation: A functional role for the 50 kd T11 sheep erythrocyte receptor protein"
"0007755380","","","2-s2.0-0007755380","1999-09-27","Infusion-related events following rituximab therapy in chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL): Association with inflammatory cytokines"
"0032530342","9731049","","2-s2.0-0032530342","1998-09-15","Rituximab (anti-CD20 monoclonal antibody) for the treatment of patients with relapsing or refractory aggressive lymphoma: A multicenter phase II study"
"0000975788","","","2-s2.0-0000975788","2000-07-13","Rituximab (IDEC-C2B8) and CVP chemotherapy in follicular or low grade B-cell lymphoma after relapse: Results after 6 months of follow-up"
"0003303016","","","2-s2.0-0003303016","1999-07-13","Phenotypic and clinical evidence supports rituximab for Waldenstrom's macroglobulinemia"
"4243970621","","","2-s2.0-4243970621","2000-09-27","Interim results from a prospective randomized controlled trial comparing Zevalin radioimmunotherapy to rituximab immunotherapy for B-cell non-Hodgkin's lymphoma: Resistance to prior chemotherapy vs response rate"
"0033055251","10100713","","2-s2.0-0033055251","1999-03-01","Therapy of B-cell lymphoma with anti-CD20 antibodies can result in the loss of CD20 antigen expression"
"7844225540","9818074","10.1023/A:1008416911099","2-s2.0-7844225540","1998-09-01","Association of serum Rituximab (IDEC-C2B8) concentration and anti- tumor response in the treatment of recurrent low-grade or follicular non-Hodgkin's lymphoma"
"0033996883","10707793","","2-s2.0-0033996883","2000-03-06","The effect of Rituximab on patients with follicular and mantle-cell lymphoma"
"0000662651","","","2-s2.0-0000662651","1999-07-13","Rituximab as first-line treatment of follicular lymphoma patients with a low tumor burden. Preliminary results of a phase II trial"
"0031927984","9704731","","2-s2.0-0031927984","1998-08-01","New approach to classifying non-Hodgkin's lymphomas: Clinical features of the major histologic subtypes"
"0003312835","","","2-s2.0-0003312835","2000-09-27","Iodine I 131 tositumomab therapy for previously untreated follicular lymphoma (FL)"
"4243320919","","","2-s2.0-4243320919","2000-09-27","Rituximab as initial therapy for patients with low-grade non-Hodgkin's lymphoma"
"0034017954","10715303","","2-s2.0-0034017954","2000-03-01","Multicenter phase II study of iodine-131 tositumomab for chemotherapy- relapsed/refractory low-grade and transformed low-grade B-cell non-Hodgkin's lymphomas"
"0000359099","","","2-s2.0-0000359099","1999-07-13","Multicenter study of Campath-1H in patients with chronic lymphocytic leukemia (B-CLL) refractory to fludarabine"
"0000521569","","","2-s2.0-0000521569","1999-07-13","Phase II study of rituximab in combination with CHOP chemotherapy in patients with previously untreated intermediate or high-grade non-Hodgkin's lymphoma"
"0003287551","","","2-s2.0-0003287551","1999-07-13","Rituxan/CHOP induction therapy in newly diagnosed patients with mantle cell lymphoma"
"0007530425","","","2-s2.0-0007530425","1999-07-13","Early molecular responses in newly diagnosed follicular lymphoma patients with Rituximab as first-line treatment"
"0034657295","10807768","","2-s2.0-0034657295","2000-05-15","Rituximab monoclonal antibody as initial systemic therapy for patients with low-grade non-Hodgkin lymphoma"
"4244164378","","","2-s2.0-4244164378","2000-09-27","Rituximab is an active agent in Waldenstrom's macroglobulinemia"
"1842413105","9166827","","2-s2.0-1842413105","1997-06-01","A clinical evaluation of the International Lymphoma Study Group classification of non-Hodgkin's lymphoma"
"0033968522","10637245","","2-s2.0-0033968522","2000-01-01","European phase II study of rituximab (chimeric anti-CD20 monoclonal antibody) for patients with newly diagnosed mantle-cell lymphoma and previously treated mantle-cell lymphoma, immunocytoma, and small B-cell lymphocytic lymphoma"
"0000470702","","","2-s2.0-0000470702","1999-07-13","Rituxan has significant activity in patients with CLL"
"0031766682","9817291","","2-s2.0-0031766682","1998-11-01","Monoclonal antibody-based therapies for hematologic malignancies"
"0026655066","1380203","10.1002/ajh.2830400404","2-s2.0-0026655066","1992-01-01","Reduced expression of CD20 antigen as a characteristic marker for chronic lymphocytic leukemia"
"0030732828","9359496","","2-s2.0-0030732828","1997-11-06","Haemopoietic stem cell transplantation for autoimmune diseases"
"0345669108","3887403","10.1073/pnas.82.8.2483","2-s2.0-0345669108","1985-09-11","Rationale for bone marrow transplantation in the treatment of autoimmune diseases"
"0026604019","1517881","","2-s2.0-0026604019","1992-01-01","Sequential dermal microvascular and perivascular changes in the development of scleroderma"
"0031723134","9793258","","2-s2.0-0031723134","1998-08-01","Stem cell transplantation for severe autoimmune diseases: Progress and problems"
"0032533235","9808541","","2-s2.0-0032533235","1998-11-15","Treatment of autoimmune disease by intense immunosuppressive conditioning and autologous hematopoietic stem cell transplantation"
"0022578857","3511372","","2-s2.0-0022578857","1986-06-18","Therapy of lupus nephritis. Controlled trial of prednisone and cytotoxic drugs"
"0022946085","3332134","","2-s2.0-0022946085","1986-12-01","Prolonged remission of severe refractory rheumatoid arthritis following allogeneic bone marrow transplantation for drug-induced aplastic anaemia"
"0028786926","7567191","","2-s2.0-0028786926","1995-10-25","Scleroderma in children"
"0026788536","1382621","10.1007/BF01695817","2-s2.0-0026788536","1992-09-01","Leukocytoclastic vasculitis complicating granulocyte colony-stimulating factor (G-CSF) induced neutrophil recovery in Tγ-lymphocytosis with severe neutropenia"
"0028927105","7537116","","2-s2.0-0028927105","1995-05-01","Effect of granulocyte colony-stimulating factor treatment on ex vivo blood cytokine response in human volunteers"
"0343924409","9014919","","2-s2.0-0343924409","1997-01-25","Treatment of systemic sclerosis with autologous haemopoietic stem cell transplantation"
"26144471987","","","2-s2.0-26144471987","1996-10-17","Autologous peripheral blood selected CD34+ cell transplantation for the treatment of severe progressive systemic sclerosis"
"0028848264","8528163","","2-s2.0-0028848264","1995-01-01","Stem cell transplantation for severe autoimmune diseases: New proposals but still unanswered questions"
"0345633110","","","2-s2.0-0345633110","1991-12-20","Systemic sclerosis (scleroderma)"
"0031906107","9461184","10.1038/nm0298-153","2-s2.0-0031906107","1998-04-07","BMT beats autoimmune disease"
"0028054192","7945491","10.1002/art.1780370904","2-s2.0-0028054192","1994-01-01","Therapy for severe interstitial lung disease in systemic sclerosis. a retrospective study"
"10344262612","8896432","","2-s2.0-10344262612","1996-11-01","Early recurrence or persistence of autoimmune diseases after unmanipulated autologous stem cell transplantation"
"0025233606","2337714","","2-s2.0-0025233606","1990-04-07","Clearance of severe psoriasis after allogenic bone marrow transplantation"
"0029029298","7539978","10.1016/S0002-9343(99)80019-9","2-s2.0-0029029298","1995-01-01","Reactivation of rheumatoid arthritis and development of leukocytoclastic vasculitis in a patient receiving granulocyte colony-stimulating factor for felty's syndrome"
"0027818816","7678082","","2-s2.0-0027818816","1993-12-01","Effects of progenitor cell dose and preleukapheresis use of human recombinant granulocyte colony-stimulating factor on the recovery of hematopoiesis after blood stem cell autografting in children"
"0029092359","7595706","","2-s2.0-0029092359","1995-10-01","Factors that influence collection and engraftment of autologous peripheral-blood stem cells"
"0025990970","1768966","","2-s2.0-0025990970","1991-01-01","Remission induction of adjuvant arthritis in rats by total body irradiation and autologous bone marrow transplantation"
"0029085513","7545634","","2-s2.0-0029085513","1995-01-01","Recombinant human G-CSF: How wide is the field of clinical applicability?"
"0019981418","6177990","10.1016/S0140-6736(82)91686-5","2-s2.0-0019981418","1982-07-10","AUTOLOGOUS BONE-MARROW TRANSPLANTATION IN CALLA-POSITIVE ACUTE LYMPHOBLASTIC LEUKAEMIA AFTER IN-VITRO TREATMENT WITH J5 MONOCLONAL ANTIBODY AND COMPLEMENT"
"0025763196","1873592","","2-s2.0-0025763196","1991-01-01","Treatment of adult acute lymphoblastic leukemia with allogeneic bone marrow transplantation. Multivariate analysis of factors affecting acute graft-versus-host disease, relapse, and relapse-free survival"
"0025833552","1717092","","2-s2.0-0025833552","1991-01-01","Failure of purged autologous bone marrow transplantation in high risk acute lymphoblastic leukaemia in first complete remission"
"0023874066","3422030","","2-s2.0-0023874066","1988-01-01","Prognostic factors in a multicenter study for treatment of acute lymphoblastic leukemia in adults"
"0029123931","7581142","","2-s2.0-0029123931","1995-01-01","Autologous bone marrow or peripheral blood stem cell transplantation followed by maintenance chemotherapy for adult acute lymphoblastic leukemia in first remission: 50 cases from a single center"
"0023019662","3466641","10.1111/j.1365-2141.1986.tb02201.x","2-s2.0-0023019662","1986-01-01","Treatment of acute lymphoblastic leukaemia in adults"
"0026598870","1531306","","2-s2.0-0026598870","1992-02-15","Autologous bone marrow transplantation in high-risk remission B-lineage acute lymphoblastic leukemia using a cocktail of three monoclonal antibodies (BA-1/CD24, BA-2/CD9, and BA-3/CD10) plus complement and 4-hydroperoxycyclophosphamide for ex vivo bone marrow purging"
"0025236707","2332770","","2-s2.0-0025236707","1990-01-01","Allogeneic bone marrow transplantation for patients with high-risk acute lymphoblastic leukemia"
"0024493125","2642717","","2-s2.0-0024493125","1989-01-01","Treatment of acute lymphoblastic leukemia in adults with intensive induction, consolidation, and maintenance chemotherapy"
"0023576862","3305794","","2-s2.0-0023576862","1987-12-01","Allogeneic bone marrow transplantation for acute lymphoblastic leukemia in remission: prolonged survival associated with acute graft-verus-host disease"
"0027753707","8136744","","2-s2.0-0027753707","1993-12-01","Fractionated total body irradiation and high-dose VP-16 with purged autologous bone marrow rescue for children with high risk relapsed acute lymphoblastic leukemia"
"0023160311","3302708","","2-s2.0-0023160311","1987-01-01","Comparison of autologous and allogneic bone marrow transplantation for treatment of high-risk refractory acute lymphoblastic leukemia"
"0026002501","1912575","","2-s2.0-0026002501","1991-01-01","Allogeneic bone marrow transplantation for high-risk acute lymphoblastic leukemia during first complete remission"
"0027410133","8453110","","2-s2.0-0027410133","1993-03-15","Autologous bone marrow transplantation after a long first remission for children with recurrent acute lymphoblastic leukemia"
"0029790774","8864441","","2-s2.0-0029790774","1996-08-01","Factors affecting engraftment and hematopoietic recovery after unpurged autografting in acute leukemia"
"0026045190","1835746","","2-s2.0-0026045190","1991-01-01","Autologous bone marrow transplantation for acute myeloblastic leukemia in Europe: Further evidence of the role of marrow purging by mafosfamide"
"0025305203","2404531","","2-s2.0-0025305203","1990-01-01","Allogeneic or autologous bone marrow transplantation for acute lymphoblastic leukemia in first complete remission"
"0028073124","7949137","","2-s2.0-0028073124","1994-12-01","One hundred twenty-five adult patients with primary acute leukemia autografted with marrow purged by mafosfamide: A 10-year single institution experience"
"0027471156","8093407","10.1016/0140-6736(93)92560-G","2-s2.0-0027471156","1993-01-09","Gene-marking to trace origin of relapse after autologous bone-marrow transplantation"
"0027436249","8410124","","2-s2.0-0027436249","1993-12-01","Adult acute lymphoblastic leukemia: A multicentric randomized trial testing bone marrow transplantation as postremission therapy"
"0025201624","2224122","","2-s2.0-0025201624","1990-11-01","Autologous bone marrow transplantation in high-risk remission T-lineage acute lymphoblastic leukemia using immunotoxins plus 4-hydroperoxycyclophosphamide for marrow purging"
"0026441152","1434834","","2-s2.0-0026441152","1992-01-01","Role of bone marrow transplant in acute lymphocytic leukemia"
"0027425603","8298555","","2-s2.0-0027425603","1993-01-01","Feasibility and efficacy of maintenance chemotherapy following autologous bone marrow transplantation for first remission acute lymphoblastic leukaemia"
"0025161013","2240470","","2-s2.0-0025161013","1990-01-01","Ex vivo chemopurging of autologous bone marrow with 4-hydroperoxycyclophosphamide to eliminate occult leukemic cells: Laboratory and clinical observations"
"0024364590","2473811","","2-s2.0-0024364590","1989-01-01","Autologous transplantation of bone marrow purged in vitro with anti-CD7-(WT1-) ricin A immunotoxin in T-cell lymphoblastic leukemia and lymphoma"
"0023269772","3547671","","2-s2.0-0023269772","1987-01-01","Acute lymphoblastic leukemia in adults: Recent progress, future directions"
"0022620995","3523241","","2-s2.0-0022620995","1986-09-04","Autologous bone marrow transplantation in patients with acute nonlymphocytic leukemia, using ex vivo marrow treatment with 4-hydroperoxycyclophosphamide"
"0025915728","2048858","","2-s2.0-0025915728","1991-01-01","Chemotherapy compared with bone marrow transplantation for adults with acute lymphoblastic leukemia in first remission"
"0025836549","1835410","","2-s2.0-0025836549","1991-01-01","Treatment of adult acute lymphoblastic leukemia with intensive cyclical chemotherapy: A follow-up report"
"0028288519","8093146","10.1056/NEJM199404283301703","2-s2.0-0028288519","1994-04-28","Infusions of donor leukocytes to treat Epstein-Barr virus-associated lymphoproliferative disorders after allogeneic bone marrow transplantation"
"0021185253","6092482","","2-s2.0-0021185253","1984-12-06","Infectious mononucleosis: A polyclonal B cell transformation in vivo"
"0018865251","6244495","10.1038/283865a0","2-s2.0-0018865251","1980-12-01","HLA-restricted T-cell recognition of Epstein-Barr virus-infected B cells [13]"
"0027990846","8052285","10.1056/NEJM199409083311017","2-s2.0-0027990846","1994-01-01","Donor T cells to treat EBV-associated lymphoma [5]"
"0027465548","8093498","10.1016/0140-6736(93)90067-Q","2-s2.0-0027465548","1993-01-23","Frequency of anti-recipient alloreactive helper T-cell precursors in donor blood and graft-versus-host disease after HLA-identical sibling bone-marrow transplantation"
"0027506845","8380053","","2-s2.0-0027506845","1993-01-01","Epstein-Barr virus infections: Biology, pathogenesis, and management"
"0028340056","8004668","10.1016/0092-8674(94)90125-2","2-s2.0-0028340056","1994-06-17","Epstein-Barr virus strategy in normal and neoplastic B cells"
"0026028852","1706642","10.1007/BF01741331","2-s2.0-0026028852","1991-11-01","Initial experience with treatment of human B cell lymphoma with anti-CD19 monoclonal antibody"
"0028261716","8123864","","2-s2.0-0028261716","1994-01-01","Epstein-Barr infection after bone marrow transplantation [2]"
"0029976798","8733698","","2-s2.0-0029976798","1996-05-01","Follow-up of leucocyte and reticulocyte counts for the prediction of early graft failure after non-HLA-identical BMT in children"
"0012566412","","","2-s2.0-0012566412","1994-07-13","Bone marrow transplantation in children"
"0028356401","8043879","","2-s2.0-0028356401","1994-01-01","Increased levels of circulating Epstein-Barr virus (EBV)-infected lymphocytes and decreased EBV nuclear antigen antibody responses are associated with the development of posttransplant lymphoproliferative disease in solid-organ transplant recipients"
"0023280951","2820090","","2-s2.0-0023280951","1987-01-01","Reconstitution of cytotoxic T lymphocyte activity following allogeneic bons marrow transplantation in man"
"0025058520","2105890","10.1007/BF01969527","2-s2.0-0025058520","1990-01-01","Prevention of infection and graft-versus-host disease by suppression of intestinal microflora in children treated with allogeneic bone marrow transplantation"
"0028816546","7799740","10.1016/S0140-6736(95)91150-2","2-s2.0-0028816546","1995-01-07","Use of gene-modified virus-specific T lymphocytes to control Epstein-Barr-virus-related lymphoproliferation"
"0025215453","2158159","","2-s2.0-0025215453","1990-01-01","Serological and molecular studies of epstein-barr virus infection in allogeneic marrow graft recipients"
"0026666918","1316791","","2-s2.0-0026666918","1992-01-01","Bone marrow transplant recipients have defective MHC-unrestricted cytotoxic responses against cytomegalovirus in comparison with Epstein-Barr virus: The importance of target cell expression of lymphocyte function- associated antigen 1 (LFA1)"
"0027467194","8447288","","2-s2.0-0027467194","1993-01-01","Posttransplantation lymphoproliferative disorders"
"0028947839","7812011","","2-s2.0-0028947839","1995-01-15","Correlative morphologic and molecular genetic analysis demonstrates three distinct categories of posttransplantation lymphoproliferative disorders"
"0028962439","7833284","10.1111/j.1365-2141.1995.tb08904.x","2-s2.0-0028962439","1995-01-01","Early identification of Epstein‐Barr virus‐associated post‐transplantation lymphoproliferative disease"
"0031454790","9389685","","2-s2.0-0031454790","1997-12-15","Allogeneic peripheral blood stem cell transplantation may be associated with a high risk of chronic graft-versus-host disease"
"0344925935","10845900","","2-s2.0-0344925935","2000-06-15","Blood stem cells compared with bone marrow as a source of hematopoietic cells for allogeneic transplantation"
"0031775659","9632272","","2-s2.0-0031775659","1998-05-02","Allogeneic bone marrow transplantation vs filgrastim-mobilised peripheral blood progenitor cell transplantation in patients with early leukaemia: First results of a randomised multicentre trial of the European Group for Blood and Marrow Transplantation"
"0242421666","9335340","10.1016/S0092-8674(01)80014-3","2-s2.0-0242421666","1997-10-03","Reactivation of latent human cytomegalovirus by allogeneic stimulation of blood cells from healthy donors"
"0026585558","1345921","","2-s2.0-0026585558","1992-01-24","Sustained engraftment of mice transplanted with IL-1-primed blood-derived stem cells"
"18844463655","10770306","","2-s2.0-18844463655","2000-04-08","Allogeneic blood and bone-marrow stem-cell transplantation in haematological malignant diseases: A randomised trial"
"0031468863","9499667","","2-s2.0-0031468863","1997-11-01","High incidence of chronic graft versus host disease after allogeneic peripheral blood progenitor cell transplantation"
"10144244635","8839878","","2-s2.0-10144244635","1996-10-01","Allogeneic peripheral blood stem cell transplantation in patients with advanced hematologic malignancies: A retrospective comparison with marrow transplantation"
"0033971243","10653869","","2-s2.0-0033971243","2000-02-01","Randomized trial of bone marrow versus lenograstim-primed blood cell allogeneic transplantation in patients with early-stage leukemia: A report from the soeiete francaise de greffe de moelle"
"0032406754","9894716","","2-s2.0-0032406754","1998-12-01","A randomised, prospective comparison of allogeneic bone marrow and peripheral blood progenitor cell transplantation in the treatment of haematological malignancies"
"0029800728","8916975","","2-s2.0-0029800728","1996-11-15","Cytomegalovirus pp65 antigenemia-guided early treatment with ganciclovir versus ganciclovir at engraftment after allogeneic marrow transplantation: A randomized double-blind study"
"18744437859","10642805","","2-s2.0-18744437859","1999-12-01","Allogeneic blood stem cell and bone marrow transplantation for acute myelogenous leukemia and myelodysplasia: Influence of stem cell source on outcome"
"0027227582","8487695","","2-s2.0-0027227582","1993-01-01","New horizons in the treatment of multiple sclerosis"
"0030680316","9357450","10.1016/S0165-5728(97)00114-8","2-s2.0-0030680316","1997-10-01","Effects of β-IFN-1b treatment in MS patients on adhesion between PBMNCs, HUVECs and MS-HBECs: An in vivo and in vitro study"
"0005489101","8857714","","2-s2.0-0005489101","1996-10-01","Neutralizing antibodies during treatment of multiple sclerosis with interferon beta-1b: Experience during the first three years"
"0030994109","9111829","","2-s2.0-0030994109","1997-05-24","Cutaneous necrosis associated with recombinant interferon injection. Report of three cases with interferon beta-1b and review of the literature"
"0030498666","9007090","10.1002/ana.410400607","2-s2.0-0030498666","1996-12-01","Interferon β-1b decreases the migration of T lymphocytes in vitro: Effects on matrix metalloproteinase-9"
"0030936913","9074844","","2-s2.0-0030936913","1997-03-25","Tizanidine. A review of its pharmacology, clinical efficacy and tolerability in the management of spasticity associated with cerebral and spinal disorders"
"0025802630","","","2-s2.0-0025802630","1991-01-01","Therapy of multiple sclerosis, with particular reference to recent clinical trials"
"0030911284","9217787","","2-s2.0-0030911284","1997-07-09","Misdiagnosis of multiple sclerosis and β-interferon [17]"
"0028955548","7818258","10.1002/ana.410370104","2-s2.0-0028955548","1995-01-01","Clinical outcomes and documentation of partial beneficial effects of immunotherapy for multiple sclerosis"
"0030892121","9139559","","2-s2.0-0030892121","1997-05-01","Intravenous immune globulin therapy for neurologic diseases"
"0030712298","9419437","","2-s2.0-0030712298","1997-12-29","T-cell receptor peptides as immunotherapy for autoimmune disease"
"0030920460","9363834","","2-s2.0-0030920460","1997-10-01","Emerging treatments in multiple sclerosis"
"0031033813","9018019","","2-s2.0-0031033813","1997-01-01","Amantadine and L-Carnitine treatment of chronic fatigue syndrome"
"0029897745","8614528","","2-s2.0-0029897745","1996-02-01","Immunoglobulins reactive with myelin basic protein promote CNS remyelination"
"0008678962","8602746","10.1002/ana.410390304","2-s2.0-0008678962","1996-04-15","Intramuscular interferon beta-1a for disease progression in relapsing multiple sclerosis"
"0024436219","2549450","","2-s2.0-0024436219","1989-01-01","Double-blind study of true vs. Sham plasma exchange in patients treated with immunosuppression for acute attacks of multiple sclerosis"
"0030987715","","","2-s2.0-0030987715","1997-01-01","Interferon content of intravenous immunoglobulin: Variation between preparations"
"0029966375","11539872","","2-s2.0-0029966375","1996-04-22","A pilot study of gabapentin as treatment for acquired nystagmus"
"0030773332","9305355","","2-s2.0-0030773332","1997-09-01","Characterization of MRI response to treatment with interferon beta-1b: Contrast-enhancing MRI lesion frequency as a primary outcome measure"
"0028348216","8145906","","2-s2.0-0028348216","1994-01-01","Chronic systemic high-dose recombinant interferon alfa-2a reduces exacerbation rate, MRI signs of disease activity, and lymphocyte interferon gamma production in relapsing-remitting multiple sclerosis"
"0032146309","9688332","10.1016/S0165-5728(98)00095-2","2-s2.0-0032146309","1998-08-01","Failure of treatment with Linomide or oral myelin tolerization to ameliorate demyelination in a viral model of multiple sclerosis"
"0029948580","8559358","","2-s2.0-0029948580","1996-01-01","Management of patients receiving interferon beta-1b for multiple sclerosis: Report of a consensus conference"
"0030071366","8572666","10.1002/ana.410390108","2-s2.0-0030071366","1996-02-14","Intravenous antigen administration as a therapy for autoimmune demyelinating disease"
"0026510639","1377973","","2-s2.0-0026510639","1992-04-06","Natural history and treatment of multiple sclerosis"
"0029834973","8757052","","2-s2.0-0029834973","1996-10-08","The phosphodiesterase inhibitor pentoxifylline reduces early side effects of interferon-β1b treatment in patients with multiple sclerosis"
"0029986881","8965116","10.1007/BF00873697","2-s2.0-0029986881","1996-04-01","The autoimmune reactivity to myelin oligodendrocyte glycoprotein (MOG) in multiple sclerosis is potentially pathogenic: Effect of copolymer 1 on MOG-induced disease"
"0029876990","8965118","","2-s2.0-0029876990","1996-04-11","A review of the clinical efficacy profile of copolymer 1: New U.S. phase III trial data"
"0031557899","9186401","","2-s2.0-0031557899","1997-06-07","Oral versus intravenous corticosteroids in acute relapses of multiple sclerosis."
"0030046876","8655728","","2-s2.0-0030046876","1996-02-29","Cutaneous ulcerations and pustular psoriasis flare caused by recombinant interferon beta injections in patients with multiple sclerosis"
"0030912908","9152109","","2-s2.0-0030912908","1997-05-24","Treatment of depression improves adherence to interferon beta-1b therapy for multiple sclerosis"
"0029889674","8649561","","2-s2.0-0029889674","1996-06-01","Effect of steroids on CSF matrix metalloproteinases in multiple sclerosis: Relation to blood-brain barrier injury"
"8544249096","9270562","","2-s2.0-8544249096","1997-08-01","Impact of interferon beta-1a on neurologic disability in relapsing multiple sclerosis"
"0030035509","8690806","","2-s2.0-0030035509","1996-07-01","Induction of circulating myelin basic protein and proteolipid protein- specific transforming growth factor-β1-secreting Th3 T cells by oral administration of myelin in multiple sclerosis patients"
"0030015204","8726668","10.1006/cyto.1996.0054","2-s2.0-0030015204","1996-05-01","Circulating serum levels of IL-1ra in patients with relapsing remitting multiple sclerosis are normal during remission phases but significantly increased either during exacerbations or in response to IFN-β treatment"
"0029936727","8625547","","2-s2.0-0029936727","1996-05-01","Intravenous immune globulin in multiple sclerosis: Clinical and neuroradiological results and implications for possible mechanisms of action"
"0028091682","7886818","10.1016/0165-6147(94)90059-0","2-s2.0-0028091682","1994-01-01","Mechanisms of action of new antiepileptic drugs: rational design and serendipitous findings"
"0029753268","8960728","","2-s2.0-0029753268","1996-12-01","Improved delayed visual reproduction test performance in multiple sclerosis patients receiving interferon β-1b"
"0030817203","9310963","","2-s2.0-0030817203","1997-10-16","Interferon gamma producing blood lymphocytes are decreased by interferon beta therapy in patients with multiple sclerosis"
"0030946161","9160341","","2-s2.0-0030946161","1997-02-01","Ingested IFN-α has biological effects in humans with relapsing-remitting multiple sclerosis"
"0030815008","9291164","","2-s2.0-0030815008","1997-04-01","Growth factors and myelin regeneration in multiple sclerosis"
"6844250787","9450771","10.1002/ana.410430114","2-s2.0-6844250787","1998-01-01","Magnetic resonance studies of intramuscular interferon β-1a for relapsing multiple sclerosis"
"0025739244","1866003","","2-s2.0-0025739244","1991-01-01","Cause of death in patients attending multiple sclerosis clinics"
"0030612938","9389504","","2-s2.0-0030612938","1997-01-01","Inteferon-γ potentiates interleukin (IL)-6 and tumor necrosis factor- α but not IL-1β induced by endotoxin in the brain"
"0029826744","8951184","","2-s2.0-0029826744","1996-11-27","The new generation of antiepileptic drugs: Advantages and disadvantages"
"0029909221","8871582","10.1002/ana.410400412","2-s2.0-0029909221","1996-10-01","Interferon beta induces interleukin-10 expression: Relevance to multiple sclerosis"
"0030989459","9109861","","2-s2.0-0030989459","1997-04-01","Quantitative assessment of sustained-release 4-aminopyridine for symptomatic treatment of multiple sclerosis"
"0029314991","7783913","","2-s2.0-0029314991","1995-01-01","Interferons in multiple sclerosis: Warnings from experiences"
"0345071936","","","2-s2.0-0345071936","1996-07-13",""
"0029993357","8632062","10.1016/0165-5728(95)00176-X","2-s2.0-0029993357","1996-02-01","Pentoxifylline, a phosphodiesterase inhibitor, induces immune deviation in patients with multiple sclerosis"
"0030730252","","","2-s2.0-0030730252","1997-11-22","Multiple sclerosis: Myelin basic protein induced mRNA expression of proinflammatory cytokines in mononuclear cells is suppressed by interferon-β1b in vitro"
"0031033111","","","2-s2.0-0031033111","1997-01-01","Botulinum toxin type A in cerebellar tremor caused by multiple sclerosis"
"0030874547","9291170","","2-s2.0-0030874547","1997-04-01","A double-blind, cross-over trial of intravenous immunoglobulin G in multiple sclerosis: Preliminary results"
"0030483220","9007089","10.1002/ana.410400606","2-s2.0-0030483220","1996-12-01","Interferon beta-1b inhibits gelatinase secretion and in vitro migration of human T cells: A possible mechanism for treatment efficacy in multiple sclerosis"
"0031017605","9023873","10.1016/S0166-2236(96)10071-0","2-s2.0-0031017605","1997-02-01","Beta-interferon and multiple sclerosis"
"0031471371","9413258","10.1016/S0165-5728(97)00134-3","2-s2.0-0031471371","1997-12-01","Chemokine-enhanced migration of human peripheral blood mononuclear cells is antagonized by interferon beta-1b through an effect on matrix metalloproteinase-9"
"0029838040","8857715","","2-s2.0-0029838040","1996-10-01","Linomide reduces the rate of active lesions in relapsing-remitting multiple sclerosis"
"0030669787","9372509","","2-s2.0-0030669787","1997-11-19","Open label gabapentin treatment for pain in multiple sclerosis"
"0027515341","8232485","","2-s2.0-0027515341","1993-12-09","The effect of corticosteroids for acute optic neuritis on the subsequent development of multiple sclerosis"
"0030799818","9291168","","2-s2.0-0030799818","1997-04-01","Treatment effects of monthly intravenous immunoglobulin on patients with relapsing-remitting multiple sclerosis: Further analyses of the Austrian immunoglobulin in MS study"
"0029934137","","","2-s2.0-0029934137","1996-12-01","Clinical efficacy of interferon beta-lb in multiple sclerosis the us/canadian multicentre trial evidence"
"0030692778","9419442","","2-s2.0-0030692778","1997-12-29","Regulation of the inflammatory response in animal models of multiple sclerosis by interleukin-12"
"0030771639","9366318","10.1016/S0022-5347(01)68162-X","2-s2.0-0030771639","1997-12-01","Intravesical capsaicin as a treatment for refractory detrusor hyperreflexia: A dual center study with long-term followup"
"0031031884","8997465","","2-s2.0-0031031884","1997-01-22","Severe vaginal bleeding associated with recombinant interferon beta-1b"
"0030892889","9119980","10.1016/S0165-5728(96)00206-8","2-s2.0-0030892889","1997-04-01","Comparison of the effects of oral versus intravenous methylprednisolone regimens on peripheral blood T lymphocyte adhesion molecule expression, T cell subsets distribution and TNF alpha concentrations in multiple sclerosis"
"0031911495","9484362","","2-s2.0-0031911495","1998-02-01","Effect of steroids on Gd-enhancing lesions before and during recombinant beta interferon 1a treatment in relapsing remitting multiple sclerosis"
"0029797827","8897084","","2-s2.0-0029797827","1996-10-22","The effect of orally and rectally administered Δ 9-tetrahydrocannabinol on spasticity: A pilot study with 2 patients"
"0030853665","9305316","","2-s2.0-0030853665","1997-10-18","Anticytokine antibodies in beta interferon-treated MS patients and the need for testing: Plight of the practicing neurologist"
"0030683529","9385477","10.1016/S0149-2918(97)80042-2","2-s2.0-0030683529","1997-12-09","Managing side effects of interferon-beta in patients with relapsing- remitting multiple sclerosis"
"0031469731","9413260","10.1016/S0165-5728(97)00133-1","2-s2.0-0031469731","1997-12-01","Nasal administration of myelin basic protein prevents relapsing experimental autoimmune encephalomyelitis in DA rats by activating regulatory cells expressing IL-4 and TGF-β mRNA"
"0029806397","","","2-s2.0-0029806397","1996-11-15","High dosage corticosteroids in the treatment of optic neuritis and prophylaxis of multiple sclerosis"
"0030919233","9161373","10.1016/S0003-9993(97)90168-4","2-s2.0-0030919233","1997-05-01","Gabapentin for relief of upper motor neuron symptoms in multiple sclerosis"
"0029836775","8855756","","2-s2.0-0029836775","1996-10-01","Pemoline-induced autoimmune hepatitis"
"0030780744","9421299","","2-s2.0-0030780744","1997-12-08","Lipopolysaccharide induces expression of tumour necrosis factor alpha in rat brain: Inhibition by methylprednisolone and by rolipram"
"0029887146","8725985","","2-s2.0-0029887146","1996-05-01","Natural alpha interferon in multiple sclerosis: Results of three preliminary series"
"0030697458","9372508","","2-s2.0-0030697458","1997-11-19","Treatment of multiple sclerosis with high-dose corticosteroids may prolong the prothrombin time to dangerous levels in patients taking warfarin"
"0030272393","8862132","10.1016/S0165-5728(96)00100-2","2-s2.0-0030272393","1996-10-01","Methylprednisolone attenuates interferon-β induced expression of HLA-DR on monocytes"
"0030950930","9109860","","2-s2.0-0030950930","1997-04-01","Effects of anti-CD4 antibody treatment on lymphocyte subsets and stimulated tumor necrosis factor alpha production: A study of 29 multiple sclerosis patients entered into a clinical trial of cM-T412"
"0029670139","8632057","10.1016/0165-5728(95)00164-6","2-s2.0-0029670139","1996-02-01","Immunoregulatory effects of interferon-β and interacting cytokines on human vascular endothelial cells implications for multiple sclerosis and other autoimmune diseases"
"0029950889","8649562","","2-s2.0-0029950889","1996-06-01","Interferon-β1b treatment decreases tumor necrosis factor-α and increases interleukin-6 production in multiple sclerosis"
"0029875377","8851689","","2-s2.0-0029875377","1996-01-01","Short-term high dose steroid therapy does not affect the hypothalamic-pituitary-adrenal axis in relapsing multiple sclerosis patients. Clinical assessment by the insulin tolerance test"
"0026640343","1520082","10.1001/archneur.1992.00530330045014","2-s2.0-0026640343","1992-01-01","An Antispasticity Effect of Threonine in Multiple Sclerosis"
"0030767497","9307252","10.1002/ana.410420307","2-s2.0-0030767497","1997-09-01","Immune deviation following pulse cyclophosphamide/methylprednisolone treatment of multiple sclerosis: Increased interleukin-4 production and associated eosinophilia"
"10544254263","8981304","10.1016/S0022-510X(96)00176-1","2-s2.0-10544254263","1996-11-01","Systemic high-dose recombinant-alpha-2a-interferon therapy modulates lymphokine production in multiple sclerosis"
"0030988572","9153489","","2-s2.0-0030988572","1997-05-01","Interferon beta results in immediate reduction of contrast-enhanced MRI lesions in multiple sclerosis patients followed by weekly MRI"
"0028936221","7529476","10.1002/ana.410370105","2-s2.0-0028936221","1995-01-31","The interferons: Biological effects, mechanisms of action, and use in multiple sclerosis"
"1842416033","9418974","10.1002/(SICI)1097-4547(19971201)50:5&lt;872::AID-JNR23&gt;3.0.CO;2-1","2-s2.0-1842416033","1997-12-01","Transplantation of CG4 oligodendrocyte progenitor cells in the myelin- deficient rat brain results in myelination of axons and enhanced oligodendroglial markers"
"0031858371","9724006","","2-s2.0-0031858371","1998-08-08","Linomide (roquinimex) affects the balance between pro- and anti- inflammatory cytokines in vitro in multiple sclerosis"
"0030040737","9053803","10.1016/0306-4522(95)00451-3","2-s2.0-0030040737","1996-03-01","Functional and neurophysiological evidence of the efficacy of trophic pharmacotherapy using an adrenocorticotrophic hormone4-9 analog in experimental allergic encephalomyelitis, an animal model of multiple sclerosis"
"0029056787","8968220","10.1002/ana.410370710","2-s2.0-0029056787","1995-01-01","Multiple sclerosis: Immune mechanism and update on current therapies"
"0027521002","8469319","","2-s2.0-0027521002","1993-04-01","Interferon beta-1b is effective in relapsing-remitting multiple sclerosis. II. MRI analysis results of a multicenter, randomized, double-blind, placebo-controlled trial"
"0030726157","9339698","","2-s2.0-0030726157","1997-10-01","VLA-4 expression on peripheral blood lymphocytes is downregulated after treatment of multiple sclerosis with interferon beta"
"0030890766","9130795","10.1016/S0306-4522(96)00514-3","2-s2.0-0030890766","1997-04-05","Longitudinal in vivo magnetic resonance imaging studies in experimental allergic encephalomyelitis: Effect of a neurotrophic treatment on cortical lesion development"
"0030610524","9153530","10.1002/ana.410410517","2-s2.0-0030610524","1997-05-01","Increases m soluble VCAM-1 correlate with a decrease in MRI lesions in multiple sclerosis treated with interferon β-1b"
"0031040578","9057726","10.1016/S0140-6736(05)61562-0","2-s2.0-0031040578","1997-03-13","How should we proceed with disease-modifying treatments for multiple sclerosis?"
"0030864154","9270566","","2-s2.0-0030864154","1997-08-01","Interferon-β interferes with the proliferation but not with the cytokine secretion of myelin basic protein-specific, T-helper type 1 lymphocytes"
"0029400839","7501140","","2-s2.0-0029400839","1995-01-01","Fatigue therapy in multiple sclerosis: Results of a double–blind, randomized, parallel trial of amantadine, pemoline, and placebo"
"0030818474","9291169","","2-s2.0-0030818474","1997-04-01","Intravenous immunoglobulin treatment in multiple sclerosis and experimental autoimmune encephalomyelitis - The Israeli Experience"
"0030043529","8708647","","2-s2.0-0030043529","1996-02-01","Lasting reduction of severe spasticity after ending chronic treatment with intrathecal baclofen"
"0028982907","7729328","10.2165/00003495-199549020-00005","2-s2.0-0028982907","1995-01-01","Multiple Sclerosis Therapy: A Practical Guide"
"0029936443","8965119","","2-s2.0-0029936443","1996-04-11","New insights into the mechanism of action of copolymer 1 in experimental allergic encephalomyelitis and multiple sclerosis"
"0030472573","8970454","","2-s2.0-0030472573","1996-12-01","Desmopressin in the management of nocturia in patients with multiple sclerosis: A double-blind, crossover trial"
"0030856261","9395124","10.1016/S0022-510X(97)00130-5","2-s2.0-0030856261","1997-11-12","Tolerance induction to myelin basic protein by intravenous synthetic peptides containing epitope P85 VVHFFKNIVTP96 in chronic progressive multiple sclerosis"
"0029893478","","","2-s2.0-0029893478","1996-12-01","The effects of interferon beta-lb in multiple sclerosis as assessed by MRI"
"0030690121","9415535","10.1016/S0022-510X(97)00159-7","2-s2.0-0030690121","1997-11-25","The effects of high-dose intravenous methylprednisolone on event- related potentials in patients with multiple sclerosis"
"0031057970","9057729","10.1016/S0140-6736(96)09377-4","2-s2.0-0031057970","1997-03-01","Randomised placebo-controlled trial of monthly intravenous immunoglobulin therapy in relapsing-remitting multiple sclerosis"
"0030918605","9193208","","2-s2.0-0030918605","1997-06-30","Relationship of the antispasticity effect of tizanidine to plasma concentration in patients with multiple sclerosis"
"0029832923","8757002","","2-s2.0-0029832923","1996-08-01","Treatment of secondary progressive multiple sclerosis with the immunomodulator linomide: A double-blind, placebo-controlled pilot study with monthly magnetic resonance imaging evaluation"
"0031038535","9050957","10.1007/s004150050068","2-s2.0-0031038535","1997-03-12","Immunological monitoring of azathioprine treatment in multiple sclerosis patients"
"0030740514","9252798","","2-s2.0-0030740514","1997-07-01","The perceived effects of smoked cannabis on patients with multiple sclerosis"
"0027429795","8232492","10.1056/NEJM199312093292411","2-s2.0-0027429795","1993-12-17","Corticosteroids and optic neuritis"
"0030932076","9113039","","2-s2.0-0030932076","1997-04-29","Intravenous immunoglobulin for multiple sclerosis (multiple letters) [15]"
"0030995211","9093250","10.1016/S0140-6736(96)06453-7","2-s2.0-0030995211","1997-03-29","Randomised trial of oral and intravenous methylprednisolone in acute relapses of multiple sclerosis"
"10544237271","8960727","","2-s2.0-10544237271","1996-12-01","Treatment with oral 3,4 diaminopyridine improves leg strength in multiple sclerosis patients: Results of a randomized, double-blind, placebo- controlled, crossover trial"
"0030807106","9191794","","2-s2.0-0030807106","1997-06-01","Clinical effectiveness of lamotrigine and plasma levels in essential and symptomatic trigeminal neuralgia"
"0030990571","9069487","","2-s2.0-0030990571","1997-03-01","Ondansetron, a 5-HT3 antagonist, improves cerebellar tremor"
"0030855423","9222213","","2-s2.0-0030855423","1997-08-19","Amelioration of refractory dysesthetic limb pain in multiple sclerosis by gabapentin"
"0002023426","","10.1016/1359-6446(96)89115-X","2-s2.0-0002023426","1996-01-01","Recent advances in matrix metalloproteinase inhibitor research"
"0025286134","2162376","10.1111/j.1471-4159.1990.tb08815.x","2-s2.0-0025286134","1990-01-01","Cannabinoid Receptors and Modulation of Cyclic AMP Accumulation in the Rat Brain"
"0031068172","9040932","","2-s2.0-0031068172","1997-02-01","Clozapine treatment of psychosis associated with multiple sclerosis."
"0029745996","","","2-s2.0-0029745996","1996-12-01","Copolymer-1 a review of its pharmacological properties and therapeutic potential in multiple sclerosis"
"0031060356","9007739","","2-s2.0-0031060356","1997-01-01","Drug therapy for acquired pendular nystagmus in multiple sclerosis"
"0030054701","8710065","","2-s2.0-0030054701","1996-08-02","Interferon alpha-2a treatment of relapsing-remitting multiple sclerosis: Disease activity resumes after stopping treatment"
"0008266721","9038425","","2-s2.0-0008266721","1997-01-01","Clinical and magnetic resonance imaging changes correlate in a clinical trial monitoring cyclosporine therapy for multiple sclerosis"
"0029791796","8759981","","2-s2.0-0029791796","1996-08-01","Sporadic corticosteroid pulses and osteoporosis in multiple sclerosis"
"0345503603","","","2-s2.0-0345503603","1996-07-13","Cannabis. Uses and abuses"
"0029948819","8649563","","2-s2.0-0029948819","1996-06-01","Interferon beta-1b serum levels in multiple sclerosis patients following subcutaneous administration"
"0031441192","9413259","10.1016/S0926-9851(97)00020-7","2-s2.0-0031441192","1997-12-01","Human CD8+ TCR-αβ+ and tcr-γδ+ cells modulate autologous autoreactive neuroantigen-specific CD4+ T-cells by different mechanisms"
"0029897746","8614531","","2-s2.0-0029897746","1996-01-01","Side effect profile of interferon beta-1b in MS: Results of an open label trial"
"0030793925","9344192","10.1016/S0190-9622(97)70170-1","2-s2.0-0030793925","1997-10-28","Cutaneous reactions to recombinant human interferon beta-1b: The clinical and histologic spectrum"
"0029794411","8874590","","2-s2.0-0029794411","1996-09-01","Nasal spray desmopressin treatment of bladder dysfunction in patients with multiple sclerosis"
"0029941797","8633710","","2-s2.0-0029941797","1996-06-13","Valproic acid for panic disorder associated with multiple sclerosis [8]"
"0030029730","8714617","","2-s2.0-0030029730","1996-03-04","Treatment of multiple sclerosis and other autoimmune diseases with cladribine"
"0028823316","7472417","","2-s2.0-0028823316","1995-01-01","Cannabinoids activate an inwardly rectifying potassium conductance and inhibit Q-type calcium currents in AtT20 cells transfected with rat brain cannabinoid receptor"
"0029996079","8965117","","2-s2.0-0029996079","1996-12-01","Safety profile of copolymer 1: Analysis of cumulative experience in the United States and Israel"
"0030777818","9400356","","2-s2.0-0030777818","1997-12-01","The quality-of-life effects of interferon beta-1b in multiple sclerosis: An extended Q-TWiST analysis"
"0030019643","8639070","","2-s2.0-0030019643","1996-02-01","The effects of amantadine and pemoline on cognitive functioning in multiple sclerosis"
"0030691881","9371858","10.1056/NEJM199711273372207","2-s2.0-0030691881","1997-11-27","Management of multiple sclerosis"
"0029899905","8964913","10.1016/0165-5728(96)00019-7","2-s2.0-0029899905","1996-05-01","A pilot study investigating the effects of orally administered pentoxifylline on selected immune variables in patients with multiple sclerosis"
"0030731322","9344704","10.1006/clin.1997.4444","2-s2.0-0030731322","1997-12-12","Inhibition of the progression of multiple sclerosis by linomide is associated with upregulation of CD4+/CD45RA+ cells and downregulation of CD4+/CD45RO+ cells"
"0030048924","8538656","10.1002/(SICI)1097-4598(199601)19:1&lt;100::AID-MUS16&gt;3.0.CO;2-#","2-s2.0-0030048924","1996-01-12","Decline of muscle fiber conduction velocity during short-term high-dose methylprednisolone therapy"
"0030608853","9404997","","2-s2.0-0030608853","1997-01-01","Reduced adhesion of PBMMCs to endothelium in methylprednisolone-treated MS patients: Preliminary results"
"0029884744","8649560","","2-s2.0-0029884744","1996-06-01","Plasma exchange combined with azathioprine in multiple sclerosis using serial gadolinium-enhanced MRI to monitor disease activity: A randomized single-masked cross-over pilot study"
"16044361810","8837609","10.1038/nm1096-1109","2-s2.0-16044361810","1996-10-01","Treatment of multiple sclerosis with T-cell receptor peptides: Results of a double-blind pilot trial"
"0030032196","","","2-s2.0-0030032196","1996-12-01","A Vaccine for Multiple Sclerosis: Is it a Feasible Option?"
"1842414797","9267740","","2-s2.0-1842414797","1997-08-19","Necrotizing cutaneous lesions caused by interferon beta injections in a patient with multiple sclerosis"
"0025921573","1826726","","2-s2.0-0025921573","1991-05-01","Biology of human immunoglobulin G Fc receptors."
"0004394728","","","2-s2.0-0004394728","1985-07-13","Monoclonal antibodies in rheumatology"
"0024424859","2476845","10.1111/j.1365-3083.1989.tb01225.x","2-s2.0-0024424859","1989-01-01","The IgG Subclass Pattern of Complement Activation Depends on Epitope Density and Antibody and Complement Concentration"
"0004364671","","","2-s2.0-0004364671","1994-07-13","Peripheral blood lymphocyte subsets after CAMPATH-1H therapy in rheumatoid arthritis-a 3 year follow-up"
"0028266872","7908767","","2-s2.0-0028266872","1994-01-01","CDR-grafted OKT4A monoclonal antibody in cynomolgus renal allograft recipients"
"0025852497","1707275","10.1002/art.1780340407","2-s2.0-0025852497","1991-01-01","Activation of CD16+ effector cells by rheumatoid factor complex. Role of natural killer cells in rheumatoid arthritis"
"0026570791","1369477","10.1038/nbt0292-169","2-s2.0-0026570791","1992-01-01","High-level expression of a Recombinant Antibody from myeloma cells using a glutamine synthetase gene as an amplifiable selectable marker"
"10544234051","","","2-s2.0-10544234051","1994-01-11","An in vivo model for determining rules of antibody design"
"0027458717","8436176","10.1002/eji.1830230216","2-s2.0-0027458717","1993-01-01","The generation of a humanized, non‐mitogenic CD3 monoclonal antibody which retains in vitro immunosuppressive properties"
"0025368193","1972161","","2-s2.0-0025368193","1990-01-01","Mechanisms of anti-CD4-mediated depletion and immunotherapy. A study using a set of chimeric anti-CD4 antibodies"
"0028670386","7698797","","2-s2.0-0028670386","1994-12-01","Physiological T-cell death: Susceptibility is modulated by activation, aging, and transformation, but the mechanism is constant"
"10544224808","","","2-s2.0-10544224808","1990-01-11","High level expression of the humanised monoclonal antibody CAMPATH-1H in Chinese hamster ovary cells"
"0025817427","1910686","","2-s2.0-0025817427","1991-01-01","Fc receptors"
"0029025475","7715639","10.1056/NEJM199505183322001","2-s2.0-0029025475","1995-05-18","Effect of hydroxyurea on the frequency of painful crises in Sickle cell anemia"
"0026500372","1536796","10.1111/j.1365-2141.1992.tb06407.x","2-s2.0-0026500372","1992-01-01","Bone marrow transplantation for severe sickle cell anaemia"
"0030051313","8636820","10.1016/S0022-3476(96)70398-0","2-s2.0-0030051313","1996-02-28","Persistence of fetal hemoglobin production after successful transplantation of cord blood stem cells in a patient with sickle cell anemia"
"0028046507","7996363","10.1016/S0022-3476(05)82006-2","2-s2.0-0028046507","1994-01-01","Effects of a long-term transfusion regimen on sickle cell-related illnesses"
"0025897050","1903244","","2-s2.0-0025897050","1991-01-01","Gonadal function after allogenic bone marrow transplantation for thalassaemia"
"0030054553","8663876","10.1056/NEJM199608083350609","2-s2.0-0030054553","1996-08-17","Bone marrow transplantation in sickle cell anemia - The dilemma of choice"
"9344231922","8663884","10.1056/NEJM199608083350601","2-s2.0-9344231922","1996-08-08","Bone marrow transplantation for sickle cell disease"
"0029049931","7795250","","2-s2.0-0029049931","1995-01-01","Neurologic complications after bone marrow transplantation for sickle cell anemia [2]"
"0028828293","8560287","","2-s2.0-0028828293","1995-01-01","Bone marrow transplantation in thalassemia"
"0025859418","1887249","","2-s2.0-0025859418","1991-01-01","Sickle cell diseases in the 1990s: The need for active and preventive intervention"
"0029915585","8704695","","2-s2.0-0029915585","1996-03-01","Neurologic complications following bone marrow transplantation for sickle cell disease"
"0030936063","","","2-s2.0-0030936063","1997-03-01","Sickle cell disease and haemotopoietic stem cell transplantation in Belgium"
"0027184519","8355742","10.1056/NEJM199309163291204","2-s2.0-0027184519","1993-01-01","Marrow transplantation in patients with thalassemia responsive to iron chelation therapy"
"8944228913","8657213","10.1056/NEJM199607183350303","2-s2.0-8944228913","1996-07-18","Placental blood as a source of hematopoietic stem cells for transplantation into unrelated recipients"
"0028098022","8311168","","2-s2.0-0028098022","1994-01-01","Bone marrow transplantation for sickle cell disease: The united states experience"
"0028966027","7849310","","2-s2.0-0028966027","1995-01-01","Neurologic complications after allogeneic marrow transplantation for sickle cell anemia"
"0029005136","7776091","10.1016/S0022-3476(95)70204-0","2-s2.0-0029005136","1995-01-01","Risk of recurrent stroke in patients with sickle cell disease treated with erythrocyte transfusions"
"0029982591","8648542","10.1016/S0022-3476(96)70335-9","2-s2.0-0029982591","1996-06-24","Hydroxyurea therapy in children severely affected with sickle cell disease"
"0029845949","8822914","","2-s2.0-0029845949","1996-09-15","Hydroxyurea for treatment of severe sickle cell anemia: A pediatric clinical trial"
"0005394459","","","2-s2.0-0005394459","1997-04-13","Stroke prevention in sickle cell disease (STOP): Baseline characteristics of trial patients"
"0028291736","7993409","","2-s2.0-0028291736","1994-12-01","Mortality in sickle cell disease. Life expectancy and risk factors for early death"
"0027400696","8467231","10.1016/0268-960X(93)90018-Y","2-s2.0-0027400696","1993-01-01","Bone marrow transplant for sickle cell disease-the dilemma"
"0021250668","6727978","","2-s2.0-0021250668","1984-01-01","Influence of sickle hemoglobinopathies on growth and development"
"0028969402","7717375","10.1002/ajh.2830480410","2-s2.0-0028969402","1995-01-01","Bone marrow transplantation in a young child with sickle cell anemia"
"0029930242","8639928","","2-s2.0-0029930242","1996-04-01","Pregnancies following high-dose cyclophosphamide with or without high-dose busulfan or total-body irradiation and bone marrow transplantation"
"0003496954","","","2-s2.0-0003496954","1980-08-02",""
"0028821145","7823998","10.1056/NEJM199502093320605","2-s2.0-0028821145","1995-01-01","Brief report: Transplantation of cord-blood stem cells into a patient with severe thalassemia"
"0026500546","1737091","","2-s2.0-0026500546","1992-01-01","Growth in children after bone marrow transplantation: Busulfan plus cyclophosphamide versus cyclophosphamide plus total body irradiation"
"0029008905","7606013","","2-s2.0-0029008905","1995-01-01","Growth in children after bone marrow transplantation for acute leukemia"
"0026040687","1922237","","2-s2.0-0026040687","1991-11-07","Bone marrow transplantation for sickle cell disease: A study of parents' decisions"
"0029057117","7581127","","2-s2.0-0029057117","1995-01-01","Graft-rejection and toxicity following bone marrow transplantation in relation to busulfan pharmacokinetics"
"0030973719","","","2-s2.0-0030973719","1997-03-01","Collaborative study of marrow transplantation for sickle cell disease: Aspects specific for transplantation of hemoglobin disorders"
"0028147445","8311169","","2-s2.0-0028147445","1994-01-01","Availability of related donors for bone marrow transplantation in sickle cell anemia"
"0027509231","8427992","","2-s2.0-0027509231","1993-01-01","Bone marrow transplantation corrects the splenic reticuloendothelial dysfunction in sickle cell anemia"
"0030854656","9241126","10.1056/NEJM199708073370602","2-s2.0-0030854656","1997-08-07","Outcome of cord-blood transplantation from related and unrelated donors"
"0030896219","9108426","","2-s2.0-0030896219","1997-04-15","Stable mixed hematopoietic chimerism in DLA-identical littermate dogs given sublethal total body irradiation before and pharmacological immunosuppression after marrow transplantation"
"0025955185","1953001","","2-s2.0-0025955185","1991-01-01","Bone marrow transplantation in sickle cell anaemia"
"0030133622","9118298","","2-s2.0-0030133622","1996-05-01","Barriers to bone marrow transplantation for sickle cell anemia"
"0028201732","8011301","","2-s2.0-0028201732","1994-05-04","Tolerance, danger, and the extended family"
"0024542607","2496159","","2-s2.0-0024542607","1989-01-01","A matched set of rat/mouse chimeric antibodies. Identification and biological properties of rat H chain constant regions μ, γ1, γ2a, γ2b, γ2c, ε, and α"
"0018110856","730824","10.1016/0021-9681(78)90071-1","2-s2.0-0018110856","1978-01-01","Excess risk of lymphomas, leukemia and myeloma in patients with rheumatoid arthritis"
"0028568188","7584505","","2-s2.0-0028568188","1994-12-01","Helplessness as a strategy for avoiding antiglobulin responses to therapeutic monoclonal antibodies"
"0022996492","3097122","","2-s2.0-0022996492","1986-12-01","Administration of F(ab')2 fragments of monoclonal antibody to L3T4 inhibits humoral immunity in mice without depleting L3T4+ cells"
"0022496831","3090139","","2-s2.0-0022496831","1986-01-01","Induction of immune tolerance by administration of monoclonal antibody to L3T4"
"0025909131","1777012","10.1016/0896-8411(91)90181-B","2-s2.0-0025909131","1991-01-01","Immunological effects of high dose administration of anti-CD4 antibody in rheumatoid arthritis patients"
"0021332936","6229268","10.1111/j.1365-2133.1984.tb07309.x","2-s2.0-0021332936","1984-01-01","T‐cell subpopulations in the blood and skin of patients with psoriasis"
"0024549385","2647894","","2-s2.0-0024549385","1989-01-01","Induction of classical transplantation tolerance in the adult"
"0000056486","","","2-s2.0-0000056486","1996-02-20","T cell hypothesis in rheumatoid arthritis (RA) tested by humanised non-depleting anti-CD4 monoclonal antibody (mAb) treatment I: Suppression of disease activity and acute phase response"
"0018099294","357213","10.1159/000250839","2-s2.0-0018099294","1978-01-01","Severe psoriasis — Oral therapy with a new retinoid"
"0027429524","8216397","10.1002/art.1780361008","2-s2.0-0027429524","1993-01-01","Chimeric cd4 monoclonal antibody cm‐t412 as a therapeutic approach to rheumatoid arthritis"
"0028280845","8145907","","2-s2.0-0028280845","1994-01-01","Phase 1 clinical trial of chimeric monoclonal anti-CD4 antibody in multiple sclerosis"
"0025829708","2025306","10.1002/art.1780340504","2-s2.0-0025829708","1991-01-01","Treatment of rheumatoid arthritis with monoclonal CD4 antibody M‐T151. Clinical results and immunopharmacologic effects in an open study, including repeated administration"
"9844224567","","","2-s2.0-9844224567","2004-12-20","How may immunosuppression lead to tolerance? the war analogy"
"0030461715","9015484","","2-s2.0-0030461715","1996-12-01","Treatment of refractory Wegener's granulomatosis with humanized monoclonal antibodies"
"0026746595","1384529","10.1016/0896-8411(92)90006-C","2-s2.0-0026746595","1992-01-01","Anti-CD4 monoclonal antibody therapy in severe psoriasis"
"0028882681","7488278","10.1002/art.1780381109","2-s2.0-0028882681","1995-01-01","Double‐blind, placebo‐controlled multicenter trial using chimeric monoclonal anti‐cd4 antibody, cm‐t412, in rheumatoid arthritis patients receiving concomitant methotrexate"
"0014305869","4877784","10.1093/oxfordjournals.qjmed.a067150","2-s2.0-0014305869","1968-01-01","Clinical studies with an articular index for the assessment of joint tenderness in patients with rheumatoid arthritis"
"0024746393","2572230","10.1016/S0896-8411(89)80002-2","2-s2.0-0024746393","1989-01-01","Anti-CD4 antibody treatment of patients with rheumatoid arthritis: I. Effect on clinical course and circulating T cells"
"0025830117","1713269","","2-s2.0-0025830117","1991-04-23","Therapeutic use of monoclonal anti-CD4 antibody in rheumatoid arthritis"
"0019486851","6116956","10.1016/S0140-6736(81)91107-7","2-s2.0-0019486851","1981-10-17","RHEUMATOID ARTHRITIS: A DISEASE OF T-LYMPHOCYTE/MACROPHAGE IMMUNOREGULATION"
"0000772077","","","2-s2.0-0000772077","1996-07-13","Results of a placebo-controlled, multicenter trial using a primatized, non-depleting, anti-CD4 monoclonal antibody in the treatment of rheumatoid arthritis"
"0025787680","1683954","10.1016/0140-6736(91)92353-4","2-s2.0-0025787680","1991-12-14","Treatment of severe systemic lupus erythematosus with anti-CD4 monoclonal antibody"
"0029759669","8761185","","2-s2.0-0029759669","1996-09-14","Does exposure to immunosuppressive therapy increase the 10 year malignancy and mortality risks in rheumatoid arthritis? A matched cohort study"
"0021763964","6471105","10.1016/0022-2836(84)90301-2","2-s2.0-0021763964","1984-08-15","Twisted hyperboloid (strophoid) as a model of β-barrels in proteins"
"0021196170","6336315","10.1038/308145a0","2-s2.0-0021196170","1984-12-01","A human T cell-specific cDNA clone encodes a protein having extensive homology to immunoglobulin chains"
"0020485895","6751382","","2-s2.0-0020485895","1982-12-01","Orthogonal packing of β-pleated sheets in proteins"
"0021744414","6435124","","2-s2.0-0021744414","1984-12-01","Diversity at the variable-joining region boundary of λ light chains has a pronounced effect on immunoglobulin ligand-binding activity"
"0017134551","785525","10.1017/S0033583500002390","2-s2.0-0017134551","1976-01-01","Structure and function of the constant regions of immunoglobulins"
"0022343664","3927286","","2-s2.0-0022343664","1985-12-01","Structural invariants of antigen binding: Comparison of immunoglobulin V(L)-V(H) and V(L)-V(L) domain dimers"
"0015866154","4760134","10.1016/0022-2836(73)90011-9","2-s2.0-0015866154","1973-09-15","Environment and exposure to solvent of protein atoms. Lysozyme and insulin"
"0016708122","1153006","10.1038/256705a0","2-s2.0-0016708122","1975-12-01","Principles of protein-protein recognition"
"76549252207","14816373","","2-s2.0-76549252207","1951-04-01","The structure of proteins; two hydrogen-bonded helical configurations of the polypeptide chain."
"0019505121","7299817","10.1016/0022-2836(81)90538-6","2-s2.0-0019505121","1981-05-25","Analysis of the tertiary structure of protein β-sheet sandwiches"
"0003128571","","","2-s2.0-0003128571","1958-07-13","The crystal structure of benzene at -3 °C"
"0022419375","3892686","","2-s2.0-0022419375","1985-12-01","Aromatic-aromatic interaction: A mechanism of protein structure stabilization"
"0000977124","","","2-s2.0-0000977124","1981-12-24","Relative orientation of close-packed  -pleated sheets in proteins"
"0016797554","813149","10.1038/258641a0","2-s2.0-0016797554","1975-12-01","Different degrees of interspecies homology in immunoglobulin λ chain constant domain correlated with three-dimensional structure"
"0016763223","","10.1007/BF01572309","2-s2.0-0016763223","1975-12-01","Structural basis for the association of heavy and light chains and the relation of subgroups to the conformation of the active site of immunoglobulins"
"0015222647","5551392","10.1016/0022-2836(71)90324-X","2-s2.0-0015222647","1971-02-14","The interpretation of protein structures: Estimation of static accessibility"
"0015809814","4586824","","2-s2.0-0015809814","1973-12-01","The complete amino acid sequence of β2-microglobulin"
"0019965821","6811754","10.1016/0022-2836(82)90147-4","2-s2.0-0019965821","1982-04-25","Unfolding and refolding of the reduced constant fragment of the immunoglobulin light chain. Kinetic role of the intrachain disulfide bond"
"0016721052","","","2-s2.0-0016721052","1975-12-01","Rotational allomerism and divergent evolution of domains in immunoglobulin light chains"
"0001427619","","","2-s2.0-0001427619","1983-03-28","CHARMM: A program for macromolecular energy, minimization, and dynamics calculations"
"0018703002","528012","10.1016/0161-5890(79)90083-X","2-s2.0-0018703002","1979-01-01","Three dimensional structure of the pFc′ fragment of guinea pig IgG1"
"0020418655","6755269","10.1038/300583a0","2-s2.0-0020418655","1982-12-01","The T lymphocyte antigen receptor - Paradigm lost"
"84950744233","","","2-s2.0-84950744233","1980-12-29","Calculated energy and conformation of clusters of benzene molecules and their relationship to crystalline benzene"
"0019505815","6118138","","2-s2.0-0019505815","1981-08-17","Analysis of structural similarities between brain Thy-1 antigen and immunoglobulin domains. Evidence for an evolutionary relationship and a hypothesis for its functional significance"
"0018544013","503199","","2-s2.0-0018544013","1979-11-01","Immunoglobulins and histocompatibility antigens."
"0013484210","4530984","10.1073/pnas.71.11.4298","2-s2.0-0013484210","1974-12-01","The three dimensional structure of a phosphorylcholine binding mouse immunoglobulin Fab and the nature of the antigen binding site"
"0343063933","270659","","2-s2.0-0343063933","1977-12-01","Structure of proteins: packing of α-helices and pleated sheets"
"0015310138","4501574","","2-s2.0-0015310138","1972-03-01","Structure of a calcium-binding carp myogen."
"0001257560","275827","","2-s2.0-0001257560","1978-01-01","The β bulge: A common small unit of nonrepetitive protein structure"
"0346589159","","","2-s2.0-0346589159","1969-07-13",""
"0020491376","7154095","10.1016/0022-2836(82)90163-2","2-s2.0-0020491376","1982-11-25","Structure of β-sheets. Origin of the right-handed twist and of the increased stability of antiparallel over parallel sheets"
"0019443447","7020376","","2-s2.0-0019443447","1981-01-01","The anatomy and taxonomy of protein structure."
"0021760017","6546418","","2-s2.0-0021760017","1984-01-11","A program for prediction of protein secondary structure from nucleotide sequence data: Application to histocompatibility antigens"
"0017654888","408498","10.1016/0022-2836(77)90232-7","2-s2.0-0017654888","1977-07-15","Analysis of interspecies variability of immunoglobulin lambda chains reveals differences in domain tertiary structures"
"0021241263","6322002","","2-s2.0-0021241263","1984-01-01","The receptor for transepithelial transport of IgA and IgM contains multiple immunoglobulin-like domains"
"0015914783","4728692","10.1016/0022-2836(73)90022-3","2-s2.0-0015914783","1973-04-05","Conformation of twisted β-pleated sheets in proteins"
"0019317327","6991952","10.1038/285378a0","2-s2.0-0019317327","1980-12-01","Analysis and prediction of protein β-sheet structures by a combinatorial approach"
"0018637113","388231","10.1038/282266a0","2-s2.0-0018637113","1979-12-01","The heavy chain of human histocompatibility antigen HLA-B7 contains an immunoglobulin-like region"
"0017876485","642001","10.1016/0022-2836(78)90201-2","2-s2.0-0017876485","1978-03-15","Packing of α-helices: Geometrical constraints and contact areas"
"0020173901","6956896","","2-s2.0-0020173901","1982-08-01","Electronic distributions within protein phenylalanine aromatic rings are reflected by the three-dimensional oxygen atom environments."
"0021100468","6643494","","2-s2.0-0021100468","1983-12-10","Molecular anatomy of the antibody binding site."
"0021967455","","","2-s2.0-0021967455","1985-01-01","Capacity of cyclosporine to induce auto-graft-versus-host disease and impair intrathymic T cell differentiation"
"84930549996","","","2-s2.0-84930549996","1987-06-14",""
"84930545522","","","2-s2.0-84930545522","1987-06-14","Bone marrow transplantation in high-risk acute lymphoblastic leukaemia in first and second remission"
"0018764352","34792","","2-s2.0-0018764352","1979-12-01","Antileukemic effect of graft-versus-host disease in human recipients of allogeneic-marrow grafts"
"84930547783","","","2-s2.0-84930547783","1982-06-14","Elimination of carcinoma cells from human bone marrow"
"84930547670","","","2-s2.0-84930547670","1985-06-14","The use of pan T monoclonal antibodies in ex vivo for prevention of acute GvHD"
"84930555060","","","2-s2.0-84930555060","1982-06-14","Bone marrow transplantation for acute leukaemia in first remission"
"0022718707","3518785","10.1111/j.1365-2141.1986.tb07512.x","2-s2.0-0022718707","1986-01-01","SUCCESSFUL TREATMENT OF LATE GRAFT FAILURE FOLLOWING T CELL DEPLETED BONE MARROW TRANSPLANTATION"
"84930549802","","","2-s2.0-84930549802","1987-06-14","Immunobiology of bone marrow transplantation"
"84930553257","","","2-s2.0-84930553257","1984-06-14","Elimination of graft versus host disease by in vitro depletion of alloreactive lymphocytes using a monoclonal rat anti-human lymphocyte antibody (CAMPATH- 1)"
"0023009536","3518418","10.1002/ajh.2830220211","2-s2.0-0023009536","1986-01-01","Philadelphia‐positive metaphases in the marrow after bone marrow transplantation for chronic granulocytic leukemia"
"0021926593","","","2-s2.0-0021926593","1985-01-01","Prospective randomized controlled trial of ex vivo treatment of donor bone marrow with monoclonal anti-T cell antibody and complement for prevention of graft-versus-host disease: A preliminary report"
"0022516937","3092411","","2-s2.0-0022516937","1986-01-01","The contribution of large granular lymphocytes to B cell activation and differentiation after Tߝcell-depleted allogeneic bone marrow transplantation"
"0019971744","6750842","10.1111/j.1399-0039.1982.tb00329.x","2-s2.0-0019971744","1982-01-01","Factors controlling the engraftment of transplanted dog bone marrow cells"
"0022538285","3530316","10.1111/j.1365-2141.1986.tb07574.x","2-s2.0-0022538285","1986-01-01","Standardization of T‐cell depletion in HLA matched bone marrow transplantation"
"84930550058","","","2-s2.0-84930550058","1984-06-14","Depletion of T lymphocytes in donor marrow prevents significant graft versus host disease in matched allogeneic leukemic marrow transplant recipients"
"84930547818","","","2-s2.0-84930547818","1985-06-14","An immunological analysis of three cases of bone marrow failure associated with Campath-l-incubation"
"0021215336","6370297","10.1111/j.1365-2141.1984.tb02188.x","2-s2.0-0021215336","1984-01-01","Bone marrow transplantation for acute nonlymphoblastic leukaemia: a survey of the European Group for Bone Marrow Transplantation (E.G.B.M.T.)"
"0019861205","7015133","","2-s2.0-0019861205","1981-12-01","Antileukemic effect of chronic graft-versus-host disease. Contribution to improved survival after allogeneic marrow transplantation"
"84930546933","","","2-s2.0-84930546933","1986-06-14","Waldmann H. Depletion of T cells from bone marrow with CAMPATH-1 and human complement. Analysis of GVHD and graft failure in a multi-centre study"
"84915876992","","","2-s2.0-84915876992","1983-12-16","Problems of mismatched bone marrow transplantation for severe combined immunodeficiency using soybean lectin fractionation"
"84930553260","","","2-s2.0-84930553260","1984-06-14","Allogeneic bone marrow transplantation for chronic myelogenous leukaemia"
"0022521334","3527302","","2-s2.0-0022521334","1986-12-30","Clonable T lymphocytes in T cell-depleted bone marrow transplants correlate with development of graft-v-host disease"
"0022273650","3910558","","2-s2.0-0022273650","1985-12-01","Graft-versus-host disease in dog and man: the Seattle experience."
"84930547397","","","2-s2.0-84930547397","1986-06-14","Lymphocyte can survive intensive conditioning for bone marrow transplantation"
"0014900566","4098172","","2-s2.0-0014900566","1970-12-01","Anaphylatoxin inactivator of human plasma: its isolation and characterization as a carboxypeptidase."
"0021999060","3888387","","2-s2.0-0021999060","1985-07-11","Clinical trial depleting T lymphocytes from donor marrow for matched and mismatched allogeneic bone marrow transplants"
"84930500837","","","2-s2.0-84930500837","1986-07-22","Prevention of graft failure by an anti-HLFA-1 monoclonal antibody in HLA-mismatched bone marrow transplantation"
"84930554669","","","2-s2.0-84930554669","1983-06-14","Bone marrow transplantation for acute lymphoblastoid leukaemia"
"84930546579","","","2-s2.0-84930546579","0000-06-14","Chromosome studies in patients with Phl+ CML submitted to BMT: Results of a European cooperative study"
"33746479468","","","2-s2.0-33746479468","1983-06-12","Marrow transplantation for acute nonlymphoblastic leukemia in first remission: Preliminary results of a randomized trial comparing cyclosporine and methotrexate for the prophylaxis of graft-versus-host disease"
"0020049270","7035950","","2-s2.0-0020049270","1982-04-05","A randomized study of the prevention of acute graft-versus-host disease"
"84912511361","","","2-s2.0-84912511361","1983-12-07","Preincubation of donor marrow with a combination of murine monoclonal anti-T cell antibodies (without complement) does not prevent graft versus host disease"
"84920246185","","","2-s2.0-84920246185","1982-01-10","Pretreatment of donor bone marrow with monoclonal antibody OKT3 for prevention of acute graft-versus-host disease in allogeneic histocompatible bone marrow transplantation"
"0018917152","6101787","10.1016/S0140-6736(80)90881-8","2-s2.0-0018917152","1980-02-16","CYCLOSPORIN A TO PREVENT GRAFT-VERSUS-HOST DISEASE IN MAN AFTER ALLOGENEIC BONE-MARROW TRANSPLANTATION"
"0020642827","6343227","10.1111/j.1600-065X.1983.tb01069.x","2-s2.0-0020642827","1983-01-01","Allogeneic Bone‐Marrow Transplantation"
"0015631505","4146020","","2-s2.0-0015631505","1973-01-01","Modification of severe graft-versus-host disease with antisera to the θ antigen or to whole serum1"
"1942421930","26916","","2-s2.0-1942421930","1978-12-01","Hemopoietic stem cell transplantation using mouse bone marrow and spleen cells fractionated by lectins"
"84920239461","","","2-s2.0-84920239461","1983-01-10","Surface markers of T cells causing lethal graft-versus-host"
"0019954401","7049469","10.1016/0090-1229(82)90128-3","2-s2.0-0019954401","1982-01-01","Bone marrow transplantation across major histocompatibility barriers in mice. IV. Graft-versus-host disease in TLI-conditioned mice"
"0014748313","4392379","","2-s2.0-0014748313","1970-01-01","Methotrexate regimens for control of graft-versus-host disease in dogs with allogeneic marrow grafts"
"0022541179","3527722","10.1002/eji.1830160812","2-s2.0-0022541179","1986-01-01","Fine specificity of antibodies produced in rhesus monkeys following in vivo treatment with anti‐T cell murine monoclonal antibodies"
"84989518810","","","2-s2.0-84989518810","1987-10-10",""
"0022535538","3091381","10.1002/eji.1830160818","2-s2.0-0022535538","1986-01-01","Differentiation antigens on rhesus monkey lymphocytes II. Characterization of RhT3, a CD3‐like antigen on T cells"
"0022534172","3085297","","2-s2.0-0022534172","1986-01-01","Monoclonal antibody theraphy: Anti-idiotypic and non-anti-indiotypic antibodies to OKT3 arising despite intense immunosuppression"
"0342473740","6582477","","2-s2.0-0342473740","1984-03-22","Human anti-idiotype antibodies in cancer patients: Is the modulation of the immune response beneficial for the patient?"
"0021909415","","","2-s2.0-0021909415","1985-01-01","The restricted human response to the murine monoclonal OKT3 antibody"
"84989528521","","","2-s2.0-84989528521","1987-10-10",""
"0020561065","6346593","","2-s2.0-0020561065","1983-01-01","Effects of in vivo administration of monoclonal antibodies specific for human T cell subpopulations on the immune system in a rhesus monkey model"
"84989542623","","","2-s2.0-84989542623","1987-10-10",""
"0022917359","","10.1016/0167-5699(86)90028-9","2-s2.0-0022917359","1986-01-01","The immune response against therapeutic monoclonal antibodies"
"0021907959","3919479","","2-s2.0-0021907959","1985-05-23","OKT4 and OKT4A antibody treatment as immunosuppression for kidney transplantation in rhesus monkeys"
"0020538297","","","2-s2.0-0020538297","1983-01-01","Immunologic follow-up of renal allograft recipients treated prophylactically by OKT3 alone"
"84989551071","","","2-s2.0-84989551071","1986-10-10",""
"13344265518","","","2-s2.0-13344265518","1990-02-22","Immunosuppressive drugs for the prevention of acute graft-vs-host disease"
"0009563904","","","2-s2.0-0009563904","1990-07-13","Treatment of extensive human chronic graft-vs-host disease"
"17444380891","","","2-s2.0-17444380891","1986-05-06","Development of a simplified centrifugation elutriation procedure for depletion of lymphocytes from human bone marrow"
"0026699785","1383132","","2-s2.0-0026699785","1992-08-24","Characterization of the membrane attack complex inhibitory protein CD59 antigen on human amniotic cells and in amniotic fluid"
"0023251152","2440322","10.1111/j.1600-0897.1987.tb00104.x","2-s2.0-0023251152","1987-01-01","Characterization of Monoclonal Antibodies Against Human Sperm Antigens by Immunoassays Including Sperm Function Assays and Epitope Evaluation"
"0023193946","2443696","","2-s2.0-0023193946","1987-09-04","Analysis of the surface labelling characteristics of human spermatozoa and the interaction with anti-sperm antibodies"
"0025179976","1698710","","2-s2.0-0025179976","1990-01-01","Human protectin (CD59), an 18,000-20,000 MW complement lysis restricting factor, inhibits C5b-8 catalysed insertion of C9 into lipid bilayers"
"0005451174","","","2-s2.0-0005451174","1989-11-24","Use of human spermatozoa and small-cell lung cancer cell lines to characterize mAb directed against NK and non-lineage antigens"
"0024796505","2697831","","2-s2.0-0024796505","1989-12-01","Membrane remodelling during sperm maturation in the epididymis."
"0024295775","3381102","","2-s2.0-0024295775","1988-12-01","Restricted lateral diffusion of PH-20, a PI-anchored sperm membrane protein"
"0025763452","1714955","10.1016/0165-0378(91)90021-H","2-s2.0-0025763452","1991-01-01","Sperm immobilizing and fertilization-blocking monoclonal antibody 2C6 to human seminal plasma antigen and characterization of the antigen epitope corresponding to the monoclonal antibody"
"0026571224","1548630","10.1016/0165-0378(92)90023-W","2-s2.0-0026571224","1992-01-01","Monoclonal antibodies affecting sperm-zona binding and/or zona-induced acrosome reaction"
"0019491615","7462636","","2-s2.0-0019491615","1981-05-15","A new microassay for spermocytotoxic antibody: Comparison with passive hemagglutination assay for antisperm antibodies in couples with unexplained infertility"
"0025944409","1765566","","2-s2.0-0025944409","1991-01-01","Use of neonatal tolerization and chemical immunosuppression for the production of monoclonal antibodies to maturation-specific sperm surface molecules"
"0025055080","2139258","10.1016/0968-0004(90)90195-H","2-s2.0-0025055080","1990-01-01","Glycophospholipid membrane anchoring provides clues to the mechanism of protein sorting in polarized epithelial cells"
"84911785332","","","2-s2.0-84911785332","1986-12-02",""
"0024614897","2720028","","2-s2.0-0024614897","1989-02-01","Identification of a major secretory glycoprotein from rat epididymis: interaction with spermatozoa."
"0018148293","639340","","2-s2.0-0018148293","1978-12-01","The micro-sperm immobilization test: the use of only motile spermatozoa and studies of complement"
"0026508723","1374057","","2-s2.0-0026508723","1992-01-01","Membrane attack complex (MAC)-mediated damage to spermatozoa: Protection of the cells by the presence on their membranes of MAC inhibitory proteins"
"0024980024","2541702","10.1016/0006-291X(89)92455-8","2-s2.0-0024980024","1989-04-28","The major maturation glycoprotein found on rat cauda epididymal sperm surface is linked to the membrane via phosphatidylinositol"
"0023335576","2440839","","2-s2.0-0023335576","1987-05-01","Further characterization of a secreted epididymal glycoprotein in mice that binds to sperm tails."
"0017229991","","","2-s2.0-0017229991","1976-12-01","Techniques for detection of iso and auto antibodies to human spermatozoa"
"0022474835","2424978","","2-s2.0-0022474835","1986-10-22","Properties of a panel of monoclonal antibodies which react with the human T cell antigen receptor on the leukemic line HPB-ALL and a subset of normal peripheral blood T lymphocytes"
"0021929388","3871355","10.1016/0092-8674(85)90321-6","2-s2.0-0021929388","1985-01-01","Cross-linking of human T cell receptor proteins: association between the T cell idiotype β subunit and the T3 glycoprotein heavy subunit"
"0019479105","6974176","10.1007/BF00405069","2-s2.0-0019479105","1981-08-01","Marker profiles of human leukemia and lymphoma cell lines"
"0022477147","3486937","","2-s2.0-0022477147","1986-10-22","Rearrangement and expression of the α, β, and γ chain T cell receptor genes in human thymic leukemia cells and functional T cells"
"0022509770","3755221","10.1038/322145a0","2-s2.0-0022509770","1986-12-01","Identification of a putative second T-cell receptor"
"84918432844","","","2-s2.0-84918432844","1982-12-23","Tumor-specific antigen of murine T-lymphoma defined with monoclonal antibody"
"0021163678","6206178","","2-s2.0-0021163678","1984-09-27","The antigen-specific, major histocompatibility complex-restricted receptor on T cells. VI. An antibody to a receptor allotype"
"0020695943","6185617","","2-s2.0-0020695943","1983-04-22","Clonotypic structures involved in antigen-specific human T cell function. Relationship to the T3 molecular complex"
"84918466512","","","2-s2.0-84918466512","1987-12-23",""
"0022500809","2424768","10.1002/eji.1830160610","2-s2.0-0022500809","1986-01-01","Expression on human thymocytes of the idiotypic structures (Ti) from two leukemia T cell lines Jurkat and HPB‐ALL"
"84918441245","","","2-s2.0-84918441245","1987-12-23","T lymphocyte antigens"
"0022537617","3092224","","2-s2.0-0022537617","1986-01-01","Expression of T3 in association with a molecule distinct from the T-cell antigen receptor heterodimer"
"84918466513","","","2-s2.0-84918466513","1986-12-23","Molecular analysis of T-cell receptor variable region gene expression"
"0021911786","3885036","","2-s2.0-0021911786","1985-01-01","The human T-cell receptor. Structure and function"
"0023262299","2437204","10.1016/0022-1759(87)90008-1","2-s2.0-0023262299","1987-04-16","Isolation of anti-idiotypic antibodies to T cells using an anti-framework determinant antibody"
"0022350012","2410507","","2-s2.0-0022350012","1985-12-01","Characteristics of a monoclonal antibody (WT-31) that recognizes a common epitope of the human T cell receptor for antigen"
"0021865545","2409202","","2-s2.0-0021865545","1985-01-01","Stimulation of a subset of normal resting T lymphocytes by a monoclonal antibody to a crossreactive determinant of the human T cell antigen receptor"
"0023019719","3489234","","2-s2.0-0023019719","1986-12-01","Diversity and structure of human T-cell receptor β-chain variable region genes"
"0020623652","6601175","","2-s2.0-0020623652","1983-06-29","The major histocompatibility complex-restricted antigen receptor on T cells. I. Isolation with a monoclonal antibody"
"0023009011","2429127","10.1016/S0140-6736(86)92870-9","2-s2.0-0023009011","1986-10-11","ANTIBODIES TO T CELL ANTIGEN RECEPTOR BETA CHAIN FAMILIES DETECT MONOCLONAL T CELL PROLIFERATION"
"0021339649","6201688","10.1016/S0140-6736(84)91451-X","2-s2.0-0021339649","1984-05-12","IMMUNOCYTOCHEMICAL DETECTION OF T AND B CELL POPULATIONS IN ROUTINE BLOOD SMEARS"
"0022496692","2938011","10.1038/320272a0","2-s2.0-0022496692","1986-12-01","A T3-like protein complex associated with the antigen receptor on murine T cells"
"4243138262","","","2-s2.0-4243138262","1994-09-06","Melphalan-total body irradiation (M-TBI) and allogeneic bone marrow transplantation (BMT) for chronic lymphocytic leukemia (CLL) and prolymphocytic leukemia (PLL)"
"0025757084","2070133","","2-s2.0-0025757084","1991-01-01","Allogeneic bone marrow transplantation in chronic lymphocytic leukemia: 17 cases. Report from the EBMTG"
"0029041994","7670405","","2-s2.0-0029041994","1995-07-26","Three weeks of ganciclovir for cytomegaloviraemia after allogeneic bone marrow transplantation"
"4243558321","","","2-s2.0-4243558321","1993-09-29","HLA-identical sibling transplants for chronic lymphocytic leukaemia. A collaborative study of the EBMTG and the IBMTR"
"0028931830","7811987","","2-s2.0-0028931830","1995-01-01","Advances in the biology and treatment of B-cell chronic lymphocytic leukemia"
"0028053190","8205094","","2-s2.0-0028053190","1994-01-01","Molecular remission after allogeneic bone marrow transplantation for chronic lymphocytic leukemia"
"0027184287","8338937","","2-s2.0-0027184287","1993-01-01","Delayed complete response after allogeneic bone marrow transplantation in chronic lymphocytic leukemia [3]"
"0028587738","7889013","","2-s2.0-0028587738","1994-12-01","Unusual infections following allogeneic bone marrow transplantation for chronic lymphocytic leukemia"
"0343976542","","","2-s2.0-0343976542","1994-04-14","Chimerism following sex-mismatched allogeneic BMT in chronic lymphocytic leukemia (CLL)"
"0025917102","1861541","10.1016/0145-2126(91)90026-P","2-s2.0-0025917102","1991-01-01","Simplified quantitative estimation in vitro of lymphocyte radiosensitivity applied to patients with chronic lymphocytic leukaemia"
"0029958975","8704689","","2-s2.0-0029958975","1996-03-01","Clinical and hematologic response of chronic lymphocytic and prolymphocytic leukemia persisting after allogeneic bone marrow transplantation with the onset of acute graft-versus-host disease: Possible role of graft-versus-leukemia"
"0004642769","","","2-s2.0-0004642769","1994-12-09","Autologous and allogeneic bone marrow transplantation for B-cell CLL: Balance between toxicity and efficacy"
"0025290953","2363690","","2-s2.0-0025290953","1990-07-04","A comparative study of the N-linked oligosaccharide structures of human IgG subclass proteins"
"0028935581","","10.1016/0003-2670(94)00664-8","2-s2.0-0028935581","1995-04-28","Determination of carbohydrate heterogeneity in the humanised antibody CAMPATH 1H by liquid chromatography and matrix-assisted laser desorption ionisation mass spectrometry"
"0025218112","2138613","","2-s2.0-0025218112","1990-12-01","Structural heterogeneity of sugar chains in immunoglobulin G: Conformation of immunoglobulin G molecule and substrate specificities of glycosyltransferases"
"0025295163","2340075","10.1007/BF01024981","2-s2.0-0025295163","1990-02-01","Analysis of the carbohydrate composition of glycoproteins by high-performance liquid chromatography"
"0021840630","2415021","10.1016/0003-2697(85)90248-9","2-s2.0-0021840630","1985-08-01","Analysis of sugars in glycoproteins by high-pressure liquid chromatography"
"0025057153","2324208","10.1016/S0021-9673(00)96974-7","2-s2.0-0025057153","1990-01-19","Analysis of glycoprotein-derived oligosaccharides by high-pH anion-exchange chromatography"
"0025308603","2363510","10.1016/0003-2697(90)90094-P","2-s2.0-0025308603","1990-05-01","Two-dimensional mapping by the high-performance liquid chromatography of oligosaccharides released from glycosphingolipids by endoglycoceramidase"
"0040208192","","","2-s2.0-0040208192","1989-07-13",""
"21844523907","","","2-s2.0-21844523907","1994-07-24",""
"0024355993","2817366","10.1016/0003-2697(89)90444-2","2-s2.0-0024355993","1989-08-01","High-performance liquid chromatography of reducing carbohydrates as strongly ultraviolet-absorbing and electrochemically sensitive 1-phenyl-3-methyl5-pyrazolone derivatives"
"0023948708","3407923","10.1016/0003-2697(88)90126-1","2-s2.0-0023948708","1988-05-15","Analyses of N-linked oligosaccharides using a two-dimensional mapping technique"
"0019888484","7287707","","2-s2.0-0019888484","1981-10-25","Facile cleavage of complex oligosaccharides from glycopeptides by almond emulsin peptide: N-glycosidase."
"0021986707","4014658","10.1016/0003-2697(85)90357-4","2-s2.0-0021986707","1985-01-01","Microquantitative analysis of neutral and amino sugars as fluorescent pyridylamino derivatives by high-performance liquid chromatography"
"0039024225","","","2-s2.0-0039024225","2004-07-13",""
"0025058850","2321750","10.1016/0003-2697(90)90025-5","2-s2.0-0025058850","1990-01-01","Estimation of elution times on reverse-phase high-performance liquid chromatography of pyridylamino derivatives of sugar chains from glycoproteins"
"0026519775","1581831","10.3109/07357909209032764","2-s2.0-0026519775","1992-01-01","Immunotherapy of minimal residual disease by immunocompetent lymphocytes and their activation by cytokines: Hematology"
"85004893940","","","2-s2.0-85004893940","1986-12-18",""
"0023636166","3322360","","2-s2.0-0023636166","1987-12-01","Risk factors for acute graft-versus-host disease"
"0023405112","2957834","","2-s2.0-0023405112","1987-01-01","T cell subsets and graft-versus-host disease"
"0025292356","2350582","","2-s2.0-0025292356","1990-06-15","Risk factors for chronic graft-versus-host disease after HLA-identical sibling bone marrow transplantation"
"0025242924","2242425","","2-s2.0-0025242924","1990-01-01","Induction of in vitro graft-versus-leukemia activity following bone marrow transplantation for chronic myeloid leukemia"
"0022911018","2943828","10.1002/stem.5530040710","2-s2.0-0022911018","1986-01-01","Acute and chronic graft‐versus‐host disease in man"
"0019794486","","10.1007/BF00199267","2-s2.0-0019794486","1981-06-01","Eradication of murine leukemia with histoincompatible marrow grafts in mice conditioned with total lymphoid irradiation (TLI)"
"0018181254","25942","","2-s2.0-0018181254","1978-12-01","Transplantation of allogeneic bone marrow without graft-versus-host disease using total lymphoid irradiation"
"0013886333","5910392","","2-s2.0-0013886333","1966-03-01","Evaluation of survival data and two new rank order statistics arising in its consideration."
"85004882063","","","2-s2.0-85004882063","1982-12-26","Bone marrow transplantation for severe aplastic anemia in HLA identical siblings using total lymphoid irradiation (TLI) and cyclophosphamide"
"0023840014","3276360","","2-s2.0-0023840014","1988-01-01","Cyclosporine v methotrexate for graft-v-host disease prevention in patients given marrow grafts for leukemia: Long-term follow-up of three controlled trials"
"74749108066","","","2-s2.0-74749108066","1984-12-18","Allogeneic bone marrow transplantation in mouse, monkey and man using lectin-separated grafts"
"0024504726","2648143","","2-s2.0-0024504726","1989-01-01","Graft-versus-host disease as adoptive immunotherapy in patients with advanced hematologic neoplasms"
"85004761913","","","2-s2.0-85004761913","1989-12-18","A new method for prevention of graft‐versus‐host disease (GVHD)"
"85004893949","","","2-s2.0-85004893949","1984-12-18","Immunosuppression and induction of transplantation tolerance by fractionated total lymphoid irradiation"
"0026713583","1422483","","2-s2.0-0026713583","1992-01-01","Molecular remission occurring after donor leukocyte infusions for the treatment of relapsed chronic myelogenous leukemia after allogeneic bone marrow transplantation"
"85004873256","","","2-s2.0-85004873256","1972-12-18","Regression models and life tables"
"85004858918","","","2-s2.0-85004858918","1987-12-18","Graft versus leukemia reactions: experimental models and clinical trials"
"0026499915","1735011","10.3109/07357909209032785","2-s2.0-0026499915","1992-01-01","Use of recombinant human interleukin-2 in conjunction with bone marrow transplantation as a model for control of minimal residual disease in malignant hematological disorders: I. Treatment of murine leukemia in conjunction with allogeneic bone marrow transplantation and IL-2-activated cell-mediated immunotherapy"
"85004877872","","","2-s2.0-85004877872","1986-12-18","Graft rejection and graft versus host disease: mirror images"
"0024372227","","","2-s2.0-0024372227","1989-01-01","Deletion of immunosuppressive prophylaxis after marrow transplantation increases hyperacute graft-versus-host disease but does not influence chronic graft-versus-host disease or relapse in patients with advanced leukemia"
"0025819698","2039833","","2-s2.0-0025819698","1991-01-01","Impact of pretransplant conditioning and donor T cells on chimerism, graft-versus-host disease, graft-versus-leukemia reactivity, and tolerance after bone marrow transplantation"
"0025124963","2202460","","2-s2.0-0025124963","1990-01-01","Management of acute graft-versus-host disease"
"85004717862","","","2-s2.0-85004717862","1988-12-18","Cellular mediated immunotherapy of leukemia in conjunction with autologous and allogeneic bone marrow transplantation in experimental animals and man. XX Meeting, American Society of Hematology, Houston, Texas"
"0000409586","13860531","","2-s2.0-0000409586","1962-03-01","Synthesis of hemoglobin in a cell-free system. I. Properties of the complete system."
"0020493642","7092866","10.1016/0006-291X(82)91457-7","2-s2.0-0020493642","1982-03-30","Targeting of the antiviral protein from Phytolacca americana with an antibody"
"0002169483","","","2-s2.0-0002169483","1982-07-13","Toxic lectins and related proteins"
"0017767146","302417","10.1038/268437a0","2-s2.0-0017767146","1977-12-01","Application of magnetic microspheres in labelling and separation of cells"
"0021863789","3859688","","2-s2.0-0021863789","1985-10-31","An immunotoxin composed of monoclonal anti-Thy 1.1 antibody and a ribosome-inactivating protein from Saponaria officinalis: Potent antitumor effects in vitro and in vivo"
"0022355089","4044586","","2-s2.0-0022355089","1985-12-01","Purified immunotoxins that are reactive with human lymphoid cells. Monoclonal antibodies conjugated to the ribosome-inactivating proteins gelonin and the pokeweed antiviral proteins"
"0345416079","","","2-s2.0-0345416079","1978-12-23","Phagocytes in vitro"
"0021354998","6142765","","2-s2.0-0021354998","1984-04-01","Prevention of Growth of Leukemia Cells in Mice by Monoclonal Antibodies Directed against Thy 1.1 Antigen Disulfide Linked to Two Ribosomal lnhibitors:Pokeweed Antiviral Protein or Ricin A Chain"
"0014983638","5275755","","2-s2.0-0014983638","1971-01-01","Colony formation by normal and leukemic human marrow cells in culture: effect of conditioned medium from human leukocytes."
"0022004755","3880666","","2-s2.0-0022004755","1985-01-01","Evidence for Absence of Toxicity of T101 Immunotoxin on Human Hematopoietic Progenitor Cells Prior to Bone Marrow Transplantation"
"0023266439","2889289","10.1007/BF02890252","2-s2.0-0023266439","1987-12-01","Hepatotoxicity of immunotoxins made with saporin, a ribosome-inactivating protein from Saponaria officinalis"
"0019510072","6790277","10.1111/j.1432-1033.1981.tb05356.x","2-s2.0-0019510072","1981-01-01","Cytotoxicity Acquired by Conjugation of an Anti‐Thy1.1 Monoclonal Antibody and the Ribosome‐Inactivating Protein, Gelonin"
"0022645317","3001980","","2-s2.0-0022645317","1986-01-01","Evaluation of the use of high-dose cytoreduction with autologous marrow rescue in various malignancies"
"0021868344","3925952","10.1016/0006-291X(85)91981-3","2-s2.0-0021868344","1985-06-28","Characterization of a Saponaria officinalis seed ribosome-inactivating protein: Immunoreactivity and sequence homologies"
"0022218801","2933450","","2-s2.0-0022218801","1985-12-01","Antibody-complement-mediated cytotoxicity is enhanced by ribosome-inactivating proteins"
"0020504572","6353579","","2-s2.0-0020504572","1983-12-01","Anti-T-Cell reagents for human bone marrow transplantation: Ricin linked to three monoclonal antibodies"
"0022489331","3510899","10.1016/0014-5793(86)80118-1","2-s2.0-0022489331","1986-01-20","Ribosome-inactivating proteins up to date"
"0021952757","3871174","","2-s2.0-0021952757","1985-01-01","Increased Efficiency in Selective Elimination of Leukemia Cells by a Combination of a Stable Derivative of Cyclophosphamide and a Human B-Cell-specific Immunotoxin Containing Pokeweed Antiviral Protein"
"0021327184","6318313","","2-s2.0-0021327184","1984-01-01","Inhibition of human acute lymphoblastic leukemia cells by immunotoxins: Potentiation by chloroquine"
"0022291407","3904769","","2-s2.0-0022291407","1985-12-01","Immunotoxins."
"0018115212","708370","","2-s2.0-0018115212","1978-12-01","Protein thiolation and reversible protein-protein conjugation. N-Succinimidyl 3-(2-pyridyldithio)propionate, a new heterobifunctional reagent"
"0021908215","3855433","","2-s2.0-0021908215","1985-01-01","Immunotoxin-mediated elimination of clonogenic tumor cells in the presence of human bone marrow"
"0022211776","3900212","","2-s2.0-0022211776","1985-12-01","Anti-T cell immunotoxins containing pokeweed anti-viral protein: Potential purging agents for human autologous bone marrow transplantation"
"0022632374","3510682","","2-s2.0-0022632374","1986-01-01","Elimination of Daudi lymphoblasts from human bone marrow using avidin-biotin immunoadsorption"
"0019309042","7363949","10.1016/0014-4827(80)90270-0","2-s2.0-0019309042","1980-01-01","Entry of lethal doses of abrin, ricin and modeccin into the cytosol of HeLa cells"
"0023199699","3319299","","2-s2.0-0023199699","1987-01-01","Normal and neoplastic plasma cell membrane phenotype: Studies with new monoclonal antibodies"
"0022553601","3510720","","2-s2.0-0022553601","1986-03-01","Elimination of Clonogenic Tumor Cells from Human Bone Marrow Using a Combination of Monoclonal Antibody:Ricin A Chain Conjugates"
"0022576064","3511171","","2-s2.0-0022576064","1986-07-23","Use of a novel colony assay to evaluate the cytotoxicity of an immunotoxin containing pokeweed antiviral protein against blast progenitor cells freshly obtained from patients with common B-lineage acute lymphoblastic leukemia"
"0021769526","6091760","10.1016/0167-4838(84)90219-X","2-s2.0-0021769526","1984-10-23","Characterization of translational inhibitors from Phytolacca americana Amino-terminal sequence determination and antibody-inhibitor conjugates"
"0021340154","6140077","","2-s2.0-0021340154","1984-01-01","Comparison of the Selective Cytotoxic Effects of Immunotoxins Containing Ricin A Chain or Pokeweed Antiviral Protein and Anti-Thy 1.1 Monoclonal Antibodies"
"0021265537","6609971","","2-s2.0-0021265537","1984-08-16","Specific inhibition of in vitro lymphocyte transformation by an anti-pan T cell (gp67) ricin A chain immunotoxin"
"0020261430","","","2-s2.0-0020261430","1982-12-01","Ribosome-inactivating proteins from plants: Properties and possible uses"
"84935797571","","","2-s2.0-84935797571","0000-07-14",""
"0021320335","6690030","","2-s2.0-0021320335","1984-01-01","Properties of Immunotoxins against a Glycolipid Antigen Associated with Burkitt's Lymphoma"
"0021933444","3896347","","2-s2.0-0021933444","1985-11-28","Use of multiple T cell-directed intact ricin immunotoxins for autologous bone marrow transplantation"
"0021050293","6139402","","2-s2.0-0021050293","1983-12-01","Selective killing of target cells by antibody-ricin A chain or antibody-gelonin hybrid molecules: Comparison of cytotoxic potency and use in immunoselection procedures"
"84921010936","","","2-s2.0-84921010936","1986-01-23","Use of Campath 1 for T-depletion in matched and mismatched transplants for CGL"
"0004073736","","","2-s2.0-0004073736","1989-07-13",""
"0021105596","6667259","","2-s2.0-0021105596","1983-12-15","Ribosome-inactivating proteins from the seeds of Saponaria officinalis L. (soapwort), of Agrostemma githago L. (corn cockle) and of Asparagus officinalis L. (asparagus), and from the latex of Hura crepitans L. (sandbox tree)."
"0021816357","3986759","","2-s2.0-0021816357","1985-05-01","Immunological and Biological Stability of Immunotoxins in Vivo as Studied by the Clearance of Disulfide-linked Pokeweed Antiviral Protein-Antibody Conjugates from Blood"
"0020265159","7085634","","2-s2.0-0020265159","1982-12-01","Entry of the toxic proteins abrin, modeccin, ricin, and diphtheria toxin into cells. II. Effect of pH, metabolic inhibitors, and ionophores and evidence for toxin penetration from endocytotic vesicles"
"0029130968","7572990","10.1002/ajh.2830500208","2-s2.0-0029130968","1995-01-01","Autologous bone marrrow transplantation versus chemotherapy in relapsed/refractory non‐hodgkin's lymphoma: Estimates of long‐term survival from the recent literatur"
"0027457160","8426201","","2-s2.0-0027457160","1993-12-01","AMOPLACE treatment of intermediate-grade and high-grade malignant lymphoma: A cancer and leukemia group B study"
"0028822481","7675049","10.1056/NEJM199510193331606","2-s2.0-0028822481","1995-10-19","Chronic lymphocytic leukemia"
"0027486439","8211202","","2-s2.0-0027486439","1993-01-01","Monoclonal antibody therapy for indolent lymphomas"
"0028941380","7884420","","2-s2.0-0028941380","1995-01-01","BEAM chemotherapy and autologous bone marrow transplantation for patients with relapsed or refractory non-Hodgkin's lymphoma"
"26844511169","","","2-s2.0-26844511169","1994-10-29","Campath-1H therapy causes clearing of lymphocytic infiltration of bone marrow in advanced refractory chronic lymphocytic leukemia"
"26844519480","","","2-s2.0-26844519480","1995-10-29",""
"84866477628","","","2-s2.0-84866477628","1995-09-29","Treatment of chronic lymphocytic leukaemia with the humanised CD52 monoclonal antibody Campath-1H"
"26844454006","","","2-s2.0-26844454006","1992-10-29","Phase I/II trials of Campath-1H, a humanized anti-lymphocyte monoclonal antibody in non-Hodgkin's lymphoma and chronic lymphocytic leukemia"
"0019455212","6972239","","2-s2.0-0019455212","1981-01-01","Regulation of in vitro erythropoiesis by normal T cells: Evidence for two T-cell subsets with opposing function"
"84990420921","","","2-s2.0-84990420921","1984-10-16","Application of antimicrobial prophylactic treatment to the prevention of infection and graft‐versus‐host disease in allogeneic bone marrow transplantation (BMT)"
"84990461908","","","2-s2.0-84990461908","1985-10-16","Immunological analysis of two cases of Campath‐I associated cases of graft failure"
"84990439529","","","2-s2.0-84990439529","1983-10-16","Marrow transplantation for acute non‐lymphoblastic leukemia in first remission: preliminary results of a randomized trial comparing cyclosporine and methotrexate for the prophylaxis of graft‐versus‐host disease"
"0019997010","6979356","","2-s2.0-0019997010","1982-09-10","Factors that affect human hemopoiesis are produced by T-cell growth dependent and independent cultured T-cell leukemia-lymphoma cells"
"0020672374","6216930","","2-s2.0-0020672374","1983-01-01","The influence of T lymphocytes and their products on hemopoietic precursor cell regeneration in spleen organ cultures"
"84990473609","","","2-s2.0-84990473609","1983-10-16","Mechanisms of early allogeneic graft rejection"
"0021263142","6375759","","2-s2.0-0021263142","1984-08-30","Incidence of acute graft-versus-host disease with and without methotrexate prophylaxis in allogeneic bone marrow transplant patients"
"0020694110","6337323","","2-s2.0-0020694110","1983-03-10","Graft-versus-host disease and survival in patients with aplastic anemia treated by marrow grafts from HLA-identical siblings. Beneficial effect of a protective environment"
"0004204553","","","2-s2.0-0004204553","1993-03-28",""
"0027255950","8397764","10.1016/0167-5699(93)90039-N","2-s2.0-0027255950","1993-01-01","Humanized antibodies"
"78651196598","14340040","","2-s2.0-78651196598","1965-12-01","A SPECTROPHOTOMETRIC ASSAY FOR AVIDIN AND BIOTIN BASED ON BINDING OF"
"0026488120","1458760","10.2165/00003088-199223060-00002","2-s2.0-0026488120","1992-01-01","The Role of Pharmacokinetics in the Development of Biotechnologically Derived Agents"
"0010625014","","","2-s2.0-0010625014","1994-07-13",""
"0028056086","8015352","10.1016/0024-3205(94)90111-2","2-s2.0-0028056086","1994-01-01","Possible consequences of human antibody responses on the biodistribution of fragments of human, humanized or chimeric monoclonal antibodies: A note of caution"
"0000665022","2434954","10.1073/pnas.84.5.1369","2-s2.0-0000665022","1987-04-29","Evolutionary relationship between the natural anti-Gal antibody and the Galα1←3Gal epitope in primates"
"0025202499","2122971","","2-s2.0-0025202499","1990-11-25","The carbohydrate structures of a mouse monoclonal IgG antibody OKT3"
"84916467591","","","2-s2.0-84916467591","1995-12-17","High performance liquid chromatographic mapping of the oligosaccharides released from the human immunoglobulin Campath-1H"
"0025086946","2174119","10.1016/0161-5890(90)90103-7","2-s2.0-0025086946","1990-01-01","A protein structural change in aglycosylated IgG3 correlates with loss of huFcγR1 and hufcγR111 binding and/or activation"
"0019934863","6811655","","2-s2.0-0019934863","1982-01-01","Structural and numerical variations of the carbohydrate moiety of immunoglobulin G"
"0015735020","4148009","","2-s2.0-0015735020","1973-12-01","Studies of biologic and serologic activities of rabbit IgG antibody depleted of carbohydrate residues"
"0027450137","8381917","10.1016/0161-5890(93)90052-D","2-s2.0-0027450137","1993-01-01","Aglycosylated chimaeric human IgG3 can trigger the human phagocyte respiratory burst"
"0026337655","1952948","10.1016/0003-9861(91)90144-8","2-s2.0-0026337655","1991-01-01","Structural study of the sugar moieties of monoclonal antibodies secreted by human-mouse hybridoma"
"0022654917","3456003","10.1016/0022-1759(86)90457-6","2-s2.0-0022654917","1986-02-12","Europium-labelled target cells in an assay of natural killer cell activity. I. A novel non-radioactive method based on time-resolved fluorescence"
"0025007695","2386941","","2-s2.0-0025007695","1990-09-01","Carbohydrate Analysis of Immunoglobulin G Myeloma Proteins by Lectin and High Performance Liquid Chromatography: Role of Glycosyltransferases in the Structures"
"0026456612","1454066","10.1016/0161-5890(92)90222-J","2-s2.0-0026456612","1992-01-01","Role of inter-heavy and light chain disulfide bonds in the effector functions of human immunoglobulin IgG1"
"0021888762","3872908","","2-s2.0-0021888762","1985-01-01","Carbohydrate chains on IgG2b: a requirement for efficient feedback immunosuppression"
"0024801675","2633046","10.1016/0161-5890(89)90055-2","2-s2.0-0024801675","1989-01-01","Antibody-dependent cytotoxicity mediated by natural killer cells is enhanced by castanospermine-induced alterations of IgG glycosylation"
"0025339176","2143269","10.1016/0161-5890(90)90076-C","2-s2.0-0025339176","1990-01-01","Proton nuclear magnetic resonance studies of the structure of the Fc fragment of human immunoglobulin G1: Comparisons of native and recombinant proteins"
"0026778517","1637829","","2-s2.0-0026778517","1992-12-01","Characterization of the oligosaccharide structures on recombinant human prorenin expressed in Chinese hamster ovary cells"
"0023690162","3260356","","2-s2.0-0023690162","1988-01-01","Immunosuppression with monoclonal antibodies in multiple sclerosis"
"0026948591","1296800","","2-s2.0-0026948591","1992-11-01","Tumor necrosis factor alpha production as a possible predictor of relapse in patients with multiple sclerosis."
"0025967507","1999225","10.1002/eji.1830210227","2-s2.0-0025967507","1991-01-01","Regulation of tumor necrosis factor (TNF) release by murine peritoneal macrophages: role of cell stimulation and specific phagocytic plasma membrane receptors"
"0023904746","3132891","10.1002/ana.410230405","2-s2.0-0023904746","1988-01-01","Tumor necrosis factor mediates myelin and oligodendrocyte damage in vitro"
"0025346772","2234501","10.1016/0304-3940(90)90458-L","2-s2.0-0025346772","1990-07-31","Extracellular tumor necrosis factor induces a decreased K+ conductance in an identified neuron of Aplysia kurodai"
"0024366885","2754393","","2-s2.0-0024366885","1989-01-01","Tumor necrosis factor identified in multiple sclerosis brain"
"0026018158","1906145","","2-s2.0-0026018158","1991-01-01","An open trial of OKT3 in patients with multiple sclerosis"
"0025761229","1651399","10.1002/jnr.490280403","2-s2.0-0025761229","1991-01-01","Analysis of a decreased Na+ conductance by tumor necrosis factor in identified neurons of Aplysia kurodai"
"0023845962","2831292","","2-s2.0-0023845962","1988-01-01","Interaction of Fc receptor (CD16) ligands induces transcription of interleukin 2 receptor (CD25) and lymphokine genes and expression of their products in human natural killer cells"
"0017367165","840858","10.3181/00379727-154-39638","2-s2.0-0017367165","1977-01-01","Mechanism of Anti-Complementary Activity of Corticosteroids in Vivo: Possible Relevance in Endotoxin Shock"
"0025221030","2253684","10.1002/eji.1830201112","2-s2.0-0025221030","1990-01-01","Glucocorticoids inhibit the production of IL 6 from monocytes, endothelial cells and fibroblasts"
"0023126661","2882294","10.1016/S0140-6736(87)92863-7","2-s2.0-0023126661","1987-04-18","EXACERBATIONS OF MULTIPLE SCLEROSIS IN PATIENTS TREATED WITH GAMMA INTERFERON"
"0001237709","","10.1007/BF02162972","2-s2.0-0001237709","1890-02-01","Untersuchungen über die bei der multiplen Herdsklerose vorkommenden Angenstörungen"
"0025282043","2358784","","2-s2.0-0025282043","1990-07-01","Dexamethasone and pentoxifylline inhibit endotoxin-induced cachectin/tumor necrosis factor synthesis at separate points in the signaling pathway"
"0018098580","568748","","2-s2.0-0018098580","1978-12-01","The pathophysiology of demyelination and its implications for the symptomatic treatment of multiple sclerosis"
"0025162044","1690930","10.1016/0166-2236(90)90068-L","2-s2.0-0025162044","1990-01-01","Ion channel organization of the myelinated fiber"
"0023772348","3260938","","2-s2.0-0023772348","1988-01-01","C5a stimulates secretion of tumor necrosis factor from human mononuclear cells in vitro. Comparison with secretion of interleukin 1β and interleukin 1α"
"0025860993","1856593","","2-s2.0-0025860993","1991-08-22","Phagocytosis of opsonized yeast induces tumor necrosis factor-α mRNA accumulation and protein release by human polymorphonuclear leukocytes"
"0025864518","1874974","10.1016/0165-5728(91)90112-K","2-s2.0-0025864518","1991-01-01","Appearance of cytokine-associated central nervous system myelin damage coincides temporally with serum tumor necrosis factor induction after recombinant interleukin-2 infusion in rats"
"0027531449","8446242","","2-s2.0-0027531449","1993-01-01","High-dose methylprednisolone inhibits the OKT3-induced cytokine-related syndrome [7]"
"0027076729","1465794","","2-s2.0-0027076729","1992-01-01","Evidence that antihuman tumor necrosis factor monoclonal antibody prevents OKT3-induced acute syndrome"
"0015970873","4362242","","2-s2.0-0015970873","1974-01-01","Impulse conduction in multiple sclerosis: a theoretical basis for modification by temperature and pharmacological agents"
"0027074264","1465859","","2-s2.0-0027074264","1992-12-01","Tumor necrosis factor α is released by monocytes in OKT3 monoclonal antibody immunosuppressive therapy"
"0021972275","2409596","","2-s2.0-0021972275","1985-01-01","Organization of ion channels in the myelinated nerve fiber"
"0028024182","8053654","10.1002/ana.410360210","2-s2.0-0028024182","1994-01-01","Repeated treatment with chimeric anti‐CD4 antibody in multiple sclerosis"
"0027082393","1486453","10.1093/brain/115.6.1611","2-s2.0-0027082393","1992-12-01","Interactions between oligodendrocytes and microglia: A major role for complement and tumour necrosis factor in oligodendrocyte adherence and killing"
"0027254102","8498839","10.1002/ana.410330606","2-s2.0-0027254102","1993-01-01","Elevated serum levels of tumor necrosis factor‐α in Guillain‐Barré syndrome"
"0026696836","1377234","","2-s2.0-0026696836","1992-07-23","Tumor necrosis factor modulates Ca2+ currents in cultured sympathetic neurons"
"0014723429","4319185","10.1093/brain/93.3.583","2-s2.0-0014723429","1970-12-01","The effects of experimental demyelination on conduction in the central nervous system"
"0024449817","2511227","10.1016/0165-5728(89)90141-0","2-s2.0-0024449817","1989-01-01","Preliminary studies of cytokine-induced functional effects on the visual pathways in the rabbit"
"12644291113","","","2-s2.0-12644291113","1993-02-09","C3a and C3a-desArg induce release of IL-6 and TNFα from human monocytes"
"0028158451","7905103","10.1016/S0140-6736(94)91119-3","2-s2.0-0028158451","1994-01-29","Treatment of multiple sclerosis"
"0001952479","","","2-s2.0-0001952479","1986-07-13","The pathophysiology of multiple sclerosis"
"0023937241","3260533","10.1016/0006-8993(88)91106-7","2-s2.0-0023937241","1988-05-10","Tumor necrosis factor and interleukin-1β: suppression of food intake by direct action in the central nervous system"
"0027160326","8498835","10.1002/ana.410330602","2-s2.0-0027160326","1993-01-01","Immune‐mediated demyelination"
"0027517309","8370768","10.1016/0165-5728(93)90027-V","2-s2.0-0027517309","1993-01-01","Murine tumor necrosis factor alpha is transported from blood to brain in the mouse"
"0025773147","1852181","","2-s2.0-0025773147","1991-01-01","Association between tumor necrosis factor-α and disease progression in patients with multiple sclerosis"
"0026323045","1782525","10.1093/brain/114.6.2437","2-s2.0-0026323045","1991-12-01","The pathophysiology of acute optic neuritis: An association of gadolinium leakage with clinical and electrophysiological deficits"
"9544236183","8822943","","2-s2.0-9544236183","1996-09-15","Eradication of polymerase chain reaction-detectable chronic lymphocytic leukemia cells is associated with improved outcome after bone marrow transplantation"
"4243839846","","","2-s2.0-4243839846","1997-09-27","Campath-1H therapy for patients with refractory CLL"
"0028344048","8111709","10.1002/1097-0142(19940301)73:5&lt;1425::AID-CNCR2820730517&gt;3.0.CO;2-D","2-s2.0-0028344048","1994-01-01","Effect of lym‐1 radioimmunoconjugate on refractory chronic lymphocytic leukemia"
"0342530626","2726771","","2-s2.0-0342530626","1989-01-01","Mouse/human chimeric monoclonal antibody in man: Kinetics and immune response"
"0018971622","7427932","","2-s2.0-0018971622","1980-09-01","Serotherapy of a Patient with a Monoclonal Antibody Directed against a Human Lymphoma-associated Antigen"
"0021680499","6333257","","2-s2.0-0021680499","1984-12-01","Effects of monoclonal antibody therapy in patients with chronic lymphocytic leukemia"
"0344759084","","10.1159/000026944","2-s2.0-0344759084","1999-06-01","Antibody therapy with rituximab for patients with low-grade non- Hodgkin's lymphoma"
"0022628844","3514799","","2-s2.0-0022628844","1986-01-01","Toxicities and side effects associated with intravenous infusions of murine monoclonal antibodies"
"0001900699","","","2-s2.0-0001900699","1999-09-27","Treatment of patients with chronic lymphocytic leukemia (CLL) using a combination of fludarabine and the anti-CD20 antibody rituximab (IDEC-C2B8)"
"0023022338","3490543","","2-s2.0-0023022338","1986-01-01","Continuous infusion of T101 monoclonal antibody in chronic lymphocytic leukemia and cutaneous T-cell lymphoma"
"0031664666","9760161","10.1007/s002770050419","2-s2.0-0031664666","1998-07-01","Rapid tumor lysis in a patient with B-cell chronic lymphocytic leukemia and lymphocytosis treated with an anti-CD20 monoclonal antibody (IDEC C2B8, rituximab)"
"0027217789","8316295","","2-s2.0-0027217789","1993-12-01","Three-dimensional structure of the human class II histocompatibility antigen HLA-DR1"
"0030888333","9104583","","2-s2.0-0030888333","1997-04-16","Altered peptide ligands: Prospects for immune intervention in autoimmune disease"
"0000046089","2440031","10.1073/pnas.84.14.4831","2-s2.0-0000046089","1987-09-01","A human β-actin expression vector system directs high-level accumulation of antisense transcripts"
"0029550029","8729880","","2-s2.0-0029550029","1995-12-01","Model building of antibody combining sites"
"0024558096","2564317","10.1016/0092-8674(89)90631-4","2-s2.0-0024558096","1989-03-24","Human CD2 3′-flanking sequences confer high-level, T cell-specific, position-independent gene expression in transgenic mice"
"0002384347","14224412","","2-s2.0-0002384347","1964-12-01","INDUCTION OF IMMUNOLOGICAL PARALYSIS IN TWO ZONES OF DOSAGE."
"0015546974","","10.1016/S0065-2776(08)60296-5","2-s2.0-0015546974","1973-12-01","Immunological Unresponsiveness"
"0024330411","2476497","","2-s2.0-0024330411","1989-01-01","The induction of peripheral T cell unresponsiveness in adult mice by monomeric human γ-globulin"
"0344052879","14160436","","2-s2.0-0344052879","1964-02-01","IMMUNOLOGIC UNRESPONSIVENESS TO HETEROLOGOUS SERUM PROTEINS INDUCED IN ADULT MICE AND TRANSFER OF THE UNRESPONSIVE STATE."
"0028877602","7821765","","2-s2.0-0028877602","1995-01-01","Structural features of the reactions between antibodies and protein antigens"
"0025835310","1907718","","2-s2.0-0025835310","1991-08-15","Making antibody fragments using phage display libraries"
"0001940078","","","2-s2.0-0001940078","1995-07-13","Antibody structure and function"
"0024698430","2669128","10.1016/S0001-2998(89)80012-1","2-s2.0-0024698430","1989-01-01","Immunologic and pharmacologic concepts of monoclonal antibodies"
"0025718897","1940360","","2-s2.0-0025718897","1991-11-15","Expression of antibody Fab domains on bacteriophage surfaces: Potential use for antibody selection"
"0024025869","2901953","","2-s2.0-0024025869","1988-06-01","The structure of the human CD2 gene and its expression in transgenic mice."
"0014760032","4192271","","2-s2.0-0014760032","1970-03-01","Cellular sites of immunologic unresponsiveness."
"0030606280","8951372","10.1006/jmbi.1996.0636","2-s2.0-0030606280","1996-11-29","Sequence and evolution of the human germline Vλ repertoire"
"0342437532","9265725","10.1016/S0958-1669(97)80068-7","2-s2.0-0342437532","1997-08-01","Production of human antibody repertoires in transgenic mice"
"0019287085","","10.1016/S0065-2776(08)60196-0","2-s2.0-0019287085","1980-12-01","Analysis of Autoimmunity through Experimental Models of Thyroiditis and Allergic Encephalomyelitis"
"2942524864","2717617","","2-s2.0-2942524864","1989-01-01","Prediction of major histocompatibility complex binding regions of protein antigens by sequence pattern analysis"
"0029933309","8717505","10.1146/annurev.immunol.14.1.1","2-s2.0-0029933309","1996-05-08","Altered peptide ligand-induced partial T cell activation: Molecular mechanisms and role in T cell biology"
"0031904016","9701247","10.1038/nm0898-939","2-s2.0-0031904016","1998-08-01","A minimal glycine-alanine repeat prevents the interaction of ubiquitinated IκBα with the proteasome: A new mechanism for selective inhibition of proteolysis"
"0029976416","8666892","10.1084/jem.183.4.1339","2-s2.0-0029976416","1996-04-01","CD4+ T cell activation and tolerance induction in B cell knockout mice"
"0000017699","13887798","","2-s2.0-0000017699","1962-05-01","Specific inhibition of antibody production. II. Paralysis induced in adult mice by small quantities of protein antigen."
"0029927482","8605939","10.1002/eji.1830260327","2-s2.0-0029927482","1996-03-01","Abnormally short serum half-lives of IgG in β2-microglobulin-deficient mice"
"0031570879","9218579","","2-s2.0-0031570879","1997-07-15","Induction of Tolerance to Human γ-Globulin in FcRγ- and FcγRII-Deficient Mice"
"0027298445","8483498","","2-s2.0-0027298445","1993-12-01","Induction of T-cell anergy by altered T-cell-receptor ligand on live antigen-presenting cells"
"0028025705","7931057","","2-s2.0-0028025705","1994-10-01","Th2 cell clonal anergy as a consequence of partial activation"
"0027185153","8334703","10.1016/0092-8674(93)90306-B","2-s2.0-0027185153","1993-07-16","Promiscuous and allele-specific anchors in HLA-DR-binding peptides"
"0015240716","5099924","","2-s2.0-0015240716","1971-12-01","Kinetic differences in unresponsiveness of thymus and bone marrow cells"
"0025226085","2247164","","2-s2.0-0025226085","1990-12-01","Phage antibodies: filamentous phage displaying antibody variable domains"
"0025740577","1908075","10.1093/nar/19.15.4133","2-s2.0-0025740577","1991-08-11","Multi-subunit proteins on the surface of filamentous phage: Methodologies for displaying antibody (Fab) heavy and light chains"
"0001306928","14271318","","2-s2.0-0001306928","1965-12-01","THE CATABOLISM OF HOMOLOGOUS AND HETEROLOGOUS 7S GAMMA GLOBULIN"
"0023200628","3500061","10.1002/eji.1830171022","2-s2.0-0023200628","1987-01-01","The internal image‐like anti‐idiotypic response to a CD3‐specific monoclonal antibody in primates is dependent on the T cell‐binding properties of the injected antibody"
"0029038178","7546387","10.1016/0952-7915(95)80013-1","2-s2.0-0029038178","1995-01-01","New methods to predict MHC-binding sequences within protein antigens"
"0024556150","2744488","10.1016/0378-1119(89)90359-4","2-s2.0-0024556150","1989-04-15","Engineering hybrid genes without the use of restriction enzymes: gene splicing by overlap extension"
"0031810114","9624683","10.1038/nbt0698-535","2-s2.0-0031810114","1998-06-01","Human antibodies by design"
"0029003999","7540727","10.1038/375685a0","2-s2.0-0029003999","1995-01-01","Inhibition of antigen processing by the internal repeat region of the epstein-barr virus nuclear antigen-1"
"0030837355","9247131","10.1016/S0014-5793(97)00553-X","2-s2.0-0030837355","1997-06-23","Cell death induction by receptors of the TNF family: Towards a molecular understanding"
"0029940855","8730099","","2-s2.0-0029940855","1996-04-01","Role of cyclin A and p27 in anti-IgM-induced G1 growth arrest of murine B-cell lymphomas"
"0031202422","9233606","","2-s2.0-0031202422","1997-08-01","ZAP-70 Tyrosine Kinase Is Required for the Dp-Regulation of Fas Ligand in Activation-Induced T Cell Apoptosis"
"0026558821","1729359","","2-s2.0-0026558821","1992-01-15","AnTI-IgM antibody-induced cell death in a human B lymphoma cell line, B104, represents a novel programmed cell death"
"0028844235","8580085","10.1093/intimm/7.11.1873","2-s2.0-0028844235","1995-11-01","APO-1(CD95)-dependent and -independent antigen receptor-induced apoptosis in human T and B cell lines"
"7844230386","","","2-s2.0-7844230386","1996-11-19","Expression of the gene for CDw52: Requirements for recognition by CAMPATH-1H antibody and for the attachment of the GPI-anchor for the two closely related gene products"
"0027394676","8385467","10.1016/0167-5699(93)90215-7","2-s2.0-0027394676","1993-01-01","Phagocyte recognition of cells undergoing apoptosis"
"0028091236","8157286","10.1111/j.1440-1711.1994.tb03754.x","2-s2.0-0028091236","1994-01-01","A flow cytometric study of cell death: Failure of some models to correlate with morphological assessment"
"0022475306","3487612","","2-s2.0-0022475306","1986-01-01","Lymphoma models for B cell activation and tolerance. III. Cell cycle dependence for negative signalling of WEHI-231 B lymphoma cells by anti-μ"
"0025126816","2209683","10.1002/eji.1830200810","2-s2.0-0025126816","1990-01-01","Anti‐immunoglobulin antibodies induce apoptosis in immature B cell lymphomas"
"0002556269","","","2-s2.0-0002556269","1978-11-06","Immunochemical analysis of immunoglobulins and their sub-units"
"0028795758","7530335","10.1038/373438a0","2-s2.0-0028795758","1995-02-02","Autocrine T-cell suicide mediated by APO-1/(Fas/CD95)"
"0027296040","8104221","","2-s2.0-0027296040","1993-10-01","Pathway of signal delivery to murine thymocytes triggered by Co-crosslinking CD3 and Thy-1 for cellular DNA fragmentation and growth inhibition"
"7844245587","","","2-s2.0-7844245587","1993-11-19","APO-1 mediated apoptosis or proliferation in human B lymphocytic leukemia: Correlation with bcl-2 oncogene expression"
"7844231835","","","2-s2.0-7844231835","1992-11-19","Tyrosine protein kinase is involved in anti-IgM-mediated signalling in BAL. 17 B lymphoma cells"
"0025741072","1940938","10.1136/jnnp.54.8.683","2-s2.0-0025741072","1991-01-01","Magnetic resonance imaging in monitoring the treatment of multiple sclerosis: Concerted Action Guidelines"
"0024419381","2479134","10.1016/0166-2236(89)90075-1","2-s2.0-0024419381","1989-01-01","Lessons from magnetic resonance imaging in multiple sclerosis"
"0028157044","7905102","10.1016/S0140-6736(94)91118-5","2-s2.0-0028157044","1994-01-29","Pathogenesis of multiple sclerosis"
"24344446987","","","2-s2.0-24344446987","1992-09-17","High-dose of methyl-prednisolone inhibits the OKT3-induced cytokine-related syndrome"
"0028812776","7569969","10.1126/science.270.5234.232","2-s2.0-0028812776","1995-11-03","How the glucocorticoids suppress immunity"
"0028314757","8195804","10.1016/0022-510X(94)90045-0","2-s2.0-0028314757","1994-01-01","Magnetic resonance imaging in monitoring the treatment of multiple sclerosis patients: Statistical power of parallel-groups and crossover designs"
"0027381828","8221048","10.1093/brain/116.5.1077","2-s2.0-0027381828","1993-10-01","Gadolinium enhancement increases the sensitivity of MRI in detecting disease activity in multiple sclerosis"
"0024990661","2245307","10.1093/brain/113.5.1477","2-s2.0-0024990661","1990-10-01","Breakdown of the blood-brain barrier precedes symptoms and other mri signs of new lesions in multiple sclerosis: Pathogenetic and clinical implications"
"0023759102","2454256","","2-s2.0-0023759102","1988-01-01","Anti-CD4 and anti-CD2 monoclonal antibody infusions in subjects with multiple sclerosis. Immunosuppressive effects and human anti-mouse responses"
"0025787089","1944803","","2-s2.0-0025787089","1991-01-01","Multiple sclerosis: A pivotal role for the T cell in lesion"
"0001432909","","","2-s2.0-0001432909","2000-07-13","From laboratory to clinic: The story of CAMPATH-1"
"0025611149","2097005","","2-s2.0-0025611149","1990-12-01","How best to analyse new strategies in bone marrow transplantation"
"0003131461","","","2-s2.0-0003131461","1977-02-02","Design and analysis of randomized clinical trials requiring prolonged observation of each patient. II. Analysis and examples"
"0000056784","","","2-s2.0-0000056784","1999-07-13","Serum levels of CAMPATH-1H in recipients of unrelated bone marrow transplants"
"0018404970","369420","","2-s2.0-0018404970","1979-01-01","No initial therapy for stage III and IV non-Hodgkin's lymphomas of favorable histologic types"
"0020373945","6897633","10.1016/0277-5379(82)90092-X","2-s2.0-0020373945","1982-01-01","Treatment of chronic lymphocytic leukaemia and well-differentiated lymphocytic lymphoma with continuous low- or intermittent high-dose prednimustine versus chlorambucil/prednisolone"
"0023992626","2456618","","2-s2.0-0023992626","1988-04-01","The treatment of indolent lymphomas: watchful waiting v aggressive combined modality treatment."
"0022650630","3515398","","2-s2.0-0022650630","1986-07-09","Radiation damage in patients treated by total-body irradiation, bone marrow grafting, and cyclosporin"
"0022657787","3511950","10.1111/j.1365-2141.1986.tb02942.x","2-s2.0-0022657787","1986-01-01","The significance of host haemopoietic cells detected by cytogenetic analysis of bone marrow from recipients of bone marrow transplants"
"0013914584","4164182","","2-s2.0-0013914584","1966-06-01","The growth of mouse bone marrow cells in vitro."
"84990477543","","","2-s2.0-84990477543","1965-10-16","The cloning of normal mast cells in tissue culture"
"0021366234","6365153","10.1111/j.1365-2141.1984.tb03973.x","2-s2.0-0021366234","1984-01-01","Cytogenetic studies on recipients of allogeneic bone marrow using the sex chromosomes as markers of cellular origin"
"0015458139","4405147","","2-s2.0-0015458139","1972-12-01","The use of cyclophosphamide for clinical marrow transplantation."
"0020318438","7116443","","2-s2.0-0020318438","1982-06-01","Human growth hormone: A multigene family"
"0017670253","913604","10.1016/0014-5793(77)80609-1","2-s2.0-0017670253","1977-10-15","Enhanced autoradiographic detection of 32P and 125I using intensifying screens and hypersensitized film"
"0017695915","912752","10.1016/0092-8674(77)90119-2","2-s2.0-0017695915","1977-01-01","A physical map of the DNA regions flanking the rabbit β-globin gene"
"0019950816","6284368","","2-s2.0-0019950816","1982-01-01","Genes of the major histocompatibility complex"
"0018403417","106394","","2-s2.0-0018403417","1979-11-15","Immunoglobulin heavy chain gene organization in mice: Analysis of a myeloma genomic clone containing variable and α constant regions"
"0019979842","6806666","10.1038/298087a0","2-s2.0-0019979842","1982-12-01","A model for the molecular requirements of immunoglobulin heavy chain class switching"
"84967745991","","","2-s2.0-84967745991","0000-05-22",""
"0018933975","6985477","10.1016/0092-8674(80)90429-8","2-s2.0-0018933975","1980-12-24","The structure and evolution of the human β-globin gene family"
"2342647836","286295","","2-s2.0-2342647836","1979-01-01","Structure of the A2m (1) allotype of human IgA: A recombinant molecule"
"0019162146","6260957","10.1016/0022-2836(80)90196-5","2-s2.0-0019162146","1980-12-01","Cloning in single-stranded bacteriophage as an aid to rapid DNA sequencing"
"0008411148","97665","","2-s2.0-0008411148","1978-12-01","Organization of immunoglobulin heavy chain genes and allelic deletion model"
"0019434650","6266915","10.1016/0378-1119(81)90028-7","2-s2.0-0019434650","1981-01-01","Isolation of β-globin-related genes from a human cosmid library"
"0019120050","6774415","","2-s2.0-0019120050","1980-12-01","DNA sequences mediating class switching in α-immunoglobulins"
"0019415073","6787603","10.1073/pnas.78.4.2437","2-s2.0-0019415073","1981-11-20","Structure of a rearranged γ1 chain gene and its implication to immunoglobulin class-switch mechanism"
"0018823555","6766206","10.1038/283351a0","2-s2.0-0018823555","1980-12-01","The role of gene deletion in the immunoglobulin heavy chain switch"
"84967739603","","","2-s2.0-84967739603","0000-05-22",""
"0018988674","6769113","","2-s2.0-0018988674","1980-01-01","Rearrangement of immunoglobin heavy chain genes during B-lymphocyte development as revealed by studies of mouse plasmacytoma cells"
"0018843979","6769593","10.1016/0092-8674(80)90089-6","2-s2.0-0018843979","1980-01-01","An immunoglobulin heavy chain variable region gene is generated from three segments of DNA: VH, D and JH"
"0019274503","6450943","10.1093/nar/8.24.5983","2-s2.0-0019274503","1980-12-20","Cloning of human immunoglobulin μ gene and comparison with mouse μ gene"
"0019308438","6772957","10.1038/285450a0","2-s2.0-0019308438","1980-12-01","Deletions in the constant region locus can account for switches in immunoglobulin heavy chain expression"
"0019831076","6163083","10.1038/290020a0","2-s2.0-0019831076","1981-12-01","The structure of eight distinct cloned human leukocyte interferon cDNAs"
"0019192185","6245773","","2-s2.0-0019192185","1980-12-01","The variability, arrangement, and rearrangement of immunoglobulin genes"
"0020059958","6804095","10.1016/0092-8674(82)90204-5","2-s2.0-0020059958","1982-01-01","Organization of the constant-region gene family of the mouse immunoglobulin heavy chain"
"0000861357","291033","","2-s2.0-0000861357","1979-01-01","Efficient transfer of large DNA fragments from agarose gels to diazobenzyloxymethyl-paper and rapid hybridization by using dextran sulfate"
"0019293247","6779282","","2-s2.0-0019293247","1980-12-01","Evolutionary approach to the question of immunoglobulin heavy chain switching: Evidence from cloned human and mouse genes"
"0019460884","6781756","10.1016/0092-8674(81)90131-8","2-s2.0-0019460884","1981-01-01","Repetitive sequences in class-switch recombination regions of immunoglobulin heavy chain genes"
"0016700864","1195397","10.1016/S0022-2836(75)80083-0","2-s2.0-0016700864","1975-11-05","Detection of specific sequences among DNA fragments separated by gel electrophoresis"
"0019179349","6774257","10.1038/286669a0","2-s2.0-0019179349","1980-12-01","An immunoglobulin deletion mutant with implications for the heavy-chain switch and RNA splicing"
"0018908498","6766532","10.1038/283733a0","2-s2.0-0018908498","1980-12-01","An immunoglobulin heavy-chain gene is formed by at least two recombinational events"
"0018903047","6446404","10.1016/0092-8674(80)90240-8","2-s2.0-0018903047","1980-01-01","The chromosomal arrangement of human α-like globin genes: Sequence homology and α-globin gene deletions"
"0019846077","6101209","10.1016/0092-8674(81)90400-1","2-s2.0-0019846077","1981-01-01","Structure of the human immunoglobulin μ locus: Characterization of embryonic and rearranged J and D genes"
"0020315254","6808515","","2-s2.0-0020315254","1982-12-01","Cloning of human immunoglobulin ε chain genes: Evidence for multiple C(ε) genes"
"84967765688","","","2-s2.0-84967765688","1973-05-22",""
"0031974145","9451427","","2-s2.0-0031974145","1998-01-26","Clinico-prognostic relevance of quantitative immunophenotyping in B- cell chronic lymphocytic leukemia with emphasis on the expression of CD20 antigen and surface immunoglobulins"
"0001854806","","","2-s2.0-0001854806","1998-09-27","Phase II pilot study of the safety and efficacy of rituximab in combination with CHOP chemotherapy in patients with previously untreated intermediate- or high-grade NHL"
"0021054153","6605169","","2-s2.0-0021054153","1983-12-01","Monoclonal antibody therapeutic trials in seven patients with T-cell lymphoma"
"0028151441","7527453","","2-s2.0-0028151441","1994-12-01","Comparison of autologous bone marrow transplantation with sequential chemotherapy for intermediate-grade and high-grade non-Hodgkin's lymphoma in first complete remission: A study of 464 patients"
"0031978239","9619748","10.1007/s004320050156","2-s2.0-0031978239","1998-05-25","Risk of secondary myeloid leukemia and myelodysplastic syndrome following standard-dose chemotherapy or high-dose chemotherapy with stem cell support in patients with potentially curable malignancies"
"0035169514","11133748","10.1182/blood.V97.1.101","2-s2.0-0035169514","2001-01-01","Rituximab (anti-CD20 monoclonal antibody) as single first-line therapy for patients with follicular lymphoma with a low tumor burden: Clinical and molecular evaluation"
"0021165704","6379051","","2-s2.0-0021165704","1984-10-04","T65 antigen modulation in a phase I monoclonal antibody trial with chronic lymphocytic leukemia patients"
"0028218049","7908690","","2-s2.0-0028218049","1994-04-01","2-Chlorodeoxyadenosine is an active salvage therapy in advanced indolent non-Hodgkin's lymphoma"
"0006818262","10707792","","2-s2.0-0006818262","2000-03-06","Treatment of mantle-cell lymphoma with Rituximab (chimeric monoclonal anti-CD20 antibody): Analysis of factors associated with response"
"0023101978","3492224","","2-s2.0-0023101978","1987-04-17","Monoclonal antibody 1F5 (anti-CD20) serotherapy of human B cell lymphomas"
"0024502001","2465039","","2-s2.0-0024502001","1989-01-01","Treatment of B-cell lymphomas with anti-idiotype antibodies alone and in combination with alpha interferon"
"0028273438","8180379","","2-s2.0-0028273438","1994-05-15","Nonfollicular small B-cell lymphomas: A heterogeneous group of patients with distinct clinical features and outcome"
"0004687518","","","2-s2.0-0004687518","1999-07-13",""
"0000629542","","","2-s2.0-0000629542","2000-07-13","Mabthera (rituximab) plus CHOP is superior to CHOP alone in elderly patients with diffuse large B-cell lymphoma (DLCL): Interim results of a randomized GELA trial"
"0031804013","9586911","","2-s2.0-0031804013","1998-05-01","Mantle-cell lymphomas have more widespread disease and a slower response to chemotherapy compared with follicle-center lymphomas: Results of a prospective comparative analysis of the German low-grade lymphoma study group"
"0033067232","10561225","","2-s2.0-0033067232","1999-06-01","Single-agent monoclonal antibody efficacy in bulky non-Hodgkin's lymphoma: Results of a phase II trial of rituximab"
"0027443113","8235693","","2-s2.0-0027443113","1993-01-01","Fludarabine single-agent therapy for relapsed low-grade non-Hodgkin's lymphomas: A phase II study of the German low-grade non-Hodgkin's lymphoma study group"
"0026668842","1520877","","2-s2.0-0026668842","1992-09-15","Monoclonal anti-idiotype antibody therapy of B-cell lymphoma: The addition of a short course of chemotherapy does not interfere with the antitumor effect nor prevent the emergence of idiotype-negative variant cells"
"0001814038","","","2-s2.0-0001814038","1999-07-13","Epratuzumab, a new anti-CD22, humanized, monoclonal antibody for the therapy of non-Hodgkin's lymphoma (NHL): Phase I/II trial results"
"0033797185","11043420","","2-s2.0-0033797185","2000-01-01","IDEC-C2B8 (Rituximab) anti-CD20 antibody treatment in relapsed advanced-stage follicular lymphomas: Results of a phase-II study of the German low-grade lymphoma study group"
"0028057250","7506951","","2-s2.0-0028057250","1994-01-15","Depletion of B cells in vivo by a chimeric mouse human monoclonal antibody to CD20"
"0028127304","7522629","","2-s2.0-0028127304","1994-10-15","Phase I clinical trial using escalating single-dose infusion of chimeric anti-CD20 monoclonal antibody (IDEC-C2B8) in patients with recurrent B-cell lymphoma"
"0000419543","","","2-s2.0-0000419543","1999-07-13","Phase I/II study of thrice weekly rituximab in chronic lymphocytic leukemia (CLL)/small lymphocytic lymphoma (SLL): A feasible and active regimen"
"0032030699","9473230","","2-s2.0-0032030699","1998-03-01","Apoptosis of malignant human B cells by ligation of CD20 with monoclonal antibodies"
"0031026736","9053464","","2-s2.0-0031026736","1997-02-01","High-dose therapy with autologous hematopoietic rescue for follicular low-grade non-Hodgkin's lymphoma"
"0033911321","10914705","","2-s2.0-0033911321","2000-07-01","Combination immunotherapy of relapsed or refractory low-grade or follicular non-Hodgkin's lymphoma with rituximab and interferon-α-2a"
"24844460009","","","2-s2.0-24844460009","1997-09-29","Second malignant neoplasms (SMN) following bone marrow transplantation (BMT) for hematologic malignancies: City of hope experience"
"0030861750","9376604","","2-s2.0-0030861750","1997-10-15","Total body irradiation and acute graft-versus-host disease: The role of gastrointestinal damage and inflammatory cytokines"
"0030000397","8611687","","2-s2.0-0030000397","1996-05-01","Malignant neoplasms following bone marrow transplantation"
"0002413870","","","2-s2.0-0002413870","1996-07-13","Immunologic factors, including AIDS"
"0032170108","9716582","","2-s2.0-0032170108","1998-09-01","Infusion of cytotoxic T cells for the prevention and treatment of Epstein-Barr virus-induced lymphoma in allogeneic transplant recipients"
"0029559867","8907621","","2-s2.0-0029559867","1995-12-01","Herpes virus-related lymphoproliferative disorders following allogeneic bone marrow transplantation: Clinical and biological characteristics of six cases"
"0032551162","9652666","10.1016/S0140-6736(97)09028-4","2-s2.0-0032551162","1998-06-20","Spectrum of AIDS-associated malignant disorders"
"0025661946","2100991","","2-s2.0-0025661946","1990-12-20","Increased incidence of lymphoproliferative disorder after immunosuppression with the monoclonal antibody OKT3 in cardiactransplant recipients"
"0028068992","7994275","","2-s2.0-0028068992","1994-01-01","Donor B cell lymphoma of the brain after allogeneic bone marrow transplantation for acute myeloid leukemia"
"9844227997","9070469","10.1056/NEJM199703273361301","2-s2.0-9844227997","1997-03-27","Solid cancers after bone marrow transplantation"
"0031749534","9626203","","2-s2.0-0031749534","1998-06-01","Posttransplant lymphoproliferative disorders not associated with Epstein-Barr virus: A distinct entity?"
"0024414690","2671734","","2-s2.0-0024414690","1989-01-01","Secondary cancers after bone marrow transplantation for leukemia or aplastic anemia"
"0027972658","8279628","","2-s2.0-0027972658","1994-01-01","Epstein-Barr virus is infrequently identified in non-Hodgkin's lymphomas associated with Hodgkin's disease"
"0028920527","7627092","10.1016/0964-1955(94)00044-5","2-s2.0-0028920527","1995-01-01","Head and neck carcinoma in Fanconi's anaemia-report of a case and review of the literature"
"0030965012","9124210","","2-s2.0-0030965012","1997-04-15","Posttransplantation lymphoproliferative disorders in bone marrow transplant recipients are aggressive diseases with a high incidence of adverse histologic and immunobiologic features"
"0032516250","9580648","10.1056/NEJM199805143382003","2-s2.0-0032516250","1998-05-14","Epstein-Barr virus and a cellular signaling pathway in lymphomas from immunosuppressed patients"
"9444259791","8779685","","2-s2.0-9444259791","1996-08-15","Posttransplant lymphoproliferative disease in pediatric liver transplantation: Interplay between primary Epstein-Barr virus infection and immunosuppression"
"0028940138","7858270","","2-s2.0-0028940138","1995-01-01","Posttransplantation lymphoproliferative disorders frequently contain type A and not type B Epstein-Barr virus"
"0019846233","7030473","","2-s2.0-0019846233","1981-11-01","Polymorphic Diffuse B-Cell Hyperplasias and Lymphomas in Renal Transplant Recipients"
"0000336139","","","2-s2.0-0000336139","1972-04-09","Regression models and life tables"
"0026697955","1327508","","2-s2.0-0026697955","1992-01-01","Primary immunodeficiencies: Genetic risk factors for lymphoma"
"0029135293","7577625","10.1111/j.1365-2141.1995.tb05262.x","2-s2.0-0029135293","1995-01-01","Large‐cell anaplastic non‐Hodgkin's lymphoma originating in donor cells after allogenic bone marrow transplantation: SHORT REPORT"
"0032525146","9573001","","2-s2.0-0032525146","1998-05-15","Semiquantitative Epstein-Barr virus (EBV) polymerase chain reaction for the determination of patients at risk for EBV-induced lymphoproliferative disease after stem cell transplantation"
"0023677838","3063441","10.1016/0011-3840(88)90011-1","2-s2.0-0023677838","1988-01-01","The diagnosis and treatment of posttransplant lymphoproliferative disorders"
"0032570535","9500643","10.1097/00007890-199802270-00028","2-s2.0-0032570535","1998-02-27","Hodgkin's disease of donor origin after allogeneic bone marrow transplantation for myelogeneous chronic leukemia"
"0026355685","1661607","","2-s2.0-0026355685","1991-12-01","Posttransplant lymphoproliferative disease in thoracic organ transplant patients: Ten years of cyclosporine-based immunosuppression"
"0032211189","9787149","","2-s2.0-0032211189","1998-11-01","Anti-B-cell monoclonal antibody treatment of severe posttransplant B- lymphoproliferative disorder: Prognostic factors and long-term outcome"
"0025642848","2173884","","2-s2.0-0025642848","1990-12-01","Secondary T-cell lymphoproliferation after marrow transplantation"
"0345186966","","","2-s2.0-0345186966","1987-07-13",""
"0345619085","","","2-s2.0-0345619085","1833-07-13","Malignancies after hematopoietic stem cell transplantation: Many questions, some answers"
"0028305339","7516697","10.1111/j.1365-2141.1994.tb03272.x","2-s2.0-0028305339","1994-01-01","Localized, late‐onset, high‐grade lymphoma following bone marrow transplantation: response to combination chemotherapy"
"0025946392","1651803","10.1002/1097-0142(19910915)68:6&lt;1285::AID-CNCR2820680618&gt;3.0.CO;2-5","2-s2.0-0025946392","1991-01-01","B‐cell lymphoproliferative disorders after bone marrow transplant. An analysis of ten cases with emphasis on epstein–barr virus detection by in situ hybridization"
"0026697957","1394157","","2-s2.0-0026697957","1992-01-01","Lymphoma risks in populations with altered immunity - A search for mechanism"
"0024486354","2537974","","2-s2.0-0024486354","1989-01-01","Epstein-Barr virus-related lymphoproliferative disorders following bone marrow transplantation: an immunologic and genotypic analysis."
"0003635321","","","2-s2.0-0003635321","1993-07-13",""
"0008206013","","","2-s2.0-0008206013","1995-07-13","Low risk of Epstein-Barr virus (EBV)-associated post-transplant lymphoproliferative disease (PTLD) in patients receiving elutriated allogeneic marrow transplants may reflect depletion of EBV infected lymphocytes from the graft"
"0027379164","8251416","10.1111/j.1365-2141.1993.tb08651.x","2-s2.0-0027379164","1993-01-01","B‐cell lymphoma of recipient origin 9 years after allogeneic bone marrow transplantation for T‐cell acute lymphoblastic leukaemia"
"0027501649","7902900","10.1016/S0140-6736(05)80084-4","2-s2.0-0027501649","1993-01-01","Incidence of non-hodgkin lymphoma in kidney and heart transplant recipients"
"0025782864","1848644","","2-s2.0-0025782864","1991-01-01","Epstein-Barr virus lymphoproliferative disease associated with acquired immunodeficiency"
"0031665347","9783755","","2-s2.0-0031665347","1998-10-16","Regaining self-control - Regulation and immunotherapy"
"0030678558","9497474","","2-s2.0-0030678558","1997-12-01","Immunosuppressive therapy for chronic uveitis: Optimising therapy with steroids and cyclosporin A"
"3543025402","","","2-s2.0-3543025402","1995-08-19","The immunotherapy of acute myeloblastic leukemia; from allogeneic BMT to gene transfer"
"0030940994","9085741","","2-s2.0-0030940994","1997-03-02","A new 'two step' procedure for 4.5 log depletion of T and B cells in allogeneic transplantation and of neoplastic cells in autologous transplantation"
"0031018433","9057668","","2-s2.0-0031018433","1997-03-11","Association of HLA-C disparity with graft failure after marrow transplantation from unrelated donors"
"0014495253","4887565","","2-s2.0-0014495253","1969-01-01","Transplantation of allogeneic and xenogeneic (rat) marrow in irradiated mice as affected by radiation exposure rates"
"0029859287","8874224","","2-s2.0-0029859287","1996-10-15","CD34+ cell dose predicts survival, posttransplant morbidity, and rate of hematologic recovery after allogeneic marrow transplants for hematologic malignancies"
"0027172909","8481519","","2-s2.0-0027172909","1993-01-01","Molecular rearrangements on chromosome 11q23 predominate in infant acute lymphoblastic leukemia and are associated with specific biologic variables and poor outcome"
"3543008613","","","2-s2.0-3543008613","1997-08-19","Enriched CD34+ bone marrow cells with Isolex 300 (Baxter TM) devices reduce severe graft-versus-host disease (GVHD) in allogeneic bone marrow transplantation with unrelated donor (UD-BMT)"
"3543038487","","","2-s2.0-3543038487","1996-08-19","Analysis of minimal residual disease predicts relapse after T-depleted BMT for childhood ALL"
"0030964190","9166834","","2-s2.0-0030964190","1997-06-01","Rapid engraftment without significant graft-versus-host disease after allogeneic transplantation of CD34+ selected cells from peripheral blood"
"3543011663","","","2-s2.0-3543011663","1997-08-26","A pilot study of allogeneic CD34+ peripheral blood stem cell transplantation (PBSCT) using mismatched related donors for patients with advanced hematologic malignancies"
"0029005823","7596150","10.1016/0145-2126(94)00162-4","2-s2.0-0029005823","1995-01-01","Cytogenetic correlation with disease status and treatment outcome in advanced stage leukemia post bone marrow transplantation: A Southwest Oncology Group Study (SWOG-8612)"
"0021816219","3875918","","2-s2.0-0021816219","1985-01-01","Quantitation of T lymphocytes in human bone marrow by a limiting dilution assay"
"0022550005","3088123","10.1016/0022-1759(86)90096-7","2-s2.0-0022550005","1986-07-11","Positive selection of viable cell populations using avidin-biotin immunoadsorption"
"0025898727","1704845","","2-s2.0-0025898727","1991-03-26","Recombinant human stem cell factor synergises with GM-CSF, G-CSF, IL-3 and Epo to stimulate human progenitor cells of the myeloid and erythroid lineages"
"0028789191","7489407","10.1038/nm1295-1268","2-s2.0-0028789191","1995-01-01","Megadose of T cell-depleted bone marrow overcomes MHC barriers in sublethally irradiated mice"
"0003265978","","","2-s2.0-0003265978","1996-12-20","Optimizing the dose and timing of lymphocyte add-back in T-cell depleted BMT between HLA-identical siblings"
"1842412438","9156247","","2-s2.0-1842412438","1997-04-01","Mixed hematopoietic chimerism after allogeneic bone marrow transplantation: The impact of quantitative PCR analysis for prediction of relapse and graft rejection in children"
"0026492401","1345104","10.1007/BF02125803","2-s2.0-0026492401","1992-01-01","Chemotherapy versus bone marrow transplantation in childhood acute lymphoblastic leukaemia"
"3543018780","","","2-s2.0-3543018780","1995-10-27","Donor leukocyte infusions for relapsed acute leukemia post BMT"
"0027509704","8435660","","2-s2.0-0027509704","1993-01-01","Donor leucocyte infusions after chemotherapy for patients relapsing with acute leukaemia following allogeneic BMT"
"3543032461","","","2-s2.0-3543032461","2004-08-19",""
"0025972344","1824981","","2-s2.0-0025972344","1991-01-01","Advantages of F(ab')2 fragments of anti-CD3 monoclonal antibody as compared to whole antibody as immunosuppressive agents in mice"
"0024245363","3065089","10.1002/eji.1830181231","2-s2.0-0024245363","1988-01-01","Higher level expression of lymphocyte function‐associated antigen‐1 (LFA‐1) on in vivo natural killer cells"
"0026580592","1534096","","2-s2.0-0026580592","1992-06-01","Effect of a single amino acid mutation on the activating and immunosuppressive properties of a ""humanized"" OKT3 monoclonal antibody"
"0024362358","2786029","","2-s2.0-0024362358","1989-01-01","Regulation of the expression of IL-6 in human monocytes"
"0025048692","2122929","","2-s2.0-0025048692","1990-01-01","Cytostasis of different tumours by a murine PPD-reactive CD4+ T lymphocyte clone is mediated by interferon-gamma and tumour necrosis factor alone or synergistically"
"12644307806","","","2-s2.0-12644307806","1996-02-09","Ex-vivo whole blood cultures for predicting cytokine-release syndrome: Dependence on target antigen and antibody isotype"
"0023808199","3262381","","2-s2.0-0023808199","1988-01-01","Regulation of interleukin-6 expression in cultured human blood monocytes and monocyte-derived macrophages"
"0028360836","8200988","","2-s2.0-0028360836","1994-06-01","In vivo effects of IgA and IgG2a anti-CD3 isotype switch variants"
"0027273050","8344347","10.1002/eji.1830230819","2-s2.0-0027273050","1993-01-01","Signaling through the LFA‐1 leucocyte integrin actively regulates intercellular adhesion and tumor necrosis factor‐α production in natural killer cells"
"0024345621","2500254","10.1016/0008-8749(89)90036-1","2-s2.0-0024345621","1989-01-01","Cytokine regulation of interleukin 6 production by human endothelial cells"
"0025196196","1700001","","2-s2.0-0025196196","1990-11-15","Human natural killer cell adhesion molecules: Differential expression after activation and participation in cytolysis"
"0018332730","222847","10.1016/0022-1759(79)90241-2","2-s2.0-0018332730","1979-05-10","The use of polymyxin B and C3H/HeJ mouse spleen cells as criteria for endotoxin contamination"
"0021173449","6427338","","2-s2.0-0021173449","1984-01-01","Dexamethasone-mediated inhibition of human T cell growth factor and γ-interferon messenger RNA"
"0024822508","2532305","","2-s2.0-0024822508","1989-12-01","Co-association of CD3ζ with a receptor (CD16) for IgG Fc on human natural killer cells"
"0027223058","8363726","10.1016/0167-5699(93)90236-E","2-s2.0-0027223058","1993-01-01","Signal transduction events leading to T-cell lymphokine gene expression"
"0028178492","8009586","","2-s2.0-0028178492","1994-01-01","A non - Activating “humanized” anti - CD3 monoclonal antibody retains immunosuppressive properties in vivo"
"0026015285","1833456","","2-s2.0-0026015285","1991-10-15","Characterization of the family of dimers associated with Fc receptors (Fc∈RI and FcγRIII)"
"0017652468","200563","","2-s2.0-0017652468","1977-12-01","Mitogenic response of mouse spleen cells and gelation of limulus lysate by lipopolysaccharide of Yersinia pestis and evidence for neutralization of the lipopolysaccharide by polymyxin B"
"0026802983","1520585","10.1038/bjc.1992.298","2-s2.0-0026802983","1992-01-01","A monoclonal antibody-β-glucuronidase conjugate as activator of the prodrug epirubicin-glucuronide for specific treatment of cancer"
"0026670255","1356620","","2-s2.0-0026670255","1992-01-01","N-(4′-Hydroxyphenylacetyl)palytoxin: A Palytoxin Prodrug That Can Be Activated by a Monoclonal Antibody-Penicillin G Amidase Conjugate"
"0027220125","8358723","","2-s2.0-0027220125","1993-01-01","Site-specific Prodrug Activation by Antibody-β-Lactamase Conjugates: Regression and Long-Term Growth Inhibition of Human Colon Carcinoma Xenograft Models"
"0024297282","3182871","","2-s2.0-0024297282","1988-11-25","A novel rat carboxypeptidase, CPA2: characterization, molecular cloning, and evolutionary implications on substrate specificity in the carboxypeptidase gene family."
"0027357432","8431510","","2-s2.0-0027357432","1993-01-01","Generation of cytotoxic agents by targeted enzymes."
"0345678344","","","2-s2.0-0345678344","1994-09-01","Design of antitumor prodrugs: Substrates for antibody targeted enzymes"
"0020059494","6275388","","2-s2.0-0020059494","1982-11-03","Rat preprocarboxypeptidase A: cDNA sequence and preliminary characterization of the gene"
"0008469346","","","2-s2.0-0008469346","1985-12-07",""
"8944233863","8764123","","2-s2.0-8944233863","1996-07-15","ZD2767, an improved system for antibody-directed enzyme prodrug therapy that results in tumor regressions in colorectal tumor xenografts"
"0025174052","2404820","","2-s2.0-0025174052","1990-03-19","Activation of prodrugs by antibody-enzyme conjugates: A new approach to cancer therapy"
"0017183517","938622","","2-s2.0-0017183517","1976-12-01","Purification and crystallization of human carboxypeptidase A"
"0024722750","2675955","10.1038/bjc.1989.270","2-s2.0-0024722750","1989-01-01","Towards generating cytotoxic agents at cancer sites"
"0028944213","7896805","10.1074/jbc.270.12.6651","2-s2.0-0028944213","1995-01-01","The sequence and conformation of human pancreatic procarboxypeptidase A2. cDNA cloning, sequence analysis, and three-dimensional model"
"0030220943","8806703","10.1006/abbi.1996.0310","2-s2.0-0030220943","1996-08-01","Expression and characterization of human pancreatic preprocarboxypeptidase A1 and preprocarboxypeptidase A2"
"0342437160","","","2-s2.0-0342437160","1984-07-14","Clinical pharmacology of folate analogs"
"0027477992","8428362","","2-s2.0-0027477992","1993-01-01","Biochemical and Cellular Pharmacology of 1843U89, a Novel Benzoquinazoline Inhibitor of Thymidylate Synthase"
"0026900387","1285323","10.1007/BF02789482","2-s2.0-0026900387","1992-08-01","Human immune response to monoclonal antibody-enzyme conjugates in ADEPT pilot clinical trial"
"0025242063","2243116","","2-s2.0-0025242063","1990-11-25","Arginine 127 stabilizes the transition state in carboxypeptidase"
"0029095503","7627964","","2-s2.0-0029095503","1995-08-01","Regressions and Cures of Melanoma Xenografts following Treatment with Monoclonal Antibody β-Lactamase Conjugates in Combination with Anticancer Prodrugs"
"0025639104","2103354","10.3233/HAB-1990-1201","2-s2.0-0025639104","1990-01-01","Binding and functional properties of a mouse-human chimeric monoclonal antibody of the human IgG1 subclass with specificity for human carcinomas"
"0029019242","7757987","","2-s2.0-0029019242","1995-06-01","In Vitro and In Vivo Activities of a Doxorubicin Prodrug in Combination with Monoclonal Antibody β-Lactamase Conjugates"
"0025731301","2004846","10.1002/ijc.2910470505","2-s2.0-0025731301","1991-01-01","A phase‐i study of repeated therapy with radiolabelled antibody to carcinoembryonic antigen using intermittent or continuous administration of cyclosporin a to suppress the immune response"
"0022370764","3840231","10.1038/317551a0","2-s2.0-0022370764","1985-12-01","Site-directed mutagenesis shows that tyrosine 248 of carboxypeptidase A does not play a crucial role in catalysis"
"0343306771","","","2-s2.0-0343306771","1984-07-13","Clinical utility of methotrexate in neoplastic disease"
"0030024847","8632489","10.1093/jnci/88.3-4.153","2-s2.0-0030024847","1996-02-21","Antibody-enzyme conjugates for cancer therapy"
"0024446208","2790791","","2-s2.0-0024446208","1989-11-01","Enhancement of the in Vitro and in Vivo Antitumor Activities of Phosphorylated Mitomycin C and Etoposide Derivatives by Monoclonal Antibody-Alkaline Phosphatase Conjugates"
"1842282943","","","2-s2.0-1842282943","1995-08-02",""
"0026250463","1805942","","2-s2.0-0026250463","1991-11-01","Generation of 5-fluorouracil from 5-fluorocytosine by monoclonal antibody-cytosine deaminase conjugates."
"0027537670","8464046","","2-s2.0-0027537670","1993-12-01","Prodrugs of doxorubicin and melphalan and their activation by a monoclonal antibody-penicillin-G amidase conjugate"
"78651140144","14086721","","2-s2.0-78651140144","1963-12-01","THE PORCINE PANCREATIC CARBOXYPEPTIDASE A SYSTEM. I. THREE FORMS OF THE"
"0026212613","1790175","","2-s2.0-0026212613","1991-12-01","In vitro and in vivo activities of monoclonal antibody-alkaline phosphatase conjugates in combination with phenol mustard phosphate"
"0024583590","2719954","","2-s2.0-0024583590","1989-12-01","Carboxypeptidase-mediated release of methotrexate from methotrexate α-peptides"
"0027942213","7923136","","2-s2.0-0027942213","1994-01-01","Regression of Established Breast Carcinoma Xenografts with Antibody-directed Enzyme Prodrug Therapy against c-erbB2 p185"
"0028455028","7765070","10.1016/0167-7799(94)90122-8","2-s2.0-0028455028","1994-01-01","Tumor targeting: Activation of prodrugs by enzyme-monoclonal antibody conjugates"
"0028985514","7834611","","2-s2.0-0028985514","1995-02-01","Methotrexate-α-Phenylalanine: Optimization of Methotrexate Prodrug for Activation by Carboxypeptidase A-Monoclonal Antibody Conjugate"
"0026536712","1731945","","2-s2.0-0026536712","1992-12-01","Activation of methotrexate-α-alanine by Carboxypeptidase A-monoclonal antibody conjugate"
"0028348376","8174122","","2-s2.0-0028348376","1994-01-01","Tumor-selective Prodrug Activation by Fusion Protein-mediated Catalysis"
"0027656118","8274519","","2-s2.0-0027656118","1993-09-01","Application of monoclonal antibodies against cytosine deaminase for the in vivo clearance of a cytosine deaminase immunoconjugate."
"0026802946","1417781","","2-s2.0-0026802946","1992-01-01","cDNA cloning and sequence analysis of human pancreatic procarboxypeptidase A1"
"33845184189","","","2-s2.0-33845184189","1989-12-01","Carboxypeptidase A"
"0027538972","7889545","10.1007/BF03033864","2-s2.0-0027538972","1993-01-01","Identification of prodrug, active drug, and metabolites in an ADEPT clinical study"
"0029328639","7578364","","2-s2.0-0029328639","1995-12-01","Site-specific prodrug activation by antibody-β-lactamase conjugates: Preclinical investigation of the efficacy and toxicity of doxorubicin delivered by antibody directed catalysis"
"1842304923","","","2-s2.0-1842304923","1996-07-13",""
"0026794283","1643640","","2-s2.0-0026794283","1992-01-01","Specific Activation of Glucuronide Prodrugs by Antibody-targeted Enzyme Conjugates for Cancer Therapy"
"0001744875","","","2-s2.0-0001744875","1996-07-13","Antibody-directed enzyme prodrug therapy (ADEPT) with active site mutants of human carboxypeptidase A; in vitro and in vivo studies on the potential of Methotrexate prodrugs"
"0021236693","6086763","10.1016/0022-1759(84)90435-6","2-s2.0-0021236693","1984-08-03","Determination of the immunoreactive function of radiolabeled monoclonal antibodies by linear extrapolation to binding at infinite antigen excess"
"0000452622","14212116","","2-s2.0-0000452622","1964-12-01","STUDIES ON THE MECHANISMS OF HYPERSENSITIVITY PHENOMENA. IX. HISTAMINE"
"0020611791","6409418","10.1016/0092-8674(83)90015-6","2-s2.0-0020611791","1983-01-01","A lymphocyte-specific cellular enhancer is located downstream of the joining region in immunoglobulin heavy chain genes"
"84969116683","","","2-s2.0-84969116683","1967-05-26",""
"0021713340","6095112","10.1038/312604a0","2-s2.0-0021713340","1984-12-01","Recombinant antibodies possessing novel effector functions"
"0021713342","6095115","10.1038/312643a0","2-s2.0-0021713342","1984-12-01","Production of functional chimaeric mouse/human antibody"
"0020567861","6409417","10.1016/0092-8674(83)90014-4","2-s2.0-0020567861","1983-01-01","A tissue-specific transcription enhancer element is located in the major intron of a rearranged immunoglobulin heavy chain gene"
"0021716682","6436822","","2-s2.0-0021716682","1984-12-01","Chimeric human antibody molecules: Mouse antigen-binding domains with human constant region domains"
"84969116665","","","2-s2.0-84969116665","1978-05-26",""
"0010431097","6312453","","2-s2.0-0010431097","1983-12-01","Functional immunoglobulin M production after transfection of cloned immunoglobulin heavy and light chain genes into lymphoid cells"
"0014135334","4168094","","2-s2.0-0014135334","1967-10-01","Immunological studies of an atypical (myeloma) immunoglobulin."
"84934265449","","","2-s2.0-84934265449","1987-07-08",""
"0019951779","6177218","10.1007/BF01965108","2-s2.0-0019951779","1982-01-01","Histamine release from human pulmonary mast cells"
"0021092716","10872333","","2-s2.0-0021092716","1983-12-01","Expression and regulation of immunoglobulin heavy chain gene transfected into lymphoid cells."
"1842306602","6402777","","2-s2.0-1842306602","1983-01-01","Immunoglobulin gene expression in transformed lymphoid cells"
"0018958832","6771329","","2-s2.0-0018958832","1980-01-01","Purification and characterization of the major allergen from Dermatophagoides pteronyssinus antigen P1"
"0021828928","3845322","10.1038/314235a0","2-s2.0-0021828928","1985-12-01","Hydrogen bonding and biological specificity analysed by protein engineering"
"0022355587","3874237","","2-s2.0-0022355587","1985-12-01","Human immune response to multiple injections of murine monoclonal IgG"
"0001451676","","","2-s2.0-0001451676","1973-11-15","Three dimensional structure of the Fab fragment of a human immunoglobin at 2.8 Å resolution"
"0018578942","398773","10.1002/eji.1830091216","2-s2.0-0018578942","1979-01-01","Analysis of the repertoire of anti‐(4‐hydroxy‐3‐nitro‐phenyl)acetyl (NP) antibodies in C 57 BL/6 mice by cell fusion. II. Characterization of idiotopes by monoclonal anti‐idiotope antibodies"
"0021760088","6364040","","2-s2.0-0021760088","1984-01-11","Graphic methods to determine the function of nucleic acid sequences"
"0020362615","6295880","10.1016/0378-1119(82)90016-6","2-s2.0-0020362615","1982-01-01","A new pair of M13 vectors for selecting either DNA strand of double-digest restriction fragments"
"0019475303","6940132","","2-s2.0-0019475303","1981-01-01","Switch from hapten-specific immunoglobulin M to immunoglobulin D secretion in a hybrid mouse cell line"
"0020338539","6765233","","2-s2.0-0020338539","1982-12-01","Immunoglobulin V region variants in hybridoma cells. I. Isolation of a variant with altered idiotypic and antigen binding specificity."
"0018179467","97089","10.1002/eji.1830080605","2-s2.0-0018179467","1978-01-01","Analysis of the repertoire of anti‐NP antibodies in C57BL/6 mice by cell fusion. I. Characterization of antibody families in the primary and hyperimmune response"
"0004493194","","","2-s2.0-0004493194","1982-12-07",""
"0021157816","","10.1016/0167-7799(84)90013-1","2-s2.0-0021157816","1984-01-01","Human monoclonal antibodies - production and potential"
"0003518480","","","2-s2.0-0003518480","1975-03-28",""
"84967831858","","","2-s2.0-84967831858","1981-05-22",""
"0020429363","7175935","10.1016/0022-2836(82)90179-6","2-s2.0-0020429363","1982-09-15","Evolution of proteins formed by β-sheets. II. The core of the immunoglobulin domains"
"0021943518","2985470","10.1016/0378-1119(85)90120-9","2-s2.0-0021943518","1985-01-01","Improved M13 phage cloning vectors and host strains: nucleotide sequences of the M13mpl8 and pUC19 vectors"
"0022349984","3002425","","2-s2.0-0022349984","1985-12-01","Fine structure-activity analysis of mutations at position 51 of tyrosyl-tRNA synthetase"
"0017835340","631324","10.1016/0014-5793(78)80145-8","2-s2.0-0017835340","1978-03-01","The use of thin acrylamide gels for DNA sequencing"
"0001529751","14284903","","2-s2.0-0001529751","1964-12-01","DETERMINATION OF ANTIBODY AFFINITY FOR HAPTENS AND ANTIGENS BY MEANS OF"
"0021105470","6644814","10.1016/S0022-2836(83)80206-X","2-s2.0-0021105470","1983-11-15","Preliminary crystallographic study of the complex between the Fab fragment of a monoclonal anti-lysozyme antibody and its antigen"
"0345995262","","","2-s2.0-0345995262","1989-07-13",""
"84908799589","","","2-s2.0-84908799589","1989-11-15",""
"0023038668","2420796","","2-s2.0-0023038668","1986-12-01","Molecular cloning of the cDNA for the two major androgen-dependent secretory proteins of 18.5 kilodaltons synthesized by the rat epididymis"
"0026714544","1386734","","2-s2.0-0026714544","1992-01-01","Genetic evidence for an androgen-regulated epididymal secretory glutathione peroxidase whose transcript does not contain a selenocysteine codon"
"0024324970","2661270","10.1016/0014-5793(89)80689-1","2-s2.0-0024324970","1989-06-19","Structures and functions associated with the group of mammalian lectins containing collagen-like sequences"
"84911000602","","","2-s2.0-84911000602","1993-11-27","Structure of the CAMPATH-1 antigen, a GPI-anchored glycoprotein which is an exceptionally good target for complement lysis"
"0003141821","","","2-s2.0-0003141821","1990-07-13","Gangliosides as targets for monoclonal antibody therapy of cancer"
"0023093460","2433267","","2-s2.0-0023093460","1987-04-03","Lipopolysaccharide size and distribution determine serum resistance in Salmonella montevideo"
"0014316888","5667579","","2-s2.0-0014316888","1968-08-01","Ultrastructural localization of the third and fourth components of complement on complement-cell complexes."
"0343670252","3883355","10.1073/pnas.82.4.1242","2-s2.0-0343670252","1985-06-13","Mouse monoclonal IgG3 antibody detecting G(D3) ganglioside: A phase I trial in patients with malignant melanoma"
"0019379107","7305916","","2-s2.0-0019379107","1981-01-01","The covalent-binding reaction of complement component C3"
"0019782188","7326238","","2-s2.0-0019782188","1981-12-01","Binding reaction between the third human complement protein and small molecules"
"0025883742","1755942","","2-s2.0-0025883742","1991-12-01","C1: Molecular interactions with activating systems"
"84910947505","","","2-s2.0-84910947505","1992-11-27","Characterization and structural analysis of CAMPATH-1 antigen"
"0024425302","2690818","","2-s2.0-0024425302","1989-01-01","Complement membrane attack on nucleated cells: Resistance, recovery and non-lethal effects"
"0024151931","3059994","","2-s2.0-0024151931","1988-12-01","Complement evasion by bacteria and parasites"
"84996114280","","","2-s2.0-84996114280","1994-11-27","Multicenter trial of an anti‐CD5 immunoconjugate in rheumatoid arthritis (abstract)"
"84996064821","","","2-s2.0-84996064821","1994-11-27","Lack of clinical effect of CD4 monoclonal antibody therapy in early rheumatoid arthritis: a placebocontrolled trial (abstract)"
"84996114746","","","2-s2.0-84996114746","1994-11-27","Continued lymphocyte suppression following single dose MAB therapy with Campath‐1H: a 20 month follow up (abstract)"
"0025090676","2402801","","2-s2.0-0025090676","1990-01-01","Serum tumor necrosis factor alpha associated with acute graft-versus-host disease in humans"
"0026594966","1740519","","2-s2.0-0026594966","1992-01-01","Increased serum concentrations of tumour necrosis factor in β thalassaemia: Effect of bone marrow transplantation"
"0024394032","2511092","","2-s2.0-0024394032","1989-01-01","T-cell depletion in allogeneic bone marrow transplantation: progress and problems"
"84930780335","","","2-s2.0-84930780335","1993-06-18","Serum interleukin-6 levels and marrow engraftment after high dose chemotherapy and autologous stem cell transplantation"
"0025891546","1900962","","2-s2.0-0025891546","1991-01-01","Differential in situ expression of cytokines in renal allograft rejection"
"0025008619","2405918","","2-s2.0-0025008619","1990-02-15","Increased serum levels of tumor necrosis factor α precede major complications of bone marrow transplantation"
"0025240733","2139454","","2-s2.0-0025240733","1990-05-01","Selective elimination in vitro of alloresponsive T cells to human transplantation antigens by toxin or radionuclide conjugated anti-il-2 receptor (Tac) monoclonal antibody"
"0024238336","3059622","","2-s2.0-0024238336","1988-12-01","Immunosuppression with monoclonal antibodies: Some speculations about tolerance in the context of tissue grafting"
"0026777992","1321933","10.1016/0145-2126(92)90021-X","2-s2.0-0026777992","1992-01-01","Effects of human interleukin 3, macrophage and granulocyte-macrophage colony-stimulating factor on monocyte function following autologous bone marrow transplantation"
"0025346242","2194592","","2-s2.0-0025346242","1990-07-01","Use of recombinant human granulocyte-macrophage colony-stimulating factor in graft failure after bone marrow transplantation"
"7344238440","","10.1016/0167-5699(81)90025-6","2-s2.0-7344238440","1981-01-01","The cellular basis of allograft rejection"
"0028226496","8167558","10.3109/10428199409059599","2-s2.0-0028226496","1994-01-01","Soluble interleukin-2 receptor levels in cytomegalovirus disease and graft versus host disease after t-lymphocyte depleted bone marrow transplantation for hematological neoplasias"
"0027294049","8101864","","2-s2.0-0027294049","1993-08-01","Donor CD8 cells prevent allogeneic marrow graft rejection in mice: Potential implications for marrow transplantation in humans"
"0026553501","1738940","","2-s2.0-0026553501","1992-01-01","Intragraft cytokine profile during human liver allograft rejection"
"0015834540","4576852","","2-s2.0-0015834540","1973-01-01","Allogeneic bone marrow transplantation in a patient with aplastic anemia using a phenotypically HL-A-identical unrelated donor"
"0025291983","2185314","","2-s2.0-0025291983","1990-01-01","Granulocyte-macrophage colony-stimulating factor stimulates human monocyte accessory cell function"
"0010566049","","","2-s2.0-0010566049","1987-10-29","Graft rejection in recipients of T-cell depleted HLA nonidentical transplants for leukemia: Identification of host derived anti-donor allocytotoxic T-lymphocytes"
"0027861097","8440338","","2-s2.0-0027861097","1993-12-01","Interleukin-3 followed by GM-CSF for delayed engraftment after autologous bone marrow transplantation"
"0024520137","2647173","","2-s2.0-0024520137","1989-01-01","Prevention of graft rejection in allogeneic bone marrow transplantation: I. Preclinical studies with antithymocyte globulins"
"0028968150","7773155","10.3109/10428199509051718","2-s2.0-0028968150","1995-01-01","Cytokine dysregulation in chronic graft versus host disease"
"0023555286","3309124","","2-s2.0-0023555286","1987-12-01","Raised serum levels of cachectin/tumor necrosis factor α in renal allograft rejection"
"0020472271","6801833","","2-s2.0-0020472271","1982-01-01","Which T cells cause graft rejection"
"0025074417","2402789","","2-s2.0-0025074417","1990-01-01","Prevention of graft rejection in allogeneic bone marrow transplantation: II. Preclinical studies with three radiation protocols"
"84930785425","","","2-s2.0-84930785425","0000-06-18","Role of cytokines in graft versus host reaction/bone marrow rejection"
"0021911471","2579185","","2-s2.0-0021911471","1985-01-01","Bone marrow graft rejection as a function of antibody-directed natural killer cells"
"0024422350","2790180","","2-s2.0-0024422350","1989-01-01","Antibody-mediated marrow failure after allogeneic bone marrow transplantation"
"0026612089","1575459","10.1002/ana.410310211","2-s2.0-0026612089","1992-01-01","1H and 31P magnetic resonance spectroscopy of the brain in degenerative cerebral disorders"
"0029431903","7477973","","2-s2.0-0029431903","1995-12-01","Changes in the amount of diseased white matter over time in patients with relapsing-remitting multiple sclerosis"
"0026002097","1940393","10.1016/0022-1759(91)90050-P","2-s2.0-0026002097","1991-10-25","A specific and reliable bioassay for the detection of femtomolar levels of human and murine tumor necrosis factors"
"0030773837","9287225","10.1126/science.277.5332.1684","2-s2.0-0030773837","1997-09-12","Synaptic efficacy enhanced by glial cells in vitro"
"0029925782","8614497","","2-s2.0-0029925782","1996-01-01","Serial gadolinium-enhanced MRI of the brain and spinal cord in early relapsing-remitting multiple sclerosis"
"0027233870","8099750","","2-s2.0-0027233870","1993-07-01","Proton spectroscopy of the brain in HIV infection: Correlation with clinical, immunologic, and MR imaging findings"
"0027450301","8441018","","2-s2.0-0027450301","1993-12-01","Proton nuclear magnetic resonance spectroscopy unambiguously identifies different neural cell types"
"0031891592","9506550","10.1002/ana.410430311","2-s2.0-0031891592","1998-03-01","Correlations between monthly enhanced MRI lesion rate and changes in T2 lesion volume in multiple sclerosis"
"0031439343","9448570","10.1093/brain/120.12.2149","2-s2.0-0031439343","1997-12-01","Nitric oxide donors reversibly block axonal conduction: Demyelinated axons are especially susceptible"
"0028107813","7801735","10.1111/j.1600-0404.1994.tb02688.x","2-s2.0-0028107813","1994-01-01","Follow‐up study of MS patients treated with high‐dose intravenous methylprednisolone"
"0028838091","7766839","","2-s2.0-0028838091","1995-01-01","A proliferative adult human oligodendrocyte progenitor"
"0031002545","9126051","10.1093/brain/120.3.393","2-s2.0-0031002545","1997-03-01","Axonal damage in acute multiple sclerosis lesions"
"0024325294","2671831","10.1016/S0149-7634(89)80048-X","2-s2.0-0024325294","1989-01-01","N-Acetyl-L-Aspartic acid: A literature review of a compound prominent in 1H-NMR spectroscopic studies of brain"
"0028143211","7934491","10.1016/S0140-6736(94)90628-9","2-s2.0-0028143211","1994-10-22","Randomised double-blind comparison of chimeric monoclonal antibody to tumour necrosis factor α (cA2) versus placebo in rheumatoid arthritis"
"0345647370","","","2-s2.0-0345647370","2004-07-13","Quantitative MRI in patients with secondary progressive MS treated monoclonal antibody, Campath-1H"
"0030901101","9109490","","2-s2.0-0030901101","1997-04-17","Induction of sodium channel clustering by oligodendrocytes"
"0028922832","7776786","10.1016/S0140-6736(95)90486-7","2-s2.0-0028922832","1995-03-04","Does interferon beta cause initial exacerbation of multiple sclerosis?"
"0028867186","7576630","10.1016/0896-6273(95)90172-8","2-s2.0-0028867186","1995-01-01","Characterization of the signaling interactions that promote the survival and growth of developing retinal ganglion cells in culture"
"0017148934","1086889","10.1136/jnnp.39.7.680","2-s2.0-0017148934","1976-01-01","Neuroelectric blocking factors in human and animal sera evaluated using the isolated frog spinal cord"
"0017191362","932762","","2-s2.0-0017191362","1976-12-01","Experimental studies of the effects of extrinsic factors on conduction in normal and demyelinated nerve. I. Temperature"
"0024947945","2517430","","2-s2.0-0024947945","1989-12-01","Studies on the specificity of the L929 cell bioassay for the measurement of tumour necrosis factor"
"0028814565","7830068","","2-s2.0-0028814565","1995-02-01","High resolution proton NMR spectroscopy of multiple sclerosis lesions"
"0032576752","9445407","10.1056/NEJM199801293380502","2-s2.0-0032576752","1998-01-29","Axonal transection in the lesions of multiple sclerosis"
"0029751983","8960740","","2-s2.0-0029751983","1996-12-01","Increased MRI activity and immune activation in two multiple sclerosis patients treated with the monoclonal anti-tumor necrosis factor antibody cA2"
"0030780349","9392578","10.1002/ana.410420515","2-s2.0-0030780349","1997-11-01","Inflammatory central nervous system demyelination: Correlation of magnetic resonance imaging findings with lesion pathology"
"0026446242","1440704","","2-s2.0-0026446242","1992-01-01","Early time course of jv-acetylaspartate, creatine and phosphocreatine, and compounds containing choline in the brain after acute stroke: A proton magnetic resonance spectroscopy study"
"0028218020","7514208","","2-s2.0-0028218020","1994-05-01","The role of oligodendrocytes and myelin on axon maturation in the developing rat retinofugal pathway"
"0025906369","2043950","10.1093/brain/114.2.801","2-s2.0-0025906369","1991-04-01","Patterns of blood-brain barrier breakdown in inflammatory demyelination"
"0028143212","7934495","10.1016/S0140-6736(94)90632-7","2-s2.0-0028143212","1994-10-22","Repeated therapy with monoclonal antibody to tumour necrosis factor α (cA2) in patients with rheumatoid arthritis"
"0023194967","3295122","10.1136/jnnp.50.5.511","2-s2.0-0023194967","1987-01-01","A double-blind controlled trial of high dose methylprednisolone in patients with multiple sclerosis: 1. clinical effects"
"0025949863","1833202","10.1002/eji.1830211009","2-s2.0-0025949863","1991-01-01","Cascade modulation by anti‐tumor necrosis factor monoclonal antibody of interferon‐γ, interleukin 3 and interleukin 6 release after triggering of the CD33/T cell receptor activation pathway"
"34447111278","","","2-s2.0-34447111278","1995-07-13","Successful treatment of T-cell prolymphocytic leukaemia (T-PLL) with human CD52 antibody, Campath-1H"
"0018095570","687708","","2-s2.0-0018095570","1978-12-01","Characterization of the surface glycoproteins of rat spermatozoa"
"0028058117","8167223","","2-s2.0-0028058117","1994-01-01","Molecular cloning and characterization of a novel human sperm antigen (HE2) specifically expressed in the proximal epididymis"
"0020680209","6298250","","2-s2.0-0020680209","1983-01-01","Changes in plasma membrane glycoproteins of rat spermatozoa during maturation in the epididymis"
"0027381859","8292828","10.1002/aja.1001980102","2-s2.0-0027381859","1993-01-01","Gene expression of CD24 core peptide molecule in developing brain and developing non‐neural tissues"
"0028109879","7528012","","2-s2.0-0028109879","1994-01-01","Molecular cloning of the rat analogue of human CD59: Structural comparison with human CD59 and identification of a putative active site"
"0022000269","3995131","10.1095/biolreprod32.3.591","2-s2.0-0022000269","1985-06-26","Immunochemical localization of secretory antigens in the human epididymis and their association with spermatozoa"
"0021940367","3995130","10.1095/biolreprod32.3.584","2-s2.0-0021940367","1985-11-13","Identification of androgen-induced proteins in human epididymis"
"0022729078","3730486","","2-s2.0-0022729078","1986-06-01","Membrane glycoproteins from spermatozoa: partial characterization of an integral Mr = approximately 24,000 molecule from rat spermatozoa that is glycosylated during epididymal maturation."
"0019464714","7011431","","2-s2.0-0019464714","1981-01-01","Surface changes in rat spermatozoa during epidydmal transit"
"0027993504","7959762","10.1006/geno.1994.1356","2-s2.0-0027993504","1994-01-01","Mapping of CD24 and homologous sequences to multiple chromosomal loci"
"0027294030","8352586","","2-s2.0-0027294030","1993-07-28","The structure and biosynthesis of glycosyl phosphatidylinositol protein anchors"
"0028567786","7744512","10.1111/j.1365-2605.1994.tb01263.x","2-s2.0-0028567786","1994-01-01","Regional variation of specific gene expression in the dog epididymis as revealed by in‐situ transcript hybridization"
"0019808404","7340848","","2-s2.0-0019808404","1981-12-01","Labelling of membrane glycoproteins on rat spermatozoa collected from different regions of the epididymis"
"0003831086","","","2-s2.0-0003831086","1997-07-13",""
"0023636367","3445971","10.1111/j.1749-6632.1987.tb25014.x","2-s2.0-0023636367","1987-01-01","Rearrangement of Sperm Surface Antigens prior to Fertilization"
"0027484972","8226859","","2-s2.0-0027484972","1993-11-05","The heat stable antigen (mouse CD24) gene is differentially regulated but has a housekeeping promoter"
"0025909389","2019286","10.1002/eji.1830210427","2-s2.0-0025909389","1991-01-01","The genes for a mouse hematopoietic differentiation marker called the heat‐stable antigen"
"0028558461","7744511","10.1111/j.1365-2605.1994.tb01262.x","2-s2.0-0028558461","1994-01-01","Gene expression in the dog epididymis: a model for human epididymal function"
"0019731150","6796498","10.1111/j.1600-065X.1981.tb00455.x","2-s2.0-0019731150","1981-01-01","Rearrangements of Immunoglobulin Genes during Differentiation and Evolution"
"0019363396","6791577","","2-s2.0-0019363396","1981-01-01","Organization and expression of eucaryotic split genes coding for proteins."
"0008261096","265521","","2-s2.0-0008261096","1977-12-01","A new method for sequencing DNA"
"0018908524","6767197","10.1038/284452a0","2-s2.0-0018908524","1980-12-01","Mouse Cμ heavy chain immunoglobulin gene segment contains three intervening sequences separating domains"
"0019880179","6779206","10.1038/289149a0","2-s2.0-0019880179","1981-12-01","Ordering of mouse immunoglobulin heavy chain genes by molecular cloning"
"0018237131","728996","10.1016/0092-8674(78)90043-0","2-s2.0-0018237131","1978-01-01","The isolation and characterization of linked δ- and β-globin genes from a cloned library of human DNA"
"0017781231","409955","10.1038/269354a0","2-s2.0-0017781231","1977-12-01","Generation length and rates of hominoid molecular evolution"
"0017760526","900125","","2-s2.0-0017760526","1977-12-01","Recombination, mutation, or constitutive expression at a Gm locus and familial hypergammaglobulinemia"
"0019414935","6264445","","2-s2.0-0019414935","1981-01-01","Linkage of the four γ subclass heavy chain genes"
"0014407722","4874239","","2-s2.0-0014407722","1968-12-01","Repeated sequences in DNA"
"0018565066","117549","","2-s2.0-0018565066","1979-12-01","Sequence of the cloned gene for the constant region of murine γ2b immunoglobulin heavy chain"
"0019177836","6255422","10.1093/nar/8.17.3933","2-s2.0-0019177836","1980-09-11","Complete nucleotide sequence of mouse imunoglobulin μ gene and comparison with other immunoglobulin heavy chain genes"
"0011323102","","","2-s2.0-0011323102","1967-12-06","Genetic Markers of the Heavy Chain Subgroups of Human  G Globulin"
"0017329598","847462","","2-s2.0-0017329598","1977-12-01","Charon phages: Safer derivatives of bacteriophage lambda for DNA cloning"
"0019889717","6791031","10.1038/292845a0","2-s2.0-0019889717","1981-12-01","Switch region of immunoglobulin Cμ gene is composed of simple tandem repetitive sequences"
"0018838328","6769752","10.1016/0378-1119(80)90168-7","2-s2.0-0018838328","1980-01-01","Immunoglobulin γ1 heavy chain gene: Structural gene sequences cloned in a bacterial plasmid"
"0019194010","7439686","","2-s2.0-0019194010","1980-12-01","Nucleotide sequences of class-switch recombination region of the mouse immunoglobulin γ2b-chain gene"
"84912363013","","","2-s2.0-84912363013","1981-12-06","Organization of immunoglobulin heavy chain genes and genetic mechanism of class switch"
"0007663470","6938980","","2-s2.0-0007663470","1980-12-01","Nucleotide sequence divergence and functional constraint in mRNA evolution"
"0019121799","6774414","","2-s2.0-0019121799","1980-12-01","Mapping of heavy chain genes for mouse immunoglobulins M and D"
"0019419871","7023698","","2-s2.0-0019419871","1981-01-01","Recombination activities of E. coli RecA protein"
"0019151964","6769121","","2-s2.0-0019151964","1980-12-01","Nucleotide sequence divergence of mouse immunoglobulin γ1 and γ2(b) chain genes and the hypothesis of intervening sequence-mediated domain transfer"
"1842319924","6767246","","2-s2.0-1842319924","1980-01-01","Rearrangement of immunoglobulin γ1-chain gene and mechanism for heavy-chain class switch"
"77957009991","","10.1016/S0076-6879(71)21033-8","2-s2.0-77957009991","1971-12-01","[31] Electron microscope heteroduplex methods for mapping regions of base sequence homology in nucleic acids"
"84912363955","","","2-s2.0-84912363955","1982-12-06","Nucleotide sequences of gene segments encoding membrane domains of immunoglobulin γ chains"
"34547642637","","10.1038/272581a0","2-s2.0-34547642637","1978-12-01","Genes in pieces: were they ever together?"
"0018867656","6769120","","2-s2.0-0018867656","1980-09-26","Exon shuffling generates an immunoglobulin heavy chain gene"
"0018321476","116231","","2-s2.0-0018321476","1979-01-01","Cloning immunoglobulin γ2b chain gene of mouse: Characterization and partial sequence determination"
"0018239377","364651","","2-s2.0-0018239377","1978-12-01","Implications of RNA.RNA splicing in evolution of eukaryotic cells"
"0019450782","6262816","10.1073/pnas.78.3.1581","2-s2.0-0019450782","1981-07-24","Cloning of mouse immunoglobulin ε gene and its location within the heavy chain gene cluster"
"0018372990","106304","10.1038/277627a0","2-s2.0-0018372990","1979-12-01","Domains and the hinge region of an immunoglobulin heavy chain are encoded in separate DNA segments"
"0018263844","622185","10.1038/271501a0","2-s2.0-0018263844","1978-12-01","Why genes in pieces?"
"0032145427","","","2-s2.0-0032145427","1998-08-01","Erratum: Prope tolerance, perioperative campath 1H, and low-dose cyclosporin monotherapy in renal allograft recipients (The Lancet (1998) June 6 (1701))"
"0032738485","10561017","","2-s2.0-0032738485","1999-11-18","Monoclonal antibody therapy of cancer"
"4243824472","","","2-s2.0-4243824472","1993-09-27","Treatment of lymphoid malignancies with Campath 1H associated with elevated serum levels of IL-6 and TNF-α"
"0006228221","","","2-s2.0-0006228221","1999-10-07","Campath-1H induces apoptosis in human chronic lymphocytic leukemia cells (CLL) in vitro independent of complement mediated lysis of Fcg receptor ligation"
"4244196322","","","2-s2.0-4244196322","1993-09-27","Control of hyperlymphocytosis and splenomegaly with Campath-1H in advanced refractory B-cell chronic lymphocytic leukemia (B-CLL)"
"0006422114","","","2-s2.0-0006422114","1994-07-13",""
"0003365755","","","2-s2.0-0003365755","2000-09-27","Blocking with Sandoglobulin (Total Human IgG) improves the biodistribution of the radiolabelled monoclonal antibody (MAB) CAMPATH-1H"
"0000041777","","","2-s2.0-0000041777","1999-07-13","Campath-1H in the treatment of T-prolymphocytic leukemia (T-PLL)"
"0033536579","","10.1006/jmbi.1999.2927","2-s2.0-0033536579","1999-10-08","Erratum: 1.9 Å structure of the therapeutic antibody CAMPATH-1H Fab in complex with a synthetic peptide antigen (Journal of Molecular Biology (1999) 289 (293-301))"
"0006499946","","","2-s2.0-0006499946","1999-09-27","Frequency and type of serious infections in fludarabine refractory chronic lymphocytic leukemia and small lymphocytic leukemia: Implications for clinical trials in this patient population"
"84879077075","","","2-s2.0-84879077075","1998-06-26","Normal immunoglobulin for intravenous use"
"84879097963","","","2-s2.0-84879097963","1995-06-26",""
"84879086120","","","2-s2.0-84879086120","2000-06-26","Measurement of antibody concentrations by haemagglutination"
"0022773783","3756089","","2-s2.0-0022773783","1986-09-01","Operation manual for control of production, preclinical toxicology and phase I trials of anti-tumour antibodies and drug antibody conjugates. Prepared by a Joint Committee of the: Cancer Research Campaign National Institute for Biological Standards and Control."
"84879104006","","","2-s2.0-84879104006","2000-06-26","Aseptic vial filling"
"84879118553","","","2-s2.0-84879118553","1995-06-26",""
"0024543532","2913162","10.1016/0022-1759(89)90121-X","2-s2.0-0024543532","1989-02-08","Detection and reduction of Protein A contamination in immobilized Protein A purified monoclonal antibody preparations"
"0000367675","","","2-s2.0-0000367675","2000-07-13","Isolation and purification of monoclonal antibodies from tissue culture supernatant"
"0028313952","8176235","10.1016/0022-1759(94)90223-2","2-s2.0-0028313952","1994-05-02","Repeated cleaning of protein A affinity column with sodium hydroxide"
"0027561894","8038892","10.1111/j.1365-3148.1993.tb00098.x","2-s2.0-0027561894","1993-01-01","Small scale production of novel therapeutic products–––a new challenge for the transfusion service?"
"0023854865","","","2-s2.0-0023854865","1988-01-01","Guidelines on the production and quality control of monoclonal antibodies of murine origin intended for use in man"
"84921072215","","","2-s2.0-84921072215","1985-01-24","Sequential autografting and allogeneic bone marrow transplantation in a patient with chronic myeloid leukemia in blast crisis"
"84921078310","","","2-s2.0-84921078310","1985-01-24","Ex-vivo treatment with pan-T monoclonal antibody combination and complement for prevention of acute GvHD. Pilot study of 25 cases"
"0021932145","2862933","","2-s2.0-0021932145","1985-11-28","Marrow transplantation for chronic myelocytic leukemia: A controlled trial of cyclosporine versus methotrexate for prophylaxis of graft-versus-host disease"
"84921083472","","","2-s2.0-84921083472","1985-01-24","Total lymphoid irradiation (TLI) as adjunct immunosuppressor for preventing late graft failure (LGF) associated with T-cell depleted marrow allograft"
"0020683917","6336949","10.1111/j.1365-2141.1983.tb02020.x","2-s2.0-0020683917","1983-01-01","Cyclosporin A is associated with faster engraftment and less mucositis than methotrexate after allogeneic bone marrow transplantation"
"0020367940","6753913","10.1111/j.1365-2141.1982.tb03930.x","2-s2.0-0020367940","1982-01-01","Regeneration of peripheral blood cells following allogeneic bone marrow transplantation for severe aplastic anaemia"
"0344278624","","","2-s2.0-0344278624","1985-01-24","T depletion using MBG6 and RFT8 monoclonal antibody combination and complement lysis prevents significant acute and chronic GVHD in allogeneic marrow transplants"
"84919572773","","","2-s2.0-84919572773","1985-12-28","Bone marrow transplantation for leukemia in Europe"
"0021917231","2860919","10.1111/j.1365-2141.1985.tb07410.x","2-s2.0-0021917231","1985-01-01","Lack of correlation between nucleated bone marrow cell dose, marrow CFU‐GM dose or marrow CFU‐E dose and the rate of HLA‐identical sibling marrow engraftment"
"84921088812","","","2-s2.0-84921088812","0000-01-24",""
"0021210878","6386507","","2-s2.0-0021210878","1984-11-29","Allogeneic marrow transplantation for thalassemia"
"84958870173","","","2-s2.0-84958870173","1984-03-02",""
"0023004788","3332114","","2-s2.0-0023004788","1986-12-01","Bone marrow transplantation in thalassaemia"
"0023158720","3550463","","2-s2.0-0023158720","1987-05-28","Marrow transplantation in patients with advanced thalassemia"
"0022271479","3893277","10.1111/j.1749-6632.1985.tb17211.x","2-s2.0-0022271479","1985-01-01","Marrow Transplantation for Thalassemia"
"0021980518","3922285","","2-s2.0-0021980518","1985-01-01","Marrow transplantation for thalassemia."
"84958945910","","","2-s2.0-84958945910","0000-03-02",""
"84958835021","","","2-s2.0-84958835021","1981-03-02",""
"0018814502","6930864","10.1111/j.1749-6632.1980.tb33656.x","2-s2.0-0018814502","1980-01-01","GLOBIN SYNTHESIS IN SEVERE AND INTERMEDIATE HOMOZYGOUS β THALASSEMIA IN ISRAEL"
"84958899052","","","2-s2.0-84958899052","1984-03-02",""
"84958926089","","","2-s2.0-84958926089","2016-03-02","Elimination of graft-versus-host disease by in vitro depletion of alloreactive lymphocytes with monoclonal rat-anti-human lymphocyte antibody (Campath-1)"
"84958923240","","","2-s2.0-84958923240","1985-03-02",""
"0021860569","2861312","10.1016/S0140-6736(85)91784-2","2-s2.0-0021860569","1985-06-15","MARROW TRANSPLANTATION FOR THALASSAEMIA FOLLOWING BUSULPHAN AND CYCLOPHOSPHAMIDE"
"0023635775","3306390","","2-s2.0-0023635775","1987-12-01","Bone marrow transplantation for thalassemia"
"84920241782","","","2-s2.0-84920241782","1982-10-06","Marrow transplantation for thalassemia"
"0020146403","7042160","","2-s2.0-0020146403","1982-06-01","Transfusion haemosiderosis and chelation therapy."
"0030843493","9180086","10.1126/science.276.5319.1719","2-s2.0-0030843493","1997-06-13","HSV-TK gene transfer into donor lymphocytes for control of allogeneic graft-versus-leukemia"
"0031007771","9129015","","2-s2.0-0031007771","1997-05-01","Tumor-specific idiotype vaccines in the treatment of patients with B- cell lymphoma - Long-term results of a clinical trial"
"0028820386","7675046","10.1056/NEJM199510193331603","2-s2.0-0028820386","1995-01-01","Reconstitution of cellular immunity against cytomegalovirus in recipients of allogeneic bone marrow by transfer of T-cell clones from the donor"
"9044254117","9816191","","2-s2.0-9044254117","1996-03-01","Yttrium-90-labeled anti-CD20 monoclonal antibody therapy of recurrent B-cell lymphoma"
"0029163551","7623531","10.1016/S0140-6736(95)92225-3","2-s2.0-0029163551","1995-08-05","Phase II trial of 131I-B1 (anti-CD20) antibody therapy with autologous stem cell transplantation for relapsed B cell lymphomas"
"0030815867","9354693","","2-s2.0-0030815867","1997-11-15","Donor leukocyte infusions are effective in relapsed multiple myeloma after allogeneic bone marrow transplantation"
"0030656557","9368780","10.1016/S0952-7915(97)80052-0","2-s2.0-0030656557","1997-10-01","Prospects for adoptive T cell therapy"
"0000079275","","","2-s2.0-0000079275","1997-08-18","A multicenter phase II study of Iodine-131 anti-B1 antibody in patients with chemotherapy-relapsed/refractory low-grade or transformed low-grade B-cell non Hodgkin's lymphoma"
"9444268741","8695836","","2-s2.0-9444268741","1996-08-15","A phase I study of bolus versus continuous infusion of the anti-CD19 immunotoxin, IgG-HD37-dgA, in patients with B-cell lymphoma"
"0344243871","","","2-s2.0-0344243871","1996-05-03","High-dose infusional humanized anti-CD33 M195: Prospects for treating minimal disease in myeloid leukemia"
"0030922328","9160688","","2-s2.0-0030922328","1997-05-15","Autologous tumor infiltrating T cells cytotoxic for follicular lymphoma cells can be expanded in vitro"
"17744401939","9427692","","2-s2.0-17744401939","1998-01-15","Phase I trial of a ligand fusion-protein (DAB389IL-2) in lymphomas expressing the receptor for interkeukin-2"
"0002429226","","","2-s2.0-0002429226","1996-12-30","IDEC-C2B8/CHOP chemoimmunotherapy in patients with low-grade lymphoma: Interim clinical and bcl-2 (PCR) results"
"0000602090","","","2-s2.0-0000602090","1996-07-02","&lt;sup&gt;131&lt;/sup&gt;I-anti-CD45 antibody plus busulfan/cyclophosphamide in matched related transplants for AML in first remission"
"0028914441","7723498","10.1016/S0140-6736(95)90757-2","2-s2.0-0028914441","1995-04-22","Transfer of myeloma idiotype-specific immunity from an actively immunised marrow donor"
"0013532754","","","2-s2.0-0013532754","1997-07-20","Pivotal phase III trial of two dose levels of Dabil-2 (Ontak) for the treatment of mycosis fungoides389"
"0001325043","","","2-s2.0-0001325043","1996-02-17","IDEC-C2B8 anti-CD20 antibody: Final report on a phase III pivotal trial in patients with relapsed low-grade or follicular lymphoma"
"13344261952","8574968","10.1038/nm0296-216","2-s2.0-13344261952","1996-02-16","T-cell mediated rejection of gene-modified HIV-specific cytotoxic T lymphocytes in HIV-infected patients"
"0030930350","9336727","10.1016/S0889-8588(05)70475-5","2-s2.0-0030930350","1997-10-20","The potential for immunoconjugates in lymphoma therapy"
"0030946394","9058719","","2-s2.0-0030946394","1997-03-15","Isolation of Epstein-Barr virus (EBV)-specific cytotoxic T lymphocytes that lyse Reed-Sternberg cells: Implications for immune-mediated therapy of EBV+ Hodgkin's disease"
"0030735798","9345055","","2-s2.0-0030735798","1997-11-15","Idiotype vaccines for non-Hodgkin's lymphoma induce polyclonal immune responses that cover mutated tumor idiotypes: Comparison of different vaccine formulations"
"0030293623","8892642","","2-s2.0-0030293623","1996-11-01","Isolation of Tyrosinase-Specific CD8+ and CD4+ T Cell Clones from the Peripheral Blood of Melanoma Patients Following in Vitro Stimulation with Recombinant Vaccinia Virus"
"0004421660","","","2-s2.0-0004421660","1997-09-27","IDEC-Y2B8 90yttrium anti-CD20 radioimmunotherapy of relapsed non-Hodgkin's lymphoma (NHL): Interim results of a phase I/II trial"
"0022671293","2423326","","2-s2.0-0022671293","1986-02-01","Modelling of the combining sites of three anti-lysozyme monoclonal antibodies and of the complex between one of the antibodies and its epitope."
"84909673124","","","2-s2.0-84909673124","1977-12-09",""
"0022519337","2426778","","2-s2.0-0022519337","1986-01-01","Three-dimensional structure of an antigen-antibody complex at 2.8 Å resolution"
"0019473314","7212273","10.1016/0003-2697(81)90104-4","2-s2.0-0019473314","1981-01-01","A nonlinear regression program for small computers"
"0345125154","3856851","","2-s2.0-0345125154","1985-01-01","Structure of proteins with single-site mutations: A minimum perturbation approach"
"0017429069","326146","","2-s2.0-0017429069","1977-01-01","Areas, volumes, packing and protein structure."
"0022797366","3507688","10.1093/protein/1.1.59","2-s2.0-0022797366","1986-10-01","The cloning and expression of an anti-peptide antibody: A system for rapid analysis of the binding properties of engineered antibodies"
"0021095485","6876161","10.1016/S0022-2836(83)80104-1","2-s2.0-0021095485","1983-07-05","Structure of a novel bence-jones protein (Rhe) fragment at 1·6 Å resolution"
"38249043063","","10.1016/0968-0004(86)90070-8","2-s2.0-38249043063","1986-01-01","Investigating antibody specificity using computer graphics and protein engineering"
"0023017207","3449853","10.1002/prot.340010112","2-s2.0-0023017207","1986-01-01","The galactan‐binding immunoglobulin Fab J539: An x‐ray diffraction study at 2.6‐Å resolution"
"0019888748","7045378","10.1016/0022-2836(81)90465-4","2-s2.0-0019888748","1981-12-25","Comparative model-building of the mammalian serine proteases"
"0022419296","3894675","10.1016/0022-2836(85)90014-2","2-s2.0-0022419296","1985-06-05","A molecular dynamics study of the C-terminal fragment of the L7 L12 ribosomal protein. Secondary structure motion in a 150 picosecond trajectory"
"0022017096","2410255","","2-s2.0-0022017096","1985-02-01","Three distinct epitopes within the loop region of hen egg lysozyme defined with monoclonal antibodies."
"0021691918","6434748","10.1016/0022-2836(84)90049-4","2-s2.0-0021691918","1984-08-25","An analysis of incorrectly folded protein models. Implications for structure predictions"
"0019061918","6254391","","2-s2.0-0019061918","1980-09-01","Ligand: a versatile computerized approach for characterization of ligand-binding systems."
"4244026254","","","2-s2.0-4244026254","1994-12-28","Correlations between changes in disability and MRI activity in multiple sclerosis: a 2 year follow-up study"
"0003994758","","","2-s2.0-0003994758","1993-03-23",""
"0020576750","6356588","10.1111/j.1423-0410.1983.tb01917.x","2-s2.0-0020576750","1983-01-01","A Technique for the Concentration of Nucleated Bone Marrow Cells for in vitro Manipulation or Cryopreservation Using the IBM 2991 Blood Cell Processor"
"0023761720","3070937","10.1111/j.1423-0410.1988.tb05079.x","2-s2.0-0023761720","1988-01-01","Separation of Mononuclear Bone Marrow Cells using the Cobe 2997 Blood Cell Separator"
"0020775034","6346604","","2-s2.0-0020775034","1983-01-01","Transplantation: Letters to editor"
"0023634311","","","2-s2.0-0023634311","1987-12-01","Hematopoietic reconstitution after autologous blood stem cell transplantation: A report of 46 cases"
"0020319192","6125343","10.1016/0011-2240(82)90157-2","2-s2.0-0020319192","1982-01-01","Enrichment and cryopreservation of bone marrow progenitor cells for autologous reinfusion"
"0023624245","","","2-s2.0-0023624245","1987-12-01","Separation of red blood cell-depleted mononuclear marrow cells by continuous-flow centrifugation using the IBM 2997 blood cell separator - results of a preclinical study in a dog model"
"0023854392","2901880","","2-s2.0-0023854392","1988-01-01","Concentration of bone marrow progenitor cells by separation on a Percoll gradient using the Haemonetics model 30"
"0022822566","2901871","","2-s2.0-0022822566","1986-12-01","Clonogenic assays and engraftment in allogeneic bone marrow transplantation."
"0022651411","3707246","","2-s2.0-0022651411","1986-07-23","Prevention of myocardial injury during brain death by total cardiac sympathectomy in the chacma baboon"
"0023938371","3048488","","2-s2.0-0023938371","1988-01-01","Alternative donor sources in HLA-mismatched marrow transplantation: T cell depletion of surgically resected cadaveric marrow"
"0022394143","3899700","","2-s2.0-0022394143","1985-12-01","Marrow harvesting for autologous marrow transplantation"
"0019870816","7307526","10.1016/0011-2240(81)90107-3","2-s2.0-0019870816","1981-01-01","Cryopreservation of human lymphocytes and stem cells (CFU-c) in large units for cancer therapy-A report based on the data of more than 400 frozen units"
"0020073545","7068909","","2-s2.0-0020073545","1982-05-14","Bone marrow processing and cryopreservation"
"0018766097","89962","","2-s2.0-0018766097","1979-12-01","Bone marrow culture in vitro. A technique for analysis and permanent recording of cellular composition"
"0020596506","6345173","10.1016/0277-5379(83)90111-6","2-s2.0-0020596506","1983-01-01","Delayed kinetics of recovery of haemopoiesis following autologous bone marrow transplantation. The role of excessively rapid marrow freezing rates after the release of fusion heat"
"0018827195","7385323","10.1046/j.1537-2995.1980.20380214894.x","2-s2.0-0018827195","1980-01-01","Description of a closed plastic bag system for the collection and cryopreservation of leukapheresis‐derived blood mononuclear leukocytes and CFUc from human donors"
"0021964423","3886515","10.1002/hon.2900030109","2-s2.0-0021964423","1985-01-01","Removal of tumour cells from bone marrow: An evaluation of the available techniques"
"0022979624","3544495","10.1111/j.1423-0410.1986.tb01953.x","2-s2.0-0022979624","1986-01-01","Standardization of the Processing of Human Bone Marrow for Allogeneic Transplantation"
"0021782623","3897206","10.1002/jca.2920020305","2-s2.0-0021782623","1985-01-01","Erythrocyte depletion of ABO‐lncompatible bone marrow"
"0023622069","2443203","","2-s2.0-0023622069","1987-12-01","Autologous bone marrow transplantation using unfractionated cells cryopreserved in dimethylsulfoxide and hydroxyethyl starch without controlled-rate freezing"
"9244263533","8648394","","2-s2.0-9244263533","1996-04-01","Feasibility and results of bone marrow transplantation after remission induction and intensification chemotherapy in de novo acute myeloid leukemia"
"0028359435","8207985","","2-s2.0-0028359435","1994-06-01","Are patients with acute leukaemia, alive and well 2 years post bone marrow transplantation cured? A European survey"
"0027368804","8227408","10.1136/jcp.46.10.915","2-s2.0-0027368804","1993-01-01","Haemopoietic regrowth after chemotherapy for acute leukaemia: An immunohistochemical study of bone marrow trephine biopsy specimens"
"0028040461","7994259","","2-s2.0-0028040461","1994-01-01","Bone marrow transplantation in 63 adult patients with acute lymphoblastic leukemia in first complete remission"
"0020042577","6121405","","2-s2.0-0020042577","1982-01-01","Bone marrow transplantation across major histocompatibility barriers in mice: II. T cell requirement for engraftment in total lymphoid irradiation-conditioned recipients"
"0025179552","2323650","","2-s2.0-0025179552","1990-01-01","Treatment of adult acute lymphoblastic leukaemia."
"0028889993","7808487","10.1056/NEJM199501263320403","2-s2.0-0028889993","1995-01-26","Autologous or allogeneic bone marrow transplantation compared with intensive chemotherapy in acute myelogenous leukemia"
"0026011136","1984385","","2-s2.0-0026011136","1991-01-15","Health, functional status, and employment of adult survivors of bone marrow transplantation"
"0027491561","8219241","","2-s2.0-0027491561","1993-01-01","Fractionated total body irradiation and high-dose etoposide as a preparatory regimen for bone marrow transplantation for 99 patients with acute leukemia in first complete remission"
"0343919553","","","2-s2.0-0343919553","1987-12-14","Prevention of GVHD in HLA-identical marrow grafts by removal of T cells with soybean agglutinin and SRBCs"
"0028012371","8199567","","2-s2.0-0028012371","1994-01-01","Allogeneic bone marrow transplantation for acute myeloid leukemia in first complete remission: The effect of FAB classification and GVHD prophylaxis"
"0023185259","2885638","10.1016/S0140-6736(87)90763-X","2-s2.0-0023185259","1987-07-25","IMPACT OF T-CELL DEPLETION ON OUTCOME OF ALLOGENEIC BONE-MARROW TRANSPLANTATION FOR STANDARD-RISK LEUKAEMIAS"
"0024230867","2847609","","2-s2.0-0024230867","1988-12-01","Cytomegalovirus pneumonia after bone marrow transplantation successfully treated with the combination of ganciclovir and high-dose intravenous immune globulin"
"0026684692","1324530","","2-s2.0-0026684692","1992-01-01","Risk factors for cytomegalovirus pneumonia following allogeneic bone marrow transplantation after prophylaxis with intravenous immunoglobulin"
"0025187435","2262566","10.1136/jcp.43.11.942","2-s2.0-0025187435","1990-01-01","Bone marrow stromal cell changes in haematological malignancies"
"0019522465","7015617","","2-s2.0-0019522465","1981-01-01","Bone marrow transplantation across major histocompatibility barriers in mice: Effect of elimination of T cells from donor grafts by treatment with monoclonal thy-1.2 plus complement or antibody alone"
"8944240370","8807107","","2-s2.0-8944240370","1996-06-01","Allogeneic bone marrow transplantation for acute leukaemia - IGCI experience"
"0026614449","1426099","","2-s2.0-0026614449","1992-01-01","Relationship of [3H]Ara-C incorporation and response to therapy with high-dose Ara-C in AML patients: A leukemia intergroup study"
"0025349802","1971763","10.1111/j.1365-2141.1990.tb06333.x","2-s2.0-0025349802","1990-01-01","Expansion by folinic acid of the peripheral blood progenitor pool after chemotherapy: its use in autografting in acute leukaemia"
"0025190044","2302454","","2-s2.0-0025190044","1990-02-15","Treatment of moderate/severe acute graft-versus-host disease after allogeneic bone marrow transplantation: An analysis of clinical risk features and outcome"
"0345206680","8932846","","2-s2.0-0345206680","1996-11-01","Graft-versus-leukemia effect in allogeneic marrow transplant recipients with acute leukemia is maintained using cyclosporin A combined with methotrexate as prophylaxis"
"0023221768","3552076","","2-s2.0-0023221768","1987-08-07","Comparison of three remission induction regimens and two postinduction strategies for the treatment of acute nonlymphocytic leukemia: A cancer and leukemic group B study"
"0017162163","188440","10.1111/j.1365-2141.1976.tb03563.x","2-s2.0-0017162163","1976-01-01","Proposals for the Classification of the Acute Leukaemias French‐American‐British (FAB) Co‐operative Group"
"0023711896","3164797","","2-s2.0-0023711896","1988-01-01","Cytogenetic pattern in acute myelogenous leukemia: A major reproducible determinant of outcome"
"0028241992","8011550","10.1111/j.1365-2141.1994.tb03253.x","2-s2.0-0028241992","1994-01-01","Allogeneic bone marrow transplantation for acute lymphoblastic leukaemia: risk factors and clinical outcome"
"0345008358","","","2-s2.0-0345008358","1988-07-13","Lymphoid reconstitution after autologous PBSC transplantation with FACS sorted CD34* haematopoietic progenitors"
"0024600716","2923805","","2-s2.0-0024600716","1989-01-01","The frequency of long-term remission in patients with acute myelogenous leukaemia treated with conventional maintenance chemotherapy: A study of 760 patients with a minimal follow-up time of 6 years"
"0025160495","2207454","","2-s2.0-0025160495","1990-01-01","Late complications after allogeneic bone marrow transplantation for leukaemia"
"11944275668","2403818","","2-s2.0-11944275668","1990-01-18","Etoposide in acute nonlymphocytic leukemia"
"0032005216","9446672","","2-s2.0-0032005216","1998-02-01","T-cell-depleted allogeneic bone marrow transplantation as postremission therapy for acute myelogenous leukemia: Freedom from relapse in the absence of graft-versus-host disease"
"0004253506","","","2-s2.0-0004253506","1995-07-13",""
"0028349180","8180404","","2-s2.0-0028349180","1994-05-15","Unrelated donor or autologous marrow transplantation for treatment of acute leukemia"
"0022467572","3535869","10.1111/j.1365-2141.1986.tb04132.x","2-s2.0-0022467572","1986-01-01","Autologous bone marrow transplantation for acute leukaemia in remission"
"0032845556","10519984","10.1046/j.1365-2141.1999.01629.x","2-s2.0-0032845556","1999-10-13","Management of relapsed acute myeloid leukaemia"
"0027529871","8422457","","2-s2.0-0027529871","1993-01-15","Autologous bone marrow transplantation for acute myeloid leukemia using busulfan plus etoposide as a preparative regimen"
"0029041258","7596171","","2-s2.0-0029041258","1995-01-01","Allogeneic bone marrow transplantation remains an efficient consolidation for adults with acute myeloid leukemia even when performed very soon after diagnosis (&lt;100 days)"
"12644313240","9003155","10.1007/s002770050239","2-s2.0-12644313240","1996-12-01","FLAG (fludarabine, cytosine arabinoside, G-CSF) for refractory and relapsed acute myeloid leukemia"
"0345450457","","","2-s2.0-0345450457","1994-07-13","Allogeneic bone marrow transplantation for acute myeloid leukemia"
"0032492441","9504514","10.1016/S0140-6736(97)09214-3","2-s2.0-0032492441","1998-03-07","Randomised comparison of addition of autologous bone-marrow transplantation to intensive chemotherapy for acute myeloid leukaemia in first remission: Results of MRC AML 10 trial"
"0027190975","8338779","10.1111/j.1365-2141.1993.tb03025.x","2-s2.0-0027190975","1993-01-01","Bone marrow transplantation for acute myeloblastic leukaemia: an EBMT Leukaemia Working Party prospective analysis from HLA‐typing"
"0030980690","9058752","","2-s2.0-0030980690","1997-04-05","Consensus conference on unrelated donor bone marrow transplantation: Royal College of Physicians of Edinburgh, October 29th and 30th, 1996 [6]"
"0141796815","10086795","","2-s2.0-0141796815","1999-03-18","Infections in adults undergoing unrelated donor bone marrow transplantation"
"0030930329","9297996","10.1016/S0140-6736(97)03098-5","2-s2.0-0030930329","1997-09-13","Outcomes of transplantation with matched-sibling and unrelated-donor bone marrow in children with leukaemia"
"0030041081","8640165","","2-s2.0-0030041081","1996-02-01","Allogeneic bone marrow transplantation vs aggressive post-remission chemotherapy for children with acute myeloid leukemia in first complete remission. A prospective study from the French society of pediatric hematology and immunology (SHIP)"
"0029807625","8915668","","2-s2.0-0029807625","1996-10-01","Treatment of acute myeloblastic leukemia in adults. The GOELAM experience"
"0032406604","9916636","","2-s2.0-0032406604","1998-12-01","Matched unrelated donor marrow transplantation in patients with advanced acute leukemia"
"0031854181","9674854","","2-s2.0-0031854181","1998-07-21","Unrelated bone marrow transplantation in patients with myelodysplastic syndromes and secondary acute myeloid leukemia: An EBMT survey"
"0030762673","9376573","","2-s2.0-0030762673","1997-10-15","Karyotype in acute myeloblastic leukemia: Prognostic significance for bone marrow transplantation in first remission: A European Group for Blood and Marrow Transplantation Study"
"20244384398","7579422","","2-s2.0-20244384398","1995-10-15","Unrelated donor marrow transplantation in children"
"0027252447","8501490","","2-s2.0-0027252447","1993-06-15","Prospective comparative study of bone marrow transplantation and postremission chemotherapy for childhood acute myelogenous leukemia"
"0033379858","10627641","","2-s2.0-0033379858","1999-12-01","The outcome of 26 patients with respiratory syncytial virus infection following allogeneic stem cell transplantation"
"0033005663","10358698","10.1002/(SICI)1096-911X(199906)32:6&lt;411::AID-MPO3&gt;3.0.CO;2-K","2-s2.0-0033005663","1999-06-01","FLAG (fludarabine, high-dose cytarabine, and G-CSF) for refractory and high-risk relapsed acute leukemia in children"
"7344264070","9753069","","2-s2.0-7344264070","1998-10-05","The influence of HLA-matched sibling donor availability on treatment outcome for patients with AML: An analysis of the AML 8A study of the EORTC Leukaemia Cooperative Group and GIMEMA"
"18844464929","9053477","","2-s2.0-18844464929","1997-02-01","Unrelated donor bone marrow transplantation for children with acute leukemia"
"0030780126","9359499","","2-s2.0-0030780126","1997-11-06","Unrelated donor bone marrow transplantation in children and young adults with acute myeloid leukaemia in remission"
"0033051112","10048418","","2-s2.0-0033051112","1999-02-25","Unrelated donor bone marrow transplantation in adults: Some current controversies"
"0027299732","8481509","","2-s2.0-0027299732","1993-01-01","Adjuvant immunotoxin therapy with anti-B4-blocked ricin after autologous bone marrow transplantation for patients with B-cell non-Hodgkin's lymphoma"
"0005661590","","","2-s2.0-0005661590","1999-07-13","Radioimmunotherapy of relapsed or refractory non-Hodgkin's lymphoma (NHL): IDEC Y2B8 Phase I/II 90 yttrium trial"
"0025336297","1693283","","2-s2.0-0025336297","1990-01-01","Therapy of lymphoma directed at idiotypes"
"0023084858","3798106","10.1126/science.3798106","2-s2.0-0023084858","1987-03-16","Human breast cancer: Correlation of relapse and survival with amplification of the HER-2/neu oncogene"
"0022539135","3489185","","2-s2.0-0022539135","1986-11-19","Radioimmunodetection of cutaneous T-cell lymphoma with 111In-labeled T101 monoclonal antibody"
"0026499209","1369023","10.1038/nbt1192-1455","2-s2.0-0026499209","1992-01-01","Primatization"" of recombinant antibodies for immunotherapy of human diseases: A macaque/human chimeric antibody against human cd4"
"0028234324","7516821","","2-s2.0-0028234324","1994-01-01","Effect of Isotype on Internalization and Cytotoxicity of CD19-Ricin A Immunotoxins"
"7844233336","10850360","","2-s2.0-7844233336","1998-11-03","Low-dose, fractionated radioimmunotherapy for B-cell malignancies using 131I-LYM-1 antibody"
"0028823422","7493367","","2-s2.0-0028823422","1995-12-01","Treatment of non-Hodgkin's lymphoma with radiolabeled murine, chimeric, or humanized LL2, an anti-CD22 monoclonal antibody"
"0027374447","8219217","","2-s2.0-0027374447","1993-11-09","A phase I study of an anti-CD22-deglycosylated ricin A chain immunotoxin in the treatment of B-cell lymphomas resistant to conventional therapy"
"0002623454","","","2-s2.0-0002623454","1999-07-13","Zevalin (IDEC-Y2B8) radioimmunotherapy of rituximab refractory follicular non-Hodgkin's lymphoma (NHL): Interim results"
"0023123277","3102699","","2-s2.0-0023123277","1987-06-02","Indium-111 T101 monoclonal antibody is superior to Iodine-131 T101 in imaging of cutaneous T-cell lymphoma"
"0005726284","","","2-s2.0-0005726284","1991-07-13","Cloning and expression of a chimeric anti-CD20 monoclonal antibody"
"0021857576","3986779","","2-s2.0-0021857576","1985-05-01","Radioimmunoimaging in Malignant Melanoma with 111ln-labeled Monoclonal Antibody 96.5"
"0005662172","","","2-s2.0-0005662172","1999-07-13","The future of I-131 anti-B1 antibody therapy - Is initial treatment an option?"
"0002406077","","","2-s2.0-0002406077","1998-07-13","Biotechnology and nuclear medicine: Radiology brings biotechnology into the picture to combat cancer"
"0024478054","2566907","","2-s2.0-0024478054","1989-01-01","p185(HER2) monoclonal antibody has antiproliferative effects in vitro and sensitizes human breast tumor cells to tumor necrosis factor"
"0002194974","","","2-s2.0-0002194974","1998-07-13","Comparison of normal organ and tumor dosimetry between 131I-and 111In/90YhLL2 anti-CD22 MAB in patients with Bcell malignancies"
"0029056665","7780133","","2-s2.0-0029056665","1995-06-15","Continuous infusion of the anti-CD22 immunotoxin IgG-RFB4-SMPT-dgA in patients with B-cell lymphoma: A phase I study"
"0026375173","1855219","","2-s2.0-0026375173","1991-01-01","Phase I Immunotoxin Trial in Patients with B-Cell Lymphoma"
"0005661586","","","2-s2.0-0005661586","1998-07-13","Radiommunotherapy of relapsed non-Hodgkin's lymphoma (NHL) with IDEC-Y2B8 90Yttrium anti-CD20 monoclonal"
"0025135552","1688734","","2-s2.0-0025135552","1990-01-01","Innovations that influence the pharmacology of monoclonal antibody guided tumor targeting"
"0032719113","10561019","","2-s2.0-0032719113","1999-11-18","Radiolabeled antibody therapy of B-cell lymphomas"
"0023147326","3469527","","2-s2.0-0023147326","1987-01-01","Radiolabeled antibody: Iodine versus radiometal chelates"
"0005683179","","","2-s2.0-0005683179","1993-07-13","Updated results of a phase I trial of I-anti-B1 (anti-CD20) radioimmunotherapy (RIT) for refractory B-cell lymphoma131"
"0000609166","","","2-s2.0-0000609166","1995-02-22","A phase II trial of iodine-131-labeled anti-CD20 (B1) antibody therapy with bone marrow transplantation for relapsed non-Hodgkin's lymphomas"
"0024414981","2475779","","2-s2.0-0024414981","1989-01-01","Shared idiotypes expressed by human B-cell lymphomas"
"0031867028","9669400","","2-s2.0-0031867028","1998-07-01","Nonmyeloablative iodine-131 anti-B1 radioimmunotherapy as outpatient therapy"
"0002049404","","","2-s2.0-0002049404","1999-09-27","Rituximab/CHOP chemoimmunotherapy in patients with low-grade lymphomas: Progression-free survival after three years median follow-up"
"0026743074","1402660","","2-s2.0-0026743074","1992-10-01","Engineered humanized dimeric forms of IgG are more effective antibodies"
"0031783693","9829722","","2-s2.0-0031783693","1998-11-01","Phase II clinical trial of bolus infusion anti-B4 blocked ricin immunoconjugate in patients with relapsed B-cell non-Hodgkin's lymphoma"
"0025055067","2297714","","2-s2.0-0025055067","1990-01-01","High dose radiolabeled antibody therapy of lymphoma"
"0002178028","","","2-s2.0-0002178028","1992-06-09","Monoclonal anti-idiotype therapy of B-cell lymphoma"
"4243977486","","","2-s2.0-4243977486","1999-09-27","ZevalinTM radioimmunotherapy of relapsed or refractory non-Hodgkin's lymphoma"
"0031730693","10850358","","2-s2.0-0031730693","1998-11-03","A revolution in the treatment of non-Hodgkin's lymphoma"
"0026063810","2066752","","2-s2.0-0026063810","1991-12-01","Targeting, dosimetry, and radioimmunotherapy of B-cell lymphomas with iodine-131-labeled LL2 monoclonal antibody"
"0027955656","8306247","10.1002/1097-0142(19940201)73:3+&lt;1049::AID-CNCR2820731344&gt;3.0.CO;2-1","2-s2.0-0027955656","1994-01-01","Murine and humanized constructs of monoclonal antibody m195 (anti‐cd33) for the therapy of acute myelogenous leukemia"
"0005692538","","","2-s2.0-0005692538","1994-07-13","131 I anti-B1 radioimmunotherapy of non-Hodgkin's lymphoma without marrow transplantation: Expanded phase I study results"
"0000376894","","","2-s2.0-0000376894","1995-09-27","Phase I study of IDEC-Y2B8: 90-Yttrium labeled anti-CD20 monoclonal antibody therapy of relapsed non-Hodgkin's lymphoma"
"0031828752","9708567","","2-s2.0-0031828752","1998-08-21","Iodine-131 anti-B1 antibody for B-cell lymphoma: An update on the Michigan phase I experience"
"0005661447","","","2-s2.0-0005661447","1994-02-17","Final report of a Phase II trial in relapsed non-Hodgkin's lymphoma"
"4243977483","","","2-s2.0-4243977483","2000-09-27","Zevalin™ radioimmunotherapy (RIT) for B-cell non-Hodgkin's lymphoma (NHL): Biodistribution and dosimetry results"
"0023144781","3545451","","2-s2.0-0023144781","1987-03-15","Penetration and Binding of Radiolabeled Anti-Carcinoembryonic Antigen Monoclonal Antibodies and Their Antigen Binding Fragments in Human Colon Multicellular Tumor Spheroids"
"0002460482","","","2-s2.0-0002460482","1999-07-13","Multicentre study of CAMPATH- 1H in patients with chronic lymphocytic leukaemia (B-CLL) refractory to fludarabine"
"0343965762","9586892","","2-s2.0-0343965762","1998-05-01","Monoclonal antibody therapy for resected Dukes' C colerectal cancer: Seven-year outcome of a multicenter randomized trial"
"0005712776","","","2-s2.0-0005712776","1988-11-10","Treatment of B-cell lymphoma with I-131 labeled murine monoclonal antibodies"
"4243278955","","","2-s2.0-4243278955","1997-09-27","A Phase III pivotal trial of IDEC-C2B8 in patients with relapsed low-grade or follicular lymphoma"
"0003357187","","","2-s2.0-0003357187","1999-11-18","Reduced-dose Zevalin radioimmunotherapy for relapsed or refractory B-cell non-Hodgkin's lymphoma (NHL) patients with pre-existing thrombocytopenia: Report of a phase II trial"
"0002466219","","","2-s2.0-0002466219","1998-07-13","Rituximab: Phase II retreatrnent study in patients with low-grade or follicular NHL"
"0023684007","3393677","","2-s2.0-0023684007","1988-01-01","Scintigraphy with In-111-labeled monoclonal antitumor antibodies: Kinetics, biodistribution, and tumor detection"
"14444270630","9713461","","2-s2.0-14444270630","1998-07-01","Maximum tolerated dose of 67Cu-2IT-BAT-LYM-1 for fractionated radioimmunotherapy of non-Hodgkin's lymphoma: A pilot study"
"4243473762","","","2-s2.0-4243473762","1998-09-27","Herceptin® (trastuzumab)"
"0005758087","","","2-s2.0-0005758087","1993-07-13","Depletion of B cells in vivo by a chimeric mouse human monoclonal antibody to CD20"
"0001600558","","","2-s2.0-0001600558","2012-12-30","Prognostic factors for non-Hodgkin's lymphoma (NHL) PTS treated with chemotherapy (CRX) may not predict response duration in patients (PTS) treated with immunotherapy: Rituximab experience"
"0000079276","","","2-s2.0-0000079276","1997-02-14","Rituxan (rituximab, IDEC-C2B8): Interim analysis of a phase II study of once weekly times 8 dosing in patients with relapsed low-grade or follicular non-Hodgkin's lymphoma"
"0027438902","7691407","10.1007/BF01518451","2-s2.0-0027438902","1993-09-01","Epitope specificity of the anti-(B cell lymphoma) monoclonal antibody, LL2"
"0032589761","10541377","","2-s2.0-0032589761","1999-10-01","Radioimmunotherapy using 131I-labeled anti-CD22 monoclonal antibody (LL2) in patients with previously treated B-cell lymphomas"
"0032743141","10561023","","2-s2.0-0032743141","1999-11-18","CHOP plus rituximab chemoimmunotherapy of indolent B-cell lymphoma"
"0024281372","2451290","","2-s2.0-0024281372","1988-01-01","Cell and environment interactions in tumor microregions: The multicell spheroid model"
"0003307473","","","2-s2.0-0003307473","1999-07-13","Prospective randomized controlled study of Zevalin (IDEC-Y2B8) radioimmunotherapy compared to rituximab immunotherapy for B-cell NHL: Report of interim results"
"0005695709","","","2-s2.0-0005695709","1986-12-30","The effect of increasing ""cold"" antibody dose on prostatic cancer metastases detection and on body distribution of PAY-276 monoclonal antibody"
"0023121347","3821917","","2-s2.0-0023121347","1987-04-02","Radioimmunodetection of cancer with the use of indium-111-labeled monoclonal antibodies"
"0020694773","6571707","","2-s2.0-0020694773","1983-01-01","Kinetic and Catabolic Considerations of Monoclonal Antibody Targeting in Erythroleukemic Mice"
"0025039727","2384792","","2-s2.0-0025039727","1990-01-01","Imaging and treatment of B-cell lymphoma"
"0021893569","3986780","","2-s2.0-0021893569","1985-05-01","Pharmacokinetics of 111ln-labeled Anti-p97 Monoclonal Antibody in Patients with Metastatic Malignant Melanoma"
"0023001672","3489782","","2-s2.0-0023001672","1986-12-01","A unique antigen on mature B cells defined by a monoclonal antibody"
"0005683178","","","2-s2.0-0005683178","1993-07-13","Targeting the c-erb-2 proto-oncogene with monoclonal antibodies"
"0005712774","","","2-s2.0-0005712774","2012-12-30","A phase II study of anti-B4-blocked ricin (anti-B4-bR) therapy following autologous bone marrow transplantation (ABMT) for B-cell non-Hodgkin's lymphoma (B-NHL)"
"0001236146","","","2-s2.0-0001236146","1999-01-03","IDEC-Y2B8: A Y-labeled anti-CD20 monoclonal antibody conjugated to MX-DTPA, a high-affinity chelator for yttrium90"
"0023754569","3264717","","2-s2.0-0023754569","1988-01-01","Relationship between internalization and cytotoxicity of ricin A-chain immunotoxins"
"0025068815","2297715","","2-s2.0-0025068815","1990-01-01","Radioimmunotherapy of human B-cell lymphoma with 90Y-conjugated antiidiotype monoclonal antibody"
"0024323126","2738686","","2-s2.0-0024323126","1989-01-01","Beta dose point kernels for radionuclides of potential use in radioimmunotherapy"
"0003285333","","","2-s2.0-0003285333","1999-07-13","Responders to rituximab show continued tumor regression over time and a progression-free survival that correlates with response classification"
"8544267259","9191878","10.1007/s002620050371","2-s2.0-8544267259","1997-07-15","Advantage of residualizing radiolabels for an internalizing antibody against the B-cell lymphoma antigen, CD22"
"0029922166","8611688","","2-s2.0-0029922166","1996-05-01","Radioimmunotherapy of relapsed B-cell lymphoma with yttrium 90 anti-idiotype monoclonal antibodies"
"0026610881","1350088","","2-s2.0-0026610881","1992-12-01","Humanization of an anti-p185HER2 antibody for human cancer therapy"
"0028308127","7517722","","2-s2.0-0028308127","1994-07-15","Antibodies to myeloid precursor cells in autoimmune neutropenia"
"0023713376","3261183","","2-s2.0-0023713376","1988-01-01","Acute myeloid leukemia with T-lymphoid features: A distinct biologic and clinical entity"
"0023721877","3164798","","2-s2.0-0023721877","1988-01-01","Morphologic and cytochemical characterization of adult lymphoid leukemias which express myeloid antigen"
"0023576024","3500372","","2-s2.0-0023576024","1987-12-01","Rearrangement of immunoglobulin and T cell antigen receptor genes in acute myeloid leukemia with lymphoid-associated markers"
"0023969803","3289656","10.1016/0268-960X(88)90003-3","2-s2.0-0023969803","1988-01-01","Mixed acute leukaemias"
"0023228898","3473183","10.1084/jem.165.6.1703","2-s2.0-0023228898","1987-08-13","High frequency of clonal immunoglobulin or T cell receptor gene rearrangements in acute myelogenous leukemia expressing terminal deoxyribonucleotidyltransferase"
"0021907434","2857851","10.1016/S0140-6736(85)92085-9","2-s2.0-0021907434","1985-03-02","CONTRIBUTION OF IMMUNOPHENOTYPE TO THE CLASSIFICATION AND DIFFERENTIAL DIAGNOSIS OF ACUTE LEUKAEMIA"
"0021240110","6324925","","2-s2.0-0021240110","1984-07-12","Heavy chain immunoglobulin gene rearrangement in acute nonlymphocytic leukemia"
"0020793569","6312838","10.1016/0003-2697(83)90418-9","2-s2.0-0020793569","1983-07-01","A technique for radiolabeling DNA restriction endonuclease fragments to high specific activity"
"0023864495","3257143","","2-s2.0-0023864495","1988-01-01","Detailed studies on expression and function of CD19 surface determinant by using B43 monoclonal antibody and the clinical potential of anti-CD19 immunotoxins"
"0022481641","3013340","","2-s2.0-0022481641","1986-01-01","3A1 (CD7) expression presedes T(β) gene rearrangements in precursor T (lymphoblastic) neoplasms"
"0023918746","2968811","","2-s2.0-0023918746","1988-01-01","Distribution of the CD45R antigen in the maturation of lymphoid and myeloid series: The CD45R negative phenotype is a constant finding in T CD4 positive lymphoproliferative disorders"
"0024307986","2547833","","2-s2.0-0024307986","1989-01-01","T cell receptor gamma and delta rearrangements in hematologic malignancies. Relationship to lymphoid differentiation"
"0022471870","3017476","","2-s2.0-0022471870","1986-12-30","Acute undifferentiated leukemia: Implications for cellular origin and clonality suggested by analysis of surface markers and immunoglobulin gene rearrangement"
"0023224295","3112510","","2-s2.0-0023224295","1987-01-01","Immunoglobulin heavy chain and T-cell receptor γ and β chain gene rearrangements in acute myeloid leukemias"
"0023084994","3543510","10.1016/0145-2126(87)90110-X","2-s2.0-0023084994","1987-01-01","Alterations of HLe-1 (T200) fluorescence intensity on acute lymphoblastic leukemia cells may relate to therapeutic outcome"
"0021358995","6607471","","2-s2.0-0021358995","1984-03-22","Conversion of a stem cell leukemia from a T-lymphoid to a myeloid phenotype induced by the adenosine deaminase inhibitor 2'-deoxycoformycin"
"0021038773","6354305","","2-s2.0-0021038773","1983-12-01","A monoclonal antibody (WT1) for detecting leukemias of T-cell precursors (T-ALL)"
"0023153579","3098329","","2-s2.0-0023153579","1987-03-30","Evidence favoring lineage fidelity in acute nonlymphocytic leukemia: Absence of immunoglobulin gene rearrangements in FAB types M4 and M5"
"84909688656","","","2-s2.0-84909688656","2015-01-24",""
"0023150571","3494942","","2-s2.0-0023150571","1987-06-10","Clinical importance of myeloid antigen expression in adult acute lymphoblastic leukemia"
"84958870013","","","2-s2.0-84958870013","1989-03-02",""
"0024535795","2783859","","2-s2.0-0024535795","1989-01-01","CD7+, CD4-, CD8- acute leukemia: A syndrome of malignant pluripotent lymphohematopoietic cells"
"0022356742","2415779","10.1016/0145-2126(85)90152-3","2-s2.0-0022356742","1985-01-01","The human leucocyte-common (LC) molecule: Dissection of leukaemias using monoclonal antibodies directed against framework and restricted antigenic determinants"
"0022578351","3080546","","2-s2.0-0022578351","1986-07-23","T cell receptor and immunoglobulin gene rearrangements in acute myeloblastic leukemia"
"0023276641","3102679","10.1084/jem.165.3.879","2-s2.0-0023276641","1987-06-18","Rearrangements of immunoglobulin and T cell receptor β and γ genes are associated with terminal deoxynucleotidyl transferase expression in acute myeloid leukemia"
"0023543526","2957002","","2-s2.0-0023543526","1987-12-01","Phenotypic similarities and differences between CALLA-positive acute lymphoblastic leukemia cells and normal marrow CALLA-positive B cell precursors"
"0024415486","2673329","10.1111/j.1365-2141.1989.tb04315.x","2-s2.0-0024415486","1989-01-01","Unusual immunophenotypes in acute leukaemias: incidence and clinical correlations"
"0022647730","3079640","","2-s2.0-0022647730","1986-06-03","Lineage promiscuity in hemopoietic differentiation and leukemia"
"0024387842","2693871","","2-s2.0-0024387842","1989-12-07","Rapid diagnosis of leukaemia: A three-stage immunophenotyping technique"
"26344436998","","","2-s2.0-26344436998","1993-10-20","Successful remission-induction of T-cell prolymphocytic leukemia (T-PLL) with humanized MoAb CAMPATH-1H (CP-1H)"
"0023936288","3282566","","2-s2.0-0023936288","1988-01-01","Cytogenetic events after bone marrow transplantation for chronic myeloid leukemia in chronic phase"
"0024517853","2785002","10.1007/BF00199919","2-s2.0-0024517853","1989-05-01","Large-scale preparation of adherent lymphokine-activated killer (A-LAK) cells for adoptive immunotherapy in man"
"0019946868","6980937","","2-s2.0-0019946868","1982-01-01","Two monoclonal anti-human T lymphocyte antibodies have similar biologic effects and recognize the same cell surface antigen"
"0020972420","6226586","10.1111/j.1600-065X.1983.tb01088.x","2-s2.0-0020972420","1983-01-01","Correlation of Functional Properties of Human Lymphoid Cell Subsets and Surface Marker Phenotypes Using Multiparameter Analysis and Flow Cytometry"
"0023630418","3318910","","2-s2.0-0023630418","1987-12-01","Interleukin 2 enhances cytotoxic cell function in vitro after T-cell depleted marrow transplantation"
"0024382451","2473805","","2-s2.0-0024382451","1989-01-01","Adherent lymphokine-activated killer cells in chronic myelogenous leukemia: A benign cell population with potent cytotoxic activity"
"0022587617","3081066","","2-s2.0-0022587617","1986-06-18","Characterization of natural killer cells with antileukemia activity following allogeneic bone marrow transplantation"
"0025228870","2366584","","2-s2.0-0025228870","1990-01-01","Induction of a syngeneic graft-versus-leukemia effect following bone marrow transplantation for chronic myeloid leukemia"
"85004792956","","","2-s2.0-85004792956","1971-12-18","A rapid banding technique for human chromosomes"
"85004746793","","","2-s2.0-85004746793","1990-12-18","Induction of in vitro graft‐versus‐leukemia activity following bone marrow transplantation for chronic myeloid leukemia"
"0023911653","3257251","","2-s2.0-0023911653","1988-01-01","Lymphokine-activated killer cells in rats. III. A simple method for the purification of large granular lymphocytes and their rapid expansion and conversion into lymphokine-activated killer cells"
"0024814301","2611134","10.1111/j.1365-2141.1989.tb00281.x","2-s2.0-0024814301","1989-01-01","Slow evolution of chronic myeloid leukaemia relapsing after BMT with T‐cell depleted donor marrow"
"2842522031","","","2-s2.0-2842522031","1993-07-13","Clinical efficacy of anti-thymocyte globulin in systemic sclerosis: Results of a placebo-controlled trial"
"0017275577","131592","10.1136/bmj.1.6015.936","2-s2.0-0017275577","1976-04-17","Immunological mechanisms in the pathogenesis of vinyl chloride disease"
"0022859332","3791722","","2-s2.0-0022859332","1986-12-01","A modified scleroderma skin scoring method"
"0024465792","2775321","10.1002/anr.1780320911","2-s2.0-0024465792","1989-01-01","Normotensive renal failure in systemic sclerosis"
"0026661183","1458783","10.1007/BF02207193","2-s2.0-0026661183","1992-09-01","Long-term follow-up study of 164 patients with definite systemic sclerosis: Classification considerations"
"0027753738","7509616","","2-s2.0-0027753738","1993-12-01","Treatment of systemic sclerosis"
"0026540461","1314885","","2-s2.0-0026540461","1992-05-01","Selective upregulation of platelet-derived growth factor α receptors by transforming growth factor β in scleroderma fibroblasts"
"0026627901","1451305","10.1111/j.1365-2230.1992.tb00210.x","2-s2.0-0026627901","1992-01-01","Atypical systemic sclerosis following exposure to vinyl chloride monomer. A case report and review of the cutaneous aspects of vinyl chloride disease"
"2842511933","","","2-s2.0-2842511933","1994-07-13","Treatment of rheumatoid arthritis with humanized monoclonal antibody, CAMPATH-1H"
"0029340767","7562747","","2-s2.0-0029340767","1995-07-01","Measurement of skin involvement in scleroderma."
"0027760946","8117539","","2-s2.0-0027760946","1993-12-01","Immunologic aspects of scleroderma"
"0030036897","8757849","","2-s2.0-0030036897","1996-08-16","Immune response in mice following immunization with DNA encoding fragment C of tetanus toxin"
"6844243479","","","2-s2.0-6844243479","2004-11-09","Early stem cell transplantation for chronic lymphocytic leukemia"
"0029906983","8921954","10.1002/eji.1830261119","2-s2.0-0029906983","1996-11-12","Peripheral T cell tolerance as a tumor escape mechanism: Deletion of CD4+ T cells specific for a monoclonal immunoglobulin idiotype secreted by a plasmacytoma"
"0029855930","8977261","","2-s2.0-0029855930","1996-12-15","Adenovirus vector infection of chronic lymphocytic leukemia B cells"
"0029418267","9532575","","2-s2.0-0029418267","1995-12-01","DNA-based immunization."
"0003258512","","","2-s2.0-0003258512","1996-07-13","Fludarabine (FAMP) and cyclophosphamide (CTX) therapy in chronic lymphocytic leukemia (CLL)"
"0028989970","7590827","","2-s2.0-0028989970","1995-06-01","Idiotypic DNA vaccines against B-cell lymphoma"
"0024773405","2519930","10.3109/08830188909044783","2-s2.0-0024773405","1989-01-01","Prospects for the treatment of b cell tumors using idiotypic vaccination"
"0030905707","9166858","","2-s2.0-0030905707","1997-06-01","Differential rates of somatic hypermutation in V(H) genes among subsets of chronic lymphocytic leukemia defined by chromosomal abnormalities"
"0030998761","9090492","","2-s2.0-0030998761","1997-04-11","Chronic lymphoproliferative disorders"
"0027411456","8456302","","2-s2.0-0027411456","1993-12-01","Heterologous protection against influenza by injection of DNA encoding a viral protein"
"0029892793","8781270","","2-s2.0-0029892793","1996-08-10","Human tumor antigens are ready to fly"
"0029036444","7596181","","2-s2.0-0029036444","1995-01-01","Fludarabine plus doxorubicin in previously treated chronic lymphocytic leukemia"
"0028355650","7520700","10.1016/0167-5699(94)90009-4","2-s2.0-0028355650","1994-06-03","The pathogenesis of chronic lymphocytic leukemia: Analysis of the antibody repertoire"
"0029737350","8710913","10.1073/pnas.93.16.8578","2-s2.0-0029737350","1996-08-06","Induction of cytotoxic T lymphocytes by intramuscular immunization with plasmid DNA is facilitated by bone marrow-derived cells"
"0005523093","","","2-s2.0-0005523093","1996-09-27","Consolidation therapy with high-dose cyclophosphamide (HDC) reduces minimal residual disease in patients with chronic lymphocytic leukemia (CLL) treated with fludarabine as induction therapy"
"8244253666","9136949","","2-s2.0-8244253666","1997-05-07","Long-term clinical outcome of B-cell chronic lymphocytic leukaemia patients in clinical remission phase evaluated at phenotypic level"
"0030834215","9293855","","2-s2.0-0030834215","1997-09-06","Results of a fludarabine induction and α-interferon maintenance protocol in pretreated patients with chronic lymphocytic leukemia and low- grade non-Hodgkin's lymphoma"
"0031571278","","","2-s2.0-0031571278","1997-08-15","DNA Vaccines Against Lymphoma: Promotion of Anti-Idiotypic Antibody Responses Induced by Single Chain Fv Genes by Fusion to Tetanus Toxin Fragment C"
"0032494788","9820306","10.1016/S0140-6736(05)60328-5","2-s2.0-0032494788","1998-11-07","Graft-versus-lymphoma effect of donor leucocyte infusion shown by real-time quantitative PCR analysis of t(14;18)"
"0033230960","10556212","","2-s2.0-0033230960","1999-11-01","Engraftment kinetics after nonmyeloablative allogeneic peripheral blood stem cell transplantation: Full donor T-cell chimerism precedes alloimmune responses"
"0022616751","3511986","","2-s2.0-0022616751","1986-06-18","Bone marrow transplantation in patients aged 45 years and older"
"0025366751","2186836","","2-s2.0-0025366751","1990-01-01","Mixed chimerism after allogeneic marrow transplantation for leukaemia: Correlation with dose of total body irradiation and graft-versus-host disease"
"0022602179","3511988","","2-s2.0-0022602179","1986-06-18","Mixed hematologic chimerism after allogeneic marrow transplantation for severe aplastic anemia is associated with a higher risk of graft rejection and a lessened incidence of acute graft-versus-host disease"
"0030925301","9192777","","2-s2.0-0030925301","1997-06-15","Engraftment of allogeneic hematopoietic progenitor cells with purine analog-containing chemotherapy: Harnessing graft-versus-leukemia without myeloablative therapy"
"0031058106","9009093","","2-s2.0-0031058106","1997-03-03","Adoptive immunotherapy for relapsed multiple myeloma after allogeneic bone marrow transplantation (BMT): Evidence for a graft-versus-myeloma effect"
"0033067350","10372139","10.1111/j.1749-6632.1999.tb08481.x","2-s2.0-0033067350","1999-01-01","Mixed hematopoietic chimerism after marrow allografts. Transplantation in the ambulatory care setting"
"0023852418","2894836","","2-s2.0-0023852418","1988-01-01","Use of minisatellite DNA probes for recognition and characterization of relapse after allogenic bone marrow transplantation"
"0027180906","8510297","10.1001/jama.1993.03510010063030","2-s2.0-0027180906","1993-07-07","Outcome After Allogeneic Bone Marrow Transplant for Leukemia in Older Adults"
"0003274693","","","2-s2.0-0003274693","1999-07-13","Non myeloablative conditioning with fludarabine/melphalan (FM) for patients with multiple myeloma (MM)"
"2042436734","10052710","","2-s2.0-2042436734","1999-02-16","Cryopreservation of the bone marrow from patients with acute myeloid leukaemia leads to functional abnormalities"
"0028358824","8046341","10.1084/jem.180.2.681","2-s2.0-0028358824","1994-08-01","Thymic and extrathymic origins of gut intraepithelial lymphocyte populations in mice"
"0032055912","9516161","","2-s2.0-0032055912","1998-04-01","Lymphoid reconstitution after autologous PBSC transplantation with FACS- sorted CD34+ hematopoietic progenitors"
"0027946718","8042594","","2-s2.0-0027946718","1994-10-26","B-cell precursor bone marrow reconstitution after bone marrow transplantation"
"0028303991","8011521","10.1111/j.1365-2141.1994.tb03263.x","2-s2.0-0028303991","1994-01-01","Cytomegalovirus (CMV) antigenaemia for rapid diagnosis and monitoring of CMV‐associated disease after bone marrow transplantation"
"0030837331","9197323","","2-s2.0-0030837331","1997-07-24","Alterations in the progenitor cell population follow recovery from myeloablative therapy and bone marrow transplantation"
"0027302730","8395913","","2-s2.0-0027302730","1993-09-01","Lymphocytopenia as an unfavorable prognostic factor in patients with cytomegalovirus infection after bone marrow transplantation"
"0029890197","8727301","","2-s2.0-0029890197","1996-06-03","Donor lymphocyte infusions"
"0027284484","8241987","","2-s2.0-0027284484","1993-01-01","Efficacy of immune globulin in preventing complications of bone marrow transplantation: A meta-analysis"
"0023165212","3799545","","2-s2.0-0023165212","1987-01-01","The Technicon H*1(TM) - An automated hematology analyzer for today and tomorrow. Complete blood count parameters"
"0027482544","8275032","","2-s2.0-0027482544","1993-01-01","Serum cytokine levels in patients undergoing bone marrow transplantation"
"0032079672","9558408","","2-s2.0-0032079672","1998-05-01","Identification of patients who may benefit from prophylactic immunotherapy after bone marrow transplantation for acute myeloid leukemia on the basis of lymphocyte recovery early after transplantation"
"0022553986","3516714","","2-s2.0-0022553986","1986-01-01","Studies of hemopoietic stromal fibroblastic colonies in patients undergoing bone marrow transplantation"
"0029618376","8542962","","2-s2.0-0029618376","1995-12-01","Alterations in both the hematopoietic microenvironment and the progenitor cell population follow the recovery from myeloablative therapy and bone marrow transplantation"
"0022470379","3521761","","2-s2.0-0022470379","1986-10-15","Marrow transplantation for severe aplastic anemia: Methotrexate alone compared with a combination of methotrexate and cyclosporine for prevention of acute graft-versus-host disease"
"0029014567","7655386","","2-s2.0-0029014567","1995-01-01","Adoptive immunotherapy using donor leukocytes following bone marrow transplantation for chronic myeloid leukemia: Is T cell dose important in determining biological response?"
"0022550712","2870935","","2-s2.0-0022550712","1986-10-29","Hemopoietic reconstitution after bone marrow transplantation"
"0027465332","8431706","","2-s2.0-0027465332","1993-01-01","Antibody response to a two-dose regimen of influenza vaccine in allogeneic T cell-depleted and autologous BMT recipients"
"4243572761","","","2-s2.0-4243572761","1998-09-27","Adoptive immunotherapy for chronic myelogenous leukaemia patients relapsing after allogeneic bone marrow transplantation using T-cell depletion with Campath 1G"
"0024292736","3285470","","2-s2.0-0024292736","1988-12-01","Assembly of a functional immunoglobulin Fv fragment in Escherichia coli"
"0042618791","","","2-s2.0-0042618791","1990-12-16","Vaccinia virus as a vector for delivering foreign antigens"
"0024791519","2515286","10.1016/0022-2836(89)90107-1","2-s2.0-0024791519","1989-12-20","Structure of vaccinia virus early promoters"
"0000233999","3095828","","2-s2.0-0000233999","1986-12-01","Eukaryotic transient-expression system based on recombinant vaccinia virus that synthesizes bacteriophage T7 RNA polymerase"
"0023935968","2840353","10.1016/0378-1119(88)90424-6","2-s2.0-0023935968","1988-05-15","A dominant selectable marker for the construction of recombinant poxviruses"
"0023941341","3130492","","2-s2.0-0023941341","1988-01-01","Escherichia coli gpt gene provides dominant selection for vaccinia virus open reading frame expression vectors"
"0001509726","","","2-s2.0-0001509726","1985-06-06","The construction and characterization of vaccinia virus recombinants expressing foreign genes"
"0025340630","2111022","10.1073/pnas.87.10.3942","2-s2.0-0025340630","1990-06-18","High-level production of a functional immunoglobulin heterodimer in a baculovirus expression system"
"0024467586","2515980","","2-s2.0-0024467586","1989-01-01","The selectivity of secretion: Protein sorting in the endoplasmic reticulum"
"0024293979","3140379","","2-s2.0-0024293979","1988-12-01","Single-chain antigen-binding proteins"
"0020357192","6818555","","2-s2.0-0020357192","1982-12-01","Regulated expression of an immunoglobulin κ gene introduced into a mouse lymphoid cell line"
"0039797301","2548200","","2-s2.0-0039797301","1989-01-01","Cap-independent translation of mRNA conferred by encephalomyocarditis virus 5' sequence improves the performance of the vaccinia virus/bacteriophage T7 hybrid expression system"
"0024461313","2677748","","2-s2.0-0024461313","1989-12-01","Binding activities of a repertoire of single immunoglobulin variable domains secreted from Escherichia coli"
"0025155473","2204064","","2-s2.0-0025155473","1990-11-09","Cytoplasmic expression system based on constitutive synthesis of bacteriophage T7 RNA polymerase in mammalian cells"
"84871466267","","","2-s2.0-84871466267","1995-04-18","Successful treatment of T-cell prolymphocytic leukaemia (T-PLL) with human CD52 antibody, Campath-1H"
"0024390256","2731337","","2-s2.0-0024390256","1989-01-01","Treatment of chronic lymphocytic leukemia with an anti-idiotypic monoclonal antibody"
"0029118503","7670093","","2-s2.0-0029118503","1995-10-01","Purine nucleoside analogs: Emerging roles in indolent lymphoproliferative disorders"
"0026320325","","10.3109/10428199109103389","2-s2.0-0026320325","1991-01-01","CLL trials in the United kingdom the medical Research council CLL trials 1, 2 and 3"
"0028265320","8025525","10.3109/10428199409051654","2-s2.0-0028265320","1994-01-01","Retreatment of chronic lymphocvtic leukemia with 2-chlorodeoxyadenbsine (cda) at relapse following cda-induced remission: No acquired resistance"
"0029062435","7669706","","2-s2.0-0029062435","1995-05-01","Purine analogs in the treatment of low-grade lymphomas and chronic lymphocytic leukemias"
"0026347961","","10.3109/10428199109103394","2-s2.0-0026347961","1991-01-01","2-chlorodeoxyadenosine treatment of refractory chronic lymphocytic leukemia"
"0028289822","7803902","10.1016/S0950-3536(05)80203-3","2-s2.0-0028289822","1994-01-01","4 Advances in therapy for childhood non-B-lymphoblastic leukaemia"
"0027389767","8417795","","2-s2.0-0027389767","1993-01-01","Marrow transplantation from unrelated donors for treatment of hematologic malignancies: Effect of mismatching for one HLA locus"
"0024791767","2819281","","2-s2.0-0024791767","1989-12-01","Allogeneic bone marrow transplantation versus chemotherapy in the treatment of childhood acute lymnphoblastic leukemia in second complete remission"
"0027998089","7878653","10.1111/j.1399-0039.1994.tb02396.x","2-s2.0-0027998089","1994-01-01","Selection of unrelated bone marrow donors by PCR‐SSP typing and subsequent nonradioactive sequence‐based typing for HLA DRB1/3/4/5, DQB1, and DPB1 alleles"
"0028109796","7935682","10.1056/NEJM199411103311902","2-s2.0-0028109796","1994-11-10","Bone marrow transplants from HLA-identical siblings as compared with chemotherapy for children with acute lymphoblastic leukemia in a second remission"
"0022625674","2868339","","2-s2.0-0022625674","1986-01-01","Improvement in treatment for children with acute lymphoblastic leukaemia. The Medical Research Council UKALL trials, 1972-84"
"11944271130","2300120","","2-s2.0-11944271130","1990-03-19","Successful allogeneic transplantation of T-cell-depleted bone marrow from closely HLA-matched unrelated donors"
"0028978650","7482491","10.1111/j.1399-0039.1995.tb02470.x","2-s2.0-0028978650","1995-01-01","Nomenclature for factors of the HLA system. 1995"
"0030993271","9169638","","2-s2.0-0030993271","1997-05-02","A consensus statement on unrelated donor bone marrow transplantation from the consensus panel chaired by EC Gordon-Smith"
"0030749222","9269758","","2-s2.0-0030749222","1997-08-15","Marrow transplants from unrelated donors for treatment of Philadelphia chromosome-positive acute lymphoblastic leukemia"
"0025274912","2329963","10.1002/mpo.2950180305","2-s2.0-0025274912","1990-01-01","Bone marrow relapse occurring as first relapse in children with acute lymphoblastic leukemia"
"0028564973","7728125","","2-s2.0-0028564973","1994-12-01","Molecular techniques for typing unrelated marrow donors: Potential impact of molecular typing disparity on donor selection"
"0032400846","9834212","","2-s2.0-0032400846","1998-12-01","Minimal residual disease status before allogeneic bone marrow transplantation is an important determinant of successful outcome for children and adolescents with acute lymphoblastic leukemia"
"0004206935","","","2-s2.0-0004206935","1996-07-13",""
"0027953484","8019453","","2-s2.0-0027953484","1994-01-01","Comparison of engraftment in recipients of matched sibling or unrelated donor marrow allografts"
"9244227107","8639926","","2-s2.0-9244227107","1996-04-01","Patterns of hematopoietic chimerism following bone marrow transplantation for childhood acute lymphoblastic leukemia from volunteer unrelated donors"
"0029960675","8932842","","2-s2.0-0029960675","1996-11-01","Bone marrow transplantation using unrelated and family related donors: The impact of HLA-C disparity"
"0030857652","9232250","","2-s2.0-0030857652","1997-07-01","European results of matched unrelated donor bone marrow transplantation for chronic myeloid leukemia. Impact of HLA class II matching"
"0031044820","9041414","","2-s2.0-0031044820","1997-03-01","Aseptic meningitis and encephalitis: The role of PCR in the diagnostic laboratory"
"0031911315","9508175","","2-s2.0-0031911315","1998-03-01","Unrelated donor bone marrow transplantation for children and adolescents with Philadelphia-positive acute lymphoblastic leukemia"
"0028813641","7823668","10.1016/S0140-6736(95)90164-7","2-s2.0-0028813641","1995-01-21","Intensification of treatment and survival in all children with lymphoblastic leukaemia: results of UK Medical Research Council trial UKALL X"
"0025789913","1824271","","2-s2.0-0025789913","1991-11-15","Allogeneic bone marrow transplantation for childhood acute lymphoblastic leukemia in second remission after intensive primary and relapse therapy according to the BFM- and CoALL-protocols: Results of the German cooperative study"
"0024537269","2643045","","2-s2.0-0024537269","1989-01-01","Effect of HLA compatibility on engraftment of bone marrow transplants in patients with leukemia or lymphoma"
"0028921178","7727769","","2-s2.0-0028921178","1995-05-01","Unrelated bone marrow donor transplants for children with leukemia or myelodysplasia"
"0026072791","1878583","","2-s2.0-0026072791","1991-01-01","Six-year experience with a comprehensive approach to the treatment of recurrent childhood acute lymphoblastic leukemia (ALL-REZ BFM 85). A relapse study of the BFM group"
"9344223316","8639808","","2-s2.0-9344223316","1996-05-15","High resolution HLA matching associated with decreased mortality after unrelated bone marrow transplantation"
"0025942273","1768970","","2-s2.0-0025942273","1991-01-01","Graft-versus-host disease in children receiving HLA-identical allogeneic bone marrow transplants with a low adjusted T lymphocyte dose"
"0025855941","2024863","","2-s2.0-0025855941","1991-06-01","Immunologic tolerance to renal allografts after bone marrow transplants from the same donors"
"0021269293","6377608","","2-s2.0-0021269293","1984-01-01","Azathioprine withdrawal in renal transplant recipient: A long–term follow–up"
"23444459237","7907762","10.1016/S0140-6736(94)91881-3","2-s2.0-23444459237","1994-03-26","Tolerance to an HLA-B,DR disparate kidney allograft after bone-marrow transplantation from same donor"
"0002142290","","","2-s2.0-0002142290","2013-02-09","The UNOS scientific renal transplant registry"
"0018186018","82836","10.1016/S0140-6736(78)91970-0","2-s2.0-0018186018","1978-12-30","CYCLOSPORIN A IN PATIENTS RECEIVING RENAL ALLOGRAFTS FROM CADAVER DONORS"
"77049284622","13391513","","2-s2.0-77049284622","1956-12-01","Renal homotransplantation in identical twins."
"0000245578","","","2-s2.0-0000245578","1943-02-23","The fate of skin homografts in man"
"0345615911","13875840","","2-s2.0-0345615911","1961-10-01","Inhibition of the rejection of renal homografts in dogs by purine analogues."
"0030915659","9145041","","2-s2.0-0030915659","1997-05-21","Chronic allograft failure: The clinical problem"
"0030973944","9122943","10.1016/S0041-1345(96)00717-8","2-s2.0-0030973944","1997-04-01","Progress toward tolerance and xenografting"
"0028560026","7809937","","2-s2.0-0028560026","1994-12-01","Renal transplantation without immunosuppression in a host with tolerance induced by allogeneic bone marrow transplantation"
"0033608550","10199733","","2-s2.0-0033608550","1999-03-27","Reversal of naturally occurring diabetes in primates by unmodified islet xenografts without chronic immunosuppression"
"0001082014","13837954","","2-s2.0-0001082014","1959-10-01","Supralethal whole body irradiation and isologous marrow transplantation in man."
"0032525243","9603161","10.1097/00007890-199805150-00003","2-s2.0-0032525243","1998-05-15","Peritransplant tolerance induction with anti-CD3 immunotoxin: A matter of proinflammatory cytokine control"
"0017252462","766892","10.1002/bjs.1800630202","2-s2.0-0017252462","1976-01-01","Long survival after renal transplantation in man"
"73649153279","13936775","","2-s2.0-73649153279","1963-06-13","Prolonged survival of human-kidney homografts by immunosuppressive drug therapy."
"0026665189","1394149","","2-s2.0-0026665189","1992-01-01","Non-Hodgkin's lymphoma time trends: United States and international data"
"0031856733","9594916","","2-s2.0-0031856733","1998-05-01","Clinical highlights from the National Cancer Data Base, 1998"
"0033006836","10200775","","2-s2.0-0033006836","1999-03-03","Cancer Statistics, 1999"
"0005504612","","","2-s2.0-0005504612","1992-06-18","Phase I/II trials of CAMPATH-1H, a humanized anti-lymphocyte monoclonal antibody in non-Hodgkin's lymphoma and chronic lymphocytic leukemia"
"4243805498","","","2-s2.0-4243805498","1996-09-27","Autografting with CD52 monoclonal antibody-purged marrow for acute lymphoblastic leukemia"
"0027319205","8100267","","2-s2.0-0027319205","1993-07-01","Compartmentalization of T lymphocytes to the site of disease: Intrahepatic CD4+ T cells specific for the protein NS4 of hepatitis C virus in patients with chronic hepatitis C"
"1642593544","","","2-s2.0-1642593544","1993-07-13","Immunity to infection"
"0023864769","3124466","10.1159/000205682","2-s2.0-0023864769","1988-01-01","Bone marrow transplantation for hepatitis-associated aplastic anemia"
"0020699231","6295145","10.1016/0002-9343(83)91119-1","2-s2.0-0020699231","1983-01-01","Aplastic anemia and non-A, non-B hepatitis"
"0026478549","1385547","10.1093/infdis/166.6.1276","2-s2.0-0026478549","1992-01-01","Hepatitis C virus is detected in a monocyte/macrophage subpopulation of peripheral blood mononuclear cells of infected patients"
"0025172126","2117412","","2-s2.0-0025172126","1990-09-15","Is hepatitis C virus involved in hepatitis-associated aplastic anemia?"
"0023576003","3676511","","2-s2.0-0023576003","1987-12-01","Incidence of aplastic anemia: The relevance of diagnostic criteria"
"0026651810","1319062","","2-s2.0-0026651810","1992-12-01","Evidence for in vitro replication of hepatitis C virus genome in a human T-cell line"
"0028556507","7534164","","2-s2.0-0028556507","1994-12-01","Impact of liver disease and hepatitis infections on allogeneic bone marrow transplantation in Europe: A survey from the European Bone Marrow Transplantation (EBMT) Group - Infectious Diseases Working Party"
"0028316548","7511444","","2-s2.0-0028316548","1994-04-01","Hepatitis C virus infection is a risk factor for liver failure from veno-occlusive disease after bone marrow transplantation"
"0026606248","1542923","10.1046/j.1537-2995.1992.32292180148.x","2-s2.0-0026606248","1992-01-01","Unaltered lymphocyte subsets in hepatitis C virus‐seropositive blood donors"
"0001644937","","","2-s2.0-0001644937","1987-12-08","Effects of short-term corticosteroid therapy in patients with chronic non-A, non-B hepatitis (NANB)"
"0021934088","3918143","10.1002/jmv.1890150102","2-s2.0-0021934088","1985-01-01","Treatment of chronic non‐A, non‐B hepatitis with acyclovir: Pilot study"
"0026694583","1348079","10.1093/infdis/165.4.723","2-s2.0-0026694583","1992-04-01","Recombinant Interferon-a for Chronic Hepatitis C in Patients Positive for Antibody to Human Immunodeficiency Virus"
"0026209184","1719255","","2-s2.0-0026209184","1991-08-01","Bone marrow transplantation in a pediatric case of acute nonlymphocytic leukemia with hepatitis C"
"0023251015","2953860","","2-s2.0-0023251015","1987-01-01","The effect of L3T4 T cell depletion on the pathogenesis of Theiler's murine encephalomyelitis virus infection in CBA mice"
"0021206810","6383025","10.1002/ajh.2830170307","2-s2.0-0021206810","1984-01-01","Marrow transplantation in hepatitis‐associated aplastic anemia"
"0026072852","1662997","","2-s2.0-0026072852","1991-01-01","Withdrawal of immunosuppressive therapy in allogeneic bone marrow transplantation reactivates chronic viral hepatitis C"
"9444271784","","","2-s2.0-9444271784","1994-12-14","CAMPATH-1G for abrogation of host resistance to T-cell depleted marrow allografts in severe aplastic anemia"
"0026486418","1385523","","2-s2.0-0026486418","1992-01-01","Intrahepatic cytotoxic T lymphocytes specific for hepatitis C virus in persons with chronic hepatitis"
"0021951837","3920112","","2-s2.0-0021951837","1985-01-01","Non-A, non-B posttransfusion hepatitis - A decade later"
"9444227131","","","2-s2.0-9444227131","1994-12-14","Allogeneic BMT for malignant and non-malignant haematological disorders using anti CDw52 (CAMPATH 1) monoclonal antibodies"
"0023910268","2966203","","2-s2.0-0023910268","1988-01-01","Successful therapy of Theiler's virus-induced demyelination (DA strain) with monoclonal anti-Lyt-2 antibody"
"0024368522","2509916","","2-s2.0-0024368522","1989-01-01","Treatment of chronic hepatitis C with recombinant interferon alfa. A multicenter randomized, controlled trial"
"0019381335","6450290","10.1001/jama.1981.03310300048019","2-s2.0-0019381335","1981-02-06","Acute Non-A, Non-B Hepatitis With Serum Sickness-like Syndrome and Aplastic Anemia"
"0029789226","8881921","","2-s2.0-0029789226","1996-08-23","Assessment of IgH PCR strategies in multiple myeloma"
"0030917947","9163614","","2-s2.0-0030917947","1997-06-09","Comparison of fluorescent consensus IgH PCR and allele-specific oligonucleotide probing in the detection of minimal residual disease in childhood ALL"
"0034161560","10685074","10.1002/(SICI)1097-0320(20000301)39:3&lt;179::AID-CYTO2&gt;3.0.CO;2-I","2-s2.0-0034161560","2000-03-01","On the use of the Kolmogorov-Smirnov statistical test for immunofluorescence histogram comparison"
"0027230190","8317459","10.1002/ajh.2830430107","2-s2.0-0027230190","1993-01-01","Detection of immunoglobulin gene rearrangement in lymphoid malignancies of B‐cell lineage by seminested polymerase chain reaction gene amplification"
"0033567968","10477712","","2-s2.0-0033567968","1999-09-15","Ig V gene mutation status and CD38 expression as novel prognostic indicators in chronic lymphocytic leukemia"
"0030814360","9376567","","2-s2.0-0030814360","1997-10-15","Recent advances in flow cytometry: Application to the diagnosis of hematologic malignancy"
"0030665507","9369425","","2-s2.0-0030665507","1997-11-24","Analysis of residual disease in chronic lymphocytic leukemia by flow cytometry"
"0033026415","10193641","","2-s2.0-0033026415","1999-02-01","Detection of minimal residual disease in B chronic lymphocytic leukemia (CLL)"
"7344224344","9753416","","2-s2.0-7344224344","1998-10-07","First line fludarabine treatment of symptomatic chronic lymphoproliferative diseases: Clinical results and molecular analysis of minimal residual disease"
"0028940167","7533868","","2-s2.0-0028940167","1995-01-01","Description of a novel FR1 IgH PCR strategy and its comparison with three other strategies for the detection of clonality in B cell malignancies"
"0031030039","9059356","","2-s2.0-0031030039","1997-02-12","Use of methyl methacrylate resin for embedding bone marrow trephine biopsy specimens"
"0026324276","1958310","10.1016/1040-8428(91)90019-9","2-s2.0-0026324276","1991-01-01","New modalities of therapy in chronic lymphocytic leukemia"
"0032827380","10516749","","2-s2.0-0032827380","1999-10-14","CD79b expression in B cell chronic lymphocytic leukemia: Its implication for minimal residual disease detection"
"0034034410","10764166","","2-s2.0-0034034410","2000-04-20","A real-time PCR assay for the quantification of residual malignant cells in B cell chronic lymphatic leukemia"
"0030698409","9324303","","2-s2.0-0030698409","1997-11-05","A novel nested-PCR strategy for the detection of rearranged immunoglobulin heavy-chain genes in B cell tumors"
"0028285289","8207975","","2-s2.0-0028285289","1994-06-01","Residual disease in B-cell chronic lymphocytic leukemia patients and prognostic value"
"0017697661","592386","10.1016/0022-2836(77)90119-X","2-s2.0-0017697661","1977-10-15","Crystal and molecular structure of the dimer of variable domains of the Bence-Jones protein ROY"
"0018064944","","10.1016/S0065-3233(08)60574-4","2-s2.0-0018064944","1978-12-01","The Structural Basis for Antibody Complementary"
"84912413842","","","2-s2.0-84912413842","1977-12-07",""
"0000187138","","","2-s2.0-0000187138","1986-04-15","The response of protein structures to amino-acid sequence changes"
"0345796909","","","2-s2.0-0345796909","1986-07-13",""
"0017614064","17883","10.1017/S0033583500000135","2-s2.0-0017614064","1977-01-01","Structural basis for the specificity of antibody-antigen reactions and structural mechanisms for the diversification of antigen-binding specificities"
"0043123724","","10.1016/0167-5699(82)90107-4","2-s2.0-0043123724","1982-01-01","The three-dimensional structure of antibodies"
"0018654090","89832","","2-s2.0-0018654090","1979-01-01","Three-dimensional structure of immunoglobulins."
"0017404875","407580","","2-s2.0-0017404875","1977-01-01","Structural implications of sequence variability in immunoglobulins"
"0023123168","3586022","10.1016/0022-2836(87)90642-5","2-s2.0-0023123168","1987-01-05","Crystallization and preliminary crystallographic data for an antiprogesterone monoclonal antibody Fab′ and steroid-Fab′ complexes"
"0016769339","1234024","10.1007/BF00539775","2-s2.0-0016769339","1975-06-01","The structure determination of the variable portion of the Bence-Jones protein Au"
"0019432764","7278298","10.1016/0022-5193(81)90275-7","2-s2.0-0019432764","1981-02-07","A predictive method for determining possible three-dimensional foldings of immunoglobulin backbones around antibody combining sites"
"0023123868","3811232","10.1016/0042-6822(87)90451-X","2-s2.0-0023123868","1987-01-01","Crystals of antibodies complexed with influenza virus neuraminidase show isosteric binding of antibody to wild-type and variant antigens"
"0346146524","805424","","2-s2.0-0346146524","1975-12-01","Variability of three dimensional structure in immunoglobulins"
"0022384330","4019512","","2-s2.0-0022384330","1985-12-01","Preliminary crystallographic study of the Fab fragments of two monoclonal anti-2-phenyloxazolone antibodies"
"0018758960","114750","10.1016/0161-5890(79)90128-7","2-s2.0-0018758960","1979-01-01","Evaluation of the structural variation among light chain variable domains"
"0022531028","3090684","","2-s2.0-0022531028","1986-12-01","The predicted structure of immunoglobulin D1.3 and its comparison with the crystal structure"
"0020534965","6300689","10.1038/302575a0","2-s2.0-0020534965","1983-12-01","Somatic generation of antibody diversity"
"84912666526","","","2-s2.0-84912666526","1985-12-07",""
"0017747498","408353","","2-s2.0-0017747498","1977-12-01","Unusual distributions of amino acids in complementarity determining (hypervariable) segments of heavy and light chains of immunoglobulins and their possible roles in specificity of antibody-combining sites"
"0019507195","6171725","10.1016/0161-5890(81)90060-2","2-s2.0-0019507195","1981-01-01","A hypothetical space-filling model of the V-regions of the galactan-binding myeloma immunoglobulin J539"
"0005584229","","","2-s2.0-0005584229","1976-12-07","Model-building Studies of Antigen-binding Sites: The Hapten-binding Site of MOPC-315"
"0021844602","4010788","10.1038/316170a0","2-s2.0-0021844602","1985-12-01","β-hairpin families in globular proteins"
"84912647144","","","2-s2.0-84912647144","1980-12-07","Possible distortion of antibody binding site of the Mcg bence-jones protein by lattice forces"
"0022565437","3951439","","2-s2.0-0022565437","1986-01-01","Standard conformations of a polypeptide chain in irregular protein regions"
"0020977127","6399980","","2-s2.0-0020977127","1983-12-01","Structural basis of antibody function."
"0030730465","9404927","","2-s2.0-0030730465","1997-11-02","Allogeneic bone marrow transplantation in patients who relapse after autologous transplantation"
"0032774458","10467328","","2-s2.0-0032774458","1999-09-03","Allogeneic bone marrow transplant or second autograft in patients with acute leukemia who relapse after an autograft"
"0033594552","10347989","10.1016/S0140-6736(98)11135-2","2-s2.0-0033594552","1999-05-22","Mixed symphohaemopoietic chimerism and graft-versus-lymphoma effects after non-myeloablative therapy and HLA-mismatched bone-marrow transplantation"
"0031849164","9704463","","2-s2.0-0031849164","1998-08-28","Donor leukocyte transfusions for treatment of leukemic relapse after bone marrow transplantation"
"0001586910","","","2-s2.0-0001586910","1997-07-13","Preliminary results of fludarabine/melphalan or 2CDA/melphalan as preparative regimens for allogeneic progenitor cell transplantation in poor candidates for conventional myeloablative conditioning"
"0017295153","820630","10.1016/0019-2791(76)90341-4","2-s2.0-0017295153","1976-01-01","Haemolytic diffusion plate assays for factors B and D of the alternative pathway of complement activation"
"0022358651","3007976","10.1016/0161-5890(85)90063-X","2-s2.0-0022358651","1985-01-01","Co-operative interaction of subcomponents of the first component of complement with IgG: A functional defect of dimeric Facb from rabbit IgG"
"0022557568","3018553","10.1016/0161-5890(86)90119-7","2-s2.0-0022557568","1986-01-01","A molecular mechanism for the activation of the first component of complement by immune complexes"
"85005399483","","","2-s2.0-85005399483","1988-12-19",""
"84969001783","","10.1111/j.1749-6632.1949.tb27297.x","2-s2.0-84969001783","1949-01-01","THE ATTRACTIONS OF PROTEINS FOR SMALL MOLECULES AND IONS"
"0022905472","","10.1016/0167-5699(86)90166-0","2-s2.0-0022905472","1986-01-01","Is IgM-like dislocation a common feature of antibody function?"
"85005270263","","","2-s2.0-85005270263","1985-12-19",""
"0022597557","2419414","","2-s2.0-0022597557","1986-01-01","Membrane factors responsible for homologous species restriction of complement-mediated lysis: Evidence for a factor other than DAF operating at the stage of C8 and C9"
"0019472804","7252154","","2-s2.0-0019472804","1981-01-01","Purification and radiolabeling of human C1q"
"0022006660","2996908","10.1002/eji.1830151003","2-s2.0-0022006660","1985-01-01","Antibody density on rat red cells determines the rate of activation of the complement component Cl"
"77956127888","14097352","","2-s2.0-77956127888","1963-12-01","THE PREPARATION OF I-131-LABELLED HUMAN GROWTH HORMONE OF HIGH SPECIFIC"
"0015598436","4734666","","2-s2.0-0015598436","1973-03-01","Effect of chemical and enzymatic radioiodination on in vitro human Clq activities."
"0019856662","6946459","","2-s2.0-0019856662","1981-12-01","Homologous species restriction in lysis of erythrocytes by terminal complement proteins"
"0021243594","6608694","10.1038/308460a0","2-s2.0-0021243594","1984-12-01","Therapeutic potential of monovalent monoclonal antibodies"
"0018942297","","","2-s2.0-0018942297","1980-01-01","Immunosuppressive properties of rabbit antibodies against a major glycoprotein restricted to rat leukocyte membranes"
"85005242580","","","2-s2.0-85005242580","1976-12-19",""
"0001321260","5319759","","2-s2.0-0001321260","1965-12-01","Complement fixation on cell surfaces by 19S and 7S antibodies"
"0020065143","7057931","10.1038/295712a0","2-s2.0-0020065143","1982-12-01","Univalent antibodies kill tumour cells in vitro and in vivo"
"85005245975","","","2-s2.0-85005245975","1988-12-19",""
"0019211021","6161872","","2-s2.0-0019211021","1980-12-01","Three rat monoclonal antibodies to human C3"
"0020616655","6310124","10.1016/S0022-2836(83)80302-7","2-s2.0-0020616655","1983-08-15","Conformation and restricted segmental flexibility of C1, the first component of human complement"
"0040593632","14285093","","2-s2.0-0040593632","1965-01-01","Quantitative titrations of mouse h-2 antibodies using cr51-labelled target cells"
"0023228459","2958690","10.1016/0161-5890(87)90039-3","2-s2.0-0023228459","1987-01-01","Synergistic complement lysis by monoclonal antibodies to the human leukocyte common antigen requires both the classical and alternative pathways"
"0023555299","2962345","","2-s2.0-0023555299","1987-01-01","Blocking of cytotoxic T cell function by monoclonal antibodies against the CD45 antigen (T200/leukocyte-common antigen)"
"0018967853","7429549","","2-s2.0-0018967853","1980-01-01","The relationship between the binding ability and the rate of activation of the complement component C1"
"84936370978","","","2-s2.0-84936370978","2015-11-01","Ex-vivo treatment of donor bone-marrow with anti-T cell immunotoxins for prevention of graft-versus host disease"
"0021917587","3882442","","2-s2.0-0021917587","1985-05-29","Comparison of three techniques for the ex vivo elimination of T cells from human bone marrow"
"0015466756","4118756","","2-s2.0-0015466756","1972-01-01","Characteristics of disparate histocompatibility barriers in congenic strains of mice: Graft-versus-host reactions"
"84945007405","","","2-s2.0-84945007405","1986-11-01",""
"0021327450","6364497","","2-s2.0-0021327450","1984-01-01","Bone marrow repopulation capacity after transplantation of lymphocyte-depleted allogeneic bone marrow using counterflow centrifugation"
"84921120073","","","2-s2.0-84921120073","1984-09-03",""
"0020975357","6354307","","2-s2.0-0020975357","1983-11-01","Allogenic bone marrow transplantation: current status and future directions."
"84945010175","","","2-s2.0-84945010175","1986-11-01",""
"84945009074","","","2-s2.0-84945009074","1985-11-01",""
"0021959901","3871644","","2-s2.0-0021959901","1985-01-01","Human bone marrow and peripheral blood T lymphocyte depletion: Efficacy and effects of both cells and monocytes on growth of hematopoietic progenitors"
"84945009922","","","2-s2.0-84945009922","1981-11-01",""
"0023194940","3498584","","2-s2.0-0023194940","1987-01-01","Studies of human bone marrow treated with soybean lectin and sheep erythrocytes: Stepwise analysis of cell morphology, phenotype and function"
"0023109776","3103275","","2-s2.0-0023109776","1987-01-01","Specific ex-vivo depletion of human bone marrow Τ lymphocytes by an anti-pan-t cell (CD5) ricin A-chain immunotoxin"
"84945002457","","","2-s2.0-84945002457","1980-11-01",""
"84945010748","","","2-s2.0-84945010748","1987-11-01",""
"0021029515","6353702","","2-s2.0-0021029515","1983-01-01","Transplantation of T-lymphocyte-depleted bone marrow between HLA-mismatched individuals"
"0023219143","3332157","","2-s2.0-0023219143","1987-09-23","Human marrow T cell dose correlates with severity of subsequent acute graft-versus-host disease"
"0023102456","3103274","","2-s2.0-0023102456","1987-01-01","Depletion of Τ lymphocytes from human bone marrow: Use of magnetic monosized polymer microspheres coated with t-lymphocyte-specific monoclonal antibodies"
"0022485060","3094209","","2-s2.0-0022485060","1986-01-01","Functional assessment of T cell depletion from bone marrow prior to therapeutic transplantation using limiting dilution culture methods"
"0025936312","1834468","10.1002/eji.1830211111","2-s2.0-0025936312","1991-01-01","A humanized monovalent CD3 antibody which can activate homologous complement"
"0028633387","7540098","10.1006/immu.1994.1054","2-s2.0-0028633387","1994-12-01","Expression of Cell Surface Markers during Differentiation of CD34+, CD38-/lo Fetal and Adult Bone Marrow Cells"
"84879069740","","","2-s2.0-84879069740","0000-06-26","Persistent lymphopenia secondary to lymphocytotoxic monoclonal antibody therapy of rheumatoid arthritis is not associated with opportunistic infections during seven years of follow-up"
"0029912735","8977262","","2-s2.0-0029912735","1996-12-15","Surface and mRNA expression of the CD52 antigen by human eosinophils but not by neutrophils"
"0034754525","12171724","10.1080/146532401753174007","2-s2.0-0034754525","2001-11-20","The current status of T-cell depleted allogeneic stem-cell transplant in adult patients with AML"
"10544231614","","","2-s2.0-10544231614","1996-01-11","Phase I/II evaluation of 2′deoxycoformycin (Pentostatin) in a five-day schedule for the treatment of relapsed/refractory chronic lymphocytic leukaemia (CLL)"
"0027941692","7994024","","2-s2.0-0027941692","1994-12-15","Long-Term Follow-Up of Patients with Hairy Cell Leukemia after Treatment with 2′-Deoxycoformycin"
"0026489388","1283078","10.1111/j.1365-2141.1992.tb06465.x","2-s2.0-0026489388","1992-01-01","Massive abdominal lymphadenopathy in hairy cell leukaemia: a report of 12 cases"
"0025101924","","10.3109/10428199009042478","2-s2.0-0025101924","1990-01-01","Treatment of hairy cell leukaemia with 2'deoxycoformycin"
"0026588745","1581231","10.1111/j.1365-2141.1992.tb04559.x","2-s2.0-0026588745","1992-01-01","Sequential administration of recombinant interferon alpha and deoxycoformycin in the treatment of hairy cell leukaemia"
"0023890049","3257929","10.1111/j.1600-0609.1988.tb00819.x","2-s2.0-0023890049","1988-01-01","Regression of intracerebral lesions in T prolymphocytic leukaemia treated with intravenous deoxycoformycin"
"0029795202","8822913","","2-s2.0-0029795202","1996-09-15","Relapse of hairy cell leukemia after 2-chlorodeoxyadenosine: Long-term follow-up of the Northwestern University experience"
"0025283382","2390480","10.1038/bjc.1990.217","2-s2.0-0025283382","1990-01-01","Deoxycoformycin in the treatment of mature B-cell malignancies"
"0025945545","1913594","10.1016/0165-4608(91)90228-M","2-s2.0-0025945545","1991-01-01","Inversions and tandem translocations involving chromosome 14q11 and 14q32 in T-prolymphocytic leukemia and T-cell leukemias in patients with ataxia telangiectasia"
"0023628816","2890401","10.1136/bmj.295.6603.873","2-s2.0-0023628816","1987-01-01","Membrane phenotype and response to deoxycoformycin in mature T cell malignancies"
"0026095680","1931613","10.1038/bjc.1991.423","2-s2.0-0026095680","1991-01-01","Deoxycoformycin in the treatment of mature T־cell leukaemias"
"34447490302","","","2-s2.0-34447490302","1996-07-22",""
"0021681936","6334721","","2-s2.0-0021681936","1984-12-01","Hairy-cell leukemia: Induction of complete remission with pentostatin (2'-deoxycoformycin)"
"34447489427","","","2-s2.0-34447489427","1996-07-22","Abnormalities of the ataxia telangiectasia gene (ATM) in T-prolymphocytic leukemia"
"0019731629","6118669","10.1016/S0140-6736(81)91491-4","2-s2.0-0019731629","1981-12-05","THERAPEUTIC SELECTIVITY OF AND PREDICTION OF RESPONSE TO 2'-DEOXYCOFORMYCIN IN ACUTE LEUKAEMIA"
"0029921908","8639440","","2-s2.0-0029921908","1996-05-20","2-Chlorodeoxyadenosine in the treatment of hairy cell leukaemia: Differences in response in patients with and without abdominal lymphadenopathy"
"0019512909","6970050","","2-s2.0-0019512909","1981-06-29","The biochemical and clinical consequences of 2'-deoxycoformycin in refractory lymphoproliferative malignancy"
"0025359319","2364167","","2-s2.0-0025359319","1990-07-01","A variant form of hairy cell leukemia resistant to α-interferon: Clinical and phenotypic characteristics of 17 patients"
"0025274664","1969613","","2-s2.0-0025274664","1990-04-19","Lasting remissions in hairy-cell leukemia induced by a single infusion of 2-chlorodeoxyadenosine"
"0028068503","7820041","","2-s2.0-0028068503","1994-01-01","Long term results with 2'deoxycoformycin in hairy cell leukemia"
"0029822176","8839829","","2-s2.0-0029822176","1996-10-01","Mycosis fungoides and Sezary syndrome"
"0023111435","2434850","","2-s2.0-0023111435","1987-06-12","Remissions in hairy-cell leukemia with pentostatin (2'-deoxycoformycin)"
"0028929938","7707126","","2-s2.0-0028929938","1995-04-01","Randomized comparison of pentostatin versus interferon alfa-2a in previously untreated patients with hairy cell leukemia: An intergroup study"
"0024551067","2565420","10.1016/S0140-6736(89)92508-7","2-s2.0-0024551067","1989-04-29","POLYMERASE CHAIN REACTION FOR DETECTION OF RESIDUAL LEUKAEMIA"
"0020535016","6338988","","2-s2.0-0020535016","1983-06-02","Fractionation of whole body irradiation before bone marrow transplantation for patients with leukaemia"
"0016693476","239852","","2-s2.0-0016693476","1975-12-01","Comment on the report from the ACS/NIH bone marrow transplant registry"
"85004906591","","","2-s2.0-85004906591","1989-12-18","Controllable factors improving survival of T‐cell depleted transplants in leukemia"
"0026059997","1993225","","2-s2.0-0026059997","1991-02-15","Detection of residual leukemia after bone marrow transplant for chronic myeloid leukemia: Role of polymerase chain reaction in predicting relapse"
"85004710563","","","2-s2.0-85004710563","1989-12-18","Selective CD8 depletion of donor marrow: retention of graft‐versus‐leukemia effect following bone marrow transplantation for chronic myelogenous leukemia"
"85004832315","","","2-s2.0-85004832315","1980-12-18",""
"0026541166","1536808","10.1111/j.1365-2141.1992.tb06397.x","2-s2.0-0026541166","1992-01-01","Second transplants for patients with chronic myeloid leukaemia in relapse after original transplant with T‐depleted donor marrow: feasibility of using busulphan alone for re‐conditioning"
"0025807721","2070062","","2-s2.0-0025807721","1991-01-01","The use of the polymerase chain reaction for the detection of minimal residual malignant disease"
"0021329318","6365154","10.1111/j.1365-2141.1984.tb03974.x","2-s2.0-0021329318","1984-01-01","Haematological reconstitution and severity of graft‐versus‐host disease after bone marrow transplantation for chronic granulocytic leukaemia: the influence of previous splenectomy"
"0021359582","6609705","10.1002/art.1780270501","2-s2.0-0021359582","1984-01-01","Total lymphoid irradiation therapy in refractory rheumatoid arthritis"
"0018756542","375588","","2-s2.0-0018756542","1979-12-01","Prolonged thoracic duct drainage in rheumatoid arthritis and systemic lupus erythematosus"
"84996056246","","","2-s2.0-84996056246","1992-11-27","Treatment of rheumatoid arthritis with a single‐dose infusion of Campath‐1H (abstract)"
"0023836460","2964240","10.1002/art.1780310108","2-s2.0-0023836460","1988-01-01","Increased helper inducer and decreased suppressor inducer phenotypes in the rheumatoid joint"
"0022570651","2423439","","2-s2.0-0022570651","1986-08-06","Functional subsets of human helper-inducer cells defined by a new monoclonal antibody, UCHL1"
"84996070672","","","2-s2.0-84996070672","1993-11-27","Sustained lymphocyte suppression after single dose Campath‐1H infusion: an 8‐month follow‐up (abstract)"
"0020024860","7042371","10.1007/BF00542323","2-s2.0-0020024860","1982-09-01","High dose intravenous methylprednisolone ""pulse"" therapy in patients with rheumatoid disease - Plasma methylprednisolone levels and adrenal function"
"0018856568","","","2-s2.0-0018856568","1980-01-01","Complications of intravenous methylprednisolone pulse therapy"
"0022347940","4062612","10.1001/archneur.1985.04060110031011","2-s2.0-0022347940","1985-01-01","High-Dose Intravenous Methylprednisolone in Myasthenia Gravis"
"0029094664","7543720","10.1159/000204115","2-s2.0-0029094664","1995-01-01","Methylprednisolone in advanced chronic lymphocytic leukaemia: Rationale for, and effectiveness of treatment suggested by disc assay"
"0344833294","","","2-s2.0-0344833294","1988-09-09","Pulse high dose methylprednisolone in the treatment of refractory and end-stage chronic lymphocytic leukaemia (CLL)"
"0017730147","336116","","2-s2.0-0017730147","1977-12-01","Comparison of daily versus intermittent chlorambucil and prednisone therapy in the treatment of patients with chronic lymphocytic leukemia"
"0018941702","6248819","","2-s2.0-0018941702","1980-01-01","Possible beneficial effect of high-dose intravenous steroid therapy in acute demyelinating disease and transverse myelitis"
"0345696333","13803359","10.1159/000205777","2-s2.0-0345696333","1959-01-01","Evaluation of the effect of massive prednisolone therapy in acute leukemia"
"0026638887","1734216","10.1002/mpo.2950200206","2-s2.0-0026638887","1992-01-01","High‐dose methylprednisolone sodium succinate as a single agent in relapsed childhood acute lymphoblastic leukaemia"
"0028261089","8201379","","2-s2.0-0028261089","1994-06-01","ESHAP - An effective chemotherapy regimen in refractory and relapsing lymphoma: A 4-year follow-up study"
"0023699971","3207601","10.1038/bjc.1988.243","2-s2.0-0023699971","1988-01-01","Infused vincristine and adriamycin with high dose methylprednisolone (Vamp) in advanced previously treated multiple myeloma patients"
"0345696332","14129063","","2-s2.0-0345696332","1964-05-28","WEEKLY HIGH-DOSAGE GLUCOCORTICOSTEROID TREATMENT OF LYMPHOCYTIC LEUKEMIAS AND LYMPHOMAS."
"0023839105","3048467","","2-s2.0-0023839105","1988-01-01","Melphalan and total body irradiation (TBI) versus cyclophosphamide and TBI as conditioning for allogeneic matched sibling bone marrow transplants for acute myeloblastic leukaemia in first remission"
"0020957909","","","2-s2.0-0020957909","1983-12-01","Bone marrow transplantation for severe aplastic anemia in HLA identical siblings using total lymphoid irradiation (TLI) and cyclophosphamide"
"0024346797","2584703","","2-s2.0-0024346797","1989-01-01","Effects of T cell depletion in radiation bone marrow chimeras. III. Characterization of allogeneic bone marrow cell populations that increase allogeneic chimerism independently of graft-vs-host disease in mixed marrow recipients"
"0027534273","8093295","10.1016/0140-6736(93)92526-Y","2-s2.0-0027534273","1993-01-02","Long-term follow-up of T-cell depletion for bone marrow transplantation"
"0021027390","6231046","10.1111/j.1365-2141.1983.00573.x","2-s2.0-0021027390","1983-01-01","Factors associated with graft rejection after HLA‐identical marrow transplantation for aplastic anaemia"
"0028085001","8199566","","2-s2.0-0028085001","1994-01-01","Graft rejection and second bone marrow transplants for acquired aplastic anaemia: A report from the aplastic anaemia working party of the European bone marrow transplant group"
"0026539577","1547350","","2-s2.0-0026539577","1992-01-01","Influence of cell dose and graft-versus-host reactivity on rejection rates after allogeneic bone marrow transplantation"
"0345341393","","","2-s2.0-0345341393","1986-01-23","Bone marrow transplantation in beta thalassemia major using T cell depleted HLA identical bone marrow allografts"
"0023719305","3056552","","2-s2.0-0023719305","1988-01-01","Graft failure in patients receiving T cell-depleted HLA-identical allogeneic marrow transplants"
"0029745548","8704255","","2-s2.0-0029745548","1996-08-01","Prevention of allogeneic marrow graft rejection by donor T cells that do not recognize recipient alloantigens: Potential role of a veto mechanism"
"0030325771","9286578","","2-s2.0-0030325771","1996-12-01","Allogeneic cell-mediated immunotherapy using donor lymphocytes for prevention of relapse in patients treated with allogeneic bone marrow transplantation for hematological malignancies."
"0344047582","","","2-s2.0-0344047582","1984-11-15","Graft failure following bone marrow transplantation. Its biology and treatment"
"0020061303","6123018","10.1016/S0140-6736(82)92840-9","2-s2.0-0020061303","1982-06-05","PRETREATMENT OF DONOR BONE MARROW WITH MONOCLONAL ANTIBODY OKT3 FOR PREVENTION OF ACUTE GRAFT-VERSUS-HOST DISEASE IN ALLOGENEIC HISTOCOMPATIBLE BONE-MARROW TRANSPLANTATION"
"0024337547","2665858","","2-s2.0-0024337547","1989-01-01","Marrow transplantation for acute lymphoblastic leukemia: Factors affecting relapse and survival"
"0017358359","136605","","2-s2.0-0017358359","1977-01-01","Marrow transplantation for treatment of aplastic anemia: an analysis of factors associated with graft rejection"
"13344291253","","","2-s2.0-13344291253","1989-02-22","A new method for prevention of graft vs host disease (GVHD)"
"0344903573","","","2-s2.0-0344903573","1988-07-13","The repopulating capacity of bone marrow grafts following pretreatment with monoclonal antibodies against T lymphocytes in Rhesus monkeys"
"0025817169","1873591","","2-s2.0-0025817169","1991-01-01","Bone marrow transplantation from related donors other than HLA-identical siblings: Effect of T cell depletion"
"0012934172","","","2-s2.0-0012934172","1993-07-13","Allogeneic BMT for leukemia using Campath-1 monoclonal antibodies &amp; post transplant alloimmunization with donor lymphocytes"
"0025373261","2191295","10.1073/pnas.87.12.4595","2-s2.0-0025373261","1990-07-17","Enhancement of bone marrow allografts from nude mice into mismatched recipients by T cells void of graft-versus-host activity"
"0344903576","","","2-s2.0-0344903576","1984-07-14","Immunosuppression and induction of transplantation tolerance by fractionated total lymphoid irradiation"
"0025264240","2329274","","2-s2.0-0025264240","1990-05-01","An absence of T cells in murine bone marrow allografts leads to an increased susceptibility to rejection by natural killer cells and T cells"
"0023786710","3049804","","2-s2.0-0023786710","1988-01-01","Effects of T cell depletion in radiation bone marrow chimeras: I. Evidence for a donor cell population which increases allogeneic chimerism but which lacks the potential to produce GVHD"
"0028058002","8311172","","2-s2.0-0028058002","1994-01-01","Marrow transplant experience for children with severe aplastic anemia"
"0026559503","1558962","","2-s2.0-0026559503","1992-01-01","Determinants of engraftment after allogeneic marrow transplantation"
"0023709308","3052626","","2-s2.0-0023709308","1988-01-01","Fractionated total body irradiation and high-dose VP 16-213 followed by allogeneic bone marrow transplantation in advanced leukemias"
"0023186993","3585867","10.1016/0165-0378(87)90089-1","2-s2.0-0023186993","1987-01-01","Monoclonal antibodies to human trophoblast and sperm antigens: Report of two WHO-sponsored workshops, June 30, 1986-Toronto, Canada"
"0005513531","","","2-s2.0-0005513531","1998-07-13","Specific localization in the equatorial region of gp20, a 20 kDa sialoglycoprotein of the capacitated human spermatozoon acquired during epididymal transit which is neccessary to penetrate zona-free hamster eggs"
"0001888740","","","2-s2.0-0001888740","1995-07-13","Carbohydrate antigens recognized by anti-sperm antibodies"
"0029747284","8828507","10.1210/en.137.10.4451","2-s2.0-0029747284","1996-10-07","Body temperature (37 C) specifically down-regulates the messenger ribonucleic acid for the major sperm surface antigen CD52 in epididymal cell culture"
"0023752770","3294333","","2-s2.0-0023752770","1988-01-01","Human sperm carbohydrate antigens defined by an antisperm human monoclonal antibody derived from an infertile woman bearing antisperm antibodies in her serum"
"0021910077","3881852","","2-s2.0-0021910077","1985-03-27","Removal of marrow T cells with OKT3-OKT11 monoclonal antibodies and complement to prevent acute graft-versus-host disease. A pilot study in ten patients"
"0029068065","7756664","","2-s2.0-0029068065","1995-01-01","Delayed infusion of immunocompetent donor cells after bone marrow transplantation breaks graft-host tolerance and allows for persistent antileukemic reactivity without severe graft-versus-host disease"
"0025963233","1994250","","2-s2.0-0025963233","1991-03-07","Graft-versus-host disease"
"0022495149","3516253","","2-s2.0-0022495149","1986-08-13","Depletion of donor lymphocytes by counterflow centrifugation successfully prevents acute graft-versus-host disease in matched allogeneic marrow transplantation"
"0029923272","8607177","10.1097/00007890-199603150-00012","2-s2.0-0029923272","1996-03-15","Combined in vitro and in vivo T lymphocyte depletion for the control of graft-versus-host disease following haploidentical marrow transplant"
"0024592842","2644980","","2-s2.0-0024592842","1989-01-01","Graft failure following bone marrow transplantation for severe aplastic anemia: Risk factors and treatment results"
"0027525864","8427991","","2-s2.0-0027525864","1993-02-15","Methotrexate, cyclosporine, or both to prevent graft-versus-host disease after HLA-identical sibling bone marrow transplants for early leukemia?"
"0027027746","1306726","","2-s2.0-0027027746","1992-12-01","Current status of unrelated-donor bone marrow transplantation. The International Marrow Unrelated Search and Transplant (IMUST) Study."
"0024038766","3076387","10.1007/BF00353826","2-s2.0-0024038766","1988-07-01","Selective depletion of marrow-T cytotoxic lymphocytes (CD8) in the prevention of graft-versus-host disease after allogeneic bone-marrow transplantation"
"0028875607","7579369","","2-s2.0-0028875607","1995-01-01","Late infections after allogeneic bone marrow transplantation: Comparison of incidence in related and unrelated donor transplant recipients"
"0023117823","3546617","","2-s2.0-0023117823","1987-09-11","Prevention of graft-versus-host disease in HLA-matched bone marrow transplantation for malignant diseases: A multicentric study of 62 patients using 3-pan-T monoclonal antibodies and rabbit complement"
"0027212680","8324231","","2-s2.0-0027212680","1993-07-01","Extended-cycle elutriation to adjust t-cell content in HLA-disparate bone marrow transplantation"
"0028006820","7919363","","2-s2.0-0028006820","1994-10-15","Phenotypic characterization of a novel bone marrow-derived cell that facilitates engraftment of allogeneic bone marrow stem cells"
"0029058771","7606012","","2-s2.0-0029058771","1995-01-01","Acute graft-versus-host disease: Grade and outcome in patients with chronic myelogenous leukemia"
"0028114646","7940731","","2-s2.0-0028114646","1994-10-27","Long-term follow-up of a randomized trial comparing T cell depletion with a combination of methotrexate and cyclosporine in adult leukemic marrow transplant recipients"
"0023182192","3304240","","2-s2.0-0023182192","1987-01-01","A comparative study of T-cell depleted and non-depleted marrow transplantation for hematological malignancy"
"0026661429","1615341","","2-s2.0-0026661429","1992-01-01","T-cell depletion and allogeneic bone marrow transplantation"
"0025127674","1698319","","2-s2.0-0025127674","1990-01-01","T cell depletion with anti-cd5 immunotoxin in histocompatible bone marrow transplantation: The correlation between residual CD5 negative T cells and subsequent graft-versus-host disease"
"0003572485","","","2-s2.0-0003572485","1993-07-13",""
"0026773113","1607923","","2-s2.0-0026773113","1992-12-01","Prevention of graft-versus-host disease by selective depletion of CD6-positive T Lymphocytes from Donor Bone Marrow"
"0025357732","2193019","","2-s2.0-0025357732","1990-01-01","T-cell depletion to prevent graft-versus-host disease after bone marrow transplantation"
"9244225193","8611446","10.1046/j.1365-2141.1996.4831024.x","2-s2.0-9244225193","1996-05-02","A phase II trial of partially incompatible bone marrow transplantation for high-risk acute lymphoblastic leukaemia in children: Prevention of graft rejection with anti-LFA-1 and anti-CD2 antibodies"
"0030965273","9160695","","2-s2.0-0030965273","1997-05-15","Use of partially mismatched related donors extends access to allogeneic marrow transplant"
"0002340968","","","2-s2.0-0002340968","1992-07-13","The role of registries in evaluating the results of bone marrow transplantation"
"0025214590","2310834","","2-s2.0-0025214590","1990-01-01","Bone marrow graft engineering by counterflow centrifugal elutriation: Results of a phase I-II clinical trial"
"0022990899","3332118","","2-s2.0-0022990899","1986-12-01","Allogeneic bone marrow transplantation for adult leukaemia with soy bean lectin fractionated marrow"
"0028179358","8142664","","2-s2.0-0028179358","1994-04-01","Effect of T-cell depletion as graft-versus-host disease prophylaxis on engraftment, relapse, and disease-free survival in unrelated marrow transplantation for chronic myelogenous leukemia"
"0003440032","","","2-s2.0-0003440032","1997-07-13",""
"0028929673","7773217","","2-s2.0-0028929673","1995-01-01","Selective T cell depletion with CD8-conjugated magnetic beads in the prevention of graft-versus-host disease after allogeneic bone marrow transplantation"
"0026621345","1438435","","2-s2.0-0026621345","1992-01-01","Selective depletion of CD8-positive T-lymphocytes for allogeneic bone marrow transplantation: engraftment, graft-versus-host disease and graft-versus leukemia."
"8944251129","8807094","","2-s2.0-8944251129","1996-06-01","Allogeneic bone marrow transplantation with T cell-depleted partially matched related donors for advanced acute lymphoblastic leukemia in children and adults: A comparative matched cohort study"
"0030040277","8552677","10.1073/pnas.93.1.7","2-s2.0-0030040277","1996-01-09","Interactions of protein antigens with antibodies"
"0030701632","9354468","","2-s2.0-0030701632","1997-10-01","X-ray crystal structure of HLA-DR4 (DRA*0101, DRB1*0401) complexed with a peptide from human collagen II"
"0345604397","","","2-s2.0-0345604397","1999-07-13","Anti-globulin responses to rat and humanised CAMPATH-1 monoclonal antibodies"
"0028014642","8302837","","2-s2.0-0028014642","1994-02-01","Bound water molecules and conformational stabilization help mediate an antigen-antibody association"
"0032488808","9480775","10.1006/jmbi.1997.1512","2-s2.0-0032488808","1998-02-06","The mechanism of an inhibitory antibody on TF-initiated blood coagulation revealed by the crystal structures of human tissue factor, Fab 5G9 and TF·5G9 complex"
"0030924992","","10.1107/S0907444996012255","2-s2.0-0030924992","1997-01-01","Refinement of macromolecular structures by the maximum-likelihood method"
"0023053742","3097327","10.1016/0022-2836(86)90245-7","2-s2.0-0023053742","1986-08-20","Phosphocholine binding immunoglobulin Fab McPC603. An X-ray diffraction study at 2.7 Å"
"0030580057","8876650","10.1006/jmbi.1996.0548","2-s2.0-0030580057","1996-10-11","Antibody-antigen interactions: Contact analysis and binding site topography"
"0028289241","8114766","10.1016/0161-5890(94)90001-9","2-s2.0-0028289241","1994-01-01","Anatomy of the antibody molecule"
"0028805536","7482746","","2-s2.0-0028805536","1995-10-27","The effect of aglycosylation on the immunogenicity of a humanized therapeutic cd3 monoclonal antibody"
"0345604402","","","2-s2.0-0345604402","1977-07-13","An extensively modified version of MolScript that includes greatly enhanced coloring capabilities"
"0027609916","8347566","10.1016/0263-7855(93)87009-T","2-s2.0-0027609916","1993-01-01","SETOR: Hardware-lighted three-dimensional solid model representations of macromolecules"
"0003439405","","","2-s2.0-0003439405","1992-02-21","Recent changes to the MOSFLM package for processing film and image plate data"
"0004314547","","","2-s2.0-0004314547","1993-07-13",""
"0021249926","6705937","","2-s2.0-0021249926","1984-01-01","Conditions influencing human sperm capacitation and penetration of zona-free hamster ova"
"0019887744","6257680","","2-s2.0-0019887744","1981-02-25","Phase separation of integral membrane proteins in Triton X-114 solution."
"0342276080","9127650","","2-s2.0-0342276080","1997-04-17","Occurrence of the interference of sperm-associated antibodies on sperm fertilizing ability as evaluated by the sperm-zona pellucida binding test and by the TEST-yolk buffer enhanced sperm penetration assay"
"0028899925","7720919","","2-s2.0-0028899925","1995-01-01","Analysis of TEST (TES and Tris) yolk buffer effects on human sperm"
"0029834994","8671487","","2-s2.0-0029834994","1996-07-01","Consensus workshop on advanced diagnostic andrology techniques"
"0022993705","","10.1002/mrd.1120150303","2-s2.0-0022993705","1986-01-01","Two simple methods for detecting acrosome‐reacted human sperm"
"0018969063","6968234","","2-s2.0-0018969063","1980-12-15","The fractionation, characterization, and subcellular localization of colony-stimulating activities released by the human monocyte-like cell line, GCT"
"0017694555","301143","10.1002/jcp.1040910303","2-s2.0-0017694555","1977-01-01","Conditions controlling the proliferation of haemopoietic stem cells in vitro"
"0020639615","6307430","","2-s2.0-0020639615","1983-01-01","Enzymatic treatment of long-term human marrow cultures reveals the preferential location of primitive hemopoietic progenitors in the adherent layer"
"0005414111","","","2-s2.0-0005414111","1985-07-12","The human hematopoietic microenvironment"
"0019206750","7230868","10.1016/0145-2126(80)90027-2","2-s2.0-0019206750","1980-01-01","The development of a liquid culture system for the growth of human bone marrow"
"0021274170","6373337","","2-s2.0-0021274170","1984-01-01","Survival of granulocytic progenitors in the nonadherent and adherent compartments of human long-term marrow cultures"
"0019051838","6933522","","2-s2.0-0019051838","1980-08-01","Long-term culture of human bone marrow cells."
"84935155009","","","2-s2.0-84935155009","0000-07-12",""
"0018486834","385205","","2-s2.0-0018486834","1979-06-01","The haemopoietic microenvironment."
"0018881146","6965596","","2-s2.0-0018881146","1980-05-30","Continuous human bone marrow culture: Ia antigen characterization of probable pluripotential stem cells"
"0002892854","","","2-s2.0-0002892854","1984-04-14","Long-term marrow culture: An overview of techniques and experience"
"0023899824","3281859","10.1111/j.1600-0609.1988.tb00830.x","2-s2.0-0023899824","1988-01-01","Role of pokeweed mitogen spleen conditioned medium in regulating haematopoiesis in long‐term human marrow cultures"
"0023640184","3621456","10.1007/BF00252951","2-s2.0-0023640184","1987-08-01","Comparative in vitro toxicity of mitoxanatrone and adriamycin in human granulocyte-macrophage progenitor cells"
"0018899281","7388176","","2-s2.0-0018899281","1980-01-01","Long-term human bone marrow cultures"
"0023907380","3338511","","2-s2.0-0023907380","1988-01-01","Kinetics of myeloid progenitor cells in human micro long-term bone marrow cultures"
"0024150273","3251634","","2-s2.0-0024150273","1988-12-01","Haemopoietic inductive capacity of irradiated stromal cell layers in human micro long-term bone marrow cultures"
"0023627351","3595769","","2-s2.0-0023627351","1987-12-01","Use of long-term human marrow cultures to demonstrate progenitor cell precursors in marrow treated with 4-hydroperoxycyclophosphamide"
"0019389821","6976897","","2-s2.0-0019389821","1981-01-01","Conditions of adherent cell growth from murine bone marrow in liquid cultures, and partial characterization of function"
"84935104488","","","2-s2.0-84935104488","1984-07-12","Recent modification of technique in human long-term bone marrow cultures"
"0023221299","3509714","","2-s2.0-0023221299","1987-07-14","T-cell depletion does not affect long-term human bone marrow culture"
"0019413605","6972777","10.1111/j.1365-2141.1981.tb02698.x","2-s2.0-0019413605","1981-01-01","A T‐LYMPHOCYTE ROLE IN DEXTER‐TYPE MARROW CULTURES"
"4243292386","","","2-s2.0-4243292386","1999-09-27","β-Thalassemia major corrected by marrow allografts and Campath-1H: Long-term follow-up"
"0032938255","10319388","","2-s2.0-0032938255","1999-01-01","Indolent nonfollicular lymphomas: Characteristics, treatment, and outcome"
"4243307454","","","2-s2.0-4243307454","1998-09-27","Treatment of acute leukemia (ALL) with Campath-1H: Initial observations"
"25344453472","","","2-s2.0-25344453472","1999-10-07","Campath-1H induces apoptosis in human chronic lymphocytic leukemia cells (CLL) in vitro independent of complement mediated lysis or Fcy-receptor ligation"
"4243535584","","","2-s2.0-4243535584","1998-09-27","Campath-1H monoclonal antibody in therapy for advanced low-grade non-Hodgkin's lymphomas: A phase II study"
"0030024595","8655683","","2-s2.0-0030024595","1996-02-21","Expression of TIA-1 and TIA-2 in t cell malignancies and T cell lymphocytosis"
"0026319101","1857968","","2-s2.0-0026319101","1991-07-19","Deleted HTLV-I provirus in blood and cutaneous lesions of patients with mycosis fungoides"
"0028276033","7918072","","2-s2.0-0028276033","1994-01-01","Trisomy 8q due to i(8q) or der(8) t(8;8) is a frequent lesion in T- prolymphocytic leukaemia: Four new cases and a review of the literature"
"0025788779","1881904","","2-s2.0-0025788779","1991-12-01","Detection of human T-lymphotropic virus-like particles in cultures of peripheral blood lymphocytes from patients with mycosis fungoides"
"0028323486","8152252","","2-s2.0-0028323486","1994-04-01","A gene on chromosome Xq28 associated with T-cell prolymphocytic leukemia in two patients with ataxia telangiectasia"
"0026355129","1654197","10.1002/1097-0142(19911001)68:7&lt;1572::AID-CNCR2820680719&gt;3.0.CO;2-1","2-s2.0-0026355129","1991-01-01","Analysis of β, γ, and δ T‐Cell receptor genes in mycosis fungoides and sezary syndrome"
"0025237556","2366582","","2-s2.0-0025237556","1990-04-01","Sezary cell-like leukemia: A distinct type of mature T cell malignancy"
"0025871804","1918492","","2-s2.0-0025871804","1991-01-01","Central nervous system involvement by cutaneous T cell lymphoma"
"0025891322","","10.3109/10428199109068049","2-s2.0-0025891322","1991-01-01","Mature t-cell leukemias and leukemia/lymphoma syndromes: Review of our experience in 175 cases"
"0029082620","7661601","10.1001/archderm.1995.01690210033005","2-s2.0-0029082620","1995-01-01","Prognostic Factors in Erythrodermic Mycosis Fungoides and the Sézary Syndrome"
"0015875008","4268230","10.1093/jnci/50.5.1145","2-s2.0-0015875008","1973-01-01","Cytogenetic, cytophotometric, and ultrastructural study of large cerebri- form cells of the sezary syndrome and description of a small-cell variant"
"0028587370","7809072","10.1073/pnas.91.26.12530","2-s2.0-0028587370","1994-12-20","Identification of the TCL1 gene involved in T-cell malignancies"
"34547387852","","","2-s2.0-34547387852","2007-08-05",""
"34547388515","","","2-s2.0-34547388515","1997-08-05","Successful treatment of T-cell prolymphocytic leukaemia with human CDw52 antibody, CAMPATH-1H"
"0028941237","7888364","10.1111/j.1365-2133.1995.tb05023.x","2-s2.0-0028941237","1995-01-01","Cutaneous infiltration in T‐cell prolymphocytic leukaemia"
"0019802745","6275274","10.1038/294770a0","2-s2.0-0019802745","1981-12-01","Type C virus particles in a cord T-cell line derived by co-cultivating normal human cord leukocytes and human leukaemic T cells"
"0028022980","8068941","","2-s2.0-0028022980","1994-09-01","Appearance of a megakaryocyte growth-promoting activity, megapoietin, during acute thrombocytopenia in the rabbit"
"0030221693","8913316","10.1016/0145-2126(96)00025-2","2-s2.0-0030221693","1996-08-01","Granulocyte-macrophage colony-stimulating factor dependent monocyte-mediated cytotoxicity post-autologous bone marrow transplantation"
"1842411208","","","2-s2.0-1842411208","1995-07-13","Post-irradiated canine serum (PICS-J) stimulates in vitro megakaryocyte (MK) progenitors and thrombopoiesis in humans"
"0024449946","2669995","","2-s2.0-0024449946","1989-01-01","Regulation of megakaryocytopoiesis"
"0024329022","2471777","","2-s2.0-0024329022","1989-01-01","Identity of Leu-19 (CD56) leukocyte differentiation antigen and neural cell adhesion molecule"
"0022646810","3944457","","2-s2.0-0022646810","1986-05-14","Modulation of in vitro myelopoiesis by LGL: Different effects on early and late progenitor cells"
"1842412384","","","2-s2.0-1842412384","2004-07-13","Stem cell factor synergizes with thrombopoietin in stimulating megakaryocytopoiesis"
"0024549531","2644984","","2-s2.0-0024549531","1989-01-01","Interacting cytokines regulate in vitro human megakaryocytopoiesis"
"0020019952","6950946","","2-s2.0-0020019952","1982-01-01","Molecules stimulating early red cell, granulocyte, macrophage, and megakaryocyte precursors in culture: Similarity in size, hydrophobicity, and charge"
"0023029215","3489766","","2-s2.0-0023029215","1986-12-01","The influence of T lymphocyte subsets and humoral factors on colony formation by human bone marrow and blood megakaryocyte progenitor cells in vitro"
"0025914789","1676038","","2-s2.0-0025914789","1991-01-01","Production of granulocyte/macrophage-colony-stimulating factor by human natural killer cells: Modulation by the p75 subunit of the interleukin 2 receptor and by the CD2 receptor"
"0023635177","3117880","","2-s2.0-0023635177","1987-12-01","Role of natural killer cells, in comparison with T lymphocytes and monocytes, in the regulation of normal human megakaryocytopoiesis in vitro"
"0023924966","2833331","","2-s2.0-0023924966","1988-01-01","Selective generation of erythroid burst-promoting activity by recombinant interleukin 2-stimulated human T lymphocytes and natural killer cells"
"0023637080","3315723","","2-s2.0-0023637080","1987-12-01","Modest stimulatory effect of recombinant human GM-CSF on colony growth from peripheral blood human megakaryocyte progenitor cells"
"0026071842","1825480","","2-s2.0-0026071842","1991-01-01","Phenotypic analysis of a resting subpopulation of human peripheral blood NK cells: The FcRγIII (CD16) molecule and NK cell differentiation"
"0026520749","1372642","","2-s2.0-0026520749","1992-01-01","Ontogeny of human natural killer (NK) cells: Fetal NK cells mediate cytolytic function and express cytoplasmic CD3ε,δ proteins"
"0022410270","3877646","","2-s2.0-0022410270","1985-12-01","Human megakaryocyte colony-stimulating factor in sera from aplastic dogs: Partial purification, characterization, and determination of hematopoietic cell lineage specificity"
"0024197352","3265584","","2-s2.0-0024197352","1988-12-01","Exogenous and endogenous regulations of human megakaryocytopoiesis."
"0029815924","8869937","10.1007/BF02988839","2-s2.0-0029815924","1996-03-01","Stem cell factor (SCF) synergizes with megakaryocyte colony stimulating activity in post-irradiated aplastic plasma in stimulating human megakaryocytopoiesis"
"0022532737","3083894","","2-s2.0-0022532737","1986-01-01","Interleukin 3 promotes the differentiation of isolated single megakaryocytes"
"0021969904","3855363","","2-s2.0-0021969904","1985-04-04","Large granular lymphocytes have a promoting activity on human peripheral blood erythroid burst-forming units"
"0026505382","1577092","","2-s2.0-0026505382","1992-01-01","Interleukin 3 directly stimulates both megakaryocyte progenitor cells and immature megakaryocytes"
"0021037706","6195261","","2-s2.0-0021037706","1983-12-01","Capacity of human large granular lymphocytes (LGL) to produce multiple lymphokines: Interleukin 2, interferon, and colony stimulating factor"
"0023199606","3496235","","2-s2.0-0023199606","1987-01-01","Human T-lymphocyte-derived megakaryocyte colony-stimulating acitivity"
"0027435048","8400305","","2-s2.0-0027435048","1993-10-15","Activated natural killer cells and interleukin-2 promote granulocytic and megakaryocytic reconstitution after syngeneic bone marrow transplantation in mice"
"0025339099","2140585","10.1002/stem.5530080304","2-s2.0-0025339099","1990-01-01","Bone marrow cell modulation and inhibition of myelopoiesis by large granular lymphocytes and natural killer cells"
"0022383111","3878721","10.1111/j.1365-2141.1985.tb02877.x","2-s2.0-0022383111","1985-01-01","Inhibitory effect of PWM‐stimulated OKT4+ subsets on erythro‐, granulo‐ and megakaryocytopoiesis in vitro"
"0028302409","8202154","","2-s2.0-0028302409","1994-12-01","Stimulation of megakaryocytopoiesis and thrombopoiesis by the c-Mpl ligand"
"0021327809","6690455","10.1002/jcp.1041180115","2-s2.0-0021327809","1984-01-01","Human megakaryocytic progenitors (CFU‐M) assayed in methylcellulose: Physical characteristics and requirements for growth"
"1842327911","","","2-s2.0-1842327911","1986-07-13","Human megakaryocytic colony formation is supported by lymphokines from isolated T lymphocyte subpopulations"
"0027520550","8111309","10.1002/stem.5530110619","2-s2.0-0027520550","1993-01-01","Regulation of megakaryocytopoiesis"
"0026748342","1627792","","2-s2.0-0026748342","1992-07-31","Growth factors affecting human thrombocytopoiesis: Potential agents for the treatment of thrombocytopenia"
"0021999178","3873957","10.1111/j.1365-2141.1985.tb07408.x","2-s2.0-0021999178","1985-01-01","A regulatory role of activated T‐lymphocytes on human megakaryocytopoiesis in vitro"
"0028199208","8202158","","2-s2.0-0028199208","1994-12-01","Cloning and expression of murine thrombopoietin cDNA and stimulation of platelet production in vivo"
"0024429330","2806434","","2-s2.0-0024429330","1989-01-01","Differential effect of natural killer cells on modulating CFU-Meg and BFU-E proliferation in situ"
"0023118107","3098321","","2-s2.0-0023118107","1987-01-01","In vitro regulation of human hematopoiesis by natural killer cells: Analysis at a clonal level"
"0019381343","7004535","","2-s2.0-0019381343","1981-04-13","Immunofluorescent identification of human megakaryocyte colonies using an antiplatelet glycoprotein antiserum"
"0025102658","2198960","","2-s2.0-0025102658","1990-08-01","Cytokine regulation of the human burst-forming unit-megakaryocyte"
"0028964228","7833281","10.1111/j.1365-2141.1995.tb08917.x","2-s2.0-0028964228","1995-01-01","The response of cord blood megakaryocyte progenitors to IL‐3, IL‐6 and aplastic canine serum varies with gestational age"
"0024571279","2521357","","2-s2.0-0024571279","1989-01-01","Production of hematopoietic colony-stimulating factors by human natural killer cells"
"0022296110","3934320","","2-s2.0-0022296110","1985-12-01","Immune regulation of in vitro murine megakaryocyte development. Role of T lymphocytes and Ia antigen expression"
"0033016915","10403909","","2-s2.0-0033016915","1999-07-05","Reduced IL-4 and interferon-gamma (IFN-γ) expression by CD4 T cells in patients with chronic lymphocytic leukaemia"
"0027424130","7691258","","2-s2.0-0027424130","1993-01-01","Excessive production of transforming growth factor-β by bone marrow stromal cells in B-cell chronic lymphocytic leukemia inhibits growth of hematopoietic precursors and interleukin-6 production"
"0031810809","9504629","10.1046/j.1365-2141.1998.00595.x","2-s2.0-0031810809","1998-06-23","Diminished production of interleukin-6 in chronic lymphocytic leukaemia (B-CLL) cells from patients at advanced stages of disease"
"0032794311","10436296","10.1159/000040948","2-s2.0-0032794311","1999-08-04","High incidence of transiently appearing complement-sensitive bone marrow precursor cells in patients with severe aplastic anemia - A possible role of high endogenous IL-2 in their suppression"
"0345291103","","","2-s2.0-0345291103","2005-08-24","Peripheral blood progenitor cell transplantation (PBSC-T) for the treatment of multiple sclerosis"
"0029002881","7612408","","2-s2.0-0029002881","1995-05-24","Immunosuppressive treatment of the pulmonary manifestations of progressive systemic sclerosis"
"0030756032","9251643","10.1016/S0140-6736(05)63388-0","2-s2.0-0030756032","1997-09-02","Autologous bone-marrow transplantation for rheumatoid arthritis [4]"
"0030255701","8984947","","2-s2.0-0030255701","1996-10-01","Autologous haemopoietic stem cell transplantation in a patient with severe pulmonary hypertension complicating connective tissue disease."
"0004137087","","","2-s2.0-0004137087","1962-03-28",""
"0030841034","9133976","","2-s2.0-0030841034","1997-03-01","Blood and marrow stem cell transplants in autoimmune disease. A consensus report written on behalf of the European League Against Rheumatism (EULAR) and the European Group for Blood and Marrow Transplantation (EBMT)"
"0029618371","8835255","","2-s2.0-0029618371","1995-12-01","Validation of the Italian version of the Stanford Childhood Health Assessment Questionnaire for measuring functional status in children with chronic arthritis"
"0030906986","9150125","","2-s2.0-0030906986","1997-01-01","Choosing appropriate patients with systemic sclerosis for treatment by autologous stem cell transplantation"
"0030667512","9411254","10.1056/NEJM199712113372416","2-s2.0-0030667512","1997-12-29","Hematopoietic stem-cell transplantation for systemic lupus erythematosus [3]"
"0000615973","","","2-s2.0-0000615973","1997-10-31","Scleroderma"
"0031028705","9053472","","2-s2.0-0031028705","1997-02-01","Peripheral-blood stem-cell transplantation versus autologous bone marrow transplantation in Hodgkin's and non-Hodgkin's lymphomas: A new matched-pair analysis of the European Group for Blood and Marrow Transplantation Registry data"
"0030749295","9208120","","2-s2.0-0030749295","1997-06-02","Prolonged remission of longstanding systemic lupus erythematosus after autologous bone marrow transplant for non-Hodgkin's lymphoma"
"0030979803","9192793","","2-s2.0-0030979803","1997-07-02","Blast crisis of chronic myelogenous leukemia in long-lasting systemic lupus erythematosus: Regression of both diseases after autologous bone marrow transplantation [1]"
"0024405579","2655606","10.1002/anr.1780320512","2-s2.0-0024405579","1989-01-01","Immunosuppression with chlorambucil, versus placebo, for scleroderma. Results of a three‐year, parallel, randomized, double‐blind study"
"0030828395","9256315","","2-s2.0-0030828395","1997-09-15","Autologous marrow stem cell transplantation for severe systemic lupus erythematosus of long duration"
"0025346261","1970938","","2-s2.0-0025346261","1990-01-01","Reconstitution of T-cell function after CD6-depleted allogeneic bone marrow transplantation"
"0027227876","8400242","","2-s2.0-0027227876","1993-01-01","Mixed T-lymphoid chimerism after allogeneic bone marrow transplantation for hematologic malignancies of children is not correlated with relapse"
"0027528349","8380510","","2-s2.0-0027528349","1993-01-01","Long-term persistence of transferred PPD-Reactive T cells after allogeneic bone marrow transplantation"
"0024321579","2526194","","2-s2.0-0024321579","1989-01-01","Triggering T cells by otherwise inert hybrid anti-CD3/antitumor antibodies requires encounter with the specific target cell"
"0020629371","6605376","","2-s2.0-0020629371","1983-01-01","Population dynamics of T lymphocytes. Renewal rate and expansion in the peripheral lymphoid organs"
"0028038290","8082308","","2-s2.0-0028038290","1994-01-01","Expression of p75 chain of IL-2 receptor in the early immunological reconstitution after allogeneic bone marrow transplantation"
"0026520570","1533591","10.1002/eji.1830220522","2-s2.0-0026520570","1992-01-01","An experimentally validated panel of subfamily‐specific oligonucleotide primers (Vα1‐w29/Vβ1‐w24) for the study of human T cell receptor variable V gene segment usage by polymerase chain reaction"
"0026094299","1834764","","2-s2.0-0026094299","1991-11-01","T cell memory is short-lived in the absence of antigen"
"0021246585","6143870","10.1016/S0140-6736(84)92391-2","2-s2.0-0021246585","1984-04-28","IS CYTOMEGALOVIRUS INFECTION A MAJOR CAUSE OF T CELL ALTERATIONS AFTER (AUTOLOGOUS) BONE-MARROW TRANSPLANTATION?"
"0025314873","2194591","","2-s2.0-0025314873","1990-07-01","T-cell-depleted autologous bone marrow transplantation therapy: Analysis of immune deficiency and late complications"
"0027402403","8442858","","2-s2.0-0027402403","1993-12-01","Lymphocyte lifespans: Homeostasis, selection and competition"
"0023551293","3311209","","2-s2.0-0023551293","1987-12-01","Mixed blood chimerism in T cell-depleted bone marrow transplant recipients: Evaluation using DNA polymorphisms"
"0028026574","7518837","","2-s2.0-0028026574","1994-08-01","Prolonged impairment of very late activating antigen-mediated T cell proliferation via the CD3 pathway after T cell-depleted allogeneic bone marrow transplantation"
"0026021278","1646664","","2-s2.0-0026021278","1991-01-01","Response to immunization against polio after allogeneic marrow transplantation"
"0024658409","2485841","10.3109/08830188909044780","2-s2.0-0024658409","1989-01-01","Veto function in vitro and in vivo"
"0026690677","1586724","","2-s2.0-0026690677","1992-01-01","Evolution of mixed chimerism after allogeneic bone marrow transplantation as determined on granulocytes and mononuclear cells by the polymerase chain reaction"
"0025602793","2148123","10.1016/0092-8674(90)90420-J","2-s2.0-0025602793","1990-12-21","Extrathymic tolerance of mature T cells: Clonal elimination as a consequence of immunity"
"0028077260","7949111","","2-s2.0-0028077260","1994-11-15","Highly Sensitive Polymerase Chain Reaction Methods Show the Frequent Survival of Residual Recipient Multipotent Progenitors after Non-T-Cell-Depleted Bone Marrow Transplantation"
"0027389327","8417794","","2-s2.0-0027389327","1993-01-01","Characterization of mixed chimerism in patients with chronic myeloid leukemia transplanted with T-cell-depleted bone marrow: Involvement of different hematologic lineages before and after relapse"
"0027158798","8469287","","2-s2.0-0027158798","1993-12-01","Virus persistence in acutely infected immunocompetent mice by exhaustion of antiviral cytotoxic effector T cells"
"0028935640","7599572","","2-s2.0-0028935640","1995-04-24","Immunisations after bone marrow transplantation: Results of a European survey and recommendations from the infectious diseases working party of the European Group for Blood and Marrow Transplantation"
"8044230330","","","2-s2.0-8044230330","1986-11-22","In vivo 'purging' of residual disease in CLL with CAMPATH-1H"
"0029566878","8652233","10.1016/0959-8049(95)00368-1","2-s2.0-0029566878","1995-01-01","Key issues in the treatment of chronic lymphocytic leukaemia (CLL)"
"0025760992","10150913","10.1016/0955-3886(91)90127-O","2-s2.0-0025760992","1991-01-01","Continuous flow cell separator use for bone marrow processing"
"0024505140","2647174","","2-s2.0-0024505140","1989-01-01","Bone marrow transplantation for severe aplastic anaemia using cyclosporin: Long-term follow-up"
"0029059073","7780125","","2-s2.0-0029059073","1995-01-01","The treatment of severe acquired aplastic anemia"
"0025900920","2070065","","2-s2.0-0025900920","1991-07-15","Increased incidence of solid malignant tumors after bone marrow transplantation for severe aplastic anemia"
"0028848895","7803802","","2-s2.0-0028848895","1995-01-01","Long-term outcome of aplastic anemia in adults treated with antithymocyte globulin: Comparison with bone marrow transplantation"
"0020582050","6340576","","2-s2.0-0020582050","1983-06-02","Predictive factors in chronic graft-versus-host disease in patients with aplastic anemia treated by marrow transplantation from HLA-identical siblings"
"0024544680","2565730","10.1111/j.1365-2141.1989.tb06313.x","2-s2.0-0024544680","1989-01-01","Long‐term study of chimaerism in bone marrow transplantation recipients for severe aplastic anaemia"
"0028244305","7951104","","2-s2.0-0028244305","1994-01-01","Successful bone marrow transplant for Fanconi anaemia in transformation"
"0025985530","1932758","","2-s2.0-0025985530","1991-01-01","Bone marrow transplantation in 107 patients with severe aplastic anemia using cyclophosphamide and thoraco-abdominal irradiation for conditioning: Long-term follow-up"
"0025900903","2039832","","2-s2.0-0025900903","1991-06-01","Evaluation of mixed chimerism by in vitro amplification of dinucleotide repeat sequences using the polymerase chain reaction"
"4243062375","","","2-s2.0-4243062375","1994-09-06","Mixed chimerism may predict graft rejection in patients transplanted for severe aplastic anaemia"
"0026516811","1728315","","2-s2.0-0026516811","1992-12-01","Bone Marrow Transplantation for Severe Aplastic Anemia: Influence of Conditioning and Graft-Versus-Host Disease Prophylaxis Regimens on Outcome"
"4243073759","","","2-s2.0-4243073759","1995-09-06","Report of Campath users meeting"
"0023794546","3056497","","2-s2.0-0023794546","1988-01-01","Bone marrow transplantation (BMT) versus immunosuppression for the treatment of severe aplastic anaemia (SAA): A report of the EBMT SAA Working Party"
"0025173471","2223634","10.1111/j.1365-2141.1990.tb07850.x","2-s2.0-0025173471","1990-01-01","LONG‐TERM STABLE MIXED CHIMAERISM FOLLOWING ALLOGENEIC MARROW TRANSPLANTATION FOR SEVERE APLASTIC ANAEMIA"
"4243185532","","","2-s2.0-4243185532","1991-09-06","Bone marrow transplantation (BMT) using T cell depletion (TCD) vs no T cell depletion in patients with severe aplastic anaemia (SAA). 10 years experience"
"0023751474","2846032","","2-s2.0-0023751474","1988-01-01","Use of a hypervariable minisatellite DNA probe (33.15) for evaluating engraftment two or more years after bone marrow transplantation for aplastic anaemia"
"0028897137","7995374","","2-s2.0-0028897137","1995-01-01","A pathogenetic link between aplastic anemia and paroxysmal nocturnal hemoglobinuria is suggested by a high frequency of aplastic anemia patients with a deficiency of phosphatidylinositol glycan anchored proteins"
"0028884057","7579428","","2-s2.0-0028884057","1995-01-01","The molecular basis of paroxysmal nocturnal hemoglobinuria"
"0029887115","9372059","","2-s2.0-0029887115","1996-06-24","The dual pathogenesis of paroxysmal nocturnal hemoglobinuria"
"0028802443","7566002","10.1056/NEJM199511093331904","2-s2.0-0028802443","1995-01-01","Natural history of paroxysmal nocturnal hemoglobinuria"
"0024325872","2675316","","2-s2.0-0024325872","1989-01-01","Paroxysmal nocturnal hemoglobinuria"
"16044365965","8774569","10.1016/S0140-6736(95)12360-1","2-s2.0-16044365965","1996-08-31","Paroxysmal nocturnal haemoglobinuria: Long-term follow-up and prognostic factors"
"0005840397","","","2-s2.0-0005840397","1999-09-27","Rituxan induced apoptosis in DHL-4 cells: Effect of IL-4 and GMCSF"
"0343415665","10706880","","2-s2.0-0343415665","2000-03-15","A recombinant bispecific single-chain antibody, CD19 x CD3, induces rapid and high lymphoma-directed cytotoxicity by unstimulated T lymphocytes"
"4243861408","","","2-s2.0-4243861408","1999-10-12","Clinical phase I/II trial with a novel ricin A-chain immunotoxin (Ki-4.dgA) in patients with refractory CD30+ lymphoma"
"4243839220","","","2-s2.0-4243839220","1998-09-27","Response of post-autograft, relapsed primary (thymic) mediastinal B cell lymphoma to humanised anti-CD20 monoclonal antibody (rituximab)"
"4243861904","","","2-s2.0-4243861904","1999-12-31","Interferon-g induces CD20 expression on multiple myeloma cells via induction of Pu.1 and augments rituximab binding to myeloma cells"
"0033571548","10552943","","2-s2.0-0033571548","1999-11-15","Responses in refractory hairy cell leukemia to a recombinant immunotoxin"
"0001160175","9699662","","2-s2.0-0001160175","1998-08-01","In vitro and in vivo targeting of immunoliposomal doxorubicin to human B-cell lymphoma"
"0032857485","10514417","","2-s2.0-0032857485","1999-10-01","A murine xenograft model for human CD30+ anaplastic large cell lymphoma: Successful growth inhibition with an anti-CD30 antibody (HeFi-1)"
"4243870376","","","2-s2.0-4243870376","1999-09-27","Rituximab (MabThera) as single agent and in combination with interferon-α-2a as treatment of untreated and first relapse follicular or other low-grade lymphomas: Preliminary results of a randomized phase II study (M39035)"
"4243854115","","","2-s2.0-4243854115","1999-09-27","Preliminary report on biological effects of Rituxan and interleukin 2 (IL-2) in patients with low-grade or mantle cell non-Hodgkin's lymphoma (NHL)"
"0032880425","10480417","10.1097/00007890-199908270-00020","2-s2.0-0032880425","1999-08-27","HuM291, a humanized anti-CD3 antibody, is immunosuppressive to T cells while exhibiting reduced mitogenicity in vitro"
"0000934292","","","2-s2.0-0000934292","2000-07-13","Phase I/II trial of multiple dose 131iodine-MAb LL2 (CD22) in patients with recurrent non-Hodgkin's lymphoma"
"0003259282","","","2-s2.0-0003259282","1999-07-13","A pilot study of anti-CD20 MoAB rituximab in AIDS-associated non-Hodgkin's lymphoma"
"0032697611","10541348","","2-s2.0-0032697611","1999-10-01","Development of a hyperimmune anti-MUC-1 single chain antibody fragments phage display library for targeting breast cancer"
"0028837618","7585597","","2-s2.0-0028837618","1995-11-15","In Vivo Antitumor Effects of Unconjugated CD30 Monoclonal Antibodies on Human Anaplastic Large-Cell Lymphoma Xenografts"
"0026701921","1406835","","2-s2.0-0026701921","1992-11-05","Interferon alfa combined with cytotoxic chemotherapy for patients with non-Hodgkin's lymphoma"
"0001123178","","","2-s2.0-0001123178","1998-07-13","Phase I trial of recombinant humanized monoclonal anti-vascular endothelial growth factor (anti-VEGF MAB) in patients (pts) with metastatic cancer"
"0028049374","8302875","","2-s2.0-0028049374","1994-02-01","Humanization of murine monoclonal antibodies through variable domain resurfacing"
"0032755495","10630255","","2-s2.0-0032755495","1999-11-01","Karnofsky lecture: Immunotherapy of lymphoma"
"0026317443","1748994","10.1016/0022-2836(91)90498-U","2-s2.0-0026317443","1991-12-05","By-passing immunization. Human antibodies from V-gene libraries displayed on phage"
"4243249370","","","2-s2.0-4243249370","1999-09-27","Patients with chemotherapy-refractory hairy cell leukemia achieve major responses to recombinant immunotoxins containing truncated Pseudomonas exotoxin and targeting either CD25 or CD22"
"0027087331","1335362","10.1016/S0092-8674(05)80055-8","2-s2.0-0027087331","1992-12-24","Costimulation of T lymphocytes: the role of CD28, CTLA-4, and B7/BB1 in interleukin-2 production and immunotherapy"
"0032404099","9850053","","2-s2.0-0032404099","1998-12-01","Realization of the therapeutic potential of CTLA-4 blockade in low-dose chemotherapy-treated tumor-bearing mice"
"0028102855","7530013","10.1016/0952-7915(94)90087-6","2-s2.0-0028102855","1994-01-01","Blockade of the CD28 co-stimulatory pathway: a means to induce tolerance"
"0032896709","10229232","10.1038/8426","2-s2.0-0032896709","1999-01-01","CD40 antibody evokes a cytotoxic T-cell response that eradicates lymphoma and bypasses T-cell help"
"0344604333","10480415","10.1097/00007890-199908270-00018","2-s2.0-0344604333","1999-08-27","A humanized anti-CD3 antibody, HuM291, with low mitogenic activity, mediates complete and reversible T-cell depletion in chimpanzees"
"0030954684","9292538","","2-s2.0-0030954684","1997-09-01","Recombinant RFB4 immunotoxins exhibit potent cytotoxic activity for CD22-bearing cells and tumors"
"4243861666","","","2-s2.0-4243861666","1999-09-27","The combination of rituximab (anti-CD20 MAb) and daily low dose interleukin-2 therapy effectively treats established human Epstein-Barr virus-associated lymphoproliferative disorder in a mouse model of human EBV-LPD"
"0033213599","10549630","10.1016/S1074-7613(00)80123-5","2-s2.0-0033213599","1999-10-01","CTLA-4 blockade reverses CD8+ T cell tolerance to tumor by a CD4+ T cell- and IL-2-dependent mechanism"
"0027957989","8306291","10.1002/1097-0142(19940201)73:3+&lt;993::AID-CNCR2820731337&gt;3.0.CO;2-7","2-s2.0-0027957989","1994-01-01","Biodistribution and preclinical radioimmunotherapy studies using radiolanthanide‐labeled immunoconjugates"
"0027431148","8232429","","2-s2.0-0027431148","1993-11-25","Recombinant interferon alfa-2b combined with a regimen containing doxorubicin in patients with advanced follicular lymphoma"
"0032739712","10561024","","2-s2.0-0032739712","1999-11-18","Treatment of plasma cell dyscrasias by antibody-mediated immunotherapy"
"0032984347","10395323","10.1038/10503","2-s2.0-0032984347","1999-07-01","Conversion of tumor-specific CD4+ T-cell tolerance to T-cell priming through in vivo ligation of cd40"
"0032979346","10367664","","2-s2.0-0032979346","1999-02-17","Pharmacology and safety assessment of humanized monoclonal antibodies for therapeutic use"
"10344237543","8931129","","2-s2.0-10344237543","1996-10-01","A comparison of two murine monoclonal antibodies humanized by CDR-grafting and variable domain resurfacing"
"0000443627","","","2-s2.0-0000443627","1999-07-13","Phase II study of rituximab after priming with IFN in patients with relapsed LG/F B-cell lymphoma"
"0002977964","","","2-s2.0-0002977964","1999-07-13","Rituxan in the treatment of chronic idiopathic thrombocytopenic purpura (ITP)"
"0034018855","10722569","10.1128/IAI.68.4.1820-1826.2000","2-s2.0-0034018855","2000-04-01","Production of protective human antipneumococcal antibodies by transgenic mice with human immunoglobulin loci"
"0032848409","10022734","10.1016/S0022-5347(01)61829-9","2-s2.0-0032848409","1999-03-01","Neutralizing anti-vascular endothelial growth factor antibody inhibits further growth of established prostate cancer and metastases in a pre- clinical model"
"0009519952","","","2-s2.0-0009519952","1998-09-27","Radioimmunotherapy (RIT) in the treatment of non-Hodgkin's lymphoma (NHL): Advantage of pretargeted RIT (PRIT(R))"
"0033997255","10707791","","2-s2.0-0033997255","2000-03-06","Humanized anti-CD20 monoclonal antibody (Rituximab) in post transplant B-lymphoproliferative disorder: A retrospective analysis on 32 patients"
"0030937996","9097924","","2-s2.0-0030937996","1997-04-10","Rapid cytotoxicity of human B lymphocytes induced by VH4-34 (VH4.21) gene-encoded monoclonal antibodies, II"
"0031806536","9650561","10.1002/(SICI)1097-0215(19980717)77:2&lt;251::AID-IJC14&gt;3.0.CO;2-E","2-s2.0-0031806536","1998-07-02","Anti-CD3-based bispecific antibody designed for therapy of human B-cell malignancy can induce T-cell activation by antigen-dependent and antigen- independent mechanisms"
"4243241627","","","2-s2.0-4243241627","1999-09-27","Sargramostim/rituximab therapy for B-cell non-Hodgkin's lymphoma (NHL) and chronic lymphocytic leukemia (CLL) patients: A toxicity profile"
"4243867984","","","2-s2.0-4243867984","1999-10-15","Efficacy of rituximab in relapsed low grade B-cell non-Hodgkin's lymphoma after autologous peripheral blood stem cell transplantation"
"4243224575","","","2-s2.0-4243224575","1999-09-27","Rituxan-induced apoptosis in DHL-4 cells can be augmented by priming with interferon-alpha (IFN)"
"0033978358","10671209","","2-s2.0-0033978358","2000-02-28","The human immunoglobulin loci introduced into mice: V (D) and J gene segment usage similar to that of adult humans"
"0031081318","9081300","10.1016/S0167-7799(97)84205-9","2-s2.0-0031081318","1997-02-01","Designing and optimizing library selection strategies for generating high-affinity antibodies"
"4243249185","","","2-s2.0-4243249185","2000-09-27","Radioimmunotherapy of relapsed/refractory non-Hodgkin's lymphoma (NHL) with 90y-labeled humanized LL2 (90y-hLL2) anti-CD22 monoclonal antibody (MAB)"
"4243292684","","","2-s2.0-4243292684","1998-09-27","Phase II study of BCNU, etoposide. ARA-C, melphalan (BEAM) and HLA-identical allogeneic marrow or blood stem cell transplantation for primary refractory or relapsed lymphoma"
"0027954426","8118023","","2-s2.0-0027954426","1994-03-01","Intensive therapy with cyclophosphamide, carmustine, etoposide ± cisplatin, and autologous bone marrow transplantation for Hodgkin's disease in first relapse after combination chemotherapy"
"0031663914","9758340","","2-s2.0-0031663914","1998-10-12","Low incidence of acute graft-versus-host disease and recurrent leukaemia in patients undergoing allogeneic haemopoietic stem cell transplantation from sibling donors with methotrexate and dose-monitored cyclosporin A prophylaxis"
"0030443703","8971372","","2-s2.0-0030443703","1996-12-01","Melphalan alone prior to allogeneic bone marrow transplantation from HLA-identical sibling donors for hematologic malignancies: Alloengraftment with potential preservation of fertility in women"
"0025228997","2307990","","2-s2.0-0025228997","1990-01-01","High-dose cytotoxic therapy and bone marrow transplantation for relapsed Hodgkin's disease"
"17944403263","8629675","10.1016/S0002-9343(97)89488-0","2-s2.0-17944403263","1996-03-01","Allogeneic bone marrow transplantation for poor-prognosis lymphoma: Response, toxicity, and survival depend on disease histology"
"24344464799","","","2-s2.0-24344464799","2004-09-04","Combined cyclophosphamide, fludarabine, alemtuzumab, and rituximab (CFAR) is active for relapsed and refractory patients with CLL"
"33750108935","16856041","","2-s2.0-33750108935","2006-10-24","Purine antagonists for chronic lymphocytic leukaemia."
"0037085770","11877305","10.1182/blood.V99.6.2245","2-s2.0-0037085770","2002-03-15","Campath-1H and fludarabine in combination are highly active in refractory chronic lymphocytic leukemia"
"0031442979","9432033","","2-s2.0-0031442979","1997-12-01","p53 abnormalities in CLL are associated with excess of prolymphocytes and poor prognosis"
"27244451794","16145065","10.1200/JCO.2005.01.9950","2-s2.0-27244451794","2005-12-01","Fludarabine in combination with alemtuzumab is effective and feasible in patients with relapsed or refractory B-cell chronic lymphocytic leukemia: Results of a phase II trial"
"21144456107","15738539","10.1200/JCO.2005.04.021","2-s2.0-21144456107","2005-12-01","Eradication of minimal residual disease in B-cell chronic lymphocytic leukemia after alemtuzumab therapy is associated with prolonged survival"
"27144437196","16219582","","2-s2.0-27144437196","2005-10-01","The efficacy of alemtuzumab for refractory chronic lymphocytic leukemia in relation to cytogenetic abnormalities of p53"
"10744231366","15160944","10.1080/10428190310001615675","2-s2.0-10744231366","2004-04-01","Maintenance therapy with a monthly injection of alemtuzumab prolongs response duration in patients with refractory B-cell chronic lymphocytic leukemia/small lymphocytic lymphoma (B-CLL/SLL)"
"0344236261","14669286","10.1002/cncr.11871","2-s2.0-0344236261","2003-12-15","Alemtuzumab as Treatment for Residual Disease after Chemotherapy in Patients with Chronic Lymphocytic Leukemia"
"0034727833","11136261","10.1056/NEJM200012283432602","2-s2.0-0034727833","2000-12-28","Genomic aberrations and survival in chronic lymphocytic leukemia"
"84871467539","","","2-s2.0-84871467539","2005-04-18","Fludarabine/rituximab (FR) followed by alemtuzumab as first-line treatment for patients with chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL): A Minnie Pearl Cancer Res Network phase II trial"
"8644274039","15512816","10.1080/10428190412331286096","2-s2.0-8644274039","2004-11-01","A pilot trial of rituximab and alemtuzumab combination therapy in patients with relapsed and/or refractory chronic lymphocytic leukemia (CLL)"
"0037220152","12393429","10.1182/blood-2002-04-1258","2-s2.0-0037220152","2003-01-01","Randomized phase 2 study of fludarabine with concurrent versus sequential treatment with rituximab in symptomatic, untreated patients with B-cell chronic lymphocytic leukemia: Results from cancer and leukemia group B 9712 (CALGB 9712)"
"0038724252","12522009","10.1182/blood-2002-07-1952","2-s2.0-0038724252","2003-05-01","Experience with alemtuzumab plus rituximab in patients with relapsed and refractory lymphoid malignancies"
"33751214547","17051245","10.1038/sj.leu.2404435","2-s2.0-33751214547","2006-12-01","Alemtuzumab as first-line therapy for B-cell chronic lymphocytic leukemia: Long-term follow-up of clinical effects, infectious complications and risk of Richter transformation [15]"
"0038811776","12721250","10.1200/JCO.2003.09.027","2-s2.0-0038811776","2003-05-01","Single-agent rituximab as first-line and maintenance treatment for patients with chronic lymphocytic leukemia or small lymphocytic lymphoma: A phase II trial of the Minnie Pearl Cancer Research Network"
"8644251919","15512812","10.1080/10428190412331283260","2-s2.0-8644251919","2004-11-01","Fludarabine in comparison to alkylator-based regimen as induction therapy for chronic lymphocytic leukemia: A systematic review and meta-analysis"
"0034667537","11023504","","2-s2.0-0034667537","2000-10-15","Cladribine with prednisone versus chlorambucil with prednisone as first-line therapy in chronic lymphocytic leukemia: Report of a prospective, randomized, multicenter trial"
"11144357657","14726385","10.1182/blood-2003-10-3729","2-s2.0-11144357657","2004-05-01","Alemtuzumab is an effective therapy for chronic lymphocytic leukemia with p53 mutations and deletions"
"0033583824","10340906","","2-s2.0-0033583824","1999-05-19","Chemotherapeutic options in chronic lymphocytic leukemia: A meta- analysis of the randomized trials"
"84871465477","","","2-s2.0-84871465477","2006-04-18","Self-administered, subcutaneous (SQ) alemtuzumab to eliminate residual disease in patients (pts) with CLL"
"14244262359","","","2-s2.0-14244262359","2003-12-25","Subcutaneous alemtuzumab following fludarabine for previously untreated patients with chronic lymphocytic leukemia (CLL): CALGB study 19901"
"15844368449","8676625","","2-s2.0-15844368449","1996-05-25","Multicentre prospective randomised trial of fludarabine versus cyclophosphamide, doxorubicin, and prednisone (CAP) for treatment of advanced-stage chronic lymphocytic leukaemia"
"0036076178","12091119","","2-s2.0-0036076178","2002-01-01","Safety and efficacy of subcutaneous Campath-1H for treating residual disease in patients with chronic lymphocytic leukemia responding to fludarabine"
"0036683449","12130484","10.1182/blood-2002-01-0159","2-s2.0-0036683449","2002-08-01","Phase II trial of subcutaneous anti-CD52 monoclonal antibody alemtuzumab (Campath-1H) as first-line treatment for patients with B-cell chronic lymphocytic leukemia (B-CLL)"
"0037043653","12167696","10.1056/NEJM200208083470619","2-s2.0-0037043653","2002-08-08","Campath-1H-induced complete remission of chronic lymphocytic leukemia despite p53 gene mutation and resistance to chemotherapy [8]"
"0028172868","7949187","","2-s2.0-0028172868","1994-11-01","p53 Mutations are associated with resistance to chemotherapy and short survival in hematologic malignancies"
"2942694373","15071604","10.1038/sj.leu.2403354","2-s2.0-2942694373","2004-06-01","Consolidation with alemtuzumab in patients with chronic lymphocytic leukemia (CLL) in first remission - Experience on safety and efficacy within a randomized multicenter phase III trial of the German CLL Study Group (GCLLSG)"
"33750199616","17026823","","2-s2.0-33750199616","2006-09-01","Updated guidelines on the management of cytomegalovirus reactivation on patients with chronic lymphocytic leukemia treated with alemtuzumab"
"26844554346","16203656","10.1080/07357900500201418","2-s2.0-26844554346","2005-10-25","Eradication of minimal residual disease with alemtuzumab in B-cell chronic lymphocytic leukemia (B-CLL) patients: The need for a standard method of detection and the potential impact of bone marrow clearance on disease outcome"
"17744410949","9596683","","2-s2.0-17744410949","1998-06-01","p53 expression in B-cell chronic lymphocytic leukemia: A marker of disease progression and poor prognosis"
"0030941458","9039259","10.1016/S0092-8674(00)81871-1","2-s2.0-0030941458","1997-02-07","p53, the cellular gatekeeper for growth and division"
"33744793781","16618945","10.1200/JCO.2005.04.6037","2-s2.0-33744793781","2006-05-20","Alemtuzumab as consolidation after a response to fludarabine is effective in purging residual disease in patients with chronic lymphocytic leukemia"
"0000820862","","","2-s2.0-0000820862","1995-07-13","The mucopolysaccharidoses"
"0032055564","9516162","","2-s2.0-0032055564","1998-04-01","Hurler syndrome: II. Outcome of HLA-genotypically identical sibling and HLA-haploidentical related donor bone marrow transplantation in fifty-four children"
"0031436199","9466288","","2-s2.0-0031436199","1997-12-02","A fludarabine-based protocol for bone marrow transplantation in Fanconi's anemia"
"0028214531","8160463","","2-s2.0-0028214531","1994-01-01","Bone marrow transplantation beyond treatment of aplasia and neoplasia"
"0033509950","10363858","10.1097/00043426-199905000-00013","2-s2.0-0033509950","1999-05-01","Fludarabine-based protocol for human umbilical cord blood transplantation in children with fanconi anemia"
"0023100542","3807892","","2-s2.0-0023100542","1987-01-01","Inhibition of DNA primase by nucleoside triphosphates and their arabinofuranosyl analogs"
"0010195558","","","2-s2.0-0010195558","1998-07-13","Matched unrelated bone marrow transplantation (BMT) using a non-myeloablative conditioning regimen"
"0001924278","","","2-s2.0-0001924278","1989-07-13","Long-term follow-up of children with Hurler's disease treated with bone marrow transplantation"
"0027505303","8093345","","2-s2.0-0027505303","1993-01-01","Induction of apoptotic cell death in chronic lymphocytic leukemia by 2-chloro-2′-deoxyadenosine and 9-β-D-arabinosyl-2-fluoroadenine"
"0027237777","8374572","","2-s2.0-0027237777","1993-01-01","Predicting results of alternative donor transplants for thalassemia using a chronic myelogenous leukemia model"
"9344245169","8639864","","2-s2.0-9344245169","1996-06-01","Outcome of unrelated donor bone marrow transplantation in 40 children with Hurler syndrome"
"0024402113","2665547","","2-s2.0-0024402113","1989-01-01","Growth in children following irradiation for bone marrow transplantation"
"0019831188","6116868","10.1016/S0140-6736(81)91059-X","2-s2.0-0019831188","1981-10-03","BONE MARROW TRANSPLANTATION FOR INBORN ERRORS"
"0027466761","8484412","","2-s2.0-0027466761","1993-01-01","Long-term outcome of Hurler syndrome following bone marrow transplantation"
"0026801110","1310314","","2-s2.0-0026801110","1992-02-05","Dual mode of inhibition of purified DNA ligase I from human cells by 9-β-D-arabinofuranosyl-2-fluoroadenine triphosphate"
"0025130572","1697861","","2-s2.0-0025130572","1990-09-25","Termination of DNA synthesis by 9-β-D-arabinofuranosyl-2-fluoroadenine: A mechanism for cytotoxicity"
"0030049045","8640178","","2-s2.0-0030049045","1996-02-01","Improved single-step PCR assay for sex identification post-allogeneic sex-mismatched BMT"
"0031842605","9628439","10.1097/00043426-199805000-00013","2-s2.0-0031842605","1998-05-01","Matched unrelated human umbilical cord blood transplantation for X- linked adrenoleukodystrophy"
"0022875823","3083884","","2-s2.0-0022875823","1986-12-01","Psychomotor development of children with mucopolysaccharidosis type 1-H following bone marrow transplantation"
"0028030951","7827779","","2-s2.0-0028030951","1994-09-01","Unrelated donor bone marrow transplants in children"
"0032784069","10455377","","2-s2.0-0032784069","1999-01-01","Donor lymphocyte infusion post-non-myeloablative allogeneic peripheral blood stem cell transplantation for chronic granulomatous disease"
"0019466750","6116856","10.1016/S0140-6736(81)91046-1","2-s2.0-0019466750","1981-10-03","REVERSAL OF CLINICAL FEATURES OF HURLER'S DISEASE AND BIOCHEMICAL IMPROVEMENT AFTER TREATMENT BY BONE-MARROW TRANSPLANTATION"
"0025614264","1965792","","2-s2.0-0025614264","1990-12-01","Bone marrow transplantation for the treatment of immune deficiency states"
"0025777811","1708088","","2-s2.0-0025777811","1991-04-01","Action of 9-β-D-arabinofuranosyl-2-fluoroadenine on RNA metabolism"
"0030003804","8695991","","2-s2.0-0030003804","1996-04-09","Bone marrow transplantation in children using unrelated donors at Huddinge Hospital"
"0040445592","","","2-s2.0-0040445592","1988-09-24","Lysosomal storage diseases treated by bone marrow transplantation"
"0030843626","9226148","","2-s2.0-0030843626","1997-07-15","Juvenile myelomonocytic leukemia"
"0027521988","8104617","10.1002/stem.5530110829","2-s2.0-0027521988","1993-01-01","Bone marrow transplantation in fanconi's anemia"
"0033945738","10886754","10.1046/j.1525-1470.2000.01754.x","2-s2.0-0033945738","2000-05-01","Disseminated BCG infection following bone marrow transplantation for X- linked severe combined immunodeficiency"
"0025900553","1722421","10.1111/j.1744-313X.1991.tb00027.x","2-s2.0-0025900553","1991-01-01","NOMENCLATURE FOR FACTORS OF THE HLA SYSTEM, 1990"
"0017581598","14751","","2-s2.0-0017581598","1977-12-01","One hundred patients with acute leukemia treated by chemotherapy, total body irradiation, and allogenic marrow transplantation"
"0024247720","3049948","","2-s2.0-0024247720","1988-12-01","Allogeneic transplantation versus intensive chemotherapy in first-remission acute leukemia: Is there a 'best choice'?"
"0027861014","8500573","","2-s2.0-0027861014","1993-12-01","Fanconi anemia diagnosis and the diepoxybutane (DEB) test"
"0026721136","1578943","","2-s2.0-0026721136","1992-01-01","Treatment results of three consecutive German AML trials: BFM-78, -83, and -87"
"0031978097","9576189","10.1046/j.1365-2141.1998.00676.x","2-s2.0-0031978097","1998-01-01","Comparison of bone marrow transplant and chemotherapy for relapsed childhood acute lymphoblastic leukaemia: The MRC UKALL X experience"
"0022601118","2872392","10.1016/S0140-6736(86)91387-5","2-s2.0-0022601118","1986-05-31","BONE-MARROW TRANSPLANTATION HAS A LIMITED ROLE IN PROLONGING SECOND MARROW REMISSION IN CHILDHOOD LYMPHOBLASTIC LEUKAEMIA"
"0026099261","1989335","","2-s2.0-0026099261","1991-01-01","Allogeneic bone marrow transplantation for leukemia using chemotherapy as conditioning: 6-year results of a single institution trial"
"0027055394","1293389","10.1007/BF01800234","2-s2.0-0027055394","1992-11-01","Bone marrow transplantation for Niemann-Pick Type IA disease"
"0031899811","9630329","","2-s2.0-0031899811","1998-04-01","Long-term survivors: An overview on late effects, sequelae and second neoplasias"
"0020576157","6344915","10.1111/j.1365-2141.1983.tb02117.x","2-s2.0-0020576157","1983-01-01","Radiosensitivity in Fanconi anaemia: application to the conditioning regimen for bone marrow transplantation"
"0015494461","4109931","","2-s2.0-0015494461","1972-02-05","Aplastic anaemia treated by marrow transplantation."
"0032928146","10458234","","2-s2.0-0032928146","1999-01-01","Allogeneic bone marrow transplantation versus chemotherapy for the treatment of childhood acute lymphoblastic leukemia in second remission: A single-institution study"
"0026628056","1578920","","2-s2.0-0026628056","1992-01-01","Update of St Jude Study XI for childhood acute lymphoblastic leukemia"
"0018771131","32941","","2-s2.0-0018771131","1979-12-01","A prospective study of androgens and bone marrow transplantation for treatment of severe aplastic anemia"
"0031057226","9074421","","2-s2.0-0031057226","1997-03-25","Hepatic GVHD after HLA-haploidentical bone marrow transplantation in children with severe combined immunodeficiency: The effect of ursodeoxycholic acid"
"0030902377","9196136","","2-s2.0-0030902377","1997-06-01","Late effects of allogeneic bone marrow transplantation for children with acute myeloblastic leukemia in first complete remission: The impact of conditioning regimen without total-body irradiation - A report from the Societe Francaise de Greffe de Moelle"
"0029834755","8932789","","2-s2.0-0029834755","1996-12-04","Bone marrow transplant indications for childhood leukemias: Achieving a consensus"
"0030877514","9226187","","2-s2.0-0030877514","1997-07-15","Bone marrow transplantation for severe aplastic anemia: Has outcome improved?"
"0029997538","8680513","10.1097/00008480-199602000-00009","2-s2.0-0029997538","1996-04-10","Bone marrow transplantation in children with hereditary disorders"
"0023224194","","10.1038/nbt0787-720","2-s2.0-0023224194","1987-01-01","Expression of biologically active human ant11hrombin iii in chinese hamster ovary cells"
"0014321756","5244736","","2-s2.0-0014321756","1968-08-01","Genetics of somatic mammalian cells, VII. Induction and isolation of nutritional mutants in Chinese hamster cells."
"0026085078","1367053","10.1007/BF00365535","2-s2.0-0026085078","1991-01-01","Serum-free medium for fermentor cultures of hybridomas"
"0026034840","1367388","10.1016/0167-7799(91)90038-J","2-s2.0-0026034840","1991-01-01","Myeloma based expression system for production of large mammalian proteins"
"0022352466","3902782","10.1007/BF02620890","2-s2.0-0022352466","1985-10-01","Long-term multiplication of the Chinese hamster ovary (CHO) cell line in a serum-free medium"
"0020614382","6409084","","2-s2.0-0020614382","1983-01-01","Polyamine starvation causes accumulation of cadaverine and its derivatives in a polyamine-dependent strain of Chinese-hamster ovary cells"
"0017751848","562838","10.1007/BF02627849","2-s2.0-0017751848","1977-09-01","Clonal growth of Chinese hamster cell lines in protein-free media"
"84883833623","14294058","","2-s2.0-84883833623","1965-02-01","CLONAL GROWTH OF MAMMALIAN CELLS IN A CHEMICALLY DEFINED, SYNTHETIC MEDIUM."
"0021126205","6387447","","2-s2.0-0021126205","1984-01-01","Post-transcriptional control of the onset of DNA synthesis by an insulin-like growth factor"
"0025967789","1993365","10.1111/j.1365-2249.1991.tb05639.x","2-s2.0-0025967789","1991-01-01","Programmed cell death (apoptosis) in lymphoid and myeloid cell lines during zinc deficiency"
"0023896498","3397072","","2-s2.0-0023896498","1988-01-01","Growth-stimulating effect of ferric citrate on hybridoma cells: Characterization and relation to transferrin function"
"0021778323","3927946","","2-s2.0-0021778323","1985-01-01","Vitamin B12-folate interrelationships."
"0023872939","","10.1007/BF00451627","2-s2.0-0023872939","1988-02-01","Polyethylene glycols for promoting the growth of mammalian cells"
"0004155427","","","2-s2.0-0004155427","1995-03-28",""
"0023062018","3582753","","2-s2.0-0023062018","1987-01-01","On the evaluation of gas-liquid interfacial effects on hybridoma viability in bubble column bioreactors."
"0024322557","","10.1038/nbt0889-799","2-s2.0-0024322557","1989-01-01","Expression of human anti-tetanus toxoid antibody in transfected murine myeloma ceils"
"0022100495","4040603","","2-s2.0-0022100495","1985-07-01","Coamplification and coexpression of human tissue-type plasminogen activator and murine dihydrofolate reductase sequences in Chinese hamster ovary cells."
"0015354459","4114812","10.1038/bjc.1972.21","2-s2.0-0015354459","1972-01-01","Eighty years of immunotherapy: A review of immunological methods used for the treatment of human cancer"
"84921619030","","","2-s2.0-84921619030","0000-01-31",""
"84921619031","","","2-s2.0-84921619031","0000-01-31",""
"0023277017","3297205","","2-s2.0-0023277017","1987-01-01","Marrow transplantation for children with acute lymphoblastic leukemia in second remission"
"0029099419","7564672","10.1016/S0140-6736(95)92710-7","2-s2.0-0029099419","1995-09-30","Autologous bone-marrow transplants compared with chemotherapy for children with acute lymphoblastic leukaemia in a second remission: a matched-pair analysis"
"0023499834","3317056","","2-s2.0-0023499834","1987-12-01","Allogeneic bone marrow transplantation after hyperfractionated total-body irradiation and cyclophosphamide in children with acute leukemia"
"0028334747","8011547","10.1111/j.1365-2141.1994.tb03251.x","2-s2.0-0028334747","1994-01-01","A second course of treatment for childhood acute lymphoblastic leukaemia: long‐term follow‐up is needed to assess results"
"0019306690","6995837","","2-s2.0-0019306690","1980-12-01","Transplantation of marrow from an unrelated donor to a patient with acute leukemia"
"0024284028","3344216","10.1093/nar/16.3.1215","2-s2.0-0024284028","1988-02-11","A simple salting out procedure for extracting DNA from human nucleated cells"
"0028152851","7949185","","2-s2.0-0028152851","1994-11-01","Chemotherapy in 998 unselected childhood acute lymphoblastic leukemia patients. Results and conclusions of the multicenter trial ALL-BFM 86"
"0025635609","10149526","10.1016/0955-3886(90)90095-Z","2-s2.0-0025635609","1990-01-01","Bone marrow processing on the Haemonetics V50 cell separator"
"0032573604","9846518","","2-s2.0-0032573604","1998-11-27","Results of different strategies for reducing cytomegalovirus-associated mortality in allogeneic stem cell transplant recipients"
"0030981399","9065718","10.1097/00043426-199701000-00006","2-s2.0-0030981399","1997-01-01","Prevention of CMV disease in allogeneic BMT recipients by cytomegalovirus antigenemia-guided preemptive ganciclovir therapy"
"0033073267","10071460","","2-s2.0-0033073267","1999-12-01","Use of PCR serum in diagnosing and monitoring cytomegalovirus reactivation in bone marrow transplant recipients"
"0006002030","","","2-s2.0-0006002030","2004-07-13","Comparative evaluation of CMV viral load using Taqman quantitative CMV PCR and comparison with CMV antigenaemia in heart and lung transplants"
"0031873744","9664203","10.2165/00003495-199856010-00012","2-s2.0-0031873744","1998-01-01","Ganciclovir. An update of its use in the prevention of cytomegalovirus infection and disease in transplant recipients"
"0029563358","8747771","","2-s2.0-0029563358","1995-12-01","Cytomegalovirus infection in the bone marrow transplant recipient"
"0032969645","10037050","","2-s2.0-0032969645","1999-02-02","The clinical utility of CMV surveillance cultures and antigenemia following bone marrow transplantation"
"0034631463","10885354","","2-s2.0-0034631463","2000-06-10","Application of viral-load kinetics to identify patients who develop cytomegalovirus disease after transplantation"
"0029959831","8913411","","2-s2.0-0029959831","1996-11-01","Cytomegalovirus prophylaxis and treatment following bone marrow transplantation"
"0031962159","9450815","10.1046/j.1365-2141.1998.00518.x","2-s2.0-0031962159","1998-02-06","Time course analysis of semi-quantitative PCR and antigenaemia assay for prevention of cytomegalovirus disease after bone marrow transplantation"
"0031739816","9827819","","2-s2.0-0031739816","1998-11-14","Cytomegalovirus pp65 antigenemia-guided pre-emptive treatment with ganciclovir after allogeneic stem transplantation: A single-center experience"
"0030981330","9096177","10.1093/jac/39.3.299","2-s2.0-0030981330","1997-04-21","Prophylaxis against CMV infection in transplant patients"
"0031014154","9116610","","2-s2.0-0031014154","1997-01-02","Clinical strategies for the management of cytomegalovirus infection and disease in allogeneic bone marrow transplant"
"0030267967","","10.1016/S0924-8579(96)00338-X","2-s2.0-0030267967","1996-10-01","Prophylaxis of cytomegalovirus infection in bone marrow transplant patients"
"0030789609","9233710","10.1097/00007890-199707150-00020","2-s2.0-0030789609","1997-07-15","Plasma polymerase chain reaction for cytomegalovirus DNA after allogeneic marrow transplantation: Comparison with polymerase chain reaction using peripheral blood leukocytes, pp65 antigenemia, and viral culture"
"0030821610","9310503","","2-s2.0-0030821610","1997-09-15","Neutropenia in allogeneic marrow transplant recipients receiving ganciclovir for prevention of cytomegalovirus disease: Risk factors and outcome"
"0033013624","10194088","","2-s2.0-0033013624","1999-06-03","Late cytomegalovirus pneumonia in adult allogeneic blood and marrow transplant recipients"
"0028832979","7886659","","2-s2.0-0028832979","1995-01-01","Detection of human cytomegalovirus antigenaemia: A rapid diagnostic technique for predicting cytomegalovirus infection/pneumonitis in lung and heart transplant recipients"
"0032880172","10091394","","2-s2.0-0032880172","1999-01-01","Management of human cytomegalovirus infection and disease after allogeneic bone marrow transplantation"
"0031885394","9543067","","2-s2.0-0031885394","1998-03-02","Fatal CMV pneumonia associated with steroid therapy after autologous transplantation in patients previously treated with fludarabine"
"0028990377","7655376","","2-s2.0-0028990377","1995-01-01","Patients ≥ age 40 years undergoing autologous or allogeneic BMT have regimen-related mortality rates and event-free survivals comparable to patients &lt; age 40 years"
"0032964563","9918315","","2-s2.0-0032964563","1999-01-20","GVL and GVHD following the infusion of a limited number of donor CD3 cells in the therapy of leukaemia relapse after bone marrow transplantation"
"0032523810","9593785","","2-s2.0-0032523810","1998-05-15","Cytotoxic T cell response against the chimeric p210 BCR-ABL protein in patients with chronic myelogenous leukemia"
"0030920348","9156268","","2-s2.0-0030920348","1997-05-01","Donor lymphocyte infusions (DLI) in patients with chronic myeloid leukemia following allogeneic bone marrow transplantation"
"0027980844","8081005","","2-s2.0-0027980844","1994-09-15","Marrow transplantation for chronic myeloid leukemia: A randomized study comparing cyclophosphamide and total body irradiation with busulfan and cyclophosphamide"
"0031933325","9519786","10.1038/sj.leu.2400917","2-s2.0-0031933325","1998-03-24","A novel BCR-ABL rearrangement in a Philadelphia chromosome-positive chronic myelogenous leukaemia variant with thrombocythaemia"
"20244374668","9573003","","2-s2.0-20244374668","1998-05-15","Toxicity and efficacy of defined doses of CD4+ donor lymphocytes for treatment of relapse after allogeneic bone marrow transplant"
"0026524521","1600415","","2-s2.0-0026524521","1992-01-01","Second HLA-identical sibling transplants for leukemia recurrence"
"0023504223","3332853","10.1016/S0950-3536(87)80039-2","2-s2.0-0023504223","1987-01-01","Bone marrow transplantation for CML"
"0029967001","8896419","","2-s2.0-0029967001","1996-11-01","Recognition of BCR-ABL positive leukemic blasts by human CD4+ T cells elicited by primary in vitro immunization with a BCR-ABL breakpoint peptide"
"8944221180","8695820","","2-s2.0-8944221180","1996-07-15","Relapse after non-T-cell-depleted allogeneic bone marrow transplantation for chronic myelogenous leukemia: Early transplantation, use of an unrelated donor, and chronic graft-versus-host disease are protective"
"0028117326","8205095","","2-s2.0-0028117326","1994-01-01","Bronchiolitis obliterans organizing pneumonia (BOOP) in children after allogeneic bone marrow transplantation"
"0027989681","7994246","","2-s2.0-0027989681","1994-09-05","Minimal residual disease in bone marrow transplant recipients with chronic myeloid leukemia"
"0026587834","1529427","10.1111/j.1399-0039.1992.tb01932.x","2-s2.0-0026587834","1992-01-01","Nomenclature for factors of the HLA system, 1991"
"0030707663","9337056","","2-s2.0-0030707663","1997-10-01","Long-term results after allogeneic bone marrow transplantation for chronic myelogenous leukemia in chronic phase: A report from the Chronic Leukemia Working Party of the European Group for Blood and Marrow Transplantation"
"0027226020","8319789","10.1111/j.1600-0609.1993.tb00161.x","2-s2.0-0027226020","1993-01-01","Increased risk of relapse in patients with chronic myelogenous leukemia given T‐cell depleted marrow compared to methotrexate combined with cyclosporin or monotherapy for the prevention of graft‐versus‐host disease"
"0000166093","","","2-s2.0-0000166093","1988-09-11","Cellular-mediated immunotherapy of leukemia in conjunction with autologous and allogeneic bone marrow transplantation in experimental animals and man"
"15844406804","","","2-s2.0-15844406804","1994-04-14","Combined use of Campath-1 G in vivo 'in the bag' in allogeneic bone marrow transplantation"
"0027939018","7826534","10.1016/0952-7915(94)90084-1","2-s2.0-0027939018","1994-01-01","What can be done to prevent graft versus host disease?"
"0032055530","9516143","","2-s2.0-0032055530","1998-04-01","Somatic hypermutation, clonal diversity, and preferential expression of the V(H) 51p1/V(L) kv325 immunoglobulin gene combination in hepatitis C virus-associated immunocytomas"
"0028178499","8204889","","2-s2.0-0028178499","1994-01-01","Similar patterns of Vκ gene usage but different degrees of somatic mutation in hairy cell leukemia, prolymphocytic leukemia, Waldenstrom's macroglobulinemia, and myeloma"
"0028966630","7703494","","2-s2.0-0028966630","1995-04-01","Frequent somatic mutations in D and/or JH segments of Ig gene in Waldenström's macroglobulinemia and chronic lymphocytic leukemia (CLL) with Richter's syndrome but not in common CLL"
"0028295179","8123836","","2-s2.0-0028295179","1994-03-15","Waldenstrom's macroglobulinemia"
"0000899560","","","2-s2.0-0000899560","1998-07-13","Expression of CD52 in human hematopoietic malignancies"
"0019641697","6273914","","2-s2.0-0019641697","1981-11-01","Plasma cell dyscrasia and peripheral neuropathy: identification of the myelin antigens that react with human paraproteins."
"0028941517","7698295","10.1111/j.1600-0609.1995.tb01779.x","2-s2.0-0028941517","1995-01-01","Fludarabine treatment in resistant Waldenstrom's macroglobulinemia"
"0242496268","","","2-s2.0-0242496268","1998-09-27","Cytogenetic abnormalities in Waldenstom's disease (WD): A single center study on 45 cases"
"10544241195","8943844","","2-s2.0-10544241195","1996-12-01","The t(9;14)(p13;q32) chromosomal translocation associated with lymphoplasmacytoid lymphoma involves the PAX-5 gene"
"0025337074","1692487","","2-s2.0-0025337074","1990-05-15","Fludarabine therapy in macroglobulinemic lymphoma"
"0027492159","8093333","","2-s2.0-0027492159","1993-02-01","Treatment of waldenstrom macroglobulinemia with 2-chlorodeoxyadenosine"
"0028354954","7514439","","2-s2.0-0028354954","1994-03-01","2chlorodeoxyadenosine therapy of patients with Waldenström macroglobulinemia previously treated with fludarabine"
"0022638308","3084084","","2-s2.0-0022638308","1986-01-01","Response of Waldenstrom's macroglobulinemia to pentostatin (2'-deoxycoformycin)"
"0025921423","1901509","10.3109/07357909109032794","2-s2.0-0025921423","1991-01-01","Waldenström's macroglobulinemia: Long-term results with the m-2 protocol"
"4243503319","","","2-s2.0-4243503319","1999-09-27","What is the final pathological diagnosis in patients with IgM paraproteins: A retrospective analysis of 106 cases"
"0023475318","3119188","10.1016/0165-4608(87)90237-8","2-s2.0-0023475318","1987-01-01","Chromosome changes in 19 patients with Waldenström's macroglobulinemia"
"0023912927","3134882","","2-s2.0-0023912927","1988-01-01","Treatment of resistant Waldenstrom's macroglobulinemia with high dose glucocorticosteroids"
"0020644493","6307428","","2-s2.0-0020644493","1983-01-01","Waldenstrom's macroglobulinemia and peripheral neuropathy: A clinical and immunologic study of 25 patients"
"0032890555","10218857","","2-s2.0-0032890555","1999-04-24","Allogeneic bone marrow transplantation for advanced Waldenstrom's macroglobulinemia"
"0027337283","8328496","10.1016/0002-9343(93)90231-D","2-s2.0-0027337283","1993-01-01","Fludarabine therapy in Waldenström's macroglobulinemia"
"0027337686","","","2-s2.0-0027337686","1993-01-01","Prognostic factors in Waldenstrom's macroglobulinemia: A report of 167 cases"
"0003842899","","","2-s2.0-0003842899","1999-07-13","Detection of t(11;18) MALT lymphoma with double color FISH and/or RT-PCR"
"0032078890","9595048","10.1016/S0165-4608(97)00346-4","2-s2.0-0032078890","1998-01-01","A case of t(8;14) with total and partial trisomy 3 in Waldenstrom macroglobulinemia"
"0027444652","8141877","","2-s2.0-0027444652","1993-09-30","A predictive model for aggressive non-Hodgkin's lymphoma"
"0023240678","3110508","","2-s2.0-0023240678","1987-01-01","The spectrum of IgM monoclonal gammopathy in 430 cases"
"0028173001","7989946","","2-s2.0-0028173001","1994-12-01","Primary therapy of Waldenström's macroglobulinemia with 2-chlorodeoxyadenosine"
"0033017554","10414453","","2-s2.0-0033017554","1999-07-12","Effect of a 2-hour infusion of 2-chlorodeoxyadenosine in the treatment of refractory or previously untreated Waldenstrom's macroglobulinemia"
"0000341636","","","2-s2.0-0000341636","1999-09-27","Should Waldenström's macroglobulinemia be considered part of the spectrum of marginal zone lymphoma?"
"0000978524","","","2-s2.0-0000978524","1967-09-01","Primary macroglobulinemia. Review with a report on thirty-one cases and notes on the value of continuous chlorambucil therapy"
"0003335031","","","2-s2.0-0003335031","1998-07-13","Rituximab therapy in previously treated Waldenstrom's macroglobulinemia: Preliminary evidence of activity"
"0032784783","10577857","","2-s2.0-0032784783","1999-12-01","World health organization classification of neoplastic diseases of the hematopoietic and lymphoid tissues: Report of the clinical advisory committee meeting - Airlie house, Virginia, November 1997"
"0022218194","3931901","10.1016/0165-4608(85)90065-2","2-s2.0-0022218194","1985-01-01","Clonal abnormalities in patients with Waldenström's macroglobulinemia with special reference to a Burkitt-type t(8;14)"
"9844262268","9375754","","2-s2.0-9844262268","1997-12-02","Cladribine (2-CDA) given as subcutaneous bolus injections is active in pretreated Waldenstrom's macroglobulinaemia"
"0032857343","10561361","","2-s2.0-0032857343","1999-09-01","Immunocytoma: A retrospective analysis from St Bartholomew's Hospital - 1972 to 1996"
"0020578284","6414077","10.1111/j.1600-0609.1983.tb00664.x","2-s2.0-0020578284","1983-01-01","Bone Marrow Histology in Waldenström's Macroglobulinaemia: Clinical Relevance of Subtype Recognition"
"0032533668","9808580","","2-s2.0-0032533668","1998-11-15","Deregulated PAX-5 transcription from a translocated IgH promoter in marginal zone lymphoma"
"0028837270","7710983","","2-s2.0-0028837270","1995-01-01","Treatment of Waldenstrom's macroglobulinemia resistant to standard therapy with 2-chlorodeoxyadenosine: Identification of prognostic factors"
"0026453505","1384792","","2-s2.0-0026453505","1992-11-15","t(9;14)(p13;q32) denotes a subset of low-grade non-Hodgkin's lymphoma with plasmacytoid differentiation"
"0033037724","10554812","10.1046/j.1365-2141.1999.01461.x","2-s2.0-0033037724","1999-07-14","High-dose therapy with autologous haemopoietic stem cell support for Waldenstrom's macroglobulinaemia"
"0030119822","8847806","","2-s2.0-0030119822","1996-04-01","Primary macroglobulinemia with t(11;18) (q21;q21)"
"0028149568","7523797","","2-s2.0-0028149568","1994-10-01","The immunological profile of B-cell disorders and proposal of a scoring system for the diagnosis of CLL"
"0028182630","8180389","","2-s2.0-0028182630","1994-01-01","Study of prognosis in Waldenstrom's macroglobulinemia: A proposal for a simple binary classification with clinical and investigational utility"
"0031778016","9626204","","2-s2.0-0031778016","1998-06-01","Activity of fludarabine in previously treated Waldenstrom's macroglobulinemia: A report of 71 cases"
"84939686757","","10.1111/j.0954-6820.1944.tb03955.x","2-s2.0-84939686757","1944-01-01","Incipient myelomatosis or «essential« hyperglobulinemia with fibrinogenopenia — a new syndrome?"
"0024854101","2518735","","2-s2.0-0024854101","1989-12-01","Waldenstrom's macroglobulinaemia: Results of a combined oral treatment in 34 newly diagnosed patients"
"0030708684","9389354","","2-s2.0-0030708684","1997-11-19","Marginal zone B-Cell lymphomas including mucosa-associated lymphoid tissue type lymphoma (MALT), monocytoid B-cell lymphoma and splenic marginal zone cell lymphoma and their relation to the reactive marginal zone"
"0031788917","9858218","10.1046/j.1365-2141.1998.01069.x","2-s2.0-0031788917","1998-12-10","Bolus administration of cladribine in the treatment of Waldenstrom macroglobulinaemia"
"0032587617","10192467","","2-s2.0-0032587617","1999-04-06","Cladribine for Waldenstrom's macroglobulinaemia [6]"
"1842406646","9031608","10.1007/s002770050247","2-s2.0-1842406646","1997-02-06","First-line treatment of Waldenstrom's disease with cladribine"
"0029041866","7773966","10.1016/S0165-4608(94)00196-0","2-s2.0-0029041866","1995-01-01","Concomitant partial tetrasomy 3q and trisomy 18 in waldenstrom macroglobulinemia"
"0027339182","8219203","","2-s2.0-0027339182","1993-11-15","Incidence of Waldenström's macroglobulinemia"
"0027190459","8487054","","2-s2.0-0027190459","1993-01-01","Primary systemic amyloidosis: A rare complication of immunoglobulin M monoclonal gammopathies and Waldenstrom's macroglobulinemia"
"0033151510","10339464","","2-s2.0-0033151510","1999-06-01","The apoptosis inhibitor gene API2 and a novel 18q gene, MLT, are recurrently rearranged in the t(11;18)(q21;q21) associated with mucosa- associated lymphoid tissue lymphomas"
"0032976375","10080598","","2-s2.0-0032976375","1999-02-01","Multicenter phase II study of fludarabine phosphate for patients with newly diagnosed lymphoplasmacytoid lymphoma, Waldenstrom's macroglobulinemia, and mantle-cell lymphoma"
"0014600299","4188212","","2-s2.0-0014600299","1969-11-01","Waldenström's macroglobulinemia with increased serum IgG levels treated with low doses of cyclophosphamide."
"0026575024","1727909","","2-s2.0-0026575024","1992-01-01","Plasmapheresis for hyperviscosity syndrome in macroglobulinemia Waldenström and multiple myeloma: Influence on blood rheology and the microcirculation"
"0031942845","9602369","10.1111/j.1600-065X.1998.tb01446.x","2-s2.0-0031942845","1998-04-01","Insight into the origin and clonal history of B-cell tumors as revealed by analysis of Immunoglobulin variable region genes"
"0009910679","","","2-s2.0-0009910679","1999-09-27","Results of a multicentric randomized study comparing the efficacy of cyclophosphamide, doxorubicin and prednisone to that of fludarabine in patients with Waldenstrom's macroglobulinemia in first relapse or primary refractory disease"
"0003335029","","","2-s2.0-0003335029","1998-09-27","Waldenstrom's macroglobulinemia: A prospective study comparing daily versus intermittent oral chlorambucil"
"0015348291","4623914","","2-s2.0-0015348291","1972-06-01","Macroglobulinemia: an analysis for forty patients."
"0032864219","10444173","10.1046/j.1365-2141.1999.01493.x","2-s2.0-0032864219","1999-08-02","Myeloablative radiochemotherapy followed by reinfusion of purged autologous stem cells for Waldenstrom's macroglobulinaemia"
"0019123358","6776808","10.1002/ajh.2830090210","2-s2.0-0019123358","1980-01-01","Successful doxorubicin therapy of primary macroglobulinemia resistant to alkylating agents"
"0028226982","7908442","","2-s2.0-0028226982","1994-03-29","Synergy between anti-CD4 and anti-tumor necrosis factor in the amelioration of established collagen-induced arthritis"
"1542427692","","","2-s2.0-1542427692","1993-07-13","The amount of anti-CD4 monoclonal antibody (mAb) entering the rheumatoid (RA) joint may determine clinical efficacy"
"0027397072","8093637","10.1056/NEJM199302113280610","2-s2.0-0027397072","1993-01-01","CD4+ T-lymphocytopenia without HIV infection - No lights, no camera, just facts"
"1542637447","","","2-s2.0-1542637447","1989-07-13","Manipulating the immune system with monoclonal antibodies. Mouse models for immunotherapy"
"0021167047","6145942","10.1016/S0140-6736(84)92009-9","2-s2.0-0021167047","1984-07-07","HOW DOES BONE-MARROW TRANSPLANTATION CURE LEUKAEMIA?"
"84921015798","","","2-s2.0-84921015798","1983-01-23",""
"4243155870","","","2-s2.0-4243155870","1981-12-16",""
"0028895152","8588244","","2-s2.0-0028895152","1995-01-01","Elucidating the Mechanism of Action of the Immunosuppressant 15–Deoxyspergualin"
"0025360246","2190395","","2-s2.0-0025360246","1990-01-01","Clinical correlations with cyclosporine blood levels after allogeneic bone marrow transplantation: An analysis of four different assays"
"0027296277","8363223","10.1111/j.1749-6632.1993.tb35865.x","2-s2.0-0027296277","1993-01-01","Deoxyspergualin: Clinical Trials in Renal Graft Rejection"
"0024267763","3063323","","2-s2.0-0024267763","1988-12-01","Cyclosporine and methylprednisolone for prophylaxis of acute graft-versus-host disease"
"0032210024","9838569","","2-s2.0-0032210024","1998-12-01","Effects of deoxyspergualin (DSG) administered in the chronic phase following kidney transplantation"
"0022647626","3513869","","2-s2.0-0022647626","1986-07-30","Hyperacute graft-v-host disease in patients not given immunosuppression after allogeneic marrow transplantation"
"2442740070","10432311","10.1042/0264-6021:3420143","2-s2.0-2442740070","1999-08-15","Methotrexate inhibits the first committed step of purine biosynthesis in mitogen-stimulated human T-lymphocytes: A metabolic basis for efficacy in rheumatoid arthritis?"
"0032501429","9875240","10.1006/bbrc.1998.9775","2-s2.0-0032501429","1998-12-09","Identification of a binding site on Hsc70 for the immunosuppressant 15-deoxyspergualin"
"0028297145","8193430","","2-s2.0-0028297145","1994-01-01","Cyclosporine monitoring improves graft-versus-host disease prophylaxis after bone marrow transplantation"
"0032701608","10619401","10.1016/S0303-7207(99)00156-2","2-s2.0-0032701608","1999-11-25","Interaction of glucocorticoid receptor isoforms with transcription factors AP-1 and NF-κB: Lack of effect of glucocorticoid receptor β"
"0026667070","1604484","","2-s2.0-0026667070","1992-01-01","Pharmacodynamic studies of cyclosporine in marrow transplant recipients: A comparison of three assay methods"
"0029780353","8824467","","2-s2.0-0029780353","1996-09-27","Prevention of lethal graft-versus-host disease following allogeneic bone marrow transplantation in mice by short course administration of LF 08-0299"
"0008848813","","","2-s2.0-0008848813","1999-07-13","Evaluation of non-myeloablative conditioning combining BEAM with in vivo pre-transplant Campath-IG for allogeneic transplantation in patients with lymphoma"
"0033253070","10629110","","2-s2.0-0033253070","1999-12-01","Steroid hormone receptors: Evolution, ligands, and molecular basis of biologic function"
"0029807036","8898375","","2-s2.0-0029807036","1996-10-31","The non-ligand binding β-isoform of the human glucocorticoid receptor (hGRβ): Tissue levels, mechanism of action, and potential physiologic role"
"0023762862","3285548","","2-s2.0-0023762862","1988-01-01","Cyclosporine levels in whole blood: Comparison of the polyclonal sandoz ciclosporin radioimmunoassay kit with the specific antibody in the new sandimmun kit"
"0020510186","6346614","","2-s2.0-0020510186","1983-01-01","Cyclosporine in human bone marrow transplantation: Serum concentration, graft-versus-host disease, and nephrotoxicity"
"0032762519","10564178","","2-s2.0-0032762519","1999-11-01","Glucocorticoids ablate IL-1β-induced β-adrenergic hyporesponsiveness in human airway smooth muscle cells"
"0028582021","7711667","","2-s2.0-0028582021","1994-12-01","Effect of graft-versus-host disease prophylaxis on relapse in patients transplanted for acute myeloid leukemia"
"0029060343","7762070","","2-s2.0-0029060343","1995-05-15","Glucocorticoids regulate calcineurin-dependent trans-activating pathways for interleukin-2 gene transcription in human t lymphocytes"
"0029786784","8853792","","2-s2.0-0029786784","1996-08-29","15-Deoxyspergualin: A newly developed immunosuppressive agent and its mechanism of action and clinical effect: A review"
"0029552642","8597379","10.1111/j.1749-6632.1995.tb31073.x","2-s2.0-0029552642","1995-01-01","LF 08‐0299 Protects Murine Recipients of Minor Antigen Disparate Donor Marrow from Lethal Graft‐versus‐Host Disease"
"4243533564","","","2-s2.0-4243533564","1999-03-23","Intravenous mycophenolate plus prednisolone and cyclosporine in the prophylaxis of GVHD after stem cell transplantation"
"0024459937","2673331","10.1111/j.1365-2141.1989.tb04325.x","2-s2.0-0024459937","1989-01-01","Graft‐versus‐host disease prevention by methotrexate combined with cyclosporin compared to methotrexate alone in patients given marrow grafts for severe aplastic anaemia: long‐term follow‐up of a controlled trial"
"0344109570","9776480","10.1016/S0162-3109(98)00034-4","2-s2.0-0344109570","1998-07-01","Induction of apoptosis by dexamethasone in the B cell lineage"
"0026748870","1375473","","2-s2.0-0026748870","1992-06-05","Cyclosporin A, FK-506, and rapamycin: Pharmacologic probes of lymphocyte signal transduction"
"0034650405","10623828","","2-s2.0-0034650405","2000-01-15","Glucocorticoids inhibit calcium- and calcineurin-dependent activation of the human IL-4 promoter"
"0023904221","3048485","","2-s2.0-0023904221","1988-01-01","T cell depletion in bone marrow transplantation for leukemia: Current results and future directions"
"84915347167","","","2-s2.0-84915347167","1988-12-14",""
"0021953296","3857402","10.1016/0145-2126(85)90016-5","2-s2.0-0021953296","1985-01-01","A novel monoclonal antibody BI-3C5 recognises myeloblasts and non-B non-T lymphoblasts in acute leukaemias and CGL blast crises, and reacts with immature cells in normal bone marrow"
"0023912153","2458788","","2-s2.0-0023912153","1988-01-01","Colony stimulating factors"
"84915291960","","","2-s2.0-84915291960","1988-12-14",""
"84915285416","","","2-s2.0-84915285416","1988-12-14",""
"0023836654","2893812","","2-s2.0-0023836654","1988-01-01","Antigen CD34+ marrow cells engraft lethally irradiated baboons"
"84915284962","","","2-s2.0-84915284962","1988-12-14",""
"0004035441","","","2-s2.0-0004035441","1967-06-12",""
"84915350239","","","2-s2.0-84915350239","1988-07-12","ABMT with marrow purging in the treatment of poor prognosis paediatric haematological diseases"
"84915334761","","","2-s2.0-84915334761","1984-12-14",""
"0021250078","6586833","","2-s2.0-0021250078","1984-08-16","Antigenic analysis of hematopoiesis. III. A hematopoietic progenitor cell surface antigen defined by a monoclonal antibody raised against KG-1a cells"
"0023627715","2444831","","2-s2.0-0023627715","1987-12-01","Distribution and epitope analysis of the cell membrane glycoprotein (HPCA-1) associated with human hemopoietic progenitor cells"
"84959802900","13782235","10.1093/jnci/27.1.67","2-s2.0-84959802900","1961-01-01","Pathologic changes in irradiated monkeys treated with bone marrow"
"84915315248","","","2-s2.0-84915315248","0000-12-14",""
"0023581632","3332182","","2-s2.0-0023581632","1987-12-01","The role of T-cells in preventing relapse in chronic myelogenous leukemia"
"0022607616","3947749","","2-s2.0-0022607616","1986-01-01","Monoclonal antibody 12-8 recgonizes a 115-kd molecule present on both unipotent and multipotent hematopoietic colony-forming cells and their precursors"
"84908810404","","","2-s2.0-84908810404","1976-12-14",""
"84915349416","","","2-s2.0-84915349416","1980-12-14",""
"0018861412","6966303","10.1016/0022-1759(80)90003-4","2-s2.0-0018861412","1980-01-01","Isolation of human T and B lymphocytes by E-rosette gradient centrifugation. Characterization of the isolated subpopulations"
"0020533527","6833407","10.1002/jcp.1041150107","2-s2.0-0020533527","1983-01-01","Segregation of mouse hemopoietic progenitor cells using the monoclonal antibody, YBM/42"
"0022545424","3486683","","2-s2.0-0022545424","1986-01-01","Lymphocyte subsets in normal bone marrow"
"0019538227","7022905","","2-s2.0-0019538227","1981-03-01","Engraftment of allogeneic bone marrow."
"0141690986","","","2-s2.0-0141690986","1982-12-11","Abrogation of histocompatibility barriers to bone marrow transplantation in rhesus monkeys"
"84932363392","","","2-s2.0-84932363392","1984-07-01","Expression of I-subregion antigens onmurine hematopoietic stem cells"
"84932326248","","","2-s2.0-84932326248","1986-07-01","In vitro marrow"
"0021350379","6199141","","2-s2.0-0021350379","1984-03-15","Monoclonal antibody (WT 1) directed against a T cell surface glycoprotein: Characteristics and immunosuppressive activity"
"0017728119","330738","","2-s2.0-0017728119","1977-12-01","Two color immunofluorescence using a fluorescence activated cell sorter"
"0019726389","7025379","","2-s2.0-0019726389","1981-01-01","Two distinct types of late onset graft-versus-host disease after bone marrow transplantation in lethally irradiated mice"
"0019485957","7018623","","2-s2.0-0019485957","1981-01-01","Isolation of murine fetal hemopoietic progenitor cells and selective fractionation of various erythroid precursors"
"0023127284","3539225","","2-s2.0-0023127284","1987-03-30","Canine pluripotent hematopoietic stem cells and CFU-GM express Ia-like antigens as recognized by two different class II-specific monoclonal antibodies"
"0020628985","6678795","","2-s2.0-0020628985","1983-01-01","Characterization of murine hemopoietic cells using rat anti-mouse monoclonal antibodies"
"0017873833","416528","","2-s2.0-0017873833","1978-01-01","The Rhesus monkey as a preclinical model for bone marrow transplantation"
"26844556724","14144352","","2-s2.0-26844556724","1964-01-01","The selective elimination of immunologically competent cells from bone marrow and lymphatic cell mixtures: I. Effect of storage at 4 C"
"0018122702","101475","10.1080/09553007814550841","2-s2.0-0018122702","1978-01-01","Mortality of monkeys after exposure to fission neutrons and the effect of autologous bone marrow transplantation"
"0020057234","6947831","","2-s2.0-0020057234","1982-01-01","Expression of Ia-like and HLA-A,B antigens on human multipotential hematopoietic progenitor cells"
"0019394294","6262956","","2-s2.0-0019394294","1981-01-01","Lasting engraftment of histoincompatible bone marrow cells in dogs"
"84912728187","","","2-s2.0-84912728187","1984-07-01","Monoclonal antibodies specific for B cells and a subset of cytotoxic/suppressor T-cells in the rhesus monkey"
"0015334126","4630654","","2-s2.0-0015334126","1972-05-01","Recovery of haemopoiesis in lethally irradiated monkeys by frozen allogeneic bone marrow grafts."
"0021965950","","","2-s2.0-0021965950","1985-01-01","Facilitation of engraftment of DLA-nonidentical marrow by treatment of the recipient with monoclonal anti-Ia antibody"
"0022409159","3862599","","2-s2.0-0022409159","1985-12-01","Studies on the use of nonhuman primates to determine the DR status of the human hematopoietic stem cell"
"0018771463","35870","","2-s2.0-0018771463","1979-01-01","Antilymphocytic antibodies and marrow transplantation: VI. graft-versus-host tolerance in dla-incompatible dogs after in vitro treatment of bone marrow with absorbed antithymocyte globulin"
"0022472214","2424920","10.1002/jcp.1041280120","2-s2.0-0022472214","1986-01-01","A fractionation procedure of mouse bone marrow cells yielding exclusively pluripotent stem cells and committed progenitors"
"0019737280","6815814","","2-s2.0-0019737280","1981-12-01","A two-step procedure for obtaining 80-fold enriched suspensions of murine pluripotent hemopoietic stem cells"
"84932392842","","","2-s2.0-84932392842","1987-07-01","Light scatter and cell surface properties of murine megakaryocyte progenitor cells"
"12444325363","","","2-s2.0-12444325363","1985-06-14","A primate preclinical model for bone marrow transplantation: Definite proof for host radioresistant clonable T cells"
"0021989332","3884061","","2-s2.0-0021989332","1985-01-01","Failure of autologous marrow reconstitution after cytolytic treatment of marrow with anti-Ia monoclonal antibody"
"84915351319","","","2-s2.0-84915351319","1970-06-26","Avoidance of acute secondary disease by purification of hemopoietic stem cells with density gradient centrifugation"
"0002157923","","","2-s2.0-0002157923","1983-01-24","The analysis of the early and late response to cytotoxic insults in the haemopoietic cell hierarchy"
"1842403447","","","2-s2.0-1842403447","1994-07-22","CD8+depleted donor lymphocyte infusion as treatment for relapsed chronic myelogenous leukemia after allogeneic bone marrow transplantation : Graft vs leukemia without graft vs host disease"
"0029013447","7768306","","2-s2.0-0029013447","1995-01-01","Nontransformed colony-derived stromal cell lines from normal human marrows. I. Growth requirement and myelopoiesis supportive ability"
"0001602693","","","2-s2.0-0001602693","1994-07-13","Long-term culture of human myeloid cells"
"0028596359","7538345","","2-s2.0-0028596359","1994-12-01","Isolation and ex vivo expansion of CD34+ cells from cord blood using dextran sedimentation and avidin column selection"
"0027952824","8118037","","2-s2.0-0027952824","1994-01-01","A polymerase chain reaction study of the stability of Ig heavy-chain and T-cell receptor δ gene rearrangements between presentation and relapse of childhood B-lineage acute lymphoblastic leukemia"
"0028900261","7534711","","2-s2.0-0028900261","1995-01-01","Positive selection of CD34+ hematopoietic cells using an immunoaffinity column results in T cell-depletion equivalent to elutriation"
"0021192397","6387854","","2-s2.0-0021192397","1984-01-01","Destruction of the intestinal mucosa after bone marrow transplantation and graft-versus-host disease."
"0018777790","35001","10.1016/0002-9343(79)91171-9","2-s2.0-0018777790","1979-01-01","Chronic graft versus host disease: A syndrome of disordered immunity"
"84931911967","","","2-s2.0-84931911967","1983-06-30","Treatment of severe acute gvhd with high dose ATG"
"84909866129","","","2-s2.0-84909866129","1985-03-02","The effects of the intestinal microflora of selectively decontaminated patients on the severity of acute graft-versus-host disease of the gut. A comparative study on selective and total decontamination in patients undergoing allogeneic bone marrow transplantation"
"0021430698","6429272","","2-s2.0-0021430698","1984-05-01","Immunosuppression, graft-versus-host disease, and infection after bone marrow transplantation."
"0023204103","3307408","","2-s2.0-0023204103","1987-01-01","Marrow transplantation for malignant disease"
"0021822464","3888312","","2-s2.0-0021822464","1985-08-28","Cyclosporine as prophylaxis for graft-versus-host disease: A randomized study in patients undergoing marrow transplantation for acute nonlymphoblastic leukemia"
"0022627247","3511579","","2-s2.0-0022627247","1986-07-09","Cyclosporine as an alternative to cyclophosphamide in the treatment of chronic graft-versus-host disease"
"84933436703","","","2-s2.0-84933436703","0000-07-04",""
"0022499263","3090877","10.1016/0002-9343(86)90511-5","2-s2.0-0022499263","1986-07-28","Infection in bone marrow transplant recipients"
"0021705512","6329356","","2-s2.0-0021705512","1984-12-01","Cytomegalovirus infection following marrow transplantation: Risk, treatment and prevention"
"0023111148","3105049","10.3109/00365548709032383","2-s2.0-0023111148","1987-01-01","Strict protective isolation in allogeneic bone marrow transplantation: Effect on infectious complications, fever and graft versus host disease"
"0021807942","3887891","","2-s2.0-0021807942","1985-01-01","Oral manifestations of bone marrow transplantation"
"0021347882","6367162","","2-s2.0-0021347882","1984-01-01","High-dose methylprednisolone treatment for acute graft-versus-host disease after bone marrow transplantation in adults"
"0021141341","6424464","10.1016/0002-9343(84)90274-2","2-s2.0-0021141341","1984-01-01","Prophylaxis of infection in patients with aplastic anemia receiving allogeneic marrow transplants"
"0021417430","6204385","","2-s2.0-0021417430","1984-04-01","Infections in bone marrow transplant recipients"
"0021982342","3922290","","2-s2.0-0021982342","1985-01-01","Prevention of infection in neutropenic bone marrow transplant patients."
"0022621341","3516042","","2-s2.0-0022621341","1986-01-01","Infectious complications in adults with bone marrow transplantation and T-cell depletion of donor marrow. Increased susceptibility to fungal infections"
"0020839454","6357581","","2-s2.0-0020839454","1983-10-01","Infection in bone marrow transplantation"
"0019536575","6455791","","2-s2.0-0019536575","1981-03-01","Specific suppressor cells and immune response to host antigens in long-term human allogeneic marrow recipients: implications for the mechanisms of graft-host tolerance and chronic graft-versus-host disease."
"0002940028","","","2-s2.0-0002940028","1981-07-27","Infection complicating bone marrow transplantation"
"0023475340","2828758","10.1007/BF01717831","2-s2.0-0023475340","1987-10-01","Cytomegalovirus (CMV) infections in patients receiving CMV-IgG-hyperimmunoglobulin prophylaxis after bone-marrow transplantation"
"0022625578","3014454","","2-s2.0-0022625578","1986-01-01","Infectious complications in pediatric patients undergoing transplantation with t lymphocyte-depleted bone marrow"
"0020579140","6417027","10.1007/BF01641254","2-s2.0-0020579140","1983-09-01","Early infectious complications in allogeneic marrow transplant recipients with acute leukemia: Effects of prophylactic measures"
"0024213527","3065930","10.3109/00365548809035663","2-s2.0-0024213527","1988-01-01","Norfloxacin for prevention of bacterial infections during severe granulocytopenia after bone marrow transplantation"
"84907468497","","","2-s2.0-84907468497","1981-10-16","Prevention of acute graft versus host disease in clinical bone marrow transplantation: Complete versus selective intestinal decontamination"
"0023872446","3283035","10.1007/BF01646924","2-s2.0-0023872446","1988-01-01","Antimicrobial prophylaxis in neutropenic patients after bone marrow transplantation"
"0021933653","2981496","","2-s2.0-0021933653","1985-03-13","Molecular epidemiology of cytomegalovirus infections associated with bone marrow transplantation"
"0035282055","11230486","","2-s2.0-0035282055","2001-03-01","Results of the fludarabine and cyclophosphamide combination regimen in chronic lymphocytic leukemia"
"0029949679","8971469","","2-s2.0-0029949679","1996-12-16","Monoclonal antibody-based therapy"
"0035871441","11304768","","2-s2.0-0035871441","2001-04-15","Rituximab dose-escalation trial in chronic lymphocytic leukemia"
"0026722446","1509634","10.1007/BF00300258","2-s2.0-0026722446","1992-06-01","Composition of fluids obtained from human epididymal cysts"
"0021953066","3886668","","2-s2.0-0021953066","1985-01-01","Characterization of maturation-dependent extrinsic proteins of the rat sperm surface"
"0023915704","3365470","","2-s2.0-0023915704","1988-04-08","Epididymal maturation and the acrosome reaction in mouse sperm: Response to zona pellucida develops coincident with modification of M42 antigen"
"0025813107","1927970","10.1002/aja.1001910306","2-s2.0-0025813107","1991-01-01","Organization of tubules in the human caput epididymidis and the ultrastructure of their epithelia"
"0022611355","3487030","10.1016/0161-5890(86)90059-3","2-s2.0-0022611355","1986-01-01","Localisation of the monocyte-binding region on human immunoglobulin G"
"0027204803","8517920","","2-s2.0-0027204803","1993-12-01","Human IgG Fc receptor heterogeneity: Molecular aspects and clinical implications"
"0025909820","1709200","","2-s2.0-0025909820","1991-05-29","The human monocyte-like cell line THP-1 expresses FcγRI and FcγRII"
"0023262380","2958407","","2-s2.0-0023262380","1987-01-01","A receptor for monomeric IgG2b on rat macrophages"
"0026879392","1464034","","2-s2.0-0026879392","1992-06-01","Radiolabeled monoclonal antibodies as anti-tumor missiles, their diagnostic success and therapeutic potential"
"0027243278","8492766","10.1118/1.597052","2-s2.0-0027243278","1993-01-01","Radioimmunotherapy dose estimation in patients with b-cell lymphoma"
"0026071621","1676659","","2-s2.0-0026071621","1991-04-19","Potential error in the measurement of tissue to blood distribution coefficients in physiological pharmacokinetic modeling: Residual tissue blood. II. Distribution of phencyclidine in the rat"
"0344106526","","","2-s2.0-0344106526","1994-12-30","Human anti-human antibody response (HAHA) to injection of&lt;sup&gt;99m&lt;/sup&gt;Tc-, &lt;sup&gt;131&lt;/sup&gt;I-, &lt;sup&gt;186&lt;/sup&gt;Re-, &lt;sup&gt;111&lt;/sup&gt;In-, and&lt;sup&gt;90&lt;/sup&gt;Y-labeled human monoclonal antibody"
"0000863923","14371624","10.3181/00379727-88-21577","2-s2.0-0000863923","1955-01-01","Organ Plasma Volume of Normal Unanesthetized Mice"
"0026512163","1542299","10.1016/0161-5890(92)90103-5","2-s2.0-0026512163","1992-01-01","Recombinant mouse monoclonal antibodies with single amino acid substitutions affecting C1q and high affinity Fc receptor binding have identical serum half-lives in the BALB/c mouse"
"0028040317","8306244","10.1002/1097-0142(19940201)73:3+&lt;1023::AID-CNCR2820731341&gt;3.0.CO;2-U","2-s2.0-0028040317","1994-01-01","The biologic window for chimeric l6 radioimmunotherapy"
"0026050344","1833457","","2-s2.0-0026050344","1991-10-15","Human FcγRI and FcγRII interact with distinct but overlapping sites on human IgG"
"0025973011","1676658","","2-s2.0-0025973011","1991-04-19","Potential error in the measurement of tissue to blood distribution coefficients in physiological pharmacokinetic modeling: Residual tissue blood. I. Theoretical considerations"
"0027216004","8417368","10.1016/0161-5890(93)90432-B","2-s2.0-0027216004","1993-01-01","A single amino acid substitution abolishes the heterogeneity of chimeric mouse/human (IgG4) antibody"
"0027213573","8340761","","2-s2.0-0027213573","1993-08-01","Structural features of human immunoglobulin G that determine isotype-specific differences in complement activation"
"0028275340","7909805","","2-s2.0-0028275340","1994-04-29","Isotype choice for chimeric antibodies affects binding properties"
"0016713311","1194857","","2-s2.0-0016713311","1975-12-01","Binding of monomeric immunoglobulins to Fc receptors of mouse macrophages"
"0024439023","2698222","","2-s2.0-0024439023","1989-01-01","Polymorphisms of human immunoglobulins: Gm, Am, Em and Km allotypes"
"0030871850","9253108","","2-s2.0-0030871850","1997-08-07","Mechanisms of the graft-versus-leukemia reaction"
"0002965815","","","2-s2.0-0002965815","1904-07-13","The proof and measurement of association between two things"
"0019407926","6945311","","2-s2.0-0019407926","1981-01-01","Expression of myeloid differentiation antigens on normal and malignant myeloid cells"
"0022598358","3516711","10.1002/eji.1830160519","2-s2.0-0022598358","1986-01-01","Presentation of alloantigens by host cells"
"84930779611","","","2-s2.0-84930779611","1988-06-18","A new human leukocyte differentiation antigen which is restricted to lymphocytes and monocytes"
"0017684690","406986","","2-s2.0-0017684690","1977-01-01","Cytogenetic and Immunoglobulin Markers of Human Leukemic B-Cell Lines"
"0022553698","3516715","","2-s2.0-0022553698","1986-10-29","Transplantation of HLA-haploidentical T-cell-depleted marrow for leukemia: Autologous marrow recovery with specific immune sensitization to donor antigens"
"0024537326","2523164","","2-s2.0-0024537326","1989-01-01","Depletion of accessory cells strongly reduces immunogenicity of T-depleted bone marrow, and thus may facilitate its engraftment"
"0020702303","6600256","","2-s2.0-0020702303","1983-01-01","The synthesis and secretion of granulocyte-monocyte colony-stimulating activity (CSA) by isolated human monocytes: Kinetics of the response to bacterial endotoxin"
"0023609786","3315725","","2-s2.0-0023609786","1987-12-01","Enhanced reconstitution of hematopoietic organs in irradiated mice, following their transplantation with bone marrow cells pretreated with recombinant interleukin 3"
"0021185101","6388063","","2-s2.0-0021185101","1984-01-01","The effect of donor pretreatment on interstitial dendritic cell content and rat cardiac allograft survival"
"0023905962","3281007","","2-s2.0-0023905962","1988-01-01","Effect of recombinant human granulocyte-macrophage colony-stimulating factor on hematopoietic reconstitution after high-dose chemotherapy and autologous bone marrow transplantation"
"0020614131","6190976","","2-s2.0-0020614131","1983-09-08","Relative efficacy of human monocytes and dendritic cells as accessory cells for T cell replication"
"0023740631","3042050","","2-s2.0-0023740631","1988-01-01","Use of recombinant human granulocyte-macrophage colony-stimulating factor in autologous marrow transplantation for lymphoid malignancies"
"0019955016","6215197","","2-s2.0-0019955016","1982-01-01","Human dendritic cells: Major stimulators of the autologous and allogeneic mixed leucocyte reactions"
"0023851443","2447983","","2-s2.0-0023851443","1988-01-01","Interleukin 1 induces human marrow stromal cells in long-term culture to produce granulocyte colony-stimulating factor and macrophage colony-stimulating factor"
"0022640933","3082974","","2-s2.0-0022640933","1986-01-01","T cell-monocyte interactions in the production of humoral factors regulating human granulopoiesis in vitro"
"0023134026","3493286","","2-s2.0-0023134026","1987-01-01","Interleukin 1 stimulates endothelial cells to release multilineage human colony-stimulating activity"
"0022972835","2945857","","2-s2.0-0022972835","1986-12-01","Capacity of B cells to function as stimulators of a primary mixed leukocyte reaction"
"0020073022","7033437","","2-s2.0-0020073022","1982-01-01","Restoration of immunogenicity to passenger cell-depleted kidney allografts by the addition of donor strain dendritic cells"
"0023870862","2962741","10.1016/0008-8749(88)90061-5","2-s2.0-0023870862","1988-01-01","Accessory cell requirements for the mixed-leukocyte reaction and polyclonal mitogens, as studied with a new technique for enriching blood dendritic cells"
"0021805959","3873688","10.1111/j.1365-3083.1985.tb01839.x","2-s2.0-0021805959","1985-01-01","Dendritic Cells and Monocytes as Accessory Cells in T‐Cell Responses in Man: II. Function as Antigen‐Presenting Cells"
"0023927861","3257446","","2-s2.0-0023927861","1988-01-01","Separation of rat bone marrow cells by counterflow centrifugal elutriation: a model for studying the effects of lymphocyte depletion"
"84914056664","","","2-s2.0-84914056664","1988-12-11","For Campath-1 users: T cell depletion with Campath-1 in allogeneic bone marrow transplantation"
"0022863163","3535927","","2-s2.0-0022863163","1986-12-01","Autologous bone marrow transplantation in acute myelogenous leukemia: In vitro treatment with myeloid cell-specific monoclonal antibodies"
"0023608127","3502337","","2-s2.0-0023608127","1987-12-01","Veiled accessory cells deduced from monocytes"
"0023629797","3111768","10.1016/0090-1229(87)90068-7","2-s2.0-0023629797","1987-01-01","Requirement for mitogen, T cell-accessory cell contact, and interleukin 1 in the induction of resting T-cell proliferation"
"0023813392","3042038","","2-s2.0-0023813392","1988-01-01","Cellular interactions"
"0023598358","3314017","","2-s2.0-0023598358","1987-12-01","Reduction of graft immunogenicity: A new perspective for preventing rejection of T-depleted grafts in a transplantation model"
"0023873318","3276361","","2-s2.0-0023873318","1988-01-01","Augmentation of donor bone marrow engraftment in histoincompatible murine recipients by granulocyte/macrophage colony-stimulating factor"
"0019519539","7009742","","2-s2.0-0019519539","1981-01-01","A monoclonal antibody that identifies human peripheral blood monocytes recognized the accessory cells required for mitogen-induced T lymphocyte proliferation"
"0021257136","6611506","10.1038/310231a0","2-s2.0-0021257136","1984-12-01","Successful transplantation across major histocompatibility barrier of deoxyguanosine-treated embryonic thymus expressing class II antigens"
"0022635416","3513396","","2-s2.0-0022635416","1986-01-01","Immune reactivity after high–dose irradiation"
"0021856376","3923613","10.1111/j.1365-3083.1985.tb01838.x","2-s2.0-0021856376","1985-01-01","Dendritic Cells and Monocytes as Accessory Cells in T‐Cell Responses in Man: I. Phenotypic Analysis of Dendritic Cells and Monocytes"
"0023951383","3281721","","2-s2.0-0023951383","1988-01-01","Functional dendritic cells are required for transfusion-induced sensitization in canine marrow graft recipients"
"0020031143","6460832","","2-s2.0-0020031143","1982-01-01","Human dendritic cells. Enrichment and characterization from peripheral blood"
"0026504705","1371817","10.1016/0140-6736(92)90795-5","2-s2.0-0026504705","1992-03-14","Effect of peripheral-blood progenitor cells mobilised by filgrastim (G-CSF) on platelet recovery after high-dose chemotherapy"
"0028316323","7517257","","2-s2.0-0028316323","1994-04-29","Peripheral blood stem cells for allogeneic transplantation"
"0028340717","7527648","","2-s2.0-0028340717","1994-01-01","G-CSF-mobilized peripheral blood progenitor cells for allogeneic transplantation: Safety, kinetics of mobilization, and composition of the graft"
"0026760405","1354619","","2-s2.0-0026760405","1992-01-01","Peripheral hematopoietic stem cell transplantation: Current concepts"
"0021857486","3892795","","2-s2.0-0021857486","1985-01-01","Death by graft–versus–host disease associated with HLA mismatch, high recipient age, low marrow cell dose, and splenectomy"
"0031665064","9723555","","2-s2.0-0031665064","1998-08-01","Humanized antibodies as potential therapeutic drugs"
"0006192027","","","2-s2.0-0006192027","1999-07-13","Drug development pipeline: CAMPATH-1H"
"4243676410","","","2-s2.0-4243676410","1998-09-27","Emergence of GPI-deficient lymphocytes following in vitro treatment with CAMPATH-1H monoclonal antibody"
"0034716486","10703815","","2-s2.0-0034716486","2000-02-26","Therapeutic monoclonal antibodies"
"0006201589","","","2-s2.0-0006201589","2000-07-13","Immune reconstitution following haematopoietic stem cell transplantation"
"0006246711","","","2-s2.0-0006246711","1999-07-13",""
"0006168770","","","2-s2.0-0006168770","1998-07-13","CAMPATH-1H exposes three mechanisms underlying the natural history of multiple sclerosis in the individual patient"
"0006231387","","","2-s2.0-0006231387","2004-07-13","CAMPATH-1H is an effective salvage therapy for fludarabine failing CLL patients. Results of a phase II trial"
"4243446281","","","2-s2.0-4243446281","1998-09-27","CAMPATH-1H monoclonal antibody in therapy for advanced low-grade non-Hodgkin's lymphomas: A phase II study"
"0032885624","10530422","","2-s2.0-0032885624","1999-10-18","BCR-negative chronic myeloid leukemia in relapse after bone marrow transplantation is susceptible to remission induction by donor lymphocyte infusions [7]"
"0006228213","","","2-s2.0-0006228213","1998-07-13","T-cell depletion and steam cell recovery using Campath monoclonal antibodies (MAbs) in G-CSF mobilised peripheral blood stem cells (PBSC): Comparison with marrow (BM)"
"0006216764","","","2-s2.0-0006216764","1994-07-13","Wellcome discontinues studies of Campath 1-H"
"0006257885","","","2-s2.0-0006257885","2000-07-13","ILEX Oncology announces third quarter results: Company continues to expand and advance its product pipeline"
"0006228209","","","2-s2.0-0006228209","1998-07-13","ILEX Oncology completes enrollment in CAMPATH-1H pivotal investigational clinical trial"
"0032431803","9747630","","2-s2.0-0032431803","1998-12-01","Chronic lymphocytic leukemia"
"0006252512","","","2-s2.0-0006252512","2000-07-13","Millennium &amp; ILEX Partners LP's Marketing Authorization Application for CAMPATH accepted for review in Europe"
"0006201580","","","2-s2.0-0006201580","2000-07-13","Millennium gains broad access to human antibody technology through collaboration with Abgenix - Major agreement underscores Millennium's leadership position in the development of antibody therapeutics"
"0006228222","","","2-s2.0-0006228222","1999-07-13","Viral reactivation and immune reconstitution following CAMPATH-1H- and fludarabine-based non-myeloablative conditioning for non-allogeneic stem cell transplantation compared to CAMPATH-based T-cell depletion regimens: A preliminary report"
"0004336831","","","2-s2.0-0004336831","2004-07-13","Human Antibodies and Hybridomas - Seventh International Conference Edinburgh, UK"
"0030941711","","","2-s2.0-0030941711","1997-05-06","BMT for children with β-thalassemia major in the UK"
"0033794143","11049025","","2-s2.0-0033794143","2000-01-01","Novel therapies for chronic lymphocytic leukemia in the 21st century"
"0006162362","","","2-s2.0-0006162362","2000-07-13","ILEX Oncology joint venture responds to FDA letter on CAMPATH"
"0006200577","","","2-s2.0-0006200577","2000-07-13","US Food and Drug Administration advisory committee recommends new treatment, CAMPATH, for patients with chronic lymphocytic leukemia"
"0006245489","","","2-s2.0-0006245489","1999-07-13","Biologics License Application filed for CAMPATH"
"0006158322","","","2-s2.0-0006158322","1999-07-13","Schering AG buy-in of $30 million may advance Campath development"
"0002850831","","","2-s2.0-0002850831","1998-07-13","Chronic lymphocytic leukemia"
"0006220942","","","2-s2.0-0006220942","2000-07-13","CAMPAITH-1H ""in the bag"" is an effective method of GVHD prevention in allogeneic stem cell transplantation"
"0030801514","9255628","10.1111/j.1600-065X.1997.tb00980.x","2-s2.0-0030801514","1997-08-02","Factors influencing the outcome of bone marrow transplants using unrelated donors"
"0000309309","","","2-s2.0-0000309309","1999-07-13","Therapy of chronic lymphocytic leukemia: It is time to move on to the next important question"
"0006252518","","","2-s2.0-0006252518","1999-07-13","Impact of donor leucocyte infusions on outcome after T cell depleted volunteer unrelated donor (VUD) bone marrow transplantation in patients with CML"
"0006159888","","","2-s2.0-0006159888","2000-07-13","Biologics license application for Campath accepted for filing by FDA"
"0006258675","","","2-s2.0-0006258675","1999-07-13","Multicenter study of CAMPATH-1H in patients with chronic lymphocytic leukemia (B-CLL) refractory to fludarabine"
"0006228224","","","2-s2.0-0006228224","2000-07-13","FDA completes initial review of Millennium &amp; ILEX Partners' BLA submission for Campath"
"0006198098","","","2-s2.0-0006198098","1997-07-13","ILEX Oncology and LeukoSite form joint venture to develop anti-leukemia compound"
"0025059547","","","2-s2.0-0025059547","1990-11-13","Clinical and experimental applications of Campath-1M: A review"
"0031755621","9827936","10.1046/j.1365-2141.1998.01007.x","2-s2.0-0031755621","1998-11-26","Successful adoptive immunotherapy for relapse of AML 9 years after T- cell-depleted BMT"
"7844222081","9827933","10.1046/j.1365-2141.1998.00972.x","2-s2.0-7844222081","1998-11-26","Prevention of EBV-induced B-lymphoproliferative disorder by ex vivo marrow B-cell depletion in HLA-phenoidentical or non-identical T-depleted bone marrow transplantation"
"0006207552","","","2-s2.0-0006207552","2000-07-13","Millennium &amp; ILEX partners to present CAMPATH at December ODAC meeting"
"4243627479","","","2-s2.0-4243627479","1998-09-27","Thyroid dysfunction following anti-lymphocyte monoclonal antibody treatment of multiple sclerosis scintigraphic assessment"
"0006228217","","","2-s2.0-0006228217","1988-07-13","Newer treatments for non-Hodgkin's lymphoma: Monoclonal antibodies"
"0034654139","10706855","","2-s2.0-0034654139","2000-03-15","Impact of bone marrow transplantation for symptomatic sickle cell disease: An interim report"
"0006162372","","","2-s2.0-0006162372","2000-07-13","Chimerism mediated immunotherapy using CAMPATH T cell depleted peripheral blood progenitor cells (PBPC) with nonablative therapy provides reliable, durable allogeneic engraftment"
"0006157334","","","2-s2.0-0006157334","2000-07-13","In brief - ILEX/Millennium Campath"
"0033784505","11055505","10.1097/00062752-200011000-00003","2-s2.0-0033784505","2000-10-30","Conditioning regimens for allogeneic stem cell transplants"
"0031869642","9685177","","2-s2.0-0031869642","1998-07-24","Chronic lymphocytic leukemia in the next decade: Where do we go from here?"
"0006248890","","","2-s2.0-0006248890","2004-07-13","International Society for Hematotherapy and Graft Engineering (ISHAGE) Sixth Annual Meeting San Diego, CA, USA"
"0006229609","","","2-s2.0-0006229609","1997-07-13","Drug development pipeline: LDP-02, LDP-01, CAMPATH-1H, MCP-1 inhibitors, LeukoSite/Warner-Lambert, interleukin-8 inhibitors, LeukoSite/Warner Lambert, CCR5 antagonists, LeukoSite, CXCR3/CCR1 antagonists, LeukoSite, CCR-3 antagonists, LeukoSite, beta-7 intergin receptor antagonists, LeukoSite"
"0006167893","","","2-s2.0-0006167893","2004-07-13","CAMPATH-1H with fludarabine: A novel, highly active combination in refractory CLL"
"0003241090","","","2-s2.0-0003241090","2000-07-13","High incidence of early and late CMV infection and delayed immune reconstitution after allogeneic transplants with nonmyeloablative conditioning using CAMPATH (anti-CD52 antibody)"
"0006210482","","","2-s2.0-0006210482","1999-07-13",""
"0006168262","","","2-s2.0-0006168262","1999-07-13","Monoclonal antibody appears effective in patients with advanced B-cell chronic lymphocytic leukemia"
"0006163045","","","2-s2.0-0006163045","1999-07-13","Preliminary results of a non-myeloabalative conditioning regimen for allogenic stem cell transplantation"
"0031739127","9817536","","2-s2.0-0031739127","1998-11-07","Multiple sclerosis: Use of MRI in evaluating new therapies"
"0006212331","","","2-s2.0-0006212331","1998-07-13","ILEX Oncology announces third quarter results. Company remains on schedule with development of lead compound, CAMPATH"
"0032439104","","","2-s2.0-0032439104","1998-12-01","Hematologic malignancies"
"4244040042","","","2-s2.0-4244040042","1998-09-27","Survival of patients after lymphocytotoxic monoclonal antibody therapy for RA"
"0006248891","","","2-s2.0-0006248891","1999-07-13","Ilex Oncology and Millennium submit Biologics License Application (BLA) for Campath. BLa eligible for six-month priority review"
"0006213685","","","2-s2.0-0006213685","2000-07-13","US Food and Drug Administration advisory committee recommends new treatment, CAMPATH, for patients with chronic lymphocytic leukemia"
"0006220939","","","2-s2.0-0006220939","2000-07-13","Millennium. Company overview"
"0006191766","","","2-s2.0-0006191766","1999-07-13","Prope (almost) tolerance using Campath-1H induction and low-dose cyclosporin monotherapy in 31 cadaveric renal allograft recipients, a follow-up of 7 to 21 months"
"0006248892","","","2-s2.0-0006248892","2000-07-13","ILEX Oncology announces second quarter results"
"18744433056","9830798","","2-s2.0-18744433056","1998-10-01","Allogeneic hemopoietic stem cell transplantation for patients with high risk acute lymphoblastic leukemia: Favorable impact of chronic graft-versus- host disease on survival and relapse"
"0006167888","","","2-s2.0-0006167888","1999-07-13","ILEX Oncology and Millennium submit Biologics License Application (BLA) for CAMPATH"
"0006169296","","","2-s2.0-0006169296","1898-07-13","Adoptive immunotherapy for chronic myelogenous leukemia patients relapsing after allogenic bone marrow transplantation using T-cell depletion with CAMPATH 1G"
"0006170362","","","2-s2.0-0006170362","1999-07-13","Biological and molecular characterization of lymphocytes in a refractory CLL responding to CAMPATH-1H treatment"
"4243708884","","","2-s2.0-4243708884","1998-09-27","Campath 1H in 5 T4-prolymphocytic leukemia (T-PLL)"
"0027470869","8416681","","2-s2.0-0027470869","1993-01-18","New approaches to the therapy of autoimmune diseases: Rheumatoid arthritis as a paradigm"
"0032841108","10472018","","2-s2.0-0032841108","1999-07-01","Multiple sclerosis and its treatment"
"0026353797","1742487","","2-s2.0-0026353797","1991-12-01","All advanced stage non-Hodgkin's lymphomas with a polymerase chain reaction amplifiable breakpoint of bcl-2 have residual cells containing the bcl-2 rearrangement at evaluation and after treatment"
"0025895866","2070059","","2-s2.0-0025895866","1991-07-01","Treatment of hemophagocytic lymphohistiocytosis with chemotherapy and bone marrow transplantation: A single-center study of 22 cases"
"0029879812","8637226","","2-s2.0-0029879812","1996-02-01","Hemophagocytic lymphohistiocytosis. Report of 122 children from the International Registry"
"0028892197","8555091","10.1111/j.1365-2141.1995.tb05384.x","2-s2.0-0028892197","1995-01-01","Accessory cells do not contribute to G‐CSF or IL‐6 production nor to rapid haematological recovery following peripheral blood stem cell transplantation"
"0027445493","8251408","10.1111/j.1365-2141.1993.tb08642.x","2-s2.0-0027445493","1993-01-01","Partial engraftment of donor bone marrow cells associated with long‐term remission of haemophagocytic lymphohistiocytosis"
"0020578818","6354720","10.1007/BF00443367","2-s2.0-0020578818","1983-09-01","Familial hemophagocytic lymphohistiocytosis"
"0021961425","3896344","","2-s2.0-0021961425","1985-11-28","Autologous bone marrow transplantation for patients with acute lymphoblastic leukemia in second or subsequent remission: Results of bone marrow treated with monoclonal antibodies BA-1, BA-2, and BA-3 plus complement"
"0019773818","7028250","","2-s2.0-0019773818","1981-11-01","Analysis of the clinical and biological significance of lymphoid phenotypes in acute leukemia"
"0026087983","1984796","","2-s2.0-0026087983","1991-01-01","Observations on the effect of chimeric anti-CD4 monoclonal antibody in patients with mycosis fungoides"
